WO2006104141A1 - 3-propenylcephem derivative - Google Patents
3-propenylcephem derivative Download PDFInfo
- Publication number
- WO2006104141A1 WO2006104141A1 PCT/JP2006/306280 JP2006306280W WO2006104141A1 WO 2006104141 A1 WO2006104141 A1 WO 2006104141A1 JP 2006306280 W JP2006306280 W JP 2006306280W WO 2006104141 A1 WO2006104141 A1 WO 2006104141A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- mmol
- group
- optionally substituted
- single bond
- Prior art date
Links
- NLFPTTDGICBEOK-SECBINFHSA-N (6R)-3-prop-1-enyl-5-thia-1-azabicyclo[4.2.0]oct-2-en-8-one Chemical class CC=CC1=CN2[C@@H](CC2=O)SC1 NLFPTTDGICBEOK-SECBINFHSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 634
- 239000000203 mixture Substances 0.000 claims abstract description 218
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 75
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 62
- 239000001257 hydrogen Substances 0.000 claims abstract description 53
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 36
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 30
- 230000002378 acidificating effect Effects 0.000 claims abstract description 24
- 125000001424 substituent group Chemical group 0.000 claims abstract description 24
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 19
- 125000004450 alkenylene group Chemical group 0.000 claims abstract description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 125000002837 carbocyclic group Chemical group 0.000 claims abstract description 14
- 125000002252 acyl group Chemical group 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims description 190
- 239000013078 crystal Substances 0.000 claims description 125
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 114
- 150000003839 salts Chemical class 0.000 claims description 90
- 239000012453 solvate Substances 0.000 claims description 69
- 125000000217 alkyl group Chemical group 0.000 claims description 68
- 239000002904 solvent Substances 0.000 claims description 44
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 34
- 125000001072 heteroaryl group Chemical group 0.000 claims description 26
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 26
- 125000003118 aryl group Chemical group 0.000 claims description 21
- 229910052736 halogen Chemical group 0.000 claims description 19
- 150000002367 halogens Chemical group 0.000 claims description 18
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- 125000003342 alkenyl group Chemical group 0.000 claims description 14
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 14
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 13
- 150000002431 hydrogen Chemical class 0.000 claims description 11
- 125000003107 substituted aryl group Chemical group 0.000 claims description 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 10
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- 125000004429 atom Chemical group 0.000 claims description 8
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 6
- 125000002619 bicyclic group Chemical group 0.000 claims description 5
- 150000001768 cations Chemical class 0.000 claims description 5
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 claims description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 4
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 4
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 2
- 229960001948 caffeine Drugs 0.000 claims description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 2
- 125000006413 ring segment Chemical group 0.000 claims description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 150000003952 β-lactams Chemical class 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 333
- 238000005160 1H NMR spectroscopy Methods 0.000 description 323
- 239000011734 sodium Substances 0.000 description 293
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 291
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 287
- 239000000243 solution Substances 0.000 description 269
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 250
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 244
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 228
- 239000000843 powder Substances 0.000 description 179
- 239000002244 precipitate Substances 0.000 description 144
- -1 cephem compound Chemical class 0.000 description 129
- 238000001914 filtration Methods 0.000 description 126
- 238000000921 elemental analysis Methods 0.000 description 116
- 238000003756 stirring Methods 0.000 description 115
- 238000006243 chemical reaction Methods 0.000 description 99
- 238000001816 cooling Methods 0.000 description 99
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 98
- 235000019439 ethyl acetate Nutrition 0.000 description 96
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 86
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 78
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 71
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 69
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 67
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 66
- 239000012044 organic layer Substances 0.000 description 63
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 62
- 239000012267 brine Substances 0.000 description 61
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 58
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 52
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 52
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 38
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 36
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 35
- 238000010898 silica gel chromatography Methods 0.000 description 35
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 35
- 235000017557 sodium bicarbonate Nutrition 0.000 description 31
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 31
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 28
- 238000005481 NMR spectroscopy Methods 0.000 description 27
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 27
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 25
- 239000011541 reaction mixture Substances 0.000 description 23
- 101150041968 CDC13 gene Proteins 0.000 description 22
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 20
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 20
- 229940126086 compound 21 Drugs 0.000 description 20
- 235000019341 magnesium sulphate Nutrition 0.000 description 20
- 229920006395 saturated elastomer Polymers 0.000 description 20
- 238000004440 column chromatography Methods 0.000 description 19
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 18
- 229940125844 compound 46 Drugs 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 18
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 17
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 16
- 239000000725 suspension Substances 0.000 description 16
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 15
- 239000010410 layer Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 238000000967 suction filtration Methods 0.000 description 14
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 12
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 11
- 159000000000 sodium salts Chemical class 0.000 description 11
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
- 229940125898 compound 5 Drugs 0.000 description 10
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 10
- 229960004592 isopropanol Drugs 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- 229910000104 sodium hydride Inorganic materials 0.000 description 10
- 229910052938 sodium sulfate Inorganic materials 0.000 description 10
- 235000011152 sodium sulphate Nutrition 0.000 description 10
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 9
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 9
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 9
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 9
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 8
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 8
- ITLHXEGAYQFOHJ-UHFFFAOYSA-N [diazo(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(=[N+]=[N-])C1=CC=CC=C1 ITLHXEGAYQFOHJ-UHFFFAOYSA-N 0.000 description 8
- 125000003277 amino group Chemical group 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 229940125904 compound 1 Drugs 0.000 description 8
- 229940126543 compound 14 Drugs 0.000 description 8
- 229940125782 compound 2 Drugs 0.000 description 8
- 229940126214 compound 3 Drugs 0.000 description 8
- 229940126540 compound 41 Drugs 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 125000002541 furyl group Chemical group 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 8
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 description 8
- 238000000634 powder X-ray diffraction Methods 0.000 description 8
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 8
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 7
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 7
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 7
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 7
- 241000606768 Haemophilus influenzae Species 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 229940125773 compound 10 Drugs 0.000 description 7
- 229940125797 compound 12 Drugs 0.000 description 7
- 229940125851 compound 27 Drugs 0.000 description 7
- 229940125878 compound 36 Drugs 0.000 description 7
- 229940127113 compound 57 Drugs 0.000 description 7
- 239000012141 concentrate Substances 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 229940047650 haemophilus influenzae Drugs 0.000 description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 7
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 7
- 239000012299 nitrogen atmosphere Substances 0.000 description 7
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 7
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 6
- FNHHVPPSBFQMEL-KQHDFZBMSA-N (3S)-5-N-[(1S,5R)-3-hydroxy-6-bicyclo[3.1.0]hexanyl]-7-N,3-dimethyl-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide Chemical compound CNC(=O)c1cc(cc2c1OC[C@@]2(C)c1ccccc1)C(=O)NC1[C@H]2CC(O)C[C@@H]12 FNHHVPPSBFQMEL-KQHDFZBMSA-N 0.000 description 6
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 6
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 6
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 6
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 6
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 6
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 6
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 6
- 235000019270 ammonium chloride Nutrition 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 6
- 229940125846 compound 25 Drugs 0.000 description 6
- 229940127204 compound 29 Drugs 0.000 description 6
- 229940125877 compound 31 Drugs 0.000 description 6
- 229940125900 compound 59 Drugs 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 125000002950 monocyclic group Chemical group 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- 125000000335 thiazolyl group Chemical group 0.000 description 6
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 5
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 5
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 5
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 5
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 5
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 5
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 5
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 5
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 description 5
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 5
- WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 description 5
- MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 description 5
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 description 5
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 5
- HCCNBKFJYUWLEX-UHFFFAOYSA-N 7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one Chemical compound O=C1N(CCOCCC)C2=CC(C=3C=NC(OC)=CC=3)=NC=C2N=C1NCC1=CN=CC=N1 HCCNBKFJYUWLEX-UHFFFAOYSA-N 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 5
- 229940127007 Compound 39 Drugs 0.000 description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 5
- 229940125936 compound 42 Drugs 0.000 description 5
- 229940127271 compound 49 Drugs 0.000 description 5
- 229940126545 compound 53 Drugs 0.000 description 5
- 229940126179 compound 72 Drugs 0.000 description 5
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 5
- 125000001786 isothiazolyl group Chemical group 0.000 description 5
- 125000000842 isoxazolyl group Chemical group 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 150000002923 oximes Chemical class 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 4
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 4
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 4
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 description 4
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 4
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 4
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 4
- GSDQYSSLIKJJOG-UHFFFAOYSA-N 4-chloro-2-(3-chloroanilino)benzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1NC1=CC=CC(Cl)=C1 GSDQYSSLIKJJOG-UHFFFAOYSA-N 0.000 description 4
- DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 4
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 4
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 description 4
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 4
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 4
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229940126657 Compound 17 Drugs 0.000 description 4
- 229940126639 Compound 33 Drugs 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 4
- LIMFPAAAIVQRRD-BCGVJQADSA-N N-[2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl]-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]-5-propan-2-ylisoquinolin-3-amine Chemical compound F[C@H]1CN(CC[C@H]1OC)C1=NC=CC(=N1)NC=1N=CC2=C(C=CC(=C2C=1)C(C)C)N1[C@@H]([C@H](C1)CS(=O)(=O)C)C LIMFPAAAIVQRRD-BCGVJQADSA-N 0.000 description 4
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 4
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 4
- 239000004305 biphenyl Substances 0.000 description 4
- 235000010290 biphenyl Nutrition 0.000 description 4
- VQFAIAKCILWQPZ-UHFFFAOYSA-N bromoacetone Chemical compound CC(=O)CBr VQFAIAKCILWQPZ-UHFFFAOYSA-N 0.000 description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 4
- 229940126142 compound 16 Drugs 0.000 description 4
- 229940125810 compound 20 Drugs 0.000 description 4
- 229940125833 compound 23 Drugs 0.000 description 4
- 229940125961 compound 24 Drugs 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 4
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000002198 insoluble material Substances 0.000 description 4
- 125000005956 isoquinolyl group Chemical group 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- YRMHIELITJAHGD-UHFFFAOYSA-K nitromethane;trichloroalumane Chemical compound [Al+3].[Cl-].[Cl-].[Cl-].C[N+]([O-])=O YRMHIELITJAHGD-UHFFFAOYSA-K 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 125000004430 oxygen atom Chemical group O* 0.000 description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 125000005493 quinolyl group Chemical group 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000009518 sodium iodide Nutrition 0.000 description 4
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 4
- 125000004434 sulfur atom Chemical group 0.000 description 4
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 3
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 3
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 3
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 3
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 3
- MHSLDASSAFCCDO-UHFFFAOYSA-N 1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea Chemical compound CN1N=C(C(C)(C)C)C=C1NC(=O)NC(C=C1)=CC=C1OC1=CC=NC=C1 MHSLDASSAFCCDO-UHFFFAOYSA-N 0.000 description 3
- QTMAZYGAVHCKKX-UHFFFAOYSA-N 2-[(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)methoxy]propane-1,3-diol Chemical compound NC1=NC=NC2=C1C(Br)=CN2COC(CO)CO QTMAZYGAVHCKKX-UHFFFAOYSA-N 0.000 description 3
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 3
- MPZMVUQGXAOJIK-UHFFFAOYSA-N 4-bromopyridine;hydron;chloride Chemical compound Cl.BrC1=CC=NC=C1 MPZMVUQGXAOJIK-UHFFFAOYSA-N 0.000 description 3
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- BGGALFIXXQOTPY-NRFANRHFSA-N C1(=C(C2=C(C=C1)N(C(C#N)=C2)C[C@@H](N1CCN(CC1)S(=O)(=O)C)C)C)CN1CCC(CC1)NC1=NC(=NC2=C1C=C(S2)CC(F)(F)F)NC Chemical compound C1(=C(C2=C(C=C1)N(C(C#N)=C2)C[C@@H](N1CCN(CC1)S(=O)(=O)C)C)C)CN1CCC(CC1)NC1=NC(=NC2=C1C=C(S2)CC(F)(F)F)NC BGGALFIXXQOTPY-NRFANRHFSA-N 0.000 description 3
- UHNRLQRZRNKOKU-UHFFFAOYSA-N CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O Chemical compound CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O UHNRLQRZRNKOKU-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 3
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 3
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 3
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- QBYJBZPUGVGKQQ-SJJAEHHWSA-N aldrin Chemical compound C1[C@H]2C=C[C@@H]1[C@H]1[C@@](C3(Cl)Cl)(Cl)C(Cl)=C(Cl)[C@@]3(Cl)[C@H]12 QBYJBZPUGVGKQQ-SJJAEHHWSA-N 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 125000006267 biphenyl group Chemical group 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 235000011089 carbon dioxide Nutrition 0.000 description 3
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 3
- 229940125758 compound 15 Drugs 0.000 description 3
- 229940126208 compound 22 Drugs 0.000 description 3
- 229940125807 compound 37 Drugs 0.000 description 3
- 229940127573 compound 38 Drugs 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 125000002883 imidazolyl group Chemical group 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 description 3
- LPOIGVZLNWEGJG-UHFFFAOYSA-N n-benzyl-5-(4-methylpiperazin-1-yl)-2-nitroaniline Chemical compound C1CN(C)CCN1C1=CC=C([N+]([O-])=O)C(NCC=2C=CC=CC=2)=C1 LPOIGVZLNWEGJG-UHFFFAOYSA-N 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 125000002971 oxazolyl group Chemical group 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 2
- OIIOPWHTJZYKIL-PMACEKPBSA-N (5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one Chemical compound C1(=C(N=C(C2=C(C(C3=CC=CC(=C3Cl)C3=NC(OC)=C(N=C3)CNC[C@H]3NC(=O)CC3)=CC=C2)Cl)C=N1)OC)CNC[C@H]1NC(=O)CC1 OIIOPWHTJZYKIL-PMACEKPBSA-N 0.000 description 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 description 2
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-Bis(diphenylphosphino)propane Substances C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- PAYROHWFGZADBR-UHFFFAOYSA-N 2-[[4-amino-5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidin-2-yl]amino]propane-1,3-diol Chemical compound C1=C(I)C(OC)=CC(C(C)C)=C1OC1=CN=C(NC(CO)CO)N=C1N PAYROHWFGZADBR-UHFFFAOYSA-N 0.000 description 2
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 2
- GDSLUYKCPYECNN-UHFFFAOYSA-N 3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxy-N-[(4-fluorophenyl)methyl]benzamide Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C(=O)NCC2=CC=C(C=C2)F)C=CC=1 GDSLUYKCPYECNN-UHFFFAOYSA-N 0.000 description 2
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 2
- IJRKLHTZAIFUTB-UHFFFAOYSA-N 5-nitro-2-(2-phenylethylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCC1=CC=CC=C1 IJRKLHTZAIFUTB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- IYHHRZBKXXKDDY-UHFFFAOYSA-N BI-605906 Chemical compound N=1C=2SC(C(N)=O)=C(N)C=2C(C(F)(F)CC)=CC=1N1CCC(S(C)(=O)=O)CC1 IYHHRZBKXXKDDY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 description 2
- WMDCXLLLINDYAM-UHFFFAOYSA-N OP(OC1=CC=CC=C1)(OC1=CC=CC=C1)=O.Cl.Cl Chemical compound OP(OC1=CC=CC=C1)(OC1=CC=CC=C1)=O.Cl.Cl WMDCXLLLINDYAM-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001782 cephems Chemical class 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical group C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical group C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- VICYTAYPKBLQFB-UHFFFAOYSA-N ethyl 3-bromo-2-oxopropanoate Chemical compound CCOC(=O)C(=O)CBr VICYTAYPKBLQFB-UHFFFAOYSA-N 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- MKIJJIMOAABWGF-UHFFFAOYSA-N methyl 2-sulfanylacetate Chemical compound COC(=O)CS MKIJJIMOAABWGF-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 2
- 125000002098 pyridazinyl group Chemical group 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 2
- MBEGFNBBAVRKLK-UHFFFAOYSA-N sodium;iminomethylideneazanide Chemical compound [Na+].[NH-]C#N MBEGFNBBAVRKLK-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 125000001425 triazolyl group Chemical group 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- 125000004758 (C1-C4) alkoxyimino group Chemical group 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
- 125000001305 1,2,4-triazol-3-yl group Chemical group [H]N1N=C([*])N=C1[H] 0.000 description 1
- 125000001401 1,2,4-triazol-4-yl group Chemical group N=1N=C([H])N([*])C=1[H] 0.000 description 1
- 125000004509 1,3,4-oxadiazol-2-yl group Chemical group O1C(=NN=C1)* 0.000 description 1
- GIGRWGTZFONRKA-UHFFFAOYSA-N 1-(bromomethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CBr)C=C1 GIGRWGTZFONRKA-UHFFFAOYSA-N 0.000 description 1
- 125000004173 1-benzimidazolyl group Chemical group [H]C1=NC2=C([H])C([H])=C([H])C([H])=C2N1* 0.000 description 1
- 125000001088 1-naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- DODRSIDSXPMYQJ-UHFFFAOYSA-N 1h-benzimidazol-4-ol Chemical compound OC1=CC=CC2=C1N=CN2 DODRSIDSXPMYQJ-UHFFFAOYSA-N 0.000 description 1
- SDGHXWKVBZYHRR-UHFFFAOYSA-N 2-(1h-imidazol-2-ylsulfonyl)-1h-imidazole Chemical compound N=1C=CNC=1S(=O)(=O)C1=NC=CN1 SDGHXWKVBZYHRR-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- GRWKNBPOGBTZMN-UHFFFAOYSA-N 2-benzyl-3-phenylpropane-1,2-diamine Chemical compound C=1C=CC=CC=1CC(N)(CN)CC1=CC=CC=C1 GRWKNBPOGBTZMN-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- JSGQQGNVTXXNQN-UHFFFAOYSA-N 2-hexadecoxy-2-oxoacetic acid Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(O)=O JSGQQGNVTXXNQN-UHFFFAOYSA-N 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- 125000001216 2-naphthoyl group Chemical group C1=C(C=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- VZXOZSQDJJNBRC-UHFFFAOYSA-N 4-chlorobenzenethiol Chemical compound SC1=CC=C(Cl)C=C1 VZXOZSQDJJNBRC-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 1
- CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
- RBWNDBNSJFCLBZ-UHFFFAOYSA-N 7-methyl-5,6,7,8-tetrahydro-3h-[1]benzothiolo[2,3-d]pyrimidine-4-thione Chemical compound N1=CNC(=S)C2=C1SC1=C2CCC(C)C1 RBWNDBNSJFCLBZ-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- IRBAWVGZNJIROV-SFHVURJKSA-N 9-(2-cyclopropylethynyl)-2-[[(2s)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C2C3=CC=C(C#CC4CC4)C=C3CCN2C(=O)N=C1OC[C@@H]1COCCO1 IRBAWVGZNJIROV-SFHVURJKSA-N 0.000 description 1
- PIVQQUNOTICCSA-UHFFFAOYSA-N ANTU Chemical compound C1=CC=C2C(NC(=S)N)=CC=CC2=C1 PIVQQUNOTICCSA-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241001279686 Allium moly Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 229910016523 CuKa Inorganic materials 0.000 description 1
- ASMQGLCHMVWBQR-UHFFFAOYSA-N Diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(O)OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-N 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241001061127 Thione Species 0.000 description 1
- 229910010068 TiCl2 Inorganic materials 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- ZEEBGORNQSEQBE-UHFFFAOYSA-N [2-(3-phenylphenoxy)-6-(trifluoromethyl)pyridin-4-yl]methanamine Chemical compound C1(=CC(=CC=C1)OC1=NC(=CC(=C1)CN)C(F)(F)F)C1=CC=CC=C1 ZEEBGORNQSEQBE-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N acetaldehyde dimethyl acetal Natural products COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 1
- MNZMECMQTYGSOI-UHFFFAOYSA-N acetic acid;hydron;bromide Chemical compound Br.CC(O)=O MNZMECMQTYGSOI-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- TWJVNKMWXNTSAP-UHFFFAOYSA-N azanium;hydroxide;hydrochloride Chemical class [NH4+].O.[Cl-] TWJVNKMWXNTSAP-UHFFFAOYSA-N 0.000 description 1
- 125000000656 azaniumyl group Chemical group [H][N+]([H])([H])[*] 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000005569 butenylene group Chemical group 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 229910002090 carbon oxide Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 1
- 229960000479 ceftriaxone sodium Drugs 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- GGRHYQCXXYLUTL-UHFFFAOYSA-N chloromethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCl GGRHYQCXXYLUTL-UHFFFAOYSA-N 0.000 description 1
- QQVDYSUDFZZPSU-UHFFFAOYSA-M chloromethylidene(dimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)=CCl QQVDYSUDFZZPSU-UHFFFAOYSA-M 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 210000002858 crystal cell Anatomy 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000006640 cycloheptyl carbonyl group Chemical group 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000006639 cyclohexyl carbonyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000006638 cyclopentyl carbonyl group Chemical group 0.000 description 1
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000002470 cystinyl group Chemical group O=C([*])C(N([H])[H])([H])C([H])([H])SSC([H])([H])C([H])(C(O[H])=O)N([H])[H] 0.000 description 1
- RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- TXFOLHZMICYNRM-UHFFFAOYSA-N dichlorophosphoryloxybenzene Chemical compound ClP(Cl)(=O)OC1=CC=CC=C1 TXFOLHZMICYNRM-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- FDRNWTJTHBSPMW-GNXCPKRQSA-L disodium;(6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound [Na+].[Na+].S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)/C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C([O-])=NN1C FDRNWTJTHBSPMW-GNXCPKRQSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- ZCRZCMUDOWDGOB-UHFFFAOYSA-N ethanesulfonimidic acid Chemical compound CCS(N)(=O)=O ZCRZCMUDOWDGOB-UHFFFAOYSA-N 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 1
- MSMGXWFHBSCQFB-UHFFFAOYSA-N ethyl cyanoformate Chemical compound CCOC(=O)C#N MSMGXWFHBSCQFB-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 229950003188 isovaleryl diethylamide Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 125000003099 maleoyl group Chemical group C(\C=C/C(=O)*)(=O)* 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- IHCHOVVAJBADAH-UHFFFAOYSA-N n-[2-hydroxy-4-(1h-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2h-chromene-3-carboxamide Chemical compound C1C2=CC(OC)=CC=C2OCC1C(=O)NC(C(=C1)O)=CC=C1C=1C=NNC=1 IHCHOVVAJBADAH-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000007344 nucleophilic reaction Methods 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Chemical group C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- RPGWZZNNEUHDAQ-UHFFFAOYSA-N phenylphosphine Chemical compound PC1=CC=CC=C1 RPGWZZNNEUHDAQ-UHFFFAOYSA-N 0.000 description 1
- NJFLMBDOPGVWLJ-UHFFFAOYSA-N phosphoric acid dihydrochloride Chemical compound Cl.Cl.OP(O)(O)=O NJFLMBDOPGVWLJ-UHFFFAOYSA-N 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 125000004585 polycyclic heterocycle group Chemical group 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000006410 propenylene group Chemical group 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 1
- ZZYXNRREDYWPLN-UHFFFAOYSA-N pyridine-2,3-diamine Chemical compound NC1=CC=CN=C1N ZZYXNRREDYWPLN-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- FHJLLATVVNUIAQ-UHFFFAOYSA-M sodium;ethyl acetate;hydrogen carbonate;hydrate Chemical compound O.[Na+].OC([O-])=O.CCOC(C)=O FHJLLATVVNUIAQ-UHFFFAOYSA-M 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical group CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 1
- WPCQASPMIALUEE-UHFFFAOYSA-N tert-butyl n-sulfamoylcarbamate Chemical compound CC(C)(C)OC(=O)NS(N)(=O)=O WPCQASPMIALUEE-UHFFFAOYSA-N 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- KAKQVSNHTBLJCH-UHFFFAOYSA-N trifluoromethanesulfonimidic acid Chemical compound NS(=O)(=O)C(F)(F)F KAKQVSNHTBLJCH-UHFFFAOYSA-N 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 125000002114 valyl group Chemical group 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Definitions
- the present invention relates to a broad-spectrum compound exhibiting a broad antibacterial spectrum against various pathogenic bacteria and a pharmaceutical composition containing the same.
- Patent document 1 discloses the following compounds.
- Patent Document 2 discloses the following compounds.
- R1-R3 Lower alkyl
- R4 Re, R, 5-membered heterocyclic lower alkyl having substituent
- Patent Document 3 discloses the following compounds.
- Patent Document 4 discloses the following compounds.
- R1 amino group or acylamino group
- R2, R3 lower alkyl
- R4 strong rumoyl lower alkyl group
- Patent document 5 discloses the following compounds.
- R3 acetyl group, having an appropriate substituent, may be, an amino group, an optionally substituted rubamoyl group, ureido, having an appropriate substituent Good heterocyclic group etc.
- Patent document 7 discloses the following compounds.
- R3 hydrogen, lower alkyl, (protected) carboxy
- R4 hydrogen, lower alkyl A: Methylene, propenylene
- Patent document 8 discloses the following compounds.
- A Quaternary nitrogen atom and the like.
- R2, R3 and R4 together with the N atom contain an additional 5- or 6-membered aromatic heteroatom selected from oxygen, sulfur and nitrogen. (Represents a heterocycle that is condensed in some cases)
- Cefmium compounds having a CONHCN group at the end of the 3-position side chain are known in the art. It is a len type (see: Patent Document 9).
- Het contains one or more of the same or different atoms selected from N, 0 and S, monocyclic or polycyclic heterocycles;
- R1 is hydrogen, optionally substituted lower alkyl, or Substituted, ret or alk represents lower alkenyl, A is substituted, ret, may ele, lower alkylene, substituted les, pos, lower alkenylene or single bond;
- B is substituted Represents an imino or single bond, D is a single bond or
- ceftriaxone sodium (trade name: Rocephine) is known as a continuous injection cefme for once or twice daily administration.
- Patent Document 1 JP-A 59-172493
- Patent Document 2 JP-A 62-195386
- Patent Document 3 JP-A-1-156984
- Patent Document 4 JP-A-5-339274
- Patent Document 5 JP-A-5-59065
- Patent Document 6 JP-A-7-41484
- Patent Document 7 JP-A-9-110877
- Patent Document 8 WO 99/67255
- Patent Document 9 WO 97/37996
- Acyl is an amino group that can be used in the field of ⁇ -ratata
- ⁇ is S, SO or O
- a group represented by is a heterocyclic group optionally having a thione N atom in the ring, which may be substituted with a substituent other than “one Y 1 —Ar 1 —Y 2 —R 1 ”;
- Y 1 and Y 2 are each independently 1) a single bond, 2) — NR 2 , —CO ⁇ , — NR 2 C ⁇ —, one CONR 2 —, one NR 2 CONR 3 —, one NR 2 S ⁇ One, one SO NR 2 —, one NR 2 S ⁇ NR 3-
- R 2 and R 3 are each independently hydrogen or lower alkyl
- N-, _N , -O_, _S-, -SO-, and a heteroatom selected from the group consisting of 1 SO- Contains
- a group, or 3) a heteroatom-containing group of 2) may be interposed, lower alkylene or lower alkenylene;
- Ar 1 represents a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group
- Wavy line means cis, trans or a mixture thereof
- a heterocyclic group having a cationic N atom in the ring is a bicyclic heterocyclic group, Ar 1 is a single bond, and R 1 is —CONHCN or —C (OH) ⁇ NCN If either not name, "a Y 1 - Ar 1 - Y 2 - R 1" group represented by the have a bond to cephem 3-position side chain moiety in said bicyclic heterocyclic group Or a pharmaceutically acceptable salt or solvate thereof.
- X is N or CY (Y is hydrogen or halogen);
- R 1 is COOH or a biologically equivalent acidic group thereof, and the acidic group is CONHR 4 -SO H -SO NHR 5 (R 4 and R 5 are each independently an amino residue)
- COMe or a compound as described in the above (1), which is a 5- to 6-membered heterocyclic group which may be substituted and has NH_ and other heterocyclic atoms as a ring-constituting atom, its pharmaceutically acceptable Salts or solvates thereof.
- X is N or CY (Y is hydrogen or halogen);
- Y 1 and Y 2 are each independently 1) a single bond, 2) -CO-, _NR 2 C ⁇ _, one CONR 2 —, one NR 2 CONR 3 —, one NR 2 S ⁇ one, one SO NR 2 —, one NR 2 S ⁇ NR 3-
- a group, or 3) a heteroatom-containing group of 2) may be interposed, lower alkylene or lower alkenylene;
- Ar 1 represents a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group
- Wavy line means cis, trans or a mixture thereof
- Y 1 is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is —CONHCN or —C (OH) ⁇ NCN, according to (12) above Compound, its pharmaceutically acceptable salt or solvate thereof.
- X is N or CY (Y is hydrogen or halogen);
- Y 1 and Y 2 are each independently 1) a single bond, 2) -CO-, _NR 2 C ⁇ _, one CONR 2 —, one NR 2 CONR 3 —, one NR 2 S ⁇ one, one SO NR 2 —, one NR 2 S ⁇ NR 3-
- R 2 and R 3 are each independently hydrogen or lower alkyl), a heteroatom-containing group selected from the group consisting of _ ⁇ _, —S—, —S ⁇ _, and —S ⁇ —, or 3)
- a hetero atom-containing group may be present, lower alkylene or lower alkenylene;
- Ar 1 is a single bond, an optionally substituted carbocyclic group or an optionally substituted heterocyclic group ;
- Wavy line means cis, trans or a mixture thereof
- a pharmaceutical composition comprising the compound according to (1) to (23) above, any one of the above, a pharmaceutically acceptable salt thereof, or a solvate thereof.
- Ar 1 represents a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group
- Y 1 and Y 2 are a single bond and Ar 1 is pyrrolyl, pyrazolyl, or chenyl), a pharmaceutically acceptable salt thereof, or a solvate thereof.
- the ring represented by (Q) is a bicyclic pyridine ring optionally substituted with a substituent other than “one Y 1 —Ar 1 —Y 2 —R 1 ”; Y 1 and Y 2 are each independently 1) single bond, 2) — NR 2 —CO ⁇ , — NR 2 C ⁇ —CONR 2 NR 2 CONR 3 NR 2 S ⁇ 1, SO NR 2 NR 2 S ⁇ NR 3 —
- R 2 and R 3 are each independently hydrogen or lower alkyl
- a heteroatom-containing group selected from the group consisting of O—, —S—, —S 0 —, and —S 0 —, or 3 2
- a hetero atom-containing group may be present, lower alkylene or lower alkenylene;
- Ar 1 is a single bond, an optionally substituted carbocyclic group or an optionally substituted heterocyclic group ;
- Ar 1 and ⁇ 2 are a single bond;
- R 1 is —CONHCN or —C (OH) ⁇ NCN, the compound according to (28) above, a pharmaceutically acceptable salt thereof, or a solvate thereof .
- Y 1 is a single bond; Ar 1 is substituted, may, allyl or substituted, may be heteroaryl; R 1 is COOH, described in (12) above Or a pharmaceutically acceptable salt or solvate thereof.
- Y 1 is a single bond; Ar 1 is optionally substituted heteroaryl; Y 2 is a single bond; R 1 is a biologically equivalent acidic group of COOH, (12) Or a pharmaceutically acceptable salt or solvate thereof.
- Y 1 is a single bond; Ar 1 is a substituted, substituted, aryl, or substituted heteroaryl; R 1 is —COOH biologically equivalent
- ⁇ is a single bond
- Ar 1 is an optionally substituted heteroaryl
- Y 2 is a single bond
- This compound exhibits a strong antibacterial action against various bacteria.
- Preferred compounds are particularly effective against gram-positive bacteria such as staphylococci and pneumococci and gram-negative bacteria such as Escherichia coli, Pseudomonas aeruginosa and Haemophilus influenzae.
- AUC blood concentration-time curve bottom area
- Acyl means an asinole group that can be used in the field of ⁇ -ratata.
- the amino group at position 6 of a penicillin derivative that has been conventionally known is substituted with an amino group at the 6-position of the penicillin derivative.
- Substituting with the 7-position amino group in means a ruyl group.
- acyl groups include organic carboxylic acid-derived acyl groups such as formyl groups, alkylcarbonyl groups (alkanoyl groups), preferably (C1-C6) alkyl-carbonyl groups (eg, acetylenoles).
- asinole groups include amino-containing nitros, halogens (eg, fluorine, chlorine, bromine, etc.), hydroxynoles, oxo, rubamoyl, (C1-C4) alkyl (eg, methinole, ethyl, propyl, isopropyl, butyl, etc.), (C1-C4) substituted with alkoxy (eg, methoxy, ethoxy, propoxy, butoxy, etc.), optionally esterified carboxyl (eg, C16 alkoxycarbonyl such as methoxycarbonyl, ethoxycarbonyl, etc.), carboxyl or halogen, etc.
- (C1-C4) alkoxyimino eg, methoxyimino, ethoxyimino, carboxymethoxyimino, 1-carboxy 1-methylethoxyimino, fluoromethoxyimino, fluoroethoxyimino, etc.
- Said Acyl is preferably of the formula:
- X is N or CY (Y is hydrogen or halogen), preferably CY (Y is hydrogen or halogen), more preferably CH.
- the configuration is preferably a thin body.
- the lower alkyl group is a linear or branched alkyl group having preferably 1 to 6 carbon atoms and the like, such as methinole, ethyl, n-propyl, isopropinole, n-butyl, isobutyl, sec-butyl, tert —Butyl, n_pentyl, n_hexyl and the like.
- the lower alkenyl group is a straight chain or branched, preferably an alkenyl group having 2 to 6 carbon atoms, and examples thereof include aryl, propenyl, butyr, and pentul.
- Cycloalkyl is an alkyl group having 3 to 6 carbon atoms, etc. Examples include til, cyclopentyl, cyclohexyl and the like.
- the above substituted les may les, lower alkyls, substituted les, may les, lower alkenyls, optionally substituted cycloalkyls, optionally substituted aryls or substituted
- Suitable substituents for the heterocyclic group include a carboxyl group, a lower alkoxycarbonyl (eg, methoxycarbonyl, ethoxycarbonyl), a strong rubamoyl group, a lower alkylthio (eg, methylthio, ethylthio), a sulfamoyl group, an amino group, Examples include a hydroxyl group, a cyano group, a strong ruberamoyloxy group, a halogen (eg, F, C1), an optionally substituted heterocyclic group (preferably a 5- to 6-membered ring, eg: thiazolyl, chenyl), lower alkyl, etc.
- the Preferred is halogen (eg, F, C1)
- Heterocyclic group means “heterocycloalkyl” or “heteroaryl”. “Heterocycloalkyl” is a non-aromatic heterocyclic group having at least one nitrogen atom, oxygen atom and / or sulfur atom in the ring and having a bond at any substitutable position (preferably Is a 5- to 7-membered ring), for example, 1-pyrrolinyl, 2-pyrrolinyl, 3-pyrrolininole, 1-pyrrolidinyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 1-imidazolinyl, 2-imidazolininole, 4-imidazolinyl , 1-imidazolidinyl, 2-imidazolidinyl, 4-imidazolidininole, 1- virazolinyl, 3- virazolinyl, 4- virazolinyl, 1- virazolidinyl, 3-virazolidinyl, 4- virazolidinyl, piperidino, 2-piperidy
- Heteroaryl means monocyclic aromatic heterocyclic groups and fused aromatic heterocyclic groups.
- a monocyclic aromatic heterocyclic group may contain 1 to 4 oxygen atoms, sulfur atoms, and Z or nitrogen atoms in the ring, any substitutable atom derived from a 5 to 8 membered aromatic ring. It means a group that has a bond at the position.
- the fused aromatic heterocyclic group may contain 1 to 4 oxygen atoms, sulfur atoms, and Z or nitrogen atoms in the ring 5 to 8 membered aromatic ring force S,:! To 4 5 Bonded to any substitutable position fused to an 8-membered aromatic carbocycle or other 5- to 8-membered aromatic heterocycle. It means a group that has a joint and is a group.
- heteroaryl examples include furyl (eg, 2-furyl, 3-furyl), cheryl (eg, 2-chenyl, 3-phenyl), pyrrolyl (eg, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl), imidazolyl (eg, 1_imidazolyl, 2-imidazolyl, 4-imidazolyl), pyrazolyl (eg, 1-pyrazolyl, 3-pyrazolyl, 4_pyrazolyl), triazolyl (eg, 1, 2, 4 -Triazolol-1-yl, 1,2,4-triazol-3-yl, 1,2,4-triazol-4-yl), tetrazolyl (eg 1-tetrazolyl, 2-tetrazolyl, 5-tetrazolyl) ), Oxazolyl (eg 2-oxazolyl, 4-oxazolyl, 5-oxazolyl), isoxazolyl (eg 3-isoxazolyl), e
- T is S, S 0 or O, preferably S.
- the group represented by is a heterocyclic group having a force thionic N atom (N + ) in the ring, which may be substituted with a substituent other than “one Y 1 —Ar 1 —Y 2 —R 1 ”. It is.
- the heterocyclic group means the above-mentioned heterocyclic group containing at least one N atom, for example:! -4, and represents a monocyclic or condensed polycyclic group. means.
- the cationic N atom may be present at any position on the ring, it is preferably present at the position where the cenyl 3-position side chain is bonded to propenyl and is represented by the following formula. It is.
- the cation is preferably a counter ion of the 4-position carboxion.
- the heterocyclic group having a cationic N atom in the ring is preferably a pyridinium group or a bicyclic heterocyclic group having a cation.
- the bicyclic heterocyclic group having a cation is preferably a group represented by the following formula.
- each of A ring and B ring independently represents a saturated or unsaturated 5- to 7-membered ring which may be substituted, and includes 1 to 3 heteroatoms as ring-constituting atoms. It's okay.
- the bicyclic heterocyclic group is more preferably a bicyclic pyridine cyclic group in which either the ring A or B is a pyridine ring, and particularly preferably, the A ring is a pyridine ring, Ring B is a benzene ring, cyclopentene, cyclohexene, or the aforementioned 5- to 6-membered heterocyclic ring (eg, thiophene, pyrrole, imidazole, oxazole, thiazole).
- heterocyclic group having the cationic N atom represented by (Q) in the ring examples are shown below.
- Group C A heterocyclic group having a cationic N atom represented by (Q) in the ring is more preferable. Is selected from group c above.
- Substituents other than “one Y 1 —Ar 1 —Y 2 —R 1 ” are the same or different 1 to 4 and preferably 1 to 2 substituents selected from the following substituent group D: Exemplary force S, preferably lower alkyl. These substituents are preferably present on the ring (eg, ring A) bonded to the side chain moiety of the cepheme when the heterocyclic group is a condensed bicyclic group.
- the group represented by “one Y 1 —Ar 1 —Y 2 —R 1 ” may be present at any position of the heterocyclic group having a cationic N atom represented by (Q) in the ring, In the case of a bicyclic heterocyclic ring, it is preferably present on the ring that is not bonded to the propenyl moiety of the cefme 3-position side chain (eg, ring B above).
- Y 1 and Y 2 are each independently 1) single bond, 2) —NR 2 , —CO—, —NR 2 CO CONR 2 NR 2 CONR 3 NR 2 S ⁇ 1, SO NR 2 NR 2 S ⁇ NR 3 —
- R 2 and R 3 are each independently hydrogen or lower alkyl
- N—, _N , _O —, _S—, _SO _, and S1 Terror atom-containing groups
- Lower alkyl includes linear or branched C1-C6 alkyl, and examples thereof include methyl, ethyl, n-propyl, i-propyl, t-butyl, n-pentyl, and n-hexyl.
- Lower alkylene means a divalent group derived from lower alkyl, preferably one (CH 3) m
- Lower alkenylene means a straight or branched lower alkenylene group having 26 carbon atoms and having one or more double bonds in the lower alkylene, and examples thereof include vinylene, propenylene. Or butenylene is mentioned. Preferred is a straight chain lower alkenylene having 23 carbon atoms, and examples thereof include vinylene and propenylene.
- the term “intervening” in “optionally containing a heteroatom-containing group” means that the heteroatom-containing group is present between 1) a carbon atom constituting a lower alkylene or a lower alkenylene, or 2) a lower group.
- the heteroatom-containing group (M) may be the same or different and one or more groups. For example, when a hetero atom group is present in lower alkylene, -M -CH -CH -M-CH -CH- M CH- M- M- CH-
- Y 1 and Y 2 are each independently, preferably a single bond, NR 0—, —CONR 2 —, —NR 0 NR 3 — (R 2 and R 3 are each independently preferably hydrogen), NH Or it is a lower alkylene, More preferably, it is a single bond.
- Ar 1 is a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group. These may be either saturated or unsaturated.
- N atom-containing heterocyclic group represented by (Q) to which “one Y 1 —Ar 1 —Y 2 —R 1 ” is bonded is a monocyclic group (eg, pyridine) (eg, compound) (I a))
- Ar 1 is preferably a substituted, may, carbocyclic group or a substituted, may,, heterocyclic group. More preferred is an unsaturated ring.
- the N atom-containing heterocyclic group represented by (Q) to which “one Y 1 —Ar 1 —Y 2 —R 1 ” is bonded is a polycyclic group (eg, bicyclic group such as condensed pyridine) (Example: Compound (I_b)), Ar 1 is preferably a single bond.
- the saturated or unsaturated carbocyclic group in Ar 1 is preferably a 3- to 10-membered ring and is a C3 C7 cycloalkyl (eg, cyclopropyl, cyclobutyl, cyclopentyl, cycloto Xyl, cycloheptyl), C5-C7 cycloalkenyl (eg, cyclopentenyl, cyclohexenyl) and aryl (eg, phenyl, naphthyl).
- C3 C7 cycloalkyl eg, cyclopropyl, cyclobutyl, cyclopentyl, cycloto Xyl, cycloheptyl
- C5-C7 cycloalkenyl eg, cyclopentenyl, cyclohexenyl
- aryl eg, phenyl, naphthyl
- the saturated or unsaturated heterocyclic group in Ar 1 means the aforementioned heterocycloalkyl or heteroaryl, preferably heteroaryl. More preferably, it is a monocyclic aromatic heterocyclic group. Specifically, it contains an oxygen atom, a sulfur atom, and a Z or nitrogen atom in the ring:!
- To 4 5 to 8 member, preferably 5 to 6 member cyclic More preferred are furyl, phenyl, pyrrolyl, pyrazolyl, imidazolinole, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyridinole, pyridazinyl, pyrimidinole, pyrajur, triazolyl and the like.
- pyrazolyl imidazolyl, oxazolyl, isoxazolyl, thiazolyl and isothiazolyl.
- Ar 1 is thiazolyl
- 1 Y 2 —! ⁇ Is preferably bonded to the 2-position of the thiazole ring.
- the substituent in “optionally substituted” of Ar 1 is selected from the substituent group D, and is preferably OH, halogen, or lower alkyl (eg, methyl).
- R 1 is important for the compounds of the present invention to exhibit high water solubility and excellent pharmacokinetics (eg, AUC, half-life) in addition to strong antibacterial activity. For example, when the compound of the present invention is used as an injection, it can be easily dissolved in water as an alkali metal salt (eg, Na salt).
- an alkali metal salt eg, Na salt
- the biologically equivalent acidic group of “COOH” generally means a so-called bioisosteric group that one skilled in the art can substitute in the hope of bioequivalence instead of “COOH”.
- the chemical structure is relatively similar to “_COOH”, and it is expected to have the same tendency as “one COOH” in terms of physical properties such as acidity, water solubility, and Z or pharmacokinetics.
- a group having an acidic proton, wherein the acidic proton moiety may form a salt (eg, alkali metal salt (eg, Na salt)), for example, J. Med. em. 1992, 35, 1176-1183, J Med. Chem. 1993, 36, 2485-2493, J Med. Chem. 1992,
- R 4 and R 5 are each independently an amino residue (eg hydrogen, OH, lower
- Norequinole substituted sulfonyl (eg, lower alkylsulfonyl, aminosulfonyl, halogenated lower alkylsulfonyl), aryl or heteroaryl)), -PO H, - ⁇ H,
- R 1 represents a biologically equivalent acidic group of COOH
- the following structure is preferably exemplified as the 3-position pyridine side chain moiety.
- the moiety may be isomerized, and may form a salt within or between molecules.
- the present invention also provides the intermediate of the above-mentioned 3-position pyridine side chain.
- the wavy line is a force that means cis, trans or a mixture thereof, preferably trans.
- Compound (I) is basically composed of a 7-amino-3-propenyl-type cephem compound as a raw material. 1) Asinoleation reaction at the 7-position, 2) At least “1 ⁇ 1 — Ar 1 — It can be synthesized by appropriately combining the reaction of forming the 3-position side chain by nucleophilic reaction of the cyclic amine having the ⁇ 2 — R 1 ′′ group and 3) the desired deprotection reaction. Preferably, the cyclic amine is reacted at the 3-position of 7-acylamino-1-propenyl-type cefme and then deprotected if desired. Further, as exemplified in Example 68 and the like, the 7-position asylation reaction may be carried out after forming the 3-position side chain. Is shown by (Acyl_ l) The case will be described below as an example.
- the compound (II) can be synthesized according to the method described in JP-A-59-172493, JP-A-1-156984, JP-A-5-339274, JP-A-7-41484, W099 / 67255, and the like.
- Compound (III) in which R 1 is —C 4 NHCN or 1 C (OH) ⁇ NCN can be synthesized according to the method described in W097 / 37996.
- R 6 is a hydrogen or amino protecting group
- R 7 is a hydrogen or carboxy protecting group
- Y is a leaving group (eg, hydroxy, halogen (Cl, Br, I, etc.), force ruberamoyloxy, substitution force ruberamoyloxy, (Siloxy, methanesulfonyloxy, toluenesulfonyloxy, etc.))
- Compound (IV) is obtained by reacting compound (IV) with compound (III) or a salt thereof (eg, alkali metal salt).
- compound (III) or a salt thereof eg, alkali metal salt.
- R 6 is an amino protecting group
- R 7 is a carboxy protecting group.
- the amount of compound ( ⁇ ) to be used is generally about:! -10 mol, preferably about:!-2 monolayer, per 1 mol of compound (11).
- reaction solvent examples include ethers (eg, dioxane, tetrahydrofuran, jetyl). Ethers, tert-butyl methyl ether, diisopropyl ether), esters (eg ethyl formate, ethyl acetate, n-butyl acetate), halogenated hydrocarbons (eg dichloromethane, chlorophenol, carbon tetrachloride), hydrocarbons (Example: n-hexane, benzene, toluene), alcohols (eg, methanol, ethanol, isopropanol), amides (example: formamide, N, N_dimethylformamide, ⁇ , ⁇ -dimethylacetamide, ⁇ -Methylpyrrolidone), ketones (eg, acetone, methyl ethyl ketone), nitriles (eg, MeCN, propionitrile), dimethyl s
- the reaction temperature is usually about _20-100 ° C, preferably about 0-50 ° C.
- the reaction time is several hours to several tens of hours.
- Nal, NaBr, KI, etc. may be used as a reaction accelerator.
- Compound (I) can be obtained by deprotecting compound (IV) by a method well known to those skilled in the art, if desired.
- reaction solvent examples include ethers (eg, anisole, dioxane, tetrahydrofuran, jetyl ether, tert-butyl methyl ether, diisopropyl ether), esters (eg, ethyl formate, ethyl acetate, n-butyl acetate), Halogenated hydrocarbons (eg, dichloromethane, chlorophenol, carbon tetrachloride), hydrocarbons (eg, n-hexane, benzene, toluene), amides (eg, formamide, ⁇ , ⁇ -dimethylformamide, ⁇ , ⁇ -dimethylacetamide, ⁇ -methylpyrrolidone), ketones (eg acetone, methyl ethyl ketone), nitriles (eg MeCN, propionitrile), nitros (eg nitromethane, nitrogen, nitrobenzene) , Dimethyl sulfox
- the reaction temperature is usually about ⁇ 70 to 50 ° C., preferably about ⁇ 50 to 0 ° C.
- Catalysts include Lewis acids (eg: 8 SnCl, TiCl), proton acids (eg: HC1, H 2 SO, HC10
- anisole is used in combination.
- the obtained compound (I) can be further chemically modified to synthesize another compound (I), a pharmaceutically acceptable salt thereof, or a solvate thereof.
- Pharmaceutically acceptable salts include inorganic bases, ammonia, organic bases, inorganic acids, organic acids And salts formed by basic amino acids, halogen ions, etc., or inner salts.
- the inorganic base include alkali metals (Na, K, etc.), alkaline earth metals (Mg, etc.), and examples of the organic base include pro-power-in, 2-phenylethylbenzylamine, dibenzylethylenediamine. , Ethanolamine, diethanolamine, trishydroxymethylaminomethane, polyhydroxyalkylamine, N-methyldarcosamine and the like.
- Examples of the inorganic acid include hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid and the like.
- Examples of the organic acid include p_toluenesulfonic acid, methanesulfonic acid, formic acid, trifluoroacetic acid, maleic acid and the like.
- Examples of basic amino acids include lysine, arginine, ornithine, histidine and the like.
- Examples of the solvate solvent include water and alcohol.
- the present invention further provides compound (I) as an intermediate for the production of compound (I), a compound in which the amino and Z or carboxy moieties at the 7-position side chain end of compound (I) are protected, and a pharmaceutically acceptable salt thereof.
- solvates are also provided.
- the compound in which the amino group at the 7-position side chain end is protected means, for example, the compound (IV) in which R 6 is an amino protecting group.
- the amino protecting group include lower alkoxycarbonyl (eg, t-butoxycarbonyl, benzyloxycarbonyl, p-nitrobenzyloxycarbonyl), (substituted) aralkanol (eg, p-nitrobenzoyl), and acyl (eg: Examples include formyl, chloroacetyl), (substituted) aralkyl (eg, trityl), and the like.
- the compound in which the carboxy moiety is protected means a compound in which the compound (IV) is protected when R 7 is a carboxy protecting group and / or R 1 is carboxy.
- the carboxy protecting group include lower alkyl (eg, methyl, ethyl, t-butyl), lower alkenyl (eg, allyl, prenyl), (substituted) aralkyl (eg, benzyl, benzhydryl, p methoxybenzyl, p nitro).
- Benzyl a silinore protecting group (t-butyldimethylsilyl, diphenyl t-butylsilyl) and the like.
- the heterocyclic group represented by (Q) in the 3-position side chain has a counter ion (eg, halogen). ,.
- the present invention further provides the compound ( ⁇ ), particularly the compounds ( ⁇ ⁇ -1) and ( ⁇ -2) as production intermediates of the compound (I).
- the present invention further provides the following production intermediate of compound (II) and crystals thereof: [Chemical 280]
- Compound (G-1) is preferably crystallized as an amine salt, more preferably a trialkylamine salt, and even more preferably a triethylamine salt.
- the ammine salt may contain a solvent (eg, water, alcohol).
- the crystal of tolylamine salt preferably shows typical peaks at least in the following positions in the powder X-ray diffraction pattern (X-ray measurement conditions: tube CuKa line, tube voltage 40 kV, tube current 50 mA). .
- the triethylamine salt is preferably prepared by dissolving compound (G-1) in a soluble solvent (eg, dimethylacetamide) and then adding triethylamine preferably at 10 to 30 ° C. Drops over time (Reference: Reference Example 10).
- a soluble solvent eg, dimethylacetamide
- Compound (G-2) is preferably crystallized as an inorganic acid salt, more preferably as a hydrochloride.
- the hydrochloride may contain a solvent (eg, water, alcohol).
- the hydrochloride crystal preferably has typical peaks at least at the following positions in the powder X-ray diffraction pattern (X-ray measurement conditions: tube CuK a line, tube voltage 40 kV, tube current 50 mA, and so on). Show.
- the hydrochloride is preferably the compound (G -1) is reacted with oxalyl chloride in an organic solvent (eg, dimethylformamide, methylene chloride or a mixture thereof) for several hours under ice-cooling at -40 ° C (Reference: Reference) Example 2).
- an organic solvent eg, dimethylformamide, methylene chloride or a mixture thereof
- Compound (G-3) is preferably crystallized as an inorganic acid salt, more preferably as a hydrochloride.
- the hydrochloride may contain a solvent (eg, water, alcohol).
- the hydrochloride crystals preferably have representative peaks at least at the positions shown below. Show.
- the hydrochloride is preferably prepared by reacting compound (G-3) with hydrochloric acid in an organic solvent (eg, ethyl acetate), concentrating and stirring for several tens of minutes under ice cooling ( Reference: Reference Example 1 (4) Crystal of compound (G-4)
- Compound (G-4) is preferably crystallized as an inorganic acid salt, more preferably as a hydrochloride.
- the hydrochloride may contain a solvent (eg, water, alcohol).
- the hydrochloride crystal preferably has typical peaks at least at the following positions in the powder X-ray diffraction pattern (X-ray measurement conditions: tube CuK a line, tube voltage 40 kV, tube current 50 mA, and so on). Show.
- the hydrochloride is preferably compound (G- It is prepared by reacting 4) with hydrochloric acid in an organic solvent (eg, ethyl acetate, methanol) and then concentrating (Reference: Reference Example 2).
- an organic solvent eg, ethyl acetate, methanol
- Each of the above crystals has advantages such as being stable with few impurities and having good Z or handleability. Therefore, it is useful as a synthetic intermediate for the cephem compound of the present invention.
- the production intermediate of the present invention contributes to the excellent antibacterial action and Z or pharmacokinetics of Compound (I).
- the compound of the present invention has a broad antibacterial activity of Specetanol, and various diseases caused by pathogenic bacteria in various mammals including humans such as respiratory tract infections, urinary tract infections, respiratory infections, sepsis , Nephritis, cholecystitis, oral infection, endocarditis, pneumonia, osteomyelitis, otitis media, enteritis, pus, wound infection, opportunistic infection, etc.
- the compounds of the present invention are particularly effective against gram-positive bacteria such as staphylococci and pneumococci and gram-negative bacteria such as Escherichia coli, Pseudomonas aeruginosa and Haemophilus influenzae.
- resistant strains of pneumococci and Haemophilus influenzae particularly penicillin-resis tant Streptococcus pneumoniae (PRSP) and non-lactamase non-producing ampicillin resistant It is also effective against Infnorensa (beta_lactamase_negative, ampicillin-resistant Haemophilus influenzae: BLNAR).
- PRSP penicillin-resis tant Streptococcus pneumoniae
- BLNAR ampicillin-resistant Haemophilus influenzae
- preferred compounds are suitable as long-lasting injections because they have good water solubility and good pharmacokinetics such as the area under the blood concentration one hour curve (AUC) and clearance.
- the compound of the present invention can be administered parenterally or orally as an injection, capsule, tablet or granule, but is preferably administered as an injection.
- the dosage is usually about 0.1 to: OOmg / day, preferably about 0.5 to 50mg / day per kg of patient or animal body weight, divided into 2 to 4 times a day as desired. What is necessary is just to administer.
- the carrier is, for example, distilled water, physiological saline or the like, and a base for adjusting pH may be used.
- Carriers when used as capsules, granules, and tablets are known excipients (eg, starch, lactose, sucrose, calcium carbonate, calcium phosphate, etc.), binders (eg, starch, gum arabic, carboxymethyl cell) Mouth, hydroxypropyl cell, crystal cell, etc.), lubricants (eg, magnesium stearate, talc, etc.).
- excipients eg, starch, lactose, sucrose, calcium carbonate, calcium phosphate, etc.
- binders eg, starch, gum arabic, carboxymethyl cell
- Mouth hydroxypropyl cell, crystal cell, etc.
- lubricants eg, magnesium stearate, talc, etc.
- Me Methyl
- Et Ethyl
- iPr Isopropyl
- Bu t-Butinole
- Ac Acetyl
- DMF Dimethylformamide
- THF Tetrahydrofuran
- PMB p_Methoxybenzyl
- Fig. 3 shows the powder X-ray diffraction pattern of compound g (hydrochloride crystals).
- Trifluoroacetic acid (3 ml) was cooled on ice, and compound 4 (946 mg, 3 mmol) was added. The mixture was stirred at room temperature for 2 hours and 10 minutes, and then added to a solution of 4N HCl / EtOAc (0.9 ml, 3.6 mmol) in ethyl acetate (10 ml) that had been ice-cooled in advance. The mixture was stirred for 30 minutes under ice cooling, and the precipitated crystals were collected by filtration to obtain Compound 5. Yield 706 mg (94%). In the NMR analysis of this product, no anti-isomer at the oxime site was found.
- Ogitalyl chloride (4.8 ml, 55 mmol) was added dropwise to a mixture of ice-cooled dimethylformamide (4.64 ml, 60 mmol) and methylene chloride (250 ml), and the mixture was stirred for 20 minutes under ice cooling. After cooling to _40 ° C, compound 5 (12.6g, 50mmol) was added and stirred at -30 ° C for 4 hours. Further, a methylene chloride solution of Vilsmeier reagent prepared from dimethylformamide (0.85 ml) and oxalyl chloride (0.87 ml) was added.
- Fig. 2 shows the powder X-ray diffraction pattern of Compound 8 (hydrochloride crystals).
- Fig. 4 shows the powder X-ray diffraction pattern of Compound 10 (hydrochloride crystals).
- Reference example 3 shows the powder X-ray diffraction pattern of Compound 10 (hydrochloride crystals).
- reaction solution was acidified with dilute hydrochloric acid, washed with brine, dried and concentrated under reduced pressure.
- the residue was subjected to silica gel chromatography (ethyl acetate-toluene) to obtain compound l_ll (3.49 g: yield; 97%).
- Acid was added to adjust the pH to 2 or less, and the aqueous layer was separated. Add NaHCO to pH 7 or higher.
- IR (KBr) cm _1 3417, 2982, 2177, 1762, 1634, 1602, 1538, 1470, 1434, 1382, 1353, 1251, 1204.
- i-Pr NH (1.40 ml, 10 mmol) was dissolved in tetrahydrofuran (10 ml), and n-butyllithium hexane solution (6 M / L, 6.24 ml) was stirred with ice-cooling for 30 minutes under ice-cooling. The solution was cooled to ⁇ 78 ° C., and a solution of Compound 29 (1.08 g, 6.66 mmol) in tetrahydrofuran (10 ml) was prepared. After stirring for 15 minutes, C1C OOMe (1.03 ml, 13.3 mmol) was added, and the mixture was further stirred for 20 minutes.
- HP-20SS was added to the aqueous layer, concentrated, subjected to HP-20SS column chromatography, and eluted with water-acetonitrile. Fractions containing the desired compound were collected and 2N-NaOH was carefully added while stirring, and when the pH exceeded 10, dry ice was added to bring the pH to 5 or less. Reduce solution Concentration under pressure and lyophilization gave compound 33 as a powder. Yield 85 mg (13%)
- i-Pr NH (1.21 ml, 8.63 mmol) was dissolved in tetrahydrofuran (10 ml), and n-butyllithiate was cooled with ice.
- IR (KBr) cm _1 3399, 2966, 1761, 1632, 1577, 1528, 1498, 1468, 1418, 1366, 1330, 1214.
- Compound 74 was obtained as an amorphous powder in the same manner as in Example 7, (3) using Compound 21 (721 mg, 1 mmol) and Compound 73 (275 mg, 1 mmol). Yield 980 mg (94%). From this compound 74 (960 mg, 0.92 mmol), 1 M / ⁇ A 1 / CH NO (9.2 ml, 9.2 mmol) was used, and compound 68 was obtained as a powder in the same manner as in Example 7, (4). . Yield 293 mg (42%)
- Compound 77 was obtained as an amorphous powder in the same manner as in Example 7, (3) using Compound 76 (640 mg, 0.87 mmol) and Compound 59 (335 mg, 0.87 mmol). Yield 953 mg (94%). From this compound 77 (9 36 mg, 0.80 mmol), 1 M / ⁇ A 1 / CH NO (8.0 ml, 8.0 mmol) was used, as in Example 7, (4).
- Compound 87 was obtained as an amorphous powder in the same manner as in Example 1, (5) using Compound 21 (721 mg, 1 mmol) and Compound 86 (248 mg, 1 mmol). Yield 810 mg (89%). From this compound 87 (800 mg, 0.88 mmol), 1 M / ⁇ A 1 / CH NO (8.8 ml, 8.8 mmol) was used, and compound 85 was obtained as a powder in the same manner as in Example 7, (4). It was. Yield 214 mg (32%)
- Compound 108 was obtained as an amorphous powder in the same manner as in Example 1, (5) using Compound 21 (721 mg, 1 mmol) and Compound 107 (265 mg, 1 mmol). Yield 805 mg (87%). From this compound 108 (791 mg, 0.85 mmol), 1 M / ⁇ A 1 / CH NO (8.5 ml, 8.5 mmol) was used, as in Example 7 (4).
- IR (KBr) cm _1 3408, 2966, 2168, 2144, 1761, 1633, 1541, 1456, 1437, 1388, 1348, 1246.
- the compound 109 was obtained as a powder by the method. Yield 261 mg (39%)
- This compound 121 (798 mg, 0.85 mmol) is dissolved in methylene chloride (10 ml) and anisol (0.58 ml), and 2M / to 8 / CH NO (2.56 ml, 5.12 mmol) is added at -20 ° C. It was. The mixture was stirred at _20 ° C for 20 minutes, and then poured into 0.3N hydrochloric acid (25 ml) and acetonitrile (30 ml) with stirring under ice-cooling. Further, ethyl ether (25 ml) was separated from the aqueous layer.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
Abstract
A compound represented by the formula: (I) wherein Acyl represents an acyl group which can be used in the field of β-lactams; T represents S, SO or O; the group represented by the formula: (Q) represents a heterocyclic group which may be substituted by a substituent other than '-Y1-Ar1-Y2-R1' and has a cationic N atom in the ring; Y1 and Y2 independently represent 1) a single bond, 2) a heteroatom-containing group selected from the group consisting of -NR2, -CO-, -NR2CO-, -CONR2-, -NR2CONR3-, -NR2SO2-, -SO2NR2-, -NR2SO2NR3- (where R2 and R3 independently represent a hydrogen or a lower alkly), -O-, -S-, -SO- and -SO2-, or 3) a lower alkylene or lower alkenylene group which may be bound through a heteroatom-containing group as listed in the item 2); Ar1 represents a single bond, a carbocyclic group which may be substituted or a haterocyclic group which may be substituted; R1 represents -CONHCN, -C(OH)=NCN or -COOH or a biologically equivalent acidic group thereof; and the wavy line means a cis, trans or a mixture thereof.
Description
明 細 書 Specification
3 -プロぺニルセフヱム誘導体 3-Propenyl cefene derivatives
技術分野 Technical field
[0001] 本発明は、種々の病原性細菌に対して幅広い抗菌スペクトルを示す広域セフエム 化合物およびそれを含有する医薬組成物に関する。 [0001] The present invention relates to a broad-spectrum compound exhibiting a broad antibacterial spectrum against various pathogenic bacteria and a pharmaceutical composition containing the same.
背景技術 Background art
[0002] グラム陽性菌およびグラム陰性菌に対して強い抗菌力を有する注射用の広域セフ ェム化合物として、近年、セフエム骨格の 3位側鎖上に 4級アンモニゥム基を有する化 合物が注目されている。その中で、 3—プロぺニル型の側鎖を有するセフヱムが公知 である(例:特許文献:!〜 8)。 [0002] In recent years, compounds having a quaternary ammonium group on the 3rd side chain of the Cefme skeleton have attracted attention as a broad-spectrum cephem compound for injection having strong antibacterial activity against Gram-positive and Gram-negative bacteria Has been. Among them, cefmes having 3-propenyl type side chains are known (eg, patent documents:! To 8).
特許文献 1は以下の化合物を開示する。 Patent document 1 discloses the following compounds.
[化 1] [Chemical 1]
[化 2]
は第 4級アンモニォ基
(例:
等) 特許文献 2は以下の化合物を開示する。 [Chemical 2] Is the fourth grade Ammonio group (Example: Etc.) Patent Document 2 discloses the following compounds.
R1〜R3 :低級アルキル R1-R3: Lower alkyl
R4:置換基有してレ、レ、5員複素環低級アルキル R4: Re, R, 5-membered heterocyclic lower alkyl having substituent
(具体例) (Concrete example)
[化 5] [Chemical 5]
A:環状又は非環状アンモニォ基 A: Cyclic or acyclic ammonio group
環状アンモニォ基の例: Examples of cyclic ammonio groups:
[化 8] [Chemical 8]
R1:アミノ基またはァシルァミノ基; R2、 R3 :低級アルキル; R4 :力ルバモイル低級ァ ルキル基 R1: amino group or acylamino group; R2, R3: lower alkyl; R4: strong rumoyl lower alkyl group
特許文献 5は以下の化合物を開示する。 Patent document 5 discloses the following compounds.
[化 9]
or acetyl 特許文献 6は以下の化合物を開示する。 [Chemical 9] or acetyl Patent Document 6 discloses the following compounds.
[化 10] [Chemical 10]
R3: ァセチル基、適当な置換基を有してレ、てもよレ、ァミノ基、適当な置換基を有し ていてもよい力ルバモイル基、ウレイド、適当な置換基を有していてもよい複素環基 等。 R3: acetyl group, having an appropriate substituent, may be, an amino group, an optionally substituted rubamoyl group, ureido, having an appropriate substituent Good heterocyclic group etc.
(具体例) (Concrete example)
[化 11] [Chemical 11]
[化 12] [Chemical 12]
R3:水素、低級アルキル、(保護)カルボキシ; R4:水素、低級アルキル
A:メチレン、プロぺニレン R3: hydrogen, lower alkyl, (protected) carboxy; R4: hydrogen, lower alkyl A: Methylene, propenylene
(具体例) (Concrete example)
[化 13] [Chemical 13]
[化 14] [Chemical 14]
A:第四級窒素原子等。 A: Quaternary nitrogen atom and the like.
特許文献 8において「第四級窒素原子」とは以下を意味する c In Patent Document 8, “quaternary nitrogen atom” means c
[化 15] [Chemical 15]
(式中、 R2、 R3および R4は、 N原子と一緒になつて、芳香族の 5もしくは 6員の、酸素、 硫黄および窒素から選択される追加のへテロ原子を含有してレ、てよレ、場合により縮 合している複素環等を表す) (Wherein R2, R3 and R4 together with the N atom contain an additional 5- or 6-membered aromatic heteroatom selected from oxygen, sulfur and nitrogen. (Represents a heterocycle that is condensed in some cases)
3位側鎖末端に CONHCN基を有するセフヱム化合物は公知である力 3—メチ
レン型である(参照:特許文献 9)。 Cefmium compounds having a CONHCN group at the end of the 3-position side chain are known in the art. It is a len type (see: Patent Document 9).
[化 16] [Chemical 16]
(式中、 Hetは N、 0及び Sから選択される同一又は異なる原子を一個以上含有する、 単環式又は多環式複素環; R1は水素、置換されていてもよい低級アルキル、又は置 換されてレ、てもよレ、低級アルケニルを表し、 Aは置換されてレ、てもよレ、低級アルキレ ン、置換されてレ、てもよレ、低級アルケニレン又は単結合; Bは置換されてレ、てもよレ、ィ ミノ又は単結合を表し、 Dは単結合又は (Wherein Het contains one or more of the same or different atoms selected from N, 0 and S, monocyclic or polycyclic heterocycles; R1 is hydrogen, optionally substituted lower alkyl, or Substituted, ret or alk represents lower alkenyl, A is substituted, ret, may ele, lower alkylene, substituted les, pos, lower alkenylene or single bond; B is substituted Represents an imino or single bond, D is a single bond or
また 1日 1回または 2回投与用の持続性注射用セフエムとしては、セフトリアキソンナ トリウム(販売名:ロセフイン(Rocephine) )が公知である。 Further, ceftriaxone sodium (trade name: Rocephine) is known as a continuous injection cefme for once or twice daily administration.
特許文献 1 :特開昭 59— 172493 Patent Document 1: JP-A 59-172493
特許文献 2 :特開昭 62— 195386 Patent Document 2: JP-A 62-195386
特許文献 3:特開平 1— 156984 Patent Document 3: JP-A-1-156984
特許文献 4 :特開平 5— 339274 Patent Document 4: JP-A-5-339274
特許文献 5:特開平 5— 59065 Patent Document 5: JP-A-5-59065
特許文献 6 :特開平 7— 41484 Patent Document 6: JP-A-7-41484
特許文献 7 :特開平 9—110877 Patent Document 7: JP-A-9-110877
特許文献 8 :WO 99/67255 Patent Document 8: WO 99/67255
特許文献 9 : WO 97/37996 Patent Document 9: WO 97/37996
発明の開示
発明が解決しょうとする課題 Disclosure of the invention Problems to be solved by the invention
[0003] 従来のセフエム化合物に比べて、さらに強力な抗菌活性を示す力、または異なる抗 菌パターンを示す新規な広域セフェム化合物の開発が要望されていた。特に、薬剤 耐性や院内感染等が問題になっている肺炎球菌やインフルエンザ菌等の耐性菌に 対しても有効な抗菌剤の開発が望まれている。より好ましくは、体内動態の良い持続 性の注射用抗菌剤の開発が望まれている。 [0003] Compared to conventional cephem compounds, there has been a demand for the development of a novel broad spectrum cephem compound that exhibits a stronger antibacterial activity or a different antibacterial pattern. In particular, the development of antibacterial agents that are effective against resistant bacteria such as pneumococci and Haemophilus influenzae, where drug resistance and nosocomial infections are problematic, is desired. More preferably, the development of a long-lasting antibacterial agent with good pharmacokinetics is desired.
課題を解決するための手段 Means for solving the problem
[0004] 本発明者らは鋭意検討した結果、セフエムの 3位に、代表的にはピリジン環等の環 状 4級アンモニゥム基等を有する 3—プロぺニル型側鎖を採用し、かつ 3位側鎖末端 の置換基として酸性基 (例: _C〇NHCN、 _CO〇H)を導入すれば、優れた抗菌 活性を示しかつ体内動態の良いセフエム化合物が得られることを見出し、以下に示 す本発明を完成した。さらに本発明は、該セフエム化合物の中間体の結晶も提供す る。 [0004] As a result of intensive studies, the present inventors have adopted a 3-propenyl-type side chain having a cyclic quaternary ammonium group such as a pyridine ring at the 3-position of cefme, and 3 We found that the introduction of an acidic group (eg, _C〇NHCN, _CO〇H) as a substituent at the end of the side chain yields a cephem compound that exhibits excellent antibacterial activity and good pharmacokinetics. The present invention has been completed. Furthermore, the present invention also provides an intermediate crystal of the cephem compound.
[0005] (1)式: [0005] Equation (1):
[化 18] [Chemical 18]
(式中、 (Where
Acylは、 β ラタタムの分野で使用可能なアシノレ基; Acyl is an amino group that can be used in the field of β-ratata;
Τは、 S、 SOまたは O ; Τ is S, SO or O;
式: Formula:
で示される基は、 "一 Y1— Ar1— Y2— R1"以外の置換基で置換されていてもよい、力 チオン性 N原子を環内に有する複素環式基; A group represented by is a heterocyclic group optionally having a thione N atom in the ring, which may be substituted with a substituent other than “one Y 1 —Ar 1 —Y 2 —R 1 ”;
Y1および Y2はそれぞれ独立して、 1)単結合、 2)— NR2、 -CO - ,— NR2C〇—、 一 CONR2—、一 NR2CONR3—、一 NR2S〇 一、一 SO NR2—、一 NR2S〇 NR3-Y 1 and Y 2 are each independently 1) a single bond, 2) — NR 2 , —CO −, — NR 2 C〇—, one CONR 2 —, one NR 2 CONR 3 —, one NR 2 S〇 One, one SO NR 2 —, one NR 2 S〇 NR 3-
2 2 22 2 2
、(R2および R3はそれぞれ独立して水素または低級アルキル)、 =N―、 _N =、 - 〇_、 _S―、 - SO- ,および一SO—からなる群から選択されるへテロ原子含有 , (R 2 and R 3 are each independently hydrogen or lower alkyl), = N-, _N =, -O_, _S-, -SO-, and a heteroatom selected from the group consisting of 1 SO- Contains
2 2
基、または 3) 2)のへテロ原子含有基が介在していてもよレ、、低級アルキレンまたは 低級アルケニレン; A group, or 3) a heteroatom-containing group of 2) may be interposed, lower alkylene or lower alkenylene;
Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; Ar 1 represents a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group;
R1は、 _CONHCN、 _C (〇H) =NCN、または _C〇OHもしくはその生物学的に 等価な酸性基; R 1 is _CONHCN, _C (〇H) = NCN, or _C〇OH or a biologically equivalent acidic group thereof;
波線は、シス、トランスまたはその混合を意味する; Wavy line means cis, trans or a mixture thereof;
但し、 However,
1)カチオン性 N原子を環内に有する複素環式基がピリジニゥム基であり、かつ Ar1が 単結合である場合、 R1は、 CONHCNまたは一 C (OH) =NCNであるものとする;1) When the heterocyclic group having a cationic N atom in the ring is a pyridinium group and Ar 1 is a single bond, R 1 shall be CONHCN or one C (OH) = NCN;
2)カチオン性 N原子を環内に有する複素環式基が 2環性の複素環式基であり、 Ar1 が単結合であり、かつ R1は— CONHCNまたは— C (OH) =NCNのいずれでもな い場合、 "一 Y1— Ar1— Y2— R1"で示される基は、該 2環性の複素環式基において セフエム 3位側鎖部分との結合手を有していない方の環上に存在するものとする) で示される化合物、その製薬上許容される塩またはそれらの溶媒和物。 2) A heterocyclic group having a cationic N atom in the ring is a bicyclic heterocyclic group, Ar 1 is a single bond, and R 1 is —CONHCN or —C (OH) ═NCN If either not name, "a Y 1 - Ar 1 - Y 2 - R 1" group represented by the have a bond to cephem 3-position side chain moiety in said bicyclic heterocyclic group Or a pharmaceutically acceptable salt or solvate thereof.
[0006] (2)Tは、 Sである、上記(1)記載の化合物、その製薬上許容される塩またはそれらの 溶媒和物。 [0006] (2) The compound according to (1) above, wherein T is S, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[0007] (3)Acylが式: [0007] (3) Acyl is the formula:
Xは、 Nまたは CY (Yは水素またはハロゲン); X is N or CY (Y is hydrogen or halogen);
Rは、 =CHZ (Zは、水素、置換されていてもよい低級アルキル、置換されていてもよ ぃシクロアルキルまたは置換されていてもよい複素環式基)または = NOR° (R°は、 水素、置換されていてもよい低級アルキル、置換されていてもよい低級アルケニル、 置換されてレ、てもよレ、シクロアルキル、置換されてレ、てもよレ、ァリールまたは置換され ていてもよい複素環式基) R is = CHZ (Z is hydrogen, an optionally substituted lower alkyl, an optionally substituted cycloalkyl or an optionally substituted heterocyclic group) or = NOR ° (R ° is Hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, substituted les, may les, cycloalkyl, substituted les, may les, aryls or substituted Good heterocyclic group)
で示される基である、上記(1)記載の化合物、その製薬上許容される塩またはそれら の溶媒和物。 Or a pharmaceutically acceptable salt thereof, or a solvate thereof.
(4) Xが CH、及び/又は I^ = NOR° (R°は水素もしくは置換されていてもよい低級 アルキル)である、上記(3)記載の化合物。 (4) The compound according to (3) above, wherein X is CH and / or I ^ = NOR ° (R ° is hydrogen or optionally substituted lower alkyl).
(5)式: Equation (5):
[化 21]
で示される基は、 "一 Y1— Ar1— Y—R1"以外の置換基で置換されていてもよい、ピ リジニゥム基、またはカチオンを有する 2環性の複素環式基である、上記(1)記載の 化合物、その製薬上許容される塩またはそれらの溶媒和物。 [Chemical 21] Groups represented in the "A Y 1 - Ar 1 - Y- R 1" may be substituted with other substituents, a bicyclic heterocyclic group having a pin Rijiniumu group or a cation, The compound according to (1) above, a pharmaceutically acceptable salt thereof or a solvate thereof.
(6) Y1及び/又は Y2は、単結合である、上記(1)記載の化合物、その製薬上許容さ れる塩またはそれらの溶媒和物。 (6) The compound according to (1), a pharmaceutically acceptable salt or a solvate thereof, wherein Y 1 and / or Y 2 is a single bond.
(7) Ar1tt,単結合、置換されていてもよいァリール、または置換されていてもよいへ テロアリールである、上記(1)記載の化合物、その製薬上許容される塩またはそれら の溶媒和物。 (7) Ar 1 tt, a single bond, an optionally substituted aryl, or an optionally substituted heteroaryl, the compound according to (1) above, a pharmaceutically acceptable salt thereof, or a solvate thereof object.
(8) 1^は、 CONHCN C (〇H) =NCNまたは COOHである、上記(1)記載 の化合物、その製薬上許容される塩またはそれらの溶媒和物。 (8) The compound according to (1), a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein 1 ^ is CONHCN C (◯ H) = NCN or COOH.
(9) は、— CONHCNまたは— C (OH) =NCNである、上記(1)記載の化合物、 その製薬上許容される塩またはそれらの溶媒和物。
(10) R1は、 COOHまたはその生物学的に等価な酸性基であり、該酸性基は、 CONHR4 - SO H - SO NHR5 (R4および R5はそれぞれ独立してァミノ残基) (9) is the compound according to the above (1), pharmaceutically acceptable salt or solvate thereof, wherein —CONHCN or —C (OH) ═NCN. (10) R 1 is COOH or a biologically equivalent acidic group thereof, and the acidic group is CONHR 4 -SO H -SO NHR 5 (R 4 and R 5 are each independently an amino residue)
3 2 3 2
-PO H OH COCH = C (〇H) CF NHSO CF CONHSO CF -PO H OH COCH = C (〇H) CF NHSO CF CONHSO CF
3 2 3 2 3 2 £3 2 3 2 3 2 £
-NHSO Me、 -CONHSO Me _NHC〇Me _C〇NHCOMe -COCH-NHSO Me, -CONHSO Me _NHC〇Me _C〇NHCOMe -COCH
、 2 2 2, 2 2 2
COMe、または置換されていてもよく環構成原子として— NH_およびその他のへテ 口原子を有する 5〜6員の複素環式基である、上記(1)記載の化合物、その製薬上 許容される塩またはそれらの溶媒和物。 COMe, or a compound as described in the above (1), which is a 5- to 6-membered heterocyclic group which may be substituted and has NH_ and other heterocyclic atoms as a ring-constituting atom, its pharmaceutically acceptable Salts or solvates thereof.
(11)式: Equation (11):
[化 22] [Chemical 22]
で示される基は、 "一 Y1— Ar1— Y一 R1"以外の置換基で置換されていてもよい、ピ リジニゥム基; Y1及び Y2は、単結合; Ar1は、置換されていてもよいァリール、または 置換されていてもよいへテロアリール; R1は、一 CONHCNまたは一 C (〇H) =NCN である、上記(1)記載の化合物、その製薬上許容される塩またはそれらの溶媒和物。 (12)式: Groups represented in the "A Y 1 - Ar 1 - Y one R 1" may be substituted with other substituents, Pi Rijiniumu group; Y 1 and Y 2 is a single bond; Ar 1 represents a substituted Optionally substituted aryl, or optionally substituted heteroaryl; R 1 is one CONHCN or one C (0H) = NCN, the compound according to the above (1), or a pharmaceutically acceptable salt thereof Or a solvate thereof. Equation (12):
(式中、 (Where
Xは、 Nまたは CY (Yは水素またはハロゲン); X is N or CY (Y is hydrogen or halogen);
Rは、 =CHZ (Zは、水素、置換されていてもよい低級アルキル、置換されていてもよ ぃシクロアルキルまたは置換されていてもよい複素環式基) または = NOR° (R。は、 水素、置換されていてもよい低級アルキル、置換されていてもよい低級アルケニル、
置換されてレ、てもよレ、シクロアルキル、置換されてレ、てもよレ、ァリールまたは置換され ていてもよい複素環式基) R is = CHZ (Z is hydrogen, an optionally substituted lower alkyl, an optionally substituted cycloalkyl or an optionally substituted heterocyclic group) or = NOR ° (R. Hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, Substituted, may, cycloalkyl, substituted, may, aryl, or an optionally substituted heterocyclic group)
で示される基; A group represented by:
Y1および Y2はそれぞれ独立して、 1)単結合、 2)
- CO - , _NR2C〇_、 一 CONR2—、一 NR2CONR3—、一 NR2S〇 一、一 SO NR2—、一 NR2S〇 NR3-Y 1 and Y 2 are each independently 1) a single bond, 2) -CO-, _NR 2 C〇_, one CONR 2 —, one NR 2 CONR 3 —, one NR 2 S〇 one, one SO NR 2 —, one NR 2 S〇 NR 3-
2 2 22 2 2
、(R2および R3はそれぞれ独立して水素または低級アルキル)、 =N―、 _N =、 - 〇_、 _ S―、 - SO - ,および一SO—からなる群から選択されるへテロ原子含有 , (R 2 and R 3 are each independently hydrogen or lower alkyl), = N-, _N =, -O_, _S-, -SO-, and a hetero selected from the group consisting of 1 SO- Containing atoms
2 2
基、または 3) 2)のへテロ原子含有基が介在していてもよレ、、低級アルキレンまたは 低級アルケニレン; A group, or 3) a heteroatom-containing group of 2) may be interposed, lower alkylene or lower alkenylene;
Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; Ar 1 represents a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group;
R1は、 _ CONHCN、 _ C (〇H) =NCN、または _ C〇OHもしくはその生物学的に 等価な酸性基; R 1 is _CONHCN, _C (〇H) = NCN, or _C〇OH or a biologically equivalent acidic group thereof;
波線は、シス、トランスまたはその混合を意味する; Wavy line means cis, trans or a mixture thereof;
但し、 Ar1が単結合である場合、 R1は、― CONHCNまたは— C (〇H) =NCNであ るものとする。) However, when Ar 1 is a single bond, R 1 shall be-CONHCN or-C (OH) = NCN. )
で示される化合物、その製薬上許容される塩またはそれらの溶媒和物。 Or a pharmaceutically acceptable salt or solvate thereof.
(13) 1^は、—CONHCNまたは C (OH) =NCNである、上記(12)記載の化合物 、その製薬上許容される塩またはそれらの溶媒和物。 (13) The compound according to (12), a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein 1 ^ is —CONHCN or C (OH) ═NCN.
(14) Y1は単結合; Ar1は置換されていてもよいァリールまたは置換されていてもよい ヘテロァリール; Y2は単結合; R1は、 CONHCNまたは一 C (〇H) =NCNである、 上記(12)記載の化合物、その製薬上許容される塩またはそれらの溶媒和物。 (14) Y 1 is a single bond; Ar 1 is an optionally substituted aryl or an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is CONHCN or one C (〇H) = NCN The compound according to (12) above, a pharmaceutically acceptable salt thereof, or a solvate thereof.
(15) Y1は単結合; Ar1は置換されていてもよいへテロアリール; Y2は単結合; R1は、 — CONHCNまたは— C (OH) =NCNである、上記(12)記載の化合物、その製薬 上許容される塩またはそれらの溶媒和物。 (15) Y 1 is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is —CONHCN or —C (OH) ═NCN, according to (12) above Compound, its pharmaceutically acceptable salt or solvate thereof.
(16) Xは CH; Rは = CHZ (Zは、置換されてレ、てもよレ、低級アルキル)または = NO R° (R。は水素、置換されてレ、てもよレ、低級アルキルまたは置換されてレ、てもよレヽァリ ール); Y1は単結合; Ar1は置換されていてもよいへテロアリール; Y2は単結合; R1は
、—CONHCNまたは— C (OH) =NCNである、上記(12)記載の化合物、その製 薬上許容される塩またはそれらの溶媒和物。 (16) X is CH; R is = CHZ (Z is substituted, optionally, lower alkyl) or = NO R ° (R. is hydrogen, substituted, optionally, lower, lower) Y 1 is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is , —CONHCN or —C (OH) ═NCN, the compound according to (12) above, a pharmaceutically acceptable salt thereof, or a solvate thereof.
(17) Xは CH; Rtt = NOR° (R°は水素、置換されてレ、てもよレ、低級アルキルまたは 置換されていてもよいァリール); Y1は単結合; Ar1は、置換されていてもよぐ〇、 Sお よび Nからなる群から選択される同一又は異なる 1〜4個のへテロ原子を含有する 5ま たは 6員のへテロアリーノレ; Y2は単結合; R1は、一CONHCNまたは一 C (OH) =N CNである、上記(12)記載の化合物、その製薬上許容される塩またはそれらの溶媒 和物。 (17) X is CH; Rtt = NOR ° (R ° is hydrogen, substituted, optionally, lower alkyl or optionally substituted aryl); Y 1 is a single bond; Ar 1 is substituted Yes, 5 or 6 membered heteroarynoles containing 1 to 4 heteroatoms identical or different selected from the group consisting of S and N; Y 2 is a single bond; R 1 is a compound according to the above (12), a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein 1 CONHCN or 1 C (OH) = NCN.
(18) Xは CH; Rは = N〇R° (R°は低級アルキルまたは置換されてレ、てもよぃァリー ル); Y1は単結合; Ar1は〇、 Sおよび Nからなる群から選択される同一又は異なる 1〜 4個のへテロ原子を含有する 5または 6員のへテロアリール; Y2は単結合; R1は— CO NHCNまたは _C (〇H) =NCNである、上記(12)記載の化合物、その製薬上許容 される塩またはそれらの溶媒和物。 (18) X is CH; R is = N ° R ° (R ° is lower alkyl or substituted or aryl); Y 1 is a single bond; Ar 1 consists of 〇, S and N 5- or 6-membered heteroaryl containing 1 to 4 heteroatoms identical or different selected from the group; Y 2 is a single bond; R 1 is —CO NHCN or _C (〇H) = NCN, The compound according to (12) above, a pharmaceutically acceptable salt thereof or a solvate thereof.
(19)式: Equation (19):
[化 24] [Chemical 24]
(式中 (In the formula
[化 25]
で示される基は、カチオン性 N原子を有する 2環性の複素環式基; [Chemical 25] The group represented by is a bicyclic heterocyclic group having a cationic N atom;
Xは、 Nまたは CY (Yは水素またはハロゲン); X is N or CY (Y is hydrogen or halogen);
Rは、 =CHZ (Zは、水素、置換されていてもよい低級アルキル、置換されていてもよ
ぃシクロアルキルまたは置換されていてもよい複素環式基)または = NOR° (R。は、 水素、置換されていてもよい低級アルキル、置換されていてもよい低級アルケニル、 置換されてレ、てもよレ、シクロアルキル、置換されてレ、てもよレ、ァリールまたは複素環 式基)で示される基; R is = CHZ (Z is hydrogen, optionally substituted lower alkyl, optionally substituted Cycloalkyl or an optionally substituted heterocyclic group) or = NOR ° (R. is hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, A group represented by (moly), cycloalkyl, substituted les, moth may, aryl, or heterocyclic groups;
Y1および Y2はそれぞれ独立して、 1)単結合、 2)
-CO - , _NR2C〇_、 一 CONR2—、一 NR2CONR3—、一 NR2S〇 一、一 SO NR2—、一 NR2S〇 NR3-Y 1 and Y 2 are each independently 1) a single bond, 2) -CO-, _NR 2 C〇_, one CONR 2 —, one NR 2 CONR 3 —, one NR 2 S〇 one, one SO NR 2 —, one NR 2 S〇 NR 3-
2 2 22 2 2
、(R2および R3はそれぞれ独立して水素または低級アルキル)、 _〇_、—S―、 - S 〇_、および— S〇—からなる群から選択されるへテロ原子含有基、または 3) 2)の (Wherein R 2 and R 3 are each independently hydrogen or lower alkyl), a heteroatom-containing group selected from the group consisting of _〇_, —S—, —S 〇_, and —S〇—, or 3) 2)
2 2
ヘテロ原子含有基が介在していてもよレ、、低級アルキレンまたは低級アルケニレン; Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; A hetero atom-containing group may be present, lower alkylene or lower alkenylene; Ar 1 is a single bond, an optionally substituted carbocyclic group or an optionally substituted heterocyclic group ;
R1は、 _CONHCN、 _C (〇H) =NCN、または _C〇OHもしくはその生物学的に 等価な酸性基; R 1 is _CONHCN, _C (〇H) = NCN, or _C〇OH or a biologically equivalent acidic group thereof;
波線は、シス、トランスまたはその混合を意味する; Wavy line means cis, trans or a mixture thereof;
但し、 Ar1が単結合であり、かつ R1は、 CONHCNまたは— C (OH) =NCNのい ずれでもない場合、 " Y1— Ar1— Y2— R1"で示される基は、該 2環性の複素環式基 においてセフヱム 3位側鎖部分との結合手を有していない方の環上に存在するものと する) However, when Ar 1 is a single bond and R 1 is neither CONHCN nor —C (OH) = NCN, the group represented by “Y 1 — Ar 1 — Y 2 — R 1 ” is In the bicyclic heterocyclic group, it should be present on the ring that does not have a bond with the side chain moiety of the caffeine 3-position)
で示される化合物、その製薬上許容される塩またはそれらの溶媒和物。 Or a pharmaceutically acceptable salt or solvate thereof.
(20) 1^は、—CONHCNまたは C (OH) =NCNである、上記(19)記載の化合物 、その製薬上許容される塩またはそれらの溶媒和物。 (20) The compound according to (19), a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein 1 ^ is —CONHCN or C (OH) ═NCN.
( 21 ) Y1は単結合; Ar1は単結合; Y2は単結合; R1は、— CONHCNまたは _ C (OH ) =NCNである、上記(19)記載の化合物、その製薬上許容される塩またはそれらの 溶媒和物。 (21) Y 1 is a single bond; Ar 1 is a single bond; Y 2 is a single bond; R 1 is —CONHCN or _ C (OH) = NCN, the compound according to (19) above, its pharmaceutically acceptable Salts or solvates thereof.
(22) Xは CH ;Rは、 =CHZ (Zは、置換されていてもよい低級アルキル)または =N OR° (R。は水素、置換されてレ、てもよレ、低級アルキルまたは置換されてレ、てもよレヽァ リール); Y1は単結合; Ar1は単結合; Y2は単結合; R1は、—CONHCNまたは— C ( OH) =NCNである、上記(19)記載の化合物、その製薬上許容される塩またはそれ
らの溶媒和物。 (22) X is CH; R is = CHZ (Z is an optionally substituted lower alkyl) or = N OR ° (R. is hydrogen, substituted, optionally, lower alkyl or substituted Y 1 is a single bond; Ar 1 is a single bond; Y 2 is a single bond; R 1 is —CONHCN or —C (OH) = NCN, (19 ) Or a pharmaceutically acceptable salt thereof Their solvates.
(23) 2環性の複素環式基が以下に示すいずれかである、上記(19)〜(22)のいず れかに記載の化合物、その製薬上許容される塩またはそれらの溶媒和物。 (23) The compound according to any one of the above (19) to (22), a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein the bicyclic heterocyclic group is any of the following: object.
[化 26] [Chemical 26]
(24)上記(1)〜(23)のレ、ずれかに記載の化合物、その製薬上許容される塩または それらの溶媒和物を含有する医薬組成物。 (24) A pharmaceutical composition comprising the compound according to (1) to (23) above, any one of the above, a pharmaceutically acceptable salt thereof, or a solvate thereof.
(25)上記(1)〜(23)のレ、ずれかに記載の化合物の 7位側鎖末端のァミノ及び Z又 はカルボキシ部分が保護された化合物、その製薬上許容される塩またはそれらの溶 媒和物。 (25) A compound in which the amino and Z or carboxy moieties at the 7-position side chain end of the compound described in (1) to (23) above are protected, a pharmaceutically acceptable salt thereof, or a compound thereof Solvent.
(26)式: Equation (26):
(式中、 (Where
Y1および Y2はそれぞれ独立して、 1)単結合、 2) _NR2、 -CO - , _NR2C〇_、 一 CONR2—、一 NR2CONR3—、一 NR2S〇 一、一 SO NR2—、一 NR2S〇 NR3_
(Rおよび Rはそれぞれ独立して水素または低級アルキル)、 = N― — N = - O S SO—、および SO—からなる群から選択されるへテロ原子含有 Y 1 and Y 2 are each independently 1) a single bond, 2) _NR 2 , -CO-, _NR 2 C〇_, one CONR 2- , one NR 2 CONR 3- , one NR 2 S〇 one, 1 SO NR 2 —, 1 NR 2 S〇 NR 3 _ (R and R are each independently hydrogen or lower alkyl), = N— — N = — containing a heteroatom selected from the group consisting of OS SO— and SO—
2 2
基、または 3) 2)のへテロ原子含有基が介在していてもよい、低級アルキレンまたは 低級アルケニレン; A lower alkylene or a lower alkenylene, optionally intervened by a group, or 3) a heteroatom-containing group of 2);
Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; Ar 1 represents a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group;
R1は、一CONHCNまたは一 C (OH) = NCN ; R 1 is one CONHCN or one C (OH) = NCN;
但し、 Y1および Y2が単結合でありかつ Ar1がピロリル、ピラゾリル、またはチェニルで ある場合を除く)で示される化合物、その製薬上許容される塩またはそれらの溶媒和 物。 Provided that Y 1 and Y 2 are a single bond and Ar 1 is pyrrolyl, pyrazolyl, or chenyl), a pharmaceutically acceptable salt thereof, or a solvate thereof.
(27) Y1および Y2が単結合; R1は、— CONHCNまたは—〇(〇Η) = Ν〇Ν ;Α が 以下に示すいずれかの複素環由来の基である、上記(26)記載の化合物、その製薬 上許容される塩またはそれらの溶媒和物。 (27) Y 1 and Y 2 are a single bond; R 1 is —CONHCN or —〇 (〇Η) = Ν〇Ν; Α is a group derived from any of the following heterocycles (26) Or a pharmaceutically acceptable salt or solvate thereof.
(28)式: Equation (28):
(式中、式: (Where formula:
[化 30] ) (Q) で示される環は、 "一 Y1— Ar1— Y2— R1"以外の置換基で置換されていてもよい、 2 環性ピリジン環;
Y1および Y2はそれぞれ独立して、 1)単結合、 2)— NR2 -CO - ,— NR2C〇— CONR2 NR2CONR3 NR2S〇 一、 SO NR2 NR2S〇 NR3— [Chemical Formula 30]) The ring represented by (Q) is a bicyclic pyridine ring optionally substituted with a substituent other than “one Y 1 —Ar 1 —Y 2 —R 1 ”; Y 1 and Y 2 are each independently 1) single bond, 2) — NR 2 —CO −, — NR 2 C〇—CONR 2 NR 2 CONR 3 NR 2 S〇 1, SO NR 2 NR 2 S〇 NR 3 —
2 2 2 2 2 2
、(R2および R3はそれぞれ独立して水素または低級アルキル)、 O—、— S―、— S 〇_、および— S〇—からなる群から選択されるへテロ原子含有基、または 3) 2)の (Wherein R 2 and R 3 are each independently hydrogen or lower alkyl), a heteroatom-containing group selected from the group consisting of O—, —S—, —S 0 —, and —S 0 —, or 3 2)
2 2
ヘテロ原子含有基が介在していてもよレ、、低級アルキレンまたは低級アルケニレン; Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; A hetero atom-containing group may be present, lower alkylene or lower alkenylene; Ar 1 is a single bond, an optionally substituted carbocyclic group or an optionally substituted heterocyclic group ;
R1は、一CONHCNまたは _C (OH) =NCN) R 1 is one CONHCN or _C (OH) = NCN)
で示される化合物、その製薬上許容される塩またはそれらの溶媒和物。 Or a pharmaceutically acceptable salt or solvate thereof.
(29) Ar1および Υ2は単結合; R1は、—CONHCNまたは— C (OH) =NCNで ある、上記(28)記載の化合物、その製薬上許容される塩またはそれらの溶媒和物。(29) Ar 1 and Υ 2 are a single bond; R 1 is —CONHCN or —C (OH) ═NCN, the compound according to (28) above, a pharmaceutically acceptable salt thereof, or a solvate thereof .
(30) Y1は単結合; Ar1は、置換されてレ、てもよレ、ァリールまたは置換されてレ、てもよ いへテロァリール; R1は、 COOHである、上記(12)記載の化合物、その製薬上許 容される塩またはそれらの溶媒和物。 (30) Y 1 is a single bond; Ar 1 is substituted, may, allyl or substituted, may be heteroaryl; R 1 is COOH, described in (12) above Or a pharmaceutically acceptable salt or solvate thereof.
( 31 ) Y1は単結合; Ar1は、置換されてレ、てもよいへテロァリール; Y2は単結合; R1は COOHの生物学的に等価な酸性基である、上記(12)記載の化合物、その製薬 上許容される塩またはそれらの溶媒和物。 (31) Y 1 is a single bond; Ar 1 is optionally substituted heteroaryl; Y 2 is a single bond; R 1 is a biologically equivalent acidic group of COOH, (12) Or a pharmaceutically acceptable salt or solvate thereof.
(32) Y1は単結合; Ar1は、置換されてレ、てもよレ、ァリールまたは置換されてレ、てもよ いへテロァリール; R1は、—COOHの生物学的に等価な酸性基である、上記(12)記 載の化合物、その製薬上許容される塩またはそれらの溶媒和物。 (32) Y 1 is a single bond; Ar 1 is a substituted, substituted, aryl, or substituted heteroaryl; R 1 is —COOH biologically equivalent The compound according to (12) above, which is an acidic group, a pharmaceutically acceptable salt thereof, or a solvate thereof.
(33) Υは単結合; Ar1は、置換されていてもよいへテロアリール; Y2は単結合; は(33) Υ is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond;
、一 COOHの生物学的に等価な酸性基である、上記(12)記載の化合物、その製薬 上許容される塩またはそれらの溶媒和物。 The compound according to (12) above, which is a biologically equivalent acidic group of COOH, a pharmaceutically acceptable salt thereof, or a solvate thereof.
(S^ Y1は単結合; Ar1は、置換されていてもよいへテロアリール; Y2は単結合; R1は 、置換されていてもよぐ環構成原子として _NH_およびその他のヘテロ原子を有 する 5 6員の複素環式基である、上記(12)記載の化合物、その製薬上許容される 塩またはそれらの溶媒和物。 (S ^ Y 1 is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is an optionally substituted ring atom _NH_ and other heteroatoms The compound according to (12), a pharmaceutically acceptable salt thereof, or a solvate thereof, which is a 56-membered heterocyclic group having
(35)式:
[化 273]Equation (35): [Chemical 273]
で示される部分が以下のいずれかの構造である、上記(12)記載の化合物、その製 薬上許容される塩またはそれらの溶媒和物。 Or a pharmaceutically acceptable salt thereof, or a solvate thereof. The compound represented by (12) above, wherein the moiety represented by:
[化 274][Chemical 274]
(36)以下のいずれかの化合物、その製薬上許容される塩またはそれらの溶媒和物 (36) Any of the following compounds, pharmaceutically acceptable salts or solvates thereof:
[化 275]
[Chemical 275]
(38)式: Equation (38):
[化 277] [Chemical 277]
(G-2)(G-2)
(39)式: Equation (39):
[化 278] [Chemical 278]
(式中、 BHはべンズヒドリル) (Where BH is Benshydryl)
で示される化合物の塩酸塩の、結 Of the hydrochloride salt of the compound represented by
(40)式: Formula (40):
[化 279] [Chemical 279]
(式中、 BHはべンズヒドリル) (Where BH is Benshydryl)
で示される化合物の塩酸塩の、結晶。 A crystal of hydrochloride of the compound represented by
発明の効果 The invention's effect
本化合物は、種々の細菌に対して強い抗菌作用を示す。好ましい化合物は、特に ブドウ球菌や肺炎球菌等のグラム陽性菌および大腸菌、緑膿菌、インフルエンザ菌 等のグラム陰性菌に対して効果がある。さらに好ましくは、肺炎球菌やインフルエンザ 困の [Ιϋί十生菌、特 (こへニシリン耐十生月市炎球困 (penicillin— resistant Streptococcus pneu moniae: PRSP)や /3—ラクタマーゼ非産生アンピシリン耐性インフルエンザ菌(beta- 1 actamase-negative, ampicillin-resistant Haemophilus influenzae: BLNAR)に対して も有効である。またより好ましいィ匕合物は、水溶性が高ぐ血中濃度—時間曲線下面 積 (AUC)、クリアランス、半減期等の体内動態も良いので、持続性の注射薬として好 適である。 This compound exhibits a strong antibacterial action against various bacteria. Preferred compounds are particularly effective against gram-positive bacteria such as staphylococci and pneumococci and gram-negative bacteria such as Escherichia coli, Pseudomonas aeruginosa and Haemophilus influenzae. More preferably, pneumococcal or influenza-resistant [Ιϋί 十 生 菌, 特 ((penicillin-resistant Streptococcus pneu moniae: PRSP) or / 3--lactamase non-producing ampicillin-resistant Haemophilus influenzae (Beta-1 actamase-negative, ampicillin-resistant Haemophilus influenzae: BLNAR), and the more preferred compound is the blood concentration-time curve bottom area (AUC), which is highly soluble in water, Because it has good pharmacokinetics such as clearance and half-life, it is suitable as a sustained injection.
発明を実施するための最良の形態
本発明書中、各用語は特に断らない限り、単独、併用のいずれの場合も以下の意 味を有する。 BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, unless otherwise specified, each term has the following meanings either independently or in combination.
Acylは、 β ラタタムの分野で使用可能なアシノレ基を意味し、例えば、従来から知 られてレ、るペニシリン誘導体の 6位のアミノ基に置換してレ、るァシル基や、セフヱムィ匕 合物の 7位ァミノ基に置換してレ、るァシル基等を意味する。そのようなァシル基の例と して、有機カルボン酸力 誘導されるァシル基、例えばホルミル基、アルキルカルボ ニル基(アルカノィル基)、好ましくは(C1〜C6)アルキル—カルボニル基(例、ァセチ ノレ、プロピオニル、ブチリノレ、イソブチリル、バレリノレ、イソバレリル、ピバロィル、へキ サノィル等)、 C3— 5アルケノィル基(例、アタリロイノレ、クロトノィノレ、マレオイル等)、 c 3— 10シクロアルキル—カルボニル基(例、シクロプロピルカルボニル、シクロプチノレ カルボニル、シクロペンチルカルボニル、シクロへキシルカルボニル、シクロへプチル カルボニル、ァダマンチルカルボニル等)、 C5— 6シクロアルケニル—カルボニル基( 例、シクロペンテニノレカノレボニノレ、シクロペンタジェ二ノレカノレボニノレ、シクロへキセニ ルカルボニル、シクロへキサジェニルカルボニル等)、ァリールカルボニル基(ァロイ ル基)、好ましくは(C6〜C14)ァリール カルボニル基(例、ベンゾィル、 1一又は 2 ナフトイル等)、ァラルキルカルボニル基、好ましくは(C7〜C19)ァラルキル カル ボニル基(例、フエ二ルァセチル、フエニルプロピオニル、 α, α, α トリフエ二ルァセ チル、 2—フエネチルカルボニル、 1一又は 2—ナフチルメチルカルボニル、ベンズヒ ドリルカルボニル等)、 5〜6員芳香族複素環カルボニル基(例、 2 又は 3 テノィル 、 2 又は 3 フロイル、ニコチノィル、イソニコチノィル、 4一又は 5 チアゾリルカル ボニル、 1 , 2,4 チアジアゾールー 3 又はー5—ィルカルボニル等)、 5〜6員芳香 族複素環ァセチル基(例、 2 _又は 3 _チェ二ルァセチル、 2 _又は 3 _フリルァセチ ル、 4_チアゾリノレァセチル、 1 , 2, 4_チアジアゾーノレ一 3—イノレアセチノレ、 1,3 _チ ァゾール _4—ィルァセチル、 1—テトラゾリルァセチル等)、アルコキシカルボニル基 、好ましくは(C1〜C6)アルコキシ—カルボニル基(例、メトキシカルボニル、エトキシ カノレボニノレ、プロポキシカノレボニノレ、イソプロポキシカノレボニノレ、ブトキシカノレボニノレ 、イソブトキシカルボニル、第三級ブトキシカルボニル等)、ァリールォキシカルボニル 基、好ましくは(C6〜C14)ァリールォキシ—カルボニル基(例、フエノキシカルボ二
ル、 1一又は 2—ナフトキシカルボニル等)、ァラルキルォキシカルボニル基、好ましく は(C7〜C19)ァラルキルォキシ カルボニル基(例、ベンジルォキシカルボニル等) 、アミノアルキルカルボニル基(例、グリシノレ、ァラニル、バリル、ロイシル、イソ口イシ ノレ、セリノレ、スレオニル、システィニル、シスチュル、メチォニル、ァスパラギル、グルタ ミル、リジノレ、アルギニル、フヱニルダリシル、フヱニルァラニル、チロシル、ヒスチジル 、トリプトファニノレ、プロリル、 2 _アミノエチルカルボニル、 3—ァミノプロピルカルボ二 ル等のアミノ C1— 6アルキル—カルボニル基等)、モノアルキルアミノアルキルカルボ ニル基 (例、メチルァミノメチルカルボニル、 2 _ェチルアミノエチルカルボニル等のモ ノ C1— 6アルキルアミノ C1— 6アルキル—カルボニル基等)、ジアルキルアミノアルキ ルカルボニル基(例、ジメチルァミノメチルカルボニル、ジェチルァミノメチルカルボ二 ル等のジ C 1一 6ァノレキノレアミノ C 1 _ 6アルキル一カルボニル基等)を挙げることがで きる。 Acyl means an asinole group that can be used in the field of β-ratata. For example, the amino group at position 6 of a penicillin derivative that has been conventionally known is substituted with an amino group at the 6-position of the penicillin derivative. Substituting with the 7-position amino group in means a ruyl group. Examples of such acyl groups include organic carboxylic acid-derived acyl groups such as formyl groups, alkylcarbonyl groups (alkanoyl groups), preferably (C1-C6) alkyl-carbonyl groups (eg, acetylenoles). ), Propionyl, butyrinole, isobutyryl, valerinole, isovaleryl, pivalolyl, hexanol, etc.), C3-5 alkenoyl group (eg, attalyloinole, crotonoinole, maleoyl etc.), c 3-10 cycloalkyl-carbonyl group (eg, cyclopropylcarbonyl) ), Cyclopentino carbonyl, cyclopentyl carbonyl, cyclohexyl carbonyl, cycloheptyl carbonyl, adamantyl carbonyl, etc.), C5-6 cycloalkenyl-carbonyl groups (eg, cyclopentenino decano levonole, cyclopenta genino decano levonole) , Shik Lohexenylcarbonyl, cyclohexaenylcarbonyl, etc.), allylcarbonyl group (alloy group), preferably (C6-C14) allyl carbonyl group (eg, benzoyl, 1 or 2 naphthoyl etc.), arral A kill carbonyl group, preferably a (C7-C19) aralkyl carbonyl group (eg phenylacetyl, phenylpropionyl, α, α, α triphenylacetyl, 2-phenethylcarbonyl, 1- or 2-naphthylmethyl) Carbonyl, benzhydrylcarbonyl, etc.), 5- to 6-membered aromatic heterocyclic carbonyl group (eg, 2 or 3 tenol, 2 or 3 furoyl, nicotinol, isonicotinoyl, 4 or 5 thiazolylcarbonyl, 1, 2,4 thiadiazole-3 Or -5-ylcarbonyl, etc.), 5- to 6-membered aromatic heterocyclic acetyl group (eg, 2_ or 3_ cherylacetyl, 2_ or 3_furylacetyl, 4_thiazolinolacetyl, 1, 2, 4_thiadiazonole 1-inoreacetinole, 1,3_thiazole_4-ylarcetyl, 1-tetrazolylacetyl, etc.), alkoxycarbonyl group, preferably (C1-C6) alkoxy-carbonyl group (eg, methoxycarbonyl, ethoxy canolebonanol, propoxycanoleboninole, isopropoxycanoleboninole, butoxycanoleboninole, isobutoxycarbonyl, tertiary butoxycarbonyl, etc.), aryloxy A carbonyl group, preferably a (C6-C14) aryloxy-carbonyl group (eg, phenoxycarbonyl) , 11 or 2-naphthoxycarbonyl, etc.), aralkyloxycarbonyl group, preferably (C7-C19) aralkyloxycarbonyl group (eg, benzyloxycarbonyl etc.), aminoalkylcarbonyl group (eg, glycinole, Arranyl, valyl, leucyl, isoquinol, serinole, threonyl, cystinyl, cistur, methionyl, asparagyl, glutamyl, lizinole, arginyl, phenyldaricyl, vinylaranyl, tyrosyl, histidyl, tryptophaninole, aminocarbonyl, prolyl, 2_ Amino C1-6 alkyl-carbonyl group such as 3-aminopropylcarbonyl), monoalkylaminoalkylcarbonyl group (eg, monoaminoaminocarbonyl such as methylaminomethylcarbonyl, 2-ethylaminoethylcarbonyl, etc.) 6 alkylamine C1-6 alkyl-carbonyl group, etc.), dialkylaminoalkylcarbonyl groups (eg, dimethylaminomethylcarbonyl, diethylaminomethylcarbonyl, etc.) Monocarbonyl group, etc.).
これらアシノレ基はアミ入ニトロ、ハロゲン (例、フッ素、塩素、臭素等)、ヒドロキシノレ、 ォキソ、力ルバモイル、 (C1〜C4)アルキル(例、メチノレ、ェチル、プロピル、イソプロ ピル、ブチル等)、(C1〜C4)アルコキシ(例、メトキシ、エトキシ、プロポキシ、ブトキシ 等)、エステル化されていてもよいカルボキシル(例、メトキシカルボニル、エトキシカル ボニル等の C1 6アルコキシカルボニル等)、カルボキシル又はハロゲン等で置換さ れていてもよい(C1〜C4)アルコキシィミノ(例、メトキシィミノ、エトキシィミノ、カルボ キシメトキシィミノ、 1 カルボキシ 1 メチルエトキシィミノ、フルォロメトキシィミノ、 フルォロエトキシィミノ等)、ヒドロキシィミノ、 4ーェチルー 2,3 ジォキソピペラジノカ ノレボニルァミノ、後記 R ( = CHZ (Zは、水素、置換されていてもよい低級アルキル、 置換されてレ、てもよレ、シクロアルキル、置換されてレ、てもよレ、ァリールまたは置換され ていてもよい複素環式基)、または = N〇R° (R°は、水素、置換されていてもよい低級 アルキル、置換されていてもよい低級アルケニル、置換されていてもよいシクロアルキ ル、置換されていてもよいァリールまたは複素環式基))等で、任意の位置が 1ないし 3個置換されていてもよい。 These asinole groups include amino-containing nitros, halogens (eg, fluorine, chlorine, bromine, etc.), hydroxynoles, oxo, rubamoyl, (C1-C4) alkyl (eg, methinole, ethyl, propyl, isopropyl, butyl, etc.), (C1-C4) substituted with alkoxy (eg, methoxy, ethoxy, propoxy, butoxy, etc.), optionally esterified carboxyl (eg, C16 alkoxycarbonyl such as methoxycarbonyl, ethoxycarbonyl, etc.), carboxyl or halogen, etc. (C1-C4) alkoxyimino (eg, methoxyimino, ethoxyimino, carboxymethoxyimino, 1-carboxy 1-methylethoxyimino, fluoromethoxyimino, fluoroethoxyimino, etc.) , Hydroxyimino, 4-ethylil 2,3 dioxopiperazinoca norebonylamino, postscript R (= CHZ (Z is hydrogen, optionally substituted lower alkyl, substituted les, optionally les, cycloalkyl, substituted les, optionally les, aryls, or optionally substituted complex Cyclic group), or = N 0 R ° (where R ° is hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted cycloalkyl, optionally substituted). 1 to 3 arbitrary positions may be substituted with a good aryl or heterocyclic group)) or the like.
上記 Acylは、好ましくは、式: Said Acyl is preferably of the formula:
[化 31]
(Acyl-1 )[Chemical 31] (Acyl-1)
Xは、 Nまたは CY(Yは水素またはハロゲン)であり、好ましくは CY (Yは水素または ハロゲン)、より好ましくは CHである。 X is N or CY (Y is hydrogen or halogen), preferably CY (Y is hydrogen or halogen), more preferably CH.
Rは、 =CHZ (Zは、水素、置換されていてもよい低級アルキル、置換されていても ょレヽシクロアルキル、置換されてレ、てもよレ、ァリールまたは置換されてレ、てもよレ、複素 環式基(好ましくは 5〜6員環))、または = N〇R° (R。は、水素、置換されていてもよい 低級アルキル、置換されていてもよい低級アルケニル、置換されていてもよいシクロ アルキル、置換されてレ、てもよレ、ァリールまたは複素環式基(好ましくは 5〜6員環) ) である。 R is = CHZ (Z is hydrogen, optionally substituted lower alkyl, optionally substituted cycloalkyl, substituted les, mayeles, aryl, or substituted les. , A heterocyclic group (preferably a 5- to 6-membered ring)), or = N ° R ° (R. is hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, substituted Optionally substituted cycloalkyl, substituted, optionally, aryl, or a heterocyclic group (preferably a 5-6 membered ring)).
Rは好ましくは、 =CHZ (Zは、置換されていてもよい低級アルキル (例:ェチル))ま たは = N〇R。であり、より好ましくは = N〇R。である。 R。は、好ましくは水素、置換され てレ、てもよレ、低級アルキルまたは置換されてレ、てもよレ、ァリールであり、より好ましくは 置換されてレ、てもよレ、低級アルキル(置換基の例:ハロゲン、置換されてレ、てもよレヽ複 素環式基 (好ましくは 5〜6員環)、または置換されてレ、てもよレ、ァリール (例:ヒドロキ シ等で置換されてレ、てもよレ、フエニル))であり、特に好ましくは低級アルキル (例:ェ チル、プロピノレ(好ましくはイソプロピル))または置換されてレ、てもよレ、ァラルキル(例 :ベンジル)である。また = CHZまたは = NOR。部分の Zや OR。の立体配置は好まし くは、シン体である。 R is preferably = CHZ (Z is an optionally substituted lower alkyl (eg ethyl)) or = N0R. And more preferably = N0R. It is. R. Is preferably hydrogen, substituted les, mayore, lower alkyl or substituted les, mayele, allyl, more preferably substituted les, mayele, lower alkyl (substituted) Examples of groups: halogen, substituted rhe or hetoleo bicyclic group (preferably 5 to 6 membered ring), or substituted rhe, het ole or aryl (eg, substituted with hydroxy, etc.) Particularly preferably lower alkyl (eg, ethyl, propinole (preferably isopropyl)) or substituted les, may, aralkyl (eg, benzyl). It is. Also = CHZ or = NOR. Z or OR of the part. The configuration is preferably a thin body.
低級アルキル基は、直鎖状又は分枝状の好ましくは炭素数 1から 6のアルキル基等 であり、メチノレ、ェチル、 n—プロピル、イソプロピノレ、 n—ブチル、イソブチル、 sec—ブ チル、 tert—ブチル、 n_ペンチル、 n_へキシル等が挙げられる。 The lower alkyl group is a linear or branched alkyl group having preferably 1 to 6 carbon atoms and the like, such as methinole, ethyl, n-propyl, isopropinole, n-butyl, isobutyl, sec-butyl, tert —Butyl, n_pentyl, n_hexyl and the like.
低級アルケニル基は、直鎖状又は分枝状の好ましくは炭素数 2から 6のアルケニル 基等であり、ァリル、プロぺニル、ブテュル、ペンテュル等が例示される。 The lower alkenyl group is a straight chain or branched, preferably an alkenyl group having 2 to 6 carbon atoms, and examples thereof include aryl, propenyl, butyr, and pentul.
シクロアルキルは、炭素数 3から 6のアルキル基等であり、シクロプロピル、シクロブ
チル、シクロペンチル、シクロへキシル等が挙げられる。 Cycloalkyl is an alkyl group having 3 to 6 carbon atoms, etc. Examples include til, cyclopentyl, cyclohexyl and the like.
上記の置換されてレ、てもよレ、低級アルキル、置換されてレ、てもよレ、低級アルケニル 、置換されていてもよいシクロアルキル、置換されていてもよいァリールまたは置換さ れていてもよい複素環式基の置換基としては、カルボキシル基、低級アルコキシカル ボニル(例:メトキシカルボニル、エトキシカルボニル)、力ルバモイル基、低級アルキ ルチオ(例:メチルチオ、ェチルチオ)、スルファモイル基、アミノ基、水酸基、シァノ基 、力ルバモイルォキシ基、ハロゲン (例: F、 C1)、置換されていてもよい複素環式基( 好ましくは 5〜6員環、例:チアゾリル、チェニル)、低級アルキル等が例示される。好 ましくは、ハロゲン (例: F、 C1)または水酸基である。 The above substituted les, may les, lower alkyls, substituted les, may les, lower alkenyls, optionally substituted cycloalkyls, optionally substituted aryls or substituted Suitable substituents for the heterocyclic group include a carboxyl group, a lower alkoxycarbonyl (eg, methoxycarbonyl, ethoxycarbonyl), a strong rubamoyl group, a lower alkylthio (eg, methylthio, ethylthio), a sulfamoyl group, an amino group, Examples include a hydroxyl group, a cyano group, a strong ruberamoyloxy group, a halogen (eg, F, C1), an optionally substituted heterocyclic group (preferably a 5- to 6-membered ring, eg: thiazolyl, chenyl), lower alkyl, etc. The Preferred is halogen (eg, F, C1) or hydroxyl group.
複素環式基とは、「ヘテロシクロアルキル」または「ヘテロァリール」を意味する。 「ヘテロシクロアルキル」は、窒素原子、酸素原子、及び/又は硫黄原子を少なくと も 1個以上環内に有する、置換可能な任意の位置に結合手を有する非芳香族複素 環式基(好ましくは 5〜7員環)を意味し、例えば、 1-ピロリニル、 2-ピロリニル、 3-ピロ リニノレ、 1-ピロリジニル、 2-ピロリジニル、 3-ピロリジニル、 1-イミダゾリニル、 2-イミダゾ リニノレ、 4-イミダゾリニル、 1-イミダゾリジニル、 2-イミダゾリジニル、 4-イミダゾリジニノレ 、 1-ビラゾリニル、 3-ビラゾリニル、 4-ビラゾリニル、 1-ビラゾリジニル、 3-ビラゾリジニル 、 4-ビラゾリジニル、ピペリジノ、 2-ピペリジル、 3-ピペリジル、 4-ピペリジル、 1-ピペラ ジニル、 2-ピペラジニル、 2-モノレホリニノレ、 3-モノレホリニノレ、モルホリノ、テトラヒドロピ ラニル等が挙げられる。なお、「非芳香族複素環式基」は、非芳香族であれば、飽和 であってもよぐ不飽和であってもよい。 Heterocyclic group means “heterocycloalkyl” or “heteroaryl”. “Heterocycloalkyl” is a non-aromatic heterocyclic group having at least one nitrogen atom, oxygen atom and / or sulfur atom in the ring and having a bond at any substitutable position (preferably Is a 5- to 7-membered ring), for example, 1-pyrrolinyl, 2-pyrrolinyl, 3-pyrrolininole, 1-pyrrolidinyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 1-imidazolinyl, 2-imidazolininole, 4-imidazolinyl , 1-imidazolidinyl, 2-imidazolidinyl, 4-imidazolidininole, 1- virazolinyl, 3- virazolinyl, 4- virazolinyl, 1- virazolidinyl, 3-virazolidinyl, 4- virazolidinyl, piperidino, 2-piperidyl, 4-piperidyl, 4 -Piperidyl, 1-piperazinyl, 2-piperazinyl, 2-monoreforinole, 3-monoreforinole, morpholino, tetrahydropyrani Etc. The. The “non-aromatic heterocyclic group” may be saturated or unsaturated as long as it is non-aromatic.
「ヘテロァリール」は、単環芳香族複素環式基及び縮合芳香族複素環式基を意味 する。 “Heteroaryl” means monocyclic aromatic heterocyclic groups and fused aromatic heterocyclic groups.
単環芳香族複素環式基は、酸素原子、硫黄原子、および Z又は窒素原子を環内 に 1〜4個含んでいてもよい 5〜8員の芳香環から誘導される、置換可能な任意の位 置に結合手を有してレ、てもよレ、基を意味する。 A monocyclic aromatic heterocyclic group may contain 1 to 4 oxygen atoms, sulfur atoms, and Z or nitrogen atoms in the ring, any substitutable atom derived from a 5 to 8 membered aromatic ring. It means a group that has a bond at the position.
縮合芳香族複素環式基は、酸素原子、硫黄原子、および Z又は窒素原子を環内 に 1〜4個含んでいてもよい 5〜8員の芳香環力 S、:!〜 4個の 5〜8員の芳香族炭素環 もしくは他の 5〜8員の芳香族へテロ環と縮合している、置換可能な任意の位置に結
合手を有してレ、てもよレ、基を意味する。 The fused aromatic heterocyclic group may contain 1 to 4 oxygen atoms, sulfur atoms, and Z or nitrogen atoms in the ring 5 to 8 membered aromatic ring force S,:! To 4 5 Bonded to any substitutable position fused to an 8-membered aromatic carbocycle or other 5- to 8-membered aromatic heterocycle. It means a group that has a joint and is a group.
「ヘテロァリール」としては、例えば、フリル(例えば、 2-フリル、 3-フリル)、チェ二ル( 例えば、 2-チェニル、 3-チェ二ル)、ピロリル(例えば、 1-ピロリル、 2-ピロリル、 3-ピロ リル)、イミダゾリル(例えば、 1_イミダゾリル、 2-イミダゾリル、 4-イミダゾリル)、ピラゾリ ル(例えば、 1-ピラゾリル、 3-ピラゾリル、 4_ピラゾリル)、トリァゾリル(例えば、 1 , 2, 4- トリァゾーノレ- 1-ィノレ、 1 , 2, 4-トリァゾール- 3-ィル、 1, 2, 4-トリァゾール -4-ィル)、テ トラゾリル(例えば、 1-テトラゾリル、 2-テトラゾリル、 5-テトラゾリル)、ォキサゾリル(例 えば、 2-ォキサゾリル、 4 -ォキサゾリル、 5 -ォキサゾリル)、イソキサゾリル(例えば、 3- イソキサゾリル、 4_イソキサゾリル、 5_イソキサゾリル)、チアゾリル(例えば、 2_チアゾリ ル、 4-チアゾリル、 5-チアゾリル)、チアジアゾリル、イソチアゾリル(例えば、 3_イソチ ァゾリル、 4-イソチアゾリル、 5_イソチアゾリル)、ピリジル(例えば、 2_ピリジル、 3_ピリ ジル、 4-ピリジル)、ピリダジニル(例えば、 3-ピリダジニル、 4_ピリダジニル)、ピリミジ ニル(例えば、 2-ピリミジェノレ、 4-ピリミジェノレ、 5-ピリミジェル)、フラザニル(例えば、 3-フラザ二ル)、ビラジニル(例えば、 2-ピラジ二ル)、ォキサジァゾリル(例えば、 1 , 3 , 4-ォキサジァゾール -2-ィル)、ベンゾフリル(例えば、 2-ベンゾ [b]フリル、 3-ベンゾ[ b]フリル、 4-ベンゾ [b]フリル、 5-ベンゾ [b]フリル、 6-ベンゾ [b]フリル、 7_ベンゾ [b]フリ ル)、ベンゾチェニル(例えば、 2-ベンゾ [b]チェニル、 3-ベンゾ [b]チェニル、 4-ベン ゾ [b]チェニル、 5-ベンゾ [b]チェニル、 6-ベンゾ [b]チェニル、 7-ベンゾ [b]チェニル) 、ベンズイミダゾリル(例えば、 1-ベンゾイミダゾリル、 2-ベンゾイミダゾリル、 4-ベンゾ イミダゾリノレ、 5-ベンゾイミダゾリノレ)、ジベンゾフリノレ、ベンゾォキサゾリノレ、キノキサリ ル(例えば、 2-キノキサリニル、 5-キノキサリニル、 6-キノキサリニル)、シンノリニル(例 えば、 3-シンノリニル、 4_シンノリニル、 5_シンノリニル、 6-シンノリニル、 7-シンノリ二 ル、 8-シンノリ二ル)、キナゾリル(例えば、 2 -キナゾリニル、 4 -キナゾリニル、 5-キナゾ リニノレ、 6-キナゾリニル、 7-キナゾリニル、 8 -キナゾリニル)、キノリル(例えば、 2-キノリ ル、 3-キノリル、 4-キノリル、 5-キノリル、 6_キノリル、 7_キノリル、 8_キノリル)、フタラジ ニル(例えば、 1_フタラジュル、 5-フタラジュル、 6_フタラジュル)、イソキノリル(例え ば、 1-イソキノリル、 3_イソキノリル、 4-イソキノリル、 5-イソキノリル、 6_イソキノリル、 7- イソキノリル、 8_イソキノリル)、プリル、プテリジニル(例えば、 2-プテリジニル、 4 -プテ
リジニノレ、 6-プテリジニル、 7-プテリジニル)、カノレバゾリノレ、フエナントリジニル、アタリ ジニル(例えば、 1-アタリジニル、 2-アタリジニル、 3-アタリジニル、 4-アタリジニル、 9- アタリジニル)、インドリル(例えば、 1-インドリル、 2-インドリル、 3-インドリル、 4-インドリ ノレ、 5-インドリル、 6-インドリル、 7-インドリル)、イソインドリル、フアナジニル(例えば、 1-フエナジニル、 2_フエナジニル)又はフエノチアジニル(例えば、 1-フエノチアジ二 ノレ、 2-フエノチアジニル、 3-フエノチアジニル、 4 -フエノチアジニル)等が挙げられる。 Examples of “heteroaryl” include furyl (eg, 2-furyl, 3-furyl), cheryl (eg, 2-chenyl, 3-phenyl), pyrrolyl (eg, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl), imidazolyl (eg, 1_imidazolyl, 2-imidazolyl, 4-imidazolyl), pyrazolyl (eg, 1-pyrazolyl, 3-pyrazolyl, 4_pyrazolyl), triazolyl (eg, 1, 2, 4 -Triazolol-1-yl, 1,2,4-triazol-3-yl, 1,2,4-triazol-4-yl), tetrazolyl (eg 1-tetrazolyl, 2-tetrazolyl, 5-tetrazolyl) ), Oxazolyl (eg 2-oxazolyl, 4-oxazolyl, 5-oxazolyl), isoxazolyl (eg 3-isoxazolyl, 4_isoxazolyl, 5_isoxazolyl), thiazolyl (eg 2_thiazolyl, 4-thiazolyl, 5-thiazolyl), thiadiazolyl, isothiazolyl (eg 3_isothiazolyl, 4-isothiazolyl, 5_isothiazolyl), pyridyl (eg 2_pyridyl, 3_pyridyl, 4 -Pyridyl), pyridazinyl (eg, 3-pyridazinyl, 4_pyridazinyl), pyrimidinyl (eg, 2-pyrimigenenole, 4-pyrimimigenole, 5-pyrimimigel), furazanyl (eg, 3-flazadinyl), birazinyl (eg, 2-pyrazinyl), oxadiazolyl (eg, 1, 3, 4-oxadiazol-2-yl), benzofuryl (eg, 2-benzo [b] furyl, 3-benzo [b] furyl, 4-benzo [b ] Furyl, 5-benzo [b] furyl, 6-benzo [b] furyl, 7_benzo [b] furyl), benzocenyl (eg 2-benzo [b] chenyl, 3-benzo [b] cheni , 4-Benzo [b] Cenyl, 5-Benzo [b] Chenyl, 6-Benzo [b] Chenyl, 7-Benzo [b] Chenyl), Benzimidazolyl (eg, 1-Benzimidazolyl, 2-Benzimidazolyl, 4- Benzoimidazolinol, 5-benzoimidazolinole), dibenzofurinole, benzoxazolinole, quinoxalyl (eg, 2-quinoxalinyl, 5-quinoxalinyl, 6-quinoxalinyl), cinnolinyl (eg, 3-cinnolinyl, 4_ Cinnolinyl, 5_cinnolinyl, 6-cinnolinyl, 7-cinnolinyl, 8-cinnolinyl), quinazolyl (eg, 2-quinazolinyl, 4-quinazolinyl, 5-quinazolinolinole, 6-quinazolinyl, 7-quinazolinyl, 8- Quinazolinyl), quinolyl (eg 2-quinolyl, 3-quinolyl, 4-quinolyl, 5-quinolyl, 6_quinolyl, 7_quinolyl, 8 _Quinolyl), phthalazinyl (eg, 1_phthaladyl, 5-phthaladuryl, 6_phthaladul), isoquinolyl (eg, 1-isoquinolyl, 3_isoquinolyl, 4-isoquinolyl, 5-isoquinolyl, 6_isoquinolyl, 7-isoquinolyl) 8_isoquinolyl), prill, pteridinyl (eg 2-pteridinyl, 4-peptidyl) Lysininore, 6-Pteridinyl, 7-Pteridinyl), Canolebasolinole, Phenanthridinyl, Atalidinyl (eg, 1-Ataridinyl, 2-Ataridinyl, 3-Ataridinyl, 4-Ataridinyl, 9-Ataridinyl), Indolyl (eg, 1- Indolyl, 2-indolyl, 3-indolyl, 4-indolinole, 5-indolyl, 6-indolyl, 7-indolyl), isoindolyl, guanazinyl (eg 1-phenazinyl, 2_phenazinyl) or phenothiazinyl (eg 1 -Phenothiazinyl, 2-phenothiazinyl, 3-phenothiazinyl, 4-phenothiazinyl) and the like.
Tは、 S、 S〇または Oであり、好ましくは Sである。 T is S, S 0 or O, preferably S.
式: Formula:
[化 32]
で示される基は、 "一 Y1— Ar1— Y2— R1"以外の置換基で置換されていてもよい、力 チオン性 N原子 (N+)を環内に有する複素環式基である。該複素環式基とは、 N原 子を少なくとも 1個、例えば:!〜 4個含有する前記の複素環式基を意味し、単環性ま たは縮合している多環性の基を意味する。カチオン性 N原子は、環上のいずれの位 置に存在していてもょレ、が、好ましくはセフヱム 3位側鎖のプロぺニルとの結合する位 置に存在し、以下の式で示される。 [Chemical 32] The group represented by is a heterocyclic group having a force thionic N atom (N + ) in the ring, which may be substituted with a substituent other than “one Y 1 —Ar 1 —Y 2 —R 1 ”. It is. The heterocyclic group means the above-mentioned heterocyclic group containing at least one N atom, for example:! -4, and represents a monocyclic or condensed polycyclic group. means. Although the cationic N atom may be present at any position on the ring, it is preferably present at the position where the cenyl 3-position side chain is bonded to propenyl and is represented by the following formula. It is.
[化 33]
該カチオンは、好ましくは 4位カルボキシァ二オンの対イオンである。該カチオン性 N原子を環内に有する複素環式基は好ましくは、ピリジニゥム基、またはカチオンを 有する 2環性の複素環式基である。カチオンを有する 2環性の複素環式基は、好まし くは以下の式で示される基である。 [Chemical 33] The cation is preferably a counter ion of the 4-position carboxion. The heterocyclic group having a cationic N atom in the ring is preferably a pyridinium group or a bicyclic heterocyclic group having a cation. The bicyclic heterocyclic group having a cation is preferably a group represented by the following formula.
(式中、 A環および B環は、それぞれ独立して、置換されていてもよい飽和または不 飽和の 5〜7員環を示し、環構成原子としてへテロ原子が 1〜3個含まれていても良 い。) (In the formula, each of A ring and B ring independently represents a saturated or unsaturated 5- to 7-membered ring which may be substituted, and includes 1 to 3 heteroatoms as ring-constituting atoms. It's okay.)
該 2環性の複素環式基は、より好ましくは、 Aまたは Bのいずれかの環がピリジン環で ある 2環性ピリジン環式基であり、特に好ましくは、 A環がピリジン環であり、 B環はべ ンゼン環、シクロペンテン、シクロへキセン、または前記の 5〜6員の複素環(例:チォ フェン、ピロール、イミダゾール、ォキサゾール、チアゾール)である。 The bicyclic heterocyclic group is more preferably a bicyclic pyridine cyclic group in which either the ring A or B is a pyridine ring, and particularly preferably, the A ring is a pyridine ring, Ring B is a benzene ring, cyclopentene, cyclohexene, or the aforementioned 5- to 6-membered heterocyclic ring (eg, thiophene, pyrrole, imidazole, oxazole, thiazole).
前記(Q)で示されるカチオン性 N原子を環内に有する複素環式基を以下に例示す る。 Examples of the heterocyclic group having the cationic N atom represented by (Q) in the ring are shown below.
[化 35]
[Chemical 35]
(Bグループ) (Group B)
[化 37] [Chemical 37]
(Cグループ) 前記(Q)で示されるカチオン性 N原子を環内に有する複素環式基は、より好ましく
は上記 cグループから選択される。 (Group C) A heterocyclic group having a cationic N atom represented by (Q) in the ring is more preferable. Is selected from group c above.
"一 Y1— Ar 1— Y2— R1 "以外の置換基としては、以下の置換基群 Dから選択される 、同一または異なる 1〜4個、好ましくは 1〜2個の置換基が例示される力 S、好ましくは 低級アルキルである。これらの置換基は、好ましくは前記複素環式基が縮合型の 2環 性基である場合、セフエム 3位側鎖部分と結合してレ、る環 (例:前記 A環)上に存在す る。 Substituents other than “one Y 1 —Ar 1 —Y 2 —R 1 ” are the same or different 1 to 4 and preferably 1 to 2 substituents selected from the following substituent group D: Exemplary force S, preferably lower alkyl. These substituents are preferably present on the ring (eg, ring A) bonded to the side chain moiety of the cepheme when the heterocyclic group is a condensed bicyclic group. The
(置換基群 D) (Substituent group D)
低級アルキル、低級アルケニル、 C3〜C7シクロアルキル、置換されていてもよい低 級アルキル (置換基:アミ人低級アルキルアミノ(例:— NHCH )、置換されていても Lower alkyl, lower alkenyl, C3 to C7 cycloalkyl, optionally substituted lower alkyl (substituent: Ami lower alkylamino (eg, —NHCH), optionally substituted
3 Three
よい低級アルキルアミノ(例:一 NHCH CH〇H)、ヒドロキシ、カルボキシ、ハロゲン Good lower alkylamino (eg 1 NHCH CHOH), hydroxy, carboxy, halogen
2 2 twenty two
)、力ルバモイル、低級アルキル力ルバモイル、ハロゲン、ヒドロキシ、カルボキシ、低 級アルコキシ、低級アルコキシカルボニル、低級アルコキシカルボニルァミノ、低級ァ ルキルカルボニル、低級アルキルカルボニルアミ入置換されていてもよいアミノ(置 換基:低級アルキル、ァミノ低級アルキル)、低級アルキルチオ、シァ入複素環式基 、ォキソ。 ), Rubamoyl, lower alkyl rubamoyl, halogen, hydroxy, carboxy, lower alkoxy, lower alkoxycarbonyl, lower alkoxycarbonylamino, lower alkylcarbonyl, lower alkylcarbonylamino optionally substituted amino (substituted) Group: lower alkyl, amino lower alkyl), lower alkylthio, sheared heterocyclic group, oxo.
"一 Y1— Ar1— Y2— R1"で示される基は、前記(Q)で示されるカチオン性 N原子を 環内に有する複素環式基の任意の位置に存在し得るが、 2環性の複素環の場合に は、好ましくは、セフエム 3位側鎖のプロぺニル部分と結合していない方の環(例:前 記 B環)上に存在する。 The group represented by “one Y 1 —Ar 1 —Y 2 —R 1 ” may be present at any position of the heterocyclic group having a cationic N atom represented by (Q) in the ring, In the case of a bicyclic heterocyclic ring, it is preferably present on the ring that is not bonded to the propenyl moiety of the cefme 3-position side chain (eg, ring B above).
Y1および Y2はそれぞれ独立して、 1 )単結合、 2)—NR2、—CO—、—NR2CO CONR2 NR2CONR3 NR2S〇 一、 SO NR2 NR2S〇 NR3— Y 1 and Y 2 are each independently 1) single bond, 2) —NR 2 , —CO—, —NR 2 CO CONR 2 NR 2 CONR 3 NR 2 S〇 1, SO NR 2 NR 2 S〇 NR 3 —
2 2 2 2 2 2
、(R2および R3はそれぞれ独立して水素または低級アルキル)、 =N―、 _N =、 _〇 ―、 _ S―、 _ SO _、および一 S〇一からなる群から選択されるへテロ原子含有基、 , (R 2 and R 3 are each independently hydrogen or lower alkyl), = N—, _N =, _O —, _S—, _SO _, and S1 Terror atom-containing groups,
2 2
または 3) 2)のへテロ原子含有基が介在していてもよい、低級アルキレンまたは低級 ァノレケニレンである。 Or 3) lower alkylene or lower anolenylene which may be intervened with the heteroatom-containing group of 2).
低級アルキルは、直鎖又は分枝状の C1〜C6アルキルを包含し、例えばメチル、ェ チル、 n—プロピル、 i—プロピル、 t—ブチル、 n—ペンチル、 n—へキシルが例示さ れる。
低級アルキレンは、低級アルキル由来の 2価の基を意味し、好ましくは一(CH ) m Lower alkyl includes linear or branched C1-C6 alkyl, and examples thereof include methyl, ethyl, n-propyl, i-propyl, t-butyl, n-pentyl, and n-hexyl. Lower alkylene means a divalent group derived from lower alkyl, preferably one (CH 3) m
2 2
- (mは:!〜 6、好ましくは 1 3の整数)で示される。 -(m is:!-6, preferably an integer of 1 3).
低級アルケニレンは、上記低級アルキレンに 1個又はそれ以上の二重結合を有す る炭素数 2 6個の直鎖状又は分枝状の低級アルケニレン基を意味し、例えば、ビニ レン、プロぺニレン又はブテニレンが挙げられる。好ましくは、炭素数 2 3個の直鎖 状の低級アルケニレンであり、例えば、ビニレン又はプロぺニレンが挙げられる。 「ヘテロ原子含有基が介在していてもよい」における「介在」とは、該ヘテロ原子含 有基が、 1)低級アルキレンもしくは低級アルケニレンを構成する炭素原子間に存在 する場合、または 2)低級アルキレンもしくは低級アルケニレンを構成する炭素原子と 、隣接する N原子含有複素環式基および Zまたは Ar1との間に存在する場合を意味 する。また該ヘテロ原子含有基 (M)は、同一または異なる、 1個またはそれ以上の基 であってよい。例えば、低級アルキレンにヘテロ原子基が介在する場合として、 -M -CH -CH -M-CH -CH— M CH— M— M— CH—などがLower alkenylene means a straight or branched lower alkenylene group having 26 carbon atoms and having one or more double bonds in the lower alkylene, and examples thereof include vinylene, propenylene. Or butenylene is mentioned. Preferred is a straight chain lower alkenylene having 23 carbon atoms, and examples thereof include vinylene and propenylene. The term “intervening” in “optionally containing a heteroatom-containing group” means that the heteroatom-containing group is present between 1) a carbon atom constituting a lower alkylene or a lower alkenylene, or 2) a lower group. It means a case where it exists between the carbon atom constituting alkylene or lower alkenylene and the adjacent N atom-containing heterocyclic group and Z or Ar 1 . The heteroatom-containing group (M) may be the same or different and one or more groups. For example, when a hetero atom group is present in lower alkylene, -M -CH -CH -M-CH -CH- M CH- M- M- CH-
2 2 2 2 2 2 例示される。 2 2 2 2 2 2 Illustrated.
Y1および Y2はそれぞれ独立して、好ましくは単結合、 NR 〇—、 -CONR2- 、— NR 〇NR3— (R2および R3はそれぞれ独立して、好ましくは水素)、 NH ま たは低級アルキレンであり、より好ましくは単結合である。 Y 1 and Y 2 are each independently, preferably a single bond, NR 0—, —CONR 2 —, —NR 0 NR 3 — (R 2 and R 3 are each independently preferably hydrogen), NH Or it is a lower alkylene, More preferably, it is a single bond.
Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていても よい複素環式基である。これらは飽和または不飽和のいずれでもよい。 Ar 1 is a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group. These may be either saturated or unsaturated.
"一 Y1— Ar1— Y2— R1"が結合する、前記(Q)で示される N原子含有複素環式基 が単環性式基 (例:ピリジン)である場合 (例:化合物(I a) )、 Ar1は好ましくは、置換 されてレ、てもよレ、炭素環式基もしくは置換されてレ、てもよレ、複素環式基である。より好 ましくは不飽和の環である。 When the N atom-containing heterocyclic group represented by (Q) to which “one Y 1 —Ar 1 —Y 2 —R 1 ” is bonded is a monocyclic group (eg, pyridine) (eg, compound) (I a)), Ar 1 is preferably a substituted, may, carbocyclic group or a substituted, may,, heterocyclic group. More preferred is an unsaturated ring.
"一 Y1— Ar1— Y2— R1"が結合する、前記(Q)で示される N原子含有複素環式基 が多環性式基 (例:縮合ピリジン等の 2環性基)である場合 (例:化合物 (I_b) )、 Ar1 は好ましくは、単結合である。 The N atom-containing heterocyclic group represented by (Q) to which “one Y 1 —Ar 1 —Y 2 —R 1 ” is bonded is a polycyclic group (eg, bicyclic group such as condensed pyridine) (Example: Compound (I_b)), Ar 1 is preferably a single bond.
Ar1における飽和または不飽和の炭素環式基は、好ましくは 3〜: 10員環であり、 C3 C7のシクロアルキル(例:シクロプロピル、シクロブチル、シクロペンチル、シクロへ
キシル、シクロへプチル)、 C5〜C7のシクロアルケニル(例:シクロペンテニル、シクロ へキセニル)およびァリール(例:フエニル、ナフチル)が例示される。 The saturated or unsaturated carbocyclic group in Ar 1 is preferably a 3- to 10-membered ring and is a C3 C7 cycloalkyl (eg, cyclopropyl, cyclobutyl, cyclopentyl, cycloto Xyl, cycloheptyl), C5-C7 cycloalkenyl (eg, cyclopentenyl, cyclohexenyl) and aryl (eg, phenyl, naphthyl).
Ar1における飽和または不飽和の複素環式基は、前記のへテロシクロアルキルまた はへテロァリールを意味し、好ましくはへテロァリールである。より好ましくは単環芳香 族複素環式基であり、詳しくは酸素原子、硫黄原子、および Z又は窒素原子を環内 に:!〜 4個含む 5〜8員、好ましくは 5〜6員環式基であり、より好ましくは、フリル、チ ェニル、ピロリル、ピラゾリル、イミダゾリノレ、ォキサゾリル、イソォキサゾリル、チアゾリ ル、イソチアゾリル、ピリジノレ、ピリダジニル、ピリミジェノレ、ピラジュル、トリァゾリル等 である。特に好ましくは、ピラゾリル、イミダゾリル、ォキサゾリル、イソォキサゾリル、チ ァゾリル、イソチアゾリルである。例えば、 Ar1がチアゾリルの場合、一Y2— !^は好まし くはチアゾール環の 2位に結合する。 The saturated or unsaturated heterocyclic group in Ar 1 means the aforementioned heterocycloalkyl or heteroaryl, preferably heteroaryl. More preferably, it is a monocyclic aromatic heterocyclic group. Specifically, it contains an oxygen atom, a sulfur atom, and a Z or nitrogen atom in the ring:! To 4 5 to 8 member, preferably 5 to 6 member cyclic More preferred are furyl, phenyl, pyrrolyl, pyrazolyl, imidazolinole, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyridinole, pyridazinyl, pyrimidinole, pyrajur, triazolyl and the like. Particularly preferred are pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl and isothiazolyl. For example, when Ar 1 is thiazolyl, 1 Y 2 —! ^ Is preferably bonded to the 2-position of the thiazole ring.
Ar1の"置換されていてもよい"における置換基は、前記置換基群 Dから選択される 、好ましくは OH、ハロゲン、低級アルキル(例:メチル)である。 The substituent in “optionally substituted” of Ar 1 is selected from the substituent group D, and is preferably OH, halogen, or lower alkyl (eg, methyl).
R1は、 CONHCN C (〇H) =NCN、または一 C〇〇Hもしくはその生物学的 に等価な酸性基を示す。 R1は、好ましくは、 CONHCNまたは C (〇H) =NCN であり、両者は異性体の関係にある。 R1は、本発明化合物が強い抗菌活性に加えて 、高い水溶性および優れた体内動態(例: AUC、半減期)を発揮するのにも重要で ある。例えば、本発明化合物を注射薬として使用する場合、アルカリ金属塩 (例: Na 塩)等として容易に水に溶解できる。 R 1 represents CONHCN C (〇H) = NCN, or 1 COOH or a biologically equivalent acidic group thereof. R 1 is preferably CONHCN or C (OH) = NCN, and both are in an isomer relationship. R 1 is important for the compounds of the present invention to exhibit high water solubility and excellent pharmacokinetics (eg, AUC, half-life) in addition to strong antibacterial activity. For example, when the compound of the present invention is used as an injection, it can be easily dissolved in water as an alkali metal salt (eg, Na salt).
COOH"の生物学的に等価な酸性基とは、一般に当業者が" COOH"の代 わりに生物学的同等性を期待して置換し得る、いわゆるバイオアイソステリック(bioiso steric)な基を意味し、具体的には、 " _ COOH"と化学構造が比較的近似し、かつ酸 性度、水溶性、および Zまたは体内動態等の物性面で "一 COOH"とほぼ同等の傾 向が期待され、かつ酸性プロトンを有する基を意味する。該酸性プロトン部分は、塩( 例:アルカリ金属塩(例: Na塩))を形成していてもよレ、。それらは例えば、 J. Med. Ch em. 1992, 35, 1176-1183, J Med. Chem. 1993, 36, 2485-2493, J Med. Chem. 1992, The biologically equivalent acidic group of “COOH” generally means a so-called bioisosteric group that one skilled in the art can substitute in the hope of bioequivalence instead of “COOH”. Specifically, the chemical structure is relatively similar to “_COOH”, and it is expected to have the same tendency as “one COOH” in terms of physical properties such as acidity, water solubility, and Z or pharmacokinetics. And a group having an acidic proton, wherein the acidic proton moiety may form a salt (eg, alkali metal salt (eg, Na salt)), for example, J. Med. em. 1992, 35, 1176-1183, J Med. Chem. 1993, 36, 2485-2493, J Med. Chem. 1992,
35, 3691-3698, J Med. Chem. 1995, 38, 617-628, Med. Res. Rev. 1983, 3, 91-118 , J Med. Chem. 2001, 44, 1560—1563, Bioorganic & Medicinal Chemistry Letters, V
ol. 4, No. 1, 41-44, 1994等に紹介されている。好ましくは、 CONHR4 SO H 35, 3691-3698, J Med. Chem. 1995, 38, 617-628, Med. Res. Rev. 1983, 3, 91-118, J Med. Chem. 2001, 44, 1560—1563, Bioorganic & Medicinal Chemistry Letters, V ol. 4, No. 1, 41-44, 1994, etc. Preferably, CONHR 4 SO H
3 Three
- SO NHR5 (R4および R5はそれぞれ独立してァミノ残基(例:水素、 OH、低級ァ-SO NHR 5 (R 4 and R 5 are each independently an amino residue (eg hydrogen, OH, lower
2 2
ノレキノレ、置換スルホニル(例:低級アルキルスルホニル、アミノスルホニル、ハロゲン 化低級アルキルスルホ二ル)、ァリールまたはへテロアリール))、 -PO H、—〇H、 Norequinole, substituted sulfonyl (eg, lower alkylsulfonyl, aminosulfonyl, halogenated lower alkylsulfonyl), aryl or heteroaryl)), -PO H, -〇H,
3 2 一 C〇CH = C (〇H) CF、 -NHSO CF、一 C〇NHS〇 CF 一 NHS〇 Me、一 3 2 One C〇CH = C (〇H) CF, -NHSO CF, One C〇NHS〇 CF One NHS〇 Me, One
3 2 3 2 3、 2 3 2 3 2 3, 2
C〇NHC〇Me、 -CONHSO Me、一 NHC〇Me、一 C〇CH C〇Me、または置 C〇NHC〇Me, -CONHSO Me, one NHC〇Me, one C〇CH C〇Me, or
2 2 twenty two
換されていてもよく(置換基の例; =〇、 = S、 _〇H等の電子吸引性基、低級アルキ ル (例:メチル))、環構成原子として— NH_およびその他のヘテロ原子(例: N、 NR' (Ra =水素、低級アルキル等)、〇、 S)を有する前記の複素環式基であり、より好まし くは 5〜6員の複素環式基である。詳しくは、—NH—の隣接部分に C = N、 N = N、 = 0、 =S等の構造を有する。該複素環式基は、テトラゾールやその誘導基、または その他の複素環式基で、以下に例示される。これらの異性体も本発明の範囲内であ る。 May be substituted (examples of substituents; electron-withdrawing groups such as = 〇, = S, _〇H, lower alkyl (eg methyl)), as ring-constituting atoms—NH_ and other heteroatoms (Example: N, NR ′ (R a = hydrogen, lower alkyl, etc.), ○, S) The above-mentioned heterocyclic group, more preferably a 5- to 6-membered heterocyclic group. Specifically, the structure adjacent to —NH— has a structure such as C = N, N = N, = 0, and = S. The heterocyclic group is tetrazole, a derivative group thereof, or other heterocyclic group, and is exemplified below. These isomers are also within the scope of the present invention.
[化 38] [Chemical 38]
R1が、上記 COOHの生物学的に等価な酸性基を示す場合、 3位ピリジン側鎖部 分として好ましくは以下の構造が例示される。当該部分は異性化されていてもよぐま た分子内または分子間で塩を形成していてもよい。 When R 1 represents a biologically equivalent acidic group of COOH, the following structure is preferably exemplified as the 3-position pyridine side chain moiety. The moiety may be isomerized, and may form a salt within or between molecules.
[化 179]
[Chemical 179]
本発明は、上記の 3位ピリジン側鎖の中間体も提供する。これらの中間体は、例え ば、ピリジン環— Ar1— Y^Ar1 :ヘテロ環基; Y3=— CN, — CONHNH , — C (NH The present invention also provides the intermediate of the above-mentioned 3-position pyridine side chain. These intermediates include, for example, the pyridine ring — Ar 1 — Y ^ Ar 1 : heterocyclic group; Y 3 = — CN, — CONHNH, — C (NH
2 2
) =NOH等)で示される化合物の Y3部分を環形成反応に付すことにより合成される) = NOH etc.) is synthesized by subjecting the Y 3 part of the compound represented by a ring formation reaction.
2 化合物(I)において波線は、シス、トランスまたはその混合を意味する力 好ましくは トランスである。 2 In compound (I), the wavy line is a force that means cis, trans or a mixture thereof, preferably trans.
化合物(I)の製法を以下に例示する。化合物(I)は基本的には、 7—ァミノ— 3—プ ロぺニル型セフヱム化合物を原料に使用して、 1) 7位のアシノレ化反応、 2)少なくとも "一 Υ1— Ar1— Υ2— R1"基を有する環状ァミンの求核反応による 3位側鎖の形成反 応、および 3)所望による脱保護反応、を適宜組合わせることにより合成できる。好ま しくは、 7—ァシルァミノ一 3 -プロぺニル型セフヱムの 3位に該環状アミンを反応させ た後、所望により脱保護すればよい。また実施例 68等に例示されるように、 3位側鎖 を形成した後、 7位ァシル化反応を行ってもよい。ァシルが前記 (Acyl_ l)で示され
る場合を例に、以下に説明する。 The production method of compound (I) is exemplified below. Compound (I) is basically composed of a 7-amino-3-propenyl-type cephem compound as a raw material. 1) Asinoleation reaction at the 7-position, 2) At least “1 Υ 1 — Ar 1 — It can be synthesized by appropriately combining the reaction of forming the 3-position side chain by nucleophilic reaction of the cyclic amine having the Υ 2 — R 1 ″ group and 3) the desired deprotection reaction. Preferably, the cyclic amine is reacted at the 3-position of 7-acylamino-1-propenyl-type cefme and then deprotected if desired. Further, as exemplified in Example 68 and the like, the 7-position asylation reaction may be carried out after forming the 3-position side chain. Is shown by (Acyl_ l) The case will be described below as an example.
ィ匕合物(II)は、特開昭 59— 172493、特開平 1— 156984、特開平 5— 339274、 特開平 7— 41484、 W099/67255等に記載の方法に準じて合成できる。 R1が— C ◦NHCNや一 C (OH) =NCNである化合物(III)は、 W097/37996に記載の方法に 準じて合成できる。 The compound (II) can be synthesized according to the method described in JP-A-59-172493, JP-A-1-156984, JP-A-5-339274, JP-A-7-41484, W099 / 67255, and the like. Compound (III) in which R 1 is —C 4 NHCN or 1 C (OH) ═NCN can be synthesized according to the method described in W097 / 37996.
[化 39] [Chemical 39]
(式中、 R6は水素またはァミノ保護基; R7は水素またはカルボキシ保護基; Yは脱離 基(例:ヒドロキシ、ハロゲン(Cl、 Br、 I等)、力ルバモイルォキシ、置換力ルバモイル ォキシ、ァシルォキシ、メタンスルホニルォキシ、トルエンスルホニルォキシ等)) (1)化合物 (IV)の製法 (Wherein R 6 is a hydrogen or amino protecting group; R 7 is a hydrogen or carboxy protecting group; Y is a leaving group (eg, hydroxy, halogen (Cl, Br, I, etc.), force ruberamoyloxy, substitution force ruberamoyloxy, (Siloxy, methanesulfonyloxy, toluenesulfonyloxy, etc.)) (1) Method for producing compound (IV)
化合物(Π)と化合物(III)またはその塩 (例:アルカリ金属塩)を反応させることにより 化合物(IV)が得られる。この場合、好ましくは R6はァミノ保護基; R7はカルボキシ保護 基である。 Compound (IV) is obtained by reacting compound (IV) with compound (III) or a salt thereof (eg, alkali metal salt). In this case, preferably R 6 is an amino protecting group; R 7 is a carboxy protecting group.
化合物(ΠΙ)の使用量は、化合物(11) 1モルに対して通常、約:!〜 10モル、好ましく は約:!〜 2モノレである。 The amount of compound (ΠΙ) to be used is generally about:! -10 mol, preferably about:!-2 monolayer, per 1 mol of compound (11).
反応溶媒としては、例えばエーテル類(例:ジォキサン、テトラヒドロフラン、ジェチル
エーテル、 tert—ブチルメチルエーテル、ジイソプロピルエーテル)、エステル類(例: ギ酸ェチル、酢酸ェチル、酢酸 n—ブチル)、ハロゲン化炭化水素類(例:ジクロロメタ ン、クロロホノレム、四塩化炭素)、炭化水素類(例: n—へキサン、ベンゼン、トルエン) 、アルコール類(例:メタノール、エタノール、イソプロパノール)、アミド類(例:ホルム アミド、 N,N_ジメチルホルムアミド、 Ν,Ν—ジメチルァセトアミド、 Ν—メチルピロリド ン)、ケトン類(例:アセトン、メチルェチルケトン)、二トリル類(例: MeCN、プロピオ二 トリル)、ジメチルスルホキシド、水などが例示される。これらの溶媒は単独で使用して も、 2種以上を混合して使用してもよい。 Examples of the reaction solvent include ethers (eg, dioxane, tetrahydrofuran, jetyl). Ethers, tert-butyl methyl ether, diisopropyl ether), esters (eg ethyl formate, ethyl acetate, n-butyl acetate), halogenated hydrocarbons (eg dichloromethane, chlorophenol, carbon tetrachloride), hydrocarbons (Example: n-hexane, benzene, toluene), alcohols (eg, methanol, ethanol, isopropanol), amides (example: formamide, N, N_dimethylformamide, Ν, Ν-dimethylacetamide, Ν -Methylpyrrolidone), ketones (eg, acetone, methyl ethyl ketone), nitriles (eg, MeCN, propionitrile), dimethyl sulfoxide, water and the like. These solvents may be used alone or in combination of two or more.
反応温度は、通常、約 _ 20〜100°C、好ましくは約 0〜50°Cである。 The reaction temperature is usually about _20-100 ° C, preferably about 0-50 ° C.
反応時間は、数時間〜数十時間である。 The reaction time is several hours to several tens of hours.
反応促進剤として、 Nal、 NaBr、 KI等を使用してもよい。 Nal, NaBr, KI, etc. may be used as a reaction accelerator.
(2)化合物 (IV)を所望により、当業者周知の方法で脱保護することにより化合物 (I) が得られる。 (2) Compound (I) can be obtained by deprotecting compound (IV) by a method well known to those skilled in the art, if desired.
反応溶媒としては、例えばエーテル類 (例:ァニソール、ジォキサン、テトラヒドロフラ ン、ジェチルエーテル、 tert—ブチルメチルエーテル、ジイソプロピルエーテル)、ェ ステル類(例:ギ酸ェチル、酢酸ェチル、酢酸 n—ブチル)、ハロゲン化炭化水素類( 例:ジクロロメタン、クロロホノレム、四塩化炭素)、炭化水素類(例: n—へキサン、ベン ゼン、トルエン)、アミド類(例:ホルムアミド、 Ν,Ν—ジメチルホルムアミド、 Ν,Ν—ジメ チルァセトアミド、 Ν—メチルピロリドン)、ケトン類(例:アセトン、メチルェチルケトン)、 二トリル類(例: MeCN、プロピオ二トリル)、ニトロ類(例:ニトロメタン、ニトロェタン、二 トロベンゼン)、ジメチルスルホキシド、水などが例示される。これらの溶媒は単独で使 用しても、 2種以上を混合して使用してもよい。 Examples of the reaction solvent include ethers (eg, anisole, dioxane, tetrahydrofuran, jetyl ether, tert-butyl methyl ether, diisopropyl ether), esters (eg, ethyl formate, ethyl acetate, n-butyl acetate), Halogenated hydrocarbons (eg, dichloromethane, chlorophenol, carbon tetrachloride), hydrocarbons (eg, n-hexane, benzene, toluene), amides (eg, formamide, Ν, Ν-dimethylformamide, Ν, Ν-dimethylacetamide, Ν-methylpyrrolidone), ketones (eg acetone, methyl ethyl ketone), nitriles (eg MeCN, propionitrile), nitros (eg nitromethane, nitrogen, nitrobenzene) , Dimethyl sulfoxide, water and the like. These solvents may be used alone or in combination of two or more.
反応温度は通常、約— 70〜50 °C、好ましくは約— 50〜0°Cである。 The reaction temperature is usually about −70 to 50 ° C., preferably about −50 to 0 ° C.
触媒としては、ルイス酸(例:八 1 SnCl, TiCl )、プロトン酸(例: HC1, H SO, HC10 Catalysts include Lewis acids (eg: 8 SnCl, TiCl), proton acids (eg: HC1, H 2 SO, HC10
3, 4 4 2 4 3, 4 4 2 4
, HCOOH,フヱノール)等が使用でき、所望によりァニソールを併用する。 , HCOOH, phenol) and the like, and if desired, anisole is used in combination.
4 Four
なお得られた化合物 (I)を更に化学修飾して別の化合物 (I)、その製薬上許容され る塩またはそれらの溶媒和物を合成することもできる。 The obtained compound (I) can be further chemically modified to synthesize another compound (I), a pharmaceutically acceptable salt thereof, or a solvate thereof.
製薬上許容される塩としては、無機塩基、アンモニア、有機塩基、無機酸、有機酸
、塩基性アミノ酸、ハロゲンイオン等により形成される塩又は分子内塩が例示される。 該無機塩基としては、アルカリ金属(Na, K等)、アルカリ土類金属(Mg等)、有機塩 基としては、プロ力イン、 2—フエニルェチルベンジルァミン、ジベンジルエチレンジァ ミン、エタノールァミン、ジエタノールァミン、トリスヒドロキシメチルァミノメタン、ポリヒド ロキシアルキルァミン、 N メチルダルコサミン等が例示される。無機酸としては、塩 酸、臭化水素酸、硫酸、硝酸、リン酸等が例示される。有機酸としては、 p_トルエン スルホン酸、メタンスルホン酸、ギ酸、トリフルォロ酢酸、マレイン酸等が例示される。 塩基性アミノ酸としては、リジン、アルギン、オル二チン、ヒスチジン等が例示される。 溶媒和物の溶媒としては水やアルコールが例示される。 Pharmaceutically acceptable salts include inorganic bases, ammonia, organic bases, inorganic acids, organic acids And salts formed by basic amino acids, halogen ions, etc., or inner salts. Examples of the inorganic base include alkali metals (Na, K, etc.), alkaline earth metals (Mg, etc.), and examples of the organic base include pro-power-in, 2-phenylethylbenzylamine, dibenzylethylenediamine. , Ethanolamine, diethanolamine, trishydroxymethylaminomethane, polyhydroxyalkylamine, N-methyldarcosamine and the like. Examples of the inorganic acid include hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid and the like. Examples of the organic acid include p_toluenesulfonic acid, methanesulfonic acid, formic acid, trifluoroacetic acid, maleic acid and the like. Examples of basic amino acids include lysine, arginine, ornithine, histidine and the like. Examples of the solvate solvent include water and alcohol.
本発明はさらに化合物 (I)の製造中間体として、化合物 (Π)、および化合物 (I)の 7 位側鎖末端のァミノおよび Zまたはカルボキシ部分が保護された化合物、その製薬 上許容される塩もしくは溶媒和物も提供する。 The present invention further provides compound (I) as an intermediate for the production of compound (I), a compound in which the amino and Z or carboxy moieties at the 7-position side chain end of compound (I) are protected, and a pharmaceutically acceptable salt thereof. Alternatively, solvates are also provided.
7位側鎖末端のァミノが保護された化合物とは、例えば、前記化合物(IV)で R6がァ ミノ保護基である化合物を意味する。該ァミノ保護基としては、低級アルコキシカルボ ニル(例: t—ブトキシカルボニル、ベンジルォキシカルボニル、 p 二トロベンジルォ キシカルボ二ル)、 (置換)ァラルカノィル(例: p 二トロべンゾィル)、ァシル(例:ホル ミル、クロロアセチル)、(置換)ァラルキル (例:トリチル)等が例示される。 The compound in which the amino group at the 7-position side chain end is protected means, for example, the compound (IV) in which R 6 is an amino protecting group. Examples of the amino protecting group include lower alkoxycarbonyl (eg, t-butoxycarbonyl, benzyloxycarbonyl, p-nitrobenzyloxycarbonyl), (substituted) aralkanol (eg, p-nitrobenzoyl), and acyl (eg: Examples include formyl, chloroacetyl), (substituted) aralkyl (eg, trityl), and the like.
カルボキシ部分が保護された化合物とは、前記化合物(IV)で R7がカルボキシ保護 基であり、および/または R1がカルボキシである場合に、それが保護されている状態 の化合物を意味する。該カルボキシ保護基としては、低級アルキル (例:メチル、ェチ ル、 t ブチル)、低級アルケニル(例:ァリル、プレニル)、(置換)ァラルキル(例:ベ ンジル、ベンズヒドリル、 p メトキシベンジル、 p ニトロべンジル)、シリノレ型保護基( t—ブチルジメチルシリル、ジフエニル t—ブチルシリル)等が例示される。また化合物 (IV)で R7がカルボキシ保護基である場合、 3位側鎖の(Q)で示される複素環式基は 、対イオン(例:ハロゲン)を有してレ、てもよレ、。 The compound in which the carboxy moiety is protected means a compound in which the compound (IV) is protected when R 7 is a carboxy protecting group and / or R 1 is carboxy. Examples of the carboxy protecting group include lower alkyl (eg, methyl, ethyl, t-butyl), lower alkenyl (eg, allyl, prenyl), (substituted) aralkyl (eg, benzyl, benzhydryl, p methoxybenzyl, p nitro). Benzyl), a silinore protecting group (t-butyldimethylsilyl, diphenyl t-butylsilyl) and the like. In addition, when R 7 is a carboxy protecting group in the compound (IV), the heterocyclic group represented by (Q) in the 3-position side chain has a counter ion (eg, halogen). ,.
本発明はさらに化合物 (I)の製造中間体として、化合物 (ΠΙ)、特に前記化合物 (ΠΙ- 1)および (ΠΙ-2)を提供する。 The present invention further provides the compound (ΠΙ), particularly the compounds (前 記 -1) and (ΠΙ-2) as production intermediates of the compound (I).
本発明はさらに以下に示す、化合物 (II)の製造中間体およびその結晶も提供する
[化 280] The present invention further provides the following production intermediate of compound (II) and crystals thereof: [Chemical 280]
( 1 ) 化合物 (G-1)の結晶 (1) Crystal of compound (G-1)
[化 281] [Chemical 281]
化合物(G-1)は、好ましくはァミン塩、より好ましくはトリアルキルアミン塩、さらに好 ましくはトリエチルァミン塩として結晶化する。該ァミン塩は溶媒 (例:水、アルコール) を含有していてもよい。トリェチルァミン塩の結晶は、粉末 X線回折パターン (X線測 定条件:管球 CuK a線、管電圧 40kV、管電流 50mA)において、好ましくは、少なく とも以下に示す位置に代表的なピークを示す。 Compound (G-1) is preferably crystallized as an amine salt, more preferably a trialkylamine salt, and even more preferably a triethylamine salt. The ammine salt may contain a solvent (eg, water, alcohol). The crystal of tolylamine salt preferably shows typical peaks at least in the following positions in the powder X-ray diffraction pattern (X-ray measurement conditions: tube CuKa line, tube voltage 40 kV, tube current 50 mA). .
2 Θ = 8. 9、 12. 2、 15. 6、 16. 5、 18. 3、 19. 4、 20. 2、 24. 1、 24. 7、 25. 2、 2 2 Θ = 8.9, 12.2, 15.6, 16.5, 18.3, 19.4, 20.2, 24.1, 24.7, 25.2, 2
6. 4 (単位:度) 該トリエチルァミン塩は、好ましくは化合物(G-1)を可溶性溶媒 (例:ジメチルァセト アミド)に溶解させた後、トリェチルァミンを好ましくは 10〜30°Cで、数時間かけて滴
下することにより調製される(参考:参考例 10)。 6.4 (unit: degree) The triethylamine salt is preferably prepared by dissolving compound (G-1) in a soluble solvent (eg, dimethylacetamide) and then adding triethylamine preferably at 10 to 30 ° C. Drops over time (Reference: Reference Example 10).
(2) 化合物 (G-2)の結晶 (2) Crystal of compound (G-2)
[化 282] [Chemical 282]
化合物(G-2)は、好ましくは無機酸塩、より好ましくは塩酸塩として結晶化する。該 塩酸塩は溶媒 (例:水、アルコール)を含有していてもよい。塩酸塩の結晶は、粉末 X 線回折パターン (X線測定条件:管球 CuK a線、管電圧 40kV、管電流 50mA、以下 同様)において、好ましくは、少なくとも以下に示す位置に代表的なピークを示す。 2 Θ = 5. 9、 9. 9、 11. 6、 13. 9、 23. 4、 23. 9、 27. 5、 27. 8 (単位:度) 該塩酸塩は好ましくは、前記化合物(G-1)を有機溶媒 (例:ジメチルホルムアミド、 塩化メチレンまたはその混合液)中、ォキザリルクロライドと、氷冷下〜— 40°Cで数時 間反応させることにより調製される(参考:参考例 2)。 Compound (G-2) is preferably crystallized as an inorganic acid salt, more preferably as a hydrochloride. The hydrochloride may contain a solvent (eg, water, alcohol). The hydrochloride crystal preferably has typical peaks at least at the following positions in the powder X-ray diffraction pattern (X-ray measurement conditions: tube CuK a line, tube voltage 40 kV, tube current 50 mA, and so on). Show. 2 Θ = 5.9, 9.9, 11.6, 13.9, 23.4, 23.9, 27.5, 27.8 (unit: degree) The hydrochloride is preferably the compound (G -1) is reacted with oxalyl chloride in an organic solvent (eg, dimethylformamide, methylene chloride or a mixture thereof) for several hours under ice-cooling at -40 ° C (Reference: Reference) Example 2).
(3)化合物 (G-3)の結晶 (3) Crystal of compound (G-3)
(式中、 BHはべンズヒドリル) (Where BH is Benshydryl)
化合物(G-3)は、好ましくは無機酸塩、より好ましくは塩酸塩として結晶化する。該 塩酸塩は溶媒 (例:水、アルコール)を含有していてもよい。塩酸塩の結晶は、粉末 X 線回折パターン (X線測定条件:管球 CuKひ線、管電圧 40kV、管電流 50mA、以下 同様)において、好ましくは、少なくとも以下に示す位置に代表的なピークを示す。 Compound (G-3) is preferably crystallized as an inorganic acid salt, more preferably as a hydrochloride. The hydrochloride may contain a solvent (eg, water, alcohol). In the powder X-ray diffraction pattern (X-ray measurement conditions: tube CuK strand, tube voltage 40 kV, tube current 50 mA, the same applies below), the hydrochloride crystals preferably have representative peaks at least at the positions shown below. Show.
2 Θ =4. 0、 16. 1、 19. 6、 20. 2、 21. 2 (単位:度) 2 Θ = 4.0, 16.1, 19.1, 20.2, 21.2 (Unit: degree)
該塩酸塩は好ましくは、化合物 (G-3)を有機溶媒 (例:酢酸ェチル)中、塩酸と反 応させた後、濃縮し、氷冷下で数十分攪拌することにより調製される (参考:参考例 1
(4)化合物(G-4)の結晶 The hydrochloride is preferably prepared by reacting compound (G-3) with hydrochloric acid in an organic solvent (eg, ethyl acetate), concentrating and stirring for several tens of minutes under ice cooling ( Reference: Reference Example 1 (4) Crystal of compound (G-4)
[化 284] [Chemical 284]
(式中、 BHはべンズヒドリル) (Where BH is Benshydryl)
化合物(G-4)は、好ましくは無機酸塩、より好ましくは塩酸塩として結晶化する。該 塩酸塩は溶媒 (例:水、アルコール)を含有していてもよい。塩酸塩の結晶は、粉末 X 線回折パターン (X線測定条件:管球 CuK a線、管電圧 40kV、管電流 50mA、以下 同様)において、好ましくは、少なくとも以下に示す位置に代表的なピークを示す。 Compound (G-4) is preferably crystallized as an inorganic acid salt, more preferably as a hydrochloride. The hydrochloride may contain a solvent (eg, water, alcohol). The hydrochloride crystal preferably has typical peaks at least at the following positions in the powder X-ray diffraction pattern (X-ray measurement conditions: tube CuK a line, tube voltage 40 kV, tube current 50 mA, and so on). Show.
2 Θ = 6. 8、 8. 3、 11. 0、 15. 7、 18. 3、 21. 6、 23. 5、 23. 7 (単位:度) 該塩酸塩は好ましくは、化合物(G-4)を有機溶媒 (例:酢酸ェチル、メタノール)中 、塩酸と反応させた後、濃縮することにより調製される (参考:参考例 2)。 2 Θ = 6.8, 8. 3, 11. 0, 15. 7, 18. 3, 21. 6, 23.5, 23.7 (unit: degree) The hydrochloride is preferably compound (G- It is prepared by reacting 4) with hydrochloric acid in an organic solvent (eg, ethyl acetate, methanol) and then concentrating (Reference: Reference Example 2).
上記の各結晶は、不純物が少なぐ安定であり、および Zまたは取り扱い性がよい 等の利点を有する。よって本発明のセフエム化合物等の合成中間体として有用であ る。 Each of the above crystals has advantages such as being stable with few impurities and having good Z or handleability. Therefore, it is useful as a synthetic intermediate for the cephem compound of the present invention.
本発明の製造中間体は、化合物 (I)が優れた抗菌作用および Zまたは体内動態を 示すのに寄与している。 The production intermediate of the present invention contributes to the excellent antibacterial action and Z or pharmacokinetics of Compound (I).
本発明化合物はスぺタトノレの広い抗菌活性を有し、人を含む各種哺乳動物におけ る病原性細菌により生ずる種々の疾病、例えば気道感染症、尿路感染症、呼吸器感 染症、敗血症、腎炎、胆嚢炎、 口腔内感染症、心内膜炎、肺炎、骨髄膜炎、中耳炎 、腸炎、畜膿、創傷感染、 日和見感染等の予防又は治療のために使用され得る。 本発明化合物は、特にブドウ球菌や肺炎球菌等のグラム陽性菌および大腸菌、緑 膿菌、インフルエンザ菌等のグラム陰性菌に対して効果がある。さらに好ましくは、肺 炎球菌やインフルエンザ菌の耐性菌、特にペニシリン it性肺炎球菌(penicillin-resis tant Streptococcus pneumoniae: PRSP)や ーラクタマーゼ非産生アンピシリン耐性
インフノレェンサ困 beta_lactamase_negative, ampicillin-resistant Haemophilus influe nzae: BLNAR)に対しても有効である。また好ましいィ匕合物は、水溶性が高ぐ血中濃 度一時間曲線下面積 (AUC)やクリアランス等の体内動態も良いので、持続性の注 射薬として好適である。 The compound of the present invention has a broad antibacterial activity of Specetanol, and various diseases caused by pathogenic bacteria in various mammals including humans such as respiratory tract infections, urinary tract infections, respiratory infections, sepsis , Nephritis, cholecystitis, oral infection, endocarditis, pneumonia, osteomyelitis, otitis media, enteritis, pus, wound infection, opportunistic infection, etc. The compounds of the present invention are particularly effective against gram-positive bacteria such as staphylococci and pneumococci and gram-negative bacteria such as Escherichia coli, Pseudomonas aeruginosa and Haemophilus influenzae. More preferably, resistant strains of pneumococci and Haemophilus influenzae, particularly penicillin-resis tant Streptococcus pneumoniae (PRSP) and non-lactamase non-producing ampicillin resistant It is also effective against Infnorensa (beta_lactamase_negative, ampicillin-resistant Haemophilus influenzae: BLNAR). In addition, preferred compounds are suitable as long-lasting injections because they have good water solubility and good pharmacokinetics such as the area under the blood concentration one hour curve (AUC) and clearance.
本発明化合物は、注射剤、カプセル剤、錠剤、顆粒剤として非経口または経口的 に投与できるが、好ましくは注射剤として投与される。投与量は、通常、患者または動 物の体重 lkg当たり、約 0. 1〜: !OOmg/日、好ましくは約 0. 5〜50mg/日を、所望 により 1日 2〜4回に分割して投与すればよい。注射剤として用いられる場合の担体 は、たとえば蒸留水、生理食塩水などであり、また pH調節のための塩基等を使用し てもよレ、。カプセル剤、顆粒剤、錠剤として用いられる場合の担体は、公知の賦形剤 ( 例:デンプン、乳糖、白糖、炭酸カルシウム、リン酸カルシウムなど)、結合剤 (例:デン プン、アラビアゴム、カルボキシメチルセル口一ス、ヒドロキシプロピルセル口一ス、結 晶セル口—スなど)、滑沢剤 (例:ステアリン酸マグネシウム、タルクなど)等である。 The compound of the present invention can be administered parenterally or orally as an injection, capsule, tablet or granule, but is preferably administered as an injection. The dosage is usually about 0.1 to: OOmg / day, preferably about 0.5 to 50mg / day per kg of patient or animal body weight, divided into 2 to 4 times a day as desired. What is necessary is just to administer. When used as an injection, the carrier is, for example, distilled water, physiological saline or the like, and a base for adjusting pH may be used. Carriers when used as capsules, granules, and tablets are known excipients (eg, starch, lactose, sucrose, calcium carbonate, calcium phosphate, etc.), binders (eg, starch, gum arabic, carboxymethyl cell) Mouth, hydroxypropyl cell, crystal cell, etc.), lubricants (eg, magnesium stearate, talc, etc.).
[0018] 以下に実施例を示す。 [0018] Examples are shown below.
(略号) (Abbreviation)
Me:メチル; Et :ェチル; iPr:イソプロピル; Bu :t—ブチノレ; Ac:ァセチル; DMF:ジ メチルホルムアミド; THF:テトラヒドロフラン; Bo t-ブトキシカルボニル; PMB:p_ メトキシベンジル; BH:ベンズヒドリノレ Me: Methyl; Et: Ethyl; iPr: Isopropyl; Bu: t-Butinole; Ac: Acetyl; DMF: Dimethylformamide; THF: Tetrahydrofuran; Bo t-Butoxycarbonyl; PMB: p_Methoxybenzyl;
参考例 1 Reference example 1
[0019] [化 40]
[0019] [Chemical 40]
(1) a→b→c (1) a → b → c
ィ匕合物 a(266.5g,0.5mol)をテトラヒドロフラン (1.51)に溶解させ、 NaI(225g,1.5mol)を加 えた。反応液は室温で 30分攪拌し、酢酸ェチル (1.51)と水 (1.51)中に注加した。有機 層を分取し、 5%Na S 0水溶液、ブラインの順に洗浄した。 MgSO乾燥し、減圧下濃 縮した。残渣を酢酸ェチルに溶解させ、氷冷下で PPh (1 57g,0.6mol)を加えた。室温 で 1時間 40分攪拌し、氷冷し、更に 20分攪拌した。析出した沈殿を濾取し、減圧下乾 燥して化合物 cを得た。淡黄色粉末。収量 440g(99%) Compound a (266.5 g, 0.5 mol) was dissolved in tetrahydrofuran (1.51), and NaI (225 g, 1.5 mol) was added. The reaction solution was stirred at room temperature for 30 minutes and poured into ethyl acetate (1.51) and water (1.51). The organic layer was separated and washed with 5% Na 2 S 0 aqueous solution and brine in this order. It was dried over MgSO and concentrated under reduced pressure. The residue was dissolved in ethyl acetate and PPh (157 g, 0.6 mol) was added under ice cooling. The mixture was stirred at room temperature for 1 hour and 40 minutes, cooled on ice, and further stirred for 20 minutes. The deposited precipitate was collected by filtration and dried under reduced pressure to obtain compound c. Pale yellow powder. Yield 440g (99%)
(2) c→d (2) c → d
化合物 c(440g,0.496mol)を塩化メチレン (2.51)に溶解させ、氷冷化で 2N-NaOH(298 ml,0.595mol)をカ卩えた。反応液は室温で 35分攪拌し、塩化メチレン層を分取し、ブラ インで洗浄した。 MgSO乾燥し、減圧下濃縮した。残渣を塩化メチレン (375ml)に溶解 させ、酢酸ェチル (750ml)をカ卩えた後、氷冷で 30分攪拌した。析出した沈殿を濾取し、 減圧下乾燥して化合物 dを得た。茶褐色粉末。収量 314g(83%) Compound c (440 g, 0.496 mol) was dissolved in methylene chloride (2.51), and 2N-NaOH (298 ml, 0.595 mol) was obtained by cooling with ice. The reaction solution was stirred at room temperature for 35 minutes, and the methylene chloride layer was separated and washed with brine. MgSO was dried and concentrated under reduced pressure. The residue was dissolved in methylene chloride (375 ml), ethyl acetate (750 ml) was added, and the mixture was stirred with ice cooling for 30 minutes. The deposited precipitate was collected by filtration and dried under reduced pressure to obtain compound d. Brown powder. Yield 314 g (83%)
(3) d→e (3) d → e
化合物 d(156g,206mmol)をテトラヒドロフラン (1.41)及びジメチルスルホキシド (160ml) に懸濁させ、 BSA(25.46ml,103mmol)に次ぃで19.6%-ClCH2CHO/CHC13(247g,616m mol)を加えた。反応液は室温で 2時間 30分攪拌した後、酢酸ェチル (1.51)と水 (1.51)を
加えた。有機層を分取し、水、ブラインの順で洗浄した。 M gSO乾燥し、減圧下濃縮 した。残渣にイソプロパノール (1.01)を加えた後、室温で 20分攪拌した。析出した沈殿 を濾取し、減圧下乾燥して化合物 eを得た。淡黄色粉末。収量 103.9g(90%) Compound d (156 g, 206 mmol) was suspended in tetrahydrofuran (1.41) and dimethyl sulfoxide (160 ml), and 19.6% -ClCH2CHO / CHC13 (247 g, 616 mmol) was added to BSA (25.46 ml, 103 mmol). The reaction solution was stirred at room temperature for 2 hours and 30 minutes, and then ethyl acetate (1.51) and water (1.51) were added. added. The organic layer was separated and washed with water and then brine. MgSO 4 was dried and concentrated under reduced pressure. Isopropanol (1.01) was added to the residue, and the mixture was stirred at room temperature for 20 minutes. The deposited precipitate was collected by filtration and dried under reduced pressure to obtain compound e. Pale yellow powder. Yield 103.9g (90%)
(4) e→f (4) e → f
化合物 e(103.8g,186mmol)を塩化メチレン (690ml)に溶解させ、 4-クロロチオフヱノー ル (9.4g,65mmol)に次いで AVN*(16.1g,65mmol)を加えた。反応液は還流下で 3時間 4 5分攪拌した後、イソプロパノール (250ml)をカ卩ぇ半分の体積まで濃縮した。更にイソ プロパノール (350ml)をカ卩えて析出した沈殿を濾取し、減圧乾燥して化合物 f¾r得た。 淡黄色粉末。収量 74.09g(72%) Compound e (103.8 g, 186 mmol) was dissolved in methylene chloride (690 ml), and 4-chlorothiophenol (9.4 g, 65 mmol) was added followed by AVN * (16.1 g, 65 mmol). The reaction solution was stirred for 3 hours and 45 minutes under reflux, and then isopropanol (250 ml) was concentrated to half the volume. Further, isopropanol (350 ml) was added, and the deposited precipitate was collected by filtration and dried under reduced pressure to obtain compound f¾r. Pale yellow powder. Yield 74.09g (72%)
(5) f→g (5) f → g
PCI (55.2g,265mmol)を塩化メチレン (670ml)に懸濁させ氷冷下でピリジン (23.6ml,29 PCI (55.2 g, 265 mmol) was suspended in methylene chloride (670 ml) and pyridine (23.6 ml, 29
2mmol)を 5分かけて滴下した。混合液に化合物 i(74.08g, 133mmol)を加え、室温で 20 分攪拌した後、 _40°Cに下げメタノール (265ml)を加えた。反応液は氷冷下で 15分攪 拌し、水 (690ml)を加えた。塩化メチレン層を分取し、水、 NaHCO水溶液 (23.5g/294 ml)、ブラインの順に洗浄した。溶液は MgSO乾燥した後、 4N-HCl/EtOAc(66.3ml,262 mmol) was added dropwise over 5 minutes. Compound i (74.08 g, 133 mmol) was added to the mixture, and the mixture was stirred at room temperature for 20 minutes, and then lowered to _40 ° C. and methanol (265 ml) was added. The reaction mixture was stirred for 15 minutes under ice cooling, and water (690 ml) was added. The methylene chloride layer was separated and washed with water, aqueous NaHCO 3 solution (23.5 g / 294 ml) and brine in this order. The solution was dried over MgSO, 4N-HCl / EtOAc (66.3 ml, 26
5mmol)及び酢酸ェチル (330ml)を加えて濃縮した。 400mlの体積に濃縮し、氷冷下で 30分攪拌した。析出した結晶を濾取し減圧乾燥して化合物 gを得た。 白色結晶。収量 54.2g(86%) 5 mmol) and ethyl acetate (330 ml) were added and concentrated. The solution was concentrated to a volume of 400 ml and stirred for 30 minutes under ice cooling. The precipitated crystals were collected by filtration and dried under reduced pressure to obtain compound g. White crystals. Yield 54.2 g (86%)
'H-NMR (d -DMSO): 3.76,3.98(2H, Abq, J = 17.1Hz), 4.24(2H, d, J = 6.3Hz), 5.23 'H-NMR (d-DMSO): 3.76,3.98 (2H, Abq, J = 17.1Hz), 4.24 (2H, d, J = 6.3Hz), 5.23
(1H, q, J = 4.8Hz), 5.31(1H, d, J = 5.1Hz), 5.38(1H, m), 6.90(1H, d, J = 15.6Hz), 6. 99(1H, s), 7.28— 7.50(10H, m), 9.22(3H, br- s). (1H, q, J = 4.8Hz), 5.31 (1H, d, J = 5.1Hz), 5.38 (1H, m), 6.90 (1H, d, J = 15.6Hz), 6.99 (1H, s) , 7.28—7.50 (10H, m), 9.22 (3H, br-s).
化合物 g (塩酸塩結晶)の粉末 X線回折パターンを図 3に示す。 Fig. 3 shows the powder X-ray diffraction pattern of compound g (hydrochloride crystals).
(6) g + h→ 8 (6) g + h → 8
化合物 g(17.36g,36.4mmol)、及び化合物 h(12.62g,40mmol)を酢酸ェチル (200ml)に 懸濁させ、 PhOP(0)Cl (4.31ml,47.3mmol)を加えた。混合液を- 30°Cに冷却し、 N-Met hylmo卬 holine(18ml,164mmol)を 15分かけて滴下した。反応液は 10分攪拌し希塩酸を 加え、有機層を分取した。有機層は 5%NaHC03、水、ブラインの順に洗浄し、 MgS04 乾燥した。減圧下で濃縮して化合物 8を得た。収量 17.52g(102%)
Ή-NMR (CDC1 ): 1.35(3H, t, J = 6.9Hz), 1.52(9H, s), 3.55,3.63(2H, Abq, J = 17.7Compound g (17.36 g, 36.4 mmol) and compound h (12.62 g, 40 mmol) were suspended in ethyl acetate (200 ml), and PhOP (0) Cl (4.31 ml, 47.3 mmol) was added. The mixture was cooled to −30 ° C., and N-Metylylholine (18 ml, 164 mmol) was added dropwise over 15 minutes. The reaction solution was stirred for 10 minutes, diluted hydrochloric acid was added, and the organic layer was separated. The organic layer was washed with 5% NaHC03, water and brine in that order and dried over MgS04. Concentration under reduced pressure gave compound 8. Yield 17.52 g (102%) Ή-NMR (CDC1): 1.35 (3H, t, J = 6.9Hz), 1.52 (9H, s), 3.55, 3.63 (2H, Abq, J = 17.7
3 Three
Hz), 4.00(2H, d, J = 6.6Hz), 4.36(2H, q, J = 6.9Hz), 5.12(1H, d, J = 5.1Hz), 5.99(1 H, m), 6.02(1H, dd, J = 4.8, 9.0Hz), 6.93(1H, d, J = 15.9Hz), 7.00(1H, s), 7.26-7.4 6(12H, m). Hz), 4.00 (2H, d, J = 6.6Hz), 4.36 (2H, q, J = 6.9Hz), 5.12 (1H, d, J = 5.1Hz), 5.99 (1 H, m), 6.02 (1H , dd, J = 4.8, 9.0Hz), 6.93 (1H, d, J = 15.9Hz), 7.00 (1H, s), 7.26-7.4 6 (12H, m).
参考例 2 Reference example 2
[化 41] [Chemical 41]
(1) 1→2→3 (1) 1 → 2 → 3
化合物1(25(¾,1.2511101)を塩化メチレン(2.51)に懸濁させ、 Boc20(381.5g, 1.75mol)に 次いで DABCO(0.14g, 1.25mmol)をカ卩えた。室温で 3日間攪拌し、減圧下で濃縮した 。残渣をエタノール (190ml)に溶解させ、氷冷しておいた NaOH(200g,5.0mol)の水 (1.1 31)溶液に加えた。混合液を 50分攪拌した後に水 (41)で薄め、 2N-塩酸 (2.61)を加えた 。析出した結晶を濾取して、化合物 3を得た。収量 343.2g(100%)
Ή-NMR (d -DMSO): 1.48(9H, s), 7.90(1H, s). Compound 1 (25 (¾, 1.2511101) was suspended in methylene chloride (2.51), and Boc20 (381.5 g, 1.75 mol) was added to DABCO (0.14 g, 1.25 mmol) .The mixture was stirred at room temperature for 3 days. The residue was dissolved in ethanol (190 ml) and added to ice-cooled NaOH (200 g, 5.0 mol) in water (1.1 31) and the mixture was stirred for 50 minutes before adding water ( 2N-hydrochloric acid (2.61) was added, and the precipitated crystals were collected by filtration to give compound 3. Yield 343.2 g (100%) NMR-NMR (d-DMSO): 1.48 (9H, s), 7.90 (1H, s).
(2) 3→4 (2) 3 → 4
化合物 3(100.5g,369mmol)をメタノール (300ml)に溶解させ、 NH2OEt 'HCl(40g,406m mol)と Et3N(56.6ml,406mmol)のメタノール (600ml)溶液を加えた。室温で 2時間 30分攪 拌した後に減圧下で濃縮した。残渣に水を加え、酢酸ェチルで抽出した。有機層は MgS04乾燥後、減圧下濃縮した。結晶性の残渣に酢酸ェチルとェチルエーテルを 加え濾取して化合物 4を得た。収量 99.7g(86%)。本品の NMR解析において、才キシム 部位のアンチ異性体は認められな力、つた。 Compound 3 (100.5 g, 369 mmol) was dissolved in methanol (300 ml), and a solution of NH2OEt′HCl (40 g, 406 mmol) and Et3N (56.6 ml, 406 mmol) in methanol (600 ml) was added. The mixture was stirred at room temperature for 2 hours and 30 minutes, and concentrated under reduced pressure. Water was added to the residue and extracted with ethyl acetate. The organic layer was dried under MgS04 and concentrated under reduced pressure. Compound 4 was obtained by adding ethyl acetate and ethyl ether to the crystalline residue and filtering. Yield 99.7 g (86%). In the NMR analysis of this product, the anti-isomer of the talented oxime site was unacceptable.
'H-NMR (d -DMSO): 1.21(3H, t, J = 6.9Hz), 1.47(9H, s), 4.11(2H, q, J = 6.9Hz), 7 'H-NMR (d-DMSO): 1.21 (3H, t, J = 6.9Hz), 1.47 (9H, s), 4.11 (2H, q, J = 6.9Hz), 7
• 34(1H, s). • 34 (1H, s).
(3) 4→5 (3) 4 → 5
トリフルォロ酢酸 (3ml)を氷冷しておき、化合物 4(946mg,3mmol)を加えた。室温で 2時 間 10分攪拌した後、あらかじめ氷冷しておいた 4N-HCl/EtOAc(0.9ml,3.6mmol)の酢 酸ェチル (10ml)溶液に加えた。氷冷下で 30分間攪拌し、析出晶を濾取して化合物 5 を得た。収量 706mg(94%)。本品の NMR解析において、ォキシム部位のアンチ異性体 は認められなかった。 Trifluoroacetic acid (3 ml) was cooled on ice, and compound 4 (946 mg, 3 mmol) was added. The mixture was stirred at room temperature for 2 hours and 10 minutes, and then added to a solution of 4N HCl / EtOAc (0.9 ml, 3.6 mmol) in ethyl acetate (10 ml) that had been ice-cooled in advance. The mixture was stirred for 30 minutes under ice cooling, and the precipitated crystals were collected by filtration to obtain Compound 5. Yield 706 mg (94%). In the NMR analysis of this product, no anti-isomer at the oxime site was found.
'H-NMR (d -DMSO): 1.25(3H, t, J = 7.2Hz), 4.19(2H, q, J = 7.2Hz), 7.00(1H, s). 'H-NMR (d-DMSO): 1.25 (3H, t, J = 7.2Hz), 4.19 (2H, q, J = 7.2Hz), 7.00 (1H, s).
(4) 6→7 (4) 6 → 7
化合物 6(108g,0.5mol)をジメチルホルムアミド (375ml)に懸濁させ、氷冷下で Etl(60ml ,0.75mol)、次いで DBU(112ml,0.75mmol)を加えた。氷冷下で 30分間攪拌し、室温ま で昇温させ更に 1時間 30分攪拌した。反応液に氷水 (21)を加え室温で 30分攪拌し、析 出した沈殿を濾取した。沈殿をエタノール (400ml)に懸濁させ、 4N_NaOH(400ml,1.6 mol)を加えた。混合液を 40°Cで 2時間攪拌した後、氷冷下で 6N-HCl(270ml,1.6mol)を 加えた。氷冷で 2時間攪拌して析出した結晶を濾取し、化合物 7を得た。収量 43.6g(4 1%)。本品の NMR解析において、ォキシム部位のアンチ異性体は認められなかった。 'H-NMR (d -DMSO): 1.20(3H, t, J = 6.9Hz), 4.11(2H, q, J = 7.2Hz), 6.84(1H, s), 7 Compound 6 (108 g, 0.5 mol) was suspended in dimethylformamide (375 ml), and Etl (60 ml, 0.75 mol) and then DBU (112 ml, 0.75 mmol) were added under ice cooling. The mixture was stirred for 30 minutes under ice cooling, warmed to room temperature, and further stirred for 1 hour and 30 minutes. Ice water (21) was added to the reaction solution, and the mixture was stirred at room temperature for 30 minutes, and the precipitated precipitate was collected by filtration. The precipitate was suspended in ethanol (400 ml) and 4N_NaOH (400 ml, 1.6 mol) was added. The mixture was stirred at 40 ° C for 2 hours, and then 6N-HCl (270 ml, 1.6 mol) was added under ice cooling. The mixture was stirred for 2 hours under ice cooling and the precipitated crystals were collected by filtration to obtain Compound 7. Yield 43.6 g (4 1%). In the NMR analysis of this product, no anti-isomer at the oxime site was observed. 'H-NMR (d-DMSO): 1.20 (3H, t, J = 6.9Hz), 4.11 (2H, q, J = 7.2Hz), 6.84 (1H, s), 7
• 23(2H, s). • 23 (2H, s).
(5) 7→5
化合物 7(19.4g,83mmol)は酢酸 (100ml)に懸濁させ、 90°Cに加温し完全に溶解させ た。室温まで徐々に室温まで冷却し、析出した結晶を濾取した。結晶を酢酸ェチル に懸濁させて 4N-HCl/EtOAc(27ml,108mmol)を加えた。析出した油状沈殿を結晶化 させ濾取し、化合物 5を得た。収量 18.5g(89%)。本品の NMR解析において、上記 (3)と 同様のスペクトルパターンを示した。またォキシム部位のアンチ異性体は認められな かった。 (5) 7 → 5 Compound 7 (19.4 g, 83 mmol) was suspended in acetic acid (100 ml), heated to 90 ° C. and completely dissolved. The mixture was gradually cooled to room temperature, and the precipitated crystals were collected by filtration. The crystals were suspended in ethyl acetate and 4N-HCl / EtOAc (27 ml, 108 mmol) was added. The precipitated oily precipitate was crystallized and collected by filtration to obtain Compound 5. Yield 18.5 g (89%). NMR analysis of this product showed the same spectral pattern as in (3) above. Also, no anti-isomer at the oxime site was observed.
(6) 5→8 (6) 5 → 8
氷冷されたジメチルホルムアミド (4.64ml,60mmol)と塩化メチレン (250ml)の混合液に オギザリルクロリド (4.8ml,55mmol)を滴下し、氷冷下で 20分間攪拌した。 _40°Cまで冷 却して化合物 5(12.6g,50mmol)を加え- 30 °Cで 4時間攪拌した。更にジメチルホルムァ ミド (0.85ml)とオギザリルクロリド (0.87ml)より調整した Vilsmeier試薬の塩化メチレン溶 液を追加した。反応液は _30°Cで更に 1時間 20分攪拌し、析出晶を濾取して化合物 8 を得た。収量 11.2g(83%)。本品の NMR解析において、ォキシム部位のアンチ異性体 は認められなかった。 Ogitalyl chloride (4.8 ml, 55 mmol) was added dropwise to a mixture of ice-cooled dimethylformamide (4.64 ml, 60 mmol) and methylene chloride (250 ml), and the mixture was stirred for 20 minutes under ice cooling. After cooling to _40 ° C, compound 5 (12.6g, 50mmol) was added and stirred at -30 ° C for 4 hours. Further, a methylene chloride solution of Vilsmeier reagent prepared from dimethylformamide (0.85 ml) and oxalyl chloride (0.87 ml) was added. The reaction solution was further stirred at _30 ° C for 1 hour and 20 minutes, and the precipitated crystals were collected by filtration to obtain Compound 8. Yield 11.2 g (83%). In the NMR analysis of this product, no anti-isomer at the oxime site was found.
'H-NMR (CD OD): 1.34(3H, t, J = 7.2Hz), 4.33(2H, q, J = 7.2Hz), 7.14(1H, s). [as 'H-NMR (CD OD): 1.34 (3H, t, J = 7.2Hz), 4.33 (2H, q, J = 7.2Hz), 7.14 (1H, s).
3 Three
CD ester] CD ester]
3 Three
化合物 8 (塩酸塩結晶)の粉末 X線回折パターンを図 2に示す。 Fig. 2 shows the powder X-ray diffraction pattern of Compound 8 (hydrochloride crystals).
(7) 8+9→10 (7) 8 + 9 → 10
化合物 9(2.39g,5mmol)は酢酸ェチル (50ml)に懸濁させ、 _30°Cで N-メチルモルホリ ン (2.20ml,20mmol)、次いで化合物 8(1.55g,5.74mmol)を加えて- 30°Cで 1時間攪拌し た。反応液に希塩酸を加え中和した後、有機層を分取して、水、 NaHC03水溶液、ブ ラインの順に洗浄した。 MgSOで乾燥後、 3.4N_HCl/MeOH(2.21ml,7.5mmol)を加え Compound 9 (2.39 g, 5 mmol) was suspended in ethyl acetate (50 ml), N-methylmorpholine (2.20 ml, 20 mmol) was added at _30 ° C, and then Compound 8 (1.55 g, 5.74 mmol) was added to -30 ° The mixture was stirred at C for 1 hour. After dilute hydrochloric acid was added to the reaction solution for neutralization, the organic layer was separated and washed with water, an aqueous NaHC03 solution, and then brine. After drying with MgSO, 3.4N_HCl / MeOH (2.21 ml, 7.5 mmol) was added.
4 Four
減圧下で濃縮して化合物 10を結晶として得た。収量 3.36g(100%) Concentration under reduced pressure gave compound 10 as crystals. Yield 3.36 g (100%)
'H-NMR (d -DMSO): 1.27(3H, t, J = 6.9Hz), 3.66, 3.91(2H, ABq, J = 17.9 Hz), 4. 'H-NMR (d-DMSO): 1.27 (3H, t, J = 6.9Hz), 3.66, 3.91 (2H, ABq, J = 17.9 Hz), 4.
6 6
11-4.22(4H, m), 5.29(1H, d, J = 4.8Hz), 5.91(1H, dd. J = 5.1, 8.1Hz), 6.27(1H, m), 6.73(1H, d, J = 15.3Hz), 6.88(1H, s), 6.98(1H, s), 7·29_7·51(10Η, m), 9.80(1H, d, J = 8.4Hz). 11-4.22 (4H, m), 5.29 (1H, d, J = 4.8Hz), 5.91 (1H, dd. J = 5.1, 8.1Hz), 6.27 (1H, m), 6.73 (1H, d, J = 15.3Hz), 6.88 (1H, s), 6.98 (1H, s), 7 · 29_7 · 51 (10mm, m), 9.80 (1H, d, J = 8.4Hz).
化合物 10 (塩酸塩結晶)の粉末 X線回折パターンを図 4に示す。
参考例 3 Fig. 4 shows the powder X-ray diffraction pattern of Compound 10 (hydrochloride crystals). Reference example 3
[化 42] [Chemical 42]
ι-' ι- '
(1) 1-1→1-2 (1) 1-1 → 1-2
化合物 l_l(173mg,0.31mmol)をジクロロメタン (1.6ml)に溶解して、氷冷攪拌下にてピ リジン(45 /1 1,0.5611111101)、五塩化リン (116mg,0.56mmol)加える。 30分間攪拌した後、あ らカじめ氷冷されたメタ一ノル (2.4ml)をカ卩ぇ 30分間攪拌した。反応液は水中に注加し て、ジクロロメタンで抽出し、重曹水、食塩水で洗浄後、乾燥して減圧下濃縮した。残 渣を酢酸ェチル (1.5ml)に溶かし、氷冷攪拌下にて 4N-塩酸の酢酸ェチル溶液 (77 /i 1 )を滴下した。次いで減圧下濃縮して残渣を酢酸ェチル (2ml)に溶解し、ェチルエー テル (2ml)を徐々に加えた。析出晶を濾取し、乾燥して化合物 l_2(80mg :収率; 54%)を 得た。 Compound l_l (173 mg, 0.31 mmol) is dissolved in dichloromethane (1.6 ml), and pyridine (45/11, 0.5611111101) and phosphorus pentachloride (116 mg, 0.56 mmol) are added under ice-cooling and stirring. After stirring for 30 minutes, methanol (2.4 ml) that had been ice-cooled in advance was stirred for 30 minutes. The reaction mixture was poured into water, extracted with dichloromethane, washed with aqueous sodium bicarbonate and brine, dried and concentrated under reduced pressure. The residue was dissolved in ethyl acetate (1.5 ml), and 4N-hydrochloric acid ethyl acetate solution (77 / i 1) was added dropwise with ice-cooling and stirring. Subsequently, the residue was concentrated under reduced pressure, the residue was dissolved in ethyl acetate (2 ml), and ethyl ether (2 ml) was gradually added. The precipitated crystals were collected by filtration and dried to obtain compound l_2 (80 mg: yield; 54%).
'H-NMR (CDC1 ): 3.50— 4· 10(4Η, m), 5.00(1H, d, J = 4.7Hz), 5.17(1H, d, J = 4.7Hz 'H-NMR (CDC1): 3.50— 4 · 10 (4Η, m), 5.00 (1H, d, J = 4.7Hz), 5.17 (1H, d, J = 4.7Hz
3 Three
), 5.76(1H, m), 6.48(0.9H, d, J = 11.3Hz), 6.92及び 6.98 (合わせて 1H, s), 7.18(0.1 H, d, J = 16.1Hz), 7.21-7.50(10H, m) ), 5.76 (1H, m), 6.48 (0.9H, d, J = 11.3Hz), 6.92 and 6.98 (1H, s), 7.18 (0.1 H, d, J = 16.1Hz), 7.21-7.50 ( 10H, m)
(2) l-2→l-4 (2) l-2 → l-4
化合物 1-2(1.56g,3.3mmol)、化合物 l_3(1.43g,4.25mmol)をテトラヒドロフラン (33ml) に懸濁し、 _30°Cに冷却して N-メチルモルホリン (l. lml,9.8mmol)を加え次いでジフヱ ニールリン酸ジクロリド (685 μ l,4.58mmol)を加えた。反応液は 1時間 10分攪拌し、 2N- 塩酸で酸性にした後、酢酸ェチルで抽出し、食塩水で洗浄後、乾燥して減圧下濃縮 した。残渣をシリカゲルクロマトグラフィーに付し、化合物ト 4(2.0g :収率; 81%)を得た
本品の NMR解析において、セフヱムの 3位のプロぺニル基の二重結合部位は E:Z= 16:84であった。 Compound 1-2 (1.56 g, 3.3 mmol) and Compound l_3 (1.43 g, 4.25 mmol) were suspended in tetrahydrofuran (33 ml), cooled to _30 ° C, and N-methylmorpholine (l.lml, 9.8 mmol) was added. Then diphenyl neil phosphate dichloride (685 μl, 4.58 mmol) was added. The reaction solution was stirred for 1 hour and 10 minutes, acidified with 2N-hydrochloric acid, extracted with ethyl acetate, washed with brine, dried and concentrated under reduced pressure. The residue was subjected to silica gel chromatography to obtain compound 4 (2.0 g: yield; 81%). In the NMR analysis of this product, the double bond site of the propenyl group at position 3 of cefme was E: Z = 16: 84.
'H-NMR (DMSO-d6): 1.47(9H, s), 3.40— 4.00(4H, m), 3.92(3H, s), 5.25(0.16H, d, J = 4.9Hz), 5.30(0.84H, d, J = 4.9Hz), 5.56(1H, m), 5.94(1H, m), 6.28(0.84H, d, J = 11.0Hz), 6.70(0.16H, d, J = 15.5Hz), 6.88及び 6.99 (合わせて 1H, s), 7.20-7.60(10 H, m), 9.72(1H, d, J = 8.5Hz), 12.09(1H, brs). 'H-NMR (DMSO-d6): 1.47 (9H, s), 3.40—4.00 (4H, m), 3.92 (3H, s), 5.25 (0.16H, d, J = 4.9Hz), 5.30 (0.84H , d, J = 4.9Hz), 5.56 (1H, m), 5.94 (1H, m), 6.28 (0.84H, d, J = 11.0Hz), 6.70 (0.16H, d, J = 15.5Hz), 6.88 And 6.99 (1H, s in total), 7.20-7.60 (10 H, m), 9.72 (1H, d, J = 8.5 Hz), 12.09 (1H, brs).
MS(ESI): 758+ (M+H)+ MS (ESI): 758 + (M + H) +
参考例 4 Reference example 4
[化 43] [Chemical 43]
(1) l-2→l-6 (1) l-2 → l-6
化合物 l-2(1.95g,4.1mmol)、化合物 l-5(1.68g,5.3mmol)をテトラヒドロフラン (41ml)に 懸濁し、 -40°Cに冷却して N-メチルモルホリン (1.34ml,12.2mmol)を加え次いでジフエ ニールリン酸ジクロリド (854 μ l,5.71mmol)を加え 1時間攪拌した。更に N-メチルモルホ リン(0.45011,4.11!111101)を加ぇ次ぃでジフェニールリン酸ジクロリド(305 1,211111101)を加ぇ 40分間攪拌した。反応液は 2N-塩酸で酸性にした後、酢酸ェチルで抽出し、食塩水 で洗浄後、乾燥して減圧下濃縮した。残渣をシリカゲルクロマトグラフィー(酢酸ェチ ル -nへキサン)に付し、化合物 l_6(2.7g:収率; 88%)を得た。 Compound l-2 (1.95 g, 4.1 mmol) and compound l-5 (1.68 g, 5.3 mmol) were suspended in tetrahydrofuran (41 ml), cooled to -40 ° C, and N-methylmorpholine (1.34 ml, 12.2 mmol). Then, diphenyl phosphoric acid dichloride (854 μl, 5.71 mmol) was added and stirred for 1 hour. Further, N-methylmorpholine (0.45011, 4.11! 111101) was added, diphenyl phosphate dichloride (305 1,211111101) was added, and the mixture was stirred for 40 minutes. The reaction solution was acidified with 2N hydrochloric acid, extracted with ethyl acetate, washed with brine, dried and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (ethyl acetate-n hexane) to obtain Compound l_6 (2.7 g: yield; 88%).
本品の NMR解析において、セフヱムの 3位のプロぺニル基の二重結合部位は E:Z= 17:83であった。 In the NMR analysis of this product, the double bond site of the propenyl group at position 3 of cefme was E: Z = 17: 83.
'H-NMR (DMSO-d6): 1.27(3H, t, J = 7.1Hz), 1.51(9H, s), 3.41— 4.10(4H, m), 4.22( 2H, q, J = 7.1Hz), 5.27(0.17H, d, J = 5.0 Hz), 5.33(0.83H, d, J = 5.0Hz), 5.58(1H, m), 5.98(1H, m), 6.27(0.83H, d, J = 10.2Hz), 6.70(0.17H, d, J = 15.5Hz), 6.88及び 6
.99 (合わせて 1H, s), 7.20-7.50(10H, m), 9.70(1H, d, J = 8.7Hz), 12.60(1H, brs). MS(ESI): 739+ (M+H)+ 'H-NMR (DMSO-d6): 1.27 (3H, t, J = 7.1Hz), 1.51 (9H, s), 3.41-4.10 (4H, m), 4.22 (2H, q, J = 7.1Hz), 5.27 (0.17H, d, J = 5.0 Hz), 5.33 (0.83H, d, J = 5.0 Hz), 5.58 (1H, m), 5.98 (1H, m), 6.27 (0.83H, d, J = 10.2 Hz), 6.70 (0.17H, d, J = 15.5 Hz), 6.88 and 6 .99 (1H, s), 7.20-7.50 (10H, m), 9.70 (1H, d, J = 8.7Hz), 12.60 (1H, brs). MS (ESI): 739 + (M + H) +
参考例 5 Reference Example 5
[化 44] [Chemical 44]
(1) l-2→l-8 (1) l-2 → l-8
ィ匕合物 l_2(1.64g,3.4mmol)、化合物 l_7(1.41g,4.5mmol)をテトラヒドロフラン (34ml)に 懸濁し、 -30°Cに冷却して N-メチルモルホリン (1.13ml,12.2mmol)を加え次いでジフヱ ニールリン酸ジクロリド (721 x l,4.82mmol)を加え 1時間 40分攪拌した。反応液は 2N- 塩酸で酸性にした後、酢酸ェチルで抽出し、食塩水で洗浄後、乾燥して減圧下濃縮 した。残渣をシリカゲルクロマトグラフィー(酢酸ェチル _nへキサン)に付し、化合物ト 8(2.19g:収率; 86%)を得た。 Compound l_2 (1.64 g, 3.4 mmol) and compound l_7 (1.41 g, 4.5 mmol) are suspended in tetrahydrofuran (34 ml), cooled to -30 ° C and N-methylmorpholine (1.13 ml, 12.2 mmol) Then, diphenyl diphosphoric dichloride (721 xl, 4.82 mmol) was added and stirred for 1 hour and 40 minutes. The reaction mixture was acidified with 2N hydrochloric acid, extracted with ethyl acetate, washed with brine, dried and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (ethyl acetate_n hexane) to obtain Compound 8 (2.19 g, yield; 86%).
本品の NMR解析において、セフヱムの 3位のプロぺニル基の二重結合部位は E:Z= 16:84であった。 In the NMR analysis of this product, the double bond site of the propenyl group at position 3 of cefme was E: Z = 16: 84.
'H-NMR (CDC1 ): 1.37(3H, t, J = 7.1Hz), 1.54(9H, s), 3.30— 3·90(4Η, m), 4.38(2H, 'H-NMR (CDC1): 1.37 (3H, t, J = 7.1Hz), 1.54 (9H, s), 3.30—3 · 90 (4Η, m), 4.38 (2H,
3 Three
q, J = 7.1Hz), 5.12(0.16H, d, J = 4.9 Hz), 5.16 (0.84H, d, J = 4.9Hz), 5.64(1H, m), 6.06(1H, m), 6.23(0.84H, d, J = 11.4Hz), 6.93及び 6.99 (合わせて 1H, s), 7.00(0.16 H, d, J = 15.0Hz), 7.20— 7.50(11H, m) q, J = 7.1Hz), 5.12 (0.16H, d, J = 4.9 Hz), 5.16 (0.84H, d, J = 4.9Hz), 5.64 (1H, m), 6.06 (1H, m), 6.23 ( 0.84H, d, J = 11.4Hz), 6.93 and 6.99 (1H, s in total), 7.00 (0.16 H, d, J = 15.0Hz), 7.20—7.50 (11H, m)
参考例 6 Reference Example 6
[化 45] [Chemical 45]
1-9 1-9
(1) 1-9→1-11
化合物 l-10(1.64g,5.5mmol)を酢酸ェチル (40ml)に懸濁し、 _20°Cに冷却してトリエ チノレアミン (0.98ml,7mmol)、メタンスルホニルクロリド (503 β 1,5.1311111101)を加ぇ_20°〇〜 -10°Cで 1時間攪拌した。次いで- 20°C冷却下、 N-メチルモルホリン (1.37ml, 12.5mmol )と化合物 l-9(2.39g,5mmol)を順次加えて 15分間攪拌した。反応液は希塩酸で酸性 にした後、食塩水で洗浄後、乾燥して減圧下濃縮した。残渣をシリカゲルクロマトダラ フィー(酢酸ェチル -トルエン)に付し、化合物 l_ll(3.49g:収率; 97%)を得た。 (1) 1-9 → 1-11 Compound l-10 (1.64 g, 5.5 mmol) is suspended in ethyl acetate (40 ml), cooled to _20 ° C and added with triethylenamine (0.98 ml, 7 mmol) and methanesulfonyl chloride (503 β1, 5.1311111101). The mixture was stirred at _20 ° 〇 to -10 ° C for 1 hour. Next, under cooling at −20 ° C., N-methylmorpholine (1.37 ml, 12.5 mmol) and compound l-9 (2.39 g, 5 mmol) were sequentially added and stirred for 15 minutes. The reaction solution was acidified with dilute hydrochloric acid, washed with brine, dried and concentrated under reduced pressure. The residue was subjected to silica gel chromatography (ethyl acetate-toluene) to obtain compound l_ll (3.49 g: yield; 97%).
'H-NMR (CDC1 ): 1.13(3H, t, J = 7.5Hz), 1.46(9H, s), 2.57(2H, m), 3.14,3.33(2H, 'H-NMR (CDC1): 1.13 (3H, t, J = 7.5Hz), 1.46 (9H, s), 2.57 (2H, m), 3.14, 3.33 (2H,
Abq, J = 16.5Hz), 3.97-4.08(2H, m), 5.02(1H, d, J = 4.8Hz), 5.72(1H, m), 5.87(1H, m), 6.44(3H, t, J = 7.5Hz), 6.76(1H, s), 6.85(1H, s), 6.99(1H, d, J = 15.9Hz), 7.13- 7.41(10H, m), 7.95(1H, d, J = 8.1Hz). Abq, J = 16.5Hz), 3.97-4.08 (2H, m), 5.02 (1H, d, J = 4.8Hz), 5.72 (1H, m), 5.87 (1H, m), 6.44 (3H, t, J = 7.5Hz), 6.76 (1H, s), 6.85 (1H, s), 6.99 (1H, d, J = 15.9Hz), 7.13- 7.41 (10H, m), 7.95 (1H, d, J = 8.1Hz ).
参考例 7 Reference Example 7
[0025] [化 46] [0025] [Chemical 46]
1-9 1-13 1-9 1-13
(1) 1-9→1-13 (1) 1-9 → 1-13
化合物 1-9(1.91g, 4mmol)、化合物 l_12(1.25g,4mmol)を酢酸ェチル (20ml)に懸濁し 、 -50°Cに冷却してジフェニールリン酸ジクロリド (717 μ l,4.8mmol)を加え次いで Ν-メ チルモルホリン (1.76ml,16mmol)を加え 30分攪拌した。反応液は 2N-塩酸で酸性にし た後、酢酸ェチルで抽出し、水、重曹水、食塩水で順次洗浄後、乾燥して減圧下濃 縮して、化合物 l_13(3.06g)を得た。 Compound 1-9 (1.91 g, 4 mmol) and compound l_12 (1.25 g, 4 mmol) were suspended in ethyl acetate (20 ml), cooled to -50 ° C and diphenyl phosphate dichloride (717 μl, 4.8 mmol) Then, Ν-methylmorpholine (1.76 ml, 16 mmol) was added and stirred for 30 minutes. The reaction mixture was acidified with 2N-hydrochloric acid, extracted with ethyl acetate, washed successively with water, aqueous sodium hydrogen carbonate, and brine, dried and concentrated under reduced pressure to give compound l_13 (3.06 g).
'H-NMR (CDC1 ): 0.99(3H, t, J = 7.2Hz), 1.53(9H, s), 1.50- 1·58(2Η, m), 2.56(2H, m), 3.17,3.35(2H, Abq, J = 17.4Hz), 3.99— 4.06(2H, m), 5.03(1H, d, J = 4.5Hz), 5.74 (1H, m), 5.87(1H, m), 6.47(3H, t, J = 7.5Hz), 6.77(1H, s), 6.90(1H, s), 6.99(1H, d, J = 15.9Hz), 7.25-7.44(10H, m), 7.90(1H, d, J = 8.1Hz). 'H-NMR (CDC1): 0.99 (3H, t, J = 7.2Hz), 1.53 (9H, s), 1.50- 1 · 58 (2Η, m), 2.56 (2H, m), 3.17, 3.35 (2H , Abq, J = 17.4Hz), 3.99—4.06 (2H, m), 5.03 (1H, d, J = 4.5Hz), 5.74 (1H, m), 5.87 (1H, m), 6.47 (3H, t, J = 7.5Hz), 6.77 (1H, s), 6.90 (1H, s), 6.99 (1H, d, J = 15.9Hz), 7.25-7.44 (10H, m), 7.90 (1H, d, J = 8.1 Hz).
参考例 8 Reference Example 8
1-9 1-15 1-9 1-15
(1) 1-9→1-15 (1) 1-9 → 1-15
化合物 l-9(1.43g, 3mmol)、化合物 l_14(988mg, 3mmol)から、参考例 7と同様の方 法により化合物 l-15(2.5g)を得た。 Compound l-15 (2.5 g) was obtained from compound l-9 (1.43 g, 3 mmol) and compound l_14 (988 mg, 3 mmol) in the same manner as in Reference Example 7.
'H-NMR (CDC1 ): 1.36(6H, m), 1.53(9H, s), 3.55,3.64(2H, Abq, J = 17.9Hz), 4.01( 'H-NMR (CDC1): 1.36 (6H, m), 1.53 (9H, s), 3.55, 3.64 (2H, Abq, J = 17.9Hz), 4.01 (
3 Three
2H, d, J = 6.9Hz), 4.66(1H, m), 5.11(1H, d, J = 4.8Hz), 5.94_6·04(2Η, m), 6.93(1H, d, J = 15.9Hz), 7.02(1H, s), 7.26_7.46(11H, m), 7.56(1H, d, J = 9.3Hz). 2H, d, J = 6.9Hz), 4.66 (1H, m), 5.11 (1H, d, J = 4.8Hz), 5.94_6.04 (2Η, m), 6.93 (1H, d, J = 15.9Hz) , 7.02 (1H, s), 7.26_7.46 (11H, m), 7.56 (1H, d, J = 9.3Hz).
参考例 9 Reference Example 9
[化 48] [Chemical 48]
1-9 1-17 1-9 1-17
(1) 1-9→1-17 (1) 1-9 → 1-17
化合物 1-9(1.38g, 2.9mmol)、化合物 l_16(965mg, 2.9mmol)から、参考例 7と同様の 方法により化合物 l-17(2.3g)を得た。 Compound l-17 (2.3 g) was obtained from compound 1-9 (1.38 g, 2.9 mmol) and compound l_16 (965 mg, 2.9 mmol) in the same manner as in Reference Example 7.
'H-NMR (CDC1 ): 1.52(9H, s), 3·53,3·60(2Η, Abq, J = 17.7Hz), 4.01(2H, d, J = 7.2 'H-NMR (CDC1): 1.52 (9H, s), 3 · 53,3 · 60 (2Η, Abq, J = 17.7Hz), 4.01 (2H, d, J = 7.2
3 Three
Hz), 4.46-4.78(4H, m), 5.12(1H, d, J = 4.8Hz), 5.94-6.04(2H, m), 6.96(1H, d, J = 1 6.8Hz), 6.99(1H, s), 7.26- 7.47(11H, m), 7.52(1H, d, J = 8.7Hz). Hz), 4.46-4.78 (4H, m), 5.12 (1H, d, J = 4.8Hz), 5.94-6.04 (2H, m), 6.96 (1H, d, J = 1 6.8Hz), 6.99 (1H, s), 7.26- 7.47 (11H, m), 7.52 (1H, d, J = 8.7Hz).
参考例 10 Reference Example 10
[化 176]
,s、 (C2H5)3N S-[Chemical 176] , s, (C 2 H 5 ) 3 N S-
H2N 、 TEA H2N 、 H 2 N, TEA H 2 N,
N C02H Ν' ,C02H N C0 2 H Ν ', C0 2 H
N DMA N DMA
'.,OEt ■OEt '., OEt ■ OEt
ィ匕合物 l (9g、 41. 8mmol)をジメチノレアセトアミド 45mLに溶角军させ、トリェチノレアミ ン(6. 4mL、 45. 98mL)を 10〜30°Cで滴下し、 2時間反応させた。得られた結晶を ろ過、酢酸塩チル 27mLで洗浄後、化合物 2 (トリエチルァミン塩結晶)を得た。収量 6 . 85g (90. 0%)。 Compound 1 (9 g, 41.8 mmol) was dissolved in 45 mL of dimethylenoacetamide, and triethinoreamin (6.4 mL, 45.98 mL) was added dropwise at 10 to 30 ° C. and reacted for 2 hours. The obtained crystals were filtered and washed with 27 mL of acetyl acetate to give compound 2 (triethylamine salt crystals). Yield 6.85 g (90.0%).
化合物 2の粉末 X線回折パターンを図 1に示す。 The powder X-ray diffraction pattern of Compound 2 is shown in FIG.
参考例 11 Reference Example 11
[化 177] [Chemical 177]
,S、 TEA , S, TEA
H2NHH 2 NH
4 (EIA-TEA) 4 (EIA-TEA)
(1)五塩化リン(2· 8g、 13. 415mmol)をジクロロメタン 15mLに溶解させた後、 5 °Cまで冷却し、ピリジン(1. 25mL、 15. 203mmol)を滴下した。この液に、化合物 1 (5. 00g、 8. 943mmol)をジクロロメタン 45mLに溶解させた液を一 5°Cで滴下した 後、 -5°Cで 1. 5時間反応させた。この反応液を、メタノーノレ 5. 45mL、ジクロロメタン 20mLを _ 15°Cまで冷却した混液中に滴下し後、 _ 15〜一 5°Cで 1時間反応させた 。その後、反応液を冷水 25mL中に流入分液後、有機層を 20%NaCl水溶液および 臭化テトラ n-プチルアンモニゥムにて洗浄した。 (1) Phosphorus pentachloride (2.8 g, 13.415 mmol) was dissolved in 15 mL of dichloromethane, cooled to 5 ° C., and pyridine (1.25 mL, 15. 203 mmol) was added dropwise. To this solution, a solution of compound 1 (5.00 g, 8.943 mmol) dissolved in 45 mL of dichloromethane was added dropwise at 15 ° C., and then reacted at −5 ° C. for 1.5 hours. This reaction solution was dropped into a mixed solution of methanol (5.45 mL) and dichloromethane (20 mL) cooled to -15 ° C, and reacted at -15 to 15 ° C for 1 hour. Thereafter, the reaction solution was poured into 25 mL of cold water, followed by liquid separation, and the organic layer was washed with 20% NaCl aqueous solution and tetra-n-butylammonium bromide.
(2)ィ匕合物 4 (2. 83g、 8. 943mmol)をジメチノレアセトアミド 8mLに溶角军させ、 - 15 〜一 10。Cまで冷却した。ここにメシルクロリド(0. 76mL、 9. 837mmol)を滴下し、 - 15〜 _ 10°Cで 2時間反応させた。
(3)— 15〜― 10°Cまで冷却させた化合物 2を含む(1)の液中に、(2)の反応液を流 人し、 N—メチノレモノレフォリン (0. 98mL、 8. 943mmol)を滴下後、 15〜一 5°Cで 1. 5時間反応させた。この反応液を 0. 5N塩酸水 25mL中に流入分液後、有機層を濃 縮、酢酸ェチル 50mLを加え濃縮し、再度酢酸ェチルを 50mL加え濃縮を行った。こ の濃縮液に酢酸ェチル 10mLを加え 5%NaCl水溶液 25mLにて 4回洗浄後、再び有 機層を濃縮した。この濃縮液にエタノール 2. 5mLを 20_ 25°Cで加え種晶を加えた 後 0〜5°Cに冷却し、 4N塩酸一酢酸ェチルを 2mLカ卩ぇ 5°Cにて 15時間静置し、化合 物 3を白色結晶として得た。収量 4. 12g。 (2) Compound 4 (2.83 g, 8.943 mmol) was dissolved in 8 mL of dimethinoreacetamide, -15 to 10. Cooled to C. Mesyl chloride (0.76 mL, 9.837 mmol) was added dropwise thereto, and the mixture was reacted at −15 to −10 ° C. for 2 hours. (3) — 15 to — The reaction solution of (2) is poured into the solution of (1) containing Compound 2 that has been cooled to 10 ° C., and N-methylolmonoreforin (0.998 mL, 8. 943 mmol) was added dropwise, followed by reaction at 15 to 15 ° C. for 1.5 hours. The reaction solution was poured into 25 mL of 0.5N aqueous hydrochloric acid, and the organic layer was concentrated, concentrated by adding 50 mL of ethyl acetate, and concentrated again by adding 50 mL of ethyl acetate. To this concentrated solution was added 10 mL of ethyl acetate, and the organic layer was concentrated again after washing 4 times with 25 mL of 5% NaCl aqueous solution. Ethanol (2.5 mL) was added to this concentrate at 20 to 25 ° C, seed crystals were added, and the mixture was cooled to 0 to 5 ° C. 4N Etyl acetate monoacetate was allowed to stand at 2 mL and 5 ° C for 15 hours. Compound 3 was obtained as white crystals. Yield 4.12g.
実施例 1 Example 1
(1) 2→3 (1) 2 → 3
硝酸銀 (13.8g,81.2mmol)を水 (50ml)に溶液し水酸化ナトリウム (6.48g,162mmol)を加 えた。得られた懸濁液に氷冷下 2(5.73g,30mmol)を加え、混合液を氷冷下で 1時間 20 分攪拌した。不溶物をセライトパッドを通して濾過し、水で洗浄した。濾液に濃塩酸を 加えると結晶が析出し、これを濾取して水で洗浄した。この結晶を減圧下で乾燥して 化合物 3を得た。収量 5.71g(92%)
Ή-NMR (CDC13): 7.54(1H, d, J = 1.5 Hz), 7.78(1H, d, J = 1.5Hz) Silver nitrate (13.8 g, 81.2 mmol) was dissolved in water (50 ml), and sodium hydroxide (6.48 g, 162 mmol) was added. 2 (5.73 g, 30 mmol) was added to the obtained suspension under ice cooling, and the mixture was stirred for 1 hour 20 minutes under ice cooling. The insoluble material was filtered through a celite pad and washed with water. When concentrated hydrochloric acid was added to the filtrate, crystals were precipitated, which were collected by filtration and washed with water. The crystals were dried under reduced pressure to obtain Compound 3. Yield 5.71 g (92%) NMR-NMR (CDC13): 7.54 (1H, d, J = 1.5 Hz), 7.78 (1H, d, J = 1.5 Hz)
(2) 3→4 (2) 3 → 4
化合物 3(5.64g,27.2mmol)をメタノール (50ml)に溶解し、氷冷下チォニルクロライド (3. 97ml,54.4mmol)を滴下した。混合液は室温で 25時間攪拌し、減圧濃縮した。残渣を 酢酸ェチルで希釈し、 NaHCO水溶液、水、及びブラインの順に洗浄した。溶液を無 Compound 3 (5.64 g, 27.2 mmol) was dissolved in methanol (50 ml), and thionyl chloride (3.97 ml, 54.4 mmol) was added dropwise under ice cooling. The mixture was stirred at room temperature for 25 hours and concentrated under reduced pressure. The residue was diluted with ethyl acetate and washed sequentially with aqueous NaHCO solution, water, and brine. No solution
3 Three
水 MgSOで乾燥し、減圧下で濃縮して化合物 4が結晶として得た。収量 5.23g(87%)It was dried over water MgSO and concentrated under reduced pressure to give compound 4 as crystals. Yield 5.23g (87%)
4 Four
'H-NMR (CDC13): 3.93(3H, s), 7.44(1H, d, J = 1.5 Hz), 7.69(1H, d, J = 1.5Hz). 'H-NMR (CDC13): 3.93 (3H, s), 7.44 (1H, d, J = 1.5 Hz), 7.69 (1H, d, J = 1.5 Hz).
(3) 5+4→6 (3) 5 + 4 → 6
化合物 4(l.llg,5mmol)、及び化合物 5(738mg,6mmol)をジォキサン (25ml)と水 (5ml) の混合溶媒に懸濁させ、次いで 5N_Na CO水溶液を加えた。混合液にテトラキストリ Compound 4 (l.llg, 5 mmol) and compound 5 (738 mg, 6 mmol) were suspended in a mixed solvent of dioxane (25 ml) and water (5 ml), and then 5N NaCO aqueous solution was added. Tetrakistri in the mixture
2 3 twenty three
フエニルホスフィンパラジウム (289mg,0.25mmol)を加えた後、窒素気流下 100。Cで 1時 間 30分攪拌した。反応液を酢酸ェチルで希釈し、水 2回、ブラインの順に洗浄した。 溶液は無水 MgSOで乾燥し、減圧下で濃縮した。得られた固体の残渣に酢酸ェチル After phenylphosphine palladium (289 mg, 0.25 mmol) was added, 100 under nitrogen flow. The mixture was stirred at C for 1 hour and 30 minutes. The reaction solution was diluted with ethyl acetate and washed twice with water and then with brine. The solution was dried over anhydrous MgSO and concentrated under reduced pressure. Ethyl acetate was added to the resulting solid residue.
4 Four
、及び NaHCO水溶液を加え、析出した沈殿物を濾過により除去した。濾液は 2N-塩 , And an aqueous NaHCO solution were added, and the deposited precipitate was removed by filtration. The filtrate is 2N-salt
3 Three
酸を加え pHを 2以下として、水層を分取した。水溶液は NaHCOを加え pHを 7以上とし Acid was added to adjust the pH to 2 or less, and the aqueous layer was separated. Add NaHCO to pH 7 or higher.
3 Three
た後酢酸ェチルで抽出した。有機層は無水 MgSOで乾燥した後減圧下で濃縮して And then extracted with ethyl acetate. The organic layer was dried over anhydrous MgSO and concentrated under reduced pressure.
4 Four
化合物 6が無色結晶として得た。収量 551mg(50%) Compound 6 was obtained as colorless crystals. Yield 551mg (50%)
'H-NMR (CDC13): 3·90(3Η, s), 7.49(2H, dd, J = 1.5 Hz, 4.5Hz), 7.85(1H, d, J = 1. 8Hz), 8.12(1H, d, J = 1.8Hz), 8.65(2H, d, J = 6Hz). 'H-NMR (CDC13): 3 · 90 (3Η, s), 7.49 (2H, dd, J = 1.5 Hz, 4.5Hz), 7.85 (1H, d, J = 1.8 Hz), 8.12 (1H, d , J = 1.8Hz), 8.65 (2H, d, J = 6Hz).
(4) 6→7 (4) 6 → 7
化合物 6(532mg,2.43mmol)をメタノール (10ml)に溶解し、シアナミド (102mg,2.43mmol )と 1.02N_MeONa/MeOH(2.38ml,2.43mmol)を加えた。 50°Cで 20時間攪拌した後、シ アナミド (204mg,4.85mmol)と 1.02N_MeONa/MeOH(4.76ml,4.86mmol)を追加して、更 に 50°Cで 15時間攪拌した。反応液は減圧下で濃縮後、水で希釈し 2N-HC1で pHを 6. 0に調整して沈殿を析出させた。この沈殿を濾取し、メタノールに懸濁させた。この懸 濁液は lN_Me〇Na/Me〇Hを加え pHを 7.3に調整し溶解させた後、溶液を減圧下で 濃縮して化合物 7が薄茶色粉末として得た。収量 333mg(55%) Compound 6 (532 mg, 2.43 mmol) was dissolved in methanol (10 ml), and cyanamide (102 mg, 2.43 mmol) and 1.02N_MeONa / MeOH (2.38 ml, 2.43 mmol) were added. After stirring at 50 ° C for 20 hours, cyanamide (204 mg, 4.85 mmol) and 1.02N_MeONa / MeOH (4.76 ml, 4.86 mmol) were added, and the mixture was further stirred at 50 ° C for 15 hours. The reaction solution was concentrated under reduced pressure, diluted with water, and the pH was adjusted to 6.0 with 2N-HC1 to precipitate. The precipitate was collected by filtration and suspended in methanol. To this suspension, lN_Me 0 Na / Me 0 H was added to adjust the pH to 7.3 and dissolved, and then the solution was concentrated under reduced pressure to obtain Compound 7 as a light brown powder. Yield 333 mg (55%)
'H-NMR (d -DMSO): 7.71(2H, d, J = 6.3Hz), 7.90(1H, d, J = 1.5 Hz), 8.12(1H, d, 'H-NMR (d-DMSO): 7.71 (2H, d, J = 6.3Hz), 7.90 (1H, d, J = 1.5 Hz), 8.12 (1H, d,
6
J = 1.8Hz), 8.55(2H, d, J = 6.0Hz). 6 J = 1.8Hz), 8.55 (2H, d, J = 6.0Hz).
(5) 8+7→9 (5) 8 + 7 → 9
化合物 8(738mg, lmmol)と化合物 7(25 lmg, lmmol)をジメチルホルムアミド (2ml)中に 懸濁し、臭化ナトリウム (309mg,3mmol)をカ卩ぇ室温で 4時間 20分攪拌した。反応液を 5 %食塩水 (30ml)攪拌中に注カ卩し、析出した沈殿を濾取した。沈殿を水で懸濁させ、 凍結乾燥して化合物 9を無定形粉末として得た。収量 851mg(102%) Compound 8 (738 mg, lmmol) and compound 7 (25 lmg, lmmol) were suspended in dimethylformamide (2 ml), and sodium bromide (309 mg, 3 mmol) was stirred at room temperature for 4 hours and 20 minutes. The reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was suspended in water and lyophilized to obtain Compound 9 as an amorphous powder. Yield 851 mg (102%)
'H-NMR (d -DMSO): 1.24(3H, t, J = 7.2Hz), 1.47(9H, s), 3.66, 3.90(2H, ABq, J ='H-NMR (d-DMSO): 1.24 (3H, t, J = 7.2Hz), 1.47 (9H, s), 3.66, 3.90 (2H, ABq, J =
17.7 Hz), 4.14(2H, q, J = 7.2Hz), 5.21(2H, d, J = 6.3Hz), 5.30(1H, d, J = 5.1Hz), 5. 95(1H, dd. J = 4.8, 8.4Hz), 6.42(1H, m), 6.87(1H, d, J = 15.9Hz), 6.91(1H, s), 7.27 -7.50(11H, m), 8.20(1H, d, J = 1.5Hz), 8.48(2H, d, J = 6.9Hz), 8.67(1H, d, J = 1.5 Hz), 8.87(2H, d, J = 9 .0Hz), 9.73(1H, d, J = 7.2Hz), 11.80(1H, s) 17.7 Hz), 4.14 (2H, q, J = 7.2Hz), 5.21 (2H, d, J = 6.3Hz), 5.30 (1H, d, J = 5.1Hz), 5.95 (1H, dd.J = 4.8, 8.4Hz), 6.42 (1H, m), 6.87 (1H, d, J = 15.9Hz), 6.91 (1H, s), 7.27 -7.50 (11H, m), 8.20 (1H, d, J = 1.5 Hz), 8.48 (2H, d, J = 6.9Hz), 8.67 (1H, d, J = 1.5Hz), 8.87 (2H, d, J = 9.0Hz), 9.73 (1H, d, J = 7.2Hz ), 11.80 (1H, s)
(6) 9→1 (6) 9 → 1
化合物 9(845mg,lmmol)を塩化メチレン (5ml)とァニソール (lml)に溶解し、 _30°Cにて 2M/l-TiCl /CH CI (3ml,6mmol)を加えた。混合液を- 30°Cで 1時間 30分攪拌した後、 Compound 9 (845 mg, lmmol) was dissolved in methylene chloride (5 ml) and anisole (lml), and 2M / l-TiCl2 / CHCI (3 ml, 6 mmol) was added at _30 ° C. After stirring the mixture at -30 ° C for 1 hour 30 minutes,
0.3N-塩酸 (30ml)とイソプロピルエーテル (30ml)に氷冷下で攪拌しながら注加した。析 出した沈殿物を濾取し、希塩酸とァセトニトリルの混合溶媒で溶解させた。溶液に HP -20SSを加え濃縮し、 HP-20SSカラムクロマトグラフィーに付し、水-ァセトニトリルで溶 離した。所望の化合物を含むフラクションを減圧下濃縮し、得られた残渣 (266mg)を水 (7ml)に懸濁させ NaHCO (34mg,0.40mmol)を加え溶解させた。溶液を凍結乾燥して 化合物 1を粉末として得た。収量 272mg(35%) The mixture was poured into 0.3N-hydrochloric acid (30 ml) and isopropyl ether (30 ml) with stirring under ice cooling. The precipitated precipitate was collected by filtration and dissolved in a mixed solvent of dilute hydrochloric acid and acetonitrile. HP-20SS was added to the solution, concentrated, subjected to HP-20SS column chromatography, and dissolved with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the resulting residue (266 mg) was suspended in water (7 ml) and dissolved by adding NaHCO 3 (34 mg, 0.40 mmol). The solution was lyophilized to give Compound 1 as a powder. Yield 272mg (35%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 3.43, 3.49(2H, ABq, J = 17.1 Hz), 4. 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 3.43, 3.49 (2H, ABq, J = 17.1 Hz), 4.
09(2H, q, J = 7.2Hz), 5.05(1H, d, J = 4.8Hz), 5.21(2H, d, J = 7.2Hz), 5.60(1H, dd. J = 4.8, 8.1Hz), 5.87(1H, m), 6.72(1H, s), 7.22(2H, s), 7.29(1H, d, J = 15.9Hz), 8.1 7(1H, d, J = 1.8Hz), 8.48(2H, d, J = 6.9Hz), 8.65(1H, d, J = 1.5Hz), 8.93(2H, d, J = 7.2Hz), 9.54(1H, d, J = 8.1Hz). 09 (2H, q, J = 7.2Hz), 5.05 (1H, d, J = 4.8Hz), 5.21 (2H, d, J = 7.2Hz), 5.60 (1H, dd. J = 4.8, 8.1Hz), 5.87 (1H, m), 6.72 (1H, s), 7.22 (2H, s), 7.29 (1H, d, J = 15.9Hz), 8.1 7 (1H, d, J = 1.8Hz), 8.48 (2H, d, J = 6.9Hz), 8.65 (1H, d, J = 1.5Hz), 8.93 (2H, d, J = 7.2Hz), 9.54 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3417, 2982, 2177, 1762, 1634, 1602, 1538, 1470, 1434, 1382, 1353, 1251, 1204. IR (KBr) cm _1 : 3417, 2982, 2177, 1762, 1634, 1602, 1538, 1470, 1434, 1382, 1353, 1251, 1204.
MS(ESI): 709+ (M+H)+
元素分析 C H N O S Na-4.5 H O - 0.2NaHCO MS (ESI): 709 + (M + H) + Elemental analysis CHNOS Na-4.5 HO-0.2NaHCO
30 25 8 6 2 2 3 30 25 8 6 2 2 3
計算値: C,46.59; H,4.43; N,14.39; S,8.24; Na,3.54 (%) Calculated values: C, 46.59; H, 4.43; N, 14.39; S, 8.24; Na, 3.54 (%)
実験値: C,46.60; Η,4·43; Ν, 14.63; SJ.45; Na,3.48 (%) Experimental value: C, 46.60; Η, 4.43; Ν, 14.63; SJ.45; Na, 3.48 (%)
実施例 2 Example 2
[化 50] [Chemical 50]
(1) 11→12 (1) 11 → 12
化合物 l l(4.02g,20mmol)をテトラヒドロフラン (30ml)に溶解し、ジフエニルジァゾメタ ン (3.88g,54.4mmol)のテトラヒドロフラン (30ml)溶液を滴下した。混合液は室温で 27時 間攪拌し、減圧濃縮した。残渣にへキサンを加え析出した結晶を濾取し化合物 12を 得た。収量 7.07g(96%) Compound l l (4.02 g, 20 mmol) was dissolved in tetrahydrofuran (30 ml), and a solution of diphenyldiazomethane (3.88 g, 54.4 mmol) in tetrahydrofuran (30 ml) was added dropwise. The mixture was stirred at room temperature for 27 hours and concentrated under reduced pressure. Hexane was added to the residue, and the precipitated crystals were collected by filtration to obtain Compound 12. Yield 7.07g (96%)
'H-NMR (CDC13): 7.09(1H, s), 7.25-7.43(10H, m), 7.59(2H, d, J = 9.0Hz), 7.99(2 H, d, J = 8.7Hz) 'H-NMR (CDC13): 7.09 (1H, s), 7.25-7.43 (10H, m), 7.59 (2H, d, J = 9.0Hz), 7.99 (2H, d, J = 8.7Hz)
(2) 12+13→14 (2) 12 + 13 → 14
化合物 12(2.94g,8mmol)、及び化合物 13(1.64g,8mmol)をジォキサン (70ml)に溶解さ せ、次いで K PO (8.49g,40mmol)を加えた。混合液にテトラキストリフエニルホスフィン Compound 12 (2.94 g, 8 mmol) and compound 13 (1.64 g, 8 mmol) were dissolved in dioxane (70 ml), and then K 3 PO 4 (8.49 g, 40 mmol) was added. Tetrakistriphenylphosphine in the mixture
3 4 3 4
パラジウム (462mg,0.4mmol)を加えた後、窒素気流下 100°Cで 4時間攪拌した。反応液
を濾過し、濾液を減圧下で濃縮した。残渣を酢酸ェチルで希釈し無水 MgSOを加え 再度濾過した。濾液を減圧下で濃縮して化合物 14を得た。収量 1.74g(60%) Palladium (462 mg, 0.4 mmol) was added, and the mixture was stirred at 100 ° C for 4 hours under a nitrogen stream. Reaction liquid The filtrate was concentrated under reduced pressure. The residue was diluted with ethyl acetate, added anhydrous MgSO and filtered again. The filtrate was concentrated under reduced pressure to give compound 14. Yield 1.74 g (60%)
'H-NMR (CDC13): 7.15(1H, s), 7.26- 7.47(10H, m), 7.54(2H, d, J = 5.4Hz), 7.72(2 H, d, J = 8.1Hz), 8.25(2H, d, J = 6.9Hz), 8.71(2H, d, J = 4.5Hz). 'H-NMR (CDC13): 7.15 (1H, s), 7.26- 7.47 (10H, m), 7.54 (2H, d, J = 5.4Hz), 7.72 (2H, d, J = 8.1Hz), 8.25 (2H, d, J = 6.9Hz), 8.71 (2H, d, J = 4.5Hz).
(3) 14→15 (3) 14 → 15
化合物 14(1. lg,3mmol)をテトラヒドロフラン (5ml)とメタノール (10ml)に溶解し、 2N_Na 〇H(4.5ml,9mmol)を加えた。反応液は 60。Cで 30分間攪拌し、 2N_HClを加ぇpHを3.5 に調整して結晶を析出させた。懸濁液を減圧下濃縮し水と酢酸ェチルを加え結晶を 濾取し、化合物 15を得た。収量 502mg(84%) Compound 14 (1. lg, 3 mmol) was dissolved in tetrahydrofuran (5 ml) and methanol (10 ml), and 2N_Na 0 H (4.5 ml, 9 mmol) was added. The reaction solution is 60. The mixture was stirred at C for 30 minutes, and 2N_HCl was added to adjust the pH to 3.5 to precipitate crystals. The suspension was concentrated under reduced pressure, water and ethyl acetate were added, and the crystals were collected by filtration to give compound 15. Yield 502mg (84%)
'H-NMR (d -DMSO): 7.78(2H, d, J = 6.0Hz), 7.87(2H, d, J = 8.7Hz), 8.07(2H, d, J 'H-NMR (d-DMSO): 7.78 (2H, d, J = 6.0Hz), 7.87 (2H, d, J = 8.7Hz), 8.07 (2H, d, J
= 8.7Hz), 8.69(2H, d, J = 6.3Hz). = 8.7Hz), 8.69 (2H, d, J = 6.3Hz).
(4) 15→16 (4) 15 → 16
化合物 15(489mg,2.45mmol)をジメチルホルムアミド (5ml)に懸濁し、 Im CO(753mg,3. Compound 15 (489 mg, 2.45 mmol) was suspended in dimethylformamide (5 ml) and Im CO (753 mg, 3.
92mmol)を加えた。 50°Cで 30分間攪拌した後、 NaNHCN(314mg,4.9mmol)を加え、室 温で 16時間攪拌した。反応液は水で希釈し 2N-HC1で pHを弱酸性に調整して沈殿を 析出させた。この沈殿を濾取し、メタノールに懸濁させた。この懸濁液は lN_MeONa/ MeOHを加え pHを 7.5に調整し溶解させた後、減圧下で濃縮して化合物 16を白色粉 末として得た。収量 654mg(108%) 92 mmol) was added. After stirring at 50 ° C for 30 minutes, NaNHCN (314 mg, 4.9 mmol) was added, and the mixture was stirred at room temperature for 16 hours. The reaction solution was diluted with water, and the pH was adjusted to slightly acidic with 2N-HC1 to precipitate the precipitate. The precipitate was collected by filtration and suspended in methanol. This suspension was dissolved by adding lN_MeONa / MeOH to pH 7.5, and then concentrated under reduced pressure to obtain Compound 16 as a white powder. Yield 654mg (108%)
'H-NMR (d -DMSO): 7.73(2H, d, J = 6.6Hz), 7.76(2H, d, J = 8.7 Hz), 8.03(1H, d, 'H-NMR (d-DMSO): 7.73 (2H, d, J = 6.6 Hz), 7.76 (2H, d, J = 8.7 Hz), 8.03 (1H, d,
J = 8.1Hz), 8.63(2H, d, J = 6.3Hz). J = 8.1Hz), 8.63 (2H, d, J = 6.3Hz).
(5) 8+16→17→10 (5) 8 + 16 → 17 → 10
化合物 8(738mg, lmmol)と化合物 16(245mg, lmmol)を用レ、、実施例 1の (5)と同様の 方法で化合物 17を無定形粉末として得た。収量 843mg(91%)。この化合物 17(828mg,0 • 90mmol)を 2M/卜 TiCl /CH CI (2.7ml,5.4mmol)を用レヽ、実施例 1の (6)と同様の方法 で化合物 10を粉末として得た。収量 326mg(47%) Compound 8 (738 mg, 1 mmol) and Compound 16 (245 mg, 1 mmol) were used in the same manner as in Example 1 (5) to obtain Compound 17 as an amorphous powder. Yield 843 mg (91%). Compound 10 was obtained as a powder in the same manner as in Example 1, (6) using Compound 17 (828 mg, 0 • 90 mmol) in 2M / 卜 TiCl 2 / CH 2 CI (2.7 ml, 5.4 mmol). Yield 326mg (47%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.44, 3.50(2H, ABq, J = 16.2 Hz), 4. 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.44, 3.50 (2H, ABq, J = 16.2 Hz), 4.
09(2H, q, J = 7.2Hz), 5.05(1H, d, J = 4.8Hz), 5.29(2H, d, J = 6.6Hz), 5.60(1H, dd. J = 4.5, 8.1Hz), 5.88(1H, m), 6.72(1H, s), 7.22(2H, s), 7.32(1H, d, J = 15.9Hz), 8.0
2(2H, d, J = 8.4Hz), 8.11( 2H, d, J = 9.0Hz), 8.51(2H, d, J = 6.6Hz), 8.93(2H, d, J = 6.6Hz), 9.53(1H, d, J = 8.1Hz). 09 (2H, q, J = 7.2Hz), 5.05 (1H, d, J = 4.8Hz), 5.29 (2H, d, J = 6.6Hz), 5.60 (1H, dd. J = 4.5, 8.1Hz), 5.88 (1H, m), 6.72 (1H, s), 7.22 (2H, s), 7.32 (1H, d, J = 15.9Hz), 8.0 2 (2H, d, J = 8.4Hz), 8.11 (2H, d, J = 9.0Hz), 8.51 (2H, d, J = 6.6Hz), 8.93 (2H, d, J = 6.6Hz), 9.53 ( (1H, d, J = 8.1Hz).
IR (KBr) cm— 3409, 2983, 2151, 1763, 1634, 1599, 1563, 1531, 1462, 1364, 1306, 1200. IR (KBr) cm— 3409, 2983, 2151, 1763, 1634, 1599, 1563, 1531, 1462, 1364, 1306, 1200.
MS(FAB+): 681+ (M+H)+ MS (FAB +): 681+ (M + H) +
元素分析 c H N O S Na-4.1 H O - 0.17NaHCO Elemental analysis c H N O S Na-4.1 H O-0.17 NaHCO
28 23 8 6 3 2 3 28 23 8 6 3 2 3
計算値: C,43.67; H,4.08; N, 14.46; S, 12.42; Na,3.47 (%) Calculated values: C, 43.67; H, 4.08; N, 14.46; S, 12.42; Na, 3.47 (%)
実験値: C,43.59; H,4.10; N, 14.50; S,12.11; Na,3.47 (%) Experimental value: C, 43.59; H, 4.10; N, 14.50; S, 12.11; Na, 3.47 (%)
実施例 3 Example 3
[化 51] [Chemical 51]
19 19
(1) 17→18 (1) 17 → 18
化合物 17(563mg,2.74mmol)をジメチルホルムアミド (10ml)に懸濁し、 Im CO(631mg, Compound 17 (563 mg, 2.74 mmol) was suspended in dimethylformamide (10 ml) and Im CO (631 mg,
2 2
3.28mmol)を加え、室温で 30分間攪拌した。また、 4 -メトキシベンジルアルコール (0.51 3ml,4.11ml)をジメチルホルムアミド (5ml)に溶解させ、 NaH(164mg,4. Immol)を加えて 1 5分間攪拌した。この溶液を前記の反応液に注加し、室温で 1時間攪拌した。残渣を 酢酸ェチルで希釈し、水で 2回洗浄した。有機層は無水 MgSOで乾燥した後減圧下 3.28 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. Further, 4-methoxybenzyl alcohol (0.51 3 ml, 4.11 ml) was dissolved in dimethylformamide (5 ml), NaH (164 mg, 4. Immol) was added, and the mixture was stirred for 15 minutes. This solution was poured into the reaction solution and stirred at room temperature for 1 hour. The residue was diluted with ethyl acetate and washed twice with water. The organic layer was dried over anhydrous MgSO and then reduced pressure
4 Four
で濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付しトルエン-酢酸ェチル (2: 1)で溶離した。溶離液を減圧下濃縮し化合物 18を白色結晶で得た。収量 882mg(92%)
Ή-NMR (CDC13): 3·82(3Η, s), 5·30(2Η, s), 6.92(2Η, d, J = 8.7Hz), 7.39(2H, d, J = 8.7Hz), 7.47(2H, d, J = 6.3Hz), 7.84(1H, d, J = 1.5Hz), 8.10(1H, d, J = 1.8Hz), 8.6 3(2H, d, J = 6.0Hz) Concentrated with. The residue was subjected to silica gel column chromatography and eluted with toluene-ethyl acetate (2: 1). The eluent was concentrated under reduced pressure to obtain Compound 18 as white crystals. Yield 882mg (92%) Ή-NMR (CDC13): 3 · 82 (3Η, s), 5 · 30 (2Η, s), 6.92 (2Η, d, J = 8.7Hz), 7.39 (2H, d, J = 8.7Hz), 7.47 (2H, d, J = 6.3Hz), 7.84 (1H, d, J = 1.5Hz), 8.10 (1H, d, J = 1.8Hz), 8.6 3 (2H, d, J = 6.0Hz)
(2) 8+18→19→16 (2) 8 + 18 → 19 → 16
化合物 8(738mg, lmmol)と化合物 18(325mg, lmmol)を用レ、、実施例 1の (5)と同様の 方法で化合物 19を無定形粉末として得た。収量 985mg(89%)。この化合物 19(973mg,0 .88mmol)を 2M/卜 TiCl /CH CI (4.4ml,8.8mmol)を用レヽ、実施例 1の (6)と同様の方法 で化合物 16を粉末として得た。収量 lllmg(15%) Compound 8 (738 mg, 1 mmol) and Compound 18 (325 mg, 1 mmol) were used in the same manner as in Example 1, (5) to obtain Compound 19 as an amorphous powder. Yield 985 mg (89%). Compound 16 was obtained as a powder in the same manner as in Example 6, (6), using Compound 19 (973 mg, 0.88 mmol) in 2M / 卜 TiCl 2 / CH 2 CI (4.4 ml, 8.8 mmol). Yield lllmg (15%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 3.42, 3.48(2H, ABq, J = 17.1 Hz), 4. 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 3.42, 3.48 (2H, ABq, J = 17.1 Hz), 4.
09(2H, q, J = 7.2Hz), 5.04(1H, d, J = 4.8Hz), 5.20(2H, d, J = 6.3Hz), 5.59(1H, dd. J = 4.8, 8.4Hz), 5.85(1H, m), 6.71(1H, s), 7.22(2H, s), 7.27(1H, d, J = 15.9Hz), 7.9 0(1H, d, J = 1.5Hz), 8.42(2H, d, J = 6.9Hz), 8.53(1H, d, J = 1.5Hz), 8.88(2H, d, J = 6.9Hz), 9.52(1H, d, J = 8.1Hz). 09 (2H, q, J = 7.2Hz), 5.04 (1H, d, J = 4.8Hz), 5.20 (2H, d, J = 6.3Hz), 5.59 (1H, dd. J = 4.8, 8.4Hz), 5.85 (1H, m), 6.71 (1H, s), 7.22 (2H, s), 7.27 (1H, d, J = 15.9Hz), 7.9 0 (1H, d, J = 1.5Hz), 8.42 (2H, d, J = 6.9Hz), 8.53 (1H, d, J = 1.5Hz), 8.88 (2H, d, J = 6.9Hz), 9.52 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3409, 2982, 1763, 1634, 1598, 1536, 1470, 1434, 1362, 1203. IR (KBr) cm _1 : 3409, 2982, 1763, 1634, 1598, 1536, 1470, 1434, 1362, 1203.
MS(ESI): 641+ (M+H)+ MS (ESI): 641 + (M + H) +
元素分析 C H N O S Na-6.0H O - 1.0NaHCO Elemental analysis C H N O S Na-6.0H O-1.0 NaHCO
計算値: C,39.34; H,4.25; N,9.83; S, 11.25; Na,5.38 (%) Calculated values: C, 39.34; H, 4.25; N, 9.83; S, 11.25; Na, 5.38 (%)
実験値: C,39.34; H,4.22; N, 10.09; S, 11.77; Na,5.31 (%) Experimental values: C, 39.34; H, 4.22; N, 10.09; S, 11.77; Na, 5.31 (%)
実施例 4 Example 4
[化 52] [Chemical 52]
(1) 2 1+18→22→20
化合物 21(721mg,lmmol)と化合物 18(325mg,lmmol)を用い、実施例 1の (5)と同様の 方法で化合物 22を無定形粉末として得た。収量 999mg(88%)。この化合物 22(983mg,0 .86mmol)を 2M/卜 TiCl /CH CI (4.3ml,8.6mmol)を用レヽ、実施例 1の (6)と同様の方法 (1) 2 1 + 18 → 22 → 20 Using Compound 21 (721 mg, 1 mmol) and Compound 18 (325 mg, 1 mmol), Compound 22 was obtained as an amorphous powder in the same manner as in Example 1, (5). Yield 999 mg (88%). Using this compound 22 (983 mg, 0.86 mmol) in 2 M / ヽ TiCl 2 / CH CI (4.3 ml, 8.6 mmol), the same method as in Example 1, (6)
4 2 2 4 2 2
で化合物 20を粉末として得た。収量 98mg(12%) Compound 20 was obtained as a powder. Yield 98 mg (12%)
'H-NMR (d -DMSO): 1.00(3H, t, J = 7.5Hz), 2.18(2H, m), 3.44, 3.50(2H, ABq, J = 'H-NMR (d-DMSO): 1.00 (3H, t, J = 7.5Hz), 2.18 (2H, m), 3.44, 3.50 (2H, ABq, J =
16.4 Hz), 5.05(1H, d, J = 4.8Hz), 5.20(2H, d, J = 5.7Hz) , 5.59(1H, dd. J = 5.1, 8.1 Hz), 5.84(1H, m), 6.20(1H, s), 6.22(1H, t, J = 8.1Hz), 7.00(2H, s), 7.28(1H, d, J = 15.9Hz), 7.90(1H, s), 8.4 2(2H, d, J = 6.6Hz), 8.53(1H, s), 8.88(2H, d, J = 6.6Hz), 9.22(1H, d, J = 7.8Hz). 16.4 Hz), 5.05 (1H, d, J = 4.8Hz), 5.20 (2H, d, J = 5.7Hz), 5.59 (1H, dd.J = 5.1, 8.1 Hz), 5.84 (1H, m), 6.20 (1H, s), 6.22 (1H, t, J = 8.1Hz), 7.00 (2H, s), 7.28 (1H, d, J = 15.9Hz), 7.90 (1H, s), 8.4 2 (2H, d , J = 6.6Hz), 8.53 (1H, s), 8.88 (2H, d, J = 6.6Hz), 9.22 (1H, d, J = 7.8Hz).
IR (KBr) cm_1:3409, 2969, 1761, 1633, 1602, 1536, 1470, 1435, 1362, 1252, 1223. MS(ESI): 624+ (M+H)+ IR (KBr) cm _1 : 3409, 2969, 1761, 1633, 1602, 1536, 1470, 1435, 1362, 1252, 1223. MS (ESI): 624 + (M + H) +
元素分析 c H N O S Na-6.0H O - 0.7NaHCO Elemental analysis c H N O S Na-6.0H O-0.7NaHCO
28 24 5 6 3 2 3 28 24 5 6 3 2 3
計算値: C,42.51; Η,4·35; Ν,8.64; S, 11.86; Na,4.82 (%) Calculated value: C, 42.51; Η, 4.35; Ν, 8.64; S, 11.86; Na, 4.82 (%)
実験値: C,42.38; Η,4·59; Ν,8.75; S, 11.73; Na,4.76 (%) Experimental value: C, 42.38; Η, 4.59; Ν, 8.75; S, 11.73; Na, 4.76 (%)
実施例 5 Example 5
[化 53] [Chemical 53]
(1) 21+24→25→23 (1) 21 + 24 → 25 → 23
化合物 21(721mg,lmmol)と化合物 24(236mg,lmmol)を用い、実施例 1の (5)と同様の 方法で化合物 25を無定形粉末として得た。収量 919mg(102%)。この化合物 25(907mg, l.Olmmol)を 2M/卜 TiCl /CH CI (3.0ml,6.0mmol)を用レヽ、実施例 1の (6)と同様の方法 Using compound 21 (721 mg, lmmol) and compound 24 (236 mg, lmmol), compound 25 was obtained as an amorphous powder in the same manner as in Example 1, (5). Yield 919 mg (102%). This compound 25 (907 mg, l.Olmmol) was used in the same manner as (6) of Example 1 using 2 M / 卜 TiCl 2 / CH CI (3.0 ml, 6.0 mmol).
4 2 2 4 2 2
で化合物 23を粉末として得た。収量 246mg(32%) To obtain Compound 23 as a powder. Yield 246 mg (32%)
'H-NMR (d -DMSO): 1·00(3Η, t, J = 7.5Hz), 2.16(2H, m), 3.43, 3.49(2H, ABq, J =
16.8 Hz), 5.04(1H, d, J = 4.8Hz), 5.31(2H, d, J = 6.9Hz) , 5.59(1H, dd. J = 4.5, 7.8 Hz), 5.85(1H, m), 6.19(1H, s), 6.21(1H, t, J = 7.8Hz), 6.98(2H, s), 7.30(1H, d, J = 15.9Hz), 7.69(1H, s), 8.61(2H, d, J = 7.2Hz),9.15(2H, d, J = 7.2Hz), 9.20(1H, d, J = 7.8Hz). 'H-NMR (d-DMSO): 1 · 00 (3Η, t, J = 7.5Hz), 2.16 (2H, m), 3.43, 3.49 (2H, ABq, J = 16.8 Hz), 5.04 (1H, d, J = 4.8Hz), 5.31 (2H, d, J = 6.9Hz), 5.59 (1H, dd.J = 4.5, 7.8 Hz), 5.85 (1H, m), 6.19 (1H, s), 6.21 (1H, t, J = 7.8Hz), 6.98 (2H, s), 7.30 (1H, d, J = 15.9Hz), 7.69 (1H, s), 8.61 (2H, d, J = 7.2Hz), 9.15 (2H, d, J = 7.2Hz), 9.20 (1H, d, J = 7.8Hz).
IR (KBr) cm" ':3420, 2969, 2171, 1761, 1610, 1530, 1475, 1437, 1359, 1256. IR (KBr) cm "': 3420, 2969, 2171, 1761, 1610, 1530, 1475, 1437, 1359, 1256.
MS(FAB): 655+ (M+H)+ MS (FAB): 655+ (M + H) +
元素分析 c H N O S Na-4.3H O - 0.25NaHCO Elemental analysis c H N O S Na-4.3H O-0.25 NaHCO
28 23 8 6 2 2 3 28 23 8 6 2 2 3
計算値: C,45.05; H,4.26; N, 14.88; S,8.52; Na,3.82 (%) Calculated values: C, 45.05; H, 4.26; N, 14.88; S, 8.52; Na, 3.82 (%)
実験値: C44.38; H,4.23; N, 15.19; S,8.39; Na,3.85 (%) Experimental value: C44.38; H, 4.23; N, 15.19; S, 8.39; Na, 3.85 (%)
実施例 6 Example 6
[化 54] [Chemical 54]
32 32
(1) 27 (1) 27
化合物 27は文献記載 (J.Heterocycl.Chem. l971,8,571〜580)の方法で合成した。 Compound 27 was synthesized by the method described in the literature (J. Heterocycl. Chem. L971, 8, 571-580).
(2) 27→28 (2) 27 → 28
化合物 27(3.03g,30mmol)と POBr (8.60g,33mmol)を 100°Cで 1時間攪拌した。室温に Compound 27 (3.03 g, 30 mmol) and POBr (8.60 g, 33 mmol) were stirred at 100 ° C. for 1 hour. At room temperature
3 Three
冷却後、氷水についで炭酸ナトリウムをカ卩ぇ pHを 7以上にした。混合液に塩化メチレ
ンを加え活性炭処理をした。濾液から塩化メチレン層を分取し MgS04乾燥後、減圧 下 (300mmHg,40°C)濃縮しィ匕合物 28を黄色オイルとして得た。収量 3.4g(69%) After cooling, the pH was adjusted to 7 or higher after adding ice carbonate and sodium carbonate. Methyl chloride in the mixture And activated carbon treatment. The methylene chloride layer was separated from the filtrate, dried over MgS04, and concentrated under reduced pressure (300 mmHg, 40 ° C.) to obtain Compound 28 as a yellow oil. Yield 3.4 g (69%)
'H-NMR (CDC13) :7.19(1H, d, J = 5.4Hz), 8.58(1H, d, J = 5.1Hz) 'H-NMR (CDC13): 7.19 (1H, d, J = 5.4Hz), 8.58 (1H, d, J = 5.1Hz)
(3) 28+13→29 (3) 28 + 13 → 29
化合物 28(1.64g,10mmol)、及び化合物 13(2.05g,10mmol)を用レ、、実施例 2の (2)と同 様の方法で化合物 29を得た。黄色結晶。収量 1.20g(74%) Compound 29 (1.64 g, 10 mmol) and Compound 13 (2.05 g, 10 mmol) were used in the same manner as in Example 2, (2) to give compound 29. Yellow crystals. Yield 1.20 g (74%)
'H-NMR (CDC13): 7.71(1H, d, J = 4.8Hz), 7·88(2Η, d, J = 6.0Hz), 8.73(2H, d, J = 5.7Hz), 8.80(1H, d, J = 4.8Hz). 'H-NMR (CDC13): 7.71 (1H, d, J = 4.8Hz), 7.88 (2Η, d, J = 6.0Hz), 8.73 (2H, d, J = 5.7Hz), 8.80 (1H, d, J = 4.8Hz).
(4) 29→30 (4) 29 → 30
i-Pr NH(1.40ml,10mmol)をテトラヒドロフラン (10ml)に溶解し、氷冷下 n -ブチルリチウ ムへキサン溶液ひ .6M/L, 6.24ml)を力卩ぇ氷冷で 30分間攪拌した。その溶液を- 78°Cに 冷却しィ匕合物 29(1.08g,6.66mmol)のテトラヒドロフラン (10ml)溶液をカ卩えた。 15分間攪 拌した後に C1C OOMe(1.03ml,13.3mmol)を加え更に 20分間攪拌した。混合液に 2N- HC1を加え室温に戻した後 Na2C03を加え pHを 7以上とした。酢酸ェチルにて抽出し 、有機層を水、ブラインの順に洗浄した。有機層は MgS04乾燥し、減圧下で濃縮した 。残渣をシリカゲルカラムクロマトグラフィーに付しトルエン-酢酸ェチル (3:1)で溶離し た。溶離液を減圧下濃縮し化合物 30を白色結晶で得た。収量 450mg(31%) i-Pr NH (1.40 ml, 10 mmol) was dissolved in tetrahydrofuran (10 ml), and n-butyllithium hexane solution (6 M / L, 6.24 ml) was stirred with ice-cooling for 30 minutes under ice-cooling. The solution was cooled to −78 ° C., and a solution of Compound 29 (1.08 g, 6.66 mmol) in tetrahydrofuran (10 ml) was prepared. After stirring for 15 minutes, C1C OOMe (1.03 ml, 13.3 mmol) was added, and the mixture was further stirred for 20 minutes. 2N-HC1 was added to the mixture and the mixture was returned to room temperature, and then Na2C03 was added to adjust the pH to 7 or higher. Extraction was performed with ethyl acetate, and the organic layer was washed with water and brine in this order. The organic layer was dried over MgS04 and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography and eluted with toluene-ethyl acetate (3: 1). The eluent was concentrated under reduced pressure to obtain Compound 30 as white crystals. Yield 450mg (31%)
'H-NMR (CDC13): 3·99(3Η, s), 7.88(2H, d, J = 6.3Hz), 8.02(1H, s), 8.76(2H, d, J = 6.0Hz). 'H-NMR (CDC13): 3 · 99 (3Η, s), 7.88 (2H, d, J = 6.3Hz), 8.02 (1H, s), 8.76 (2H, d, J = 6.0Hz).
(5) 30→31 (5) 30 → 31
化合物 30(437mg,1.98mmol)をメタノール (8ml)に溶解し、 NaNHCN(139mg,2.17mmol )を加えた。室温で 1時間 30分攪拌した後、 NaNHCN(127mg,1.98mmol)を追加して、 更に室温で 40分攪拌した。反応液は減圧下で濃縮後、水で希釈し 2N-HC1で pHを 2. 0に調整して沈殿を析出させた。この沈殿を濾取し、メタノールに懸濁させた。この懸 濁液は lN_Me〇Na/Me〇Hを加え pHを 7.7に調整し溶解させた後、溶液を減圧下で 濃縮して化合物 31が薄茶色粉末として得た。収量 501mg(100%) Compound 30 (437 mg, 1.98 mmol) was dissolved in methanol (8 ml) and NaNHCN (139 mg, 2.17 mmol) was added. After stirring at room temperature for 1 hour and 30 minutes, NaNHCN (127 mg, 1.98 mmol) was added, and the mixture was further stirred at room temperature for 40 minutes. The reaction solution was concentrated under reduced pressure, diluted with water, and the pH was adjusted to 2.0 with 2N-HC1 to precipitate a precipitate. The precipitate was collected by filtration and suspended in methanol. This suspension was added with lN_Me 0 Na / Me 0 H to adjust the pH to 7.7 and dissolved, and then the solution was concentrated under reduced pressure to obtain Compound 31 as a light brown powder. Yield 501mg (100%)
'H-NMR (d -DMSO): 7.97(2H, d, J = 6.3Hz), 8.17(1H, s), 8.65(2H, d, J = 6.3Hz).'H-NMR (d-DMSO): 7.97 (2H, d, J = 6.3Hz), 8.17 (1H, s), 8.65 (2H, d, J = 6.3Hz).
(6) 8+31→32→26
化合物 8(738mg, Immol)と化合物 3 l(252mg, Immol)を用い、実施例 1の (5)と同様の 方法で化合物 32を無定形粉末として得た。収量 871mg(93%)。この化合物 32(854mg,0 .92mmol)を 2M/卜 TiCl /CH CI (2.8,5.6mmol)を用レ、、実施例 1の (6)と同様の方法で (6) 8 + 31 → 32 → 26 Using Compound 8 (738 mg, Immol) and Compound 31 (252 mg, Immol), Compound 32 was obtained as an amorphous powder in the same manner as in Example 1, (5). Yield 871 mg (93%). This compound 32 (854 mg, 0.92 mmol) was used in the same manner as (6) of Example 1 using 2 M / 卜 TiCl 2 / CH 2 CI (2.8, 5.6 mmol).
4 2 2 4 2 2
化合物 26を粉末として得た。収量 304mg(41%) Compound 26 was obtained as a powder. Yield 304 mg (41%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.44, 3.49(2H, ABq, J = 16.8 Hz), 4. 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.44, 3.49 (2H, ABq, J = 16.8 Hz), 4.
6 6
09(2H, q, J = 7.2Hz), 5.05(1H, d, J = 4.8Hz), 5.30(2H, d, J = 6.9Hz), 5.60(1H, dd. J = 4.8, 8.4Hz), 5.87(1H, m), 6.72(1H, s), 7.22(2H, s), 7.31(1H, d, J = 15.6Hz), 8.5 3(1H, s), 8.72(2H, d, J = 6.9Hz), 9.09(2H, d, J = 7.2Hz), 9.53(1H, d, J = 8.1Hz). IR (KBr) cm_1:3430, 2981, 2930, 2174, 1762, 1635, 1606, 1531, 1467, 1401, 1341, 1202. 09 (2H, q, J = 7.2Hz), 5.05 (1H, d, J = 4.8Hz), 5.30 (2H, d, J = 6.9Hz), 5.60 (1H, dd. J = 4.8, 8.4Hz), 5.87 (1H, m), 6.72 (1H, s), 7.22 (2H, s), 7.31 (1H, d, J = 15.6Hz), 8.5 3 (1H, s), 8.72 (2H, d, J = 6.9 Hz), 9.09 (2H, d, J = 7.2Hz), 9.53 (1H, d, J = 8.1Hz). IR (KBr) cm _1 : 3430, 2981, 2930, 2174, 1762, 1635, 1606, 1531, 1467, 1401, 1341, 1202.
MS(FAB): 688+ (M+H)+ MS (FAB): 688+ (M + H) +
元素分析 c H N O S Na-4.7H O - 0.35NaHCO Elemental analysis c H N O S Na-4.7H O-0.35NaHCO
27 22 9 6 3 2 3 27 22 9 6 3 2 3
計算値: C,40.97; Η,3·99; Ν, 15.72; S,12.00; Na,3.87 (%) Calculated value: C, 40.97; Η, 3.99; Ν, 15.72; S, 12.00; Na, 3.87 (%)
実験値: C,40.96; H,3.73; N, 15.90; S, 11.99; Na,3.91 (%) Experimental value: C, 40.96; H, 3.73; N, 15.90; S, 11.99; Na, 3.91 (%)
実施例 7 Example 7
[化 55] [Chemical 55]
(1) 34→35 (1) 34 → 35
化合物 34(1.49g,6mmol)を 2N-NaOH(4.8ml,9.6mmol)に懸濁させ、室温で 45分間攪
拌した。反応液に 2N-HCl(4.8ml,9.6mmol)をカ卩ぇ結晶を析出させた。結晶を濾取して 化合物 35を得た。 白色結晶。収量 1.24g(98%) Compound 34 (1.49 g, 6 mmol) was suspended in 2N-NaOH (4.8 ml, 9.6 mmol) and stirred for 45 minutes at room temperature. Stir. Crystals of 2N-HCl (4.8 ml, 9.6 mmol) were precipitated in the reaction solution. The crystals were collected by filtration to give compound 35. White crystals. Yield 1.24 g (98%)
'H-NMR (d -DMSO): 8.11(2H, d, J = 5.4Hz), 8.76(2H, d, J = 5.4Hz), 8.92(1H, s). 'H-NMR (d-DMSO): 8.11 (2H, d, J = 5.4Hz), 8.76 (2H, d, J = 5.4Hz), 8.92 (1H, s).
(2) 35→36 (2) 35 → 36
化合物 35(1.24g,6.0mmol)をジメチルホルムアミド (10ml)に懸濁し、 Im CO(1.39g,7.2 mmol)を加えた。室温で 2時間攪拌した後、 t_BuOH(2.87ml,30mmol)と t-BuOK(67mg, 0.6mmol)をカ卩え、 50°Cで 4時間攪拌した。反応液は水で希釈し酢酸ェチルで抽出し た。有機層を水、ブラインで洗浄し MgSO乾燥した後、減圧下で濃縮した。残渣から へキサンで結晶化させ、濾取して化合物 36を得た。淡黄色結晶。収量 1.04mg(66%) H-NMR (CDC1 ): 1.66(9H, s), 7.88(2H, d, J = 6.3Hz), 7.95(1H, s), 8.70(2H, br-s). Compound 35 (1.24 g, 6.0 mmol) was suspended in dimethylformamide (10 ml), and Im CO (1.39 g, 7.2 mmol) was added. After stirring at room temperature for 2 hours, t_BuOH (2.87 ml, 30 mmol) and t-BuOK (67 mg, 0.6 mmol) were added and stirred at 50 ° C. for 4 hours. The reaction solution was diluted with water and extracted with ethyl acetate. The organic layer was washed with water and brine, dried over MgSO and concentrated under reduced pressure. The residue was crystallized from hexane and collected by filtration to give compound 36. Pale yellow crystals. Yield 1.04 mg (66%) H-NMR (CDC1): 1.66 (9H, s), 7.88 (2H, d, J = 6.3 Hz), 7.95 (1H, s), 8.70 (2H, br-s).
(3) 21+36→37 (3) 21 + 36 → 37
化合物 21(721mg,lmmol)と化合物 36(262mg,lmmol)をジメチルホルムアミド (2m 1)中 に溶解し、臭化ナトリウム (309mg,3mmol)をカ卩ぇ室温で 4時間攪拌した。反応液は水で 希釈し酢酸ェチルで抽出した。有機層を水、ブラインで洗浄し MgSO乾燥した後、減 圧下で濃縮して化合物 37を得た。収量 899mg(87%) Compound 21 (721 mg, 1 mmol) and compound 36 (262 mg, 1 mmol) were dissolved in dimethylformamide (2m 1), and sodium bromide (309 mg, 3 mmol) was stirred at room temperature for 4 hours. The reaction solution was diluted with water and extracted with ethyl acetate. The organic layer was washed with water and brine, dried over MgSO, and concentrated under reduced pressure to give compound 37. Yield 899mg (87%)
'H-NMR (d -DMSO): 1·03(3Η, t, J = 7.2Hz), 1.48(9H, s), 1.61(9H, s), 2.23(2H, m) 'H-NMR (d-DMSO): 1.03 (3Η, t, J = 7.2Hz), 1.48 (9H, s), 1.61 (9H, s), 2.23 (2H, m)
, 3.68, 3.93(2H, ABq, J = 17.4 Hz), 5.33(3H, m), 5.90(1H, dd. J = 4.8, 7.8Hz), 6.36 (1H, t, J = 8.1Hz), 6.42(1H, m), 6.78(1H, s), 6.92(1H, d, J = 15.6Hz), 6.92(1H, s), 7.27- 7.51(10H, m), 8.64(2H, d, J = 6.9Hz), 8.82(1H, s), 9.05(2H, d, J = 6.9Hz), 9.4 1(1H, d, J = 7.8Hz), 11.54(1H, s) , 3.68, 3.93 (2H, ABq, J = 17.4 Hz), 5.33 (3H, m), 5.90 (1H, dd. J = 4.8, 7.8Hz), 6.36 (1H, t, J = 8.1Hz), 6.42 ( 1H, m), 6.78 (1H, s), 6.92 (1H, d, J = 15.6Hz), 6.92 (1H, s), 7.27-7.51 (10H, m), 8.64 (2H, d, J = 6.9Hz ), 8.82 (1H, s), 9.05 (2H, d, J = 6.9Hz), 9.4 1 (1H, d, J = 7.8Hz), 11.54 (1H, s)
(4) 37→33 (4) 37 → 33
化合物 37(879mg,0.86mmol)を塩化メチレン (10ml)とァニソール (0.86ml)に溶解し、 -3 0。Cにて 1M/卜 Aに 1 /CH NO (8.6ml,8.6mmol)を加えた。混合液を _30°Cで 30分攪拌 した後、 0.3N -塩酸 (70ml)とァセトニトリル (70ml)に氷冷下で攪拌しながら注加した。溶 液にイソプロピルエーテル (50ml)とへキサン (25ml)を加え水層 (下層)を分取した。水層 に HP-20SSを加え濃縮し、 HP-20SSカラムクロマトグラフィーに付し、水-ァセトニトリル で溶離した。所望の化合物を含むフラクションを集め攪拌しながら 2N-NaOHを注意 深く加え、 pHが 10を超えた時点でドライアイスを投入し、 pHを 5以下にした。溶液を減
圧下濃縮し、凍結乾燥して化合物 33を粉末として得た。収量 85mg(13%) Compound 37 (879 mg, 0.86 mmol) was dissolved in methylene chloride (10 ml) and anisole (0.86 ml), −30. In C, 1 / CH NO (8.6 ml, 8.6 mmol) was added to 1M / 卜 A. The mixture was stirred at _30 ° C for 30 minutes, and then poured into 0.3N-hydrochloric acid (70 ml) and acetonitrile (70 ml) with stirring under ice cooling. Isopropyl ether (50 ml) and hexane (25 ml) were added to the solution, and the aqueous layer (lower layer) was separated. HP-20SS was added to the aqueous layer, concentrated, subjected to HP-20SS column chromatography, and eluted with water-acetonitrile. Fractions containing the desired compound were collected and 2N-NaOH was carefully added while stirring, and when the pH exceeded 10, dry ice was added to bring the pH to 5 or less. Reduce solution Concentration under pressure and lyophilization gave compound 33 as a powder. Yield 85 mg (13%)
'H-NMR (D O): 1·05(3Η, t, J = 7.5Hz), 2.22(2H, m), 3.66(2H, s), 5.27(3H, m), 5.8 'H-NMR (D O): 1.05 (3Η, t, J = 7.5Hz), 2.22 (2H, m), 3.66 (2H, s), 5.27 (3H, m), 5.8
0(1H, d, J = 4.8Hz), 6.12(1H, m), 6.32(1H, t, J = 7.8Hz), 6.46(1H, s), 6.96(1H, d, J = 15.6Hz), 8.47(2H, d, J = 6.9Hz), 8.64(1H, s), 8.81(2H, d, J = 6.9Hz). 0 (1H, d, J = 4.8Hz), 6.12 (1H, m), 6.32 (1H, t, J = 7.8Hz), 6.46 (1H, s), 6.96 (1H, d, J = 15.6Hz), 8.47 (2H, d, J = 6.9Hz), 8.64 (1H, s), 8.81 (2H, d, J = 6.9Hz).
IR (KBr) cm_1:3409, 2967, 2872, 1762, 1634, 1529, 1489, 1457, 1368, 1286, 1212. MS(ESI): 625+ (M+H)+ IR (KBr) cm _1 : 3409, 2967, 2872, 1762, 1634, 1529, 1489, 1457, 1368, 1286, 1212. MS (ESI): 625+ (M + H) +
元素分析 c H N O S Na-4.2 H O - 0.45NaHCO Elemental analysis c H N O S Na-4.2 H O-0.45 NaHCO
計算値: C,43.37; H,4.22; N,11.06; S,12.66; Na,4.39 (%) Calculated values: C, 43.37; H, 4.22; N, 11.06; S, 12.66; Na, 4.39 (%)
実験値: C,43.67; H,4.11; N, 10.76; S,11.83; Na,4.42 (%) Experimental value: C, 43.67; H, 4.11; N, 10.76; S, 11.83; Na, 4.42 (%)
実施例 8 Example 8
[化 56] [Chemical 56]
39 40 41 42 39 40 41 42
(1) 39+40→41 (1) 39 + 40 → 41
化合物 39(1.48g,10mmol)と化合物 40(2.39g,15mmol)を酢酸 (20ml)に溶解し、 Zn粉末 (2.45g,38mmol)をカ卩えた。反応液は室温で 2時間攪拌した後、還流下、 1時間 40分攪 拌し、減圧下で濃縮した。残渣を酢酸ェチルと水で懸濁し pHが 8以上になるまで Na
COをカ卩えてセライトパッドを通して濾過した。濾液から有機層を分取し、ブラインで 洗浄後、 MgSO乾燥した。溶液を減圧下濃縮し、残渣からェチルエーテルにより結晶 化させ、濾取して化合物 41を得た。淡黄色結晶。収量 1.19g(52%) Compound 39 (1.48 g, 10 mmol) and compound 40 (2.39 g, 15 mmol) were dissolved in acetic acid (20 ml), and Zn powder (2.45 g, 38 mmol) was prepared. The reaction solution was stirred at room temperature for 2 hours, stirred at reflux for 1 hour and 40 minutes, and concentrated under reduced pressure. Suspend the residue in ethyl acetate and water until the pH is 8 or higher. The CO was collected and filtered through a celite pad. The organic layer was separated from the filtrate, washed with brine and dried over MgSO. The solution was concentrated under reduced pressure, crystallized from the residue with ethyl ether, and collected by filtration to give compound 41. Pale yellow crystals. Yield 1.19 g (52%)
'H-NMR (CDC13): 1.40(3H, t, J = 7.2Hz), 2.52(3H, s), 4.37(2H, q, J = 7.2Hz), 7.1 'H-NMR (CDC13): 1.40 (3H, t, J = 7.2Hz), 2.52 (3H, s), 4.37 (2H, q, J = 7.2Hz), 7.1
4(1H, d, J = 3.0Hz), 7.38(2H, d, J = 6.9Hz), 8.59(2H, d, J = 6.9Hz). 4 (1H, d, J = 3.0Hz), 7.38 (2H, d, J = 6.9Hz), 8.59 (2H, d, J = 6.9Hz).
(2) 41→42 (2) 41 → 42
化合物 41(1.38g,6mmol)をメタノール (200ml)に溶解し、 2N-NaOH(15ml,30mmol)を 加えた。反応液は還流下で 2時間攪拌し、減圧下でメタノールを濃縮後、 2N-HCK15 ml,30mmol)をカ卩ぇ結晶を析出させた。結晶を濾取して化合物 42を得た。 白色結晶。 収量 1.19g(98%) Compound 41 (1.38 g, 6 mmol) was dissolved in methanol (200 ml), and 2N-NaOH (15 ml, 30 mmol) was added. The reaction solution was stirred under reflux for 2 hours, and after concentrating methanol under reduced pressure, 2N-HCK (15 ml, 30 mmol) was precipitated as a crystal. The crystals were collected by filtration to give compound 42. White crystals. Yield 1.19 g (98%)
'H-NMR (d -DMSO): 2.47(3H, s), 7.44(1H, s), 7.56(2H, d, J = 6.3Hz), 8.55(2H, d, 'H-NMR (d-DMSO): 2.47 (3H, s), 7.44 (1H, s), 7.56 (2H, d, J = 6.3Hz), 8.55 (2H, d,
J = 6.3Hz). J = 6.3Hz).
(3) 42→43 (3) 42 → 43
化合物 42(880mg,4.4mmol)をジメチルホルムアミド (10ml)に懸濁し、 Im CO(l. lg,5.72 mmol)を加えた。室温で 2時間 30分攪拌した後、 t-BuOK(2.97g,26mmol)を加え、 60°C で 5時間攪拌した。反応液は水で希釈し酢酸ェチルで抽出した。有機層を水、ブライ ンで洗浄し MgSO乾燥した後、減圧下で濃縮した。残渣からイソプロピルエーテルで 結晶化させ、濾取して化合物 43を得た。淡黄色結晶。収量 364mg(32%) Compound 42 (880 mg, 4.4 mmol) was suspended in dimethylformamide (10 ml), and Im CO (l. Lg, 5.72 mmol) was added. After stirring at room temperature for 2 hours and 30 minutes, t-BuOK (2.97 g, 26 mmol) was added, and the mixture was stirred at 60 ° C for 5 hours. The reaction solution was diluted with water and extracted with ethyl acetate. The organic layer was washed with water and brine, dried over MgSO, and concentrated under reduced pressure. The residue was crystallized from isopropyl ether and collected by filtration to give compound 43. Pale yellow crystals. Yield 364 mg (32%)
'H-NMR (CDC13): 1·60(9Η, s), 2.47(3H, s), 7.07(1H, d, J = 3.3Hz), 7.33(2H, d, J = 6.3Hz), 8.58(2H, d, J = 6.3Hz). 'H-NMR (CDC13): 1 · 60 (9Η, s), 2.47 (3H, s), 7.07 (1H, d, J = 3.3Hz), 7.33 (2H, d, J = 6.3Hz), 8.58 ( (2H, d, J = 6.3Hz).
(4) 21+43→44→38 (4) 21 + 43 → 44 → 38
化合物 21(721mg,lmmol)と化合物 43(258mg,lmmol)を用レ、、実施例 7の (3)と同様の 方法で化合物 44を無定形粉末として得た。収量 962mg(94%)。この化合物 44(947mg,0 • 92mmol)を 1M/卜 Aに 1 /CH NO (9.2ml,9.2mmol)を用レヽ、実施例 7の (4)と同様の方法 で化合物 38を粉末として得た。収量 282mg(42%) Compound 21 (721 mg, 1 mmol) and Compound 43 (258 mg, 1 mmol) were used in the same manner as in Example 7, (3) to obtain Compound 44 as an amorphous powder. Yield 962 mg (94%). Using Compound 44 (947 mg, 0 • 92 mmol) in 1 M / 卜 A and 1 / CH NO (9.2 ml, 9.2 mmol) in the same manner as in Example 7, (4), Compound 38 was obtained as a powder. . Yield 282 mg (42%)
'H-NMR (d -DMSO+D〇): 1·00(3Η, t, J = 7.5Hz), 2.18(2H, m), 3.46, 3.53(2H, AB q, J = 16.8 Hz), 5.05(1H, d, J = 5.1Hz), 5.09(2H, d, J = 6.6Hz) , 5.62(1H, d. J = 4.8 Hz), 5.84(1H, m), 6.22(1H, s), 6.24(1H, t, J = 7.8Hz), 7.23(1H, d, J = 16.2Hz), 7.61
(1H, s), 8.04(2H, d, J = 7.2Hz), 8.63(2H, d, J = 6.9Hz). 'H-NMR (d-DMSO + D〇): 1 · 00 (3Η, t, J = 7.5Hz), 2.18 (2H, m), 3.46, 3.53 (2H, AB q, J = 16.8 Hz), 5.05 (1H, d, J = 5.1Hz), 5.09 (2H, d, J = 6.6Hz), 5.62 (1H, d. J = 4.8 Hz), 5.84 (1H, m), 6.22 (1H, s), 6.24 (1H, t, J = 7.8Hz), 7.23 (1H, d, J = 16.2Hz), 7.61 (1H, s), 8.04 (2H, d, J = 7.2Hz), 8.63 (2H, d, J = 6.9Hz).
IR (KBr) cm— 3407, 2966, 1761, 1633, 1565, 1533, 1472, 1442, 1402, 1334, 1216. MS(ESI): 621+ (M+H)+ IR (KBr) cm— 3407, 2966, 1761, 1633, 1565, 1533, 1472, 1442, 1402, 1334, 1216. MS (ESI): 621+ (M + H) +
元素分析 c H N O S Na-4.5H O - 0.1NaHCO Elemental analysis c H N O S Na-4.5H O-0.1NaHCO
29 27 6 6 2 2 3 29 27 6 6 2 2 3
計算値: C,47.74; H,4.97; N, 11.48; S,8.76; Na,3.45 (%) Calculated value: C, 47.74; H, 4.97; N, 11.48; S, 8.76; Na, 3.45 (%)
実験値: C47.56; H,4.75; N,11.62; S,8.73; Na,3.43 (%) Experimental value: C47.56; H, 4.75; N, 11.62; S, 8.73; Na, 3.43 (%)
実施例 9 Example 9
[化 57] [Chemical 57]
(1) 46→47 (1) 46 → 47
i-Pr NH(1.21ml,8.63mmol)をテトラヒドロフラン (10ml)に溶解し、氷冷下 n -ブチルリチ i-Pr NH (1.21 ml, 8.63 mmol) was dissolved in tetrahydrofuran (10 ml), and n-butyllithiate was cooled with ice.
2 2
ゥムへキサン溶液 (2.7M/L, 3.19ml)を力卩ぇ氷冷で 30分間攪拌した。その溶液を- 78°C に冷却し化合物 46(1.08g,6.66mmol)のテトラヒドロフラン (10ml)溶液を加えた。 15分間 攪拌した後にドライアイス粉碎品を加え更に室温で 1時間 20分間攪拌した。酢酸ェチ ル及び水を加え NaHC03を加え pHを 7以上とした。水層を分取し、 2N-塩酸を加え pH を 2.1に調整して結晶を析出させた。濾取して化合物 47を白色結晶で得た。収量 812 mg(68%) The hexane solution (2.7M / L, 3.19ml) was stirred with vigorous ice cooling for 30 minutes. The solution was cooled to −78 ° C., and a solution of compound 46 (1.08 g, 6.66 mmol) in tetrahydrofuran (10 ml) was added. After stirring for 15 minutes, dry ice powder was added and the mixture was further stirred at room temperature for 1 hour and 20 minutes. Ethyl acetate and water were added, NaHC03 was added, and the pH was adjusted to 7 or higher. The aqueous layer was separated, and 2N hydrochloric acid was added to adjust the pH to 2.1 to precipitate crystals. Filtration gave compound 47 as white crystals. Yield 812 mg (68%)
'H-NMR (d -DMSO): 8·06(2Η, d, J = 6.0Hz), 8.58(1H, s), 8.73(2H, d, J = 6.0Hz). 'H-NMR (d-DMSO): 8.06 (2Η, d, J = 6.0Hz), 8.58 (1H, s), 8.73 (2H, d, J = 6.0Hz).
6
(2) 47→48 6 (2) 47 → 48
化合物 47(412mg,2mmol)を用い、実施例 7の (2)と同様の方法で化合物 48を白色結 晶として得た。収量 313mg(60%) Using Compound 47 (412 mg, 2 mmol), Compound 48 was obtained as a white crystal in the same manner as in Example 7, (2). Yield 313 mg (60%)
'H-NMR (CDC13): 1.62(9H, s), 7.85(2H, d, J = 6.3Hz), 8.10(1H, s), 8.74(2H, d, J = 6.0Hz) 'H-NMR (CDC13): 1.62 (9H, s), 7.85 (2H, d, J = 6.3Hz), 8.10 (1H, s), 8.74 (2H, d, J = 6.0Hz)
(3) 21+48→49→45 (3) 21 + 48 → 49 → 45
化合物 21(721mg,lmmol)と化合物 48(262mg,lmmol)を用レ、、実施例 7の (3)と同様の 方法で化合物 49を無定形粉末として得た。収量 998mg(97%)。この化合物 49(980mg,0 .95mmol)lM/l-AlCl /CH NO (9.5ml,9.5mmol)を用レ、、実施例 7の (4)と同様の方法で 化合物 45を粉末として得た。収量 152mg(21%) Compound 21 (721 mg, 1 mmol) and Compound 48 (262 mg, 1 mmol) were used in the same manner as in Example 7, (3) to obtain Compound 49 as an amorphous powder. Yield 998 mg (97%). This compound 49 (980 mg, 0.95 mmol) 1M / l-AlCl 3 / CH 2 NO (9.5 ml, 9.5 mmol) was used, and compound 45 was obtained as a powder in the same manner as in Example 7, (4). Yield 152 mg (21%)
'H-NMR (d -DMSO): 1.00(3H, t, J = 7.5Hz), 2.17(2H, m), 3.47, 3.54(2H, ABq, J = 'H-NMR (d-DMSO): 1.00 (3H, t, J = 7.5Hz), 2.17 (2H, m), 3.47, 3.54 (2H, ABq, J =
17.4 Hz), 5.08(1H, d, J = 5.1Hz), 5.30(2H, d, J = 6.6Hz) , 5.62(1H, dd. J = 4.8, 7.8 Hz), 5.91(1H, m), 6.21(1H, s), 6.23(1H, t, J = 7.8Hz), 7.00(2H, s), 7.29(1H, d, J = 16.2Hz), 8.25(1H, s), 8.67(2H, d, J = 6.3Hz), 9,07(2H, d, J = 6.3Hz), 9.23(2H, d, J17.4 Hz), 5.08 (1H, d, J = 5.1 Hz), 5.30 (2H, d, J = 6.6 Hz), 5.62 (1H, dd. J = 4.8, 7.8 Hz), 5.91 (1H, m), 6.21 (1H, s), 6.23 (1H, t, J = 7.8Hz), 7.00 (2H, s), 7.29 (1H, d, J = 16.2Hz), 8.25 (1H, s), 8.67 (2H, d, J = 6.3Hz), 9,07 (2H, d, J = 6.3Hz), 9.23 (2H, d, J
= 8.1Hz). = 8.1Hz).
IR (KBr) cm_1:3409, 2968, 1763, 1605, 1526, 1467, 1397, 1344, 1217. IR (KBr) cm _1 : 3409, 2968, 1763, 1605, 1526, 1467, 1397, 1344, 1217.
MS(ESI): 625+ (M+H)+ MS (ESI): 625 + (M + H) +
元素分析 C H N O S Na-4.4H O - 0.25NaHCO Elemental analysis C H N O S Na-4.4H O-0.25 NaHCO
計算値: C,43.82; Η,4·33; Ν, 11.25; S, 12.88; Na,3.85 (%) Calculated value: C, 43.82; Η, 4.33; Ν, 11.25; S, 12.88; Na, 3.85 (%)
実験値: C,43.56; Η,3·94; Ν, 11.63; S, 12.69; Na,3.92 (%) Experimental value: C, 43.56; Η, 3.94; Ν, 11.63; S, 12.69; Na, 3.92 (%)
実施例 10 Example 10
[化 58]
[Chemical 58]
(1) 51→52 (1) 51 → 52
化合物 51(497mg,2.61mmol)を用レ、、実施例 7の (2)と同様の方法で化合物 52を白色 結晶として得た。収量 161mg(25%) Compound 51 (497 mg, 2.61 mmol) was used in the same manner as in Example 7, (2) to give compound 52 as white crystals. Yield 161 mg (25%)
'H-NMR (CDC13): 1.64(9H, s), 7.21(1H, s), 7.76(2H, d, J = 4.8Hz), 8.77(2H, d, J = 6.3Hz) 'H-NMR (CDC13): 1.64 (9H, s), 7.21 (1H, s), 7.76 (2H, d, J = 4.8Hz), 8.77 (2H, d, J = 6.3Hz)
(2) 21+52→53→50 (2) 21 + 52 → 53 → 50
化合物 21(426mg,0.59mmol)と化合物 52(146mg,0.59mmol)を用い、実施例 7の (3)と 同様の方法で化合物 53を無定形粉末として得た。収量 564mg(94%)。この化合物 53(5 45mg,0.54mmol)から 1M/卜 A 1 /CH NO (5.4ml,5.4mmol)を用レヽ、実施例 7の (4)と同 Using Compound 21 (426 mg, 0.59 mmol) and Compound 52 (146 mg, 0.59 mmol), Compound 53 was obtained as an amorphous powder in the same manner as in Example 7, (3). Yield 564 mg (94%). From this compound 53 (545 mg, 0.54 mmol), 1 M / 卜 A 1 / CH NO (5.4 ml, 5.4 mmol) was used, the same as in Example 7 (4).
3 3 2 3 3 2
様の方法で化合物 50を粉末として得た。収量 41mg(10%) Compound 50 was obtained as a powder in the same manner. Yield 41 mg (10%)
'H-NMR (d -DMSO): 1.00(3H, t, J = 7.2Hz), 2.18(2H, m), 3.44, 3.49(2H, ABq, J = 'H-NMR (d-DMSO): 1.00 (3H, t, J = 7.2Hz), 2.18 (2H, m), 3.44, 3.49 (2H, ABq, J =
6 6
16.6 Hz), 5.05(1H, d, J = 4.2Hz), 5.32(2H, d, J = 6.9Hz) , 5.60(1H, dd. J = 5.1, 7.5 Hz), 5.84(1H, m), 6.21(1H, s), 6.22(1H, t, J = 8.1Hz), 7.05(2H, s), 7.32(1H, d, J = 15.9Hz), 7.38(1H, s), 8.60(2H, d, J = 6.3Hz), 9.13(2H, d, J = 6.6Hz), 9.22(2H, d, J = 7.8Hz). 16.6 Hz), 5.05 (1H, d, J = 4.2 Hz), 5.32 (2H, d, J = 6.9 Hz), 5.60 (1H, dd. J = 5.1, 7.5 Hz), 5.84 (1H, m), 6.21 (1H, s), 6.22 (1H, t, J = 8.1Hz), 7.05 (2H, s), 7.32 (1H, d, J = 15.9Hz), 7.38 (1H, s), 8.60 (2H, d, J = 6.3Hz), 9.13 (2H, d, J = 6.6Hz), 9.22 (2H, d, J = 7.8Hz).
IR (KBr) cm— 3419, 2967, 1762, 1634, 1527, 1474, 1431, 1359, 1249. IR (KBr) cm— 3419, 2967, 1762, 1634, 1527, 1474, 1431, 1359, 1249.
MS(ESI): 609+ (M+H)+ MS (ESI): 609+ (M + H) +
元素分析 c H N O S Na- 3.6H O - 0.7NaHCO
計算値: C44. ll; Η,4·13; Ν, 11.14; S,8.50; Na,5.18 (%) Elemental analysis c HNOS Na- 3.6HO-0.7NaHCO Calculated value: C44. Ll; Η, 4 · 13; Ν, 11.14; S, 8.50; Na, 5.18 (%)
実験値: C,43.81; Η,4·01; Ν, 11.47; S,8.41; Na,5.24 (%) Experimental value: C, 43.81; Η, 4.01; Ν, 11.47; S, 8.41; Na, 5.24 (%)
実施例 11 Example 11
[化 59] [Chemical 59]
60 60
(1) 55→56 (1) 55 → 56
化合物 55(6.31g,50mmol)を酢酸 (50ml)に溶解し、 Br (3.07ml,60mmol)の酢酸 (25ml) 溶液を加えた。反応液は室温で 75時間攪拌し、減圧下で濃縮した。残渣に水を加え ェチルエーテルで抽出した。有機層を NaHC03水溶液、ブラインの順に洗浄し、 MgS 04乾燥した後、減圧下濃縮した。結晶性残渣にへキサンを加え濾取して化合物 56を 白色結晶として得た。収量 5.86g(57%) Compound 55 (6.31 g, 50 mmol) was dissolved in acetic acid (50 ml), and a solution of Br (3.07 ml, 60 mmol) in acetic acid (25 ml) was added. The reaction was stirred at room temperature for 75 hours and concentrated under reduced pressure. Water was added to the residue and extracted with ethyl ether. The organic layer was washed with an aqueous NaHC03 solution and brine in that order, dried over MgS 04, and concentrated under reduced pressure. Hexane was added to the crystalline residue and collected by filtration to obtain Compound 56 as white crystals. Yield 5.86 g (57%)
'H-NMR (CDC13): 2.49(3H, s), 7.59(1H, s), 9.78(1H, s). 'H-NMR (CDC13): 2.49 (3H, s), 7.59 (1H, s), 9.78 (1H, s).
(2) 56→57 (2) 56 → 57
化合物 56(5.13g,25mmol)を用レ、、実施例 1の (1)と同様の方法で化合物 57を白色結 晶として得た。収量 3.13g(57%) Compound 56 (5.13 g, 25 mmol) was used as a white crystal in the same manner as in Example 1, (1). Yield 3.13 g (57%)
'H-NMR (CDC13): 2.46(3H, s), 7.69(1H, s). 'H-NMR (CDC13): 2.46 (3H, s), 7.69 (1H, s).
(3) 57→58
化合物 57(3.07g,13.9mmol)を塩化メチレン (30ml)に溶解し、ジフエニルジァゾメタン( 3.51g, 18.1mmol)の塩化メチレン (20ml)溶液を滴下した。混合液は室温で 1時間攪拌 し、減圧濃縮した。残渣にへキサンを加え析出した結晶を濾取し化合物 58を得た。収 量 4. 14g(77%) (3) 57 → 58 Compound 57 (3.07 g, 13.9 mmol) was dissolved in methylene chloride (30 ml), and a solution of diphenyldiazomethane (3.51 g, 18.1 mmol) in methylene chloride (20 ml) was added dropwise. The mixture was stirred at room temperature for 1 hour and concentrated under reduced pressure. Hexane was added to the residue, and the precipitated crystals were collected by filtration to obtain Compound 58. Yield 4.14 g (77%)
'H-NMR (CDC13): 2.44(3H, s), 7.02(1H, s), 7·25_7·67(10Η, m), 7.68(1H, s). 'H-NMR (CDC13): 2.44 (3H, s), 7.02 (1H, s), 7 · 25_7 · 67 (10Η, m), 7.68 (1H, s).
(4) 13+58→59 (4) 13 + 58 → 59
化合物 13(2.05g,10mmol)、及び化合物 58(3.87g,10mmol)を用レ、、実施例 2の (2)と同 様の方法で化合物 59を得た。無色オイル。収量 3.57g(92%) Compound 59 was obtained in the same manner as in Example 2, (2) using Compound 13 (2.05 g, 10 mmol) and Compound 58 (3.87 g, 10 mmol). Colorless oil. Yield 3.57g (92%)
'H-NMR (CDC13): 2.59(3H, s); 7.07(1H, s); 7.25-7.43(12H, m), 7.84(1H, s), 7.67( 2H, d, J = 5.4Hz). 'H-NMR (CDC13): 2.59 (3H, s); 7.07 (1H, s); 7.25-7.43 (12H, m), 7.84 (1H, s), 7.67 (2H, d, J = 5.4Hz).
(5) 21+59→60→54 (5) 21 + 59 → 60 → 54
化合物 21(721mg,lmmol)と化合物 59(385mg,lmmol)を用レ、、実施例 7の (3)と同様の 方法で化合物 60を無定形粉末として得た。収量 1.10g(96%)。この化合物 60(1.09g,0.9 5mmol)から 1M/卜 A 1 /CH NO (9.5ml,9.5mmol)を用レ、、実施例 7の (4)と同様の方法 Compound 21 (721 mg, 1 mmol) and Compound 59 (385 mg, 1 mmol) were used in the same manner as in Example 7, (3) to obtain Compound 60 as an amorphous powder. Yield 1.10 g (96%). Using this compound 60 (1.09 g, 0.9 5 mmol) from 1 M / 卜 A 1 / CH NO (9.5 ml, 9.5 mmol), the same method as in Example 7, (4)
3 3 2 3 3 2
で化合物 54を粉末として得た。収量 91mg(17%) To obtain Compound 54 as a powder. Yield 91 mg (17%)
'H-NMR (d -DMSO): 1·00(3Η, t, J = 7.8Hz), 2.18(2H, m), 3.45, 3.51(2H, ABq, J = 'H-NMR (d-DMSO): 1 · 00 (3Η, t, J = 7.8Hz), 2.18 (2H, m), 3.45, 3.51 (2H, ABq, J =
6 6
16.8 Hz), 5.06(1H, d, J = 4.8Hz), 5.25(2H, d, J = 6.9Hz) , 5.60(1H, dd. J = 5.1, 8.1 Hz), 5.86(1H, m), 6.21(1H, s), 6.22(1H, t, J = 7.8Hz), 7.00(2H, s), 7.30(1H, d, J = 15.9Hz), 7.49(1H, s), 8.19(2H, d, J = 6.9Hz), 8.92(2H, d, J = 6.9Hz), 9.21(2H, d, J = 7.5Hz). 16.8 Hz), 5.06 (1H, d, J = 4.8Hz), 5.25 (2H, d, J = 6.9Hz), 5.60 (1H, dd. J = 5.1, 8.1 Hz), 5.86 (1H, m), 6.21 (1H, s), 6.22 (1H, t, J = 7.8Hz), 7.00 (2H, s), 7.30 (1H, d, J = 15.9Hz), 7.49 (1H, s), 8.19 (2H, d, J = 6.9Hz), 8.92 (2H, d, J = 6.9Hz), 9.21 (2H, d, J = 7.5Hz).
IR (KBr) cm— 3409, 2966, 1762, 1633, 1599, 1535, 1456, 1437, 1386, 1355, 1295. MS(ESI): 638+ (M+H)+ IR (KBr) cm— 3409, 2966, 1762, 1633, 1599, 1535, 1456, 1437, 1386, 1355, 1295. MS (ESI): 638+ (M + H) +
元素分析 c H N O S Na- 5.1H O - 0.1NaHCO Elemental analysis c H N O S Na- 5.1H O-0.1NaHCO
29 26 5 6 3 2 3 29 26 5 6 3 2 3
計算値: C,45.99; H,4.81 ; N,9.22; S, 12.66; Na,3.33(%) Calculated value: C, 45.99; H, 4.81; N, 9.22; S, 12.66; Na, 3.33 (%)
実験値: C,45.94; H,4.50; N,9.31 ; S, 12.62; Na,3.44 (%) Experimental value: C, 45.94; H, 4.50; N, 9.31; S, 12.62; Na, 3.44 (%)
実施例 12 Example 12
[化 60]
[Chemical 60]
67 67
(1) 62→63,13+63→64 (1) 62 → 63,13 + 63 → 64
化合物 62(2.46g,10mmol)をジメチルホルムアミド (20ml)に溶解し、 NaH in MineraloiK 480mg, 12mmol)を加えた。室温で 30分攪拌した後、 POM_I(1.94ml,12mmol)を加え、 室温で 30分攪拌した。反応液は水で希釈し酢酸ェチルで抽出した。有機層を水、ブ ラインで洗浄し MgSO乾燥した後、減圧下で濃縮した。残渣 (63)と化合物 13(2.05g,10 Compound 62 (2.46 g, 10 mmol) was dissolved in dimethylformamide (20 ml), and NaH in MineraloiK 480 mg, 12 mmol) was added. After stirring at room temperature for 30 minutes, POM_I (1.94 ml, 12 mmol) was added, and the mixture was stirred at room temperature for 30 minutes. The reaction solution was diluted with water and extracted with ethyl acetate. The organic layer was washed with water and brine, dried over MgSO, and concentrated under reduced pressure. Residue (63) and compound 13 (2.05 g, 10
4 Four
mmol)を用い、実施例 2の (2)と同様の方法で化合物 64を得た。収量 1.60g(45%) 'H-NMR (CDC13): 1·20(9Η, s), 1·38(3Η, t, J = 7.2Hz), 2.28(6H, s), 4.35(2H, q, J = 7.2Hz), 6.28(2H, s), 7.21(2H, d, J = 6.3Hz), 8.64(2H, d, J = 6.0Hz). Compound 64 was obtained in the same manner as in Example 2, (2). Yield 1.60g (45%) 'H-NMR (CDC13): 1 · 20 (9Η, s), 1 · 38 (3Η, t, J = 7.2Hz), 2.28 (6H, s), 4.35 (2H, q , J = 7.2Hz), 6.28 (2H, s), 7.21 (2H, d, J = 6.3Hz), 8.64 (2H, d, J = 6.0Hz).
(2) 64→65 (2) 64 → 65
化合物 64(1.59g,4.44mmol)を用い、実施例 8の (2)と同様の方法で化合物 65を茶褐 色結晶として得た。収量 643mg(67%) Using compound 64 (1.59 g, 4.44 mmol), compound 65 was obtained as brownish brown crystals in the same manner as in Example 8, (2). Yield 643 mg (67%)
'H-NMR (d -DMSO): 2.24(3H, s), 2.27(3H, s), 7.28(2H, d, J = 6.0Hz), 8.55(2H, d, 'H-NMR (d-DMSO): 2.24 (3H, s), 2.27 (3H, s), 7.28 (2H, d, J = 6.0Hz), 8.55 (2H, d,
6 6
J = 6.3Hz), 11.55(1H, s), 12.2(1H, br_s). J = 6.3Hz), 11.55 (1H, s), 12.2 (1H, br_s).
(3) 65→66 (3) 65 → 66
化合物 65(640mg,2.96mmol)を用レ、、実施例 8の (3)と同様の方法で化合物 66を白 色結晶として得た。収量 242mg(30%)
Ή-NMR (CDC13): 1·59(9Η, s), 2.32(6Η, s), 7.25(2Η, d, J = 6.3Hz), 8.62(2H, d, J = 6.0Hz), 8.86(1H, br- s). Compound 65 (640 mg, 2.96 mmol) was used in the same manner as in Example 8, (3) to give compound 66 as white crystals. Yield 242mg (30%) Ή-NMR (CDC13): 1 · 59 (9Η, s), 2.32 (6Η, s), 7.25 (2Η, d, J = 6.3Hz), 8.62 (2H, d, J = 6.0Hz), 8.86 (1H , br- s).
(4) 21+66→67→61 (4) 21 + 66 → 67 → 61
化合物 21(620mg,0.86mmol)と化合物 66(234mg,0.86mmol)を用レ、、実施例 7の (3)と 同様の方法で化合物 67を無定形粉末として得た。収量 824mg(92%)。この化合物 67(8 07mg,0.78mmol)から 1M/卜 A 1 /CH NO (7.8ml,7.8mmol)を用レヽ、実施例 7の (4 )と同 様の方法で化合物 61を粉末として得た。収量 244mg(41%) Compound 21 (620 mg, 0.86 mmol) and Compound 66 (234 mg, 0.86 mmol) were used in the same manner as in Example 7, (3) to obtain Compound 67 as an amorphous powder. Yield 824 mg (92%). From this compound 67 (8 07 mg, 0.78 mmol), 1 M / 卜 A 1 / CH NO (7.8 ml, 7.8 mmol) was used, and compound 61 was obtained as a powder in the same manner as in Example 7, (4). . Yield 244 mg (41%)
'H-NMR (D O): 1.03(3H, t, J = 7.5Hz), 2.20(2H, m), 2.38(6H, s), 3.64(2H, s), 5.17 'H-NMR (DO): 1.03 (3H, t, J = 7.5Hz), 2.20 (2H, m), 2.38 (6H, s), 3.64 (2H, s), 5.17
(2H, d, J = 6.6Hz), 5.24(1H, d, J = 4.8Hz) , 5.78(1H, d. J = 4.5Hz), 6.08(1H, m), 6. 31(1H, t, J = 8.1Hz), 6.44(1H, s), 6.93(1H, d, J = 15.6Hz), 7.82(2H, d, J = 6.6Hz), 8.58(2H, d, J = 6.9Hz). (2H, d, J = 6.6Hz), 5.24 (1H, d, J = 4.8Hz), 5.78 (1H, d. J = 4.5Hz), 6.08 (1H, m), 6.31 (1H, t, J = 8.1Hz), 6.44 (1H, s), 6.93 (1H, d, J = 15.6Hz), 7.82 (2H, d, J = 6.6Hz), 8.58 (2H, d, J = 6.9Hz).
IR (KBr) cm_1:3399, 2966, 1761, 1632, 1577, 1528, 1498, 1468, 1418, 1366, 1330, 1214. IR (KBr) cm _1 : 3399, 2966, 1761, 1632, 1577, 1528, 1498, 1468, 1418, 1366, 1330, 1214.
MS(ESI): 635+ (M+H)+ MS (ESI): 635 + (M + H) +
元素分析 C H N O S Na-4.7H O - 0.2NaHCO Elemental analysis C H N O S Na-4.7H O-0.2NaHCO
計算値: C,47.84; Η,5· 13; Ν, 11.08; S,8.46; Na,3.64(%) Calculated value: C, 47.84; Η, 5 · 13; Ν, 11.08; S, 8.46; Na, 3.64 (%)
実験値: C,47.80; H,4.92; N, 11.15; S,8.39; Na,3.58 (%) Experimental value: C, 47.80; H, 4.92; N, 11.15; S, 8.39; Na, 3.58 (%)
実施例 13 Example 13
[化 61]
[Chemical 61]
(1) 69→70 (1) 69 → 70
化合物 69(4.27g,30mmol)をジメチルホルムアミド (30ml)に溶解し、 K CO (5.38g,39m Compound 69 (4.27 g, 30 mmol) was dissolved in dimethylformamide (30 ml) and K 2 CO 3 (5.38 g, 39 m
2 3 mol)、次いで Etl(4.80ml,60mmol)を加えた。室温で 16時間攪拌した後、水で希釈しジ ェチルエーテルで抽出した。有機層を水、ブラインで洗浄し MgSO乾燥した後、減圧 2 3 mol) followed by Etl (4.80 ml, 60 mmol). The mixture was stirred at room temperature for 16 hours, diluted with water and extracted with diethyl ether. The organic layer was washed with water and brine, dried over MgSO,
4 Four
下で濃縮した。残渣を酢酸 (20ml)に溶解し、 AcONa(6.40g,78mmol)を加えた。混合液 は 60°Cに加温し Br (3.84ml,75mmol)を加えた後、 85°Cで 6時間攪拌した。反応液は 50 Concentrated under. The residue was dissolved in acetic acid (20 ml) and AcONa (6.40 g, 78 mmol) was added. The mixture was heated to 60 ° C and Br (3.84 ml, 75 mmol) was added, followed by stirring at 85 ° C for 6 hours. 50 reaction solutions
2 2
°Cまで下げ、 Zn粉末 (3.92g,60mmol)を加えて更に 85°Cで 50分攪拌した。不溶物をセ ライトパッドを通して濾過し、濾液に水を加えへキサンで抽出した。有機層を水、 NaH C03水溶液の順に洗浄し、減圧下、濃縮して化合物 70を得た。収量 5.65g(76%) 'H-NMR (CDC13): 1.38(3H, t, J = 7.2Hz), 2.55(3H, s), 4.35(2H, q, J = 7.2Hz), 7.4 2(1H, s). The temperature was lowered to ° C, Zn powder (3.92 g, 60 mmol) was added, and the mixture was further stirred at 85 ° C for 50 minutes. The insoluble material was filtered through a celite pad, water was added to the filtrate, and the mixture was extracted with hexane. The organic layer was washed with water and a NaH C03 aqueous solution in this order, and concentrated under reduced pressure to obtain Compound 70. Yield 5.65g (76%) 'H-NMR (CDC13): 1.38 (3H, t, J = 7.2Hz), 2.55 (3H, s), 4.35 (2H, q, J = 7.2Hz), 7.4 2 (1H , S).
(2) 13+70→71 (2) 13 + 70 → 71
化合物 13(2.05g,10mmol)、及び化合物 70(2.49g,10mmol)を用レ、、実施例 2の (2)と同 様の方法で化合物 71を得た。 白色結晶。収量 2.08g(84%) Compound 71 was obtained in the same manner as in Example 2, (2) using Compound 13 (2.05 g, 10 mmol) and Compound 70 (2.49 g, 10 mmol). White crystals. Yield 2.08 g (84%)
'H-NMR (CDC13): 1.40(3H, t, J = 6.9Hz), 2.55(3H, s), 4.38(2H, q, J = 7.2Hz), 7.3 1(2H, d, J = 6.0Hz), 7.47(1H, s), 8.68(2H, d, J = 6.3Hz). 'H-NMR (CDC13): 1.40 (3H, t, J = 6.9Hz), 2.55 (3H, s), 4.38 (2H, q, J = 7.2Hz), 7.3 1 (2H, d, J = 6.0Hz ), 7.47 (1H, s), 8.68 (2H, d, J = 6.3Hz).
(3) 71→72
化合物 71(2.04g,8.25mmol)を MeOH(20ml)に溶解させ、 2N-NaOH(12.4ml,24.8mmol )を加えた。室温で 2時間 40分間攪拌して減圧下で濃縮した後、 2N-HCl(12.4ml,24.8 mmol)を加え結晶を析出させた。結晶を濾取して化合物 72を得た。 白色結晶。収量 1. 71g(95%) (3) 71 → 72 Compound 71 (2.04 g, 8.25 mmol) was dissolved in MeOH (20 ml) and 2N-NaOH (12.4 ml, 24.8 mmol) was added. After stirring at room temperature for 2 hours and 40 minutes and concentrating under reduced pressure, 2N-HCl (12.4 ml, 24.8 mmol) was added to precipitate crystals. The crystals were collected by filtration to give compound 72. White crystals. Yield 1.71 g (95%)
'H-NMR (d -DMSO): 2.49(3H, s), 7.45(2H, d, J = 6.0Hz), 7.96(1H, s), 8.64(2H, d, 'H-NMR (d-DMSO): 2.49 (3H, s), 7.45 (2H, d, J = 6.0Hz), 7.96 (1H, s), 8.64 (2H, d,
J = 6.0Hz). J = 6.0Hz).
(4) 72→73 (4) 72 → 73
化合物 72(822mg,3.75mmol)を用レ、、実施例 7の (2)と同様の方法で化合物 73を白色 結晶として得た。収量 1.04g(100%) Compound 72 (822 mg, 3.75 mmol) was used in the same manner as in Example 7, (2) to give compound 73 as white crystals. Yield 1.04 g (100%)
'H-NMR (CDC13): 1.60(9H, s),2.52(3H,s), 7.29(2H, d, J = 6.3Hz), 7.42(1H, s), 8.6 6(2H, d, J = 6.3Hz) 'H-NMR (CDC13): 1.60 (9H, s), 2.52 (3H, s), 7.29 (2H, d, J = 6.3Hz), 7.42 (1H, s), 8.6 6 (2H, d, J = (6.3Hz)
(5) 21+73→74→68 (5) 21 + 73 → 74 → 68
化合物 21(721mg,lmmol)と化合物 73(275mg,lmmol)を用い、実施例 7の (3)と同様の 方法で化合物 74を無定形粉末として得た。収量 980mg(94%)。この化合物 74(960mg,0 .92mmol)から 1M/卜 A 1 /CH NO (9.2ml,9.2mmol)を用レヽ、実施例 7の (4)と同様の方 法で化合物 68を粉末として得た。収量 293mg(42%) Compound 74 was obtained as an amorphous powder in the same manner as in Example 7, (3) using Compound 21 (721 mg, 1 mmol) and Compound 73 (275 mg, 1 mmol). Yield 980 mg (94%). From this compound 74 (960 mg, 0.92 mmol), 1 M / 卜 A 1 / CH NO (9.2 ml, 9.2 mmol) was used, and compound 68 was obtained as a powder in the same manner as in Example 7, (4). . Yield 293 mg (42%)
'H-NMR (D O): 1·03(3Η, t, J = 7.5Hz), 2.21(2H, m), 2.51(3H, s), 3.65(2H, s), 5.25 'H-NMR (D O): 1 · 03 (3Η, t, J = 7.5Hz), 2.21 (2H, m), 2.51 (3H, s), 3.65 (2H, s), 5.25
(1H, d, J = 4.8Hz), 5.27(2H, d, J = 6.9Hz) , 5.78(1H, d. J = 4.8Hz), 6.11(1H, m), 6. 31(1H, t, J = 8.1Hz), 6.45(1H, s), 6.96(1H, d, J = 15.9Hz), 7.91(1H, s), 8.05(2H, d, J = 6.9Hz), 8.77(2H, d, J = 6.6Hz). (1H, d, J = 4.8Hz), 5.27 (2H, d, J = 6.9Hz), 5.78 (1H, d. J = 4.8Hz), 6.11 (1H, m), 6. 31 (1H, t, J = 8.1Hz), 6.45 (1H, s), 6.96 (1H, d, J = 15.9Hz), 7.91 (1H, s), 8.05 (2H, d, J = 6.9Hz), 8.77 (2H, d, J = 6.6Hz).
IR (KBr) cm— 3409, 2965, 1762, 1633, 1528, 1462, 1378, 1351, 1218. IR (KBr) cm— 3409, 2965, 1762, 1633, 1528, 1462, 1378, 1351, 1218.
MS(ESI): 638+ (M+H)+ MS (ESI): 638+ (M + H) +
元素分析 c H N O S Na-4.2H O - 0.2NaHCO Elemental analysis c H N O S Na-4.2H O-0.2NaHCO
計算値: C,46.63; H,4.64; N,9.31; S, 12.79; Na,3.67(%) Calculated values: C, 46.63; H, 4.64; N, 9.31; S, 12.79; Na, 3.67 (%)
実験値: C46.48; H,4.56; N,9.52; S, 12.70; Na,3.61 (%) Experimental value: C46.48; H, 4.56; N, 9.52; S, 12.70; Na, 3.61 (%)
実施例 14 Example 14
[化 62]
[Chemical 62]
(1) 76+59→77→75 (1) 76 + 59 → 77 → 75
化合物 76(640mg,0.87mmol)と化合物 59(335mg,0.87mmol)を用い、実施例 7の (3)と 同様の方法で化合物 77を無定形粉末として得た。収量 953mg(94%)。この化合物 77(9 36mg,0.80mmol)から 1M/卜 A 1 /CH NO (8.0ml,8.0mmol)を用レヽ、実施例 7の (4)と同 Compound 77 was obtained as an amorphous powder in the same manner as in Example 7, (3) using Compound 76 (640 mg, 0.87 mmol) and Compound 59 (335 mg, 0.87 mmol). Yield 953 mg (94%). From this compound 77 (9 36 mg, 0.80 mmol), 1 M / 卜 A 1 / CH NO (8.0 ml, 8.0 mmol) was used, as in Example 7, (4).
3 3 2 3 3 2
様の方法で化合物 75を粉末として得た。収量 115mg(18%) Compound 75 was obtained as a powder in the same manner. Yield 115 mg (18%)
'H-NMR (D O): 0·89(3Η, t, J = 7.5Hz), 1.45(2H, m), 2.18(2H, m), 2.63(3H, s), 3.6 'H-NMR (D O): 0 · 89 (3Η, t, J = 7.5Hz), 1.45 (2H, m), 2.18 (2H, m), 2.63 (3H, s), 3.6
2 2
5(2H, s), 5.25(3H, m), 5.77(1H, d. J = 4.5Hz), 6.10(1H, m), 6.31(1H, t, J = 8.1Hz), 6.43(1H, s), 6.96(1H, d, J = 15.6Hz), 7.68(1H, s), 8.03(2H, d, J = 6.6Hz), 8.73(2H, d, J = 6.0Hz). 5 (2H, s), 5.25 (3H, m), 5.77 (1H, d. J = 4.5Hz), 6.10 (1H, m), 6.31 (1H, t, J = 8.1Hz), 6.43 (1H, s ), 6.96 (1H, d, J = 15.6Hz), 7.68 (1H, s), 8.03 (2H, d, J = 6.6Hz), 8.73 (2H, d, J = 6.0Hz).
IR (KBr) cm— 3409, 2968, 2929, 2870, 1762, 1632, 1600, 1535, 1456, 1437, 1385, 1357, 1294, 1224. IR (KBr) cm— 3409, 2968, 2929, 2870, 1762, 1632, 1600, 1535, 1456, 1437, 1385, 1357, 1294, 1224.
MS(ESI): 652+ (M+H)+ MS (ESI): 652+ (M + H) +
元素分析 c H N O S Na- 3.7H O - 0.5NaHCO Elemental analysis c H N O S Na- 3.7H O-0.5NaHCO
30 28 5 6 3 2 3 30 28 5 6 3 2 3
計算値: C,46.82; H,4.63; N,8.95; S, 12.30; Na,4.41(%) Calculated values: C, 46.82; H, 4.63; N, 8.95; S, 12.30; Na, 4.41 (%)
実験値: C,46.65; H,4.43; N,9.20; S, 11.64; Na,4.22 (%) Experimental value: C, 46.65; H, 4.43; N, 9.20; S, 11.64; Na, 4.22 (%)
実施例 15 Example 15
(1) 76+48→79→78 (1) 76 + 48 → 79 → 78
化合物 76(735mg,lmmol)と化合物 48(262mg,lmmol)を用レ、、実施例 7の (3)と同様の 方法で化合物 79を無定形粉末として得た。収量 985mg(95%)。この化合物 79(968mg,0 • 93mmol)から 1M/卜 A 1 /CH NO (9.3ml,9.30mmol)を用レヽ、実施例 7の (4)と同様の方 Compound 76 (735 mg, 1 mmol) and compound 48 (262 mg, 1 mmol) were used in the same manner as in Example 7, (3), and compound 79 was obtained as an amorphous powder. Yield 985 mg (95%). From this compound 79 (968 mg, 0 • 93 mmol), 1 M / 卜 A 1 / CH NO (9.3 ml, 9.30 mmol) was used, as in Example 7 (4).
3 3 2 3 3 2
法で化合物 78を粉末として得た。収量 151mg(22%) Compound 78 was obtained as a powder. Yield 151 mg (22%)
'H-NMR (D O): 0.89(3H, t, J = 7.5Hz), 1.45(2H, m), 2.17(2H, m), 3.65(2H, s), 5.2 'H-NMR (D 2 O): 0.89 (3H, t, J = 7.5Hz), 1.45 (2H, m), 2.17 (2H, m), 3.65 (2H, s), 5.2
2 2
5(1H, d, J = 4.5Hz), 5.31(1H, d, J = 6.6Hz), 5.77(1H, d. J = 4.5Hz), 6.11(1H, m), 6. 28(1H, t, J = 7.5Hz), 6.41(1H, s), 6.99(1H, d, J = 15.6Hz), 8.17(1H, s), 8.49(2H, d, J = 6.3Hz), 8.89(2H, d, J = 6.3Hz). 5 (1H, d, J = 4.5Hz), 5.31 (1H, d, J = 6.6Hz), 5.77 (1H, d.J = 4.5Hz), 6.11 (1H, m), 6.28 (1H, t , J = 7.5Hz), 6.41 (1H, s), 6.99 (1H, d, J = 15.6Hz), 8.17 (1H, s), 8.49 (2H, d, J = 6.3Hz), 8.89 (2H, d , J = 6.3Hz).
IR (KBr) cm"1:3410, 2958, 2930, 2870, 1763, 1608, 1527, 1466, 1396, 1344, 1293, 1217. IR (KBr) cm " 1 : 3410, 2958, 2930, 2870, 1763, 1608, 1527, 1466, 1396, 1344, 1293, 1217.
MS(ESI): 639+ (M+H)+ MS (ESI): 639 + (M + H) +
元素分析 C H N O S Na- 3.2H O - 0.2NaHCO Elemental analysis C H N O S Na- 3.2H O-0.2NaHCO
28 25 6 6 3 2 3 28 25 6 6 3 2 3
計算値: C,46.07; Η,4·33; Ν, 11.43; S, 13.09; Na,3.75(%) Calculated value: C, 46.07; Η, 4.33; Ν, 11.43; S, 13.09; Na, 3.75 (%)
実験値: C,46.19; H,4.49; N,11.17; S, 12.04; Na,3.79 (%) Experimental value: C, 46.19; H, 4.49; N, 11.17; S, 12.04; Na, 3.79 (%)
実施例 16 Example 16
(1) 76+36→81→80 (1) 76 + 36 → 81 → 80
化合物 76(735mg,lmmol)と化合物 36(262mg,lmmol)を用い、実施例 7の (3)と同様の 方法で化合物 81を無定形粉末として得た。収量 954mg(92%)。この化合物 81(937mg,0 •90mmol)から 1M/卜 A1C1 /CH NO (9.0ml,9.0mmol)を用い、実施例 7の (4)と同様の方 Compound 81 was obtained as an amorphous powder in the same manner as in Example 7, (3) using Compound 76 (735 mg, 1 mmol) and Compound 36 (262 mg, 1 mmol). Yield 954 mg (92%). Using this compound 81 (937 mg, 0 • 90 mmol) and 1 M / 卜 A1C1 / CH NO (9.0 ml, 9.0 mmol), the same method as in Example 7, (4)
3 3 2 3 3 2
法で化合物 80を粉末として得た。収量 177mg(26%) Method gave compound 80 as a powder. Yield 177 mg (26%)
'H-NMR (D O): 0·90(3Η, t, J = 7.2Hz), 1.46(2H, m), 2.19(2H, m), 3.65(2H, s), 5.2 'H-NMR (D O): 0 · 90 (3Η, t, J = 7.2Hz), 1.46 (2H, m), 2.19 (2H, m), 3.65 (2H, s), 5.2
2 2
6(3H, m, ), 5.78(1H, d. J = 4.8Hz), 6.11(1H, m), 6.31(1H, t, J = 7.5Hz), 6.44(1H, s) , 6.96(1H, d, J = 15.9Hz), 8.46(2H, d, J = 6.6Hz), 8.62(1H, s), 8.80(2H, d, J = 6.6H z). 6 (3H, m,), 5.78 (1H, d. J = 4.8Hz), 6.11 (1H, m), 6.31 (1H, t, J = 7.5Hz), 6.44 (1H, s), 6.96 (1H, d, J = 15.9Hz), 8.46 (2H, d, J = 6.6Hz), 8.62 (1H, s), 8.80 (2H, d, J = 6.6H z).
IR (KBr) cm"1:3418, 2958, 2930, 2870, 1763, 1635, 1530, 1489, 1458, 1367, 1288, 1216. IR (KBr) cm " 1 : 3418, 2958, 2930, 2870, 1763, 1635, 1530, 1489, 1458, 1367, 1288, 1216.
MS(ESI): 639+ (M+H)+ MS (ESI): 639+ (M + H) +
元素分析 c H N O S Na-4.1H O - 0.2NaHCO Elemental analysis c H N O S Na-4.1H O-0.2NaHCO
28 25 6 6 3 2 3 28 25 6 6 3 2 3
計算値: C,45.08; H,4.48; N,11.19; S, 12.80; Na,3.67(%) Calculated values: C, 45.08; H, 4.48; N, 11.19; S, 12.80; Na, 3.67 (%)
実験値: C,45.10; H,4.18; N,11.04; S,11.84; Na,3.67 (%) Experimental value: C, 45.10; H, 4.18; N, 11.04; S, 11.84; Na, 3.67 (%)
実施例 17 Example 17
[化 65]
[Chemical 65]
(1) 83+36→84→82 (1) 83 + 36 → 84 → 82
化合物 83(752mg,lmmol)と化合物 36(262mg,lmmol)を用レ、、実施例 7の (3)と同様の 方法で化合物 84を無定形粉末として得た。収量 990mg(93%)。この化合物 84(974mg,0 .92mmol)から 1M/卜 A 1 /CH NO (9.2ml,9.2mmol)を用レヽ、実施例 7の (4)と同様の方 法で化合物 82を粉末として得た。収量 139mg(19%) Compound 83 (752 mg, 1 mmol) and Compound 36 (262 mg, 1 mmol) were used in the same manner as in Example 7, (3) to obtain Compound 84 as an amorphous powder. Yield 990 mg (93%). From this compound 84 (974 mg, 0.92 mmol), 1 M / 卜 A 1 / CH NO (9.2 ml, 9.2 mmol) was used, and compound 82 was obtained as a powder in the same manner as in Example 7, (4). . Yield 139 mg (19%)
'H-NMR (D O): 1.29(6H, m), 3.66(2H, s), 4.48(1H, m), 5.26(3H, m), 5.80(1H, d. J 'H-NMR (D 2 O): 1.29 (6H, m), 3.66 (2H, s), 4.48 (1H, m), 5.26 (3H, m), 5.80 (1H, d. J
= 4.5Hz), 6.12(1H, m), 6.92(1H, s), 6.97(1H, d, J = 15.3Hz), 8.45(2H, d, J = 6.6Hz) , 8.62(1H, s), 8.80(2H, d, J = 6.6Hz). = 4.5Hz), 6.12 (1H, m), 6.92 (1H, s), 6.97 (1H, d, J = 15.3Hz), 8.45 (2H, d, J = 6.6Hz), 8.62 (1H, s), 8.80 (2H, d, J = 6.6Hz).
IR (KBr) cm— 3410, 2977, 1764, 1635, 1532, 1488, 1456, 1368, 1292, 1210. IR (KBr) cm— 3410, 2977, 1764, 1635, 1532, 1488, 1456, 1368, 1292, 1210.
MS(ESI): 656+ (M+H)+ MS (ESI): 656 + (M + H) +
元素分析 C H N O S Na-4.5H O - 0.25NaHCO Elemental analysis C H N O S Na-4.5H O-0.25NaHCO
計算値: C,41.97; H,4.30; N, 12.57; S, 12.34; Na,3.69(%) Calculated values: C, 41.97; H, 4.30; N, 12.57; S, 12.34; Na, 3.69 (%)
実験値: C41.97; H,4.25; N, 12.64; S,11.80; Na,3.76 (%) Experimental value: C41.97; H, 4.25; N, 12.64; S, 11.80; Na, 3.76 (%)
実施例 18 Example 18
[化 66]
[Chemical 66]
87 87
(1) 41→86 (1) 41 → 86
化合物 41(1.16g,5.74mmol)をジメチルホルムアミド (10ml)に懸濁し、 Im CO(753mg,3. Compound 41 (1.16 g, 5.74 mmol) was suspended in dimethylformamide (10 ml), and Im CO (753 mg, 3.
92mmol)を加えた。室温で 40分間攪拌した後、 NaNHCN(845mg,13.1mmol)をカロえ、室 温で 1時間攪拌した。反応液は水で希釈し 2N-HC1で pHを 6.1に調整して沈殿を析出 させた。この沈殿を濾取し、メタノールに懸濁させた。この懸濁液は lN-MeONa/MeO Hをカ卩ぇ pHを 8.6に調整し溶解させた後、減圧下で濃縮して化合物 86を白色粉末とし て得た。収量 1.33g(93%) 92 mmol) was added. After stirring at room temperature for 40 minutes, NaNHCN (845 mg, 13.1 mmol) was prepared and stirred at room temperature for 1 hour. The reaction solution was diluted with water and the pH was adjusted to 6.1 with 2N-HC1 to precipitate the precipitate. The precipitate was collected by filtration and suspended in methanol. This suspension was prepared by dissolving lN-MeONa / MeO H by adjusting the pH to 8.6 and then concentrating under reduced pressure to obtain Compound 86 as a white powder. Yield 1.33g (93%)
'H-NMR (d -DMSO): 7.73(2H, d, J = 6.6Hz), 7.76(2H, d, J = 8.7 Hz), 8.03(1H, d, 'H-NMR (d-DMSO): 7.73 (2H, d, J = 6.6Hz), 7.76 (2H, d, J = 8.7 Hz), 8.03 (1H, d,
J = 8.1Hz), 8.63(2H, d, J = 6.3Hz). J = 8.1Hz), 8.63 (2H, d, J = 6.3Hz).
(2) 21+86→87→85 (2) 21 + 86 → 87 → 85
化合物 21(721mg,lmmol)と化合物 86(248mg,lmmol)を用い、実施例 1の (5)と同様の 方法で化合物 87を無定形粉末として得た。収量 810mg(89%)。この化合物 87(800mg,0 .88mmol)から 1M/卜 A 1 /CH NO (8.8ml,8.8mmol)を用レ、、実施例 7の (4)と同様の方 法で化合物 85を粉末として得た。収量 214mg(32%) Compound 87 was obtained as an amorphous powder in the same manner as in Example 1, (5) using Compound 21 (721 mg, 1 mmol) and Compound 86 (248 mg, 1 mmol). Yield 810 mg (89%). From this compound 87 (800 mg, 0.88 mmol), 1 M / 卜 A 1 / CH NO (8.8 ml, 8.8 mmol) was used, and compound 85 was obtained as a powder in the same manner as in Example 7, (4). It was. Yield 214 mg (32%)
'H-NMR (d -DMSO): 1·00(3Η, t, J = 7.2Hz), 2.18(2H, m), 2.63(3H, s), 3.44, 3.50( 'H-NMR (d-DMSO): 1 · 00 (3Η, t, J = 7.2Hz), 2.18 (2H, m), 2.63 (3H, s), 3.44, 3.50 (
2H, ABq, J = 17.0 Hz), 5.06(1H, d, J = 4.8Hz), 5.12(2H, d, J = 6.6Hz) , 5.60(1H, d d. J = 5.1, 7.8Hz), 5.82(1H, m), 6.21(1H, s), 6.23(1H, t, J = 7.5Hz), 7.00(2H, s), 7. 27(1H, d, J = 15.9Hz), 7.64(1H, s), 8.08(2H, d, J = 6.3Hz), 8.65(2H, d, J = 5.4Hz),
9.22(2H, d, J = 7.8Hz), 11.75(1H, br-s). 2H, ABq, J = 17.0 Hz), 5.06 (1H, d, J = 4.8 Hz), 5.12 (2H, d, J = 6.6 Hz), 5.60 (1H, d d. J = 5.1, 7.8 Hz), 5.82 (1H, m), 6.21 (1H, s), 6.23 (1H, t, J = 7.5Hz), 7.00 (2H, s), 7.27 (1H, d, J = 15.9Hz), 7.64 (1H, s), 8.08 (2H, d, J = 6.3Hz), 8.65 (2H, d, J = 5.4Hz), 9.22 (2H, d, J = 7.8Hz), 11.75 (1H, br-s).
IR (KBr) cm— 3397, 2967, 2153, 1761, 1633, 1565, 1535, 1442, 1393, 1329, 1220. MS(FAB): 689+ (M+H)+ IR (KBr) cm— 3397, 2967, 2153, 1761, 1633, 1565, 1535, 1442, 1393, 1329, 1220. MS (FAB): 689 + (M + H) +
元素分析 c H N O S Na-4.3H O - 0.15NaHCO Elemental analysis c H N O S Na-4.3H O-0.15 NaHCO
計算値: C,47.85; H,4.76; N, 14.81; S,8.47; Na,3.49(%) Calculated value: C, 47.85; H, 4.76; N, 14.81; S, 8.47; Na, 3.49 (%)
実験値: C47.70; H,4.66; N, 14.87; S,8.66; Na,3.44 (%) Experimental value: C47.70; H, 4.66; N, 14.87; S, 8.66; Na, 3.44 (%)
実施例 19 Example 19
[化 67] [Chemical 67]
(1) 89 (1) 89
化合物 89は文献記載 (J.Org.Chem. l996,61,9068〜9069)の方法で合成した。 Compound 89 was synthesized by the method described in the literature (J. Org. Chem. L996, 61, 9068 to 9069).
(2) 89→90 (2) 89 → 90
化合物 89(4.38g,28.6mmol)をクロ口ホルム (50ml)に溶解させ、 NBS(5.09g,28.6mmol) をカロえた。室温で 90分間攪拌した後、 Na S 0の水溶液、次いで 4N-NaOH(10ml)を 加えた。有機層を分取し MgSO乾燥した後、減圧下で濃縮して化合物 90を白色結晶 として得た。収量 6.53g(98%) Compound 89 (4.38 g, 28.6 mmol) was dissolved in black mouth form (50 ml) to give NBS (5.09 g, 28.6 mmol). After stirring at room temperature for 90 minutes, an aqueous solution of Na SO and then 4N-NaOH (10 ml) were added. The organic layer was separated, dried over MgSO, and concentrated under reduced pressure to give compound 90 as white crystals. Yield 6.53g (98%)
'H-NMR (CDCl ): 1.35(3H, t, J = 7.2Hz), 2.28(3H, s), 4.30(2H, q, J = 7.2 Hz), 6.8 'H-NMR (CDCl): 1.35 (3H, t, J = 7.2 Hz), 2.28 (3H, s), 4.30 (2H, q, J = 7.2 Hz), 6.8
3(1H, d, J = 2.7Hz), 9.12(1H, br-s).
(3) 90→91,13+91→92→93 3 (1H, d, J = 2.7Hz), 9.12 (1H, br-s). (3) 90 → 91,13 + 91 → 92 → 93
化合物 90(2.32g,10mmol)をジメチルホルムアミド (20ml)に溶解し、 NaH in MineraloiK 440mg, l lmmol)を加えた。室温で 15分攪拌した後、 POM-Cl(1.59ml,l lmmol)を加え、 室温で 30時間攪拌した。反応液に NaH in Mineraloil(0.12g,3mmol)と POM_Cl(0.43ml, 3mmol)を追加し、更に 17時間攪拌した。反応液は水で希釈し酢酸ェチルで抽出した 。有機層を水、ブラインで洗浄し MgSO乾燥した後、減圧下で濃縮した。残渣 (91)と 化合物 13(2.05g,10mmol)を用レ、、実施例 2の (2)と同様の方法で化合物 92収量 2.41g( 70%)。この化合物 92(2.4g,6.97mmol)を用い、実施例 8の (2)と同様の方法で化合物 93 を淡黄色結晶として得た。収量 1.33g(94%) Compound 90 (2.32 g, 10 mmol) was dissolved in dimethylformamide (20 ml), and NaH in MineraloiK 440 mg, l mmol) was added. After stirring at room temperature for 15 minutes, POM-Cl (1.59 ml, 11 mmol) was added, and the mixture was stirred at room temperature for 30 hours. NaH in Mineraloil (0.12 g, 3 mmol) and POM_Cl (0.43 ml, 3 mmol) were added to the reaction solution, and the mixture was further stirred for 17 hours. The reaction solution was diluted with water and extracted with ethyl acetate. The organic layer was washed with water and brine, dried over MgSO and concentrated under reduced pressure. Using the residue (91) and compound 13 (2.05 g, 10 mmol), the yield of compound 92 was 2.41 g (70%) in the same manner as (2) of Example 2. Using this compound 92 (2.4 g, 6.97 mmol), compound 93 was obtained as pale yellow crystals in the same manner as (2) of Example 8. Yield 1.33g (94%)
'H-NMR (d -DMSO): 2.45(3H, s), 7.09(1H, d, J = 2.7Hz), 7.46(2H, d, J = 6.0Hz), 'H-NMR (d-DMSO): 2.45 (3H, s), 7.09 (1H, d, J = 2.7Hz), 7.46 (2H, d, J = 6.0Hz),
8.49(2H, d, J = 6.3Hz), 11.93(1H, s), 12.33(1H, br-s). 8.49 (2H, d, J = 6.3Hz), 11.93 (1H, s), 12.33 (1H, br-s).
(4) 93→94 (4) 93 → 94
化合物 93(809mg,4mmol)を用い、実施例 18の (1)と同様の方法で化合物 94を淡黄色 結晶として得た。収量 812mg(82%) Using compound 93 (809 mg, 4 mmol), compound 94 was obtained as pale yellow crystals in the same manner as in Example 18, (1). Yield 812 mg (82%)
'H-NMR (d -DMSO): 2.40(3H, s), 6.72(1H, d, J = 2.7Hz), 7.37(2H, d, J = 6.3Hz), 'H-NMR (d-DMSO): 2.40 (3H, s), 6.72 (1H, d, J = 2.7Hz), 7.37 (2H, d, J = 6.3Hz),
8.42(2H, d, J = 6.3Hz), 11.20(1H, s). 8.42 (2H, d, J = 6.3Hz), 11.20 (1H, s).
(5) 21+94→95→88 (5) 21 + 94 → 95 → 88
化合物 21(721mg,lmmol)と化合物 94(248mg,lmmol)を用い、実施例 1の (5)と同様の 方法で化合物 95を無定形粉末として得た。収量 811mg(89%)。この化合物 95(800mg,0 .88mmol)から 1M/卜 A 1 /CH NO (8.8ml,8.8mmol)を用レ、、実施例 7の (4)と同様の方 法で化合物 88を粉末として得た。収量 244mg(37%) Compound 95 was obtained as an amorphous powder in the same manner as in (5) of Example 1 using Compound 21 (721 mg, 1 mmol) and Compound 94 (248 mg, 1 mmol). Yield 811 mg (89%). From this compound 95 (800 mg, 0.88 mmol), 1M / 卜 A 1 / CH NO (8.8 ml, 8.8 mmol) was used, and compound 88 was obtained as a powder in the same manner as in Example 7, (4). It was. Yield 244 mg (37%)
'H-NMR (d -DMSO): 1.00(3H, t, J = 7.5Hz), 2.17(2H, m), 2.51(3H, s), 3.44, 3.50( 'H-NMR (d-DMSO): 1.00 (3H, t, J = 7.5Hz), 2.17 (2H, m), 2.51 (3H, s), 3.44, 3.50 (
2H, ABq, J = 16.6 Hz), 5.05(1H, d, J = 4.8Hz), 5.10(2H, d, J = 6.6Hz) , 5.59(1H, d d. J = 4.8, 7.8Hz), 5.81(1H, m), 6.20(1H, s), 6.22(1H, t, J = 7.8Hz), 7.00(2H, s), 7. 06(lH,s), 7.26(1H, d, J = 15.9Hz), 8.00(2H, d, J = 7.2Hz), 8.62(2H, d, J = 7.2Hz), 9 • 21(2H, d, J = 8.1Hz), 11.82(1H, s). 2H, ABq, J = 16.6 Hz), 5.05 (1H, d, J = 4.8 Hz), 5.10 (2H, d, J = 6.6 Hz), 5.59 (1H, d d. J = 4.8, 7.8 Hz), 5.81 (1H, m), 6.20 (1H, s), 6.22 (1H, t, J = 7.8Hz), 7.00 (2H, s), 7.06 (lH, s), 7.26 (1H, d, J = 15.9 Hz), 8.00 (2H, d, J = 7.2Hz), 8.62 (2H, d, J = 7.2Hz), 9 • 21 (2H, d, J = 8.1Hz), 11.82 (1H, s).
IR (KBr) cm_1:3399, 2967, 2152, 1761, 1633, 1578, 1525, 1497, 1464, 1365, 1319, 1222.
MS(FAB): 667+ (M+H)+ IR (KBr) cm _1 : 3399, 2967, 2152, 1761, 1633, 1578, 1525, 1497, 1464, 1365, 1319, 1222. MS (FAB): 667 + (M + H) +
元素分析 C H N O S Na-4.7H O - 0.05NaHCO Elemental analysis C H N O S Na-4.7H O-0.05NaHCO
計算値: C,47.77; Η,4·86; Ν, 14.83; S,8.49; Na,3.20(%) Calculated value: C, 47.77; Η, 4.86; Ν, 14.83; S, 8.49; Na, 3.20 (%)
実験値: C,47.74; H,4.61; N, 14.79; S,8.92; Na,3.17 (%) Experimental value: C, 47.74; H, 4.61; N, 14.79; S, 8.92; Na, 3.17 (%)
実施例 20 Example 20
[化 68] [Chemical 68]
104 104
(1) 97→98 (1) 97 → 98
化合物 97(24.2g,0.2mol)とシユウ酸ジェチル (27.2ml,0.2mol)をテトラヒドロフラン (200 ml)に溶解させ- 78°Cに冷却した後、 LiN(TMS) /THF(1M/L,200ml)を 30分かけて滴下 した。反応液は _78°Cで 10分間攪拌した後、徐々に室温まで昇温させながら 1時間 30 分攪拌した。反応後、 _78°Cに冷却して 6N- HCl(60ml)をカ卩え、室温に昇温させなが ら攪拌した。減圧下、濃縮して lN-NaOH(120ml)と酢酸ェチル、及びジェチルエーテ ルをカ卩ぇ析出した沈殿を濾取した。沈殿は氷水で洗浄した後風乾して、化合物 98を 得た。淡黄色色粉末。収量 47.01g水分含 (106%) Compound 97 (24.2g, 0.2mol) and cetyl oxalate (27.2ml, 0.2mol) were dissolved in tetrahydrofuran (200ml) and cooled to -78 ° C, then LiN (TMS) / THF (1M / L, 200ml) ) Was added dropwise over 30 minutes. The reaction solution was stirred at _78 ° C for 10 minutes, and then stirred for 1 hour and 30 minutes while gradually warming to room temperature. After the reaction, the mixture was cooled to _78 ° C., 6N-HCl (60 ml) was added, and the mixture was stirred while raising the temperature to room temperature. Concentration under reduced pressure gave a precipitate in which lN-NaOH (120 ml), ethyl acetate, and jetyl ether were precipitated and collected by filtration. The precipitate was washed with ice water and air-dried to obtain Compound 98. Pale yellow powder. Yield 47.01g with water (106%)
'H-NMR (CDC1 ): 1.26(3H, t, J = 6.9Ηζ), 4· 16(2Η, q, J = 7.2 Hz), 6.41(1H, s), 7.6 'H-NMR (CDC1): 1.26 (3H, t, J = 6.9Ηζ), 4 · 16 (2Η, q, J = 7.2 Hz), 6.41 (1H, s), 7.6
9(2H, br-d, J=4.2Hz), 8.65(1H, br_d, J=4.2Hz).
(2) 98→99 9 (2H, br-d, J = 4.2Hz), 8.65 (1H, br_d, J = 4.2Hz). (2) 98 → 99
あらかじめ- 30°Cに冷却した 4N-HCl(36ml)に実施例 20の (1)で得た化合物 98(23.5g, O. lmol相当)とヒドラジン 1水和物 (4.4ml,90mmol)を加え、 80°Cで 1時間攪拌した。反応 液を氷冷にして lN-Na〇H(65ml)加えた。析出した沈殿を濾取しィ匕合物 99を得た。淡 黄色結晶。収量 16.89g(78%)。 Compound 98 (23.5 g, equivalent to O. lmol) obtained in Example 20 (1) and hydrazine monohydrate (4.4 ml, 90 mmol) were added to 4N-HCl (36 ml) previously cooled to -30 ° C. The mixture was stirred at 80 ° C for 1 hour. The reaction mixture was ice-cooled and lN-NaOH (65 ml) was added. The deposited precipitate was collected by filtration to obtain Compound 99. Pale yellow crystals. Yield 16.89 g (78%).
'H-NMR (d -DMSO): 1.33(3H, m), 4.35(2H, m), 7.47+7.53(lH, s+s), 7.84(2H, m), 'H-NMR (d-DMSO): 1.33 (3H, m), 4.35 (2H, m), 7.47 + 7.53 (lH, s + s), 7.84 (2H, m),
8.64(2H, m). 8.64 (2H, m).
(3) 99→100→101 (3) 99 → 100 → 101
化合物 99(4.34g,20mmol)をエタノール (80ml)に懸濁させ、 lN-NaOH(100ml, 100mmo 1)を加えた。反応液は 60°Cで 2時間攪拌し、減圧下でエタノールを濃縮除去後、氷冷 下 2N-HCl(50ml, 100mmol)を加え結晶を析出させた。結晶を濾取して化合物 100を得 た。収量 3.90g(103%)。この化合物 100(946mg,5mmol)をジメチルホルムアミド (6ml)に懸 濁し、 Im CO(973mg,6mmol)をカロえた。室温で 1時間 45分攪拌した後、酢酸ェチル (15 ml)を加え結晶を析出させた。この結晶を濾取し、化合物 101を得た。収量 1.05g(88% ) Compound 99 (4.34 g, 20 mmol) was suspended in ethanol (80 ml), and lN-NaOH (100 ml, 100 mmo 1) was added. The reaction solution was stirred at 60 ° C. for 2 hours, and ethanol was concentrated and removed under reduced pressure. Then, 2N-HCl (50 ml, 100 mmol) was added under ice cooling to precipitate crystals. The crystals were collected by filtration to give compound 100. Yield 3.90 g (103%). This compound 100 (946 mg, 5 mmol) was suspended in dimethylformamide (6 ml), and Im CO (973 mg, 6 mmol) was calored. After stirring at room temperature for 1 hour and 45 minutes, ethyl acetate (15 ml) was added to precipitate crystals. The crystals were collected by filtration to obtain Compound 101. Yield 1.05g (88%)
'H-NMR (d -DMSO): 7.17(1H, s), 7.82(1H, s), 7.93(2H, d, J = 6.3Hz), 8.04(1H, s), 'H-NMR (d-DMSO): 7.17 (1H, s), 7.82 (1H, s), 7.93 (2H, d, J = 6.3Hz), 8.04 (1H, s),
8.70(2H, d, J = 6.0Hz), 8.83(1H, s). 8.70 (2H, d, J = 6.0Hz), 8.83 (1H, s).
(4) 101→102 (4) 101 → 102
NaNHCN(141mg,2.2mmol)をジメチルホルムアミド (lml)に懸濁し、 101(239mg, lmmol )を加えた。反応液は室温で 1時間 10分攪拌した後、水 (4ml)で希釈し、 2N-HC1により pHを 3に調整し結晶を析出させた。この結晶を濾取し、化合物 102を得た。収量 165m g(77%) NaNHCN (141 mg, 2.2 mmol) was suspended in dimethylformamide (lml) and 101 (239 mg, lmmol) was added. The reaction solution was stirred at room temperature for 1 hour and 10 minutes, diluted with water (4 ml), and adjusted to pH 3 with 2N-HC1 to precipitate crystals. The crystals were collected by filtration to obtain Compound 102. Yield 165 mg (77%)
'H-NMR (d -DMSO): 7.49(1H, s), 8.19(2H, br-s), 8.79(2H, d, J = 6.6Hz). 'H-NMR (d-DMSO): 7.49 (1H, s), 8.19 (2H, br-s), 8.79 (2H, d, J = 6.6Hz).
(5) 102→103 (5) 102 → 103
化合物 102(2.2g,10.3mmol)をメタノール (20ml)に懸濁し、氷冷下で lN_MeoNa/Me〇 H(10ml)をカ卩えた。混合液は室温で 1時間攪拌した後、減圧下で濃縮した。残渣にィ ソプロパノールをカ卩ぇ析出した沈殿を濾取して化合物 103を得た。収量 2.40g(102%) 'H-NMR (d -DMSO): 7.08(1H, s), 7.79(2H, d, J = 6.0 Hz), 8.56(1H, d, J = 6.3Hz).
(6) 21+103→104→96 Compound 102 (2.2 g, 10.3 mmol) was suspended in methanol (20 ml), and lN_MeoNa / Me0H (10 ml) was obtained under ice cooling. The mixture was stirred at room temperature for 1 hour and then concentrated under reduced pressure. Compound 103 was obtained by filtering the precipitate in which isopropanol was precipitated in the residue. Yield 2.40 g (102%) 'H-NMR (d-DMSO): 7.08 (1H, s), 7.79 (2H, d, J = 6.0 Hz), 8.56 (1H, d, J = 6.3 Hz). (6) 21 + 103 → 104 → 96
化合物 21(721mg,lmmol)と化合物 103(235mg,lmmol)を用い、実施例 1の (5)と同様 の方法で化合物 104を無定形粉末として得た。収量 782mg(87%)。この化合物 104(770 mg,0.86mmol)から 1M/卜 A 1 /CH NO (8.6ml,8.6mmol)を用レヽ、実施例 7の (4)と同様 の方法で化合物 96を粉末として得た。収量 208mg(32%) Using compound 21 (721 mg, 1 mmol) and compound 103 (235 mg, 1 mmol), compound 104 was obtained as an amorphous powder in the same manner as in Example 1, (5). Yield 782 mg (87%). From this compound 104 (770 mg, 0.86 mmol), 1M / 卜 A 1 / CH NO (8.6 ml, 8.6 mmol) was used, and compound 96 was obtained as a powder in the same manner as in Example 7, (4). Yield 208 mg (32%)
'H-NMR (d -DMSO): 1.00(3H, t, J = 7.5Hz), 2.17(2H, m), 3.45, 3.52(2H, ABq, J = 'H-NMR (d-DMSO): 1.00 (3H, t, J = 7.5Hz), 2.17 (2H, m), 3.45, 3.52 (2H, ABq, J =
17.1 Hz), 5.06(1H, d, J = 5.1Hz), 5.22(2H, d, J = 6.9Hz) , 5.61(1H, dd. J = 4.8, 7.8 Hz), 5.86(1H, m), 6.20(1H, s), 6.22(1H, t, J = 7.5Hz), 7.00(2H, s), 7.28(1H, d, J = 15.9Hz), 7.44(1H, s), 8.45(2H, d, J = 6.9Hz), 8.91(2H, d, J = 6.9Hz), 9.22(2H, d, J = 8.1Hz), 14.04(1H, br-s). 17.1 Hz), 5.06 (1H, d, J = 5.1 Hz), 5.22 (2H, d, J = 6.9 Hz), 5.61 (1H, dd. J = 4.8, 7.8 Hz), 5.86 (1H, m), 6.20 (1H, s), 6.22 (1H, t, J = 7.5Hz), 7.00 (2H, s), 7.28 (1H, d, J = 15.9Hz), 7.44 (1H, s), 8.45 (2H, d, J = 6.9Hz), 8.91 (2H, d, J = 6.9Hz), 9.22 (2H, d, J = 8.1Hz), 14.04 (1H, br-s).
IR (KBr) cm_1:3409, 2967, 2165, 1762, 1636, 1604, 1530, 1473, 1437, 1398, 1347, 1214. IR (KBr) cm _1 : 3409, 2967, 2165, 1762, 1636, 1604, 1530, 1473, 1437, 1398, 1347, 1214.
MS(ESI): 632+ (M+H)+ MS (ESI): 632 + (M + H) +
元素分析 C H N O S Na-4.8H O - O. lNaHCO Elemental analysis C H N O S Na-4.8H O-O. lNaHCO
計算値: C,45.09; H,4.54; N, 16.84; S,8.57; Na,3.38(%) Calculated value: C, 45.09; H, 4.54; N, 16.84; S, 8.57; Na, 3.38 (%)
実験値: C,45.26; Η,4·39; Ν, 15.71; S,8.57; Na,3.36 (%) Experimental value: C, 45.26; Η, 4.39; Ν, 15.71; S, 8.57; Na, 3.36 (%)
実施例 21 Example 21
[化 69] [Chem 69]
108
(1) 59→106 108 (1) 59 → 106
化合物 59(2.17g,5.64mmol)をテトラヒドロフラン (10ml)とメタノール (20ml)に溶解し、 2 N-NaOH(8.5ml,17mmol)を加えた。反応液は室温で 2時間 20分間攪拌し、ェチルェ 一テルに次いで 2N_HCl(8.5ml,17mmol)を加え pHを 7に調整して結晶を析出させた。 結晶を濾取し、化合物 106を得た。 白色結晶。収量 1.16g(94%) Compound 59 (2.17 g, 5.64 mmol) was dissolved in tetrahydrofuran (10 ml) and methanol (20 ml), and 2 N-NaOH (8.5 ml, 17 mmol) was added. The reaction solution was stirred at room temperature for 2 hours and 20 minutes, and then 2N_HCl (8.5 ml, 17 mmol) was added to ethyl ether, and the pH was adjusted to 7 to precipitate crystals. The crystals were collected by filtration to obtain Compound 106. White crystals. Yield 1.16 g (94%)
'H-NMR (d -DMSO): 2.58(3H, s), 7.52(2H, d, J =6.3Hz), 7.81(1H, s), 8.63(2H, d, 'H-NMR (d-DMSO): 2.58 (3H, s), 7.52 (2H, d, J = 6.3Hz), 7.81 (1H, s), 8.63 (2H, d,
6 6
J = 6.0Hz). J = 6.0Hz).
(2) 106→107 (2) 106 → 107
化合物 106(1.14g,5.2mmol)を用レ、、実施例 18の (1)と同様の方法で化合物 107を白 色結晶として得た。収量 1.38g(100%) Compound 106 (1.14 g, 5.2 mmol) was used in the same manner as in Example 18, (1) to give Compound 107 as white crystals. Yield 1.38 g (100%)
'H-NMR (d -DMSO): 2.49(3H, s),7.46(2H, d, J =6.0Hz), 7.46(1H, s), 8.59(2H, d, J 'H-NMR (d-DMSO): 2.49 (3H, s), 7.46 (2H, d, J = 6.0Hz), 7.46 (1H, s), 8.59 (2H, d, J
6 6
= 6.0Hz). = 6.0Hz).
(3) 21+107→108→105 (3) 21 + 107 → 108 → 105
化合物 21(721mg,lmmol)と化合物 107(265mg,lmmol)を用い、実施例 1の (5)と同様 の方法で化合物 108を無定形粉末として得た。収量 805mg(87%)。この化合物 108(791 mg,0.85mmol)から 1M/卜 A 1 /CH NO (8.5ml,8.5mmol)を用レヽ、実施例 7の (4)と同様 Compound 108 was obtained as an amorphous powder in the same manner as in Example 1, (5) using Compound 21 (721 mg, 1 mmol) and Compound 107 (265 mg, 1 mmol). Yield 805 mg (87%). From this compound 108 (791 mg, 0.85 mmol), 1 M / 卜 A 1 / CH NO (8.5 ml, 8.5 mmol) was used, as in Example 7 (4).
3 3 2 3 3 2
の方法で化合物 105を粉末として得た。収量 225mg(34%) Thus, compound 105 was obtained as a powder. Yield 225 mg (34%)
'H-NMR (d -DMSO): 1·00(3Η, t, J = 7.5Hz), 2.17(2H, m), 2.63(3H, s), 3.45, 3.51( 'H-NMR (d-DMSO): 1 · 00 (3Η, t, J = 7.5Hz), 2.17 (2H, m), 2.63 (3H, s), 3.45, 3.51 (
6 6
2H, ABq, J = 17.0 Hz), 5.06(1H, d, J = 4.8Hz), 5.26(2H, d, J = 6.6Hz) , 5.60(1H, d d. J = 5.1, 7.8Hz), 5.86(1H, m), 6.20(1H, s), 6.22(1H, t, J = 7.8Hz), 7.00(2H, s), 7. 30(1H, d, J = 15.9Hz), 7.73(1H, s), 8.24(2H, d, J = 6.9Hz), 8.94(2H, d, J = 6.9Hz), 9.22(2H, d, J = 7.8Hz). 2H, ABq, J = 17.0 Hz), 5.06 (1H, d, J = 4.8 Hz), 5.26 (2H, d, J = 6.6 Hz), 5.60 (1H, d d. J = 5.1, 7.8 Hz), 5.86 (1H, m), 6.20 (1H, s), 6.22 (1H, t, J = 7.8Hz), 7.00 (2H, s), 7.30 (1H, d, J = 15.9Hz), 7.73 (1H, s), 8.24 (2H, d, J = 6.9Hz), 8.94 (2H, d, J = 6.9Hz), 9.22 (2H, d, J = 7.8Hz).
IR (KBr) cm_1:3408, 2966, 2168, 2144, 1761, 1633, 1541, 1456, 1437, 1388, 1348, 1246. IR (KBr) cm _1 : 3408, 2966, 2168, 2144, 1761, 1633, 1541, 1456, 1437, 1388, 1348, 1246.
MS(ESI): 662+ (M+H)+ MS (ESI): 662+ (M + H) +
元素分析 c H N O S Na-4.6H O - O .2NaHCO Elemental analysis c H N O S Na-4.6H O-O .2NaHCO
30 26 7 5 3 2 3 30 26 7 5 3 2 3
計算値: C,46.30; H,4.55; N, 12.52; S, 12.28; Na,3.52(%) Calculated value: C, 46.30; H, 4.55; N, 12.52; S, 12.28; Na, 3.52 (%)
実験値: C,46.27; H,4.44; N, 12.61; S, 12.22; Na,3.50 (%)
実施例 22 Experimental value: C, 46.27; H, 4.44; N, 12.61; S, 12.22; Na, 3.50 (%) Example 22
[0049] [化 70] [0049] [Chemical 70]
(1) 21+7→110→109 (1) 21 + 7 → 110 → 109
化合物 21(721mg,lmmol)と化合物 7(251mg,lmmol)を用レ、、実施例 1の (5)と同様の 方法で化合物 110を無定形粉末として得た。収量 783mg(86%)。この化合物 110(773m g,0.85mmol)力ら 1M - A 1 /CH NO (8.5ml,8.5mmol)を用レ、、実施例 7の (4)と同様の Compound 21 (721 mg, 1 mmol) and Compound 7 (251 mg, 1 mmol) were used in the same manner as in Example 1, (5) to obtain Compound 110 as an amorphous powder. Yield 783 mg (86%). This compound 110 (773 mg, 0.85 mmol) force 1M-A 1 / CH NO (8.5 ml, 8.5 mmol) was used, the same as in Example 7 (4).
3 3 2 3 3 2
方法で化合物 109を粉末として得た。収量 261mg(39%) The compound 109 was obtained as a powder by the method. Yield 261 mg (39%)
'H-NMR (d -DMSO): 1.00(3H, t, J = 7.5Hz), 2.18(2H, m), 3.44, 3.50(2H, ABq, J = 'H-NMR (d-DMSO): 1.00 (3H, t, J = 7.5Hz), 2.18 (2H, m), 3.44, 3.50 (2H, ABq, J =
17.0 Hz), 5.05(1H, d, J = 4.8Hz), 5.21(2H, d, J = 7.2Hz) , 5.60(1H, dd. J = 5.1, 7.8 Hz), 5.85(1H, m), 6.20(1H, s), 6.22(1H, t, J = 8.1Hz), 7.00(2H, s), 7.28(1H, d, J = 15.6Hz), 8.17(1H, d, J = 1.5Hz), 8.48(2H, d, J = 6.9Hz), 8.64(1H, d, J = 1.5Hz), 8. 92(2H, d, J = 6.6Hz), 9.22(2H, d, J = 7.8Hz). 17.0 Hz), 5.05 (1H, d, J = 4.8Hz), 5.21 (2H, d, J = 7.2Hz), 5.60 (1H, dd.J = 5.1, 7.8 Hz), 5.85 (1H, m), 6.20 (1H, s), 6.22 (1H, t, J = 8.1Hz), 7.00 (2H, s), 7.28 (1H, d, J = 15.6Hz), 8.17 (1H, d, J = 1.5Hz), 8.48 (2H, d, J = 6.9Hz), 8.64 (1H, d, J = 1.5Hz), 8.92 (2H, d, J = 6.6Hz), 9.22 (2H, d, J = 7.8Hz).
IR (KBr) cm_1:3408, 2967, 2172, 1761, 1634, 1539, 1469, 1435, 1351, 1250, 1223. MS(ESI): 648+ (M+H)+ IR (KBr) cm _1 : 3408, 2967, 2172, 1761, 1634, 1539, 1469, 1435, 1351, 1250, 1223. MS (ESI): 648 + (M + H) +
元素分析 C H N O S Na-4.0H O - O. lNaHCO Elemental analysis C H N O S Na-4.0H O-O. lNaHCO
29 24 7 5 3 2 3 29 24 7 5 3 2 3
計算値: C,46.59; Η,4·31; Ν, 13.07; S, 12.82; Na,3.37(%) Calculated value: C, 46.59; Η, 4.31; Ν, 13.07; S, 12.82; Na, 3.37 (%)
実験値: C,46.55; Η,4·15; Ν, 13.28; S, 12.59; Na,3.40 (%) Experimental value: C, 46.55; Η, 4.15; Ν, 13.28; S, 12.59; Na, 3.40 (%)
実施例 23 Example 23
(1) 21+112→113→111 (1) 21 + 112 → 113 → 111
化合物 21(721mg,lmmol)と化合物 112(345mg,lmmol)を用レ、、実施例 1の (5)と同様 の方法で化合物 113を無定形粉末として得た。収量 778mg(85%)。この化合物 113(759 mg,0.83mmol)から 1M/卜 A 1 /CH NO (8.3ml,8.3mmol)を用レヽ、実施例 7の (4)と同様 Compound 21 (721 mg, 1 mmol) and Compound 112 (345 mg, 1 mmol) were used in the same manner as in Example 1, (5) to obtain Compound 113 as an amorphous powder. Yield 778 mg (85%). From this compound 113 (759 mg, 0.83 mmol), 1 M / 卜 A 1 / CH NO (8.3 ml, 8.3 mmol) was used, as in Example 7, (4).
3 3 2 3 3 2
の方法で化合物 111を粉末として得た。収量 191mg(30%) Thus, compound 111 was obtained as a powder. Yield 191 mg (30%)
'H-NMR (d -DMSO): 1.00(3H, t, J = 7.5Hz), 2.18(2H, m), 3.43, 3.51(2H, ABq, J = 'H-NMR (d-DMSO): 1.00 (3H, t, J = 7.5Hz), 2.18 (2H, m), 3.43, 3.51 (2H, ABq, J =
13.4 Hz), 5.07(1H, d, J = 5.1Hz), 5.31(2H, d, J = 6.0Hz) , 5.61(1H, dd. J = 4.8, 8.1 Hz), 5.86(1H, m), 6.21(1H, s), 6.22(1H, t, J = 7.8Hz), 7.01(2H, s), 7.32(1H, d, J = 15.6Hz), 8.46(1H, s), 8.59(2H, d, J = 5.7Hz), 9.07(2H, d, J = 6.3Hz), 9.23(2H, d, J = 7.8Hz). 13.4 Hz), 5.07 (1H, d, J = 5.1 Hz), 5.31 (2H, d, J = 6.0 Hz), 5.61 (1H, dd. J = 4.8, 8.1 Hz), 5.86 (1H, m), 6.21 (1H, s), 6.22 (1H, t, J = 7.8Hz), 7.01 (2H, s), 7.32 (1H, d, J = 15.6Hz), 8.46 (1H, s), 8.59 (2H, d, J = 5.7Hz), 9.07 (2H, d, J = 6.3Hz), 9.23 (2H, d, J = 7.8Hz).
IR (KBr) cm"1:3416, 2966, 2159, 1761, 1634, 1604, 1523, 1468, 1354, 1299, 1215. MS(FAB): 671+ (M+H)+ IR (KBr) cm " 1 : 3416, 2966, 2159, 1761, 1634, 1604, 1523, 1468, 1354, 1299, 1215. MS (FAB): 671+ (M + H) +
元素分析 C H N O S Na-4.2H O - 0.25NaHCO Elemental analysis C H N O S Na-4.2H O-0.25 NaHCO
28 23 8 5 3 2 3 28 23 8 5 3 2 3
計算値: C,44.22; Η,4·16; Ν, 14.60; S, 12.54; Na,3.75(%) Calculated value: C, 44.22; Η, 4.16; Ν, 14.60; S, 12.54; Na, 3.75 (%)
実験値: C,44.26; Η,4·11; Ν, 14.56; S, 12.51; Na,3.71 (%) Experimental value: C, 44.26; Η, 4.11; Ν, 14.56; S, 12.51; Na, 3.71 (%)
実施例 24 Example 24
[化 72]
[Chemical 72]
116 116
(1) 21+115→116→114 (1) 21 + 115 → 116 → 114
化合物 21(721mg,lmmol)と化合物 115(252mg,lmmol)を用レ、、実施例 1の (5)と同様 の方法で化合物 116を無定形粉末として得た。収量 829mg(91%)。この化合物 116(817 mg,0.89mmol)から 1M/卜 A 1 /CH NO (8.9ml,8.9mmol)を用レヽ、実施例 7の (4)と同様 Compound 21 (721 mg, 1 mmol) and Compound 115 (252 mg, 1 mmol) were used in the same manner as in Example 1, (5) to obtain Compound 116 as an amorphous powder. Yield 829 mg (91%). From this compound 116 (817 mg, 0.89 mmol), 1 M / 卜 A 1 / CH NO (8.9 ml, 8.9 mmol) was used, as in Example 7 (4).
3 3 2 3 3 2
の方法で化合物 114を粉末として得た。収量 171mg(25%) Thus, compound 114 was obtained as a powder. Yield 171 mg (25%)
'H-NMR (d -DMSO): 1·00(3Η, t, J = 7.2Hz), 2.18(2H, m), 3.45, 3.51(2H, ABq, J = 'H-NMR (d-DMSO): 1 · 00 (3Η, t, J = 7.2Hz), 2.18 (2H, m), 3.45, 3.51 (2H, ABq, J =
6 6
16.7 Hz), 5.06(1H, d, J = 5.1Hz), 5.27(2H, d, J = 6.9Hz) , 5.60(1H, dd. J = 4.8, 7.8 Hz), 5.86(1H, m), 6.21(1H, s), 6.23(1H, t, J = 7.5Hz), 7.00(2H, s), 7.31(1H, d, J = 15.9Hz), 8.59(2H, d, J = 6.9Hz), 8.97(1H, s), 9.02(2H, d, J = 6.3Hz), 9.22(2H, d, J = 7.8Hz). 16.7 Hz), 5.06 (1H, d, J = 5.1 Hz), 5.27 (2H, d, J = 6.9 Hz), 5.60 (1H, dd.J = 4.8, 7.8 Hz), 5.86 (1H, m), 6.21 (1H, s), 6.23 (1H, t, J = 7.5Hz), 7.00 (2H, s), 7.31 (1H, d, J = 15.9Hz), 8.59 (2H, d, J = 6.9Hz), 8.97 (1H, s), 9.02 (2H, d, J = 6.3Hz), 9.22 (2H, d, J = 7.8Hz).
IR (KBr) cm— 3419, 2966, 2179, 2153, 1762, 1635, 1605, 1530, 1492, 1458, 1361, 1216. IR (KBr) cm— 3419, 2966, 2179, 2153, 1762, 1635, 1605, 1530, 1492, 1458, 1361, 1216.
MS(FAB): 671+ (M+H)+ MS (FAB): 671+ (M + H) +
元素分析 c H N O S Na-4.1H O - 0.4NaHCO Elemental analysis c H N O S Na-4.1H O-0.4NaHCO
28 23 8 5 3 2 3 28 23 8 5 3 2 3
計算値: C,43.83; H,4.09; N, 14.40; S, 12.36; Na,4.14(%) Calculated values: C, 43.83; H, 4.09; N, 14.40; S, 12.36; Na, 4.14 (%)
実験値: C,43.69; H,4.07; N, 14.64; S, 12.49; Na,4.12 (%) Experimental value: C, 43.69; H, 4.07; N, 14.64; S, 12.49; Na, 4.12 (%)
実施例 25 Example 25
[化 73]
[Chemical 73]
(1) 21+31→118→117 (1) 21 + 31 → 118 → 117
化合物 21(635mg,0.88mmol)と化合物 31(224mg,0.88mmol)を用い、実施例 1の (5)と 同様の方法で化合物 118を無定形粉末として得た。収量 687mg(85%)。この化合物 118 (6777mg,0.74mmol)から 1M/ト A 1 /CH NO (7.4ml,7.4mmol)を用レヽ、実施例 7の (4)と 同様の方法で化合物 117を粉末として得た。収量 88mg(16%) Compound 118 was obtained as an amorphous powder in the same manner as (5) of Example 1 using Compound 21 (635 mg, 0.88 mmol) and Compound 31 (224 mg, 0.88 mmol). Yield 687 mg (85%). From this compound 118 (6777 mg, 0.74 mmol), 1M / to A 1 / CH 2 NO (7.4 ml, 7.4 mmol) was used, and compound 117 was obtained as a powder in the same manner as in Example 7, (4). Yield 88 mg (16%)
'H-NMR (d -DMSO): 1.00(3H, t, J = 7.5Hz), 2.17(2H, m), 3.45, 3.51(2H, ABq, J = 'H-NMR (d-DMSO): 1.00 (3H, t, J = 7.5Hz), 2.17 (2H, m), 3.45, 3.51 (2H, ABq, J =
17.4 Hz), 5.06(1H, d, J = 4.8Hz), 5.30(2H, d, J = 6.9Hz) , 5.61(1H, dd. J = 4.8, 7.8 Hz), 5.87(1H, m), 6.21(1H, s), 6.22(1H, t, J = 7.5Hz), 7.01(2H, s), 7.31(1H, d, J = 16.5Hz), 8.53(1H, s), 8.72(2H, d, J = 6.9Hz), 9.09(2H, d, J = 7.2Hz), 9.23(2H, d, J = 7.8Hz). 17.4 Hz), 5.06 (1H, d, J = 4.8Hz), 5.30 (2H, d, J = 6.9Hz), 5.61 (1H, dd. J = 4.8, 7.8 Hz), 5.87 (1H, m), 6.21 (1H, s), 6.22 (1H, t, J = 7.5Hz), 7.01 (2H, s), 7.31 (1H, d, J = 16.5Hz), 8.53 (1H, s), 8.72 (2H, d, J = 6.9Hz), 9.09 (2H, d, J = 7.2Hz), 9.23 (2H, d, J = 7.8Hz).
IR (KBr) cm"1:3417, 2966, 2172, 1761, 1635, 1604, 1527, 1466, 1400, 1337 IR (KBr) cm " 1 : 3417, 2966, 2172, 1761, 1635, 1604, 1527, 1466, 1400, 1337
MS(FAB): 671+ (M+H)+ MS (FAB): 671+ (M + H) +
元素分析 C H N O S Na- 3.5H O Elemental analysis C H N O S Na- 3.5H O
計算値: C,45.83; H,4.12; N, 15.27; S, 13.11; Na,3.13(%) Calculated values: C, 45.83; H, 4.12; N, 15.27; S, 13.11; Na, 3.13 (%)
実験値: C,45.64; Η,4· 13; Ν, 15.39; S, 12.91; Na,3.12 (%) Experimental value: C, 45.64; Η, 4 · 13; Ν, 15.39; S, 12.91; Na, 3.12 (%)
実施例 26 Example 26
[化 74]
[Chemical 74]
121 121
(1) 120+103→121→119 (1) 120 + 103 → 121 → 119
化合物 120(700mg,0.92mmol)と化合物 103(239mg,1.01mmol)をジメチルァセトアミド、( 1.8ml)中に懸濁し、氷冷下臭化ナトリウム (949mg,9.2mmol)をカ卩えた。反応液は氷冷 で 4時間 20分攪拌した後、水 (30ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿 をェチルエーテルで洗浄、減圧下で乾燥して化合物 121を無定形粉末として得た。 収量 798mg(92%)。この化合物 121(798mg,0.85mmol)を塩化メチレン (10ml)とァニソ一 ル (0.58ml)に溶解し、 -20°Cにて 2M/ト八 1 /CH NO (2.56ml,5.12mmol)を加えた。混 合液を _20°Cで 20分間攪拌した後、 0.3N -塩酸 (25ml)とァセトニトリル (30ml)中に氷冷 下で攪拌しながら注カ卩した。更にェチルエーテル (25ml)を力卩ぇ水層を分取した。水層 に 0.3N -塩酸 (25ml)とァセトニトリル (25ml)を追加し完全に溶解させた。 HP-20SSをカロ え濃縮し、 HP-20SSカラムクロマトグラフィーに付し、水 -ァセトニトリルで溶離した。所 望の化合物を含むフラクションを減圧下濃縮し、析出した沈殿を濾取した。この沈殿 物 (184mg)を水 (5ml)とァセトニトリル (2.51111)に懸濁させ^^^0 (23mg,0.28mmol)を加 え溶解させた。溶液を濃縮後、凍結乾燥して化合物 119を粉末として得た。収量 185m g(25%)。本品の NMR解析において、セフヱムの 3位のプロぺニル基の二重結合部位 は E:Z=55:45であった。 Compound 120 (700 mg, 0.92 mmol) and compound 103 (239 mg, 1.01 mmol) were suspended in dimethylacetamide (1.8 ml), and sodium bromide (949 mg, 9.2 mmol) was obtained under ice cooling. The reaction solution was ice-cooled and stirred for 4 hours and 20 minutes, and then poured into water (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was washed with ethyl ether and dried under reduced pressure to obtain Compound 121 as an amorphous powder. Yield 798 mg (92%). This compound 121 (798 mg, 0.85 mmol) is dissolved in methylene chloride (10 ml) and anisol (0.58 ml), and 2M / to 8 / CH NO (2.56 ml, 5.12 mmol) is added at -20 ° C. It was. The mixture was stirred at _20 ° C for 20 minutes, and then poured into 0.3N hydrochloric acid (25 ml) and acetonitrile (30 ml) with stirring under ice-cooling. Further, ethyl ether (25 ml) was separated from the aqueous layer. To the aqueous layer, 0.3N-hydrochloric acid (25 ml) and acetonitrile (25 ml) were added and completely dissolved. HP-20SS was concentrated, subjected to HP-20SS column chromatography, and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the deposited precipitate was collected by filtration. This precipitate (184 mg) was suspended in water (5 ml) and acetonitrile (2.51111), and ^^^ 0 (23 mg, 0.28 mmol) was added and dissolved. The solution was concentrated and lyophilized to give Compound 119 as a powder. Yield 185 mg (25%). In the NMR analysis of this product, the double bond site of the propenyl group at position 3 of cefme was E: Z = 55: 45.
'H-NMR (D O): 3.39-3.74(2H, m), 3.97及び4.00(合ゎせて3^ s), 5.1ト 5·38(3Η, m
), 5.80及び 5·84(合わせて 1H, d, J = 4.8Hz) , 5.89及び6.13(合ゎせて1^ m), 6.53(0. 45H, d, J = 11.4Hz), 7.00(0.55H, d, J = 16.2Hz), 7.22及び7.25(合ゎせて1^ s), 8. 25(2H, m), 8.71及び 8.76(合わせて 1H, d, J = 6.9Hz). 'H-NMR (DO): 3.39-3.74 (2H, m), 3.97 and 4.00 (3 ^ s in total), 5.1 to 5 · 38 (3Η, m ), 5.80 and 5.84 (total 1H, d, J = 4.8Hz), 5.89 and 6.13 (total 1 ^ m), 6.53 (0.45H, d, J = 11.4Hz), 7.00 (0.55 H, d, J = 16.2Hz), 7.22 and 7.25 (total 1 ^ s), 8.25 (2H, m), 8.71 and 8.76 (1H, d, J = 6.9Hz in total).
IR (KBr) cm_1:3410, 2165, 1762, 1637, 1605, 1538, 1472, 1437, 1399, 1349, 1216. MS(ESI): 669+ (M-Na+2H)+ IR (KBr) cm _1 : 3410, 2165, 1762, 1637, 1605, 1538, 1472, 1437, 1399, 1349, 1216. MS (ESI): 669 + (M-Na + 2H) +
元素分析 C H N O S ClNa- 5.1H O - O. lNaHCO Elemental analysis C H N O S ClNa- 5.1H O-O. lNaHCO
計算値: C,39.61; H,3.86; N, 17.70; S,8.10; Cl,4.48; Na,3.20 (%) Calculated values: C, 39.61; H, 3.86; N, 17.70; S, 8.10; Cl, 4.48; Na, 3.20 (%)
実験値: C39.69; H,3.72; N, 17.47; S,8.62; Cl;4.66; Na,3.22 (%) Experimental value: C39.69; H, 3.72; N, 17.47; S, 8.62; Cl; 4.66; Na, 3.22 (%)
実施例 27 Example 27
[化 75] [Chemical 75]
(1) 123+103→124→122 (1) 123 + 103 → 124 → 122
化合物 123(690mg,0.93mmol)と化合物 103(241mg,1.03mmol)を用い、実施例 7の (4) と同様の方法で化合物 122を粉末として得た。収量 184mg(24%)。本品の NMR解析に おいて、セフエムの 3位のプロぺニル基の二重結合部位は E:Z=35:65であった。 Compound 122 was obtained as a powder in the same manner as in Example 7, (4) using Compound 123 (690 mg, 0.93 mmol) and Compound 103 (241 mg, 1.03 mmol). Yield 184 mg (24%). In the NMR analysis of this product, the double bond site of the propenyl group at the 3-position of cefm was E: Z = 35: 65.
'H-NMR (D O): 1.17(3H, m), 3·26_3·56(2Η, m), 4.20(2H, m), 4.97—5.17(3H, m), 5.'H-NMR (D 2 O): 1.17 (3H, m), 3.26_3 · 56 (2Η, m), 4.20 (2H, m), 4.97-5.17 (3H, m), 5.
69及び 5.73(合わせて 1H, d, J =4 .5Hz), 5.76及び6.02(合ゎせて1^ m), 6.39(0.65H , d, J = 11.1Hz) , 6.85(0.35H, d, J = 15.6Hz), 7.11及び7.15(合ゎせて1 s), 8.13(2
H, m), 8.57及び8.63(合ゎせて1 d, J = 6.3Hz). 69 and 5.73 (total 1H, d, J = 4.5Hz), 5.76 and 6.02 (total 1 ^ m), 6.39 (0.65H, d, J = 11.1Hz), 6.85 (0.35H, d, J = 15.6Hz), 7.11 and 7.15 (1 s combined), 8.13 (2 H, m), 8.57 and 8.63 (1d combined, J = 6.3Hz).
IR (KBr) cm— 3417, 2983, 2165, 1762, 1637, 1602, 1533, 1473, 1401, 1351, 1216. IR (KBr) cm— 3417, 2983, 2165, 1762, 1637, 1602, 1533, 1473, 1401, 1351, 1216.
MS(ESI): 650+ (M-Na+2H)+ MS (ESI): 650 + (M-Na + 2H) +
元素分析 C H N O S ClNa-4.7H O Elemental analysis C H N O S ClNa-4.7H O
26 22 11 6 2 2 26 22 11 6 2 2
計算値: C,41.29; H,4.18; N,20.37; S,8.48; Na,3.04 (%) Calculated values: C, 41.29; H, 4.18; N, 20.37; S, 8.48; Na, 3.04 (%)
実験値: C,41.12; H,4.07; N,20.13; S,8.37; Na,3.31 (%) Experimental value: C, 41.12; H, 4.07; N, 20.13; S, 8.37; Na, 3.31 (%)
実施例 28 Example 28
[化 76] [Chemical 76]
1 27 1 27
(1) 126+103→127→125 (1) 126 + 103 → 127 → 125
化合物 126(700mg,0.95mmol)と化合物 103(245mg,1.04mmol)を用レ、、実施例 7の (4) と同様の方法で化合物 125を粉末として得た。収量 225mg(27%)。本品の NMR解析に おいて、セフエムの 3位のプロぺニル基の二重結合部位は E:Z=36:64であった。 Compound 126 (700 mg, 0.95 mmol) and Compound 103 (245 mg, 1.04 mmol) were used in the same manner as in Example 7, (4) to obtain Compound 125 as a powder. Yield 225 mg (27%). In the NMR analysis of this product, the double bond site of the propenyl group at the 3-position of Cephem was E: Z = 36: 64.
-NMR (D 0): 1· 18(3Η, m), 3.28- 3·61(2Η, m), 4.14(2H, m), 4.96— 5.19(3H, m), 5.68 -NMR (D 0): 1 · 18 (3Η, m), 3.28-3 · 61 (2Η, m), 4.14 (2H, m), 4.96-5.19 (3H, m), 5.68
2 2
及び 5.72(合わせて 1H, d, J =4 .5Hz), 5.79及び 6.04(合わせて 1H, m), 6.41(0.64H, d, J = 10.8Hz), 6.82及び 6.83(合わせて 1H, s), 6.92(0.36H, d, J = 17.7Hz), 7.07及び 7.10(合わせて 1H, s), 8.13(2H, m), 8.57及び 8·63(合わせて 1H, d, J = 6.6Hz). And 5.72 (total 1H, d, J = 4.5Hz), 5.79 and 6.04 (total 1H, m), 6.41 (0.64H, d, J = 10.8Hz), 6.82 and 6.83 (total 1H, s) 6.92 (0.36H, d, J = 17.7Hz), 7.07 and 7.10 (1H, s combined), 8.13 (2H, m), 8.57 and 8.63 (1H, d, J = 6.6Hz combined).
IR (KBr) cm"1:3418, 2979, 2164, 1763, 1637, 1603, 1532, 1473, 1439, 1396, 1348,
1207. IR (KBr) cm " 1 : 3418, 2979, 2164, 1763, 1637, 1603, 1532, 1473, 1439, 1396, 1348, 1207.
MS(FAB): 649+ (M_Na+2H)+ MS (FAB): 649+ (M_Na + 2H) +
元素分析 C H N O S ClNa- 3.9H O Elemental analysis C H N O S ClNa- 3.9H O
26 22 11 6 2 2 26 22 11 6 2 2
計算値: C,43.77; H,4.19; N, 18.90; S,8.66; Na,3.10 (%) Calculated values: C, 43.77; H, 4.19; N, 18.90; S, 8.66; Na, 3.10 (%)
実験値: C43.73; H,3.95; N,29.18; S,8.43; Na,3.36 (%)) Experimental value: C43.73; H, 3.95; N, 29.18; S, 8.43; Na, 3.36 (%))
実施例 29 Example 29
(1) 125→128 (1) 125 → 128
[化 77] [Chemical 77]
化合物 125(E:Z=36:64)を Na塩の状態で HP-20SSカラムクロマトグラフィーに付し、水 -ァセトニトリルで溶離した。 Z体のみを含むフラクションを集め減圧下濃縮し、凍結乾 燥して化合物 128を粉末として得た。収量 39mg(3%) Compound 125 (E: Z = 36: 64) was subjected to HP-20SS column chromatography in the form of Na salt and eluted with water-acetonitrile. Fractions containing only Z form were collected, concentrated under reduced pressure, and lyophilized to obtain Compound 128 as a powder. Yield 39 mg (3%)
H-NMR (d -DMSO): 1.30(3H, t, J = 7.2Hz), 3.43, 3.67(2H, ABq, J = 17.7 Hz), 4.2 H-NMR (d-DMSO): 1.30 (3H, t, J = 7.2Hz), 3.43, 3.67 (2H, ABq, J = 17.7 Hz), 4.2
6 6
6(2H, q, J = 7.5Hz), 5.06- 5·29(2Η, m), 5.30(1H, d, J = 2.7Hz) , 5.83(1H, m), 5.90(1 H, m), 5.51(1H, d, J = l l. lHz), 6.98(1H, s), 7.32(1H, s), 8.29(2H, m), 8.69(2H, d, J = 5.7Hz). 6 (2H, q, J = 7.5Hz), 5.06- 5.29 (2mm, m), 5.30 (1H, d, J = 2.7Hz), 5.83 (1H, m), 5.90 (1 H, m), 5.51 (1H, d, J = l l. LHz), 6.98 (1H, s), 7.32 (1H, s), 8.29 (2H, m), 8.69 (2H, d, J = 5.7Hz).
IR (KBr) cm— 3421, 2980, 2550, 2165, 1925, 1763, 1667, 1636, 1534, 1473, 1398, 1352, 1210. IR (KBr) cm— 3421, 2980, 2550, 2165, 1925, 1763, 1667, 1636, 1534, 1473, 1398, 1352, 1210.
MS(FAB): 649+ ( M-Na+2H)+ MS (FAB): 649+ (M-Na + 2H) +
元素分析 C H N〇 S Na-4.5H 0+1.8NaHCO +0.3CitricacidNaSalt Elemental analysis C H N 0 S Na-4.5H 0 + 1.8NaHCO + 0.3CitricacidNaSalt
28 23 8 5 3 2 3 28 23 8 5 3 2 3
計算値: C,37.49; H,3.63; N, 14.29; S,6.54; Na,8.68(%) Calculated values: C, 37.49; H, 3.63; N, 14.29; S, 6.54; Na, 8.68 (%)
実験値: C37.10; H,3.55; N, 14.69; S,6.44; Na,8.88 (%) Experimental value: C37.10; H, 3.55; N, 14.69; S, 6.44; Na, 8.88 (%)
(2) 127→190 (2) 127 → 190
[化 78]
[Chemical 78]
化合物 127(4.6g,5mmol)力 2M/TiCl /CH CI (15ml,30mmol)を用い、実施例 1 (6)と Using compound 127 (4.6 g, 5 mmol) force 2M / TiCl 2 / CH CI (15 ml, 30 mmol) and Example 1 (6)
4 2 2 4 2 2
同様の方法で化合物 190を粉末として得た。収量 0.61g(19%) In a similar manner, Compound 190 was obtained as a powder. Yield 0.61 g (19%)
'H-NMR (d -DMSO): 1.00(3H, t, J = 7.2Hz), 2.18(2H, m), 3.44, 3.49(2H, ABq, J = 'H-NMR (d-DMSO): 1.00 (3H, t, J = 7.2Hz), 2.18 (2H, m), 3.44, 3.49 (2H, ABq, J =
6 6
16.6 Hz), 5.05(1H, d, J = 4.2Hz), 5.32(2H, d, J = 6.9Hz) , 5.60(1H, dd. J = 5.1, 7.5 Hz), 5.84(1H, m), 6.21(1H, s), 6.22(1H, t, J = 8.1Hz), 7.05(2H, s), 7.32(1H, d, J = 15.9Hz), 7.38(1H, s), 8.60(2H, d, J = 6.3Hz), 9.13(2H, d, J = 6.6Hz), 9.22(2H, d, J = 7.8Hz). 16.6 Hz), 5.05 (1H, d, J = 4.2 Hz), 5.32 (2H, d, J = 6.9 Hz), 5.60 (1H, dd. J = 5.1, 7.5 Hz), 5.84 (1H, m), 6.21 (1H, s), 6.22 (1H, t, J = 8.1Hz), 7.05 (2H, s), 7.32 (1H, d, J = 15.9Hz), 7.38 (1H, s), 8.60 (2H, d, J = 6.3Hz), 9.13 (2H, d, J = 6.6Hz), 9.22 (2H, d, J = 7.8Hz).
IR (KBr) cm— 3419, 2967, 1762, 1634, 1527, 1474, 1431, 1359, 1249. IR (KBr) cm— 3419, 2967, 1762, 1634, 1527, 1474, 1431, 1359, 1249.
MS(ESI): 609+ (M-Na+2H)+ MS (ESI): 609 + (M-Na + 2H) +
元素分析 c H N O S Na- 3.6H O -0.7NaHCO Elemental analysis c H N O S Na- 3.6H O -0.7NaHCO
27 2 3 6 7 2 2 3 27 2 3 6 7 2 2 3
計算値: C,44.11; H,4.13; N,11.14; S,8.50; Na,5.18 (%) Calculated values: C, 44.11; H, 4.13; N, 11.14; S, 8.50; Na, 5.18 (%)
実験値: C,43.81; Η,4·01; Ν, 11.47; S,8.41; Na,5.24 (%) Experimental value: C, 43.81; Η, 4.01; Ν, 11.47; S, 8.41; Na, 5.24 (%)
実施例 30 Example 30
[化 79] [Chemical 79]
(1) 8+130→131→129
化合物 8(738mg,lmmol)と化合物 130(234mg,lmmol)を用い、実施例 1の (5)と同様の 方法で化合物 131を無定形粉末として得た。収量 795mg(87%)。この化合物 131(790mg ,0.86mmol)力 2M /卜 TiCl /CH CI (2.5ml,5mmol)を用レ、、実施例 1の (6)と同様の方法 で化合物 129を粉末として得た。収量 210mg(29%) (1) 8 + 130 → 131 → 129 Compound 131 was obtained as an amorphous powder in the same manner as in Example 5, (5), using Compound 8 (738 mg, 1 mmol) and Compound 130 (234 mg, 1 mmol). Yield 795 mg (87%). Compound 129 was obtained as a powder in the same manner as in Example 6, (6), using Compound 131 (790 mg, 0.86 mmol), 2 M / 卜 TiCl 2 / CH 2 CI (2.5 ml, 5 mmol). Yield 210mg (29%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.42, 3.49(2H, ABq, J = 16.5 Hz), 4. 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.42, 3.49 (2H, ABq, J = 16.5 Hz), 4.
09(2H, q, J = 6.9Hz), 5.04(1H, d, J = 4.8Hz), 5.08(2H, d, J = 6.9Hz), 5.59(1H, dd, J = 4.8, 8.1Hz), 5.83(1H, m), 6.72(1H, s), 7.17(1H, s), 7.23-7.26(3H, m), 7.86(1H, s), 8.18(2H, d, J = 7.2Hz), 8.64(2H, d, J = 6.9Hz), 9.54(1H, d, J = 8.1Hz), 12.03(1H , s). 09 (2H, q, J = 6.9Hz), 5.04 (1H, d, J = 4.8Hz), 5.08 (2H, d, J = 6.9Hz), 5.59 (1H, dd, J = 4.8, 8.1Hz), 5.83 (1H, m), 6.72 (1H, s), 7.17 (1H, s), 7.23-7.26 (3H, m), 7.86 (1H, s), 8.18 (2H, d, J = 7.2Hz), 8.64 (2H, d, J = 6.9Hz), 9.54 (1H, d, J = 8.1Hz), 12.03 (1H, s).
IR (KBr) cm_1:3398, 2984, 2154, 1761, 1635, 1572, 1530, 1475, 1393, 1335, 1296, 1219. IR (KBr) cm _1 : 3398, 2984, 2154, 1761, 1635, 1572, 1530, 1475, 1393, 1335, 1296, 1219.
MS(FAB): 648+ (M- Na+2H)+ MS (FAB): 648+ (M- Na + 2H) +
元素分析 C H N O S Na-6.5 H O Elemental analysis C H N O S Na-6.5 H O
計算値: C,42.74; H,4.74; N, 16.02; S,8.15; Na,2.92 (%) Calculated value: C, 42.74; H, 4.74; N, 16.02; S, 8.15; Na, 2.92 (%)
実験値: C,43.00; H,4.24; N, 15.90; S,8.10; Na,2.94 (%) Experimental value: C, 43.00; H, 4.24; N, 15.90; S, 8.10; Na, 2.94 (%)
実施例 31 Example 31
[化 80] [Chemical 80]
86 133 86 133
(1) 8+86→133→132 (1) 8 + 86 → 133 → 132
化合物 8(738mg,lmmol)と化合物 86(248mg,lmmol)を用い、実施例 1の (5)と同様の 方法で化合物 133を無定形粉末として得た。収量 847mg(91%)。この化合物 133(840mg ,0.91mmol)力 2M/卜 TiCl /CH CI (2.5ml,5mmol)を用レヽ、実施例 1の (6)と同様の方法
で化合物 132を粉末として得た。収量 284mg(36%) Compound 133 was obtained as an amorphous powder in the same manner as in Example 1, (5), using Compound 8 (738 mg, 1 mmol) and Compound 86 (248 mg, 1 mmol). Yield 847 mg (91%). This compound 133 (840 mg, 0.91 mmol) force 2 M / 卜 TiCl 2 / CH CI (2.5 ml, 5 mmol) was used in the same manner as in Example 1, (6). Compound 132 was obtained as a powder. Yield 284 mg (36%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 2.62(3H, s), 3.42, 3.49(2H, ABq, J = 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 2.62 (3H, s), 3.42, 3.49 (2H, ABq, J =
17.1 Hz), 4.09(2H, q, J = 6.9Hz), 5.04(1H, d, J = 5.1Hz), 5.12(2H, d, J = 7.2Hz), 5 • 60(1H, dd, J = 4.5, 8.1Hz), 5.83(1H, m), 6.72(1H, s), 7·23_7·28(3Η, m), 7.65(1H, s ), 8.08(2H, d, J = 7.2Hz), 8.66(2H, d, J = 7.2Hz), 9.54(1H, d, J = 8.1Hz), 11.76(1H, s). 17.1 Hz), 4.09 (2H, q, J = 6.9 Hz), 5.04 (1H, d, J = 5.1 Hz), 5.12 (2H, d, J = 7.2 Hz), 5 • 60 (1H, dd, J = 4.5, 8.1Hz), 5.83 (1H, m), 6.72 (1H, s), 723_7 · 28 (3Η, m), 7.65 (1H, s), 8.08 (2H, d, J = 7.2Hz), 8.66 (2H, d, J = 7.2Hz), 9.54 (1H, d, J = 8.1Hz), 11.76 (1H, s).
IR (KBr) cm_1:3398, 2154, 1762, 1633, 1604, 1565, 1537, 1487, 1471, 1442, 1392,IR (KBr) cm _1 : 3398, 2154, 1762, 1633, 1604, 1565, 1537, 1487, 1471, 1442, 1392,
1329, 1220. 1329, 1220.
MS(FAB): 684+ (M+H)+ MS (FAB): 684 + (M + H) +
元素分析 C H N O S Na-6.0 H O Elemental analysis C H N O S Na-6.0 H O
計算値: C,43.99; H,4.84; N, 15.92; S,8.10; Na,2.90 (%) Calculated values: C, 43.99; H, 4.84; N, 15.92; S, 8.10; Na, 2.90 (%)
実験値: C,44.12; H,4.42; N, 15.85; S,8.07; Na,2.82 (%) Experimental value: C, 44.12; H, 4.42; N, 15.85; S, 8.07; Na, 2.82 (%)
実施例 32 Example 32
[化 81] [Chemical 81]
136 136
(1) 8+135→136→134 (1) 8 + 135 → 136 → 134
化合物 8(738mg,lmmol)と化合物 135(188mg,lmmol)を用レ、、実施例 1の (5)と同様の 方法で化合物 136を無定形粉末として得た。収量 796mg(82%)。この化合物 136(790mg ,0.82mmol)力、ら 2M/ト Aに 1 /CH NO (2.5ml,5mmol)を用レ、、実施例 7の (4)と同様の方 法で化合物 134を粉末として得た。収量 242mg(38%) Compound 8 (738 mg, 1 mmol) and compound 135 (188 mg, 1 mmol) were used in the same manner as in Example 1, (5), and compound 136 was obtained as an amorphous powder. Yield 796 mg (82%). Using this compound 136 (790 mg, 0.82 mmol), 1M / NO 2 (2.5 ml, 5 mmol) for 2 M / ton A, compound 134 as a powder in the same manner as in Example 7, (4) Obtained. Yield 242mg (38%)
'H-NMR (D O): 1.30(3H, t, J = 7.2Hz), 3.65(2H, s), 4.25(2H, q, J = 6.9Hz), 5.17(2 'H-NMR (D 2 O): 1.30 (3H, t, J = 7.2Hz), 3.65 (2H, s), 4.25 (2H, q, J = 6.9Hz), 5.17 (2
H, d, J = 6.0Hz), 5.26(1H, d, J = 5.1Hz) , 5.82(1H, d, J = 4.8Hz), 6.10(1H, m), 6.64
(1H, s), 6.93(1H, d, J = 15.6Hz), 6.97(1H, s), 7.01(1H, s), 8.20(2H, d, J = 7.2Hz), 8 .54(2H, d, J = 6.9Hz). H, d, J = 6.0Hz), 5.26 (1H, d, J = 5.1Hz), 5.82 (1H, d, J = 4.8Hz), 6.10 (1H, m), 6.64 (1H, s), 6.93 (1H, d, J = 15.6Hz), 6.97 (1H, s), 7.01 (1H, s), 8.20 (2H, d, J = 7.2Hz), 8.54 (2H, d, J = 6.9Hz).
IR (KBr) cm— 3407, 2981, 1762, 1633, 1592, 1537, 1518, 1468, 1409, 1352, 1298, 1217. IR (KBr) cm— 3407, 2981, 1762, 1633, 1592, 1537, 1518, 1468, 1409, 1352, 1298, 1217.
MS(FAB): 646+ (M+H)+ MS (FAB): 646 + (M + H) +
元素分析 C H N O S Na- 6.5 H O Elemental analysis C H N O S Na- 6.5 H O
計算値: C,42.52; H,4.89; N, 12.85; S,8.41; Na,3.01 (%) Calculated values: C, 42.52; H, 4.89; N, 12.85; S, 8.41; Na, 3.01 (%)
実験値: C,42.82; H,4.68; N, 12.90; S,8.17; Na,3.20 (%) Experimental value: C, 42.82; H, 4.68; N, 12.90; S, 8.17; Na, 3.20 (%)
実施例 33 Example 33
[化 82] [Chemical 82]
139 139
(1) 8+138→139→137 (1) 8 + 138 → 139 → 137
化合物 8(370mg,0.5mmol)と化合物 138(177mg,0.5mmol)を用レ、、実施例 1の (5)と同 様の方法で化合物 139を無定形粉末として得た。収量 509mg(89%)。この化合物 139(5 00mg,0.44mmol)から 2M/卜 A 1 /CH NO (2.0ml,4mmol)を用レヽ、実施例 7の (4)と同様 の方法で化合物 137を粉末として得た。収量 185mg(67%) Compound 8 (370 mg, 0.5 mmol) and compound 138 (177 mg, 0.5 mmol) were used in the same manner as in Example 1, (5) to obtain compound 139 as an amorphous powder. Yield 509 mg (89%). From this compound 139 (500 mg, 0.44 mmol), 2M / 卜 A 1 / CH NO (2.0 ml, 4 mmol) was used, and compound 137 was obtained as a powder in the same manner as in Example 7, (4). Yield 185mg (67%)
'H-NMR (D O): 1.28(3H, t, J = 7.2Hz), 3.63, 3,67(2H, Abq, J = 17.6Hz), 4.22(2H, q, J = 7.2Hz), 5.05(2H, d, J = 6.9Hz), 5.24(1H, d, J = 4.8Hz) , 5.79(1H, d, J = 4.8H z), 6.06(1H, m), 6.90_6.95(3H, m), 7.08(1H, s), 7.66(1H, s), 7.88(2H, d, J = 6.3Hz), 8.41(2H, d, J = 6.9Hz). 'H-NMR (DO): 1.28 (3H, t, J = 7.2Hz), 3.63, 3,67 (2H, Abq, J = 17.6Hz), 4.22 (2H, q, J = 7.2Hz), 5.05 ( 2H, d, J = 6.9Hz), 5.24 (1H, d, J = 4.8Hz), 5.79 (1H, d, J = 4.8Hz), 6.06 (1H, m), 6.90_6.95 (3H, m ), 7.08 (1H, s), 7.66 (1H, s), 7.88 (2H, d, J = 6.3Hz), 8.41 (2H, d, J = 6.9Hz).
IR (KBr) cm_1:3398, 2984, 1762, 1634, 1569, 1533, 1476, 1398, 1341, 1296, 1217. MS(FAB): 624+ (M_Na+2H)+
元素分析 C H N O S Na- 7.0 H O IR (KBr) cm _1 : 3398, 2984, 1762, 1634, 1569, 1533, 1476, 1398, 1341, 1296, 1217. MS (FAB): 624+ (M_Na + 2H) + Elemental analysis CHNOS Na- 7.0 HO
計算値: C,42.02; Η,4·96; Ν, 12.70; S,8.31; Na,2.98 (%) Calculated value: C, 42.02; Η, 4.96; Ν, 12.70; S, 8.31; Na, 2.98 (%)
実験値: C,42.05; H,4.74; N, 12.71; S,8.36; Na,3.35 (%) Experimental value: C, 42.05; H, 4.74; N, 12.71; S, 8.36; Na, 3.35 (%)
実施例 34 Example 34
[化 83] [Chemical 83]
(1) 141→142 (1) 141 → 142
化合物 141(2.58,12.911111101)とジメチルホルムァミドジメチルァセタール(1.7(¾,14.2111 mol)をジメチルホルムアミド (20ml)に溶解させ、 90°Cで 3時間攪拌した後、減圧濃縮し た。残渣をトルエン (20ml)に溶解させ 100°Cで 2時間攪拌した。減圧濃縮後、残渣をシ リカゲルカラムクロマトグラフィーに付し、トルエン-酢酸ェチルで溶離させた。溶離液 を減圧濃縮して化合物 142を得た。収量 2.25g(70%) Compound 141 (2.58, 12.911111101) and dimethylformamide dimethylacetal (1.7 (¾, 14.2111 mol) were dissolved in dimethylformamide (20 ml), stirred at 90 ° C for 3 hours, and concentrated under reduced pressure. Dissolved in toluene (20 ml) and stirred for 2 hours at 100 ° C. After concentration under reduced pressure, the residue was subjected to silica gel column chromatography and eluted with toluene-ethyl acetate. Yield 2.25 g (70%)
'H-NMR (CDCl ): 0.87(3H, t, J = 7.2Hz), 2.86(3H, br— s), 3.28(3H, br- s), 3.93(2H, q, J = 7.2Hz), 7.50(2H, br— d, J = 4.2Hz), 7.75(1H, s), 8.68(2H, d, J = 5.7Hz). 'H-NMR (CDCl): 0.87 (3H, t, J = 7.2Hz), 2.86 (3H, br—s), 3.28 (3H, br-s), 3.93 (2H, q, J = 7.2Hz), 7.50 (2H, br—d, J = 4.2Hz), 7.75 (1H, s), 8.68 (2H, d, J = 5.7Hz).
(2) 142→143 (2) 142 → 143
化合物 142(2.24g,9.0mmol)と H NNH ·Η 0(474mg,9.47mmol)をエタノール (10ml)に 溶解させ、 2N-HCl(0.45ml)を加えた後 80°Cで 2時間攪拌した。反応液を減圧濃縮し、 析出した結晶を濾取し、水で洗浄して化合物 143を得た。収量 1.71g(87%)
Ή-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 4.19(2H, q, J = 6.9Hz), 7.74(2H, d, JCompound 142 (2.24 g, 9.0 mmol) and H 2 NNH · Η0 (474 mg, 9.47 mmol) were dissolved in ethanol (10 ml), 2N-HCl (0.45 ml) was added, and the mixture was stirred at 80 ° C. for 2 hr. The reaction mixture was concentrated under reduced pressure, and the precipitated crystals were collected by filtration and washed with water to give compound 143. Yield 1.71 g (87%) Ή-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 4.19 (2H, q, J = 6.9Hz), 7.74 (2H, d, J
= 6.0Hz), 8.35(1H, s), 8.62(2H, d, J = 5.7Hz). = 6.0Hz), 8.35 (1H, s), 8.62 (2H, d, J = 5.7Hz).
(3) 143→144 (3) 143 → 144
化合物 143(888mg,4.1mmol)を4N-NaOH(10ml,40mmol)に溶解させ還流下で3時間 攪拌した。室温に戻した後 2N-HC1を加え pHを 3.5に調整し、析出した結晶を濾取し て化合物 144を得た。収量 366mg(47%) Compound 143 (888 mg, 4.1 mmol) was dissolved in 4N-NaOH (10 ml, 40 mmol) and stirred under reflux for 3 hours. After returning to room temperature, 2N-HC1 was added to adjust the pH to 3.5, and the precipitated crystals were collected by filtration to obtain Compound 144. Yield 366 mg (47%)
'H-NMR (d -D MSO): 7.79(2H, br-d, J = 4.5Hz), 8.38(1H, br-s), 8.62(2H, br_d, J 'H-NMR (d-D MSO): 7.79 (2H, br-d, J = 4.5Hz), 8.38 (1H, br-s), 8.62 (2H, br_d, J
= 3.9Hz). = 3.9Hz).
(4) 144→145 (4) 144 → 145
化合物 144(366mg,1.93mmol)を用レ、、実施例 18の (1)と同様の方法で化合物 145を 得た。収量 402mg(89%) Compound 144 (366 mg, 1.93 mmol) was used in the same manner as in Example 18, (1) to obtain Compound 145. Yield 402 mg (89%)
'H-NMR (d -DMSO): 7.95(2H, d, J = 4.2Hz), 8.01(1H, s), 8.51(2H, d, J = 4.8Hz). 'H-NMR (d-DMSO): 7.95 (2H, d, J = 4.2Hz), 8.01 (1H, s), 8.51 (2H, d, J = 4.8Hz).
(5) 8+145→146 (5) 8 + 145 → 146
化合物 8(672mg,0.77mmol)と化合物 145(180mg,0.77mmol)を用い、実施例 1の (5)と 同様の方法で化合物 146を無定形粉末として得た。収量 714mg(101%) Using Compound 8 (672 mg, 0.77 mmol) and Compound 145 (180 mg, 0.77 mmol), Compound 146 was obtained as an amorphous powder in the same manner as in Example 1, (5). Yield 714mg (101%)
(6) 146→147 (6) 146 → 147
化合物 146(714mg,0.78mmol)を塩化メチレン (10ml)とァニソール (0.8ml)に溶解し、 -2 0°Cにて 2M/卜 TiCl /CH CI (2.4ml,4.8mmol)を加えた。混合液を- 20°Cで 30分間攪拌 した後、 0.3N-塩酸 (30ml)とイソプロピルエーテル (30ml)に氷冷下で攪拌しながら注加 した。析出した沈殿物を濾取し、希塩酸とァセトニトリルの混合溶媒に溶解させた。溶 液に HP-20SSを加え濃縮し、 HP-20SSカラムクロマトグラフィーに付し、水-ァセトニトリ ルで溶離した。所望の化合物を含むフラクションを減圧下濃縮し、化合物 147を得た 。収量 72mg(14%) Compound 146 (714 mg, 0.78 mmol) was dissolved in methylene chloride (10 ml) and anisole (0.8 ml), and 2 M / 卜 TiCl 2 / CH 2 CI (2.4 ml, 4.8 mmol) was added at −20 ° C. The mixture was stirred at −20 ° C. for 30 minutes, and then poured into 0.3N hydrochloric acid (30 ml) and isopropyl ether (30 ml) with stirring under ice cooling. The deposited precipitate was collected by filtration and dissolved in a mixed solvent of dilute hydrochloric acid and acetonitrile. HP-20SS was added to the solution, concentrated, subjected to HP-20SS column chromatography, and eluted with water-acetonitrile. Fractions containing the desired compound were concentrated under reduced pressure to give compound 147. Yield 72 mg (14%)
(7) 147→140 (7) 147 → 140
化合物 147(51.8mg,0.08mmol)を水 (10ml)とァセトニトリル (10ml)に懸濁させ、 NaHCO 3(6.7mg,0.08mmol)を加えた。完全に溶解させて減圧濃縮後、凍結乾燥し化合物 140 を得た。収量 53mg(86%) Compound 147 (51.8 mg, 0.08 mmol) was suspended in water (10 ml) and acetonitrile (10 ml), and NaHCO 3 (6.7 mg, 0.08 mmol) was added. After complete dissolution, concentration under reduced pressure, and lyophilization, Compound 140 was obtained. Yield 53 mg (86%)
'H-NMR (d -DMSO): 1.21(3H, t, J = 7.2Hz), 3.42, 3,48(2H, Abq, J = 16.7Hz), 4.0
7(2H, q, J = 7.2Hz), 5.02(1H, d, J = 4.8Hz), 5.22(2H, d, J = 6.9Hz), 5.56(1H, dd, J = 5.1, 8.4 Hz), 5.84(1H, m), 6.70(1H, s), 7.19(2H, s), 7.28(1H, s, J = 15.9Hz), 8.13 (1H, s), 8.84(2H, d, J = 7.2Hz), 8.89(2H, d, J = 7.2Hz), 9.51(1H, d, J = 8.1Hz). IR (KBr) cm_1:3410, 2981, 2225, 2160, 1764, 1659, 1636, 1600, 1532, 1464, 1369, 1297, 1238. 'H-NMR (d-DMSO): 1.21 (3H, t, J = 7.2Hz), 3.42, 3,48 (2H, Abq, J = 16.7Hz), 4.0 7 (2H, q, J = 7.2Hz), 5.02 (1H, d, J = 4.8Hz), 5.22 (2H, d, J = 6.9Hz), 5.56 (1H, dd, J = 5.1, 8.4 Hz), 5.84 (1H, m), 6.70 (1H, s), 7.19 (2H, s), 7.28 (1H, s, J = 15.9Hz), 8.13 (1H, s), 8.84 (2H, d, J = 7.2Hz ), 8.89 (2H, d, J = 7.2Hz), 9.51 (1H, d, J = 8.1Hz). IR (KBr) cm _1 : 3410, 2981, 2225, 2160, 1764, 1659, 1636, 1600, 1532 , 1464, 1369, 1297, 1238.
MS(ESI): 649+ (M-Na+2H)+ MS (ESI): 649 + (M-Na + 2H) +
元素分析 C H N O S Na- 5.0 H O - 0.1 NaHCO Elemental analysis C H N O S Na- 5.0 H O-0.1 NaHCO
計算値: C,42.32; H,4.34; N, 18.21; S,8.34; Na,3.29 (%) Calculated values: C, 42.32; H, 4.34; N, 18.21; S, 8.34; Na, 3.29 (%)
実験値: C41.89; H,4.23; N, 17.88; S,8.18; Na,3.58 (%) Experimental value: C41.89; H, 4.23; N, 17.88; S, 8.18; Na, 3.58 (%)
実施例 35 Example 35
[化 84] [Chemical 84]
(1) 149→150 (1) 149 → 150
化合物 149(5.0g,36.2mmol)をメタノール (40ml)に懸濁させ、チォユルク口ライド (8.61g ,72.4mmol)を滴下した。混合液は室温で 3日間攪拌した後、更に還流下で 3時間攪拌 した。混合液にトルエンをカ卩ぇ減圧濃縮した。残渣を水に溶解させ NaHCOで中和し Compound 149 (5.0 g, 36.2 mmol) was suspended in methanol (40 ml), and thiollucide (8.61 g, 72.4 mmol) was added dropwise. The mixture was stirred at room temperature for 3 days, and further stirred under reflux for 3 hours. Toluene was concentrated in the mixed solution under reduced pressure. Dissolve the residue in water and neutralize with NaHCO
、析出した結晶を濾取して化合物 150を得た。収量 4.58g(83%) The precipitated crystals were collected by filtration to obtain Compound 150. Yield 4.58 g (83%)
'H-NMR (d -DMSO): 3.74(3H, s), 6.43(1H, d, J = 8.7Hz), 6.80(2H, s), 7.80(1H, dd 'H-NMR (d-DMSO): 3.74 (3H, s), 6.43 (1H, d, J = 8.7Hz), 6.80 (2H, s), 7.80 (1H, dd
, J = 2.4, 8.7Hz), 8.48(1H, d, J = 2.1Hz).
(2) 150→151 , J = 2.4, 8.7Hz), 8.48 (1H, d, J = 2.1Hz). (2) 150 → 151
BrCH CH(OMe) (10.65g,63mmol)を希塩酸(濃塩酸 1.5mlと水 70ml)に溶解させ、 90 BrCH CH (OMe) (10.65 g, 63 mmol) was dissolved in dilute hydrochloric acid (concentrated hydrochloric acid 1.5 ml and water 70 ml).
°Cで 1時間 30分攪拌した。混合液は室温に戻した後に化合物 150(3.3g,21.7mmol)と N aHCO (5g,60mmol)を加えた。 60°Cで 30分間攪拌した後、 K COで pH=10にして酢酸 ェチルで抽出した。有機層はブラインで洗浄して MgSOで乾燥した後に減圧下で濃 縮した。残渣をエタノール (40ml)に溶解させた後、濃硫酸 (1.2ml)をカ卩えた.析出した 結晶を濾取して化合物 151を得た。収量 3.3g(55%) The mixture was stirred at ° C for 1 hour and 30 minutes. The mixture was returned to room temperature, and then Compound 150 (3.3 g, 21.7 mmol) and NaHCO 3 (5 g, 60 mmol) were added. After stirring at 60 ° C for 30 minutes, the pH was adjusted to 10 with K 2 CO and extracted with ethyl acetate. The organic layer was washed with brine, dried over MgSO and concentrated under reduced pressure. The residue was dissolved in ethanol (40 ml) and concentrated sulfuric acid (1.2 ml) was added. The precipitated crystals were collected by filtration to give compound 151. Yield 3.3g (55%)
'H-NMR (d -DMSO): 3.97(3H, s), 8.07(1H, d, J = 9.3Hz), 8.27(1H, dd, J = 1.8, 9.6 'H-NMR (d-DMSO): 3.97 (3H, s), 8.07 (1H, d, J = 9.3Hz), 8.27 (1H, dd, J = 1.8, 9.6
Hz), 8.28(1H, d, J = 2.4Hz), 8.47(1H, d, J = 2.1Hz), 9.64(1H, m). Hz), 8.28 (1H, d, J = 2.4Hz), 8.47 (1H, d, J = 2.1Hz), 9.64 (1H, m).
(3) 151→152 (3) 151 → 152
化合物 151(3.27g,11.9mmol)をメタノール (50ml)とテトラヒドロフラン (50ml)の混合溶媒 に懸濁させ 4N-Na〇H(12ml,48mmol)をカ卩えた。還流下で 2時間攪拌し、室温に戻した 後 2N-HC1)を加え pHを 3.5とした。析出した結晶を濾取して化合物 152を得た。収量 1. 61g(83%) Compound 151 (3.27 g, 11.9 mmol) was suspended in a mixed solvent of methanol (50 ml) and tetrahydrofuran (50 ml) to obtain 4N—NaOH (12 ml, 48 mmol). The mixture was stirred for 2 hours under reflux, returned to room temperature, and then 2N-HC1) was added to adjust the pH to 3.5. The precipitated crystals were collected by filtration to obtain Compound 152. Yield 1.61 g (83%)
'H-NMR (d -DMSO): 7.59(2H, m), 7.65(1H, m), 8.08(1H, s), 9.26(1H, m). 'H-NMR (d-DMSO): 7.59 (2H, m), 7.65 (1H, m), 8.08 (1H, s), 9.26 (1H, m).
(4) 152→153 (4) 152 → 153
化合物 152(1.61g,9.93mmol)を用い、実施例 18の (1)と同様の方法で化合物 153を得 た。収量 525mg(25%) Compound 153 was obtained in the same manner as in Example 18, (1), using Compound 152 (1.61 g, 9.93 mmol). Yield 525mg (25%)
'H-NMR (d -DMSO): 7.42(1H, d, J = 9.3Hz), 7.54(1H, d, J = 1.2Hz), 7.69(1H, dd, 'H-NMR (d-DMSO): 7.42 (1H, d, J = 9.3Hz), 7.54 (1H, d, J = 1.2Hz), 7.69 (1H, dd,
J = 1.5, 9.3Hz), 8.00(1H, d, J = 1.2Hz), 9.04(1H, m). J = 1.5, 9.3Hz), 8.00 (1H, d, J = 1.2Hz), 9.04 (1H, m).
(5) 8+153→154→155→148 (5) 8 + 153 → 154 → 155 → 148
化合物 8(738mg,lmmol)と化合物 153(208mg,lmmol)を用レ、、実施例 1の (5)と同様の 方法で化合物 154を無定形粉末として得た。収量 791mg(97%)。この化合物 154(791mg ,0.97mmol)力、ら 2 M/l-TiCl /CH CI (3.0ml,6mmol)を用レヽ、実施例 34の (6)と同様の方 法で化合物 155を粉末として得た。収量 92mg(15%)。更にこの化合物 155(90.1mg,0.14 5mmol)から実施例 34の (7)と同様の方法で化合物 148を粉末として得た。収量 95mg(8 6%) Compound 8 (738 mg, 1 mmol) and Compound 153 (208 mg, 1 mmol) were used in the same manner as in Example 1, (5) to obtain Compound 154 as an amorphous powder. Yield 791 mg (97%). Using this compound 154 (791 mg, 0.97 mmol) strength, et al. 2 M / l-TiCl / CH CI (3.0 ml, 6 mmol), compound 155 was obtained as a powder in the same manner as in Example 34, (6). It was. Yield 92 mg (15%). Further, Compound 148 was obtained as a powder from Compound 155 (90.1 mg, 0.145 mmol) in the same manner as in Example 34 (7). Yield 95 mg (8 6%)
'H-NMR (d -DMSO): 1.21(3H, t, J = 6.9Hz), 3.38, 3,45(2H, Abq, J = 17.4Hz), 4.0
8(2H, q, J = 6.6Hz), 5.01(1H, d, J = 4.8Hz), 5.12(2H, d, J = 6.3Hz), 5.57(1H, m), 5 .75(1H, m), 6.71(1H, s), 7.18— 7.22(3H, m), 8.12(1H, d, J = 9.3Hz), 8.21(1H, d, J = 2.1Hz), 8.37(1H, d, J = 8.1Hz), 8.41(1H, s), 9.41(1H, s), 9.52(1H, d, J = 7.5Hz). IR (KBr) cm— 3419, 2983, 2157, 1761, 1649, 1601, 1530, 1445, 1385, 1294, 1237. MS(FAB): 622+ (M-Na+2H)+ 'H-NMR (d-DMSO): 1.21 (3H, t, J = 6.9Hz), 3.38, 3,45 (2H, Abq, J = 17.4Hz), 4.0 8 (2H, q, J = 6.6Hz), 5.01 (1H, d, J = 4.8Hz), 5.12 (2H, d, J = 6.3Hz), 5.57 (1H, m), 5.75 (1H, m ), 6.71 (1H, s), 7.18— 7.22 (3H, m), 8.12 (1H, d, J = 9.3Hz), 8.21 (1H, d, J = 2.1Hz), 8.37 (1H, d, J = 8.1Hz), 8.41 (1H, s), 9.41 (1H, s), 9.52 (1H, d, J = 7.5Hz). IR (KBr) cm— 3419, 2983, 2157, 1761, 1649, 1601, 1530, 1445, 1385, 1294, 1237. MS (FAB): 622 + (M-Na + 2H) +
元素分析 c H N O S Na- 6.0 H O - 0.1 NaHCO Elemental analysis c H N O S Na- 6.0 H O-0.1 NaHCO
計算値: C,41.24; H,4.52; N, 16.58; S,8.44; Na,3.33 (%) Calculated values: C, 41.24; H, 4.52; N, 16.58; S, 8.44; Na, 3.33 (%)
実験値: C,41.26; H,4.10; N, 16.49; S,8.55; Na,3.73 (%) Experimental value: C, 41.26; H, 4.10; N, 16.49; S, 8.55; Na, 3.73 (%)
実施例 36 Example 36
[化 85] [Chemical 85]
(1) 157→158 (1) 157 → 158
化合物 157(2.07g,14.61mmol)とチォグリコール酸メチル (1.55g, 14.61mmol)および K Compound 157 (2.07 g, 14.61 mmol) with methyl thioglycolate (1.55 g, 14.61 mmol) and K
CO (2.42g, 17.53mmol)をジメチルホルムアミド (15ml)に加え、 50。Cで 3時間攪拌した。 反応液を室温に戻し不溶物を濾去し、濾液に水を加え酢酸ェチルで抽出した。有機 層は水、ブラインの順に洗浄し、 MgSOで乾燥した後、減圧下で濃縮した。残渣にへ キサン-酢酸ェチル (4: 1)を加え結晶化させ、濾取して化合物 158を得た。収量 842mg( 30%) CO (2.42 g, 17.53 mmol) is added to dimethylformamide (15 ml) and 50. Stir at C for 3 hours. The reaction solution was returned to room temperature, insolubles were removed by filtration, water was added to the filtrate, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and brine in that order, dried over MgSO, and concentrated under reduced pressure. Hexane-ethyl acetate (4: 1) was added to the residue for crystallization, and the residue was collected by filtration to give Compound 158. Yield 842mg (30%)
'H-NMR (CDCl ): 3.98(3H, s), 7.37(1H, m), 8.02(1H, s), 8.17(1H, m), 8.69(1H, m).
(2) 158→159 'H-NMR (CDCl): 3.98 (3H, s), 7.37 (1H, m), 8.02 (1H, s), 8.17 (1H, m), 8.69 (1H, m). (2) 158 → 159
化合物 158(842mg,4.36mmol)と NaNHCN(279mg,4.36mmol)をメタノール (10ml)に懸 濁させ、室温で 3日間攪拌した。反応液にイソプロパノールを加え析出晶を濾取して 化合物 159を得た。収量 597mg(61%) Compound 158 (842 mg, 4.36 mmol) and NaNHCN (279 mg, 4.36 mmol) were suspended in methanol (10 ml) and stirred at room temperature for 3 days. Isopropanol was added to the reaction solution, and the precipitated crystals were collected by filtration to obtain Compound 159. Yield 597 mg (61%)
'H-NMR (d -DMSO): 7.23(1H, dd, J = 4.8, 8.1Hz), 7.55(1H, s), 8.07(1H, dd, J = 1. 'H-NMR (d-DMSO): 7.23 (1H, dd, J = 4.8, 8.1Hz), 7.55 (1H, s), 8.07 (1H, dd, J = 1.
6 6
5, 8.1Hz), 8.38(1H, dd, J = 1.5, 4.5Hz). 5, 8.1Hz), 8.38 (1H, dd, J = 1.5, 4.5Hz).
(3) 8+159→160→161→156 (3) 8 + 159 → 160 → 161 → 156
化合物 8(738mg,lmmol)と化合物 159(225mg,lmmol)を用レ、、実施例 1の (5)と同様の 方法で化合物 160を無定形粉末として得た。収量 87 8mg(97%)。この化合物 160(878m g,0.97mmol)力ら 2M/卜 TiCl /CH CI (2.9ml,5.8mmol)を用レ、、実施例 34の (6)と同様の Compound 8 (738 mg, 1 mmol) and Compound 159 (225 mg, 1 mmol) were used in the same manner as in Example 1, (5) to obtain Compound 160 as an amorphous powder. Yield 87 8 mg (97%). Using this compound 160 (878 mg, 0.97 mmol) force 2M / 卜 TiCl 2 / CH CI (2.9 ml, 5.8 mmol), the same as in Example 34 (6)
4 2 2 4 2 2
方法で化合物 161を粉末として得た。収量 72mg(12%)。更にこの化合物 161(50.9mg,0. 079mmol)から実施例 34の (7)と同様の方法で化合物 156を粉末として得た。収量 52mg (86%) The compound 161 was obtained as a powder. Yield 72 mg (12%). Further, Compound 156 was obtained as a powder from Compound 161 (50.9 mg, 0.079 mmol) in the same manner as in Example 34, (7). Yield 52 mg (86%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.42, 3,49(2H, Abq, J = 17.1Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.42, 3,49 (2H, Abq, J = 17.1Hz), 4.0
6 6
9(2H, q, J = 6.9Hz), 5.05(1H, d, J = 4.8Hz), 5.48(2H, d, J = 7.2Hz), 5.58(1H, dd, J = 4.2, 8.1Hz), 5.85(1H, m), 6.72(1H, s), 7.20(2H, s), 7.37(1H, d, J = 15.6Hz), 8.04 -8.09(2H, m), 8.98(1H, d, J = 8.1Hz), 9.15(1H, d, J = 6.3Hz), 9.52(1H, d, J = 8.4Hz ). 9 (2H, q, J = 6.9Hz), 5.05 (1H, d, J = 4.8Hz), 5.48 (2H, d, J = 7.2Hz), 5.58 (1H, dd, J = 4.2, 8.1Hz), 5.85 (1H, m), 6.72 (1H, s), 7.20 (2H, s), 7.37 (1H, d, J = 15.6Hz), 8.04 -8.09 (2H, m), 8.98 (1H, d, J = 8.1Hz), 9.15 (1H, d, J = 6.3Hz), 9.52 (1H, d, J = 8.4Hz).
IR (KBr) cm"1:3418, 2983, 2173, 1764, 1602, 1536, 1472, 1363, 1200. IR (KBr) cm " 1 : 3418, 2983, 2173, 1764, 1602, 1536, 1472, 1363, 1200.
MS(FAB): 639+ (M_Na+2H)+ MS (FAB): 639+ (M_Na + 2H) +
元素分析 C H N O S Na- 5.0 H O - 0.2 NaHCO Elemental analysis C H N O S Na- 5.0 H O-0.2 NaHCO
26 21 8 6 3 2 3 26 21 8 6 3 2 3
計算値: C,41.00; H,4.10; N, 14.60; S, 12.53; Na,3.59 (%) Calculated values: C, 41.00; H, 4.10; N, 14.60; S, 12.53; Na, 3.59 (%)
実験値: C, 41.26; H,4.05; N,15.11; S, 11.86; Na,3.89 (%) Experimental values: C, 41.26; H, 4.05; N, 15.11; S, 11.86; Na, 3.89 (%)
実施例 37 Example 37
[化 86]
[Chemical 86]
(1) 163→164 (1) 163 → 164
化合物 163(3.15g,20mmol)と Et N(2.02g,20mmol)をテトラヒドロフラン (35ml)に溶解さ Compound 163 (3.15 g, 20 mmol) and Et N (2.02 g, 20 mmol) were dissolved in tetrahydrofuran (35 ml).
3 Three
せ、 -15°Cで C :OOEt(2.39g,22mmol)を加え 15分間攪拌した。この溶液を _15°Cに冷 却して NaBH (2.01g,53mmol)の水 (18ml)溶液を加えて更に 30分間攪拌した。反応液 C: OOEt (2.39 g, 22 mmol) was added at -15 ° C, and the mixture was stirred for 15 minutes. This solution was cooled to _15 ° C., a solution of NaBH (2.01 g, 53 mmol) in water (18 ml) was added, and the mixture was further stirred for 30 minutes. Reaction liquid
4 Four
は水をカ卩ぇ酢酸ェチルで抽出した。有機層はブライン洗浄の後、 MgSOで乾燥して Extracted water with ketyl acetate. The organic layer is washed with brine and then dried over MgSO.
4 Four
減圧下で濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、へキサン-酢酸 ェチルで溶離させた。溶離液を減圧濃縮して化合物 164を得た。収量 2.32g(81%) 'H-NMR (CDCl ): 4.80(2H, s), 7.29(1H, m), 7.92(1H, m), 8.30(1H, m). Concentrated under reduced pressure. The residue was subjected to silica gel column chromatography, eluting with hexane-ethyl acetate. The eluent was concentrated under reduced pressure to give Compound 164. Yield 2.32 g (81%) 'H-NMR (CDCl): 4.80 (2H, s), 7.29 (1H, m), 7.92 (1H, m), 8.30 (1H, m).
3 Three
(2) 164→157 (2) 164 → 157
C :〇COCl(4.10g,32.2mmol)を塩化メチレン (50ml)に溶解させ、 _78°Cでジメチルス ルホキシド (2.74ml,38.6mmol)の塩化メチレン (30ml)溶液を加え、同温度で 15分間攪 拌した。次いで化合物 164(2.32g,16.1mmol)と Et N(8.91ml,64.4mmol)の塩化メチレン ( C: ○ COCl (4.10 g, 32.2 mmol) was dissolved in methylene chloride (50 ml), dimethyl sulfoxide (2.74 ml, 38.6 mmol) in methylene chloride (30 ml) was added at _78 ° C, and the mixture was stirred at the same temperature for 15 min. Stir. Compound 164 (2.32 g, 16.1 mmol) and Et N (8.91 ml, 64.4 mmol) in methylene chloride (
3 Three
30ml)溶液を上記の反応液に注加した。反応液は _15°Cに昇温させ 20分間攪拌した 後、飽和 NH C1水溶液を加えた。有機層を分取し、ブライン洗浄の後、 MgSOで乾燥 30 ml) solution was poured into the above reaction mixture. The reaction mixture was heated to _15 ° C and stirred for 20 minutes, and then a saturated NH 4 C1 aqueous solution was added. Separate the organic layer, wash with brine, and dry over MgSO
4 4 して減圧下で濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、へキサン- 酢酸ェチルで溶離させた。溶離液を減圧濃縮して化合物 157を得た。収量 2.07g(91% )
Ή-NMR (CDC1 ): 7.43(1H, dd, J = 4.8, 7.8Hz), 8.24(1H, dd, J = 2.1, 7.8Hz), 8.62(4 4 and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography, eluting with hexane-ethyl acetate. The eluent was concentrated under reduced pressure to give Compound 157. Yield 2.07g (91%) Ή-NMR (CDC1): 7.43 (1H, dd, J = 4.8, 7.8Hz), 8.24 (1H, dd, J = 2.1, 7.8Hz), 8.62 (
1H, dd, J = 2.1, 4.5Hz), 10.46(1H, m). 1H, dd, J = 2.1, 4.5Hz), 10.46 (1H, m).
(3) 157→165 (3) 157 → 165
化合物 157(1.26g,8.93mmol)をテトラヒドロフラン (20ml)に溶解させ、 _40°Cで 3mol/L_ MeMgCl/THFを加え 5分間攪拌した。反応液に 2N-塩酸を加えた後、 5%NaHC〇水 溶液で中和して酢酸ェチルで抽出した。有機層はブライン洗浄の後、 MgSOで乾燥 して減圧下で濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、へキサン- 酢酸ェチルで溶離させた。溶離液を減圧濃縮して化合物 165を得た。収量 1.33g(95% ) Compound 157 (1.26 g, 8.93 mmol) was dissolved in tetrahydrofuran (20 ml), 3 mol / L_MeMgCl / THF was added at _40 ° C, and the mixture was stirred for 5 minutes. 2N-hydrochloric acid was added to the reaction mixture, and the mixture was neutralized with 5% aqueous NaHC0 and extracted with ethyl acetate. The organic layer was washed with brine, dried over MgSO and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography, eluting with hexane-ethyl acetate. The eluent was concentrated under reduced pressure to give Compound 165. Yield 1.33g (95%)
'H-NMR (CDCl ): 1·52(3Η, d, J = 6.3Hz), 5.24(2H, q, J = 6.3Hz), 7.29(1H, m), 7.9 'H-NMR (CDCl): 1 · 52 (3Η, d, J = 6.3Hz), 5.24 (2H, q, J = 6.3Hz), 7.29 (1H, m), 7.9
7(1H, m), 8.29(1H, m). 7 (1H, m), 8.29 (1H, m).
(4) 165→166 (4) 165 → 166
C :〇COCl(2.15g, 16.9mmol)を塩化メチレン (25ml)に溶解させ、 _78°Cでジメチルス ルホキシド (1.44ml,20.3mmol)を加え、 _78°Cで 15分間攪拌した。次に化合物 165(1.33 g,8.46mmol)と Et N(4.7ml,33.8mmol)の塩化メチレン (15ml)溶液を上記の反応液に注 加した。反応液は- 15°Cに昇温させ 30分間攪拌した後、飽和 NH C1水溶液をカ卩えた。 有機層を分取し、水、ブラインの順に洗浄した後、 MgSOで乾燥して減圧下で濃縮し た。残渣をシリカゲルカラムクロマトグラフィーに付し、へキサン-酢酸ェチルで溶離さ せた。溶離液を減圧濃縮して化合物 166を得た。収量 1.17g(89%) C: ○ COCl (2.15 g, 16.9 mmol) was dissolved in methylene chloride (25 ml), dimethyl sulfoxide (1.44 ml, 20.3 mmol) was added at _78 ° C, and the mixture was stirred at _78 ° C for 15 minutes. Next, a solution of compound 165 (1.33 g, 8.46 mmol) and Et N (4.7 ml, 33.8 mmol) in methylene chloride (15 ml) was added to the above reaction solution. The reaction solution was heated to −15 ° C. and stirred for 30 minutes, and then a saturated NH 4 C1 aqueous solution was prepared. The organic layer was separated, washed successively with water and brine, dried over MgSO and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography, eluting with hexane-ethyl acetate. The eluent was concentrated under reduced pressure to give Compound 166. Yield 1.17 g (89%)
'H-NMR (CDCl ): 2.71(3H, s), 7.35(1H, dd, J = 4.5, 7.5Hz), 7.92(1H, dd, J = 1.8, 'H-NMR (CDCl): 2.71 (3H, s), 7.35 (1H, dd, J = 4.5, 7.5Hz), 7.92 (1H, dd, J = 1.8,
7.5Hz), 8.50(1H, dd, J = 1.8, 4.5Hz). 7.5Hz), 8.50 (1H, dd, J = 1.8, 4.5Hz).
(5) 166→167 (5) 166 → 167
化合物 166(707mg,4.54mmol)から、実施例 36の (1)と同様の方法で化合物 167を得 た。収量 850mg(90%) Compound 167 was obtained from compound 166 (707 mg, 4.54 mmol) in the same manner as in Example 36, (1). Yield 850 mg (90%)
'H-NMR (CDCl ): 2.77(3H, s), 3.95(3H, s), 7.38(1H, dd, J = 4.5, 8.1Hz), 8.12(1H, m), 8.70(1H, d, J = 4.2Hz). 'H-NMR (CDCl): 2.77 (3H, s), 3.95 (3H, s), 7.38 (1H, dd, J = 4.5, 8.1Hz), 8.12 (1H, m), 8.70 (1H, d, J = 4.2Hz).
(6) 167→168 (6) 167 → 168
化合物 167(850mg,4.1mmol)から、実施例 35の (3)と同様の方法で化合物 168を得た
。収量 699mg(88%) Compound 168 was obtained from compound 167 (850 mg, 4.1 mmol) in the same manner as in Example 35, (3). . Yield 699mg (88%)
'H-NMR (d -DMSO): 2.72(3H, s), 7.54(1H, m), 8.38(1H, m), 8.71(1H, m). 'H-NMR (d-DMSO): 2.72 (3H, s), 7.54 (1H, m), 8.38 (1H, m), 8.71 (1H, m).
(7) 168→169 (7) 168 → 169
化合物 168(493mg,2.55mmol)をジメチルホルムアミド (5ml)に懸濁させ、カルボニル ジイミダゾール (828mg,5.1mmol)を加えた。室温で 1時間攪拌した後、 NaNHCN(392m g,6.1mmol)をカ卩え、更に室温で 2時間攪拌した。反応液を水で希釈し 2N-HC1で pHを 6.1に調整して沈殿を析出させた。この沈殿を濾取し、減圧下で乾燥して化合物 169 を得た。収量 399mg(72%) Compound 168 (493 mg, 2.55 mmol) was suspended in dimethylformamide (5 ml), and carbonyldiimidazole (828 mg, 5.1 mmol) was added. After stirring at room temperature for 1 hour, NaNHCN (392 mg, 6.1 mmol) was added, and the mixture was further stirred at room temperature for 2 hours. The reaction solution was diluted with water, and the pH was adjusted to 6.1 with 2N-HC1 to precipitate the precipitate. The precipitate was collected by filtration and dried under reduced pressure to obtain Compound 169. Yield 399mg (72%)
'H-NMR (d -DMSO): 2.67(3H, s), 7.49(1H, m), 8.29(1H, m), 8.65(1H, m). 'H-NMR (d-DMSO): 2.67 (3H, s), 7.49 (1H, m), 8.29 (1H, m), 8.65 (1H, m).
(8) 169→170,8+170→171→172→162 (8) 169 → 170,8 + 170 → 171 → 172 → 162
化合物 169(483mg,2.22mmol)をメタノール (5ml)に懸濁させ、 lN_MeONa/MeOH(2.0 ml,2mmol)を加えた。混合液を減圧下で濃縮して化合物 170を得た。収量 477mg(100% )。この化合物 170(468mg,1.96mmol)と化合物 8(1.45g,1.96mmol)を用レ、、実施例 1の (5 )と同様の方法で化合物 171を無定形粉末として得た。収量 1.67g(85%)。この化合物 17 l(1.67g,1.67mmol)力ら 2M/ト TiCl /CH CI (5.0ml,10mmol)を用レヽ、実施例 34の (6)と 同様の方法で化合物 172を粉末として得た。収量 233mg(21%)。更にこの化合物 172(2 33mg,0.356mmol)から実施例 34の (7)と同様の方法で化合物 162を粉末として得た。収 量 245mg(90%) Compound 169 (483 mg, 2.22 mmol) was suspended in methanol (5 ml) and lN_MeONa / MeOH (2.0 ml, 2 mmol) was added. The mixture was concentrated under reduced pressure to give compound 170. Yield 477 mg (100%). Compound 170 (468 mg, 1.96 mmol) and Compound 8 (1.45 g, 1.96 mmol) were used in the same manner as in Example 1, (5) to obtain Compound 171 as an amorphous powder. Yield 1.67 g (85%). Compound 172 was obtained as a powder in the same manner as in Example 34, (6), using this compound 17 l (1.67 g, 1.67 mmol) and 2 M / t TiCl 2 / CH 2 CI (5.0 ml, 10 mmol). Yield 233 mg (21%). Further, Compound 162 was obtained as a powder from Compound 172 (2 33 mg, 0.356 mmol) in the same manner as in Example 34, (7). Yield 245 mg (90%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 2.79(3H, s), 3.42, 3,50(2H, Abq, J = 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 2.79 (3H, s), 3.42, 3,50 (2H, Abq, J =
17.0Hz), 4.09(2H, q, J = 7.2Hz), 5.06(1H, d, J = 4.8Hz), 5.46(2H, d, J = 7.2Hz), 5. 60(1H, dd, J = 4.8, 8.4Hz), 5.88(1H, m), 6.71(1H, s), 7.32(2H, s), 7.37(1H, d, J = 1 5.9Hz), 8.06(1H, dd, J = 6.0, 8.1Hz), 8.94(1H, dd, J = 1.2, 8.1Hz), 9.15(1H, d, J = 6.0Hz), 9.52(1H, d, J = 8.1Hz). 17.0Hz), 4.09 (2H, q, J = 7.2Hz), 5.06 (1H, d, J = 4.8Hz), 5.46 (2H, d, J = 7.2Hz), 5.60 (1H, dd, J = 4.8, 8.4Hz), 5.88 (1H, m), 6.71 (1H, s), 7.32 (2H, s), 7.37 (1H, d, J = 1 5.9Hz), 8.06 (1H, dd, J = 6.0, 8.1Hz), 8.94 (1H, dd, J = 1.2, 8.1Hz), 9.15 (1H, d, J = 6.0Hz), 9.52 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3420, 2983, 2166, 1764, 1664, 1601, 1534, 1383, 1331, 1200. IR (KBr) cm _1 : 3420, 2983, 2166, 1764, 1664, 1601, 1534, 1383, 1331, 1200.
MS(FAB): 675+ (M+H)+ MS (FAB): 675+ (M + H) +
元素分析 C H N O S Na- 5.0 H O Elemental analysis C H N O S Na- 5.0 H O
計算値: C,42.40; H,4.35; N, 14.65; S, 12.58; Na,3.01 (%) Calculated value: C, 42.40; H, 4.35; N, 14.65; S, 12.58; Na, 3.01 (%)
実験値: C,42.40; H,4.29; N, 14.72; S, 12.44; Na,3.37 (%)
実施例 38 Experimental value: C, 42.40; H, 4.29; N, 14.72; S, 12.44; Na, 3.37 (%) Example 38
[化 87] [Chemical 87]
(1) 174→175 (1) 174 → 175
KHCO3(2.0g,20mmol)を水に溶解させ、氷冷下で化合物 174(1.26g,8.93mmol)を加 えた。塩化メチレンで抽出し、有機層を MgSOで乾燥して減圧下で濃縮した。残渣を KHCO3 (2.0 g, 20 mmol) was dissolved in water, and compound 174 (1.26 g, 8.93 mmol) was added under ice cooling. Extracted with methylene chloride and the organic layer was dried over MgSO and concentrated under reduced pressure. The residue
4 Four
テトラヒドロフラン (10ml)で溶解し、 _78°Cに冷却された LDA(i-Pr2NH3.5ml,25mmol+2. 6MnBuLi 9.2ml,24mmol)のテトラヒドロフラン (12ml)溶液に加えた。反応液は 1時間攪 拌し、ジメチルホルムアミド (2.5ml,32mmol)を加えた。反応液を室温まで昇温させなが ら攪拌した後、水を加えた。減圧下で低沸点溶媒を濃縮した後、酢酸ェチルで 3回抽 出した。有機層はブラインで洗浄し、 MgS〇4で乾燥後、減圧濃縮した。 It was dissolved in tetrahydrofuran (10 ml) and added to a solution of LDA (i-Pr2NH3.5 ml, 25 mmol + 2.6 MnBuLi 9.2 ml, 24 mmol) in tetrahydrofuran (12 ml) cooled to _78 ° C. The reaction was stirred for 1 hour and dimethylformamide (2.5 ml, 32 mmol) was added. The reaction mixture was stirred while warming to room temperature, and water was added. After concentrating the low-boiling solvent under reduced pressure, it was extracted three times with ethyl acetate. The organic layer was washed with brine, dried over MgS04, and concentrated under reduced pressure.
残渣はチォグリコール酸メチル (1.94g,18.3mmol)および K2C03(2.75g, 19.9mmol)と 共にジメチルホルムアミドに懸濁させ、 60°Cで 3時間攪拌した。反応液を室温まで冷 却し、水をカ卩え、析出した沈殿を濾取して化合物 175を得た。収量 725mg(19%) 'H-NMR (CDCl ): 3.98(3H, s), 7.81(1H, m), 8.16(1H, s), 8.55(1H, d, J = 5.7Hz), 9. The residue was suspended in dimethylformamide together with methyl thioglycolate (1.94 g, 18.3 mmol) and K2C03 (2.75 g, 19.9 mmol), and stirred at 60 ° C for 3 hours. The reaction solution was cooled to room temperature, water was added, and the deposited precipitate was collected by filtration to obtain Compound 175. Yield 725mg (19%) 'H-NMR (CDCl): 3.98 (3H, s), 7.81 (1H, m), 8.16 (1H, s), 8.55 (1H, d, J = 5.7Hz), 9.
3 Three
19(1H, s). 19 (1H, s).
(2) 175→176 (2) 175 → 176
化合物 175(730mg,3.8mmol)から、実施例 35の (3)と同様の方法で化合物 176を得た 。収量 498mg(68%)
Ή-NMR (d -DMSO): 7.89(1H, m), 8.02(1H, s), 8.29(1H, d, J = 5.7Hz), 9.03(1H, s) Compound 176 was obtained from compound 175 (730 mg, 3.8 mmol) in the same manner as in Example 35, (3). Yield 498mg (68%) Ή-NMR (d-DMSO): 7.89 (1H, m), 8.02 (1H, s), 8.29 (1H, d, J = 5.7Hz), 9.03 (1H, s)
(3) 176→177 (3) 176 → 177
化合物 176(498mg,2.78mmol)から、実施例 37の (7)と同様の方法で化合物 177を得 た。収量 560mg(99%) Compound 177 was obtained from compound 176 (498 mg, 2.78 mmol) in the same manner as in Example 37, (7). Yield 560 mg (99%)
'H-NMR (d -DMSO): 7.97(1H, s), 8.45(2H, s), 9.30(1H, s). 'H-NMR (d-DMSO): 7.97 (1H, s), 8.45 (2H, s), 9.30 (1H, s).
(4) 177→178,8+178→179→180→173 (4) 177 → 178,8 + 178 → 179 → 180 → 173
化合物 177(560mg,2.75mmol)をメタノール (10ml)に懸濁させ、 ΙΝ-MeONa/MeOH ( 2.48ml,2.48mmol)を加えた。混合液を減圧下で乾燥して化合物 178を得た。収量 602 mg(97%)。この化合物 178(602mg,2.68mmol)と化合物 8(1.97g,2.68mmol)を用レヽ、実施 例 1の (5)と同様の方法で化合物 179を無定形粉末として得た。収量 2.44g(92%)。次い でこの化合物 179(2.43g,2.46mol)から 2M/卜 TiCl /CH CI (7.4ml, 14.8mmol)を用レヽ、 実施例 34の (6)と同様の方法で化合物 180を粉末として得た。収量 713mg(45%)。更に この化合物 180(720mg,1.13mmol)力 実施例 34の (7)と同様の方法で化合物 173を粉 末として得た。収量 741mg(87%) Compound 177 (560 mg, 2.75 mmol) was suspended in methanol (10 ml), and ΙΝ-MeONa / MeOH (2.48 ml, 2.48 mmol) was added. The mixture was dried under reduced pressure to give compound 178. Yield 602 mg (97%). Compound 179 was obtained as an amorphous powder in the same manner as in Example 5, (5) using Compound 178 (602 mg, 2.68 mmol) and Compound 8 (1.97 g, 2.68 mmol). Yield 2.44 g (92%). Next, from this compound 179 (2.43 g, 2.46 mol), 2M / 卜 TiCl 2 / CH CI (7.4 ml, 14.8 mmol) was used, and compound 180 was obtained as a powder in the same manner as in Example 34 (6). It was. Yield 713 mg (45%). Further, Compound 180 (720 mg, 1.13 mmol) force Compound 173 was obtained as a powder in the same manner as in Example 34 (7). Yield 741 mg (87%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.43, 3,49(2H, Abq, J = 16.8Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.43, 3,49 (2H, Abq, J = 16.8Hz), 4.0
9(2H, q, J = 6.6Hz), 5.04(1H, d, J = 4.5Hz), 5.34(2H, d, J = 6.9Hz), 5.60(1H, dd, J = 4.8, 8.4Hz), 5.88(1H, m), 6.71(1H, s), 7.22(2H, s), 7.33(1H, d, J = 15.6Hz), 8.13 (lH,s), 8.71(2H, s), 9.53(1H, d, J = 8.1Hz), 9.63(1H, s). 9 (2H, q, J = 6.6Hz), 5.04 (1H, d, J = 4.5Hz), 5.34 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 4.8, 8.4Hz), 5.88 (1H, m), 6.71 (1H, s), 7.22 (2H, s), 7.33 (1H, d, J = 15.6Hz), 8.13 (lH, s), 8.71 (2H, s), 9.53 (1H , d, J = 8.1Hz), 9.63 (1H, s).
IR (KBr) cm— 3425, 2173, 1761, 1604, 1531, 1483, 1457, 1360, 1199. IR (KBr) cm— 3425, 2173, 1761, 1604, 1531, 1483, 1457, 1360, 1199.
MS(FAB): 639+ (M_Na+2H)+ MS (FAB): 639+ (M_Na + 2H) +
元素分析 C H N O S Na- 5.0 H O Elemental analysis C H N O S Na- 5.0 H O
計算値: C,41.60; H,4.16; N, 14.93; S, 12.81; Na,3.06 (%) Calculated values: C, 41.60; H, 4.16; N, 14.93; S, 12.81; Na, 3.06 (%)
実験値: C,41.75; H,4.22; N, 15.01; S, 12.25; Na,3.43 (%) Experimental value: C, 41.75; H, 4.22; N, 15.01; S, 12.25; Na, 3.43 (%)
実施例 39 Example 39
(1) 8+182→183→184→181 (1) 8 + 182 → 183 → 184 → 181
化合物 8(738mg,lmmol)と化合物 182(202mg,lmmol)をジメチルホルムアミド (5ml)とジ メチルスルホキシド (5ml)中に懸濁させ、臭化ナトリウム (309mg,3mmol)を加え室温で 4 時間攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、析出した沈殿を濾取した 。沈殿を減圧下で乾燥して化合物 183を無定形粉末として得た。収量 952mg(97%)。こ の化合物 183(952mg,0.97mol)力ら 2M/ト TiCl /CH CI (2.9ml,5.8mmol)を用い、実施 例 34の (6)と同様の方法で化合物 184を粉末として得た。収量 63mg(10%)。更にこのィ匕 合物 184(59mg,0.092mmol)力 実施例 34の (7)と同様の方法で化合物 181を粉末とし て得た。収量 62mg(88%) Compound 8 (738 mg, lmmol) and Compound 182 (202 mg, lmmol) were suspended in dimethylformamide (5 ml) and dimethylsulfoxide (5 ml), sodium bromide (309 mg, 3 mmol) was added, and the mixture was stirred at room temperature for 4 hours. . The reaction solution was poured into 5% brine (30 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to give Compound 183 as an amorphous powder. Yield 952 mg (97%). Using this compound 183 (952 mg, 0.97 mol), 2M / ton TiCl 2 / CH 2 CI (2.9 ml, 5.8 mmol), compound 184 was obtained as a powder in the same manner as in (34) of Example 34. Yield 63 mg (10%). Further, this compound 184 (59 mg, 0.092 mmol) force Compound 181 was obtained as a powder in the same manner as in Example 34, (7). Yield 62 mg (88%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 3.42, 3,47(2H, Abq, J = 16.5Hz), 3.8 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 3.42, 3,47 (2H, Abq, J = 16.5Hz), 3.8
9(3H, s), 4.09(2H, q, J = 6.9Hz), 5.03(1H, d, J = 5.1Hz), 5.05(2H, d, J = 6.6Hz), 5. 58(1H, dd, J = 4.8, 8.4Hz), 5.80(1H, m), 6.71(1H, s), 7.02(1H, d, J = 2.1Hz), 7.21- 7.25(3H, m), 7.78(1H, d, J = 2.1Hz), 8.03(1H, d, J = 6.9Hz), 8.59(1H, d, J = 7.2Hz) , 9.52(1H, d, J = 8.1Hz). 9 (3H, s), 4.09 (2H, q, J = 6.9Hz), 5.03 (1H, d, J = 5.1Hz), 5.05 (2H, d, J = 6.6Hz), 5.58 (1H, dd , J = 4.8, 8.4Hz), 5.80 (1H, m), 6.71 (1H, s), 7.02 (1H, d, J = 2.1Hz), 7.21- 7.25 (3H, m), 7.78 (1H, d, J = 2.1Hz), 8.03 (1H, d, J = 6.9Hz), 8.59 (1H, d, J = 7.2Hz), 9.52 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3420, 2984, 1763, 1634, 1604, 1561, 1499, 1472, 1405, 1336, 1298, 1221. IR (KBr) cm _1 : 3420, 2984, 1763, 1634, 1604, 1561, 1499, 1472, 1405, 1336, 1298, 1221.
MS(FAB): 638+ (M- Na+2H)+ MS (FAB): 638+ (M- Na + 2H) +
元素分析 C H N O S Na-6.0 H O Elemental analysis C H N O S Na-6.0 H O
計算値: C,43.80; H,4.99; N, 12.77; S,8.35; Na,2.99 (%) Calculated values: C, 43.80; H, 4.99; N, 12.77; S, 8.35; Na, 2.99 (%)
実験値: C,43.41; H,4.82; N, 12.64; S,8.23; Na,3.04 (%) Experimental value: C, 43.41; H, 4.82; N, 12.64; S, 8.23; Na, 3.04 (%)
実施例 40
[化 89] Example 40 [Chemical 89]
(1) 182→186→187 (1) 182 → 186 → 187
化合物 182(408mg,2.02mmol)から、実施例 37の (7)と同様の方法で化合物 186を得 た。収量 323mg(71%)。この化合物 186(323mg, 1.43mmol)をメタノール (5ml)に懸濁させ 、 ΙΝ-MeONa/MeOH (1.35ml,1.35mmol)を加えた。混合液を減圧下で乾燥して化合 物 187を得た。収量 342mg(96%) Compound 186 was obtained from compound 182 (408 mg, 2.02 mmol) in the same manner as in Example 37, (7). Yield 323 mg (71%). This compound 186 (323 mg, 1.43 mmol) was suspended in methanol (5 ml), and ΙΝ-MeONa / MeOH (1.35 ml, 1.35 mmol) was added. The mixture was dried under reduced pressure to give Compound 187. Yield 342 mg (96%)
'H-NMR (d -DMSO): 4.88(1H, s), 6.99(1H, d, J = 2.1Hz), 7.46(3H, m), 8.40(2H, d, 'H-NMR (d-DMSO): 4.88 (1H, s), 6.99 (1H, d, J = 2.1Hz), 7.46 (3H, m), 8.40 (2H, d,
J = 6.0Hz). J = 6.0Hz).
(2) 8+187→188→189→185 (2) 8 + 187 → 188 → 189 → 185
化合物 8(1.0111¾,1.3711111101)と化合物187(34111¾, 1.3711111101)を用ぃ、実施例 1の (5)と 同様の方法で化合物 188を無定形粉末として得た。収量 1.04g(75%)。この化合物 188( 1.04g, 1.03mmol)から 2M/卜 TiCl /CH CI (3.1ml,6.2mmol)を用い、実施例 34の (6)と同 様の方法で化合物 189を粉末として得た。収量 26mg(4%)。更にこの化合物 189(25mg, 0.038mmol)から実施例 34の (7)と同様の方法で化合物 185を粉末として得た。収量 27 mg(91%) Compound 188 was obtained as an amorphous powder in the same manner as in (5) of Example 1 using Compound 8 (1.0111¾, 1.3711111101) and Compound 187 (34111¾, 1.3711111101). Yield 1.04 g (75%). Using this compound 188 (1.04 g, 1.03 mmol) and 2M / 卜 TiCl 2 / CH CI (3.1 ml, 6.2 mmol), compound 189 was obtained as a powder in the same manner as in Example 34 (6). Yield 26 mg (4%). Further, Compound 185 was obtained as a powder from Compound 189 (25 mg, 0.038 mmol) in the same manner as in Example 34, (7). Yield 27 mg (91%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.3Hz), 3.35— 3.48(2H, m), 3.92(3H, s), 4.09( 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.3Hz), 3.35—3.48 (2H, m), 3.92 (3H, s), 4.09 (
2H, q, J = 6.3Hz), 5.03(1H, d, J = 4.8Hz), 5.07(2H, m), 5.58(1H, m), 5.81(1H, m), 6.72(1H, s), 7.21-7.28(4H, m), 7.92(1H, m), 8.11(1H, d, J = 6.6Hz), 8.66(1H, d, J
= 7.5Hz), 9.53(1H, d, J = 8. 4Hz). 2H, q, J = 6.3Hz), 5.03 (1H, d, J = 4.8Hz), 5.07 (2H, m), 5.58 (1H, m), 5.81 (1H, m), 6.72 (1H, s), 7.21-7.28 (4H, m), 7.92 (1H, m), 8.11 (1H, d, J = 6.6Hz), 8.66 (1H, d, J = 7.5Hz), 9.53 (1H, d, J = 8.4Hz).
IR (KBr) cm— 3420, 2983, 2181, 2146, 1763, 1634, 1604, 1561, 1496, 1469, 1433, IR (KBr) cm— 3420, 2983, 2181, 2146, 1763, 1634, 1604, 1561, 1496, 1469, 1433,
1402, 1334, 1220. 1402, 1334, 1220.
MS(FAB): 662+ (M_Na+2H)+ MS (FAB): 662+ (M_Na + 2H) +
元素分析 C H N O S Na- 5.0 H O - 0.1NaHCO Elemental analysis C H N O S Na- 5.0 H O-0.1 NaHCO
計算値: C,44.68; H,4.65; N, 16.12; S,8.20; Na,3.23 (%) Calculated value: C, 44.68; H, 4.65; N, 16.12; S, 8.20; Na, 3.23 (%)
実験値: C,44.74; H,4.67; N, 15.85; S,8.15; Na,3.50 (%) Experimental value: C, 44.74; H, 4.67; N, 15.85; S, 8.15; Na, 3.50 (%)
実施例 41 Example 41
[化 90] [Chemical 90]
(1) 2+3→4 (1) 2 + 3 → 4
化合物2(83911¾,1.5011111101)と化合物3(33111¾,1.5011111101)をジメチルホルムァミド(2.5 ml)中に懸濁し、臭化ナトリウム (463mg,4.50mmol)を加え室温で 3時間攪拌した。反応 液を 5%食塩水 (75ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥し て化合物 4を無定形粉末として得た。収量 1.047g(98%) Compound 2 (83911¾, 1.5011111101) and compound 3 (33111¾, 1.5011111101) were suspended in dimethylformamide (2.5 ml), sodium bromide (463 mg, 4.50 mmol) was added, and the mixture was stirred at room temperature for 3 hours. The reaction solution was poured into 5% brine (75 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 4 as an amorphous powder. Yield 1.047g (98%)
'H-NMR (d -DMSO): 3.49, 3.55(2H, ABq, J = 14.1 Hz), 3.60, 3.88(2H, ABq, J = 1
8.2 Hz), 5· 18(1Η, d, J = 4.8Hz), 5.30(2H, d, J = 6.2Hz), 5.76(1H, dd. J = 8.3, 4.8H z), 6.40(1H, dt, J = 15.9, 6.2Hz), 6.79(1H, d, J = 15.9Hz), 6.91(1H, s), 7.20-7.50(1 6H, m), 7.65(1H, dd, J = 8.1, 6.0Hz), 8.42(1H, d, J = 8.1Hz), 8.66(1H, d, J = 6.0Hz ), 9.17(1H, d, J = 8.3Hz), 13.1(1H, brs) 'H-NMR (d-DMSO): 3.49, 3.55 (2H, ABq, J = 14.1 Hz), 3.60, 3.88 (2H, ABq, J = 1 8.2 Hz), 5.18 (1Η, d, J = 4.8Hz), 5.30 (2H, d, J = 6.2Hz), 5.76 (1H, dd.J = 8.3, 4.8Hz), 6.40 (1H, dt , J = 15.9, 6.2Hz), 6.79 (1H, d, J = 15.9Hz), 6.91 (1H, s), 7.20-7.50 (16H, m), 7.65 (1H, dd, J = 8.1, 6.0Hz ), 8.42 (1H, d, J = 8.1Hz), 8.66 (1H, d, J = 6.0Hz), 9.17 (1H, d, J = 8.3Hz), 13.1 (1H, brs)
(2) 4→1 (2) 4 → 1
化合物4(68½¾,0.9651!111101)を塩化メチレン(4.11111)とァニソール(0.681111)に溶解し、 0 °Cに冷却し、 TFA (トリフルォロ酢酸) 2.0mlをカ卩えた。混合液を 0°Cで 35分攪拌した後 、 IPA40mlに氷冷下で攪拌しながら注カ卩した。析出した沈殿物を濾取し、飽和 NaHC 〇水で溶解させた。溶液を HP-20SSカラムクロマトグラフィーに付し、水-ァセトニトリ Compound 4 (68½¾, 0.9651! 111101) was dissolved in methylene chloride (4.11111) and anisole (0.681111), cooled to 0 ° C., and 2.0 ml of TFA (trifluoroacetic acid) was obtained. The mixture was stirred at 0 ° C for 35 minutes, and then poured into 40 ml of IPA with stirring under ice cooling. The deposited precipitate was collected by filtration and dissolved in saturated NaHC water. The solution is subjected to HP-20SS column chromatography and water-acetononitrile is added.
3 Three
ルで溶離した。所望の化合物を含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥 して化合物 1を粉末として得た。収量 342mg(56%) Elution. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 1 as a powder. Yield 342 mg (56%)
'H-NMR (D20): 3.50, 3.58(2H, ABq, J = 17.4 Hz), 3.61, 3.67(2H, ABq, J = 15.2 H z), 5.05(1H, d, J = 4.5Hz), 5.41(2H, d, J = 6.6Hz), 5.59(1H, d. J = 4.5Hz), 6.12(1H, dt, J = 15.9, 6.6Hz), 6.85(1H, d, J = 15.9Hz), 7.19(1H, s), 7.26-7.40(5H, m), 7.70( 1H, dd, J = 8.1, 6.0Hz), 8.47(1H, d, J = 8.1Hz), 8.59(1H, d, J = 6.0Hz). 'H-NMR (D20): 3.50, 3.58 (2H, ABq, J = 17.4 Hz), 3.61, 3.67 (2H, ABq, J = 15.2 Hz), 5.05 (1H, d, J = 4.5 Hz), 5.41 (2H, d, J = 6.6Hz), 5.59 (1H, d. J = 4.5Hz), 6.12 (1H, dt, J = 15.9, 6.6Hz), 6.85 (1H, d, J = 15.9Hz), 7.19 (1H, s), 7.26-7.40 (5H, m), 7.70 (1H, dd, J = 8.1, 6.0Hz), 8.47 (1H, d, J = 8.1Hz), 8.59 (1H, d, J = 6.0 Hz).
IR (KBr) cm_1:3427, 2165, 1761, 1658, 1594, 1540, 1399, 1337, 1200, 766. IR (KBr) cm _1 : 3427, 2165, 1761, 1658, 1594, 1540, 1399, 1337, 1200, 766.
MS(FAB): 565+ (M+H)+ MS (FAB): 565 + (M + H) +
元素分析 C H N O SNa- 3.9 H O Elemental analysis C H N O SNa- 3.9 H O
27 21 6 5 2 27 21 6 5 2
計算値: C,51.08; H,4.57; N, 13.24; S,5.05; Na,3.62 (%) Calculated value: C, 51.08; H, 4.57; N, 13.24; S, 5.05; Na, 3.62 (%)
実験値: C,51.07; H,4.44; N, 13.23; S,5.06; Na,3.78 (%) Experimental value: C, 51.07; H, 4.44; N, 13.23; S, 5.06; Na, 3.78 (%)
実施例 42 Example 42
[化 91]
[Chemical 91]
(1) 2+6→7 (1) 2 + 6 → 7
化合物 2(839mg, 1.50mmol)と化合物 6(339mg, 1.50mmol)をジメチルスルホキシド (2.5 ml)中に懸濁させ、臭化ナトリウム (463mg,4.50mmol)を加えて、実施例 41の (1)と同様 の手法にて化合物 7を無定形粉末として得た。収量 1.123g(103%) Compound 2 (839 mg, 1.50 mmol) and Compound 6 (339 mg, 1.50 mmol) were suspended in dimethyl sulfoxide (2.5 ml), sodium bromide (463 mg, 4.50 mmol) was added, and Example 41 (1) In the same manner as above, Compound 7 was obtained as an amorphous powder. Yield 1.123 g (103%)
'H-NMR (d -DMSO): 3.50, 3.57(2H, ABq, J = 14.0 Hz), 3.63, 3.88(2H, ABq, J = 1'H-NMR (d-DMSO): 3.50, 3.57 (2H, ABq, J = 14.0 Hz), 3.63, 3.88 (2H, ABq, J = 1
7.7 Hz), 5.20(1H, d, J = 4.8Hz), 5.39(2H, d, J = 6.3Hz), 5.78(1H, dd. J = 8.0, 4.8H z), 6.43(1H, dt, J = 15.6, 6.3Hz), 6.93(1H, d, J = 15.6Hz), 6.93(1H, s), 7.15-7.52(1 5H, m), 8.78(1H, d, J = 6.9Hz), 8.82(1H, d, J = 6.9Hz), 9.18(1H, d, J = 8.0Hz), 9.9 5(1H, s). 7.7 Hz), 5.20 (1H, d, J = 4.8 Hz), 5.39 (2H, d, J = 6.3 Hz), 5.78 (1H, dd. J = 8.0, 4.8 Hz), 6.43 (1H, dt, J = 15.6, 6.3Hz), 6.93 (1H, d, J = 15.6Hz), 6.93 (1H, s), 7.15-7.52 (1 5H, m), 8.78 (1H, d, J = 6.9Hz), 8.82 ( 1H, d, J = 6.9Hz), 9.18 (1H, d, J = 8.0Hz), 9.9 5 (1H, s).
(2) 7→5 (2) 7 → 5
化合物 7(1.114g,1.532mmol)を塩化メチレン (7ml)とァニソール (1.1ml)に溶解し、 0°C に冷却し、 TFA 3.3mlを加え、実施例 41の (2)と同様の手法にて、化合物 5を粉末とし て得た。収量 482mg(48%) Compound 7 (1.114 g, 1.532 mmol) was dissolved in methylene chloride (7 ml) and anisole (1.1 ml), cooled to 0 ° C., 3.3 ml of TFA was added, and the same procedure as in (2) of Example 41 was performed. Thus, Compound 5 was obtained as a powder. Yield 482mg (48%)
'H-NMR (d -DMSO): 3.41, 3.50(2H, ABq, J = 16.8 Hz), 3.49, 3.57(2H, ABq, J = 1 'H-NMR (d-DMSO): 3.41, 3.50 (2H, ABq, J = 16.8 Hz), 3.49, 3.57 (2H, ABq, J = 1
1.1 Hz), 4.96(1H, d, J = 4.8Hz), 5.42(2H, d, J = 6.9Hz), 5.47(1H, dd. J = 8.1, 4.8H z), 5.91(1H, dt, J = 15.8, 6.9Hz), 7.15- 7.30(6H, m), 7.34(1H, d, J = 15.8Hz), 8.83(1 H, d, J = 6.6Hz), 8.87(1H, dd, J = 6.6, 1 .2Hz), 9.05(1H, d, J = 8.1Hz), 9.99(1H, d, J = 1.2Hz). 1.1 Hz), 4.96 (1H, d, J = 4.8 Hz), 5.42 (2H, d, J = 6.9 Hz), 5.47 (1H, dd. J = 8.1, 4.8 Hz), 5.91 (1H, dt, J = 15.8, 6.9Hz), 7.15- 7.30 (6H, m), 7.34 (1H, d, J = 15.8Hz), 8.83 (1 H, d, J = 6.6Hz), 8.87 (1H, dd, J = 6.6 , 1.2Hz), 9.05 (1H, d, J = 8.1Hz), 9.99 (1H, d, J = 1.2Hz).
IR (KBr) cm— 3433, 2178, 1760, 1606, 1542, 1512, 1362, 1123, 856.
MS(ESI): 561 (M-Na+2H) IR (KBr) cm— 3433, 2178, 1760, 1606, 1542, 1512, 1362, 1123, 856. MS (ESI): 561 (M-Na + 2H)
元素分析 C H N O S Na- 3.8 H O Elemental analysis C H N O S Na- 3.8 H O
計算値: C,47.97; H,4.12; N,12.91; S,9,85; Na,3.53 (%) Calculated value: C, 47.97; H, 4.12; N, 12.91; S, 9, 85; Na, 3.53 (%)
実験値: C48.01; H,4.19; N,12.71; S,9,80; Na,3.73 (%) Experimental value: C48.01; H, 4.19; N, 12.71; S, 9,80; Na, 3.73 (%)
実施例 43 Example 43
[化 92] [Chem 92]
10 11 12 10 11 12
(1) 10→11 (1) 10 → 11
化合物 10(3.04g,16.0mmol)を 28%アンモニア水 (40ml)中に懸濁させ、 60°Cにて 7時間 攪拌した。水を加え、析出物をろ過し、乾燥して化合物 11を褐色結晶として得た。収 量 1.60g(62%) Compound 10 (3.04 g, 16.0 mmol) was suspended in 28% aqueous ammonia (40 ml) and stirred at 60 ° C. for 7 hours. Water was added, and the precipitate was filtered and dried to obtain Compound 11 as brown crystals. Yield 1.60 g (62%)
'H-NMR (d -DMSO): 7.18(1H, dd, J = 8.9, 4.5Hz), 7.26(1H, s), 7.54(1H, s), 7.77(1 'H-NMR (d-DMSO): 7.18 (1H, dd, J = 8.9, 4.5Hz), 7.26 (1H, s), 7.54 (1H, s), 7.77 (1
H, d, J = 8.9Hz), 8.11(1H, s), 8.38(1H, d, 4.5Hz), 11.74(1H, s). H, d, J = 8.9Hz), 8.11 (1H, s), 8.38 (1H, d, 4.5Hz), 11.74 (1H, s).
(2) 11→12 (2) 11 → 12
化合物 11(1.58g、 9.80mmol)をピリジン (19ml)に溶解し、メタンスルホユルクロリド (4.5 5ml、 58.8mmol)を加えて 60°Cにて 2時間 20分攪拌した。ピリジンを減圧留去し、水、酢 酸ェチルを加えて抽出し、飽和食塩水で洗浄、無水硫酸ナトリウムで乾燥した。溶媒 を減圧留去して得られた結晶をメタノール (16ml)で溶解し、氷冷下 2N Na〇H水溶液
を注加し、 1時間 45分攪拌した。 2規定塩酸をカ卩えて pH=6とし、析出物を濾過して、化 合物 12を褐色粉末として得た。収量 281mg(20%) Compound 11 (1.58 g, 9.80 mmol) was dissolved in pyridine (19 ml), methanesulfur chloride (4.5 5 ml, 58.8 mmol) was added, and the mixture was stirred at 60 ° C. for 2 hours and 20 minutes. Pyridine was distilled off under reduced pressure, extracted by adding water and ethyl acetate, washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crystals were dissolved in methanol (16 ml). Was added and stirred for 1 hour and 45 minutes. 2N hydrochloric acid was added to adjust the pH to 6, and the precipitate was filtered to obtain Compound 12 as a brown powder. Yield 281mg (20%)
'H-NMR (d -DMSO): 7.36(1H, dd, J = 8.4, 4.5Hz), 7.52(1H, s), 7.93(1H, d, J = 8.4 'H-NMR (d-DMSO): 7.36 (1H, dd, J = 8.4, 4.5Hz), 7.52 (1H, s), 7.93 (1H, d, J = 8.4
6 6
Hz), 8.54(1H, d, 4.5Hz), 12.69(1H, s). Hz), 8.54 (1H, d, 4.5Hz), 12.69 (1H, s).
(3) 12→13 (3) 12 → 13
化合物 12(27 4mg,1.91mmol)、アジ化ナトリウム (137mg、 2.10mmol)、塩化アンモニゥ ム (112mg、 2. lOmmol)をジメチルホルムアミド (3ml)中に懸濁させ、 115°Cにて 3時間 45 分攪拌した。反応液に冷却後水を加えて、析出物をろ過し、化合物 13を淡褐色結晶 として得た。収量 225mg(63%) Compound 12 (27 4 mg, 1.91 mmol), sodium azide (137 mg, 2.10 mmol), ammonium chloride (112 mg, 2. lOmmol) were suspended in dimethylformamide (3 ml) at 115 ° C for 3 hours 45 Stir for minutes. Water was added to the reaction solution after cooling, and the precipitate was filtered to obtain Compound 13 as light brown crystals. Yield 225 mg (63%)
(DMSOに不溶で、 NMRデータ-なし) (Insoluble in DMSO, no NMR data)
(4) 13→14 (4) 13 → 14
化合物 13(216mg,1.16mmol)をジメチルホルムアミド (3ml)中に溶解し、氷冷下にて水 素化ナトリウム (46mg、 1.1 6mmol)、トリフエニルメチルクロリド (323mg、 1.16mmol)を順 に加え、室温で 2時間攪拌した。水、酢酸ェチルを加え、不溶物を濾去して、濾液を 酢酸ェチルで抽出し、飽和食塩水で洗浄、無水硫酸ナトリウムで乾燥した。溶媒を留 去後、シリカゲルカラムクロマトグラフィー(へキサン:酢酸ェチル =2:1〜1:1)、化合 物 14を無色結晶として得た。収量 101mg (20%) Compound 13 (216 mg, 1.16 mmol) was dissolved in dimethylformamide (3 ml), and sodium hydride (46 mg, 1.16 mmol) and triphenylmethyl chloride (323 mg, 1.16 mmol) were sequentially added under ice cooling. Stir at room temperature for 2 hours. Water and ethyl acetate were added, insolubles were removed by filtration, and the filtrate was extracted with ethyl acetate, washed with saturated brine, and dried over anhydrous sodium sulfate. After the solvent was distilled off, silica gel column chromatography (hexane: ethyl acetate = 2: 1 to 1: 1), compound 14 was obtained as colorless crystals. Yield 101mg (20%)
'H-NMR (d -DMSO): 7.10-7.24(m, 8H), 7.40- 7.48(m, 9H), 7.82(1H, d, J = 8.1Hz), 'H-NMR (d-DMSO): 7.10-7.24 (m, 8H), 7.40-7.48 (m, 9H), 7.82 (1H, d, J = 8.1Hz),
6 6
8.40(1H, dd, 8.1, 1.1Hz), 12.23(1H, s). 8.40 (1H, dd, 8.1, 1.1Hz), 12.23 (1H, s).
(5) 14→8 (5) 14 → 8
化合物 9(153mg、 0.221mmol)をジクロロメタン (4ml)に懸濁させ、氷冷下炭酸水素ナト リウム水溶液 (28mg、 0.332mmolを水 4mlに溶解)を加え、ジクロロメタンで抽出し、硫酸 マグネシウムで乾燥した。溶媒を留去後、速やかに化合物 14(95mg、 0.221mmol)を加 えて、ジメチルホルムアミド (1.8ml)に溶解し、臭化ナトリウム (68mg、 0.664mmol)を加え て、室温で 16時間攪拌した。反応液を 5%食塩水 (20ml)攪拌中に注加し、析出した沈 殿を濾取した。沈殿を減圧乾燥して 4級塩を無定形粉末として得た。これを塩化メチ レン (l. lml)、ァニソール (0.19ml)に溶解し、 0°Cに冷却し、 TFA 0.56mlを加え、実施 例 41の (2)と同様の手法にて化合物 8を粉末として得た。収量 13mg(7%)
Ή-NMR (D20): 1.28(3H, t, J = 6.9Hz), 3.59, 3.66(2H, ABq, J = 17.3 Hz), 4.23(2H , q, J = 6.9 Hz), 5.22(1H, d, J = 4.8Hz), 5.42(2H, d, J = 6.0Hz), 5.80(1H, d. J = 4.8 Hz), 6.17(1H, dt, J = 15.8, 6.0Hz), 6.84(1H, d, J = 15.8Hz), 6.97(1H, s), 7.32 (2H, s), 7.57(1H, dd, J = 8.4, 6.0Hz), 8.43(1H, d, J = 8.4Hz), 8.44(1H, d, J = 6.0Hz). IR (KBr) cm— 3419, 1760, 1616, 1532, 1384, 1358, 1202, 1037. Compound 9 (153 mg, 0.221 mmol) was suspended in dichloromethane (4 ml), an aqueous sodium hydrogen carbonate solution (28 mg, 0.332 mmol dissolved in 4 ml of water) was added under ice cooling, extracted with dichloromethane, and dried over magnesium sulfate. . After the solvent was distilled off, compound 14 (95 mg, 0.221 mmol) was quickly added and dissolved in dimethylformamide (1.8 ml), sodium bromide (68 mg, 0.664 mmol) was added, and the mixture was stirred at room temperature for 16 hours. The reaction mixture was poured into 5% brine (20 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain a quaternary salt as an amorphous powder. This is dissolved in methylene chloride (l.lml) and anisole (0.19ml), cooled to 0 ° C, 0.56ml of TFA is added, and compound 8 is powdered in the same manner as in Example 41 (2). Got as. Yield 13 mg (7%) NMR-NMR (D20): 1.28 (3H, t, J = 6.9Hz), 3.59, 3.66 (2H, ABq, J = 17.3 Hz), 4.23 (2H, q, J = 6.9 Hz), 5.22 (1H, d , J = 4.8Hz), 5.42 (2H, d, J = 6.0Hz), 5.80 (1H, d. J = 4.8 Hz), 6.17 (1H, dt, J = 15.8, 6.0Hz), 6.84 (1H, d , J = 15.8Hz), 6.97 (1H, s), 7.32 (2H, s), 7.57 (1H, dd, J = 8.4, 6.0Hz), 8.43 (1H, d, J = 8.4Hz), 8.44 (1H , d, J = 6.0Hz). IR (KBr) cm— 3419, 1760, 1616, 1532, 1384, 1358, 1202, 1037.
MS(FAB): 644+ (M+H)+ MS (FAB): 644 + (M + H) +
元素分析 C H N O S Na- 5.3 H 0 - 1.9NaHCO Elemental analysis C H N O S Na- 5.3 H 0-1.9 NaHCO
25 11 11 5 2 2 3 25 11 11 5 2 2 3
計算値: C,35.95; H,3.87; N,17.14 (%) Calculated value: C, 35.95; H, 3.87; N, 17.14 (%)
実験値: C, 36.25; H,4.15; N,16.76 (%) Experimental value: C, 36.25; H, 4.15; N, 16.76 (%)
実施例 45 Example 45
[化 93] [Chemical 93]
19 19
(1) 20→19 (1) 20 → 19
化合物 20(156mg,1.50mmol)、アジ化ナトリウム (107mg、 1.65mmol)、塩化アンモニゥ ム (88mg、 1.65mmol)をジメチルホルムアミド (1.5ml)中に懸濁させ、 115°Cにて 2時間攪 拌した。無機塩をろ過し、ジメチルホルムアミド (1.5ml)で洗浄して、化合物 21のジメチ ルホルムアミド溶液を得た。化合物 9(1.038g、 1.50mmol)をジクロロメタン (10ml)に懸濁 させ、氷冷下炭酸水素ナトリウム水溶液 (189mg、 2.25mmolを水 10mlに溶解)を加え、 ジクロロメタンで抽出し、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメ チルホルムアミド (3ml)に溶解し、化合物 21のジメチルホルムアミド溶液と混合して、臭 化ナトリウム (463mg、 4.50mmol)を加えて、室温で 5時間攪拌した。反応液を 5%食塩
水 (50ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して 4級塩を無 定形粉末として得た。これを塩化メチレン (5.6ml)、ァニソール (0.939ml)に溶解し、 0°C に冷却し、 TFA 2.8mlを加え、実施例 41の (2)と同様の手法にて化合物 19を粉末とし て得た。収量 45mg(4%) Compound 20 (156 mg, 1.50 mmol), sodium azide (107 mg, 1.65 mmol), ammonium chloride (88 mg, 1.65 mmol) were suspended in dimethylformamide (1.5 ml) and stirred at 115 ° C for 2 hours. did. The inorganic salt was filtered and washed with dimethylformamide (1.5 ml) to obtain a dimethylformamide solution of compound 21. Compound 9 (1.038 g, 1.50 mmol) was suspended in dichloromethane (10 ml), aqueous sodium hydrogen carbonate solution (189 mg, 2.25 mmol dissolved in 10 ml of water) was added under ice-cooling, extracted with dichloromethane, and dried over magnesium sulfate. . After distilling off the solvent, it was immediately dissolved in dimethylformamide (3 ml), mixed with a dimethylformamide solution of compound 21, sodium bromide (463 mg, 4.50 mmol) was added, and the mixture was stirred at room temperature for 5 hours. 5% sodium chloride solution Water (50 ml) was added while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain a quaternary salt as an amorphous powder. This was dissolved in methylene chloride (5.6 ml) and anisole (0.939 ml), cooled to 0 ° C., 2.8 ml of TFA was added, and compound 19 was powdered in the same manner as (2) of Example 41. Obtained. Yield 45 mg (4%)
'H-NMR (D20): 1.29(3H, t, J = 7.1Hz), 3·66(2Η, s), 4.25(2H, q, J = 7.1 Hz), 5.27( 1H, d, J = 4.5Hz), 5.31(2H, d, J = 6.9Hz), 5.82(1H, d, J = 4.5Hz), 6.12(1H, dt, J = 15.9, 6.9Hz), 6.97(1H, s), 6.98(1H, d, J = 15.9Hz), 8.51(2H, d, J = 7.1Hz), 8.88(2H , d, J = 7.1Hz). 'H-NMR (D20): 1.29 (3H, t, J = 7.1Hz), 3.66 (2Η, s), 4.25 (2H, q, J = 7.1 Hz), 5.27 (1H, d, J = 4.5 Hz), 5.31 (2H, d, J = 6.9Hz), 5.82 (1H, d, J = 4.5Hz), 6.12 (1H, dt, J = 15.9, 6.9Hz), 6.97 (1H, s), 6.98 ( 1H, d, J = 15.9Hz), 8.51 (2H, d, J = 7.1Hz), 8.88 (2H, d, J = 7.1Hz).
IR (KBr) cm_1:3419, 1761, 1637, 1611, 1536, 1389, 1038. IR (KBr) cm _1 : 3419, 1761, 1637, 1611, 1536, 1389, 1038.
MS(FAB): 605+ (M+H)+ MS (FAB): 605+ (M + H) +
元素分析 C H N O S Na- 6.0 H O - 1.0NaHCO Elemental analysis C H N O S Na- 6.0 H O-1.0 NaHCO
23 21 10 5 2 2 3 23 21 10 5 2 2 3
計算値: C, 36.18; H,4.30; N,17.58; S, 8.05; Na, 5.77 (%) Calculated values: C, 36.18; H, 4.30; N, 17.58; S, 8.05; Na, 5.77 (%)
実験値: C, 36.10; H,4.37; N,17.58; S, 8.63; Na, 5.60 (%) Experimental values: C, 36.10; H, 4.37; N, 17.58; S, 8.63; Na, 5.60 (%)
実施例 46 Example 46
[化 94] [Chemical 94]
23 24 25 23 24 25
化合物 23(318mg,1.50mmol)をテトラヒドロフラン (3ml)中に溶解し、室温にてメタンス ルホンアミド (143mg,1.50mmol)、次いで DBU(0.224ml,1.50mmol)を加えた。室温で 2時 間攪拌した後、減圧濃縮し、水、 2規定塩酸で PH=4とした。さらに減圧濃縮して生じ た析出物をろ過、水洗して、化合物 24を淡褐色結晶として得た。収量 311mg(87%) 'H-NMR (d -DMSO): 3.33(3H, s), 7.36(1H, dd, J = 8.4, 4.8Hz), 7.52(1H, s), 7.97(1 Compound 23 (318 mg, 1.50 mmol) was dissolved in tetrahydrofuran (3 ml), and methanesulfonamide (143 mg, 1.50 mmol) and then DBU (0.224 ml, 1.50 mmol) were added at room temperature. After stirring two hours at room temperature, concentrated under reduced pressure, water was set to P H = 4 with 2N hydrochloric acid. Further, the precipitate formed by concentration under reduced pressure was filtered and washed with water to obtain Compound 24 as light brown crystals. Yield 311mg (87%) 'H-NMR (d-DMSO): 3.33 (3H, s), 7.36 (1H, dd, J = 8.4, 4.8Hz), 7.52 (1H, s), 7.97 (1
6 6
H, d, J = 8.4Hz), 8.51(1H, dd, J = 4.8, 1.4Hz), 12.27(1H, brs). H, d, J = 8.4Hz), 8.51 (1H, dd, J = 4.8, 1.4Hz), 12.27 (1H, brs).
(2) 24→25 (2) 24 → 25
化合物 24(286mg,1.20mmol)をメタノール中に懸濁し、ナトリウムメトキシドメタノール 溶液を pH=7.3となるまで滴下して、得られた溶液を減圧濃縮して、化合物 25を褐色 粉末として得た。収量 323mg(103%)。 Compound 24 (286 mg, 1.20 mmol) was suspended in methanol, a sodium methoxide methanol solution was added dropwise until pH = 7.3, and the resulting solution was concentrated under reduced pressure to obtain compound 25 as a brown powder. Yield 323 mg (103%).
'H-NMR (d -DMSO): 2.92(3H, s), 6.82(1H, s), 7.09(1H, dd, J = 8.3, 4.5Hz), 7.73(1 'H-NMR (d-DMSO): 2.92 (3H, s), 6.82 (1H, s), 7.09 (1H, dd, J = 8.3, 4.5Hz), 7.73 (1
6 6
H, d, J = 8.3Hz), 8.30(1H, dd, J = 4.5, 1.5Hz), 11.33(1H, brs). H, d, J = 8.3Hz), 8.30 (1H, dd, J = 4.5, 1.5Hz), 11.33 (1H, brs).
(3) 25→26 (3) 25 → 26
化合物 9(809mg、 1.20mmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナト リウム水溶液 (151mg、 0.332mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (2.4ml)に 溶解し、化合物 25(312mg、 1.20mmol)と混合し、臭化ナトリウム (370mg、 3.60mmol)を 加えて、室温で 2時間 30分攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、析 出した沈殿を濾取した。沈殿を減圧乾燥して化合物 26を無定形粉末として得た。収 量 857mg(85%) Compound 9 (809 mg, 1.20 mmol) is suspended in dichloromethane (10 ml), and an aqueous sodium hydrogen carbonate solution (151 mg, 0.332 mmol is dissolved in 10 ml of water) is added under ice cooling, extracted with dichloromethane, and dried over magnesium sulfate. did. After distilling off the solvent, immediately dissolve in dimethylformamide (2.4 ml), mix with compound 25 (312 mg, 1.20 mmol), add sodium bromide (370 mg, 3.60 mmol), and stir at room temperature for 2 hours 30 minutes. did. The reaction solution was poured into 5% brine (30 ml) with stirring, and the precipitated precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 26 as an amorphous powder. Yield 857mg (85%)
'H-NMR (d -DMSO): 1.21(3H, t, J = 6.9Hz), 2.94(3H, s), 3.61, 3.89(2H, ABq, J = 'H-NMR (d-DMSO): 1.21 (3H, t, J = 6.9Hz), 2.94 (3H, s), 3.61, 3.89 (2H, ABq, J =
6 6
17.7 Hz), 4.09(2H, q, J = 6.9 Hz), 5.26(1H, d, J = 5.0Hz), 5.46(2H, d, J = 5.7Hz), 5.89(1H, dd, J = 8.3, 5.0Hz), 6.43(1H, dt, J = 16.2, 5.7Hz), 6.74(1H, s), 6.76(1H, d , J = 16.2Hz), 6.91(1H, s), 7.20_7.53(m, 13H), 7.65(1H, dd, J = 8.1, 5.9Hz), 8.43(1 H, d, J = 8.1Hz), 8.66(1H, d, J = 5.9Hz), 9.64(1H, d, J = 8.3Hz), 13.0(1H, brs). 17.7 Hz), 4.09 (2H, q, J = 6.9 Hz), 5.26 (1H, d, J = 5.0 Hz), 5.46 (2H, d, J = 5.7 Hz), 5.89 (1H, dd, J = 8.3, 5.0Hz), 6.43 (1H, dt, J = 16.2, 5.7Hz), 6.74 (1H, s), 6.76 (1H, d, J = 16.2Hz), 6.91 (1H, s), 7.20_7.53 (m , 13H), 7.65 (1H, dd, J = 8.1, 5.9Hz), 8.43 (1 H, d, J = 8.1Hz), 8.66 (1H, d, J = 5.9Hz), 9.64 (1H, d, J = 8.3Hz), 13.0 (1H, brs).
(4) 26→22 (4) 26 → 22
化合物 26(844mg,1.00mmol)を塩化メチレン (5ml)とァニソール (0.84ml)に溶解し、 0°C
に冷却し、 TFA 2.5mlを加え、実施例 41の (2)と同様の手法にて、化合物 22を粉末とし て得た。収量 479mg(59%) Compound 26 (844 mg, 1.00 mmol) was dissolved in methylene chloride (5 ml) and anisole (0.84 ml), and 0 ° C After cooling to 2.5 mL of TFA, Compound 22 was obtained as a powder in the same manner as in Example 41 (2). Yield 479mg (59%)
'H-NMR (d -DMSO): 1.21(3H, t, J = 6.9Hz), 2.94(3H, s), 3.61, 3.89(2H, ABq, J = 'H-NMR (d-DMSO): 1.21 (3H, t, J = 6.9Hz), 2.94 (3H, s), 3.61, 3.89 (2H, ABq, J =
17.7 Hz), 4.08(2H, q, J = 6.9 Hz), 5.02(1H, d, J = 5.0Hz), 5.43(2H, d, J = 7.2Hz), 5.57(1H, dd, J = 8.0, 5.0Hz), 5.87(1H, dt, J = 15.6, 7.2Hz), 6.71(1H, s), 7.21(2H, s) , 7.27(1H, d, J = 15.6Hz), 7.30(1H, s), 7.70(1H, dd, J = 8.1, 6.0Hz), 8.42(1H, d, J = 8.1Hz), 8.73(1H, d, J = 6.0Hz), 9.51(1H, d, J = 8.0Hz). 17.7 Hz), 4.08 (2H, q, J = 6.9 Hz), 5.02 (1H, d, J = 5.0 Hz), 5.43 (2H, d, J = 7.2 Hz), 5.57 (1H, dd, J = 8.0, 5.0Hz), 5.87 (1H, dt, J = 15.6, 7.2Hz), 6.71 (1H, s), 7.21 (2H, s), 7.27 (1H, d, J = 15.6Hz), 7.30 (1H, s) , 7.70 (1H, dd, J = 8.1, 6.0Hz), 8.42 (1H, d, J = 8.1Hz), 8.73 (1H, d, J = 6.0Hz), 9.51 (1H, d, J = 8.0Hz) .
IR (KBr) cm_1:3417, 1764, 1666, 1594, 1533, 1389, 1362, 1300, 1115. IR (KBr) cm _1 : 3417, 1764, 1666, 1594, 1533, 1389, 1362, 1300, 1115.
MS(FAB): 697+ (M+H)+ MS (FAB): 697+ (M + H) +
元素分析 c H N O S Na- 5.4 H O - 0.1NaHCO Elemental analysis c H N O S Na- 5.4 H O-0.1 NaHCO
計算値: C,39.07; H,4.51; N,13.96; S, 11.99; Na 3.27 (%) Calculated values: C, 39.07; H, 4.51; N, 13.96; S, 11.99; Na 3.27 (%)
実験値: C,39.02; H,4.22; N,13.94; S, 12.09; Na 3.22 (%) Experimental value: C, 39.02; H, 4.22; N, 13.94; S, 12.09; Na 3.22 (%)
実施例 47 Example 47
[化 95]
[Chemical 95]
(1) 23→28 (1) 23 → 28
化合物 23(340mg,1.60mmol)をテトラヒドロフラン (4ml)中に溶解し、室温にて Boc_sulf amide(315mg, 1.60mmol)、次いで DBU(0.240ml,1.60mmol)を加えた。室温で 1時間 30 分、 50°Cで 15時間攪拌した後、減圧濃縮し、水、 2規定塩酸で pH=4とした。溶液を HP -20SSカラムクロマトグラフィーに付し、望むフラクションを減圧濃縮、次いで凍結乾燥 し、化合物 28を無色粉末として得た。収量 106mg(20%) Compound 23 (340 mg, 1.60 mmol) was dissolved in tetrahydrofuran (4 ml), and Boc_sulfamide (315 mg, 1.60 mmol) and then DBU (0.240 ml, 1.60 mmol) were added at room temperature. The mixture was stirred at room temperature for 1 hour and 30 minutes and at 50 ° C for 15 hours, then concentrated under reduced pressure, and adjusted to pH = 4 with water and 2N hydrochloric acid. The solution was subjected to HP-20SS column chromatography, and the desired fraction was concentrated under reduced pressure and then lyophilized to obtain Compound 28 as a colorless powder. Yield 106 mg (20%)
(2) 28→29 (2) 28 → 29
化合物 28(101mg,0.296mmol)をメタノール中に懸濁し、ナトリウムメトキシドメタノール 溶液を pH=7.7となるまで滴下して、得られた溶液を減圧濃縮して、 28のナトリウム塩を 得た。化合物 9(199mg、 0.296mmol)をジクロロメタン (6ml)に懸濁させ、氷冷下炭酸水 素ナトリウム水溶液 (37.3mg、 0.443mmolを水 6mlに溶解)を加え、ジクロロメタンで抽出 し、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (lml) に溶解し、 28のナトリウム塩と混合し、臭化ナトリウム (208mg、 0.887mmol)を加えて、室
温で 2時間 35分攪拌した。反応液を 5%食塩水 (15ml)攪拌中に注加し、析出した沈殿 を濾取した。沈殿を減圧乾燥して化合物 29を無定形粉末として得た。収量 208mg(75 %) Compound 28 (101 mg, 0.296 mmol) was suspended in methanol, a sodium methoxide methanol solution was added dropwise until pH = 7.7, and the resulting solution was concentrated under reduced pressure to obtain 28 sodium salt. Suspend compound 9 (199 mg, 0.296 mmol) in dichloromethane (6 ml), add aqueous sodium hydrogen carbonate solution (37.3 mg, 0.443 mmol dissolved in 6 ml of water) under ice-cooling, extract with dichloromethane, and dry over magnesium sulfate. did. After distilling off the solvent, immediately dissolve in dimethylformamide (lml), mix with 28 sodium salt, add sodium bromide (208mg, 0.887mmol), Stir at temperature for 2 hours 35 minutes. The reaction solution was poured into 5% brine (15 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 29 as an amorphous powder. Yield 208 mg (75%)
'H-NMR (d -DMSO): 1.21(3H, t, J = 7.1Hz), 1.34(9H, s), 3.61 , 3.88(2H, ABq, J = 'H-NMR (d-DMSO): 1.21 (3H, t, J = 7.1Hz), 1.34 (9H, s), 3.61, 3.88 (2H, ABq, J =
17.3 Hz), 4.08(2H, q, J = 7.1 Hz), 5.25(1H, d, J = 4.8Hz), 5.45(2H, d, J = 6.0Hz), 5.87(1H, dd, J = 8.1, 4.8Hz), 6.42(1H, dt, J = 15.9, 6.0Hz), 6.73(1H, s), 6.75(1H, d , J = 15.9Hz), 6.90(1H, s), 7.15_7.53(m, 13H), 7.66(1H, dd, J = 8.3, 5.7Hz), 8.44(1 H, d, J = 8.3Hz), 8.66(1H, d, J = 5.7Hz), 9.61( 1H, d, J = 8.1Hz), 9.66(1H, s). (3) 29→27 17.3 Hz), 4.08 (2H, q, J = 7.1 Hz), 5.25 (1H, d, J = 4.8 Hz), 5.45 (2H, d, J = 6.0 Hz), 5.87 (1H, dd, J = 8.1, 4.8Hz), 6.42 (1H, dt, J = 15.9, 6.0Hz), 6.73 (1H, s), 6.75 (1H, d, J = 15.9Hz), 6.90 (1H, s), 7.15_7.53 (m , 13H), 7.66 (1H, dd, J = 8.3, 5.7Hz), 8.44 (1 H, d, J = 8.3Hz), 8.66 (1H, d, J = 5.7Hz), 9.61 (1H, d, J = 8.1Hz), 9.66 (1H, s). (3) 29 → 27
化合物 29(201mg,0.214mmol)を塩化メチレン (1.2ml)とァニソール (0.20ml)に溶解し、 -30°Cに冷却し、 2M塩化アルミニウムニトロメタン溶液 0.5mlを加えた。混合液を _30°C で 45分攪拌した後、ジイソプロピルエーテル 10ml/0.2N塩酸 10mlに氷冷下で攪拌し ながら注加した。析出した沈殿物を濾取し、 NaHCO水で溶解させた。溶液を HP-20S Compound 29 (201 mg, 0.214 mmol) was dissolved in methylene chloride (1.2 ml) and anisole (0.20 ml), cooled to −30 ° C., and 0.5 ml of 2M aluminum chloride nitromethane solution was added. The mixture was stirred at _30 ° C for 45 minutes and then poured into 10 ml of diisopropyl ether / 10 ml of 0.2N hydrochloric acid while stirring under ice cooling. The deposited precipitate was collected by filtration and dissolved with aqueous NaHCO. HP-20S solution
Sカラムクロマトグラフィーに付し、水 -ァセトニトリルで溶離した。また濾液の水層も同 様に精製した.両者を併せて NaHCO水に溶解させ、再度 HP-20SSカラムクロマトグ ラフィ一に付し、水 -ァセトニトリルで溶離した。所望の化合物を含むフラクションを減 圧下濃縮し、濃縮液を凍結乾燥して化合物 27を粉末として得た。収量 30mg(17%) 'H-NMR (d -DMSO): 1.21(3H, t, J = 6.9Hz), 3.43, 3.49(2H, ABq, J = 16.5 Hz), 4.S column chromatography and elution with water-acetonitrile. The aqueous layer of the filtrate was purified in the same manner. Both were dissolved in NaHCO aqueous solution, subjected to HP-20SS column chromatography again and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 27 as a powder. Yield 30 mg (17%) 'H-NMR (d-DMSO): 1.21 (3H, t, J = 6.9 Hz), 3.43, 3.49 (2H, ABq, J = 16.5 Hz), 4.
08(2H, q, J = 6.9 Hz), 5.01(1H, d, J = 4.8Hz), 5.36(2H, d, J = 6.0Hz), 5.57(1H, dd, J = 8.1, 4.8Hz), 5.77(2H, s), 5.86(1H, dt, J = 16.1, 6.0Hz), 6.70(1H, s), 7.21(2H, s) , 7.26(1H, d, J = 16.1Hz), 7.52(1H, brs), 8.34(1H, d, J = 7.2Hz), 8.59(1H, brs), 9.5 2(1H, d, J = 8.1Hz). 08 (2H, q, J = 6.9 Hz), 5.01 (1H, d, J = 4.8Hz), 5.36 (2H, d, J = 6.0Hz), 5.57 (1H, dd, J = 8.1, 4.8Hz), 5.77 (2H, s), 5.86 (1H, dt, J = 16.1, 6.0Hz), 6.70 (1H, s), 7.21 (2H, s), 7.26 (1H, d, J = 16.1Hz), 7.52 (1H , brs), 8.34 (1H, d, J = 7.2Hz), 8.59 (1H, brs), 9.5 2 (1H, d, J = 8.1Hz).
IR (KBr) cm— 3418, 1761, 1595, 1533, 1388, 1305, 1300, 1127, 1036, 770. IR (KBr) cm— 3418, 1761, 1595, 1533, 1388, 1305, 1300, 1127, 1036, 770.
MS(FAB): 698+ (M+H)+ MS (FAB): 698+ (M + H) +
元素分析 c H N O S Na- 5.0 H O - 0.6NaHCO Elemental analysis c H N O S Na- 5.0 H O-0.6 NaHCO
計算値: C, 36.68; H,4.16; N, 15.04; S, 11.48; Na 4.39 (%) Calculated values: C, 36.68; H, 4.16; N, 15.04; S, 11.48; Na 4.39 (%)
実験値: C, 36.67; H,4.04; N,15.15; S, 11.56; Na 4.22 (%) Experimental values: C, 36.67; H, 4.04; N, 15.15; S, 11.56; Na 4.22 (%)
実施例 49
[化 96] Example 49 [Chemical 96]
Na+ Na +
41 41
(1) 31→38 (1) 31 → 38
化合物 31(1.28g,5.46mmol)をエタノール (10ml)中に懸濁し、室温にて 2N水酸化ナト リウム水溶液 (13.7ml,27.4mmol)を滴下した。室温にて 1時間 20分攪拌し、濃塩酸を加 えて pH=3.5に調整した。析出物を濾取し、減圧乾燥して化合物 38を淡褐色結晶とし て得た。収量 986mg(88%) Compound 31 (1.28 g, 5.46 mmol) was suspended in ethanol (10 ml), and 2N aqueous sodium hydroxide solution (13.7 ml, 27.4 mmol) was added dropwise at room temperature. The mixture was stirred at room temperature for 1 hour and 20 minutes, and concentrated hydrochloric acid was added to adjust to pH = 3.5. The precipitate was collected by filtration and dried under reduced pressure to obtain compound 38 as light brown crystals. Yield 986 mg (88%)
'H-NMR (d -DMSO): 7.96(2H, d, J = 5.6 Hz), 8.68(2H, d, J = 5.6 Hz), 8.79(1H, s). 'H-NMR (d-DMSO): 7.96 (2H, d, J = 5.6 Hz), 8.68 (2H, d, J = 5.6 Hz), 8.79 (1H, s).
(2) 38→39 (2) 38 → 39
化合物 38(975mg,4.73mmol)をジメチルホルムアミド (10ml)に懸濁させ、室温にて力 ルポニルジイミダゾール (l. l lg,5.23mmol)を加えた。室温で 3時間攪拌し、反応液を 酢酸ェチル (30ml)に注加した。氷冷下撹拌し、生じた沈殿を濾取して、減圧乾燥し、 化合物 39を淡褐色結晶として得た。収量 937mg(77%)
Ή-NMR (d -DMSO): 7.23(1H, s), 8.06(2H, d, J = 6.0 Hz), 8.19(1H, s), 8.74(2H, d,Compound 38 (975 mg, 4.73 mmol) was suspended in dimethylformamide (10 ml), and force sulfonyldiimidazole (l. L lg, 5.23 mmol) was added at room temperature. The mixture was stirred at room temperature for 3 hours, and the reaction solution was poured into ethyl acetate (30 ml). The mixture was stirred under ice cooling, and the resulting precipitate was collected by filtration and dried under reduced pressure to obtain Compound 39 as light brown crystals. Yield 937 mg (77%) Ή-NMR (d-DMSO): 7.23 (1H, s), 8.06 (2H, d, J = 6.0 Hz), 8.19 (1H, s), 8.74 (2H, d,
6 6
J = 6.0 Hz), 9.08(1H, s), 9.11(1H, s). J = 6.0 Hz), 9.08 (1H, s), 9.11 (1H, s).
(3) 39→40 (3) 39 → 40
化合物 39(30611¾,1.2011111101)ょり実施例46の(1)と同様の手法にて化合物40を淡褐 色結晶として得た。収量 282mg(83%) Compound 39 (30611¾, 1.2011111101) was obtained as pale brown crystals by the same method as in Example 46 (1). Yield 282 mg (83%)
'H-NMR (d -DMSO): 3 .37(3H, s), 8·37(2Η, d, J = 5.6 Hz), 8.83(2H, d, J = 5.6 Hz) 'H-NMR (d-DMSO): 3.37 (3H, s), 8.37 (2Η, d, J = 5.6 Hz), 8.83 (2H, d, J = 5.6 Hz)
6 6
, 8.79(1H, s). , 8.79 (1H, s).
(4) 40→41 (4) 40 → 41
化合物 40(276mg,0.976mmol)をメタノール中に懸濁し、ナトリウムメトキシドメタノール 溶液を pH=7.5となるまで滴下して、得られた溶液を減圧濃縮して、 40のナトリウム塩を 得た。化合物 9(658mg、 0.976mmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水 素ナトリウム水溶液 (123mg、 1.46mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出 し、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (2ml) に溶解し、 40のナトリウム塩と混合し、臭化ナトリウム (301mg,2.92mmol)を加えて、室 温で 2時間 10分攪拌した。反応液を 5 %食塩水 (30ml)攪拌中に注加し、析出した沈殿 を濾取した。沈殿を減圧乾燥して化合物 41を無定形粉末として得た。収量 783mg(91 %) Compound 40 (276 mg, 0.976 mmol) was suspended in methanol, a sodium methoxide methanol solution was added dropwise until pH = 7.5, and the resulting solution was concentrated under reduced pressure to obtain 40 sodium salt. Compound 9 (658 mg, 0.976 mmol) was suspended in dichloromethane (10 ml), and an aqueous sodium hydrogen carbonate solution (123 mg, 1.46 mmol dissolved in 10 ml of water) was added under ice cooling, extracted with dichloromethane, and dried over magnesium sulfate. . After distilling off the solvent, it was quickly dissolved in dimethylformamide (2 ml), mixed with 40 sodium salt, sodium bromide (301 mg, 2.92 mmol) was added, and the mixture was stirred at room temperature for 2 hours and 10 minutes. The reaction mixture was poured into 5% brine (30 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 41 as an amorphous powder. Yield 783 mg (91%)
'H-NMR (d -DMSO): 1.21(3H, t, J = 7.2Hz), 2.89(3H, s), 3.63, 3.89(2H, ABq, J = 'H-NMR (d-DMSO): 1.21 (3H, t, J = 7.2Hz), 2.89 (3H, s), 3.63, 3.89 (2H, ABq, J =
6 6
17.9 Hz), 4.08(2H, q, J = 7.2 Hz), 5.25(2H, d, J = 6.9Hz), 5.27(1H, d, J = 5.1Hz), 5.90(1H, dd, J = 8.4, 5.1Hz), 6.41(1H, dt, J = 15.8, 6.9Hz), 6.73(1H, s), 6.86(1H, d , J = 15.8Hz), 6.90(1H, s ), 7.21(2H, s), 7.23- 7.50(m, 10H), 8.57(2H, d, J = 7.1Hz), 8.95(2H, d, J = 7.1Hz), 9.00(1H, s), 9.62(1H, d, J = 8.4Hz). 17.9 Hz), 4.08 (2H, q, J = 7.2 Hz), 5.25 (2H, d, J = 6.9 Hz), 5.27 (1H, d, J = 5.1 Hz), 5.90 (1H, dd, J = 8.4, 5.1Hz), 6.41 (1H, dt, J = 15.8, 6.9Hz), 6.73 (1H, s), 6.86 (1H, d, J = 15.8Hz), 6.90 (1H, s), 7.21 (2H, s) , 7.23- 7.50 (m, 10H), 8.57 (2H, d, J = 7.1Hz), 8.95 (2H, d, J = 7.1Hz), 9.00 (1H, s), 9.62 (1H, d, J = 8.4 Hz).
(5) 41→37 (5) 41 → 37
化合物 41(773mg,0.873mmol)を塩化メチレン (4.6ml)とァニソール (0.77ml)に溶解し、 0°Cに冷却し、 TFA 2.3mlをカ卩え、実施例 41の (2)と同様の手法にて、化合物 37を粉末 として得た。収量 387mg(54%) Compound 41 (773 mg, 0.873 mmol) was dissolved in methylene chloride (4.6 ml) and anisole (0.77 ml), cooled to 0 ° C., and 2.3 ml of TFA was added, as in (2) of Example 41. By the procedure, compound 37 was obtained as a powder. Yield 387mg (54%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.1Hz), 2.90(3H, s), 3.43, 3.51(2H, ABq, J = 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.1Hz), 2.90 (3H, s), 3.43, 3.51 (2H, ABq, J =
6 6
16.4 Hz), 4.09(2H, q, J = 7.1 Hz), 5.05(1H, d, J = 4.8Hz), 5.26(2H, d, J = 6.9Hz),
5.60(1H, dd, J = 8.4, 4.8Hz), 5.87(1H, dt, J = 16.1, 6.9Hz), 6.72(1H, s), 7.21(2H, s) , 7.30(1H, d, J = 16.1 Hz), 8.58(2H, d, J = 7.2Hz), 8.98(1H, s), 9.02(2H, d, J = 7.2 Hz), 9.53(1H, d, J = 8.4Hz). 16.4 Hz), 4.09 (2H, q, J = 7.1 Hz), 5.05 (1H, d, J = 4.8 Hz), 5.26 (2H, d, J = 6.9 Hz), 5.60 (1H, dd, J = 8.4, 4.8Hz), 5.87 (1H, dt, J = 16.1, 6.9Hz), 6.72 (1H, s), 7.21 (2H, s), 7.30 (1H, d, J = 16.1 Hz), 8.58 (2H, d, J = 7.2 Hz), 8.98 (1H, s), 9.02 (2H, d, J = 7.2 Hz), 9.53 (1H, d, J = 8.4 Hz).
IR (KBr) cm_1:3410, 1765, 1636, 1601, 1531, 1387, 1345, 1257, 1125, 1034, 969.IR (KBr) cm _1 : 3410, 1765, 1636, 1601, 1531, 1387, 1345, 1257, 1125, 1034, 969.
MS(ESI): 719+ (M-Na+2H)+ MS (ESI): 719 + (M-Na + 2H) +
元素分析 C H N O S Na-4.4 H O Elemental analysis C H N O S Na-4.4 H O
計算値: C,39.54; H,4.15; N,13.66; S, 15.64; Na 2.80 (%) Calculated values: C, 39.54; H, 4.15; N, 13.66; S, 15.64; Na 2.80 (%)
実験値: C39.54; Η,3·99; N,13.79; S, 15.52; Na 3.01 (%) Experimental value: C39.54; Η, 3.99; N, 13.79; S, 15.52; Na 3.01 (%)
実施例 50 Example 50
[化 97] [Chemical 97]
(1) 43→44 (1) 43 → 44
化合物 9(675mg、 l.OOmmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナト リウム水溶液 (126mg、 1.50mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (2ml)に溶 解し、化合物 43(455mg、 l.OOmmol)と混合し、臭化ナトリウム (309mg、 3.00mmol)を加 えて、室温で 5時間 30分攪拌した。反応液を 5%食塩水 (40ml)攪拌中に注加し、析出 した沈殿を濾取した。沈殿を減圧乾燥して化合物 44を無定形粉末として得た。収量 9
61mg(84%) Compound 9 (675 mg, l.OOmmol) is suspended in dichloromethane (10 ml), aqueous sodium hydrogen carbonate solution (126 mg, 1.50 mmol dissolved in 10 ml of water) is added under ice cooling, extracted with dichloromethane, and magnesium sulfate is added. Dried. After distilling off the solvent, quickly dissolve in dimethylformamide (2 ml), mix with compound 43 (455 mg, l.OOmmol), add sodium bromide (309 mg, 3.00 mmol), and at room temperature for 5 hours 30 minutes. Stir. The reaction solution was poured into 5% brine (40 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 44 as an amorphous powder. Yield 9 61mg (84%)
'H-NMR (d -DMSO): 1.23(3H, t, J = 6.9Hz), 3.64, 3.90(2H, ABq, J = 17.1 Hz), 3. 'H-NMR (d-DMSO): 1.23 (3H, t, J = 6.9Hz), 3.64, 3.90 (2H, ABq, J = 17.1 Hz), 3.
74(3H, s), 3.76(3H, s), 4.10(2H, q, J = 6.9Hz), 5.18- 5.30(7H, m), 5.91(1H, dd, J = 8.3, 4.8Hz), 6.42(1H, dt, J = 16.2, 7.2Hz), 6.74(1H, s), 6·86_6·94(7Η, m), 7.20-7.5 4(16H, m), 8.28(1H, dd, J = 8.9, 2.3Hz), 8.33(1H, d, J = 2.3H z), 8.49(2H, d, J = 7. 2Hz), 8.92(2H, d, J = 7.2Hz), 9.64(1H, d, J = 8.3Hz). 74 (3H, s), 3.76 (3H, s), 4.10 (2H, q, J = 6.9Hz), 5.18-5.30 (7H, m), 5.91 (1H, dd, J = 8.3, 4.8Hz), 6.42 (1H, dt, J = 16.2, 7.2Hz), 6.74 (1H, s), 6.86_6.94 (7Η, m), 7.20-7.5 4 (16H, m), 8.28 (1H, dd, J = 8.9 , 2.3Hz), 8.33 (1H, d, J = 2.3H z), 8.49 (2H, d, J = 7.2 Hz), 8.92 (2H, d, J = 7.2Hz), 9.64 (1H, d, J = 8.3Hz).
(2) 44→42 (2) 44 → 42
化合物 44(945mg,0.831mmol)を塩化メチレン (10ml)とァニソール (0.945ml)に溶解し、 -30°Cに冷却し、 2M塩化アルミニウムニトロメタン溶液 4.2mlを加えた。混合液を _30°C で 45分攪拌した後、ジイソプロピルエーテル 50ml/0.2N塩酸 50mlに氷冷下で攪拌し ながら注加した。析出した沈殿物と、濾液の水層を混合し、ァセトニトリルをカ卩えて溶 解させた。 HP-20SSを加えて減圧濃縮し、 HP-20SSカラムクロマトグラフィーに付して 、水-ァセトニトリルで溶離した。 目的のフラクションを減圧濃縮し、 NaHCO水で pH=7 Compound 44 (945 mg, 0.831 mmol) was dissolved in methylene chloride (10 ml) and anisole (0.945 ml), cooled to −30 ° C., and 4.2 ml of 2M aluminum chloride nitromethane solution was added. The mixture was stirred at _30 ° C for 45 minutes and then poured into 50 ml of diisopropyl ether / 50 ml of 0.2N hydrochloric acid while stirring under ice cooling. The deposited precipitate and the aqueous layer of the filtrate were mixed, and acetonitrile was dissolved to dissolve. HP-20SS was added and the mixture was concentrated under reduced pressure, subjected to HP-20SS column chromatography and eluted with water-acetonitrile. Concentrate the desired fraction under reduced pressure and pH = 7 with aqueous NaHCO solution.
.8として溶解した。これの溶液を再び HP-20SSカラムクロマトグラフィーに付し、水-ァ セトニトリルで溶離した。所望の化合物を含むフラクションを減圧下濃縮し、濃縮液を 凍結乾燥して化合物 42を粉末として得た。収量 274mg(43%) Dissolved as .8. This solution was again subjected to HP-20SS column chromatography and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 42 as a powder. Yield 274 mg (43%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.42, 3.49(2H, ABq, J = 17.1Hz), 4.1 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.42, 3.49 (2H, ABq, J = 17.1Hz), 4.1
9(2H, q, J = 6.9Hz), 5.04(1H, d , J = 4.8Hz), 5.16(2H, d, J = 7.1Hz), 5.59(1H, dd, J = 8.0, 4.8Hz), 5.83(1H, dt, J = 15.9, 7.1Hz), 6.71(1H, s), 6.78(1H, d, J = 8.7Hz), 7 .21(2H, s), 7.27(1H, d, J = 15.9Hz), 7.95(1H, dd, J = 8.7, 2.7Hz), 8.30(2H, d, J = 7. 2Hz), 8.38(1H, d, J = 2.7Hz), 8.74(2H, d, J = 7.2Hz), 9.53(1H, d, J = 8.0Hz). 9 (2H, q, J = 6.9Hz), 5.04 (1H, d, J = 4.8Hz), 5.16 (2H, d, J = 7.1Hz), 5.59 (1H, dd, J = 8.0, 4.8Hz), 5.83 (1H, dt, J = 15.9, 7.1Hz), 6.71 (1H, s), 6.78 (1H, d, J = 8.7Hz), 7.21 (2H, s), 7.27 (1H, d, J = 15.9Hz), 7.95 (1H, dd, J = 8.7, 2.7Hz), 8.30 (2H, d, J = 7.2Hz), 8.38 (1H, d, J = 2.7Hz), 8.74 (2H, d, J = 7.2Hz), 9.53 (1H, d, J = 8.0Hz).
IR (KBr) cm— 3421, 1764, 1627, 1601, 1533, 1488, 1387, 1300, 1159, 1036, 829. MS(FAB): 673+ (M- Na+2H)+ IR (KBr) cm— 3421, 1764, 1627, 1601, 1533, 1488, 1387, 1300, 1159, 1036, 829. MS (FAB): 673+ (M- Na + 2H) +
元素分析 c H N O S Na-4.7 H O - 0.2NaHCO Elemental analysis c H N O S Na-4.7 H O-0.2NaHCO
計算値: C,39.47; H,4.16; N,15.22; S, 13.06; Na 3.75 (%) Calculated value: C, 39.47; H, 4.16; N, 15.22; S, 13.06; Na 3.75 (%)
実験値: C39.44; H,4.01; N,15.17; S, 13.00; Na 3.78 (%) Experimental value: C39.44; H, 4.01; N, 15.17; S, 13.00; Na 3.78 (%)
実施例 52 Example 52
[化 98]
[Chemical 98]
(1) 43→51 (1) 43 → 51
化合物 50(765mg,1.06mmol)、化合物 43(483mg,1.06mmol)をジメチルホルムアミド (2. 3ml),ジメチルスルホキシド (2.3ml)の混液に懸濁させ、臭化ナトリウム (328mg,3.18mm ol)を加えた。室温で 5時間 40分撹拌後、反応液を 5%食塩水 (30ml)攪拌中に注加し、 析出した沈殿を濾取した。沈殿を減圧乾燥して化合物 51を無定形粉末として得た。 収量 1.22g(94%) Compound 50 (765 mg, 1.06 mmol) and compound 43 (483 mg, 1.06 mmol) were suspended in a mixed solution of dimethylformamide (2.3 ml) and dimethyl sulfoxide (2.3 ml), and sodium bromide (328 mg, 3.18 mmol) was suspended. added. After stirring at room temperature for 5 hours and 40 minutes, the reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 51 as an amorphous powder. Yield 1.22g (94%)
'H-NMR (d -DMSO): 1.03(3H, t, J二 7.2Hz), 1.47(9H, s), 2.22(2H, sept, J = 7.2Hz 'H-NMR (d-DMSO): 1.03 (3H, t, J 2 7.2Hz), 1.47 (9H, s), 2.22 (2H, sept, J = 7.2Hz
6 6
), 3.66, 3.91(2H, ABq, J = 17.4 Hz), 3.75(3H, s), 3.76(3H, s), 5.15_5.30(7H, m), 5. 88(1H, dd, J = 7.2, 5.4Hz), 6.30 - 6.45(1H, m), 6.36(1H, t, J = 7.2Hz), 6.77(1H, s), 6.86-6.94(7H, m), 7.20-7. 58(14H, m), 8.28(1H, dd, J = 9.0, 2.4Hz), 8.34(1H, d, J = 2.4Hz), 8.49(2H, d, J = 7.2Hz), 8.93(2H, d, J = 7.2Hz), 9.39(1H, d, J = 7.2Hz), 1 1.5(1H, brs). ), 3.66, 3.91 (2H, ABq, J = 17.4 Hz), 3.75 (3H, s), 3.76 (3H, s), 5.15_5.30 (7H, m), 5.88 (1H, dd, J = 7.2, 5.4Hz), 6.30-6.45 (1H, m), 6.36 (1H, t, J = 7.2Hz), 6.77 (1H, s), 6.86-6.94 (7H, m), 7.20-7. 58 (14H , m), 8.28 (1H, dd, J = 9.0, 2.4Hz), 8.34 (1H, d, J = 2.4Hz), 8.49 (2H, d, J = 7.2Hz), 8.93 (2H, d, J = 7.2Hz), 9.39 (1H, d, J = 7.2Hz), 1 1.5 (1H, brs).
(2) 51→49 (2) 51 → 49
化合物 51(1.21g,0.994mmol)を塩化メチレン (12ml)とァニソール (1.2ml)に溶解し、 -3 0°Cに冷却し、 2M塩化アルミニウムニトロメタン溶液 5.4mlを加え、実施例 50の (2)と同 様の手法にて化合物 49を無定形粉末として得た。収量 197mg(26%) Compound 51 (1.21 g, 0.994 mmol) was dissolved in methylene chloride (12 ml) and anisole (1.2 ml), cooled to −30 ° C., 5.4 ml of 2M aluminum chloride nitromethane solution was added, and (2) of Example 50 ) To give Compound 49 as an amorphous powder. Yield 197 mg (26%)
'H-NMR (d -DMSO): 1·00(3Η, t, J = 7.6Hz), 2.18(2H, sept, J = 7.6Hz), 3.43, 3.50( 'H-NMR (d-DMSO): 1 · 00 (3Η, t, J = 7.6Hz), 2.18 (2H, sept, J = 7.6Hz), 3.43, 3.50 (
6 6
2H, ABq, J = 16.8Hz), 5.05(1H, d , J = 4.8Hz), 5.16(2H, d, J = 7.2Hz), 5.60(1H, dd , J = 8.0, 4.8Hz), 5.82(1H, dt, J = 15.6, 7.2Hz), 6.21(1H, s), 6.22(1H, t, 7.6Hz), 6.7
8(2H, d, J = 8.4Hz), 6.98(2H, s), 7.28(1H, d, J = 15.6Hz), 7.94(1H, dd, J = 8.4, 2.8 Hz), 8.30(2H, d, J = 7.2Hz), 8.39(1H, d, J = 2.8Hz), 8.74(2H, d, J = 7.2Hz), 9.20(1 H, d, J = 8.0Hz). 2H, ABq, J = 16.8Hz), 5.05 (1H, d, J = 4.8Hz), 5.16 (2H, d, J = 7.2Hz), 5.60 (1H, dd, J = 8.0, 4.8Hz), 5.82 ( 1H, dt, J = 15.6, 7.2Hz), 6.21 (1H, s), 6.22 (1H, t, 7.6Hz), 6.7 8 (2H, d, J = 8.4Hz), 6.98 (2H, s), 7.28 (1H, d, J = 15.6Hz), 7.94 (1H, dd, J = 8.4, 2.8 Hz), 8.30 (2H, d , J = 7.2Hz), 8.39 (1H, d, J = 2.8Hz), 8.74 (2H, d, J = 7.2Hz), 9.20 (1 H, d, J = 8.0Hz).
IR (KBr) cm_1:3399, 1763, 1600, 1526, 1488, 1470, 1388, 1300, 1157, 829. IR (KBr) cm _1 : 3399, 1763, 1600, 1526, 1488, 1470, 1388, 1300, 1157, 829.
MS(FAB): 656+ (M+H)+ MS (FAB): 656+ (M + H) +
元素分析 c H N O S Na-4.4 H O - 0.2NaHCO Elemental analysis c H N O S Na-4.4 H O-0.2NaHCO
30 26 5 7 2 2 3 30 26 5 7 2 2 3
計算値: C,48.25; H,4.69; N,9.32; S, 8.53; Na 3.67 (%) Calculated values: C, 48.25; H, 4.69; N, 9.32; S, 8.53; Na 3.67 (%)
実験値: C48.17; H,4.58; N,9.73; S, 8.72; Na 3.73 (%) Experimental value: C48.17; H, 4.58; N, 9.73; S, 8.72; Na 3.73 (%)
実施例 53 Example 53
[化 99] [Chemical 99]
Na+ Na +
33 53 33 53
( 1) 33→53 (1) 33 → 53
化合物 33(562mg,3.00mmol)、アジ化ナトリウム (215mg、 3.30mmol)、塩化アンモニゥ ム (177mg、 3.30mmol)をジメチルホルムアミド (6ml)中に懸濁させ、 115°Cにて 2時間 25 分攪拌した。室温に冷却後水、次いで 2N-HC1をカ卩えて pH=4とし、析出物を濾取して 、化合物 53を無色結晶として得た。収量 764mg(lll%) Compound 33 (562 mg, 3.00 mmol), sodium azide (215 mg, 3.30 mmol) and ammonium chloride (177 mg, 3.30 mmol) were suspended in dimethylformamide (6 ml) and stirred at 115 ° C for 2 hours and 25 minutes. did. After cooling to room temperature, water and then 2N-HC1 were added to adjust pH = 4, and the precipitate was collected by filtration to obtain Compound 53 as colorless crystals. Yield 764mg (lll%)
'H-NMR (d -DMSO): 8·13(2Η, d, J = 6.0Hz), 8.78(2H, d, J = 6.0Hz), 8.83(1H, s). 'H-NMR (d-DMSO): 8 · 13 (2Η, d, J = 6.0Hz), 8.78 (2H, d, J = 6.0Hz), 8.83 (1H, s).
6 6
(2) 53→52 (2) 53 → 52
化合物 9(1.349g、 2.00mmol)をジクロロメタン (15ml)に懸濁させ、氷冷下炭酸水素ナ トリウム水溶液 (252mg、 3.00mmolを水 15mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (4ml)に溶
解し、化合物 53(461mg,2.00mmol)と混合し、ジメチルスルホキシド (12ml)、臭化ナトリ ゥム (617mg、 6. OOmmol)を加えて、室温で 7時間攪拌した。反応液を 5%食塩水 (80ml) 攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して 4級塩を無定形粉 末として得た。これを塩化メチレン (16ml)、ァニソール (1.6ml)に溶解し、 _30°Cに冷却 し、 2M塩化アルミニウムニトロメタン溶液 4.8mlを加え、実施例 50の (2)と同様の手法に て化合物 52を粉末として得た。収量 122mg(8%) Compound 9 (1.349 g, 2.00 mmol) is suspended in dichloromethane (15 ml), aqueous sodium hydrogen carbonate solution (252 mg, 3.00 mmol dissolved in 15 ml of water) is added under ice cooling, extracted with dichloromethane, and magnesium sulfate is added. Dried. After removing the solvent, quickly dissolve in dimethylformamide (4 ml). The mixture was mixed with Compound 53 (461 mg, 2.00 mmol), dimethylsulfoxide (12 ml) and sodium bromide (617 mg, 6.OOmmol) were added, and the mixture was stirred at room temperature for 7 hours. The reaction solution was poured into 5% brine (80 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain a quaternary salt as an amorphous powder. This was dissolved in methylene chloride (16 ml) and anisole (1.6 ml), cooled to _30 ° C, 4.8 ml of 2M aluminum chloride nitromethane solution was added, and compound 52 was prepared in the same manner as in Example 50 (2). Obtained as a powder. Yield 122 mg (8%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.8Hz), 3.46, 3.54(2H, ABq, J = 17.0Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.8Hz), 3.46, 3.54 (2H, ABq, J = 17.0Hz), 4.0
6 6
8(2H, q, J = 6.8 Hz), 5.08(1H, d, J = 4.6Hz), 5.29(2H, d, J = 6.8Hz), 5.63(1H, dd, J = 7.6, 4.6Hz), 5.93(1H, dt, J = 16.0, 6.8Hz), 6.72(1H, s), 7.25(2H, s), 7.34(1H, d, J = 16.0Hz), 8.62(2H, d, J = 6.2Hz), 8.97(1H, s), 9.05(2H, d, J = 6.2Hz), 9.56(1H, d , J = 7.6Hz). 8 (2H, q, J = 6.8 Hz), 5.08 (1H, d, J = 4.6 Hz), 5.29 (2H, d, J = 6.8 Hz), 5.63 (1H, dd, J = 7.6, 4.6 Hz), 5.93 (1H, dt, J = 16.0, 6.8Hz), 6.72 (1H, s), 7.25 (2H, s), 7.34 (1H, d, J = 16.0Hz), 8.62 (2H, d, J = 6.2Hz ), 8.97 (1H, s), 9.05 (2H, d, J = 6.2Hz), 9.56 (1H, d, J = 7.6Hz).
IR (KBr) cm_1:3398, 1762, 1635, 1530, 1388, 1300, 1155, 1036, 990. IR (KBr) cm _1 : 3398, 1762, 1635, 1530, 1388, 1300, 1155, 1036, 990.
MS(ESI): 666+ (M-Na+2H)+ MS (ESI): 666 + (M-Na + 2H) +
元素分析 C H N O S Na- 4.6 H O - 0.2NaHCO Elemental analysis C H N O S Na- 4.6 H O-0.2 NaHCO
26 22 11 5 3 2 3 26 22 11 5 3 2 3
計算値: C,39.97; H,4.02; N, 19.57; S, 12.22; Na 3.50 (%) Calculated: C, 39.97; H, 4.02; N, 19.57; S, 12.22; Na 3.50 (%)
実験値: C,40.08; H,3.94; N,19.36; S, 12.04; Na 3.59 (%) Experimental value: C, 40.08; H, 3.94; N, 19.36; S, 12.04; Na 3.59 (%)
実施例 54 Example 54
[化 100] [Chemical 100]
56 56
(1) 55→56 (1) 55 → 56
化合物 50(659mg,0.913mmol)、化合物 55(350mg,0.913mmol)をジメチルホルムアミド
(3ml)に懸濁させ、臭化ナトリウム (282mg,2.74mmol)を加えた。室温で 7時間撹拌後、 反応液を 5%食塩水 (40ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧 乾燥して化合物 56を無定形粉末として得た。収量 936mg(89%) Compound 50 (659 mg, 0.913 mmol) and compound 55 (350 mg, 0.913 mmol) were converted to dimethylformamide. (3 ml) and sodium bromide (282 mg, 2.74 mmol) was added. After stirring at room temperature for 7 hours, the reaction solution was poured into 5% brine (40 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 56 as an amorphous powder. Yield 936 mg (89%)
'H-NMR (d -DMSO): 1.03(3H, t, J = 7.7Hz), 1.47(9H, s), 2.23(2H, sept, J = 7.7Hz 'H-NMR (d-DMSO): 1.03 (3H, t, J = 7.7Hz), 1.47 (9H, s), 2.23 (2H, sept, J = 7.7Hz
), 3.67, 3.91(2H, ABq, J = 17.8 Hz), 5.32(1H, d, J = 4.8Hz), 5.35(2H, d, J = 6.2Hz) , 5.89(1H, dd, J = 7.6, 4.8Hz), 6.36(1H, t, J = 7.7Hz), 6.45(1H, dt, J = 15.8, 6.2Hz) , 6.77(1H, s), 6.92(1H, s), 6.97(1H, d, J = 15.8Hz), 7.28— 7.58(20H, m), 7.80-8.28(3 H, m), 8.62(1H, d, J = 6.6Hz), 9.12(2H, d, J = 6.6Hz), 9.39(1H, d, J = 7.6Hz). ), 3.67, 3.91 (2H, ABq, J = 17.8 Hz), 5.32 (1H, d, J = 4.8 Hz), 5.35 (2H, d, J = 6.2 Hz), 5.89 (1H, dd, J = 7.6, 4.8Hz), 6.36 (1H, t, J = 7.7Hz), 6.45 (1H, dt, J = 15.8, 6.2Hz), 6.77 (1H, s), 6.92 (1H, s), 6.97 (1H, d, J = 15.8Hz), 7.28—7.58 (20H, m), 7.80-8.28 (3H, m), 8.62 (1H, d, J = 6.6Hz), 9.12 (2H, d, J = 6.6Hz), 9.39 (1H, d, J = 7.6Hz).
(2) 56→54 (2) 56 → 54
化合物 56(933mg,0.812mmol)を塩化メチレン (9ml)とァニソール (0.933ml)に溶解し、 - 30。Cに冷却し、 2M塩ィ匕アルミニウムニトロメタン溶液 4. lmlをカ卩え、実施例 50の (2)と同 様の手法にて化合物 54を無定形粉末として得た。収量 199mg(33%) Compound 56 (933 mg, 0.812 mmol) was dissolved in methylene chloride (9 ml) and anisole (0.933 ml). After cooling to C, 4 ml of a 2M salt / aluminum nitromethane solution was added, and Compound 54 was obtained as an amorphous powder in the same manner as in Example 50 (2). Yield 199mg (33%)
'H-NMR (d -DMSO): 0.99(3H, t, J = 7.6Hz), 2.17(2H, sept, J = 7.6Hz), 3.44, 3.51('H-NMR (d-DMSO): 0.99 (3H, t, J = 7.6Hz), 2.17 (2H, sept, J = 7.6Hz), 3.44, 3.51 (
2H, ABq, J = 17.8Hz), 5.06(1H, d , J = 4.8Hz), 5.29(2H, d, J = 7.2Hz), 5.60(1H, dd , J = 7.4, 4.8Hz), 5.87(1H, dt, J = 16.0, 7.2Hz), 6.20(1H, s), 6.22(1H, t, J = 7.6Hz), 7.00(2H, s), 7.32(1H, d, J = 16.0Hz), 7.64(1H, t, J = 7.2Hz), 7.76(1H, d, J = 7.2Hz ), 7.79(1H, d, J = 12.0Hz), 8.48 (1H, d, J = 6.4H z), 9.03(2H, d, J = 6.4Hz), 9.21(1 H, d, J = 7.4Hz). 2H, ABq, J = 17.8Hz), 5.06 (1H, d, J = 4.8Hz), 5.29 (2H, d, J = 7.2Hz), 5.60 (1H, dd, J = 7.4, 4.8Hz), 5.87 ( 1H, dt, J = 16.0, 7.2Hz), 6.20 (1H, s), 6.22 (1H, t, J = 7.6Hz), 7.00 (2H, s), 7.32 (1H, d, J = 16.0Hz), 7.64 (1H, t, J = 7.2Hz), 7.76 (1H, d, J = 7.2Hz), 7.79 (1H, d, J = 12.0Hz), 8.48 (1H, d, J = 6.4H z), 9.03 (2H, d, J = 6.4Hz), 9.21 (1 H, d, J = 7.4Hz).
IR (KBr) cm_1:3408, 1763, 1603, 1526, 1406, 1371, 1155. IR (KBr) cm _1 : 3408, 1763, 1603, 1526, 1406, 1371, 1155.
MS(FAB): 636+ (M_Na+2H)+ MS (FAB): 636+ (M_Na + 2H) +
元素分析 C H FN O S Na-4.0 H O - O. lNaHCO Elemental analysis C H FN O S Na-4.0 H O-O. lNaHCO
計算値: C,48.98; H,4.52; F, 2.57; N,9.49; S, 8.69; Na 3.43 (%) Calculated values: C, 48.98; H, 4.52; F, 2.57; N, 9.49; S, 8.69; Na 3.43 (%)
実験値: C48.83; H,4.36; F, 2.52; N,9.67; S, 8.77; Na 3.60 (%) Experimental value: C48.83; H, 4.36; F, 2.52; N, 9.67; S, 8.77; Na 3.60 (%)
実施例 55 Example 55
[化 101]
[Chemical 101]
(1) 58→59 (1) 58 → 59
化合物 58(2.130g,6.862mmol)をメタノール (21ml)に溶解し、過塩素酸銀 (1.56g,7.55 mmol)のメタノール溶液 (16ml)を室温にて滴下した。 50分撹拌後、析出物を濾取し、 化合物 59を淡黄橙色結晶として得た。収量 2.112g(104%) Compound 58 (2.130 g, 6.862 mmol) was dissolved in methanol (21 ml), and a methanol solution (16 ml) of silver perchlorate (1.56 g, 7.55 mmol) was added dropwise at room temperature. After stirring for 50 minutes, the precipitate was collected by filtration to obtain Compound 59 as pale yellow orange crystals. Yield 2.112 g (104%)
(2) 59→60 (2) 59 → 60
4-ブロモピリジン塩酸塩 (1.334g,6.862mmol)をジェチルエーテル /2N NaOHに溶解 し、ジェチルエーテルで抽出した。有機層を水、飽和食塩水で洗浄し、硫酸ナトリウ ムで乾燥した。ジメチルホルムアミド (13ml)を加えてジェチルエーテルを減圧留去し、 化合物 59(2.112g,6.862mmol)を加えて 70°Cにて 1時間撹拌した。酢酸ェチルを加え、 不溶物をセライトパッドろ過した。濾液を水、飽和食塩水で洗浄し、硫酸ナトリウムで 乾燥した。溶媒を減圧留去して、シリカゲルクロマトグラフィーに付しへキサン:酢酸ェ チル = 1 :3で溶出した。 目的のフラクションを濃縮して、化合物 60を油状物質として得 た。収量 812mg(44%) 4-Bromopyridine hydrochloride (1.334 g, 6.862 mmol) was dissolved in jetyl ether / 2N NaOH and extracted with jetyl ether. The organic layer was washed with water and saturated brine, and dried over sodium sulfate. Dimethylformamide (13 ml) was added, and the ethyl ether was distilled off under reduced pressure. Compound 59 (2.112 g, 6.862 mmol) was added, and the mixture was stirred at 70 ° C. for 1 hour. Ethyl acetate was added, and the insoluble material was filtered through a Celite pad. The filtrate was washed with water and saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel chromatography and eluted with hexane: ethyl acetate = 1: 3. The desired fraction was concentrated to give compound 60 as an oily substance. Yield 812 mg (44%)
'H-NMR (d -DMSO): 1.34(3H, t, J = 7.2Hz), 4.43(2H, t, J = 7.2Hz), 7.65(2H, d, J 'H-NMR (d-DMSO): 1.34 (3H, t, J = 7.2Hz), 4.43 (2H, t, J = 7.2Hz), 7.65 (2H, d, J
= 4.8Hz), 8.65(2H, d, J = 4.8Hz). = 4.8Hz), 8.65 (2H, d, J = 4.8Hz).
(3) 60→61
化合物 60(298mg,1.21mmol)をメタノール (3ml)に懸濁させ、シァナミドナトリウム塩 (81 mg, 1.27mmol)をカ卩えて 50分撹拌した。溶液を半分濃縮し、ジェチルエーテルをカロえ て、生じた沈殿物をろ過し、減圧乾燥して、化合物 61を無色結晶として得た。収量 25 6mg(65%) (3) 60 → 61 Compound 60 (298 mg, 1.21 mmol) was suspended in methanol (3 ml), and cyanamide sodium salt (81 mg, 1.27 mmol) was added and stirred for 50 minutes. The solution was concentrated half way, and the resulting precipitate was removed and the resulting precipitate was filtered and dried under reduced pressure to obtain Compound 61 as colorless crystals. Yield 25 6mg (65%)
'H-NMR (d -DMSO): 7.54(2H, d, J = 4.6Hz), 8.60(2H, d, J = 4.6Hz). 'H-NMR (d-DMSO): 7.54 (2H, d, J = 4.6Hz), 8.60 (2H, d, J = 4.6Hz).
(4) 61→62 (4) 61 → 62
化合物 9(522mg、 0.773mmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナ トリウム水溶液 (97mg、 1.16mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (2ml)に溶 解し、化合物 61(254mg,0.773mmol)と混合し、臭化ナトリウム (239mg、 2.32mmol)を加 えて、室温で 5時間攪拌した。反応液を 5%食塩水 (25ml)攪拌中に注加し、析出した 沈殿を濾取した。沈殿を減圧乾燥して化合物 62を無定形粉末として得た。収量 553m g(83%) Compound 9 (522 mg, 0.773 mmol) is suspended in dichloromethane (10 ml), aqueous sodium hydrogen carbonate solution (97 mg, 1.16 mmol dissolved in 10 ml of water) is added under ice cooling, extracted with dichloromethane, and dried over magnesium sulfate. did. After the solvent was distilled off, it was quickly dissolved in dimethylformamide (2 ml), mixed with compound 61 (254 mg, 0.773 mmol), sodium bromide (239 mg, 2.32 mmol) was added, and the mixture was stirred at room temperature for 5 hours. The reaction solution was poured into 5% brine (25 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 62 as an amorphous powder. Yield 553 mg (83%)
JH-NMR (d -DMSO): 1.23(3H, t, J = 7.0Hz), 3.63, 3.86(2H, ABq, J = 17.6Hz), 4.0 J H-NMR (d-DMSO): 1.23 (3H, t, J = 7.0Hz), 3.63, 3.86 (2H, ABq, J = 17.6Hz), 4.0
9(2H, q, J = 7.0 Hz), 5.20(2H, d, J = 6.0Hz), 5.29(1H, d, J = 4.8Hz), 5.92(1H, dd, J = 7.0, 4.8Hz), 6.35(1H, dt, J = 16.0, 6.0Hz), 6.76(1H, s), 6.90 (1H, d, J = 16.0Hz), 6.94(1H, s), 7.26-7.43(m, 12H), 8.02(2H, d, J = 5.8Hz), 8.77(2H, d, J = 5.8Hz), 9.9 (2H, q, J = 7.0 Hz), 5.20 (2H, d, J = 6.0 Hz), 5.29 (1H, d, J = 4.8 Hz), 5.92 (1H, dd, J = 7.0, 4.8 Hz), 6.35 (1H, dt, J = 16.0, 6.0Hz), 6.76 (1H, s), 6.90 (1H, d, J = 16.0Hz), 6.94 (1H, s), 7.26-7.43 (m, 12H), 8.02 (2H, d, J = 5.8Hz), 8.77 (2H, d, J = 5.8Hz), 9.
65(1H, d, J = 7.0Hz). 65 (1H, d, J = 7.0Hz).
(5) 62→57 (5) 62 → 57
化合物 62(539mg,1.04mmol)を塩化メチレン (3.2ml)に溶解し、 0°Cに冷却し、 TFA 1. 6mlを加え、実施例 41の (2)と同様の手法にて、化合物 57を粉末として得た。収量 195 mg(39%) Compound 62 (539 mg, 1.04 mmol) was dissolved in methylene chloride (3.2 ml), cooled to 0 ° C., 1.6 ml of TFA was added, and compound 57 was prepared in the same manner as in Example 41 (2). Obtained as a powder. Yield 195 mg (39%)
'H-NMR (DMSO): 1.22(3H, t, J = 6.9Hz), 3.40, 3.47(2H, ABq, J = 16.8Hz), 4.09(2 H, q, J = 6.9Hz), 5.04(1H, d, J = 4.8Hz), 5.19(2H, d, J = 6.6Hz), 5.59(1H, dd, J = 8 • 4, 4.8Hz), 5.78(1H, dt, J = 16.2, 6.6Hz), 6.72(1H, s), 7.23(2H, s), 7.26(1H, d, J = 16.2Hz), 8.02(2H, d, J = 7.2Hz), 8.81(2H, d, J = 7.2Hz), 9.54(1H, d, J = 8.4Hz). IR (KBr) cm_1:3417, 2179, 2158, 1763, 1624, 1531, 1356, 1036. 'H-NMR (DMSO): 1.22 (3H, t, J = 6.9Hz), 3.40, 3.47 (2H, ABq, J = 16.8Hz), 4.09 (2H, q, J = 6.9Hz), 5.04 (1H , d, J = 4.8Hz), 5.19 (2H, d, J = 6.6Hz), 5.59 (1H, dd, J = 8 • 4, 4.8Hz), 5.78 (1H, dt, J = 16.2, 6.6Hz) , 6.72 (1H, s), 7.23 (2H, s), 7.26 (1H, d, J = 16.2Hz), 8.02 (2H, d, J = 7.2Hz), 8.81 (2H, d, J = 7.2Hz) , 9.54 (1H, d, J = 8.4Hz). IR (KBr) cm _1 : 3417, 2179, 2158, 1763, 1624, 1531, 1356, 1036.
MS(ESI): 699+ (M-Na+2H)+
元素分析 C H N O S Na- 3.1H O - 0.2NaHCO MS (ESI): 699 + (M-Na + 2H) + Elemental analysis CHNOS Na- 3.1HO-0.2NaHCO
26 21 10 6 4 2 3 26 21 10 6 4 2 3
計算値: C, 39.66; H, 3.48; N, 17.65; S, 16.17; Na, 3.48 (%) Calculated: C, 39.66; H, 3.48; N, 17.65; S, 16.17; Na, 3.48 (%)
実験値: C, 39.62; H, 3.47; N, 17.64; S, 16.13; Na, 3.59 (%) Experimental values: C, 39.62; H, 3.47; N, 17.64; S, 16.13; Na, 3.59 (%)
実施例 56 Example 56
[化 102] [Chemical 102]
(1) 64→65 (1) 64 → 65
化合物64(33011¾,1.5011111101)をテトラヒドロフラン(3.31111)中に懸濁させ、ジフヱニルジ ァゾメタン (320mg,1.65mmol)を加えて還流下 2時間撹拌した。酢酸ェチル、水を加え 、酢酸ェチルで抽出した。有機層を飽和食塩水で洗浄し、硫酸ナトリウムで乾燥した 。溶媒を減圧留去し、シリカゲルクロマトグラフィーに付して、へキサン:酢酸ェチル = 1 :4で溶出した。 目的のフラクションを減圧濃縮して、化合物 65を淡橙色泡状物質とし て得た。収量 348mg(60%) Compound 64 (33011¾, 1.5011111101) was suspended in tetrahydrofuran (3.31111), diphenyldiazomethane (320 mg, 1.65 mmol) was added, and the mixture was stirred under reflux for 2 hours. Ethyl acetate and water were added and extracted with ethyl acetate. The organic layer was washed with saturated brine and dried over sodium sulfate. The solvent was distilled off under reduced pressure, subjected to silica gel chromatography, and eluted with hexane: ethyl acetate = 1: 4. The desired fraction was concentrated under reduced pressure to give Compound 65 as a pale orange foam. Yield 348mg (60%)
'H-NMR (d -DMSO): 2.60(3H, s), 7.12(1H, s), 7.30— 7.53(10H, m), 7.64(2H, d, J = 'H-NMR (d-DMSO): 2.60 (3H, s), 7.12 (1H, s), 7.30—7.53 (10H, m), 7.64 (2H, d, J =
6 6
6.0Hz), 8.72(2H, d, J = 6.0Hz). 6.0Hz), 8.72 (2H, d, J = 6.0Hz).
(2) 65→66 (2) 65 → 66
化合物 50(614mg,0.851mmol)、化合物 65(329mg,0.851mmol)をジメチルホルムアミド
(2.4ml)に懸濁させ、臭化ナトリウム (263mg,2.55mmol)を加えた。室温で 7時間撹拌後 、反応液を 5%食塩水 (30ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧 乾燥して化合物 66を無定形粉末として得た。収量 883mg(90%) Compound 50 (614 mg, 0.851 mmol) and compound 65 (329 mg, 0.851 mmol) were converted to dimethylformamide. (2.4 ml) and sodium bromide (263 mg, 2.55 mmol) was added. After stirring at room temperature for 7 hours, the reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 66 as an amorphous powder. Yield 883 mg (90%)
'H-NMR (d -DMSO): 1.03(3H, t, J = 7.6Hz), 1.47(9H, s), 2.24(2H, sept, J = 7.6Hz 'H-NMR (d-DMSO): 1.03 (3H, t, J = 7.6Hz), 1.47 (9H, s), 2.24 (2H, sept, J = 7.6Hz
), 2.71(3H, s), 3.68, 3.91(2H, ABq, J = 17.6 Hz), 5.33(1H, d, J = 4.8Hz), 5.39(2H, d, J = 6.6Hz), 5.89(1H, dd, J = 7.6, 4.8Hz), 6.37(1H, t, J = 7.6Hz), 6.48(1H, dt, J = 15.2, 6.2Hz), 6.78(1H, s), 6.93(1H, s), 6.94(1H, d, J = 15.2Hz), 7.12(1H, s), 7.25- 7.54(20H, m), 8.39(1H, d, J = 6.2Hz), 9.11(2H, d, J = 6.2Hz), 9.40(1H, d, J = 7.6Hz ), 11.5(1H, brs). ), 2.71 (3H, s), 3.68, 3.91 (2H, ABq, J = 17.6 Hz), 5.33 (1H, d, J = 4.8Hz), 5.39 (2H, d, J = 6.6Hz), 5.89 (1H , Dd, J = 7.6, 4.8Hz), 6.37 (1H, t, J = 7.6Hz), 6.48 (1H, dt, J = 15.2, 6.2Hz), 6.78 (1H, s), 6.93 (1H, s) 6.94 (1H, d, J = 15.2Hz), 7.12 (1H, s), 7.25-7.54 (20H, m), 8.39 (1H, d, J = 6.2Hz), 9.11 (2H, d, J = 6.2 Hz), 9.40 (1H, d, J = 7.6Hz), 11.5 (1H, brs).
(3) 66→63 (3) 66 → 63
化合物 66(872mg,0.756mmol)を塩化メチレン (4.4ml)とァニソール (0.872ml)に溶解し 、 0°Cに冷却し、 TFA 4.4mlをカ卩え、実施例 41の (2)と同様の手法にて、化合物 63を粉 末として得た。収量 146mg(26%) Compound 66 (872 mg, 0.756 mmol) was dissolved in methylene chloride (4.4 ml) and anisole (0.872 ml), cooled to 0 ° C., and 4.4 ml of TFA was added, the same as in Example 41 (2). By the method, Compound 63 was obtained as a powder. Yield 146 mg (26%)
'H-NMR (d -DMSO): 1·00(3Η, t, J = 7.5Hz), 2.17(2H, sept, J = 7.5Hz), 3.43, 3.51( 'H-NMR (d-DMSO): 1 · 00 (3Η, t, J = 7.5Hz), 2.17 (2H, sept, J = 7.5Hz), 3.43, 3.51 (
2H, ABq, J = 17.1Hz), 5.06(1H, d , J = 4.8Hz), 5.27(2H, d, J = 6.9Hz), 5.60(1H, dd , J = 8.0, 4.8Hz), 5.84(1H, dt, J = 15.9, 6.9Hz), 6.20(1H, s), 6.22(1H, t, 7.5Hz), 7.0 1(2H, s), 7.30(1H, d, J = 15.9Hz), 8.20(1H, d, J = 7.2Hz), 8.95(2H, d, J = 7.2Hz), 9 .23(1H, d, J = 8.0Hz). 2H, ABq, J = 17.1Hz), 5.06 (1H, d, J = 4.8Hz), 5.27 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 8.0, 4.8Hz), 5.84 ( 1H, dt, J = 15.9, 6.9Hz), 6.20 (1H, s), 6.22 (1H, t, 7.5Hz), 7.0 1 (2H, s), 7.30 (1H, d, J = 15.9Hz), 8.20 (1H, d, J = 7.2Hz), 8.95 (2H, d, J = 7.2Hz), 9.23 (1H, d, J = 8.0Hz).
IR (KBr) cm_1:3408, 1763, 1631, 1526, 1360, 1158. IR (KBr) cm _1 : 3408, 1763, 1631, 1526, 1360, 1158.
MS(ESI): 639+ (M-Na+2H)+ MS (ESI): 639+ (M-Na + 2H) +
元素分析 C H N O S Na- 3.4 H O - 0.2NaHCO Elemental analysis C H N O S Na- 3.4 H O-0.2 NaHCO
計算値: C,44.76; H,4.53; Ν, Ι Ι.10; S, 12.71; Na 3.65 (%) Calculated values: C, 44.76; H, 4.53; Ν, Ι Ι.10; S, 12.71; Na 3.65 (%)
実験値: C,44.78; H,4.41; N,11.02; S, 12.76; Na 3.72 (%) Experimental value: C, 44.78; H, 4.41; N, 11.02; S, 12.76; Na 3.72 (%)
実施例 57 Example 57
67 67
~ 67 ~ 67
(1) 40→68 (1) 40 → 68
化合物 40(308mg,1.08mmol)をメタノール中に懸濁し、ナトリウムメトキシドメタノール 溶液を pH=7.5となるまで滴下して、得られた溶液を減圧濃縮して、 40のナトリウム塩を 得た。これに化合物 50 (782mg, 1.08mmol)を加え、ジメチルホルムアミド (3m 1)に溶解 し、次いで臭化ナトリウム (335mg,3.25mmol)を加えて、室温で 5時間攪拌した。反応液 を 5%食塩水 (30ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して 化合物 68を無定形粉末として得た。収量 949mg(90%) Compound 40 (308 mg, 1.08 mmol) was suspended in methanol, a sodium methoxide methanol solution was added dropwise until pH = 7.5, and the resulting solution was concentrated under reduced pressure to obtain 40 sodium salt. To this was added compound 50 (782 mg, 1.08 mmol), dissolved in dimethylformamide (3 ml), then sodium bromide (335 mg, 3.25 mmol) was added and stirred at room temperature for 5 hours. The reaction mixture was poured into 5% brine (30 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 68 as an amorphous powder. Yield 949 mg (90%)
'H-NMR (d -DMSO): 1.03(3H, t, J = 7.2Hz), 1.48(9H, s), 2.23(2H, sept, J = 7.2Hz 'H-NMR (d-DMSO): 1.03 (3H, t, J = 7.2Hz), 1.48 (9H, s), 2.23 (2H, sept, J = 7.2Hz
), 2.89(3H, s), 3.67, 3.91(2H, ABq, J = 17.6 Hz), 5.27(2H, d, J = 6.8Hz), 5.32(1H, d, J = 5.2Hz), 5.89(1H, dd, J = 8.0, 5.2Hz), 6.36(1H, t, J = 7.2Hz), 6.43(1H, dt, J = 16.4, 6.8Hz), 6.77(1H, s), 6.91(1H, d, J = 16.4Hz), 7.10— 7.52(m, 10H), 8.58(2H, d, J = 6.0Hz), 8.96(2H, d, J = 6.0Hz), 9.00(1H, s), 9.38(1H, d, J = 8.0Hz), 11.5(1H, brs). ), 2.89 (3H, s), 3.67, 3.91 (2H, ABq, J = 17.6 Hz), 5.27 (2H, d, J = 6.8Hz), 5.32 (1H, d, J = 5.2Hz), 5.89 (1H , dd, J = 8.0, 5.2Hz), 6.36 (1H, t, J = 7.2Hz), 6.43 (1H, dt, J = 16.4, 6.8Hz), 6.77 (1H, s), 6.91 (1H, d, J = 16.4Hz), 7.10—7.52 (m, 10H), 8.58 (2H, d, J = 6.0Hz), 8.96 (2H, d, J = 6.0Hz), 9.00 (1H, s), 9.38 (1H, d, J = 8.0Hz), 11.5 (1H, brs).
(2) 68→67 (2) 68 → 67
化合物 68(949mg,0.980mmol)を塩化メチレン (4.7ml)とァニソール (0.949ml)に溶解し 、 0°Cに冷却し、 TFA 4.7mlをカ卩え、実施例 41の (2)と同様の手法にて、化合物 67を粉 末として得た。収量 239mg(30%) Compound 68 (949 mg, 0.980 mmol) was dissolved in methylene chloride (4.7 ml) and anisole (0.949 ml), cooled to 0 ° C., and 4.7 ml of TFA was added, as in (2) of Example 41. By the method, Compound 67 was obtained as a powder. Yield 239 mg (30%)
'H-NMR (d -DMSO): 1.00(3H, t, 7.5Hz), 2.17(2H, sept, 7.5Hz), 3.43, 3.51(2H, A
Bq, J = 17.1Hz), 5.06(1H, d , J = 4.8Hz), 5.27(2H, d, J = 6.9Hz), 5.60(1H, dd, J = 8 .0, 4.8Hz), 5.84(1H, dt, J = 15.9, 6.9Hz), 6.20(1H, s), 6.22(1H, t, 7.5Hz), 7.01(2H, s), 7.30(1H, d, J = 15.9Hz ), 8.20(1H, d, J = 7.2Hz), 8.95(2H, d, J = 7.2Hz), 9.23(1 H, d, J = 8.0Hz). 'H-NMR (d-DMSO): 1.00 (3H, t, 7.5Hz), 2.17 (2H, sept, 7.5Hz), 3.43, 3.51 (2H, A Bq, J = 17.1Hz), 5.06 (1H, d, J = 4.8Hz), 5.27 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 8.0, 4.8Hz), 5.84 ( 1H, dt, J = 15.9, 6.9Hz), 6.20 (1H, s), 6.22 (1H, t, 7.5Hz), 7.01 (2H, s), 7.30 (1H, d, J = 15.9Hz), 8.20 ( 1H, d, J = 7.2Hz), 8.95 (2H, d, J = 7.2Hz), 9.23 (1 H, d, J = 8.0Hz).
IR (KBr) cm_1:3408, 1763, 1631, 1526, 1360, 1158. IR (KBr) cm _1 : 3408, 1763, 1631, 1526, 1360, 1158.
MS(ESI): 639+ (M-Na+2H)+ MS (ESI): 639 + (M-Na + 2H) +
元素分析 c H N O S Na- 3.4 H O - 0.2NaHCO Elemental analysis c H N O S Na- 3.4 H O-0.2 NaHCO
計算値: C,44.76; H,4.53; Ν,Ι Ι.10; S, 12.71; Na 3.65 (%) Calculated values: C, 44.76; H, 4.53; Ν, Ι Ι.10; S, 12.71; Na 3.65 (%)
実験値: C,44.78; H,4.41; N,11.02; S, 12.76; Na 3.72 (%) Experimental value: C, 44.78; H, 4.41; N, 11.02; S, 12.76; Na 3.72 (%)
実施例 58 Example 58
[化 104] [Chemical 104]
(1) 70→71 (1) 70 → 71
化合物 70(496mg,3.00mmol)より実施例 55の (3)と同様の手法にて化合物 71を無色 結晶として得た。収量 398mg(72%) Compound 71 was obtained as colorless crystals from Compound 70 (496 mg, 3.00 mmol) in the same manner as in Example 55, (3). Yield 398 mg (72%)
'H-NMR (d -DMSO): 3.28(2H, s), 7.21(2H, d, J = 4.4Hz), 8.41(2H, d, J = 4.4Hz). 'H-NMR (d-DMSO): 3.28 (2H, s), 7.21 (2H, d, J = 4.4Hz), 8.41 (2H, d, J = 4.4Hz).
(2) 71→69 (2) 71 → 69
化合物 71(183mg,1.00mmol)をジメチルホルムアミド (2ml)中に懸濁し、クロロトリメチ ルシラン (0.133ml,1.05mmol)を室温にて滴下した。一方、化合物 9(674mg、 l.OOmmol) をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナトリウム水溶液 (126mg、 1.50m molを水 10mlに溶解)をカ卩え、ジクロロメタンで抽出し、硫酸マグネシウムで乾燥した。 溶媒を留去後、速やかに先の懸濁液と混合 (ジメチルホルムアミド 2mlで洗いこみ)し、
臭化ナトリウム (309mg、 3.00mmol)を加えて、室温で 3時間 20分攪拌した。反応液を 5 %食塩水 (30ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して 4級 塩を含む無定形粉末を得た。これを塩ィ匕メチレン (3.6ml)、ァニソール (0.605ml)に溶 解し、 0°Cに冷却し、 TFA 1.8mlを加え、実施例 41の (2)と同様の手法にて化合物 69 を粉末として得た。収量 44mg(6%) Compound 71 (183 mg, 1.00 mmol) was suspended in dimethylformamide (2 ml), and chlorotrimethylsilane (0.133 ml, 1.05 mmol) was added dropwise at room temperature. On the other hand, Compound 9 (674 mg, l.OOmmol) was suspended in dichloromethane (10 ml), and an aqueous sodium hydrogen carbonate solution (126 mg, 1.50 mmol) was dissolved in 10 ml of water under ice-cooling, and extracted with dichloromethane. Dried over magnesium sulfate. After distilling off the solvent, immediately mix with the previous suspension (wash with 2 ml of dimethylformamide), Sodium bromide (309 mg, 3.00 mmol) was added, and the mixture was stirred at room temperature for 3 hr 20 min. The reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain an amorphous powder containing a quaternary salt. This was dissolved in salt methylene (3.6 ml) and anisole (0.605 ml), cooled to 0 ° C., 1.8 ml of TFA was added, and compound 69 was prepared in the same manner as in Example 41 (2). Obtained as a powder. Yield 44 mg (6%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.1Hz), 3.34(2H, s), 3.41, 3.49(2H, ABq, J = 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.1Hz), 3.34 (2H, s), 3.41, 3.49 (2H, ABq, J =
15.9Hz), 4.09(2H, q, J = 7.1 Hz), 5.03(1H, d, J = 4.7Hz), 5.22(2H, d, J = 7.7Hz), 5. 59(1H, dd, J = 8.1, 4.7Hz), 5.83(1H, dt, J = 15.8, 7.7Hz), 6.72(1H, s), 7.22(2H, s), 7.27(1H, d, J = 15.8Hz), 7.95(2H, d, J = 6.9Hz), 8.83(2H, d, J = 6.9Hz), 9.53(1H, d, J = 8.1Hz). 15.9Hz), 4.09 (2H, q, J = 7.1 Hz), 5.03 (1H, d, J = 4.7Hz), 5.22 (2H, d, J = 7.7Hz), 5.59 (1H, dd, J = 8.1, 4.7Hz), 5.83 (1H, dt, J = 15.8, 7.7Hz), 6.72 (1H, s), 7.22 (2H, s), 7.27 (1H, d, J = 15.8Hz), 7.95 (2H, d, J = 6.9Hz), 8.83 (2H, d, J = 6.9Hz), 9.53 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3418, 2162, 1762, 1604, 1533, 1364, 1291, 1036. IR (KBr) cm _1 : 3418, 2162, 1762, 1604, 1533, 1364, 1291, 1036.
MS(ESI): 597+ (M-Na+2H)+ MS (ESI): 597 + (M-Na + 2H) +
元素分析 C H N O S Na- 3.5 H O - 0.4NaHCO Elemental analysis C H N O S Na- 3.5 H O-0.4NaHCO
計算値: C, 42.65; H, 4.28; N, 15.67; S, 8.97; Na 4.50 (%) Calculated: C, 42.65; H, 4.28; N, 15.67; S, 8.97; Na 4.50 (%)
実験値: C, 42.67; H, 4.45; N, 15.59; S, 9.13; Na 4.58 (%) Experimental values: C, 42.67; H, 4.45; N, 15.59; S, 9.13; Na 4.58 (%)
実施例 59 Example 59
[化 105] [Chemical 105]
74 74
(1) 73→74 (1) 73 → 74
化合物 9(675mg、 l.OOmmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナト リウム水溶液 (126mg、 1.50mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫
酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (3ml)に溶 解し、化合物 73(365mg,1.00mmol)と混合し、臭化ナトリウム (309mg、 3.00mmol)を加え て、室温で 4時間 20分攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、析出し た沈殿を濾取した。沈殿を減圧乾燥して化合物 74を無定形粉末として得た。収量 954 mg(91%) Compound 9 (675 mg, l.OOmmol) is suspended in dichloromethane (10 ml), and an aqueous sodium hydrogen carbonate solution (126 mg, 1.50 mmol is dissolved in 10 ml of water) is added under ice cooling, followed by extraction with dichloromethane and sulfurization. Dried with magnesium acid. After distilling off the solvent, quickly dissolve in dimethylformamide (3 ml), mix with compound 73 (365 mg, 1.00 mmol), add sodium bromide (309 mg, 3.00 mmol), and stir at room temperature for 4 hours and 20 minutes. did. The reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 74 as an amorphous powder. Yield 954 mg (91%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 3.65, 3.90(2H, ABq, J = 17.9Hz), 4.1 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 3.65, 3.90 (2H, ABq, J = 17.9Hz), 4.1
6 6
0(2H, q, J = 7.2 Hz), 5.29(1H, d, J = 4.8Hz), 5.33(2H, d, J = 6.6Hz), 5.93(1H, dd, J = 8.4, 4.8Hz), 6.44(1H, dt, J = 15.8, 6.6Hz), 6.75(1H, s), 6.93(1H, s), 6.94(1H, d, J = 15.8Hz), 7.11(1H, s), 7.20— 7.60(m, 22H), 8.22(2H, d, J = 8.7Hz), 8.34(2H, d, J = 8.7Hz), 8.58(2H, d, J = 6.9Hz), 9.07 (2H, d, J = 6.9Hz), 9.66(1H, d, J = 8.4Hz). (2) 74→72 0 (2H, q, J = 7.2 Hz), 5.29 (1H, d, J = 4.8Hz), 5.33 (2H, d, J = 6.6Hz), 5.93 (1H, dd, J = 8.4, 4.8Hz), 6.44 (1H, dt, J = 15.8, 6.6Hz), 6.75 (1H, s), 6.93 (1H, s), 6.94 (1H, d, J = 15.8Hz), 7.11 (1H, s), 7.20—7.60 (m, 22H), 8.22 (2H, d, J = 8.7Hz), 8.34 (2H, d, J = 8.7Hz), 8.58 (2H, d, J = 6.9Hz), 9.07 (2H, d, J = 6.9Hz), 9.66 (1H, d, J = 8.4Hz). (2) 74 → 72
化合物74(94611¾,0.90311111101)を塩化メチレン(5.71111)とァニソール(0.9461111)に溶解し 、 0°Cに冷却し、 TFA 2.9mlをカ卩え、実施例 41の (2)と同様の手法にて、化合物 72を粉 末として得た。収量 243mg(36%) Compound 74 (94611¾, 0.90311111101) was dissolved in methylene chloride (5.71111) and anisole (0.9461111), cooled to 0 ° C., and 2.9 ml of TFA was added. Compound 72 was obtained as a powder. Yield 243 mg (36%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.42, 3.50(2H, ABq, J = 16.8Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.42, 3.50 (2H, ABq, J = 16.8Hz), 4.0
6 6
9(2H, q, J = 6.9Hz), 5.04(1H, d, J = 4.9Hz), 5.28(2H, d, J = 7.8Hz), 5.59(1H, dd, J = 8.0, 4.9Hz), 5.87(1H, dt, J = 15.8, 7.8Hz), 6.72(1H, s), 7.24(2H, s), 7.30(1H, d, J 9 (2H, q, J = 6.9Hz), 5.04 (1H, d, J = 4.9Hz), 5.28 (2H, d, J = 7.8Hz), 5.59 (1H, dd, J = 8.0, 4.9Hz), 5.87 (1H, dt, J = 15.8, 7.8Hz), 6.72 (1H, s), 7.24 (2H, s), 7.30 (1H, d, J
= 15.8Hz), 7.97(2H, d, J = 8.3Hz), 8.02(2H, d, J = 8.3Hz), 8.50(2H, d, J = 6.8Hz),= 15.8Hz), 7.97 (2H, d, J = 8.3Hz), 8.02 (2H, d, J = 8.3Hz), 8.50 (2H, d, J = 6.8Hz),
9.01(2H, d, J = 6.8Hz), 9.54(1H, d, J = 8.0Hz). 9.01 (2H, d, J = 6.8Hz), 9.54 (1H, d, J = 8.0Hz).
IR (KBr) cm— 3408, 1763, 1631, 1526, 1360, 1158. IR (KBr) cm— 3408, 1763, 1631, 1526, 1360, 1158.
MS(ESI): 639+ (M-Na+2H)+ MS (ESI): 639 + (M-Na + 2H) +
元素分析 c H N O S Na- 3.4 H O - 0.2NaHCO Elemental analysis c H N O S Na- 3.4 H O-0.2 NaHCO
28 25 6 6 3 2 3 28 25 6 6 3 2 3
計算値: C,44.76; H,4.53; Ν, Ι Ι.10; S, 12.71; Na 3.65 (%) Calculated values: C, 44.76; H, 4.53; Ν, Ι Ι.10; S, 12.71; Na 3.65 (%)
実験値: C,44.78; H,4.41; N,11.02; S, 12.76; Na 3.72 (%) Experimental value: C, 44.78; H, 4.41; N, 11.02; S, 12.76; Na 3.72 (%)
実施例 60 Example 60
[化 106]
[Chem 106]
81 81
(1) 76+77→78 (1) 76 + 77 → 78
4-ブロモピリジン塩酸塩 76(1.95g, 10.0mmol)をジェチルエーテル /2N NaOHに溶解 し、ジェチルエーテルで抽出した。有機層を水、飽和食塩水で洗浄し、硫酸ナトリウ ムで乾燥した。ジメチルホルムアミド (14ml)を加えてジェチルエーテルを減圧留去し、 氷冷下にて化合物 77(1.66g,10.0mmol)、 LiBHEt 1Mテトラヒドロフラン溶液 (11. Oml)を 加えて 80°Cにて 16時間撹拌した。酢酸ェチル、水中に反応液を注加し、酢酸ェチル で抽出した。有機層を水、飽和食塩水で洗浄し、硫酸ナトリウムで乾燥した。溶媒を 減圧留去し、シリカゲルクロマトグラフィーに付して、へキサン:酢酸ェチル = 1 :3で溶 出した。 目的のフラクションを濃縮し、化合物 78を油状物質として得た。収量 2.00g(82 %) 4-Bromopyridine hydrochloride 76 (1.95 g, 10.0 mmol) was dissolved in jetyl ether / 2N NaOH and extracted with jetyl ether. The organic layer was washed with water and saturated brine, and dried over sodium sulfate. Dimethylformamide (14 ml) was added and the diethyl ether was distilled off under reduced pressure. Under ice-cooling, Compound 77 (1.66 g, 10.0 mmol) and LiBHEt 1M tetrahydrofuran solution (11. Oml) were added, and the mixture was heated at 80 ° C. Stir for hours. The reaction mixture was poured into ethyl acetate and water, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel chromatography, and eluted with hexane: ethyl acetate = 1: 3. The desired fraction was concentrated to give compound 78 as an oily substance. Yield 2.00 g (82%)
'H-NMR (d -DMSO): 1.33(3H, t, J = 7.2Hz), 4.33(2H, q, J = 7.2 Hz), 7.07(2H, d, J 'H-NMR (d-DMSO): 1.33 (3H, t, J = 7.2Hz), 4.33 (2H, q, J = 7.2 Hz), 7.07 (2H, d, J
= 5.3Hz), 7.30(2H, d, J = 8.7Hz), 8.06(2H, d, J = 8.7Hz), 8.54(2H, d, J = 5.3Hz).= 5.3Hz), 7.30 (2H, d, J = 8.7Hz), 8.06 (2H, d, J = 8.7Hz), 8.54 (2H, d, J = 5.3Hz).
(2) 78→79 (2) 78 → 79
化合物 78(817mg,3.36mmol)より実施例 49の (1)と同様の手法にて化合物 79を無色
結晶として得た。収量 523mg(72%) Compound 79 was purified from Compound 78 (817 mg, 3.36 mmol) in the same manner as in Example 49, (1). Obtained as crystals. Yield 523mg (72%)
'H-NMR (d -DMSO): 7.24(2H, d, J = 5.6Hz), 7.38(2H, d, J = 8.4Hz), 8.07(2H, d, J 'H-NMR (d-DMSO): 7.24 (2H, d, J = 5.6Hz), 7.38 (2H, d, J = 8.4Hz), 8.07 (2H, d, J
= 8.4Hz), 8.65(2H, d, J = 5.6Hz). = 8.4Hz), 8.65 (2H, d, J = 5.6Hz).
(3) 79→80 (3) 79 → 80
化合物 79(323mg,1.50mmol)より、実施例 56の (1)と同様の手法にて化合物 80を無色 結晶として得た。収量 436mg(76%) Compound 80 was obtained as colorless crystals from Compound 79 (323 mg, 1.50 mmol) in the same manner as in Example 56, (1). Yield 436 mg (76%)
'H-NMR (d -DMSO): 7.06(2H, d, J = 6.0Hz), 7.07(1H, s), 7.28— 7.42(8H, m), 7.53 ( d, 4H, J = 7.2Hz), 8.21(2H, d, J = 8.8Hz), 8.53(2H, d, J = 6.0Hz). 'H-NMR (d-DMSO): 7.06 (2H, d, J = 6.0Hz), 7.07 (1H, s), 7.28—7.42 (8H, m), 7.53 (d, 4H, J = 7.2Hz), 8.21 (2H, d, J = 8.8Hz), 8.53 (2H, d, J = 6.0Hz).
(4) 80→81 (4) 80 → 81
化合物 9(675mg、 l.OOmmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナト リウム水溶液 (126mg、 1.50mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (3ml)に溶 解し、化合物 80(381mg,1.00mmol)と混合し、臭化ナトリウム (309mg、 3.00mmol)を加え て、室温で 4時間攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、析出した沈 殿を濾取した。沈殿を減圧乾燥して化合物 81を無定形粉末として得た。収量 919mg( 86%) Compound 9 (675 mg, l.OOmmol) is suspended in dichloromethane (10 ml), aqueous sodium hydrogen carbonate solution (126 mg, 1.50 mmol dissolved in 10 ml of water) is added under ice cooling, extracted with dichloromethane, and magnesium sulfate is added. Dried. After the solvent was distilled off, it was immediately dissolved in dimethylformamide (3 ml), mixed with compound 80 (381 mg, 1.00 mmol), sodium bromide (309 mg, 3.00 mmol) was added, and the mixture was stirred at room temperature for 4 hours. The reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 81 as an amorphous powder. Yield 919mg (86%)
'H-NMR (d -DMSO): 1.23(3H, t,J = 7.2Hz), 3.62, 3.88(2H, ABq, J = 17.0Hz), 4.1 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.2Hz), 3.62, 3.88 (2H, ABq, J = 17.0Hz), 4.1
0(2H, q, J = 7.2 Hz), 5.20(2H, d, J = 6.9Hz), 5.29(1H, d, J = 5.1Hz), 5.92(1H, dd, J = 8.3, 5.1Hz), 6.37(1H, dt, J = 15.9, 6.9Hz), 6.75(1H, s), 6.87(1H, d, J = 15.9Hz), 6.93(1H, s), 7.09(1H, s), 7.20-7.85(m, 26H), 8.32(2H, d, J = 8.7Hz), 8. 84(2H, d, J = 7.5Hz), 9.65(1H, d, J = 8.3Hz). 0 (2H, q, J = 7.2 Hz), 5.20 (2H, d, J = 6.9Hz), 5.29 (1H, d, J = 5.1Hz), 5.92 (1H, dd, J = 8.3, 5.1Hz), 6.37 (1H, dt, J = 15.9, 6.9Hz), 6.75 (1H, s), 6.87 (1H, d, J = 15.9Hz), 6.93 (1H, s), 7.09 (1H, s), 7.20-7.85 (m, 26H), 8.32 (2H, d, J = 8.7Hz), 8.84 (2H, d, J = 7.5Hz), 9.65 (1H, d, J = 8.3Hz).
(5) 81→75 (5) 81 → 75
化合物81(91111¾,0.85611111101)を塩化メチレン(5.51111)とァニソール(0.9111111)に溶解し 、 0°Cに冷却し、 TFA 2.7mlをカ卩え、実施例 41の (2)と同様の手法にて、化合物 75を粉 末として得た。収量 252mg(39%) Compound 81 (91111¾, 0.85611111101) was dissolved in methylene chloride (5.51111) and anisole (0.9111111), cooled to 0 ° C, TFA 2.7 ml was added, and the same procedure as (2) of Example 41 was used. Compound 75 was obtained as a powder. Yield 252 mg (39%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.39, 3.46(2H, ABq, J = 18.0Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.39, 3.46 (2H, ABq, J = 18.0Hz), 4.0
9(2H, q, J = 6.9Hz), 5.03(1H, d, J = 5.0Hz), 5.17(2H, d, J = 7.2Hz), 5.59(1H, dd, J = 8.0, 5.0Hz), 5.79(1H, dt, J = 15.6, 7.2Hz), 6.72(1H, s), 7.18(2H, d, J = 8.7Hz), 7.
22(1H, d, J = 15.6Hz), 7.24(2H, s), 7.53(2H, d, J = 7. 5Hz), 8.00(2H, d, J = 8.7Hz) 8.85(2H, d, J = 7.5Hz), 9.53(1H, d, J = 8.0Hz). 9 (2H, q, J = 6.9Hz), 5.03 (1H, d, J = 5.0Hz), 5.17 (2H, d, J = 7.2Hz), 5.59 (1H, dd, J = 8.0, 5.0Hz), 5.79 (1H, dt, J = 15.6, 7.2Hz), 6.72 (1H, s), 7.18 (2H, d, J = 8.7Hz), 7. 22 (1H, d, J = 15.6Hz), 7.24 (2H, s), 7.53 (2H, d, J = 7.5Hz), 8.00 (2H, d, J = 8.7Hz) 8.85 (2H, d, J = 7.5Hz), 9.53 (1H, d, J = 8.0Hz).
IR (KBr) cm— 3398, 1765, 1639, 1604, 1560, 1534, 1511, 1383, 1292, 1200, 1159, 1035. IR (KBr) cm— 3398, 1765, 1639, 1604, 1560, 1534, 1511, 1383, 1292, 1200, 1159, 1035.
MS(ESI): 651+ (M-Na+2H)+ MS (ESI): 651 + (M-Na + 2H) +
元素分析 C H N O S Na-4.4 H O Elemental analysis C H N O S Na-4.4 H O
計算値: C,46.32; H,4.53; N,11.18; S, 8.53; Na 3.06 (%) Calculated values: C, 46.32; H, 4.53; N, 11.18; S, 8.53; Na 3.06 (%)
実験値: C46.27; H,4.43; N,11.33; S, 8.66; Na 3.31 (%) Experimental value: C46.27; H, 4.43; N, 11.33; S, 8.66; Na 3.31 (%)
実施例 61 Example 61
[化 107] [Chemical 107]
84 84
(1) 43→84 (1) 43 → 84
化合物 83(736mg,1.00mmol)、化合物 43(483mg,1.06mmol)をジメチルホルムアミド (4. 5ml),に懸濁させ、臭化ナトリウム (309mg,3.00mmol)をカ卩えた。室温で 4時間 35分撹拌 後、反応液を 5%食塩水 (30ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減 圧乾燥して化合物 84を無定形粉末として得た。収量 1.322g(94%) Compound 83 (736 mg, 1.00 mmol) and compound 43 (483 mg, 1.06 mmol) were suspended in dimethylformamide (4.5 ml), and sodium bromide (309 mg, 3.00 mmol) was obtained. After stirring at room temperature for 4 hours and 35 minutes, the reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was reduced pressure dried to obtain Compound 84 as an amorphous powder. Yield 1.322 g (94%)
'H-NMR (d -DMSO): 0.90(3H, t, J = 7.5Hz), 1.44 (2H, sext, J = 7.5Hz), 1.47(9H, s), 2.20(2H, q, J = 7.2Hz), 3.66, 3.92(2H, ABq, J = 18.0Hz), 3.75(3H, s), 3.76(3H, s), 5.12— 5.30(6H, m), 5.32(1H, d, J = 4.8Hz), 5.88(1H, dd, J = 7.8, 4.8Hz), 6.38(1H
, t, J = 7.5Hz), 6.40-6.60(1H, m), 6.77(1H, s), 6.86_6.95(7H, m), 7.15- 7·60(14Η, m ), 8.28(1H, dd, J = 8.7, 2.4Hz), 8.34(1H, d, J = 2.4Hz), 8.49(2H, d, J = 7.2Hz), 8.93 (2H, d, J = 7.2Hz), 9.39(1H, d, J = 7.8Hz), 11.5(1H, brs). 'H-NMR (d-DMSO): 0.90 (3H, t, J = 7.5Hz), 1.44 (2H, sext, J = 7.5Hz), 1.47 (9H, s), 2.20 (2H, q, J = 7.2 Hz), 3.66, 3.92 (2H, ABq, J = 18.0Hz), 3.75 (3H, s), 3.76 (3H, s), 5.12—5.30 (6H, m), 5.32 (1H, d, J = 4.8Hz ), 5.88 (1H, dd, J = 7.8, 4.8Hz), 6.38 (1H , t, J = 7.5Hz), 6.40-6.60 (1H, m), 6.77 (1H, s), 6.86_6.95 (7H, m), 7.15- 7 · 60 (14mm, m), 8.28 (1H, dd, J = 8.7, 2.4Hz), 8.34 (1H, d, J = 2.4Hz), 8.49 (2H, d, J = 7.2Hz), 8.93 (2H, d, J = 7.2Hz), 9.39 (1H, d, J = 7.8Hz), 11.5 (1H, brs).
(2) 84→82 (2) 84 → 82
化合物 84(1.31g,0.987mmol)を塩化メチレン (13ml)とァニソール (1.31ml)に溶解し、 - 30°Cに冷却し、 2M塩ィ匕アルミニウムニトロメタン溶液 5.0mlをカ卩え、実施例 50の (2)と同 様の手法にて化合物 82を無定形粉末として得た。収量 98mg(12%) Compound 84 (1.31 g, 0.987 mmol) was dissolved in methylene chloride (13 ml) and anisole (1.31 ml), cooled to −30 ° C., and 5.0 ml of 2M salt-aluminum nitromethane solution was added. Compound 82 was obtained as an amorphous powder by the same method as in (2). Yield 98 mg (12%)
'H-NMR (d -DMSO): 0.87(3H, t, J = 7.5Hz), 1.40(2H, sept, J = 7.5Hz), 3.41, 3.49('H-NMR (d-DMSO): 0.87 (3H, t, J = 7.5Hz), 1.40 (2H, sept, J = 7.5Hz), 3.41, 3.49 (
2H, ABq, J = 17.4Hz), 5.04(1H, d , J = 5.0Hz), 5.14(2H, d, J = 6.9Hz), 5.58(1H, dd , J = 7.7, 5.0Hz), 5.81(1H, dt, J = 15.3, 6.9Hz), 6.18(1H, s), 6.23(1H, t, 7.5Hz), 6.7 6(2H, d, J = 8.9Hz), 6.9 8(2H, s), 7.26(1H, d, J = 15.3Hz), 7.93(1H, dd, J = 8.9, 2.7 Hz), 8.28(2H, d, J = 6.9Hz), 8.37(1H, d, J = 2.7Hz), 8.72(2H, d, J = 6.9Hz), 9.18(1 H, d, J = 7.7Hz). 2H, ABq, J = 17.4Hz), 5.04 (1H, d, J = 5.0Hz), 5.14 (2H, d, J = 6.9Hz), 5.58 (1H, dd, J = 7.7, 5.0Hz), 5.81 ( 1H, dt, J = 15.3, 6.9Hz), 6.18 (1H, s), 6.23 (1H, t, 7.5Hz), 6.7 6 (2H, d, J = 8.9Hz), 6.9 8 (2H, s), 7.26 (1H, d, J = 15.3Hz), 7.93 (1H, dd, J = 8.9, 2.7 Hz), 8.28 (2H, d, J = 6.9Hz), 8.37 (1H, d, J = 2.7Hz), 8.72 (2H, d, J = 6.9Hz), 9.18 (1 H, d, J = 7.7Hz).
IR (KBr) cm_1:3408, 1762, 1626, 1601, 1527, 1489, 1389, 1301, 1158. IR (KBr) cm _1 : 3408, 1762, 1626, 1601, 1527, 1489, 1389, 1301, 1158.
MS(ESI): 648+ (M_Na+2H)+ MS (ESI): 648+ (M_Na + 2H) +
元素分析 C H N O S Na-4.5 H O - 0.6NaHCO Elemental analysis C H N O S Na-4.5 H O-0.6 NaHCO
計算値: C,47.37; H,4.73; N, 8.74; S, 8.00; Na 4.59 (%) Calculated value: C, 47.37; H, 4.73; N, 8.74; S, 8.00; Na 4.59 (%)
実験値: C,47.22; H,4.64; N, 8.99; S, 8.41; Na 4.74 (%) Experimental value: C, 47.22; H, 4.64; N, 8.99; S, 8.41; Na 4.74 (%)
実施例 62 Example 62
[化 108]
[Chemical 108]
90 90
89 89
(1) 86→87 (1) 86 → 87
化合物 86(1.54g,10.0mmol)をエタノール (15ml)に懸濁させ、濃硫酸 (0.15ml)を加え て還流下 22時間撹拌した。エタノールを減圧留去し、水、酢酸ェチルを加え、酢酸ェ チルで抽出した。有機層を水、飽和食塩水で洗浄し、硫酸ナトリウムで乾燥後、溶媒 を減圧留去して、シリカゲルクロマトグラフィーに付した。へキサン:酢酸ェチル = 1 : 1 で溶出し、 目的のフラクションを濃縮して、化合物 87を油状物質として得た。収量 1.72 g(94%) Compound 86 (1.54 g, 10.0 mmol) was suspended in ethanol (15 ml), concentrated sulfuric acid (0.15 ml) was added, and the mixture was stirred under reflux for 22 hours. Ethanol was distilled off under reduced pressure, water and ethyl acetate were added, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over sodium sulfate, and the solvent was evaporated under reduced pressure and subjected to silica gel chromatography. Elution was performed with hexane: ethyl acetate = 1: 1, and the desired fraction was concentrated to obtain Compound 87 as an oily substance. Yield 1.72 g (94%)
'H-NMR (d -DMSO): 1.3K3H, t, J = 7.2Hz), 4.29(2H, q, J = 7.2 Hz), 6.05(1H, s), 'H-NMR (d-DMSO): 1.3K3H, t, J = 7.2Hz), 4.29 (2H, q, J = 7.2 Hz), 6.05 (1H, s),
6 6
7.43(2H, d, J = 8.2Hz), 7.81(2H, d, J = 8.2Hz). 7.43 (2H, d, J = 8.2Hz), 7.81 (2H, d, J = 8.2Hz).
(2) 76+87→88 (2) 76 + 87 → 88
4 -ブロモピリジン塩酸塩 76(2.21g, 11.4mmol)をジェチルエーテル /2N NaOHに溶解 し、ジェチルエーテルで抽出した。有機層を水、飽和食塩水で洗浄し、硫酸ナトリウ ムで乾燥した。ジメチルホルムアミド (15ml)を加えてジェチルエーテルを減圧留去し、 氷冷下にて化合物 87(2.07g, 11.4mmol)、 LiBHEt 1Mテトラヒドロフラン溶液 (12.6ml)を
加えて室温にて 50分撹拌した。酢酸ェチル、水中に反応液を注加し、酢酸ェチルで 抽出した。有機層を水、飽和食塩水で洗浄し、硫酸ナトリウムで乾燥した。溶媒を減 圧留去し、シリカゲルクロマトグラフィーに付して、へキサン:酢酸ェチル = 1 : 1で溶出 した。 目的のフラクションを濃縮し、化合物 88を油状物質として得た。収量 2.00g(82%) 'H-NMR (d -DMSO): 1.42(3H, t, J = 7.2Hz), 4.41(2H, q, J = 7.2 Hz), 7.05(2H, d, J4-Bromopyridine hydrochloride 76 (2.21 g, 11.4 mmol) was dissolved in jetyl ether / 2N NaOH and extracted with jetyl ether. The organic layer was washed with water and saturated brine, and dried over sodium sulfate. Dimethylformamide (15 ml) was added and the diethyl ether was distilled off under reduced pressure.Compound 87 (2.07 g, 11.4 mmol) and LiBHEt 1M tetrahydrofuran solution (12.6 ml) were added under ice cooling. In addition, the mixture was stirred at room temperature for 50 minutes. The reaction mixture was poured into ethyl acetate and water and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, and dried over sodium sulfate. The solvent was distilled off under reduced pressure, subjected to silica gel chromatography, and eluted with hexane: ethyl acetate = 1: 1. The desired fraction was concentrated to give compound 88 as an oil. Yield 2.00 g (82%) 'H-NMR (d-DMSO): 1.42 (3H, t, J = 7.2 Hz), 4.41 (2H, q, J = 7.2 Hz), 7.05 (2H, d, J
= 6.3Hz), 7.58(2H, d, J = 8.7Hz), 8.09(2H, d, J = 8.7Hz), 8.42(2H, d, J = 6.3Hz).= 6.3Hz), 7.58 (2H, d, J = 8.7Hz), 8.09 (2H, d, J = 8.7Hz), 8.42 (2H, d, J = 6.3Hz).
(3) 88→89 (3) 88 → 89
化合物 88(1.06g,4.10mmol)より実施例 49の (1)と同様の手法にて化合物 89を無色結 晶として得た。収量 717mg(76%) Compound 89 was obtained as a colorless crystal from Compound 88 (1.06 g, 4.10 mmol) in the same manner as in Example 49, (1). Yield 717 mg (76%)
'H-NMR (d -DMSO): 7.17(2H, d, J = 6.0Hz), 7.64(2H, d, J = 8.4Hz), 8.02(2H, d, J 'H-NMR (d-DMSO): 7.17 (2H, d, J = 6.0Hz), 7.64 (2H, d, J = 8.4Hz), 8.02 (2H, d, J
= 8.4Hz), 8.44(2H, d, J = 6.0Hz), 13.0(1H, brs). = 8.4Hz), 8.44 (2H, d, J = 6.0Hz), 13.0 (1H, brs).
(4) 89→90 (4) 89 → 90
化合物 89(578mg,2.50mmol)より、実施例 56の (1)と同様の手法にて化合物 90を淡褐 色結晶として得た。収量 892mg(90%) Compound 90 was obtained as pale brown crystals from Compound 89 (578 mg, 2.50 mmol) in the same manner as in Example 56, (1). Yield 892 mg (90%)
'H-NMR (d -DMSO): 6·99(1Η, s), 7.20(2Η, d, J = 6·2Ηζ), 7.29_7·56(10Η, m), 7.69 'H-NMR (d-DMSO): 6 · 99 (1Η, s), 7.20 (2Η, d, J = 6 · 2Ηζ), 7.29_7 · 56 (10Η, m), 7.69
(d, 2H, J = 8.4Hz), 8.18(2H, d, J = 8.4Hz), 8.45(2H, d, J = 6.2Hz). (d, 2H, J = 8.4Hz), 8.18 (2H, d, J = 8.4Hz), 8.45 (2H, d, J = 6.2Hz).
(5) 90→91 (5) 90 → 91
化合物 9(675mg、 l.OOmmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナト リウム水溶液 (126mg、 1.50mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (3ml)に溶 解し、化合物 90(398mg,1.00mmol)と混合し、臭化ナトリウム (309mg、 3.00mmol)を加え て、室温で 8時間 30分攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、析出し た沈殿を濾取した。沈殿を減圧乾燥して化合物 91を無定形粉末として得た。収量 970 mg(90%) Compound 9 (675 mg, l.OOmmol) is suspended in dichloromethane (10 ml), aqueous sodium hydrogen carbonate solution (126 mg, 1.50 mmol dissolved in 10 ml of water) is added under ice-cooling, extracted with dichloromethane, and magnesium sulfate is added. Dried. After distilling off the solvent, quickly dissolve in dimethylformamide (3 ml), mix with compound 90 (398 mg, 1.00 mmol), add sodium bromide (309 mg, 3.00 mmol), and stir at room temperature for 8 hours 30 minutes. did. The reaction solution was poured into 5% brine (30 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 91 as an amorphous powder. Yield 970 mg (90%)
'H-NMR (d -DMSO): 1.23(3H, t, J = 7.2Hz), 3.61, 3.85(2H, ABq, J = 17.6Hz), 4.1 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.2Hz), 3.61, 3.85 (2H, ABq, J = 17.6Hz), 4.1
0(2H, q, J = 7.2 Hz), 5.14(2H, d, J = 6.9Hz), 5.28(1H, d, J = 5.1Hz), 5.92(1H, dd, J = 8.1, 5.1Hz), 6.32(1H, dt, J = 15.9, 6.9Hz), 6.75(1H, s), 6.86(1H, d, J = 15.9Hz), 6.92(1H, s), 7.11(1H, s), 7.24— 7.58(m, 22H), 7.70(2H, d, J = 7.4Hz), 7.87 (2H, d, J
= 8.7Hz), 8.31(2H, d, J = 8.7Hz), 8.61(2H, d, J = 7.4Hz), 9.65(1H, d, J = 8.1Hz).0 (2H, q, J = 7.2 Hz), 5.14 (2H, d, J = 6.9Hz), 5.28 (1H, d, J = 5.1Hz), 5.92 (1H, dd, J = 8.1, 5.1Hz), 6.32 (1H, dt, J = 15.9, 6.9Hz), 6.75 (1H, s), 6.86 (1H, d, J = 15.9Hz), 6.92 (1H, s), 7.11 (1H, s), 7.24—7.58 (m, 22H), 7.70 (2H, d, J = 7.4Hz), 7.87 (2H, d, J = 8.7Hz), 8.31 (2H, d, J = 8.7Hz), 8.61 (2H, d, J = 7.4Hz), 9.65 (1H, d, J = 8.1Hz).
(6) 91→85 (6) 91 → 85
化合物 91(958mg,0.888mmol)を塩化メチレン (5.8ml)とァニソール (0.958ml)に溶解し 、 0°Cに冷却し、 TFA 2.9mlをカ卩え、実施例 41の (2)と同様の手法にて、化合物 85を粉 末として得た。収量 228mg(33%) Compound 91 (958 mg, 0.888 mmol) was dissolved in methylene chloride (5.8 ml) and anisole (0.958 ml), cooled to 0 ° C, TFA 2.9 ml was added, and the same as in Example 41 (2) By the method, Compound 85 was obtained as a powder. Yield 228 mg (33%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.0Hz), 3.37, 3.45(2H, ABq, J = 17.1Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.0Hz), 3.37, 3.45 (2H, ABq, J = 17.1Hz), 4.0
6 6
9(2H, q, J = 7.0Hz), 5.01(1H, d, J = 4.8Hz), 5.17(2H, d, J = 6.9Hz), 5.58(1H, dd, J 9 (2H, q, J = 7.0Hz), 5.01 (1H, d, J = 4.8Hz), 5.17 (2H, d, J = 6.9Hz), 5.58 (1H, dd, J
= 8.1, 4.8Hz), 5.75(1H, dt, J = 15.9, 6.9Hz), 6.71(1H, s), 7.21(1H, d, J = 15.9Hz),= 8.1, 4.8Hz), 5.75 (1H, dt, J = 15.9, 6.9Hz), 6.71 (1H, s), 7.21 (1H, d, J = 15.9Hz),
7.22(2H, s), 7.56(2H, d, J = 8.4Hz), 7.58(2H, d, J = 7.2Hz), 8.03(2H, d, J = 8.4Hz)7.22 (2H, s), 7.56 (2H, d, J = 8.4Hz), 7.58 (2H, d, J = 7.2Hz), 8.03 (2H, d, J = 8.4Hz)
, 8.64(2H, d, J = 7.2Hz), 9.51(1H, d, J = 8.1Hz). 8.64 (2H, d, J = 7.2Hz), 9.51 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3398, 1764, 1625, 1594, 1560, 1538, 1384, 1105, 1036. IR (KBr) cm _1 : 3398, 1764, 1625, 1594, 1560, 1538, 1384, 1105, 1036.
MS(ESI): 667+ (M-Na+2H)+ MS (ESI): 667 + (M-Na + 2H) +
元素分析 C H N O S Na-4.5 H O - O. lNaHCO Elemental analysis C H N O S Na-4.5 H O-O. lNaHCO
29 25 6 7 3 2 3 29 25 6 7 3 2 3
計算値: C,44.91; H,4.42; N,10.80; S, 12.36; Na 3.25 (%) Calculated value: C, 44.91; H, 4.42; N, 10.80; S, 12.36; Na 3.25 (%)
実験値: C,44.95; H,4.38; N,10.95; S, 12.19; Na 3.25 (%) Experimental value: C, 44.95; H, 4.38; N, 10.95; S, 12.19; Na 3.25 (%)
実施例 63 Example 63
[化 109] [Chemical 109]
la+ la +
94
(1) 39→93 94 (1) 39 → 93
化合物 39(308mg,1.20mmol)、エタンスルホンアミド (131mg,1.20mmol)より実施例 46 の (1)と同様の手法にて化合物 93を無色結晶として得た。収量 282mg(83%) Compound 93 was obtained as colorless crystals from Compound 39 (308 mg, 1.20 mmol) and ethanesulfonamide (131 mg, 1.20 mmol) in the same manner as in Example 46, (1). Yield 282 mg (83%)
'H-NMR (d -DMSO): 1.28(3H, d, J = 7.2Hz), 3.47(2H, q, J = 7.2Hz), 8.22(2H, d, J 'H-NMR (d-DMSO): 1.28 (3H, d, J = 7.2Hz), 3.47 (2H, q, J = 7.2Hz), 8.22 (2H, d, J
6 6
= 5.6 Hz), 8.76(2H, d, J = 5.6 Hz), 8.91(1H, s). = 5.6 Hz), 8.76 (2H, d, J = 5.6 Hz), 8.91 (1H, s).
(2) 93→94 (2) 93 → 94
化合物 93(333mg,1.12mmol)をメタノール中に懸濁し、ナトリウムメトキシドメタノール 溶液を pH=8.9となるまで滴下して、得られた溶液を減圧濃縮して、 93のナトリウム塩を 得た。化合物 9(756mg、 1.12mmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水 素ナトリウム水溶液 (141mg、 1.68mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出 し、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (4ml) に溶解し、 93のナトリウム塩と混合し、臭化ナトリウム (346mg,3.36mmol)を加えて、室 温で 4時間 15分攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、析出した沈殿 を濾取した。沈殿を減圧乾燥して化合物 94を無定形粉末として得た。収量 836mg(83 %) Compound 93 (333 mg, 1.12 mmol) was suspended in methanol, a sodium methoxide methanol solution was added dropwise until pH = 8.9, and the resulting solution was concentrated under reduced pressure to obtain 93 sodium salt. Compound 9 (756 mg, 1.12 mmol) was suspended in dichloromethane (10 ml), an aqueous sodium hydrogen carbonate solution (141 mg, 1.68 mmol dissolved in 10 ml of water) was added under ice-cooling, extracted with dichloromethane, and dried over magnesium sulfate. . After distilling off the solvent, it was immediately dissolved in dimethylformamide (4 ml), mixed with 93 sodium salt, sodium bromide (346 mg, 3.36 mmol) was added, and the mixture was stirred at room temperature for 4 hours and 15 minutes. The reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 94 as an amorphous powder. Yield 836 mg (83%)
'H-NMR (d -DMSO): 1·13(3Η, t, J = 7.4Hz), 1.22(3H, t, J = 7.2Hz), 3.10(2H, q, J 'H-NMR (d-DMSO): 1 · 13 (3Η, t, J = 7.4Hz), 1.22 (3H, t, J = 7.2Hz), 3.10 (2H, q, J
6 6
= 7.4 Hz), 3.65, 3.91(2H, ABq, J = 17.6Hz), 4.10(2H, q, J = 7.2Hz), 5.27(2H, d, J = 6.6Hz), 5.29(1H, d, J = 4.8Hz), 5.92(1H, dd, J = 8.3, 4.8Hz), 6.43(1H, dt, J = 15.8 , 6.6Hz), 6.75(1H, s), 6.87(1H, d, J = 15.8Hz), 6.92(1H, s), 7.24(2H, s), 7.24— 7.52( m, 10H), 8.59(2H, d, J = 6.9Hz), 8.97(2H, d, J = 6.9Hz), 9.01(1H, s), 9.65(1H, d, J = 8.3Hz). = 7.4 Hz), 3.65, 3.91 (2H, ABq, J = 17.6Hz), 4.10 (2H, q, J = 7.2Hz), 5.27 (2H, d, J = 6.6Hz), 5.29 (1H, d, J = 4.8Hz), 5.92 (1H, dd, J = 8.3, 4.8Hz), 6.43 (1H, dt, J = 15.8, 6.6Hz), 6.75 (1H, s), 6.87 (1H, d, J = 15.8Hz ), 6.92 (1H, s), 7.24 (2H, s), 7.24—7.52 (m, 10H), 8.59 (2H, d, J = 6.9Hz), 8.97 (2H, d, J = 6.9Hz), 9.01 (1H, s), 9.65 (1H, d, J = 8.3Hz).
(3) 94→92 (3) 94 → 92
化合物 94(829mg,0.873mmol)を塩化メチレン (5 ml)とァニソール (0.83ml)に溶解し、 0 °Cに冷却し、 TFA 2.5mlを加え、実施例 41の (2)と同様の手法にて、化合物 92を粉末 として得た。収量 386mg(50%) Compound 94 (829 mg, 0.873 mmol) was dissolved in methylene chloride (5 ml) and anisole (0.83 ml), cooled to 0 ° C, 2.5 ml of TFA was added, and the same procedure as in Example 41 (2) was performed. Compound 92 was obtained as a powder. Yield 386 mg (50%)
'H-NMR (d -DMSO): 1.13(3H, t, J = 7.5Hz), 1.22(3H, t, J = 6.9Hz), 3.09(2H, q, J 'H-NMR (d-DMSO): 1.13 (3H, t, J = 7.5Hz), 1.22 (3H, t, J = 6.9Hz), 3.09 (2H, q, J
6 6
= 7.5Hz), 3.43, 3.51(2H, ABq, J = 16.5Hz), 4.09(2H, q, J = 6.9Hz), 5.05(1H, d, J = 5.0Hz), 5.27(2H, d, J = 7.2Hz), 5.60(1H, dd, J = 8.1, 5.0Hz), 5.87(1H, dt, J = 15.9,
6.9Hz), 6.72(1H, s), 7.22(2H, s), 7.30(1H, d, J = 15.9Hz), 8.59(2H, d, J = 7.1Hz), 9.02(2H, d, J = 7.1Hz), 8.98(1H, s), 9.54(1H, d, J = 8.1Hz). = 7.5Hz), 3.43, 3.51 (2H, ABq, J = 16.5Hz), 4.09 (2H, q, J = 6.9Hz), 5.05 (1H, d, J = 5.0Hz), 5.27 (2H, d, J = 7.2Hz), 5.60 (1H, dd, J = 8.1, 5.0Hz), 5.87 (1H, dt, J = 15.9, 6.9Hz), 6.72 (1H, s), 7.22 (2H, s), 7.30 (1H, d, J = 15.9Hz), 8.59 (2H, d, J = 7.1Hz), 9.02 (2H, d, J = 7.1Hz), 8.98 (1H, s), 9.54 (1H, d, J = 8.1Hz).
I R (KBr) cm— 3422, 1764, 1636, 1600, 1531, 1388, 1341, 1255, 1218, 1113, 1035 827. I R (KBr) cm— 3422, 1764, 1636, 1600, 1531, 1388, 1341, 1255, 1218, 1113, 1035 827.
MS(ESI): 733+ (M-Na+2H)+ MS (ESI): 733 + (M-Na + 2H) +
元素分析 c H N O S Na- 3.8 H O - 0.1NaHCO Elemental analysis c H N O S Na- 3.8 H O-0.1 NaHCO
計算値: C, 40.58; H, 4.21; N, 13.47; S, 15.42; Na, 3.04 (%) Calculated values: C, 40.58; H, 4.21; N, 13.47; S, 15.42; Na, 3.04 (%)
実験値: C, 40.71; H, 4.15; N, 13.60; S, 15.15; Na, 3.08 (%) Experimental values: C, 40.71; H, 4.15; N, 13.60; S, 15.15; Na, 3.08 (%)
実施例 64 Example 64
[化 110] [Chem 110]
Na+ Na +
97 97
(1) 39→96 (1) 39 → 96
化合物 39(308mg,1.20mmol)、トリフルォロメタンスルホンアミド (179mg,1.20mmol)より 実施例 46の (1)と同様の手法にて化合物 96を無色結晶として得た。収量 282mg(90%) 'H-NMR (d -DMSO): 8·55(2Η, d, J = 6·4Ηζ), 8.97(2H, d, J = 6.4Hz), 9.02(1H, s). Compound 96 was obtained as colorless crystals from Compound 39 (308 mg, 1.20 mmol) and trifluoromethanesulfonamide (179 mg, 1.20 mmol) in the same manner as in Example 46, (1). Yield 282 mg (90%) 'H-NMR (d-DMSO): 8 · 55 (2Η, d, J = 6 · 4Ηζ), 8.97 (2H, d, J = 6.4Hz), 9.02 (1H, s).
(2) 96→97 (2) 96 → 97
化合物 96(358mg,1.06mmol)をメタノール中に懸濁し、ナトリウムメトキシドメタノール 溶液を pH=8.2となるまで滴下して、得られた溶液を減圧濃縮して、 96のナトリウム塩を
得た。化合物 9(715mg、 1.06mmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水 素ナトリウム水溶液 (134mg、 1.59mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出 し、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (4ml) に溶解し、 96のナトリウム塩と混合し、臭化ナトリウム (327mg,3.18mmol)を加えて、室 温で 4時間 35分攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、析出した沈殿 を濾取した。沈殿を減圧乾燥して化合物 97を無定形粉末として得た。収量 943mg(95 %) Compound 96 (358 mg, 1.06 mmol) was suspended in methanol, sodium methoxide methanol solution was added dropwise until pH = 8.2, and the resulting solution was concentrated under reduced pressure to give 96 sodium salt. Obtained. Compound 9 (715 mg, 1.06 mmol) was suspended in dichloromethane (10 ml), and an aqueous sodium hydrogen carbonate solution (134 mg, 1.59 mmol dissolved in 10 ml of water) was added under ice cooling, extracted with dichloromethane, and dried over magnesium sulfate. . After distilling off the solvent, it was immediately dissolved in dimethylformamide (4 ml), mixed with 96 sodium salt, sodium bromide (327 mg, 3.18 mmol) was added, and the mixture was stirred at room temperature for 4 hours and 35 minutes. The reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 97 as an amorphous powder. Yield 943 mg (95%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.0Hz), 3.65, 3.90(2H, ABq, J = 17.6Hz), 4.1 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.0Hz), 3.65, 3.90 (2H, ABq, J = 17.6Hz), 4.1
0(2H, q, J = 7.0Hz), 5.28(2H, d, J = 6.9Hz), 5.29(1H, d, J = 4.7Hz), 5.92(1H, dd, J = 8.3, 4.7Hz), 6.42(1H, dt, J = 16.1, 6.9Hz), 6.75(1H, s), 6.87(1H, d, J = 16.1Hz), 6.92(1H, s), 7.24(2H, s), 7.24— 7.53(m, 10H), 8.60(2H, d, J = 7.1Hz), 8 .98(2H, d, J = 7.1Hz), 9.10(1H, s), 9.65(1H, d, J = 8.3Hz). 0 (2H, q, J = 7.0Hz), 5.28 (2H, d, J = 6.9Hz), 5.29 (1H, d, J = 4.7Hz), 5.92 (1H, dd, J = 8.3, 4.7Hz), 6.42 (1H, dt, J = 16.1, 6.9Hz), 6.75 (1H, s), 6.87 (1H, d, J = 16.1Hz), 6.92 (1H, s), 7.24 (2H, s), 7.24—7.53 (m, 10H), 8.60 (2H, d, J = 7.1Hz), 8.98 (2H, d, J = 7.1Hz), 9.10 (1H, s), 9.65 (1H, d, J = 8.3Hz) .
(3) 97→95 (3) 97 → 95
化合物 97(933mg,0.994mmol)を塩化メチレン (5.6 ml)とァニソール (0.93ml)に溶解し 、 0°Cに冷却し、 TFA 2.8mlをカ卩え、実施例 41の (2)と同様の手法にて、化合物 95を粉 末として得た。収量 270mg(31%) Compound 97 (933 mg, 0.994 mmol) was dissolved in methylene chloride (5.6 ml) and anisole (0.93 ml), cooled to 0 ° C., and 2.8 ml of TFA was added, as in Example 41 (2). By the method, Compound 95 was obtained as a powder. Yield 270 mg (31%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.43, 3.51(2H, ABq, J = 16.5Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.43, 3.51 (2H, ABq, J = 16.5Hz), 4.0
9(2H, q, J = 6.9Hz), 5.05(1H, d, J = 4.8Hz), 5.28(2H, d, J = 7.0Hz), 5.60(1H, dd, J = 8.3, 4.8Hz), 5.86(1H, dt, J = 15.8, 7.0Hz), 6.72(1H, s), 7.22(2H, s), 7.31(1H, d, J = 15.8Hz), 8.61(2H, d, J = 6.9Hz), 9.04( 2H, d, J = 6.9Hz), 9.08(1H, s), 9.54(1H, d , J = 8.3Hz). 9 (2H, q, J = 6.9Hz), 5.05 (1H, d, J = 4.8Hz), 5.28 (2H, d, J = 7.0Hz), 5.60 (1H, dd, J = 8.3, 4.8Hz), 5.86 (1H, dt, J = 15.8, 7.0Hz), 6.72 (1H, s), 7.22 (2H, s), 7.31 (1H, d, J = 15.8Hz), 8.61 (2H, d, J = 6.9Hz ), 9.04 (2H, d, J = 6.9Hz), 9.08 (1H, s), 9.54 (1H, d, J = 8.3Hz).
IR (KBr) cm— 3422, 1764, 1636, 1600, 1531, 1388, 1341, 1255, 1218, 1113, 1035, 827. IR (KBr) cm— 3422, 1764, 1636, 1600, 1531, 1388, 1341, 1255, 1218, 1113, 1035, 827.
MS(ESI): 773+ (M-Na+2H)+ MS (ESI): 773 + (M-Na + 2H) +
元素分析 c H F N O S Na- 3.8 H O - 0.3NaHCO Elemental analysis c H F N O S Na- 3.8 H O-0.3 NaHCO
計算値: C, 37.52; H, 3.26; F, 6.52; N, 12.82; S, 14.67; Na, 3.42 (%) Calculated values: C, 37.52; H, 3.26; F, 6.52; N, 12.82; S, 14.67; Na, 3.42 (%)
実験値: C, 37.71; H, 3.37; F, 6.14; N, 13.02; S, 14.79; Na, 3.29 (%) Experimental values: C, 37.71; H, 3.37; F, 6.14; N, 13.02; S, 14.79; Na, 3.29 (%)
実施例 65
[化 111] Example 65 [Chem 111]
9 9
^ ·► 98 ^ · ► 98
(1) 34→99 (1) 34 → 99
化合物 34(1.758g,7.98mmol)をジメチルホルムアミド (18ml)中に懸濁させ、 1,1 ' -チォ カルボニルジイミダゾール (1.56g,8.78mmol)を加え、 1時間 20分撹拌した。水を加え、 析出した沈殿をろ過し、減圧乾燥して化合物 99を淡褐色結晶として得た。収量 2.44g( 93%) Compound 34 (1.758 g, 7.98 mmol) was suspended in dimethylformamide (18 ml), 1,1′-thiocarbonyldiimidazole (1.56 g, 8.78 mmol) was added, and the mixture was stirred for 1 hour and 20 minutes. Water was added, and the deposited precipitate was filtered and dried under reduced pressure to obtain Compound 99 as light brown crystals. Yield 2.44 g (93%)
'H-NMR (d -DMSO): 7.13(1H, dd, J = 1.7, 1.2Hz), 7.84(2H, s), 8.05(1H, t, J = 1.7 'H-NMR (d-DMSO): 7.13 (1H, dd, J = 1.7, 1.2Hz), 7.84 (2H, s), 8.05 (1H, t, J = 1.7
6 6
Hz), 8.08(2H, d, J = 6.3Hz), 8.67— 8.74(4H, m). Hz), 8.08 (2H, d, J = 6.3Hz), 8.67-8.74 (4H, m).
(2) 99→100 (2) 99 → 100
化合物 99(2.428g,7.349mmol)より、テトラヒドロフラン (24ml)中に懸濁させ、三フッ化 ホウ素ジェチルエーテル錯塩 (4.62ml,36.7mmol)を室温で滴下し、室温で 1時間 45分 、 70°Cで 1時間撹拌した。半量になるまで減圧濃縮し、水、ついで飽和 NaHCO水を Compound 99 (2.428 g, 7.349 mmol) was suspended in tetrahydrofuran (24 ml), boron trifluoride jetyl ether complex salt (4.62 ml, 36.7 mmol) was added dropwise at room temperature, and 1 hour 45 minutes at room temperature. Stir at ° C for 1 hour. Concentrate in vacuo to half volume, add water, then saturated aqueous NaHCO
3 加えて pH=3.5とした。生じた沈殿をろ過し、減圧乾燥して化合物 100を淡黄色結晶と して得た。収量 2.07g(107%) 3 In addition, pH = 3.5. The resulting precipitate was filtered and dried under reduced pressure to obtain Compound 100 as pale yellow crystals. Yield 2.07 g (107%)
'H-NMR (d -DMSO): 8.34(2H, d, J = 5.6Hz), 8.88(2H, d, J = 5.6Hz), 8.97(1H, s). 'H-NMR (d-DMSO): 8.34 (2H, d, J = 5.6Hz), 8.88 (2H, d, J = 5.6Hz), 8.97 (1H, s).
6 6
(3) 100→98 (3) 100 → 98
化合物 100(394mg,1.50mmol)をメタノール中に懸濁し、ナトリウムメトキシドメタノール 溶液で pH=8.3に調整し、得られた溶液を減圧濃縮して、 100のナトリウム塩を得た。化
合物 9(1.012mg、 1.50mmol)をジクロロメタン (15ml)に懸濁させ、氷冷下炭酸水素ナトリ ゥム水溶液 (189mg、 1.80mmolを水 15mlに溶解)を加え、ジクロロメタンで抽出し、硫酸 マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (5ml)に溶解 し、 100のナトリウム塩と混合し、臭化ナトリウム (463mg,4.50mmol)を加えて、室温で 3 時間 20分攪拌した。反応液を 5%食塩水 (45ml)攪拌中に注加し、析出した沈殿を濾 取した。沈殿を減圧乾燥して 4級塩を含む無定形粉末を得た。これを塩化メチレン (7. 2ml)とァニソール (1.20ml)に溶解し、 0°Cに冷却し、 TFA 3.6mlを加え、実施例 41の (2) と同様の手法にて、化合物 98を粉末として得た。収量 46mg(4%) Compound 100 (394 mg, 1.50 mmol) was suspended in methanol, adjusted to pH = 8.3 with sodium methoxide methanol solution, and the resulting solution was concentrated under reduced pressure to obtain 100 sodium salt. Conversion Compound 9 (1.012 mg, 1.50 mmol) was suspended in dichloromethane (15 ml), and an aqueous sodium hydrogen carbonate solution (189 mg, 1.80 mmol dissolved in 15 ml of water) was added under ice cooling, followed by extraction with dichloromethane, magnesium sulfate. And dried. After distilling off the solvent, it was immediately dissolved in dimethylformamide (5 ml), mixed with 100 sodium salt, sodium bromide (463 mg, 4.50 mmol) was added, and the mixture was stirred at room temperature for 3 hours and 20 minutes. The reaction solution was poured into 5% brine (45 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain an amorphous powder containing a quaternary salt. This was dissolved in methylene chloride (7.2 ml) and anisole (1.20 ml), cooled to 0 ° C, 3.6 ml of TFA was added, and compound 98 was powdered in the same manner as in (2) of Example 41. Got as. Yield 46 mg (4%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 3.42, 3.50(2H, ABq, J = 16.8Hz), 4.0'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 3.42, 3.50 (2H, ABq, J = 16.8Hz), 4.0
9(2H, q, J = 7.2Hz), 5.04(1H, d, J = 4.8Hz), 5.27(2H, d, J = 6.3Hz), 5.59(1H, dd, J = 8.4, 4.8Hz), 5.86(1H, dt, J = 15.6, 6.3Hz), 6.72(1H, s), 7.22(2H, s), 7.30(1H, d, J = 15.6Hz), 8.60(2H, d, J = 6.9Hz), 9.04(2H, d, J = 6.9Hz), 9.54(1H, d, J = 8.4Hz). IR (KBr) cm"1:3419, 1762, 1633, 1604, 1532, 1387, 1158, 1036. 9 (2H, q, J = 7.2Hz), 5.04 (1H, d, J = 4.8Hz), 5.27 (2H, d, J = 6.3Hz), 5.59 (1H, dd, J = 8.4, 4.8Hz), 5.86 (1H, dt, J = 15.6, 6.3Hz), 6.72 (1H, s), 7.22 (2H, s), 7.30 (1H, d, J = 15.6Hz), 8.60 (2H, d, J = 6.9Hz ), 9.04 (2H, d, J = 6.9Hz), 9.54 (1H, d, J = 8.4Hz). IR (KBr) cm " 1 : 3419, 1762, 1633, 1604, 1532, 1387, 1158, 1036.
MS(ESI): 698+ (M_Na+2H)+ MS (ESI): 698+ (M_Na + 2H) +
元素分析 C H N O S Na- 5.2 H O - 0.4NaHCO Elemental analysis C H N O S Na- 5.2 H O-0.4 NaHCO
計算値: C, 38.85; H, 3.90; N, 14.88; S, 15.14; Na, 3.80 (%) Calculated: C, 38.85; H, 3.90; N, 14.88; S, 15.14; Na, 3.80 (%)
実験値: C, 39.06; H, 3.95; N, 14.73; S, 14.64; Na, 3.81 (%) Experimental value: C, 39.06; H, 3.95; N, 14.73; S, 14.64; Na, 3.81 (%)
実施例 66 Example 66
[化 112]
[Chem 112]
106 106
(1) 102→103 (1) 102 → 103
化合物 102(789mg,3,35mmol)をジメチルホルムアミド (8ml)中に溶解し、炭酸カリウム ( 509mg,3.69mmol)、さらに p-メトキシベンジルブロミド (741mg,3.69mmolのジメチルホル ムアミド (2ml)溶液)を加え、室温にて 1時間撹拌した。反応混合物を水、酢酸ェチル中 にあけ、酢酸ェチルで抽出した。有機層を水、飽和食塩水で洗浄し、無水硫酸ナトリ ゥムで乾燥した。溶媒を減圧留去し、化合物 103を液状物質として得た。収量 1.18g(9 9%) Compound 102 (789 mg, 3, 35 mmol) is dissolved in dimethylformamide (8 ml), and potassium carbonate (509 mg, 3.69 mmol) is added followed by p-methoxybenzyl bromide (741 mg, 3.69 mmol of dimethylformamide (2 ml) solution). And stirred at room temperature for 1 hour. The reaction mixture was poured into water and ethyl acetate and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure to obtain Compound 103 as a liquid substance. Yield 1.18 g (9 9%)
'H-NMR (CDCl ): 3.82(3H, s), 5.30(2H, s), 6.91(2H, d, J = 8.7Hz), 7.38(2H, d, J = 'H-NMR (CDCl): 3.82 (3H, s), 5.30 (2H, s), 6.91 (2H, d, J = 8.7Hz), 7.38 (2H, d, J =
8.7Hz), 7.42(1H, dd, J = 8.4, 2.1Hz), 7.63(1H, d, J = 2.1Hz), 7.71(1H, d, J = 8.4H z). 8.7Hz), 7.42 (1H, dd, J = 8.4, 2.1Hz), 7.63 (1H, d, J = 2.1Hz), 7.71 (1H, d, J = 8.4H z).
(2) 103→105 (2) 103 → 105
化合物 103(1.154g,3,439mmol)、化合物 104(917mg, 4.47mmol)、燐酸カリウム (2.19g ,10.3mmol)をジォキサン (12ml)中に懸濁させ、テトラキストリフエニルホスフィンパラジ ゥム (199mg,0.172mmol)を加え、マイクロウエーブ照射した (120°Cxl5分)。反応液を水 、酢酸ェチル中にあけ、酢酸ェチルで抽出した。有機層を水、飽和食塩水で洗浄し 、無水硫酸ナトリウムで乾燥した。溶媒を減圧留去して、シリカゲルクロマトグラフィー に付し、へキサン:酢酸ェチル = 1 :3で溶出した。 目的のフラクションを濃縮し、化合
物 105を無色結晶として得た。収量 787mg(65%) Compound 103 (1.154 g, 3,439 mmol), compound 104 (917 mg, 4.47 mmol) and potassium phosphate (2.19 g, 10.3 mmol) were suspended in dioxane (12 ml), and tetrakistriphenylphosphine paradium (199 mg, 0.172 mmol) was suspended. mmol) and microwave irradiation (120 ° Cxl for 5 minutes). The reaction solution was poured into water and ethyl acetate and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, subjected to silica gel chromatography, and eluted with hexane: ethyl acetate = 1: 3. Concentrate the desired fraction and combine Compound 105 was obtained as colorless crystals. Yield 787mg (65%)
'H-NMR (CDCl ): 3.83(3H, s), 5.34(2H, s), 6.93(2H, d, J = 8.7Hz), 7.42(2H, d, J = 'H-NMR (CDCl 3): 3.83 (3H, s), 5.34 (2H, s), 6.93 (2H, d, J = 8.7Hz), 7.42 (2H, d, J =
8.7Hz), 7.48(2H, d, J = 6.2 Hz), 7.54(1H, dd, J = 8.3, 1.8Hz), 7.71(1H, d, J = 1.8H z), 7.95 (1H, d, J = 8.3Hz), 8.71(2H, d, J = 6.2 Hz). 8.7 Hz), 7.48 (2H, d, J = 6.2 Hz), 7.54 (1H, dd, J = 8.3, 1.8 Hz), 7.71 (1H, d, J = 1.8 Hz), 7.95 (1H, d, J = 8.3Hz), 8.71 (2H, d, J = 6.2 Hz).
(3) 105→106 (3) 105 → 106
化合物 9(675mg、 l.OOmmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナト リウム水溶液 (126mg、 1.50mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (4ml)に溶 解し、化合物 105(354mg,1.00mmol)と混合し、臭化ナトリウム (309mg、 3.00mmol)を加 えて、室温で 2時間 20分攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、析出 した沈殿を濾取した。沈殿を減圧乾燥して化合物 106を無定形粉末として得た。収量 874mg(84%) Compound 9 (675 mg, l.OOmmol) is suspended in dichloromethane (10 ml), aqueous sodium hydrogen carbonate solution (126 mg, 1.50 mmol dissolved in 10 ml of water) is added under ice cooling, extracted with dichloromethane, and magnesium sulfate is added. Dried. After distilling off the solvent, quickly dissolve in dimethylformamide (4 ml), mix with compound 105 (354 mg, 1.00 mmol), add sodium bromide (309 mg, 3.00 mmol), and stir at room temperature for 2 hours and 20 minutes. did. The reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 106 as an amorphous powder. Yield 874 mg (84%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.64, 3.90(2H, ABq, J = 17.4Hz), 3.7 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.64, 3.90 (2H, ABq, J = 17.4Hz), 3.7
7(3H, s), 4.10(2H, q, J = 6.9 Hz), 5.29(1H, d, J = 5.1Hz), 5.32(2H, d, J = 6.6Hz), 5. 34(2H, s), 5.92(1H, dd, J = 8.1, 5.1Hz), 6.43(1H, dt, J = 15.9, 6.6Hz), 6.75(1H, s), 6.92(1H, d, J = 15.9Hz), 6.92(1H, s), 6.98(2H, d, J = 8.7Hz), 7.21-7.58(15H, m), 8 .12(1H, dd, J = 8.4, 1.8Hz), 8.31(1H, d, J = 1.8Hz), 8.61(2H, d, J = 7.1Hz), 9.09(2 H, d, J = 7.1Hz), 9.65(1H, d, J = 8.1Hz). 7 (3H, s), 4.10 (2H, q, J = 6.9 Hz), 5.29 (1H, d, J = 5.1 Hz), 5.32 (2H, d, J = 6.6 Hz), 5.34 (2H, s ), 5.92 (1H, dd, J = 8.1, 5.1Hz), 6.43 (1H, dt, J = 15.9, 6.6Hz), 6.75 (1H, s), 6.92 (1H, d, J = 15.9Hz), 6.92 (1H, s), 6.98 (2H, d, J = 8.7Hz), 7.21-7.58 (15H, m), 8.12 (1H, dd, J = 8.4, 1.8Hz), 8.31 (1H, d, J = 1.8Hz), 8.61 (2H, d, J = 7.1Hz), 9.09 (2H, d, J = 7.1Hz), 9.65 (1H, d, J = 8.1Hz).
(4) 106→101 (4) 106 → 101
化合物 106(868mg,0.837mmol)を塩化メチレン (5.2 ml)とァニソール (0.87ml)に溶解し 、 0°Cに冷却し、 TFA 2.6mlをカ卩え、実施例 41の (2)と同様の手法にて、化合物 101を 粉末として得た。収量 167mg(26%) Compound 106 (868 mg, 0.837 mmol) was dissolved in methylene chloride (5.2 ml) and anisole (0.87 ml), cooled to 0 ° C., and 2.6 ml of TFA was added, and the same as in Example 41 (2). By the procedure, compound 101 was obtained as a powder. Yield 167 mg (26%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.1Hz), 3.41, 3.49(2H, ABq, J = 17.1Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.1Hz), 3.41, 3.49 (2H, ABq, J = 17.1Hz), 4.0
9(2H, q, 7.1Hz), 5.04(1H, d, J = 5.1Hz), 5.27(2H, d, J = 7.2Hz), 5.60(1H, dd, J = 8. 3, 5.1Hz), 5.86(1H, dt, J = 16.1, 7.2Hz), 6.72(1H, s), 7.23(2H, s), 7.30(1H, d, J = 1 6.1Hz), 7.44(1H, d, J = 8.1Hz), 7.88(1H, dd, J = 8.1, 1.7Hz), 8.00(1H, d, J = 1.7Hz ), 8.10(2H, d, J = 6.8Hz), 9.01(2H, d, J = 6.8Hz), 9.54(1H, d, J = 8.3Hz). 9 (2H, q, 7.1Hz), 5.04 (1H, d, J = 5.1Hz), 5.27 (2H, d, J = 7.2Hz), 5.60 (1H, dd, J = 8.3, 5.1Hz), 5.86 (1H, dt, J = 16.1, 7.2Hz), 6.72 (1H, s), 7.23 (2H, s), 7.30 (1H, d, J = 6.1 Hz), 7.44 (1H, d, J = 8.1 Hz), 7.88 (1H, dd, J = 8.1, 1.7Hz), 8.00 (1H, d, J = 1.7Hz), 8.10 (2H, d, J = 6.8Hz), 9.01 (2H, d, J = 6.8 Hz), 9.54 (1H, d, J = 8.3 Hz).
IR (KBr) cm_1:3418, 1764, 1634, 1598, 1531, 1386, 1298, 1158, 1035.
MS(ESI): 669 (M-Na+2H) IR (KBr) cm _1 : 3418, 1764, 1634, 1598, 1531, 1386, 1298, 1158, 1035. MS (ESI): 669 (M-Na + 2H)
元素分析 C H C1N O S Na-4.8 H O Elemental analysis C H C1N O S Na-4.8 H O
29 24 6 7 2 2 29 24 6 7 2 2
計算値: C, 44.79; H, 4.36; N, 10.81; S, 8.25; Na, 2.96 (%) Calculated: C, 44.79; H, 4.36; N, 10.81; S, 8.25; Na, 2.96 (%)
実験値: C, 44.83; H, 4.24; N, 10.90; S, 8.27; Na, 3.21 (%) Experimental values: C, 44.83; H, 4.24; N, 10.90; S, 8.27; Na, 3.21 (%)
実施例 67 Example 67
[化 113] [Chem 113]
(1) 108→109 (1) 108 → 109
化合物 108(645mg,3.00mmol)より実施例 66の (1)と同様の手法にて化合物 109を液 状物質として得た。収量 923mg(92%) Compound 109 was obtained as a liquid substance from Compound 108 (645 mg, 3.00 mmol) in the same manner as in Example 66, (1). Yield 923mg (92%)
'H-NMR (CDCl ): 2.57(3H, s), 3.82(3H, s), 5.26(2H, s), 6.91(2H, d, J = 8.7Hz), 7. 'H-NMR (CDCl): 2.57 (3H, s), 3.82 (3H, s), 5.26 (2H, s), 6.91 (2H, d, J = 8.7Hz), 7.
3 Three
33-7.4K4H, m), 7.78(1H, d, J = 8.4Hz). 33-7.4K4H, m), 7.78 (1H, d, J = 8.4Hz).
(2) 109→110 (2) 109 → 110
化合物 109(874mg,2.60mmol)より、実施例 66の (2)と同様の手法にて化合物 110を無 色結晶として得た。収量 721mg(83%) Compound 110 was obtained as colorless crystals from Compound 109 (874 mg, 2.60 mmol) in the same manner as in Example 66, (2). Yield 721mg (83%)
'H-NMR (CDCl ): 2.68(3H, s), 3·83(3Η, s), 5· 33(2Η, s), 6·93(2Η, d, J = 8.9Hz), 7. 'H-NMR (CDCl): 2.68 (3H, s), 3 · 83 (3Η, s), 5 · 33 (2Η, s), 6 · 93 (2Η, d, J = 8.9Hz), 7.
3 Three
41(2H, d, J = 8.9Hz), 7.45— 7.53(4H, m), 7.94 (1H, d, J = 8.7Hz), 8.68(2H, d, J = 6. 0 Hz).
(3) 110→111 41 (2H, d, J = 8.9Hz), 7.45—7.53 (4H, m), 7.94 (1H, d, J = 8.7Hz), 8.68 (2H, d, J = 6.0 Hz). (3) 110 → 111
化合物 9(675mg、 l.OOmmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナト リウム水溶液 (126mg、 1.50mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (4ml)に溶 解し、化合物 110(333mg,1.00mmol)と混合し、臭化ナトリウム (309mg、 3.00mmol)を加 えて、室温で 4時間攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、析出した 沈殿を濾取した。沈殿を減圧乾燥して化合物 111を無定形粉末として得た。収量 877 mg(86%) Compound 9 (675 mg, l.OOmmol) is suspended in dichloromethane (10 ml), aqueous sodium hydrogen carbonate solution (126 mg, 1.50 mmol dissolved in 10 ml of water) is added under ice cooling, extracted with dichloromethane, and magnesium sulfate is added. Dried. After the solvent was distilled off, it was quickly dissolved in dimethylformamide (4 ml), mixed with compound 110 (333 mg, 1.00 mmol), sodium bromide (309 mg, 3.00 mmol) was added, and the mixture was stirred at room temperature for 4 hours. The reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 111 as an amorphous powder. Yield 877 mg (86%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.1Hz), 2.63(3H, s), 3.64, 3.90(2H, ABq, J = 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.1Hz), 2.63 (3H, s), 3.64, 3.90 (2H, ABq, J =
18.2Hz), 3.77(3H, s), 4.10(2H, q, J = 7.1Hz), 5.27— 5.37(5H, m), 5.92(1H, dd, J = 8. 3, 4.8Hz), 6.44(1H, dt, J = 15.3, 6.6Hz), 6.75(1H, s), 6.92(1H, d, J = 15.3Hz), 6.92 (1H, s), 6.98(2H, d, J = 8.7Hz), 7.22— 7.57(15H, m), 7.95— 8.07(2H, m), 8.56(2H, d, J = 7.1Hz), 9.05(2H, d, J = 7.1Hz), 9.65(1H, d, J = 8.3Hz). 18.2Hz), 3.77 (3H, s), 4.10 (2H, q, J = 7.1Hz), 5.27— 5.37 (5H, m), 5.92 (1H, dd, J = 8.3, 4.8Hz), 6.44 ( 1H, dt, J = 15.3, 6.6Hz), 6.75 (1H, s), 6.92 (1H, d, J = 15.3Hz), 6.92 (1H, s), 6.98 (2H, d, J = 8.7Hz), 7.22-7.57 (15H, m), 7.95-8.07 (2H, m), 8.56 (2H, d, J = 7.1Hz), 9.05 (2H, d, J = 7.1Hz), 9.65 (1H, d, J = (8.3Hz).
(4) 111→107 (4) 111 → 107
化合物 l l l(868mg,0.855mmol)を塩化メチレン (5.2 ml)とァニソール (0.87ml)に溶解し 、 0°Cに冷却し、 TFA 2.6mlをカ卩え、実施例 41の (2)と同様の手法にて、化合物 107を 粉末として得た。収量 248mg(38%) Compound lll (868 mg, 0.855 mmol) was dissolved in methylene chloride (5.2 ml) and anisole (0.87 ml), cooled to 0 ° C., and 2.6 ml of TFA was added, the same as in Example 41 (2). By the method, Compound 107 was obtained as a powder. Yield 248mg (38%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.1Hz), 2.52(3H, s), 3.41, 3.49(2H, ABq, J = 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.1Hz), 2.52 (3H, s), 3.41, 3.49 (2H, ABq, J =
17.1Hz), 4.09(2H, q, J = 7.1Hz), 5.04(1H, d, J = 5.0Hz), 5.26(2H, d, J = 6.8Hz), 5. 59(1H, dd, J = 8.0, 5.0Hz), 5.86(1H, dt, J = 15.6, 6.8Hz), 6.72(1H, s), 7.23(2H, s), 7.30(1H, d, J = 15.6Hz), 7.53(1H, d, J = 7.8Hz), 7.72- 7.78(2H, m), 8.45(2H, d, J = 7.2Hz), 8.96(2H, d, J = 7.2Hz), 9.54(1H, d, J = 8.0Hz). 17.1Hz), 4.09 (2H, q, J = 7.1Hz), 5.04 (1H, d, J = 5.0Hz), 5.26 (2H, d, J = 6.8Hz), 5.59 (1H, dd, J = 8.0, 5.0Hz), 5.86 (1H, dt, J = 15.6, 6.8Hz), 6.72 (1H, s), 7.23 (2H, s), 7.30 (1H, d, J = 15.6Hz), 7.53 (1H, d, J = 7.8Hz), 7.72-7.78 (2H, m), 8.45 (2H, d, J = 7.2Hz), 8.96 (2H, d, J = 7.2Hz), 9.54 (1H, d, J = 8.0 Hz).
IR (KBr) cm_1:3408, 1765, 1633, 1586, 1531, 1385, 1159, 1035. IR (KBr) cm _1 : 3408, 1765, 1633, 1586, 1531, 1385, 1159, 1035.
MS(ESI): 649+ (M-Na+2H)+ MS (ESI): 649 + (M-Na + 2H) +
元素分析 C H N O S Na-4.7 H O Elemental analysis C H N O S Na-4.7 H O
計算値: C, 47.70; H, 4.86; N, 11.13; S, 8.49; Na, 3.04 (%) Calculated values: C, 47.70; H, 4.86; N, 11.13; S, 8.49; Na, 3.04 (%)
実験値: C, 47.66; H, 4.63; N, 11.36; S, 8.28; Na, 2.85 (%) Experimental values: C, 47.66; H, 4.63; N, 11.36; S, 8.28; Na, 2.85 (%)
実施例 68
Example 68
化合物5(13011¾,カ価0.19511111101)を水(5.21111)に溶解し、 5%NaHCO水で pH=7.2に調 整した。これに Penicillin G amidase (carrier fixed, 146U)(44.5mg)を加え、 5%NaHCO 水で pHを 7-8に調整しながら、室温で 3時間撹拌した。 Amidaseを濾別し、水 (3ml)洗 いしたのち、 0.2N HC1で ρΗ=6·5とし、ァセトニトリル (4ml)を添加した。これに化合物 11 3(79.0mg,0.293mmol)を 10分毎に 15.8mgずつ 5回に分けて加えた。ァセトニトリルを減 圧留去し、 HP-20SSカラムクロマトグラフィーに付して、水-ァセトニトリルで溶離した。 所望の化合物を含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥して化合物 114 を粉末として得た。収量 104mg (見かけ 81%) Compound 5 (13011¾, valence 0.19511111101) was dissolved in water (5.21111) and adjusted to pH = 7.2 with 5% aqueous NaHCO 3 solution. Penicillin Gamidase (carrier fixed, 146U) (44.5 mg) was added thereto, and the mixture was stirred at room temperature for 3 hours while adjusting the pH to 7-8 with 5% aqueous NaHCO 3 solution. Amidase was separated by filtration, washed with water (3 ml), 0.2N HC1 to ρΗ = 6.5, and acetonitrile (4 ml) was added. To this, Compound 11 3 (79.0 mg, 0.293 mmol) was added in 5 portions, 15.8 mg every 10 minutes. The acetonitrile was distilled off under reduced pressure, subjected to HP-20SS column chromatography and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 114 as a powder. Yield 104mg (apparent 81%)
実施例 69 Example 69
[化 115]
[Chemical 115]
(1) 1→2 (1) 1 → 2
1(27.6 g)のメタノール (500 mL)溶液に氷浴撹拌下ヒドロキシルァミン塩酸塩 (17.9 g) を加えた。室温まで自然昇温させ、さらに室温で 2時間撹拌した。終夜静置後メタノ ールを減圧留去し Et 0(400 mL)を加えて結晶性の沈殿を吸引濾取した。減圧乾燥 後化合物 2(39.6g,収率 100%)を淡桃色結晶として得た。 Hydroxylamine hydrochloride (17.9 g) was added to a solution of 1 (27.6 g) in methanol (500 mL) with stirring in an ice bath. The mixture was naturally warmed to room temperature and further stirred at room temperature for 2 hours. After standing overnight, the methanol was distilled off under reduced pressure, Et 0 (400 mL) was added, and the crystalline precipitate was collected by suction filtration. After drying under reduced pressure, Compound 2 (39.6 g, yield 100%) was obtained as pale pink crystals.
'H-NMR (DMSO) δ: 8.11 (2Η, d, J = 6.9 Hz), 8.41 (2H, s), 8.87 (2H,q, J = 6.9 Hz) , 12.7 (1H, brs). 'H-NMR (DMSO) δ: 8.11 (2Η, d, J = 6.9 Hz), 8.41 (2H, s), 8.87 (2H, q, J = 6.9 Hz), 12.7 (1H, brs).
(2) 2→3 (2) 2 → 3
2(39.8 g)の DMF(500 mL)溶液に室温で N_クロロコハク酸イミド (33.4 g)を加えた。室 温で 3時間撹拌後、 _20°C庫で終夜静置した。 DMFを減圧留去し水 (500 mL)加えて 氷浴にて冷却した。 pHを 3.5付近に調整し沈殿を吸引濾取した。減圧乾燥後化合物 3(30.9 g,収率 79%)を淡黄色の粉末として得た。 N_chlorosuccinimide (33.4 g) was added to a solution of 2 (39.8 g) in DMF (500 mL) at room temperature. After stirring at room temperature for 3 hours, the mixture was allowed to stand at _20 ° C overnight. DMF was distilled off under reduced pressure, water (500 mL) was added, and the mixture was cooled in an ice bath. The pH was adjusted to around 3.5, and the precipitate was collected by suction filtration. After drying under reduced pressure, compound 3 (30.9 g, yield 79%) was obtained as a pale yellow powder.
'H-NMR (d -DMSO) δ: 7.77 (2Η, d, J = 5.1 Hz), 8.71 (2H, brs), 13.0 (1H, s). 'H-NMR (d-DMSO) δ: 7.77 (2Η, d, J = 5.1 Hz), 8.71 (2H, brs), 13.0 (1H, s).
(3) 3→4 (3) 3 → 4
3(34.91 g)の THF(400 mL)溶液に氷浴撹拌下プロピオール酸ェチル (45.2 mL)をカロ えた後、トリェチルァミン (37.3 mL)の THF(300 mL)を 5時間かけて滴下した。氷冷で 1 時間撹拌後、飽和塩化アンモニゥム水 (100 mL)、水 (200 mL)、酢酸ェチル (500 mL)
をカ卩えて減圧下有機層を約 300mL (有機層として)まで濃縮した。酢酸ェチル (300 m L)を加え分液し、有機層を飽和食塩水で洗浄した。この有機層は無水硫酸マグネシ ゥムで乾燥後、減圧濃縮して残渣をシリカゲルカラムクロマトグラフィーにより精製 (へ キサン-酢酸ェチル)しィ匕合物 4(28.0 g,収率 57%)を淡茶色結晶として得た。 3 (34.91 g) in THF (400 mL) was stirred with an ice bath to stir propylate ethyl (45.2 mL), and then triethylamine (37.3 mL) in THF (300 mL) was added dropwise over 5 hours. After stirring on ice for 1 hour, saturated ammonium chloride water (100 mL), water (200 mL), ethyl acetate (500 mL) The organic layer was concentrated to about 300 mL (as an organic layer) under reduced pressure. Ethyl acetate (300 mL) was added for liquid separation, and the organic layer was washed with saturated brine. This organic layer was dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and the residue was purified by silica gel column chromatography (hexane-ethyl acetate) .Compound 4 (28.0 g, yield 57%) was pale brown Obtained as crystals.
'H-NMR (CDC1 ) δ 1.45 (3H, t, J = 7.2 Hz), 4.48 (2H, q, J = 7.2 Hz), 7.31 (1H, s)'H-NMR (CDC1) δ 1.45 (3H, t, J = 7.2 Hz), 4.48 (2H, q, J = 7.2 Hz), 7.31 (1H, s)
, 7.73 (2H, d, J = 6.0 Hz), 8.77 (2H, d, J = 6.0 Hz). 7.73 (2H, d, J = 6.0 Hz), 8.77 (2H, d, J = 6.0 Hz).
(4) 4→5 (4) 4 → 5
4(27.96 g)のメタノール (300 mL)溶液に氷浴撹拌下シアナミドのモノナトリウム塩 (9.8 4 g)をカ卩えた。室温で 1.5時間撹拌後、メタノールを約 50mLまで減圧濃縮した。イソプ ロパノール (300 mL)をカ卩えて沈殿を吸引濾取した。減圧乾燥後、化合物 5(31.5 g,収 率 82%)を淡茶色の粉末として得た。 Cyanamide monosodium salt (9.8 4 g) was added to a solution of 4 (27.96 g) in methanol (300 mL) with stirring in an ice bath. After stirring at room temperature for 1.5 hours, methanol was concentrated under reduced pressure to about 50 mL. Isopropanol (300 mL) was added and the precipitate was collected by suction filtration. After drying under reduced pressure, compound 5 (31.5 g, yield 82%) was obtained as a light brown powder.
'H-NMR (d -DMSO) δ: 7.43 (1Η, s), 7.89 (2Η, d, J = 6.0 Hz), 8.73 (2H, d, J = 6.0 'H-NMR (d-DMSO) δ: 7.43 (1Η, s), 7.89 (2Η, d, J = 6.0 Hz), 8.73 (2H, d, J = 6.0
Hz). Hz).
(5) 6→7→8 (5) 6 → 7 → 8
窒素雰囲気下、化合物 6 (4.36 g, 5.0 mmol)のジメチルホルムアミド(15 mL)溶液に 臭化ナトリウム(2.57 g, 25 mmol)を加え、室温下 6時間攪拌した。この反応液に化合 物 5(984 mg, 4.17 mmol)を加えさらに 6時間攪拌した。ジメチルホルムアミド (10 mL)を 加えて希釈しあら力じめ氷浴にて冷却した撹拌下の 5%食塩水 (180 mL)に注加した。 同温で 20分撹拌後、沈殿を吸引濾取し、減圧下五酸化リンを用いて乾燥して、黄土 色粉末状の粗生成物 7(4.57 g)を得た。この粗生成物を塩化メチレン (60 mL)に溶解し 、窒素雰囲気下ァニソール(3.26 mL, 30 mmol)を加え- 4 0°Cに冷却した。 _40°C下、 塩化チタニウム (IV) (2.0M塩化メチレン溶液, 15 mL, 30 mmol)を滴下した後、 - 20°C で 1時間攪拌した。この反応液を氷浴攪拌下の水(200 mL)に注ぎ、ジイソプロピルェ 一テル (150 mL)をカ卩えた。析出物を吸引濾取して得られた沈殿を重曹水で溶解させ HP20ssカラムクロマトグラフィーに付して集めた分画 (水一ァセトニトリル)を減圧濃縮 し、さらに ODSカラムクロマトグラフィーにより精製、濃縮、凍結乾燥した。化合物 8 (52 0 mg,収率 14%)を粉末として得た。 Under a nitrogen atmosphere, sodium bromide (2.57 g, 25 mmol) was added to a solution of compound 6 (4.36 g, 5.0 mmol) in dimethylformamide (15 mL), and the mixture was stirred at room temperature for 6 hours. Compound 5 (984 mg, 4.17 mmol) was added to the reaction solution, and the mixture was further stirred for 6 hours. Dimethylformamide (10 mL) was added for dilution, and the mixture was poured into 5% brine (180 mL) with stirring and cooled in an ice bath. After stirring at the same temperature for 20 minutes, the precipitate was collected by suction filtration and dried using phosphorus pentoxide under reduced pressure to obtain a crude product 7 (4.57 g) as an ocher powder. This crude product was dissolved in methylene chloride (60 mL), and anisole (3.26 mL, 30 mmol) was added under a nitrogen atmosphere, followed by cooling to −40 ° C. Titanium (IV) chloride (2.0M methylene chloride solution, 15 mL, 30 mmol) was added dropwise at _40 ° C, and the mixture was stirred at -20 ° C for 1 hour. The reaction mixture was poured into water (200 mL) under ice bath stirring, and diisopropyl ether (150 mL) was added. The precipitate obtained by suction filtration was dissolved in sodium bicarbonate water, and the fraction (water mononitrile) collected by HP20ss column chromatography was concentrated under reduced pressure, and further purified and concentrated by ODS column chromatography. Lyophilized. Compound 8 (52 mg, yield 14%) was obtained as a powder.
'H-NMR (D O) δ: 1.27 (3H, t, J = 7.1), 3.67 (2H, s), 4.22 (2H,q, J = 7.1), 5.26 (1
H, d, J = 4.5 Hz), 5.37 (1H, d, J = 6.9 Hz), 5.80 (1H, d, J = 4.5 Hz), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.92 (1H, s), 7.02 (1H, d, J = 15.6 Hz), 7.47 (1H, s), 8.47 (2H, d, J = 6.6 Hz), 8.99 (2H, d, J = 6.6). 'H-NMR (DO) δ: 1.27 (3H, t, J = 7.1), 3.67 (2H, s), 4.22 (2H, q, J = 7.1), 5.26 (1 H, d, J = 4.5 Hz), 5.37 (1H, d, J = 6.9 Hz), 5.80 (1H, d, J = 4.5 Hz), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.92 ( 1H, s), 7.02 (1H, d, J = 15.6 Hz), 7.47 (1H, s), 8.47 (2H, d, J = 6.6 Hz), 8.99 (2H, d, J = 6.6).
IR (KBr) cm—1: 3411, 2982, 2171, 1763, 1607, 1561, 1532, 1475, 1439, 1389, 1357,IR (KBr) cm— 1 : 3411, 2982, 2171, 1763, 1607, 1561, 1532, 1475, 1439, 1389, 1357,
1299, 1201, 1150, 1091, 1034, 1000. 1299, 1201, 1150, 1091, 1034, 1000.
MS(ESI): 650+ (M - Na + 2H)+ MS (ESI): 650+ (M-Na + 2H) +
元素分析 C H N NaO S -4.9 H O Elemental analysis C H N NaO S -4.9 H O
27 22 9 7 2 2 27 22 9 7 2 2
計算値: C,42.67; H,4.22; N, 16.59; S,8.44; Na,3.03 (%) Calculated value: C, 42.67; H, 4.22; N, 16.59; S, 8.44; Na, 3.03 (%)
実験値: C42.60; H,4.03; N, 16.41 ; S,9.04; Na,3.46 (%) Experimental value: C42.60; H, 4.03; N, 16.41; S, 9.04; Na, 3.46 (%)
実施例 70 Example 70
10 11 10 11
13 13
(1) 9→10 (1) 9 → 10
化合物 9(14.9 g, 67.4 mmol)のメタノーノレ (180 mL)溶液にヒドロキシルァミン塩酸塩 ( 97 %)(9.96g, 134.7 mmol)を加え、室温にて 1時間撹拌した。メタノールを減圧留去し た後に 2規定水酸化ナトリウムを加えて pHを 3付近に調整した。酢酸ェチルで 2回抽
出し、有機層は無水硫酸マグネシウムで乾燥して減圧下濃縮した。化合物 10(13.68g ,収率 86%)を橙色油状物質として得た。 Hydroxylamine hydrochloride (97%) (9.96 g, 134.7 mmol) was added to a methanol (180 mL) solution of compound 9 (14.9 g, 67.4 mmol), and the mixture was stirred at room temperature for 1 hour. Methanol was distilled off under reduced pressure, and then 2N sodium hydroxide was added to adjust the pH to around 3. Extract twice with ethyl acetate The organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. Compound 10 (13.68 g, 86% yield) was obtained as an orange oil.
'H-NMR (CDC1 ) δ 1.37 (3Η, t, J = 6.9 Hz), 3.24 and 3.54 (2H, ABq, J = 18.3 Hz 'H-NMR (CDC1) δ 1.37 (3Η, t, J = 6.9 Hz), 3.24 and 3.54 (2H, ABq, J = 18.3 Hz
), 4.36 (2H, q, J = 6.9 Hz), 7.48 (2H, d, J = 4.8 Hz), 8.45 (2H, d, J = 4.8 Hz). ), 4.36 (2H, q, J = 6.9 Hz), 7.48 (2H, d, J = 4.8 Hz), 8.45 (2H, d, J = 4.8 Hz).
(2) 10→11 (2) 10 → 11
化合物 10(13.9 g, 56.1 mmol)の酢酸ェチル (100 mL)溶液に 4規定 HC卜 AcOEt(14 mL, 56.1 mmol)を加えた。酢酸ェチルを減圧留去し、残渣にジメチルァセトアミド (150 mL)をカ卩ぇ 150°Cにて 3時間撹拌した。室温まで冷却後、終夜静置した。ジメチルァ セトアミドを減圧留去し酢酸ェチル-飽和重曹水で抽出した。有機層を水で 2回、飽 和食塩水で 1回洗浄し、無水硫酸マグネシウムで乾燥後減圧濃縮した。残渣をシリカ ゲルカラムクロマトグラフィー (へキサン一酢酸ェチル)で精製しィ匕合物 11(6.33 g,収 率 52%)を無色の結晶として得た。 4N HC 卜 AcOEt (14 mL, 56.1 mmol) was added to a solution of compound 10 (13.9 g, 56.1 mmol) in ethyl acetate (100 mL). Ethyl acetate was distilled off under reduced pressure, and dimethylacetamide (150 mL) was stirred at 150 ° C. for 3 hours. After cooling to room temperature, it was allowed to stand overnight. Dimethylacetamide was distilled off under reduced pressure and extracted with ethyl acetate-saturated aqueous sodium bicarbonate. The organic layer was washed twice with water and once with saturated Japanese salt water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexyl monoacetate) to obtain Compound 11 (6.33 g, yield 52%) as colorless crystals.
'H-NMR (CDC1 ) δ 1.46 (3Η, t, J = 7.2 Hz), 4.49 (2H, q, J = 7.2 Hz), 7.13 (1H, s) 'H-NMR (CDC1) δ 1.46 (3Η, t, J = 7.2 Hz), 4.49 (2H, q, J = 7.2 Hz), 7.13 (1H, s)
, 7.69 (2H, d, J = 6.0 Hz), 8.80 (2H, d, J = 6.0 Hz). 7.69 (2H, d, J = 6.0 Hz), 8.80 (2H, d, J = 6.0 Hz).
(3) 11→12 (3) 11 → 12
化合物 11(6.33g, 29 mmol)のメタノール (45 mL)溶液にシァナミド (1.28 g, 30.5 mmol )をカロえ、氷浴下、 1.0N NaOMe/MaOH(30.5 mL, 30.5 mmol)を加えて室温まで昇温 後、同温にて 1時間撹拌した。減圧下メタノールを留去し、水 (80 mL)をカ卩え、 IN HC1 で pHを 3付近に調整した。沈殿を吸引濾取して減圧乾燥し、淡黄土色の粉末 (4.32 g )を得た。この粉末にメタノール (70 mL)を加えた懸濁液に IN NaOMe/MeOH(29 mL) を pHを注意深く確認しながら加えた。メタノールを減圧濃縮し Et 0を加えて沈殿を吸 引濾取し、化合物 12(6.55 g,収率 96%)を無色の無定形粉末として得た。 Cyanamide (1.28 g, 30.5 mmol) was added to a solution of compound 11 (6.33 g, 29 mmol) in methanol (45 mL), and 1.0N NaOMe / MaOH (30.5 mL, 30.5 mmol) was added to the room temperature in an ice bath. After heating, the mixture was stirred at the same temperature for 1 hour. Methanol was distilled off under reduced pressure, water (80 mL) was added, and the pH was adjusted to around 3 with IN HC1. The precipitate was collected by suction filtration and dried under reduced pressure to obtain a light ocher powder (4.32 g). IN NaOMe / MeOH (29 mL) was added to the suspension obtained by adding methanol (70 mL) to this powder while carefully checking the pH. Methanol was concentrated under reduced pressure, Et 0 was added, and the precipitate was collected by suction filtration to obtain Compound 12 (6.55 g, yield 96%) as a colorless amorphous powder.
'H-NMR (d -DMSO) δ: 7.43 (1Η, s), 7.89 (2Η, d, J = 6.3 Hz), 8.72 (2H, d, J = 6.3 'H-NMR (d-DMSO) δ: 7.43 (1Η, s), 7.89 (2Η, d, J = 6.3 Hz), 8.72 (2H, d, J = 6.3
Hz). Hz).
(4) 6→13 (4) 6 → 13
化合物 6(4.3 g)と 12(708mg, 3.0 mmol)を用レ、、実施例 69の (5)と同様の方法で化合 物 13(405 mg,収率 18%)を得た。 Compound 6 (4.3 mg) and 12 (708 mg, 3.0 mmol) were used in the same manner as in Example 69, (5) to give compound 13 (405 mg, yield 18%).
'H-NMR (D O) δ: 1.27 (3H, t, J = 7.1 Hz), 3.67 (2H, s), 4.22 (2H,q, J = 7.1 Hz), 5
.26 (1H, d, J = 4.5 Hz), 5.35 (1H, d, J = 6.6 Hz), 5.80 (1H, d, J = 4.5 Hz), 6.11 (1H , dt, J = 6.6, 15.6 Hz), 6.93 (1H, s ), 7.00 (1H, d, J = 15.6 Hz), 7.51 (1H, s), 8.42 ( 2H, d, J = 6.9 Hz), 8.97 (2H, d, J = 6.9 Hz). 'H-NMR (DO) δ: 1.27 (3H, t, J = 7.1 Hz), 3.67 (2H, s), 4.22 (2H, q, J = 7.1 Hz), 5 .26 (1H, d, J = 4.5 Hz), 5.35 (1H, d, J = 6.6 Hz), 5.80 (1H, d, J = 4.5 Hz), 6.11 (1H, dt, J = 6.6, 15.6 Hz) , 6.93 (1H, s), 7.00 (1H, d, J = 15.6 Hz), 7.51 (1H, s), 8.42 (2H, d, J = 6.9 Hz), 8.97 (2H, d, J = 6.9 Hz) .
IR (KBr) cm—1: 3424, 2980, 2171, 1763, 1606, 1532, 1468, 1387, 1338, 1200, 1150, 1091, 1035. IR (KBr) cm— 1 : 3424, 2980, 2171, 1763, 1606, 1532, 1468, 1387, 1338, 1200, 1150, 1091, 1035.
MS(ESI): 650+ (M - Na + 2H)+ MS (ESI): 650+ (M-Na + 2H) +
元素分析 C H N NaO S -4.9 H O Elemental analysis C H N NaO S -4.9 H O
計算値: C,43.71; H,4.05; N, 16.99; S,8.64; Na,3.10 (%) Calculated values: C, 43.71; H, 4.05; N, 16.99; S, 8.64; Na, 3.10 (%)
実験値: C43.64; H,3.93; N, 16.87; S,8.79; Na,3.35 (%) Experimental value: C43.64; H, 3.93; N, 16.87; S, 8.79; Na, 3.35 (%)
実施例 71 Example 71
[化 117] [Chemical 117]
化合物 14(1.26g)と 5(354 mg)を用レ、、実施例 69の (5)と同様の方法で化合物 15(152 mg,収率 14%)を得た。 Compound 14 (1.26 g) and 5 (354 mg) were used in the same manner as in Example 69, (5) to give compound 15 (152 mg, yield 14%).
'H-NMR (D O) δ: 3.67 (2Η, s), 3.95 (3H, s), 5.26 (1H, d, J = 4.8 Hz), 5.37 (1H, d, 'H-NMR (D O) δ: 3.67 (2Η, s), 3.95 (3H, s), 5.26 (1H, d, J = 4.8 Hz), 5.37 (1H, d,
J = 6.6 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.13 (1H, dt, J = 6.6, 15.9 Hz), 6.95 (1H, s ), 7.01 (1H, d, J = 15.9 Hz), 7.48 (1H, s), 8.48 (2H, d, J = 6.9 Hz), 9.00 (2H, d, J = 6 • 9 Hz). J = 6.6 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.13 (1H, dt, J = 6.6, 15.9 Hz), 6.95 (1H, s), 7.01 (1H, d, J = 15.9 Hz) , 7.48 (1H, s), 8.48 (2H, d, J = 6.9 Hz), 9.00 (2H, d, J = 6 • 9 Hz).
IR (KBr) cm"1: 3481, 2940, 2170, 1763, 1608, 1561, 1532, 1474, 1439 1356, 1212, 1175, 1149, 1036, 1001. IR (KBr) cm " 1 : 3481, 2940, 2170, 1763, 1608, 1561, 1532, 1474, 1439 1356, 1212, 1175, 1149, 1036, 1001.
MS(ESI): 636+ (M - Na + 2H)+
元素分析 C H N NaO S -4.4 H O MS (ESI): 636 + (M-Na + 2H) + Elemental analysis CHN NaO S -4.4 HO
計算値: C,42.38; H,3.94; N, 17.11; S,8.70 ; Na,3.12 (%) Calculated values: C, 42.38; H, 3.94; N, 17.11; S, 8.70; Na, 3.12 (%)
実験値: C,42.30; H,3.91; N, 17.04; S,8.92; Na,3.48 (%) Experimental value: C, 42.30; H, 3.91; N, 17.04; S, 8.92; Na, 3.48 (%)
実施例 72 Example 72
[0096] [化 118] [0096] [Chemical 118]
化合物 14(1.26 g)と化合物 12(354 mg)を用レ、、実施例 69の (5)と同様の方法で化合 物 16(118 mg,収率 11%)を得た。 Compound 14 (118 mg, yield 11%) was obtained in the same manner as in Example 69, (5), using Compound 14 (1.26 g) and Compound 12 (354 mg).
H-NMR (D O) δ: 3.67 (2Η, s), 3.95 (3H, s), 5.25 (1H, d, J = 4.8 Hz), 5.35 (1H, d, H-NMR (D O) δ: 3.67 (2Η, s), 3.95 (3H, s), 5.25 (1H, d, J = 4.8 Hz), 5.35 (1H, d,
J = 6.6 Hz), 5.79 (1H, d, J = 4.8 Hz), 6.11 (1H, dt, J = 6.6, 15.6 Hz), 6.95 (1H, s ), 7.00 (1H, d, J = 15.6 Hz), 7.52 (1H, s), 8.42 (2H, d, J = 6.9 Hz), 8.97 (2H, d, J = 6 .9 Hz). J = 6.6 Hz), 5.79 (1H, d, J = 4.8 Hz), 6.11 (1H, dt, J = 6.6, 15.6 Hz), 6.95 (1H, s), 7.00 (1H, d, J = 15.6 Hz) , 7.52 (1H, s), 8.42 (2H, d, J = 6.9 Hz), 8.97 (2H, d, J = 6.9 Hz).
IR (KBr) cm"1: 3422, 2940, 2171, 1763, 1606, 1532, 1467, 1389, 1338, 1214, 1179,IR (KBr) cm " 1 : 3422, 2940, 2171, 1763, 1606, 1532, 1467, 1389, 1338, 1214, 1179,
1149, 1036, 1000. 1149, 1036, 1000.
MS(ESI): 636+ (M - Na + 2H)+ MS (ESI): 636+ (M-Na + 2H) +
元素分析 C H N NaO S · 3.2 H O Elemental analysis C H N NaO S3.2 H O
計算値: C,43.66; H,3.72; N, 17.62; S,8.97; Na,3.21 (%) Calculated values: C, 43.66; H, 3.72; N, 17.62; S, 8.97; Na, 3.21 (%)
実験値: C43.72; H,4.02; N, 17.62; S,9.24; Na,3.32 (%) Experimental value: C43.72; H, 4.02; N, 17.62; S, 9.24; Na, 3.32 (%)
実施例 73 Example 73
[0097] [化 119]
[0097] [Chemical 119]
19 19
(1) 17→18 (1) 17 → 18
Heterocycles 1998, 48, 1237の方法に従い合成した 17(2.70 g)より、実施例 69の (4) と同様の方法で化合物 18(2.47 g,収率 84 %)を得た。 Compound 18 (2.47 g, yield 84%) was obtained from 17 (2.70 g) synthesized according to the method of Heterocycles 1998, 48, 1237 in the same manner as in Example 69 (4).
'H-NMR (d -DMSO) δ: 1.97 (2Η, m), 2.86 (2H, t, J = 7.5 Hz), 3.14 - 3.19 (4H, m) 'H-NMR (d -DMSO) δ: 1.97 (2Η, m), 2.86 (2H, t, J = 7.5 Hz), 3.14-3.19 (4H, m)
6 6
, 7.41 (1H, d, J = 5.1 Hz), 8.22 (1H, d, J = 5.1 Hz). 7.41 (1H, d, J = 5.1 Hz), 8.22 (1H, d, J = 5.1 Hz).
(2) 6+18→19 (2) 6 + 18 → 19
6(1.31 g)と 18(313 mg)を用いて実施例 69の (5)と同様の方法で化合物 19(122 mg, 11 Compound 19 (122 mg, 11 mg) was prepared in the same manner as in Example 69 (5) using 6 (1.31 g) and 18 (313 mg).
%)を得た。 %).
'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 2.30 (2H, m), 3.30 - 3.40 (4H, m), 3.6 'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 2.30 (2H, m), 3.30-3.40 (4H, m), 3.6
2 2
2 (2H, s), 4.25 (2H, q, J = 6.9), 5.21 (1H, d, J = 6.3 Hz), 5.25 (1H, d, J = 4.8 Hz), 5 .81 (1H, d, J = 4.8 Hz), 6.00 (1H, dt, J = 6.3, 15.9 Hz), 6.98 (1H, s ), 7.93 (1H, d, J = 6.3 Hz), 8.54 (1H, d, J = 6.3 Hz). 2 (2H, s), 4.25 (2H, q, J = 6.9), 5.21 (1H, d, J = 6.3 Hz), 5.25 (1H, d, J = 4.8 Hz), 5.81 (1H, d, J = 4.8 Hz), 6.00 (1H, dt, J = 6.3, 15.9 Hz), 6.98 (1H, s), 7.93 (1H, d, J = 6.3 Hz), 8.54 (1H, d, J = 6.3 Hz) .
IR(KBr) cm—1: 3424, 2976, 2164, 1763, 1607, 1568, 1532, 1444, 1374, 1297, 1198,IR (KBr) cm— 1 : 3424, 2976, 2164, 1763, 1607, 1568, 1532, 1444, 1374, 1297, 1198,
1165, 1090, 1035. 1165, 1090, 1035.
MS(ESI): 645+ (M - Na + 2H)+ MS (ESI): 645+ (M-Na + 2H) +
元素分析 C H N NaO S - 3.7 H O Elemental analysis C H N NaO S-3.7 H O
27 25 8 6 2 2 27 25 8 6 2 2
計算値: C,45.59; H,4.59; N, 15.75; S,9.02; Na,3.23 (%)
実験値: C,45.54; Η,4·58; Ν, 15.65; S,9.20; Na,3.46 (%) Calculated values: C, 45.59; H, 4.59; N, 15.75; S, 9.02; Na, 3.23 (%) Experimental value: C, 45.54; Η, 4.58; Ν, 15.65; S, 9.20; Na, 3.46 (%)
実施例 74 Example 74
[化 120] [Chemical 120]
(1) 19→20 (1) 19 → 20
化合物 19(2.0 g, 10.5 mmol)の EtOH(30 mL)溶液に 2N水酸化ナトリウム水溶液 (26. 3 mL)を加えて室温で 2時間撹拌した。 5N塩酸水溶液 (10.5 mL)を加えた後、 Et〇H を減圧留去した。残渣に水 (30 mL)を加えて氷冷し 1N塩酸水溶液を加えて pHを 3付 近に調整した。沈殿を吸引濾取、減圧乾燥し 20(1.76 g,収率 100%)を淡茶色の粉末と して得た。 To a solution of compound 19 (2.0 g, 10.5 mmol) in EtOH (30 mL) was added 2N aqueous sodium hydroxide solution (26.3 mL), and the mixture was stirred at room temperature for 2 hr. After adding 5N hydrochloric acid aqueous solution (10.5 mL), EtOH was distilled off under reduced pressure. Water (30 mL) was added to the residue, ice-cooled, and 1N hydrochloric acid aqueous solution was added to adjust the pH to about 3. The precipitate was collected by suction filtration and dried under reduced pressure to obtain 20 (1.76 g, yield 100%) as a light brown powder.
'H-NMR (d -DMSO) δ: 7.15 (1Η, s), 7.26 (1Η, dd, J = 4.5, 8.4 Hz), 7.80 - 7.84 (1 'H-NMR (d -DMSO) δ: 7.15 (1Η, s), 7.26 (1Η, dd, J = 4.5, 8.4 Hz), 7.80-7.84 (1
6 6
H, m), 8.44 (1H, brs), 12.0 (1H, brs). H, m), 8.44 (1H, brs), 12.0 (1H, brs).
(2) 20→21 (2) 20 → 21
化合物 20(1.76 g, 10.9 mmol)の DMF(20 mL)溶液にカルボニルジイミダゾール (1.94 g, 11.9 mmol)を加え、室温で 1時間撹拌後、氷冷した。シアナミド (958mg, 22.8 mmol )の DMF(10 mL)溶液に氷冷下水素化ナトリウム (60%w/w, 912mg, 22.8mmol)を加え同 温で 20分撹拌した懸濁液を先の反応液に注加した。室温にて 1時間撹拌後 2N塩酸 (11.4 mL)を加え、減圧下 DMFを留去した。残渣に水 (60 mL)を加えて氷冷下撹拌し、
IN塩酸水溶液を加えて pHを 3付近に調整した。析出した沈殿を吸引濾取、減圧乾 燥し 21(1.18 g, 58 %)を得た。 Carbonyldiimidazole (1.94 g, 11.9 mmol) was added to a DMF (20 mL) solution of compound 20 (1.76 g, 10.9 mmol), and the mixture was stirred at room temperature for 1 hour and then ice-cooled. To a solution of cyanamide (958 mg, 22.8 mmol) in DMF (10 mL) under ice-cooling, sodium hydride (60% w / w, 912 mg, 22.8 mmol) was added and stirred at the same temperature for 20 minutes. Added to. After stirring at room temperature for 1 hour, 2N hydrochloric acid (11.4 mL) was added, and DMF was distilled off under reduced pressure. Water (60 mL) was added to the residue and stirred under ice cooling. IN aqueous hydrochloric acid was added to adjust the pH to around 3. The deposited precipitate was collected by suction filtration and dried under reduced pressure to obtain 21 (1.18 g, 58%).
'H-NMR (d -DMSO) δ: 7.01 (1Η, s), 7.63 (1Η, dd, J = 5.7, 8.1 Hz), 8.40 (1H, d, J 'H-NMR (d-DMSO) δ: 7.01 (1Η, s), 7.63 (1Η, dd, J = 5.7, 8.1 Hz), 8.40 (1H, d, J
= 8.1 Hz), 8.65 (1H, d, J = 5.7 Hz), 12.8 (1H, brs). = 8.1 Hz), 8.65 (1H, d, J = 5.7 Hz), 12.8 (1H, brs).
(3) 21→22 (3) 21 → 22
化合物 21(1.18 g)のメタノール (7 mL)溶液に 1.0N NaOMe/MeOH(4.5 mL)を加え濃 縮乾固した。得られた淡桃色の粉末 22を次反応に用いた。 To a solution of compound 21 (1.18 g) in methanol (7 mL) was added 1.0N NaOMe / MeOH (4.5 mL), and the mixture was concentrated to dryness. The obtained light pink powder 22 was used in the next reaction.
(4) 6+22→23 (4) 6 + 22 → 23
化合物 6(872 mg)と 22(208 mg)を用いて、実施例 69の (5)と同様の方法で化合物 23(8 7mg,収率 12%)を得た。 Compound 23 (87 mg, yield 12%) was obtained in the same manner as in Example 69, (5), using Compound 6 (872 mg) and 22 (208 mg).
'H-NMR (D O) δ: 1.27 (3H, t, J = 6.9 Hz), 3.62 (2H, s), 4.22 (2H,q, J = 6.9 Hz), 5 'H-NMR (D O) δ: 1.27 (3H, t, J = 6.9 Hz), 3.62 (2H, s), 4.22 (2H, q, J = 6.9 Hz), 5
.22 (1H, d, J = 4.8 Hz), 5.43 (2H, d, J = 6.3 Hz), 5.79 (1H, d, J = 4.8 Hz), 6.15 (1H.22 (1H, d, J = 4.8 Hz), 5.43 (2H, d, J = 6.3 Hz), 5.79 (1H, d, J = 4.8 Hz), 6.15 (1H
, dt, J = 6.3, 15.9 Hz), 6.87 (1H, d, J = 15.9 Hz), 6.93 (1H, s), 7.23 (1H, s), 7.69 (1, dt, J = 6.3, 15.9 Hz), 6.87 (1H, d, J = 15.9 Hz), 6.93 (1H, s), 7.23 (1H, s), 7.69 (1
H, dd, J = 6.0, 8.5 Hz), 8.48 (1H, d, J = 8.5 Hz), 8.59 (1H, d, J = 6.0 Hz). H, dd, J = 6.0, 8.5 Hz), 8.48 (1H, d, J = 8.5 Hz), 8.59 (1H, d, J = 6.0 Hz).
IR (KBr) cm"1: 3409, 2984, 2164, 1762, 1664, 1592, 1532, 1460, 1335, 1201, 1160,IR (KBr) cm " 1 : 3409, 2984, 2164, 1762, 1664, 1592, 1532, 1460, 1335, 1201, 1160,
1122, 1091, 1036. 1122, 1091, 1036.
MS(ESI): 644+ (M + H)+ MS (ESI): 644 + (M + H) +
元素分析 C H N NaO S -4.3 H O - 0.2 NaHCO Elemental analysis C H N NaO S -4.3 H O-0.2 NaHCO
計算値: C,42.65; H,4.21; N, 17.08; S,8.69; Na,3.74 (%) Calculated value: C, 42.65; H, 4.21; N, 17.08; S, 8.69; Na, 3.74 (%)
実験値: C,42.66; Η,4· 13; Ν, 16.87; S,9.18; Na,3.77 (%) Experimental value: C, 42.66; Η, 4.13; Ν, 16.87; S, 9.18; Na, 3.77 (%)
実施例 75 Example 75
24 25 26 27 24 25 26 27
(1) 24→25 (1) 24 → 25
化合物 24(2.57 g, 20 mmol)の THF(40 mL)溶液にトリェチルァミン (2.79 mL, 20 mmo 1)を加え氷浴にて冷却し撹拌した。この溶液にクロログリオキシノレ酸ェチル (2.23 mL, 20 mmol)の THF(20 mL)溶液を 10分間かけて滴下した。室温まで昇温し、さらに同温 で 30分間撹拌後、酢酸ェチルー水で抽出した。有機層を飽和食塩水で洗浄し、無 水硫酸マグネシウムで乾燥後、濃縮、減圧乾燥した。化合物 25(4.62g,収率 100%)を 淡黄土色結晶として得た。 To a solution of compound 24 (2.57 g, 20 mmol) in THF (40 mL) was added triethylamine (2.79 mL, 20 mmo 1), and the mixture was cooled in an ice bath and stirred. To this solution, a solution of ethyl chloroglyoxynolate (2.23 mL, 20 mmol) in THF (20 mL) was added dropwise over 10 minutes. The mixture was warmed to room temperature, further stirred at the same temperature for 30 minutes, and extracted with ethyl acetate water. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, concentrated and dried under reduced pressure. Compound 25 (4.62 g, yield 100%) was obtained as pale ocher crystals.
'H-NMR (CDC1 ) δ 1.46 (3Η, t, J = 7.2 Hz), 4.46 (2H, q, J = 7.2 Hz), 7.41 (1H, d 'H-NMR (CDC1) δ 1.46 (3Η, t, J = 7.2 Hz), 4.46 (2H, q, J = 7.2 Hz), 7.41 (1H, d
, J = 5.4 Hz), 8.37 (1H, d, J = 5.4 Hz), 9.34 (1H, brs), 9.64 (1H, s). , J = 5.4 Hz), 8.37 (1H, d, J = 5.4 Hz), 9.34 (1H, brs), 9.64 (1H, s).
(2) 25→26 (2) 25 → 26
化合物 25(1.14g, 5.0 mmol)のトルエン (10 mL)溶液に Lawesson試薬 (2.43g, 6.0 mm ol)を加え 1時間還流した。室温まで冷却後、酢酸ェチル-重曹水で抽出し、有機層を 無水硫酸マグネシウムで乾燥し、減圧濃縮した。得られた残渣をシリカゲルカラムクロ マトグラフィー (へキサン-酢酸ェチル)により精製し、化合物 26(534 mg,収率 51%)を黄 土色結晶として得た。 Lawesson's reagent (2.43 g, 6.0 mmol) was added to a solution of compound 25 (1.14 g, 5.0 mmol) in toluene (10 mL), and the mixture was refluxed for 1 hour. After cooling to room temperature, the mixture was extracted with ethyl acetate-sodium bicarbonate water, and the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane-ethyl acetate) to obtain Compound 26 (534 mg, yield 51%) as ocher crystals.
H-NMR (d -DMSO) δ 1.39 (3Η, t, J = 6.9). 4.46 (2H, q, J = 6.9 Hz), 8.32 (1H, dd H-NMR (d -DMSO) δ 1.39 (3Η, t, J = 6.9). 4.46 (2H, q, J = 6.9 Hz), 8.32 (1H, dd
, J = 0.9, 5.7 Hz), 8.67 (1H, d, J = 5.7 Hz), 9.51 (1H, d, J = 0.9 Hz). , J = 0.9, 5.7 Hz), 8.67 (1H, d, J = 5.7 Hz), 9.51 (1H, d, J = 0.9 Hz).
(3) 26→27 (3) 26 → 27
化合物 26(18.25 g, 87.6 mmol)のメタノール (300 mL)溶液に氷浴撹拌下、 NaNHCN( 5.89 g, 90.2 mmol)を加えた後、室温で 2時間撹拌した。析出物を吸引濾趣しイソプロ パノール一エタノール混液で洗浄した。濾取物を減圧乾燥し化合物 27(9.75g,収率 4
9%)を得た。 NaNHCN (5.89 g, 90.2 mmol) was added to a solution of compound 26 (18.25 g, 87.6 mmol) in methanol (300 mL) with stirring in an ice bath, and the mixture was stirred at room temperature for 2 hr. The precipitate was filtered off with suction and washed with a mixture of isopropanol and ethanol. The filtered product was dried under reduced pressure to give compound 27 (9.75 g, yield 4 9%) was obtained.
H-NMR (d -DMSO) δ 8.13 (1H, dd, J = 0.9, 5.4 Hz), 8.52 (1H, d, J = 5.4 Hz), 9.2 H-NMR (d-DMSO) δ 8.13 (1H, dd, J = 0.9, 5.4 Hz), 8.52 (1H, d, J = 5.4 Hz), 9.2
9 (1H, d, J = 0.9 Hz). 9 (1H, d, J = 0.9 Hz).
(4) 6+27→28 (4) 6 + 27 → 28
6(689 mg)と 27(149 mg)を用いて、実施例 69の (5)と同様の方法で化合物 28(35 mg, 収率 7%)を得た。 6 (689 mg) and 27 (149 mg) were used to obtain compound 28 (35 mg, yield 7%) in the same manner as in Example 69, (5).
'H-NMR (D O) δ: 1.28 (3H, t, J = 7.2 Hz), 3.67 (2H, s), 4.22 (2H,q, J = 7.2 Hz), 5 'H-NMR (D O) δ: 1.28 (3H, t, J = 7.2 Hz), 3.67 (2H, s), 4.22 (2H, q, J = 7.2 Hz), 5
.26 (1H, d, J = 4.5 Hz), 5.47 (1H, d, J = 6.6 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.17 (1H , dt, J = 6.6, 15.6 Hz), 6.93 (1H, s), 7.03 (1H, d, J = 15.6 Hz), 8.67 (1H, d, J = 6.6 Hz), 8.74 (1H, d, J = 6.6 Hz), 9.72 (1H, s). .26 (1H, d, J = 4.5 Hz), 5.47 (1H, d, J = 6.6 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.17 (1H, dt, J = 6.6, 15.6 Hz) , 6.93 (1H, s), 7.03 (1H, d, J = 15.6 Hz), 8.67 (1H, d, J = 6.6 Hz), 8.74 (1H, d, J = 6.6 Hz), 9.72 (1H, s) .
IR (KBr) cm"1: 3425, 2180, 1762, 1606, 1532, 1363, 1304, 1200, 1166, 1123, 1084, 1036. IR (KBr) cm " 1 : 3425, 2180, 1762, 1606, 1532, 1363, 1304, 1200, 1166, 1123, 1084, 1036.
MS(ESI): 662+ (M + H)+ MS (ESI): 662 + (M + H) +
元素分析 C H N NaO S - 3.9 H O Elemental analysis C H N NaO S-3.9 H O
計算値: C,41.02; Η,3·83; Ν, 17.22; S, 13.14; Na,3.14 (%) Calculated value: C, 41.02; Η, 3.83; Ν, 17.22; S, 13.14; Na, 3.14 (%)
実験値: C,40.98; H,3.72; N, 17.21; S, 13.11; Na,3.47 (%) Experimental value: C, 40.98; H, 3.72; N, 17.21; S, 13.11; Na, 3.47 (%)
実施例 76 Example 76
[化 122] [Chemical 122]
濃塩酸 (2 mL)、水 (4 mL)の混合溶液を- 30°Cに冷却し、化合物 29(2.21g, 10 mmol) 、メチルヒドラジン (0.51 mL, 9.5 mmol)を順次加えた。室温まで昇温後 80°Cで 1時間 撹拌した。氷浴で冷却し IN NaOH水溶液を用いて pHを 5付近に調整した。酢酸ェチ ル (100 mL)、クロ口ホルム (50 mL)を加えて抽出した。水層を再度クロ口ホルムで抽出 し、有機層は合わせて無水硫酸マグネシウムで乾燥後、減圧濃縮した。残渣をシリカ ゲルカラムクロマトグラフィーで精製し化合物 30(509 mg,収率 22%)、化合物 31(591 m g,収率 26%)をそれぞれ無色の結晶として得た。 A mixed solution of concentrated hydrochloric acid (2 mL) and water (4 mL) was cooled to −30 ° C., and compound 29 (2.21 g, 10 mmol) and methylhydrazine (0.51 mL, 9.5 mmol) were sequentially added. The mixture was warmed to room temperature and stirred at 80 ° C for 1 hour. The solution was cooled in an ice bath and the pH was adjusted to around 5 using IN NaOH aqueous solution. Ethyl acetate (100 mL) and black mouth form (50 mL) were added for extraction. The aqueous layer was extracted again with chloroform, and the organic layers were combined, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain compound 30 (509 mg, yield 22%) and compound 31 (591 mg, yield 26%) as colorless crystals.
30: 'H-NMR (CDC1 ) δ: 1.42 (3H, t, J = 7.2 Hz), 4.25 (3H, s), 4.39 (2H, q, J = 7.2 30: 'H-NMR (CDC1) δ: 1.42 (3H, t, J = 7.2 Hz), 4.25 (3H, s), 4.39 (2H, q, J = 7.2
Hz), 7.21 (1H, s), 7.68 (2H, dd, J = 1.8, 4.8 Hz), 8.63 (2H, dd, J = 1.8, 4.8 Hz). 31 : JH-NMR (CDC1 ) δ: 1.42 (3H, t, J = 7.2 Hz), 4.03 (3H, s), 4.45 (2H, q, J = 7.2Hz), 7.21 (1H, s), 7.68 (2H, dd, J = 1.8, 4.8 Hz), 8.63 (2H, dd, J = 1.8, 4.8 Hz). 31: J H-NMR (CDC1) δ: 1.42 (3H, t, J = 7.2 Hz), 4.03 (3H, s), 4.45 (2H, q, J = 7.2
Hz), 6.97 (1H, s), 7.37 (2H, dd, J = 1.5, 4.5 Hz), 8.74 (2H, dd, J = 1.5, 4.5 Hz).Hz), 6.97 (1H, s), 7.37 (2H, dd, J = 1.5, 4.5 Hz), 8.74 (2H, dd, J = 1.5, 4.5 Hz).
(2) 30→32 (2) 30 → 32
化合物 30(505 mg, 2.18 mmol)のメタノール (4 mL)溶液に氷浴撹拌下、シアナミド (96 mg, 2.19 mmol), 1.0N NaOMe/MeOHを順次加え室温まで昇温した。室温で 3時間 撹拌した後 50°Cで 6時間撹拌し、室温下で一夜静置した。シァナミド (96 mg, 2.19 mm ol)及び 1.0N NaOMe/MeOHを追加し 50°Cで 8時間撹拌した。室温で一夜終夜静置 した後、メタノールを減圧留去し、水 (5 mL)を加え氷冷、撹拌した。 2N HC1で pHを 3 付近に調整し沈殿を吸引濾取した。濾取物を減圧乾燥して化合物 32(369mg,収率 7 4%)を得た。 Cyanamide (96 mg, 2.19 mmol) and 1.0N NaOMe / MeOH were sequentially added to a methanol (4 mL) solution of compound 30 (505 mg, 2.18 mmol) while stirring in an ice bath, and the mixture was warmed to room temperature. The mixture was stirred at room temperature for 3 hours, then stirred at 50 ° C for 6 hours, and allowed to stand overnight at room temperature. Cyanamide (96 mg, 2.19 mmol) and 1.0N NaOMe / MeOH were added, and the mixture was stirred at 50 ° C. for 8 hours. After standing overnight at room temperature, methanol was evaporated under reduced pressure, water (5 mL) was added, and the mixture was cooled with ice and stirred. The pH was adjusted to around 3 with 2N HC1, and the precipitate was collected by suction filtration. The filtered product was dried under reduced pressure to obtain Compound 32 (369 mg, yield 74%).
'H-NMR (d -DMSO) δ: 4.20 (3Η, s), 7.50 (1Η, s), 8.29 (2H, brs), 8.81 (2H, brs). 'H-NMR (d-DMSO) δ: 4.20 (3Η, s), 7.50 (1Η, s), 8.29 (2H, brs), 8.81 (2H, brs).
(3) 32→33 (3) 32 → 33
化合物 32(369mg, 1.62 mmol)のメタノール (3 mL)懸濁液に 1.0N NaOMe/MeOH(1.6 2 mL)を加え溶液とした後に濃縮乾固して白色粉末の化合物 33(455 mg)を得た。 1.0N NaOMe / MeOH (1.6 2 mL) is added to a suspension of compound 32 (369 mg, 1.62 mmol) in methanol (3 mL) to make a solution, and then concentrated to dryness to obtain compound 33 (455 mg) as a white powder. It was.
(4) 6+33→34 (4) 6 + 33 → 34
化合物 6(1.08g)と化合物 33(258 mg)を用いて、実施例 69の (5)と同様の方法で化合 物 34(120 mg,収率 15%)を得た。 Compound 34 (120 mg, 15% yield) was obtained in the same manner as in Example 69, (5), using Compound 6 (1.08 g) and Compound 33 (258 mg).
'H-NMR (D O) δ: 1.28 (3H, t, J = 7.2 Hz), 3.64 (1H, d, J = 17.7 Hz), 3.71 (1H, d,
J = 17.7 Hz), 4.11 (3H, s), 4.22 (2H, q, J = 7.2 Hz), 5.25 - 5.26 (2H, m), 5.80 (1H d, J = 4.5 Hz), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.91 (1H, s ), 6.99 (1H, d, J = 15.6'H-NMR (DO) δ: 1.28 (3H, t, J = 7.2 Hz), 3.64 (1H, d, J = 17.7 Hz), 3.71 (1H, d, J = 17.7 Hz), 4.11 (3H, s), 4.22 (2H, q, J = 7.2 Hz), 5.25-5.26 (2H, m), 5.80 (1H d, J = 4.5 Hz), 6.12 (1H, dt , J = 6.9, 15.6 Hz), 6.91 (1H, s), 6.99 (1H, d, J = 15.6
Hz), 7.23 (1H, s), 8.22 (2H, d, J = 7.2 Hz), 8.97 (2H, d, J = 7.2 Hz). Hz), 7.23 (1H, s), 8.22 (2H, d, J = 7.2 Hz), 8.97 (2H, d, J = 7.2 Hz).
IR (KBr) cm—1: 3419, 2980, 2186, 2151, 1764, 1636, 1604, 1522, 1475, 1437, 1388IR (KBr) cm— 1 : 3419, 2980, 2186, 2151, 1764, 1636, 1604, 1522, 1475, 1437, 1388
1347, 1301, 1201, 1155, 1035, 1001. 1347, 1301, 1201, 1155, 1035, 1001.
MS(ESI): 663+ (M - Na + 2H)+ MS (ESI): 663+ (M-Na + 2H) +
元素分析 C H N NaO S - 4.6 H O Elemental analysis C H N NaO S-4.6 H O
計算値: C,43.81; H,4.49; N, 18.25; S,8.36; Na,3.00 (%) Calculated values: C, 43.81; H, 4.49; N, 18.25; S, 8.36; Na, 3.00 (%)
実験値: C,43.81; H,4.28; N, 18.15; S,8.24; Na,3.26 (%) Experimental value: C, 43.81; H, 4.28; N, 18.15; S, 8.24; Na, 3.26 (%)
実施例 77 Example 77
[化 123] [Chemical 123]
38-2 38-2
(1) 35→36 (1) 35 → 36
化合物 35(10.0 g, 72.4 mmol)のエタノール (145 mL)溶液にブロモピルビン酸ェチル エステル (90%w/w, 12.1 mL, 86.8 mmol)を加え、還流下 1.5時間撹拌した。エタノール を半量減圧留去し、析出した沈殿を吸引濾取した。この粉末に酢酸ェチル (200 mL) 、飽和重曹水 (200 mL)を加えて抽出した。有機層を飽和食塩水で洗浄し、無水硫酸 マグネシウムで乾燥後、減圧濃縮した。残渣にジイソプロピルエーテルを加え沈殿を 吸引濾取して化合物 36(8.45 g,収率 50%)を桃色結晶として得た。
Ή-NMR (CDC1 ) δ: 1.45 (3H, t, J = 6.9 Hz), 4.47 (2H, q, J = 6.9 Hz), 7.89 (2H, d d, J = 1.5, 4.5 Hz), 8.28 (1H, s), 8.75 (2H, d, J = 5.4 Hz). Bromopyruvate ethyl ester (90% w / w, 12.1 mL, 86.8 mmol) was added to a solution of compound 35 (10.0 g, 72.4 mmol) in ethanol (145 mL), and the mixture was stirred for 1.5 hours under reflux. Ethanol was distilled off by a half amount under reduced pressure, and the deposited precipitate was collected by suction filtration. The powder was extracted by adding ethyl acetate (200 mL) and saturated aqueous sodium bicarbonate (200 mL). The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. Diisopropyl ether was added to the residue, and the precipitate was collected by suction filtration to give compound 36 (8.45 g, yield 50%) as pink crystals. NMR-NMR (CDC1) δ: 1.45 (3H, t, J = 6.9 Hz), 4.47 (2H, q, J = 6.9 Hz), 7.89 (2H, dd, J = 1.5, 4.5 Hz), 8.28 (1H, s), 8.75 (2H, d, J = 5.4 Hz).
(2) 36→37-l→37-2 (2) 36 → 37-l → 37-2
化合物 36(8.44g, 36 mmol)をメタノール (100 mL)で懸濁させ NaNHCN(3.53 g, 54 m mol)を加えた。 50°Cで 30分間撹拌し、メタノールを減圧留去した。エタノールを加えて 、不溶物を濾取し、化合物 37-l(7.82g,収率 86%)を淡黄土色粉末として得た。 Compound 36 (8.44 g, 36 mmol) was suspended in methanol (100 mL), and NaNHCN (3.53 g, 54 mmol) was added. The mixture was stirred at 50 ° C for 30 minutes, and methanol was distilled off under reduced pressure. Ethanol was added and the insoluble material was collected by filtration to obtain Compound 37-l (7.82 g, yield 86%) as a light ocher powder.
H-NMR (d -DMSO) δ 7.89 (2Η, dd, J = 1.8, 4.5 Hz), 8.18 (1H, s), 8.70 (2H, dd, JH-NMR (d-DMSO) δ 7.89 (2Η, dd, J = 1.8, 4.5 Hz), 8.18 (1H, s), 8.70 (2H, dd, J
= 1.8, 4.5 Hz). = 1.8, 4.5 Hz).
化合物 37-1(1.26g, 5 mmol)を水 15mlに溶解して 2NHCl(2.5mL)を加えて中和した。析 出物を濾取、乾燥して 1.2gの粉末を得た。このうち 0.6gをメタノール (lOmL)に懸濁して 、 1Mテトラメチルダァニジンのメタノール溶液を加えて、 pH5.7に調製した。反応液を 濃縮して、イソプロピルエーテルから結晶化して化合物 37_2(698mg)を得た。 Compound 37-1 (1.26 g, 5 mmol) was dissolved in 15 ml of water and neutralized with 2N HCl (2.5 mL). The precipitate was collected by filtration and dried to obtain 1.2 g of powder. 0.6 g of this was suspended in methanol (10 mL), and a methanol solution of 1M tetramethyldanidine was added to adjust to pH 5.7. The reaction solution was concentrated and crystallized from isopropyl ether to obtain Compound 37_2 (698 mg).
H-NMR (d -DMSO) δ 2.89 (12H, s), 7.78 (1H, s), 7.88 (2H, dd, J = 1.5, 4.5 Hz),H-NMR (d-DMSO) δ 2.89 (12H, s), 7.78 (1H, s), 7.88 (2H, dd, J = 1.5, 4.5 Hz),
8.70 (2H, dd, J = 1.5, 4.5 Hz). 8.70 (2H, dd, J = 1.5, 4.5 Hz).
(3) 6+37-l→38-l (3) 6 + 37-l → 38-l
化合物 6(806 mg)と化合物 37-1(202 mg)を用いて、実施例 69の (5)と同様の方法で 化合物 38-l(41mg,収率 7%)を得た。 Compound 38-l (41 mg, 7% yield) was obtained in the same manner as in Example 69, (5), using Compound 6 (806 mg) and Compound 37-1 (202 mg).
'H-NMR (D O) δ: 1.28 (3H, t, J = 7.2 Hz), 3.65 (1H, d, J = 17.4 Hz), 3.71 (1H, d, 'H-NMR (D O) δ: 1.28 (3H, t, J = 7.2 Hz), 3.65 (1H, d, J = 17.4 Hz), 3.71 (1H, d,
J = 17.4 Hz), 4.22 (2H,q, J = 7.2 Hz), 5.26 (1H, d, J = 4.5 Hz), 5.33 (1H, d, J = 6.9J = 17.4 Hz), 4.22 (2H, q, J = 7.2 Hz), 5.26 (1H, d, J = 4.5 Hz), 5.33 (1H, d, J = 6.9
Hz), 5.80 (1H, d, J = 4.5 Hz), 6.14 (1H, dt, J = 6.9, 15.3 Hz), 6.93 (1H, s), 7.01 (1Hz), 5.80 (1H, d, J = 4.5 Hz), 6.14 (1H, dt, J = 6.9, 15.3 Hz), 6.93 (1H, s), 7.01 (1
H, d, J = 15.3 Hz), 8.40 (1H, s), 8.47 (2H, d, J = 6.9 Hz), 8.91 (2H, d, J = 6.9 Hz).H, d, J = 15.3 Hz), 8.40 (1H, s), 8.47 (2H, d, J = 6.9 Hz), 8.91 (2H, d, J = 6.9 Hz).
IR (KBr) cm—1: 3846, 3418, 3055, 2984, 2162, 1762, 1635, 1598, 1532, 1469, 1440,IR (KBr) cm— 1 : 3846, 3418, 3055, 2984, 2162, 1762, 1635, 1598, 1532, 1469, 1440,
1357, 1300, 1203, 1156, 1124, 1091, 1037, 1002. 1357, 1300, 1203, 1156, 1124, 1091, 1037, 1002.
MS(ESI): 688+ (M + H)+ MS (ESI): 688+ (M + H) +
元素分析 C H N NaO S - 5.3 H O Elemental analysis C H N NaO S-5.3 H O
計算値: C,41.41; H,4.20; N,16.10; S, 12.28; Na,2.94 (%) Calculated values: C, 41.41; H, 4.20; N, 16.10; S, 12.28; Na, 2.94 (%)
実験値: C,41.31; H,4.20; N, 16.08; S, 12.36; Na,3.24 (%) Experimental value: C, 41.31; H, 4.20; N, 16.08; S, 12.36; Na, 3.24 (%)
(4) 6- 2+37- 2→38- 2
化合物 6_2(674mg、 l.OOmmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素 ナトリウム水溶液 (126mg、 1.50mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、 硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (2ml)に 溶解し、化合物 37-2(345mg,1.00mmol)と混合し、ヨウ化ナトリウム (450mg、 3.00mmol) を加えて、室温で 2時間 30分攪拌した。反応液を 5%食塩水 (30ml)攪拌中に注加し、 析出した沈殿を濾取した。沈殿を減圧乾燥して無定形粉末 (874mg)を得た。この無定 形粉末 (874mg)を塩化メチレン (5 ml)とァニソール (0.97ml)に溶解し、 0°Cに冷却し、 TF A (トリフルォロ酢酸) 5mlをカ卩え、 45分間攪拌した後濃縮した。残渣をイソプロピルェ 一テルで洗浄した後、水とァセトニトリルの混合液に溶解して、 HP-20SSカラムクロマト グラフィ一に付して、水 -ァセトニトリルで溶離した。所望の化合物を含むフラクション を減圧下濃縮して化合物 38— 2を粉末として得た。収量 286mg(41%) (4) 6- 2 + 37- 2 → 38- 2 Compound 6_2 (674 mg, l.OOmmol) was suspended in dichloromethane (10 ml), aqueous sodium hydrogen carbonate solution (126 mg, 1.50 mmol dissolved in 10 ml of water) was added under ice cooling, extracted with dichloromethane, and dried over magnesium sulfate. . After distilling off the solvent, quickly dissolve in dimethylformamide (2 ml), mix with compound 37-2 (345 mg, 1.00 mmol), add sodium iodide (450 mg, 3.00 mmol), and at room temperature for 2 hours 30 minutes. Stir. The reaction mixture was poured into 5% brine (30 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain amorphous powder (874 mg). Dissolve this amorphous powder (874 mg) in methylene chloride (5 ml) and anisole (0.97 ml), cool to 0 ° C, add 5 ml of TFA (trifluoroacetic acid), stir for 45 minutes, and concentrate. did. The residue was washed with isopropyl ether, dissolved in a mixture of water and acetonitrile, subjected to HP-20SS column chromatography, and eluted with water-acetonitrile. Fractions containing the desired compound were concentrated under reduced pressure to give compound 38-2 as a powder. Yield 286 mg (41%)
'H-NMR (d -DMSO) δ: 1.22 (3H, t, J = 6.9 Hz), 3.65,3.71 (2H, ABq, J = 17.6 Hz)'H-NMR (d-DMSO) δ: 1.22 (3H, t, J = 6.9 Hz), 3.65,3.71 (2H, ABq, J = 17.6 Hz)
, 4.10 (2H,q, J = 6.9 Hz), 5.22 (1H, d, J = 5.1 Hz), 5.4 (1H, m), 5.81 (1H, dd, J = 5. 1 Hz,8.1 Hz), 6.33 (1H, m), 6.74 (1H, s), 6.97 (1H, d, J = 15.3 Hz), 7.22 (2H, s), 8. 48 (1H, s), 8.61 (2H, d, J = 6.9 Hz), 8.91 (2H, d, J = 6.9 Hz), 9.60 (1H, d, J = 8.1 Hz). , 4.10 (2H, q, J = 6.9 Hz), 5.22 (1H, d, J = 5.1 Hz), 5.4 (1H, m), 5.81 (1H, dd, J = 5.1 Hz, 8.1 Hz), 6.33 (1H, m), 6.74 (1H, s), 6.97 (1H, d, J = 15.3 Hz), 7.22 (2H, s), 8. 48 (1H, s), 8.61 (2H, d, J = 6.9 Hz), 8.91 (2H, d, J = 6.9 Hz), 9.60 (1H, d, J = 8.1 Hz).
元素分析 C H N O S - 3.8 H O Elemental analysis C H N O S-3.8 H O
計算値: C,44.17; H,4.20; N, 17.17; S, 13.10 (%) Calculated values: C, 44.17; H, 4.20; N, 17.17; S, 13.10 (%)
実験値: C,44.24; H,4.32; N, 17.10; S, 13.26 (%) Experimental value: C, 44.24; H, 4.32; N, 17.10; S, 13.26 (%)
実施例 78 Example 78
[化 124] [Chemical 124]
43
(1 ) 39→40 43 (1) 39 → 40
ァセチルビリジン 39(22.1 g, 200 mmol)を 30%HBr-AcOH(225 mL)に溶解し氷浴にて 冷却した。臭素 (11.3 mL, 220 mmol)を滴下し、室温まで昇温後同温で 2時間撹拌し た。さらに 60°Cに加熱し 1時間撹拌した。室温まで冷却後この反応液を氷冷撹拌下 のジェチルエーテル (1 L)中に注加した。析出した沈殿を濾取しジェチルエーテル、 アセトンで洗浄した。得られた粉末を減圧乾燥し化合物 40(53.8 g, 96%)を淡黄色粉 末として得た。 Acetylviridine 39 (22.1 g, 200 mmol) was dissolved in 30% HBr-AcOH (225 mL) and cooled in an ice bath. Bromine (11.3 mL, 220 mmol) was added dropwise, and the mixture was warmed to room temperature and stirred at the same temperature for 2 hr. The mixture was further heated to 60 ° C and stirred for 1 hour. After cooling to room temperature, the reaction solution was poured into jetyl ether (1 L) under ice-cooling and stirring. The deposited precipitate was collected by filtration and washed with jetyl ether and acetone. The obtained powder was dried under reduced pressure to obtain Compound 40 (53.8 g, 96%) as a pale yellow powder.
H-NMR (d -DMSO) δ 5.04 (2Η, s), 8.06 (2H, dd, J = 1.5, 4.8 Hz), 8.95 (2H, dd, J H-NMR (d -DMSO) δ 5.04 (2Η, s), 8.06 (2H, dd, J = 1.5, 4.8 Hz), 8.95 (2H, dd, J
= 1.5, 4.8 Hz). = 1.5, 4.8 Hz).
(2) 40→41 (2) 40 → 41
化合物 40(53.8g, 192 mmol)をエタノール (500 mL)に懸濁させ ethyl thioozamate(26. 8 g, 201 mmol)をカ卩え、 60°Cで 4時間撹拌した。反応液を氷冷下で 30分間撹拌し、析 出物を濾取した。得られた粉末を酢酸ェチル (500 mL)、 NaHCO (19.3 g)/H 0( 500 mL)で撹拌、溶解し、有機層は水、飽和食塩水で洗浄後無水硫酸マグネシウムで乾 燥した。減圧濃縮後得られた結晶をジイソプロピルエーテルで洗浄し、減圧乾燥して 化合物 41(30.7g,収率 68%)を茶褐色結晶として得た。 Compound 40 (53.8 g, 192 mmol) was suspended in ethanol (500 mL), ethyl thioozamate (26.8 g, 201 mmol) was added, and the mixture was stirred at 60 ° C. for 4 hours. The reaction solution was stirred for 30 minutes under ice cooling, and the precipitate was collected by filtration. The obtained powder was stirred and dissolved with ethyl acetate (500 mL) and NaHCO 3 (19.3 g) / H 0 (500 mL), and the organic layer was washed with water and saturated brine and dried over anhydrous magnesium sulfate. The crystals obtained after concentration under reduced pressure were washed with diisopropyl ether and dried under reduced pressure to give compound 41 (30.7 g, yield 68%) as brown crystals.
'H-NMR (CDC1 ) δ 1.48 (3Η, t, J = 7.2 Hz), 4.53 (2H, q, J = 7.2 Hz), 7.93 (2H, d d, J = 1.5, 4.5), 7.99 (1H, s), 8.70 (2H, d, J = 6.0 Hz). 'H-NMR (CDC1) δ 1.48 (3Η, t, J = 7.2 Hz), 4.53 (2H, q, J = 7.2 Hz), 7.93 (2H, dd, J = 1.5, 4.5), 7.99 (1H, s ), 8.70 (2H, d, J = 6.0 Hz).
(3) 4 1→42 (3) 4 1 → 42
化合物 41(2.38g, 10.2 mmol)のメタノール (30 mL)溶液に NaNHCN(650 mg, 10.2 mm ol)を加え室温にて 1時間撹拌した。 NaNHCN(195 mg)を追加し 40°Cで 1時間撹拌した 。反応液を氷冷し、析出した沈殿を濾取して減圧乾燥することにより化合物 42(1.30 g ,収率 51%)を無色の粉末として得た。 NaNHCN (650 mg, 10.2 mmol) was added to a solution of compound 41 (2.38 g, 10.2 mmol) in methanol (30 mL), and the mixture was stirred at room temperature for 1 hour. NaNHCN (195 mg) was added, and the mixture was stirred at 40 ° C for 1 hr. The reaction solution was ice-cooled, and the deposited precipitate was collected by filtration and dried under reduced pressure to obtain Compound 42 (1.30 g, yield 51%) as a colorless powder.
H-NMR (d -DMSO) δ 7.91 (2Η, dd, J = 1.5, 4.5 Hz), 8.43 (1H, s), 8.63 (2H, dd, J H-NMR (d -DMSO) δ 7.91 (2Η, dd, J = 1.5, 4.5 Hz), 8.43 (1H, s), 8.63 (2H, dd, J
= 1.5, 4.5 Hz). = 1.5, 4.5 Hz).
(4) 6+42→43 (4) 6 + 42 → 43
化合物 6(1.05 g)と化合物 42(252 mg)を用いて、実施例 69の (5)と同様の方法で化合 物 43(31 mg,収率 4%)を得た。
Ή-NMR (D O) δ: 1.27 (3H, t, J = 6.9 Hz), 3.65 (1H, d, J = 17.4 Hz), 3.72 (1H, d,Compound 43 (31 mg, 4% yield) was obtained in the same manner as in Example 69, (5), using Compound 6 (1.05 g) and Compound 42 (252 mg). Ή-NMR (DO) δ: 1.27 (3H, t, J = 6.9 Hz), 3.65 (1H, d, J = 17.4 Hz), 3.72 (1H, d,
2 2
J = 17.4 Hz), 4.22 (2H,q, J = 6.9 Hz), 5.25 - 5.30 (2H, m), 5.80 (1H, d, J = 4.8 Hz), 6.14 (1H, dt, J = 7.2, 15.3 Hz), 6.92 (1H, s), 7.00 (1H, d, J = 15.3 Hz), 8.39 (1H, d , J = 6.9 Hz), 8.56 (1H, s), 8.81 (2H, d, J = 6.9 Hz). J = 17.4 Hz), 4.22 (2H, q, J = 6.9 Hz), 5.25-5.30 (2H, m), 5.80 (1H, d, J = 4.8 Hz), 6.14 (1H, dt, J = 7.2, 15.3 Hz), 6.92 (1H, s), 7.00 (1H, d, J = 15.3 Hz), 8.39 (1H, d, J = 6.9 Hz), 8.56 (1H, s), 8.81 (2H, d, J = 6.9 Hz).
IR (KBr) cm—1: 3419, 2983, 2183, 2154, 1763, 1636, 1602, 1532, 1491, 1461, 1364, 1291, 1203, 1155, 1090, 1036, 1001. IR (KBr) cm— 1 : 3419, 2983, 2183, 2154, 1763, 1636, 1602, 1532, 1491, 1461, 1364, 1291, 1203, 1155, 1090, 1036, 1001.
MS(ESI): 688+ (M + H)+ MS (ESI): 688+ (M + H) +
元素分析 c H N NaO S -4.9 H O - 0.1 NaHCO Elemental analysis c H N NaO S -4.9 H O-0.1 NaHCO
27 22 9 6 3 2 3 27 22 9 6 3 2 3
計算値: C,41.50; H,4.10; N, 16.07; S, 12.26; Na,3.22 (%) Calculated values: C, 41.50; H, 4.10; N, 16.07; S, 12.26; Na, 3.22 (%)
実験値: C,41.40; H,3.96; N, 16.22; S, 12.31; Na,3.42 (%) Experimental value: C, 41.40; H, 3.96; N, 16.22; S, 12.31; Na, 3.42 (%)
実施例 79 Example 79
[化 125] [Chemical 125]
(1) 31→45 (1) 31 → 45
実施例 76の (2)と同様の方法で化合物 31(586 mg)力 化合物 44(503 mg)を得た。 H-NMR (d -DMSO) δ 4.04 (3Η, s), 7.23 (1H, brs), 7.67 (2H, brs), 8.75 (2H, brs). Compound 31 (586 mg) compound 44 (503 mg) was obtained in the same manner as in Example 76, (2). H-NMR (d-DMSO) δ 4.04 (3Η, s), 7.23 (1H, brs), 7.67 (2H, brs), 8.75 (2H, brs).
6 6
(2) 44→45 (2) 44 → 45
実施例 76の (3)と同様の方法で化合物 44(500 mg)から化合物 45(568 mg)を得た。
(3) 45+46→47→48 Compound 45 (568 mg) was obtained from compound 44 (500 mg) in the same manner as in Example 76, (3). (3) 45 + 46 → 47 → 48
化合物 45(180 mg, 0.722 mmol)の DMF(3.0 mL)溶液に 46(664 mg, 0.90 mmol),臭 化ナトリウム (278 mg, 2.7 mmol)を加えて室温で 6時間撹拌した。 DMF(3 mL)を加えて 希釈し氷冷撹拌下の 5%食塩水 (80 mL)に注加した。同温で 20分間撹拌後沈殿を濾 取し、減圧下五酸化リンを用いて乾燥した。黄土色粉末状の粗成生物 47(777 mg)を 得た。この粗生成物を塩化メチレン(15 mL)に溶解し、窒素雰囲気下ァニソール(0.4 7 mL, 4.32 mmol)を加え- 40°Cに冷却した。 _40°C下、塩化チタニウム (IV) (2.0M塩化 メチレン溶液, 2.16 mL, 4.32 mmol)を滴下した後、 - 20°Cで 1時間攪拌した。この反 応液を氷浴撹拌下の水(40 mL)に注ぎ、ジイソプロピルエーテル (80 mL)を加えた。 析出物を吸引濾取して得られた沈殿を重曹水で溶解させ ODSカラムクロマトグラフィ 一に付して集めた分画 (水—ァセトニトリル)を減圧濃縮し、凍結乾燥した。化合物 48 ( 62 mg,収率 10%)を粉末として得た。 46 (664 mg, 0.90 mmol) and sodium bromide (278 mg, 2.7 mmol) were added to a DMF (3.0 mL) solution of compound 45 (180 mg, 0.722 mmol), and the mixture was stirred at room temperature for 6 hours. DMF (3 mL) was added for dilution, and the mixture was poured into 5% brine (80 mL) under ice-cooling and stirring. After stirring at the same temperature for 20 minutes, the precipitate was collected by filtration and dried using phosphorus pentoxide under reduced pressure. Ocherous powdery crude product 47 (777 mg) was obtained. This crude product was dissolved in methylene chloride (15 mL), and anisole (0.4 7 mL, 4.32 mmol) was added under a nitrogen atmosphere, followed by cooling to -40 ° C. Titanium (IV) chloride (2.0M methylene chloride solution, 2.16 mL, 4.32 mmol) was added dropwise at _40 ° C, and the mixture was stirred at -20 ° C for 1 hour. The reaction solution was poured into water (40 mL) with stirring in an ice bath, and diisopropyl ether (80 mL) was added. The precipitate obtained by suction filtration was dissolved in sodium bicarbonate water, and the fraction (water-acetonitrile) collected by ODS column chromatography was concentrated under reduced pressure and lyophilized. Compound 48 (62 mg, yield 10%) was obtained as a powder.
'H-NMR (D O) δ: 1.28 (3H, t, J = 7.2 Hz), 3.67 (2H, brs), 4.08 (3H, s), 4.23 (2H, q, J = 7.2 Hz), 5.26 (1H, d, J = 4.5 Hz), 5.33 (1H, d, J = 6.9 Hz), 5.80 (1H, d, J = 4 'H-NMR (DO) δ: 1.28 (3H, t, J = 7.2 Hz), 3.67 (2H, brs), 4.08 (3H, s), 4.23 (2H, q, J = 7.2 Hz), 5.26 (1H , d, J = 4.5 Hz), 5.33 (1H, d, J = 6.9 Hz), 5.80 (1H, d, J = 4
.5 Hz), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.94 (1H, s ), 6.99 (1H, d, J = 15.6 Hz), 7.1.5 Hz), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.94 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 7.1
4 (1H, s), 8.19 (2 H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 Hz). 4 (1H, s), 8.19 (2 H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 Hz).
IR (KBr) cm"1: 3427, 2168, 1762, 1636, 1606, 1536, 1475, 1388, 1368, 1338, 1294,IR (KBr) cm " 1 : 3427, 2168, 1762, 1636, 1606, 1536, 1475, 1388, 1368, 1338, 1294,
1201, 1157, 1090, 1038. 1201, 1157, 1090, 1038.
MS(ESI): 707+ (M + H)+ MS (ESI): 707 + (M + H) +
元素分析 C H N NaO S - 6.0 H O -0.4 NaHCO Elemental analysis C H N NaO S-6.0 H O -0.4 NaHCO
計算値: C,41.28; Η,4·56; Ν, 16.95; SJ.76; Na,3.89 (%) Calculated value: C, 41.28; Η, 4.56; Ν, 16.95; SJ.76; Na, 3.89 (%)
実験値: C41.14; H,4.26; N,17.13; SJ.90; Na,3.98 (%) Experimental value: C41.14; H, 4.26; N, 17.13; SJ.90; Na, 3.98 (%)
実施例 80 Example 80
[化 126]
[Chemical 126]
52 52
(1) 48→49 (1) 48 → 49
化合物 48(1.48g, 4.90 mmol)のメタノール (20 mL)溶液を氷浴にて冷却し 5N水酸化 ナトリウム水溶液 (3.9 mL)をカ卩えた。室温で 1時間撹拌後、 5N水酸化ナトリウム水溶液 (0.98 mL)を追加し、さらに 1.5時間撹拌した。再度氷冷し 5N塩酸水溶液 (4.8 mL)を 加えて、メタノールを減圧留去した。残渣の pHを 3.5付近に調整し、析出物を濾取し、 減圧乾燥して化合物 49(580 mg,収率 66%)を黄土色粉末として得た。 A solution of compound 48 (1.48 g, 4.90 mmol) in methanol (20 mL) was cooled in an ice bath, and 5N aqueous sodium hydroxide solution (3.9 mL) was added. After stirring at room temperature for 1 hour, 5N aqueous sodium hydroxide solution (0.98 mL) was added, and the mixture was further stirred for 1.5 hours. The mixture was ice-cooled again, 5N aqueous hydrochloric acid solution (4.8 mL) was added, and methanol was evaporated under reduced pressure. The pH of the residue was adjusted to around 3.5, and the precipitate was collected by filtration and dried under reduced pressure to obtain Compound 49 (580 mg, 66% yield) as an ocher powder.
H-NMR (d -DMSO) δ 7.42 (1H, s), 7.65 (1H, d, J = 6.0 Hz), 8.38 (1H, d, J = 6.0H-NMR (d-DMSO) δ 7.42 (1H, s), 7.65 (1H, d, J = 6.0 Hz), 8.38 (1H, d, J = 6.0
Hz), 9.20 (1H, brs), 12.8 (1H, brs). Hz), 9.20 (1H, brs), 12.8 (1H, brs).
(2) 49→50 (2) 49 → 50
実施例 74の (2)と同様の方法で行い、化合物 49(580 mg)から化合物 50(578 mg,収 率 87%)を得た。 In the same manner as in Example 74 (2), compound 50 (578 mg, yield 87%) was obtained from compound 49 (580 mg).
H-NMR (d -DMSO) δ 7.24 (1H, s), 7.79 (1H, d, J = 6.9 Hz), 8.37 (1H, d, J = 6.9 H-NMR (d-DMSO) δ 7.24 (1H, s), 7.79 (1H, d, J = 6.9 Hz), 8.37 (1H, d, J = 6.9
Hz), 9.25 (1H, s), 12.9 (1H, brs). Hz), 9.25 (1H, s), 12.9 (1H, brs).
(3) 50→51 (3) 50 → 51
実施例 74の (3)と同様の方法で化合物 51を淡黄土色粉末として得、そのまま次反応 に用いた。 Compound 51 was obtained as a light ocher powder by the same method as in Example 74, (3), and used as such in the next reaction.
(4) 46+51→52 (4) 46 + 51 → 52
化合物 46(738 mg)と化合物 51(208 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 52(69 mg,収率 9%)を得た。 Compound 52 (69 mg, 9% yield) was obtained in the same manner as in Example 79, (3), using Compound 46 (738 mg) and Compound 51 (208 mg).
H-NMR (D O) δ: 1.28 (3H, t, J = 6.9 Hz), 3.65 (2H, ABq, J = 17.8 Hz), 4.22 (2H, q, J = 6.9 Hz), 5.24 (3H, d, J = 4.8 Hz), 5.79 (1H, d, J = 6.6 Hz), 6.13 (1H, dt, J = 6.9, 15.9 Hz), 6.89 - 6.94 (2H, m), 7.27 (1H, s), 7.82 (1H, d, J = 7.2 Hz), 8.29 (1H,
d, J = 7.2 Hz). H-NMR (DO) δ: 1.28 (3H, t, J = 6.9 Hz), 3.65 (2H, ABq, J = 17.8 Hz), 4.22 (2H, q, J = 6.9 Hz), 5.24 (3H, d, J = 4.8 Hz), 5.79 (1H, d, J = 6.6 Hz), 6.13 (1H, dt, J = 6.9, 15.9 Hz), 6.89-6.94 (2H, m), 7.27 (1H, s), 7.82 ( 1H, d, J = 7.2 Hz), 8.29 (1H, d, J = 7.2 Hz).
IR (KBr) cm—1: 3425, 2160, 1762, 1598, 1535, 1372, 1333, 1202, 1165, 1120, 1092 1036, 1003. IR (KBr) cm— 1 : 3425, 2160, 1762, 1598, 1535, 1372, 1333, 1202, 1165, 1120, 1092 1036, 1003.
MS(ESI): 644+ (M + H)+ MS (ESI): 644 + (M + H) +
元素分析 c H N NaO S - 5.3 H O - 0.2 NaHCO Elemental analysis c H N NaO S-5.3 H O-0.2 NaHCO
26 22 9 6 2 2 3 26 22 9 6 2 2 3
計算値: C,41.63; H,4.37; N, 16.68; S,8.48; Na,3.65 (%) Calculated values: C, 41.63; H, 4.37; N, 16.68; S, 8.48; Na, 3.65 (%)
実験値: C41.76; H,4.33; N, 16.16; S,8.88; Na,3.85 (%) Experimental value: C41.76; H, 4.33; N, 16.16; S, 8.88; Na, 3.85 (%)
実施例 81 Example 81
[化 127] [Chemical 127]
55 55
(1) 53→54 (1) 53 → 54
化合物 53(1.37 g)から実施例 75の (3)と同様の方法で化合物 54(1.04 g,収率 61%)を 得た。 Compound 54 (1.04 g, yield 61%) was obtained from compound 53 (1.37 g) in the same manner as in Example 75, (3).
H-NMR (d -DMSO) δ 7.30 - 7.34 (1H, m), 8.14 - 8.18 (1H, m), 8.52 - 54 (1H, m H-NMR (d -DMSO) δ 7.30-7.34 (1H, m), 8.14-8.18 (1H, m), 8.52-54 (1H, m
6 6
), 9.00 (1H, m). ), 9.00 (1H, m).
(2) 46+54→55 (2) 46 + 54 → 55
化合物 46(1.86 g)と化合物 54(338 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 55(236 mg, 18%)を得た。 Compound 55 (236 mg, 18%) was obtained in the same manner as in Example 79, (3), using Compound 46 (1.86 g) and Compound 54 (338 mg).
'H-NMR (D O) δ: 1.30 (3H, t, J = 7.2 Hz), 3.65 (2H, s), 4.25 (2H,q, J = 7.2 Hz), 5 'H-NMR (D O) δ: 1.30 (3H, t, J = 7.2 Hz), 3.65 (2H, s), 4.25 (2H, q, J = 7.2 Hz), 5
2 2
.26 (1H, d, J = 4.8 Hz), 5.36 (2H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.11 (1H , dt, J = 6.9, 13.5 Hz), 6.96 (1H, d, J = 13.5 Hz), 6.99 (1H, s), 8.10 (1H, t, J = 7.2 Hz), 8.51 - 8.94 (2H, m), 9.29 (1H, s).
IR (KBr) cm : 3418, 2984, 2168, 1763, 1636, 1601, 1533, 1380, 1304, 1203, 1166.26 (1H, d, J = 4.8 Hz), 5.36 (2H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.11 (1H, dt, J = 6.9, 13.5 Hz) , 6.96 (1H, d, J = 13.5 Hz), 6.99 (1H, s), 8.10 (1H, t, J = 7.2 Hz), 8.51-8.94 (2H, m), 9.29 (1H, s). IR (KBr) cm: 3418, 2984, 2168, 1763, 1636, 1601, 1533, 1380, 1304, 1203, 1166
1136, 1037, 1002. 1136, 1037, 1002.
MS(ESI): 605+ (M + H)+ MS (ESI): 605+ (M + H) +
元素分析 C H N NaO S - 3.7 H O Elemental analysis C H N NaO S-3.7 H O
24 21 8 6 2 2 24 21 8 6 2 2
計算値: C,42.94; H,4.26; N, 16.69; S,9.55; Na,3.42 (%) Calculated value: C, 42.94; H, 4.26; N, 16.69; S, 9.55; Na, 3.42 (%)
実験値: C42.99; H,4.14; N, 16.61; S,9.36; Na,3.49 (%) Experimental value: C42.99; H, 4.14; N, 16.61; S, 9.36; Na, 3.49 (%)
実施例 82 Example 82
[化 128] [Chemical 128]
(1) 56→57 (1) 56 → 57
化合物 56(1.51 g)から実施例 75の (3)と同様の方法で化合物 57(939 mg,収率 56%)を 得た。 Compound 57 (939 mg, yield 56%) was obtained from compound 56 (1.51 g) in the same manner as in Example 75, (3).
H-NMR (d -DMSO) δ 7.74 (2Η, dd, J = 1.5, 4.5 Hz), 8.55 (2H, dd, J = 1.5, 4.5 H H-NMR (d -DMSO) δ 7.74 (2Η, dd, J = 1.5, 4.5 Hz), 8.55 (2H, dd, J = 1.5, 4.5 H
6 6
z). z).
(2) 4 6+57→58 (2) 4 6 + 57 → 58
化合物 46(1.86 g)と化合物 57(338 mg)を用いて化合物 58(253 mg,収率 19%)で得た 'H-NMR (D O) δ: 1.30 (3H, t, J = 7.2 Hz), 3.64 (2H, s), 4.25 (2H,q, J = 7.2 Hz), 5 'H-NMR (DO) δ: 1.30 (3H, t, J = 7.2 Hz) obtained from compound 58 (253 mg, yield 19%) using compound 46 (1.86 g) and compound 57 (338 mg) , 3.64 (2H, s), 4.25 (2H, q, J = 7.2 Hz), 5
2 2
.26 (1H, d, J = 4.8 Hz), 5.34 (2H, d, J = 7.2 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.09 (1H , dt, J = 7.2, 15.6 Hz), 6.97 (1H, d, J = 15.6 Hz), 6.98 (1H, s), 8.37 (2H, d, J = 6.9 Hz), 8.91 (2H, d, J = 6.9 Hz). .26 (1H, d, J = 4.8 Hz), 5.34 (2H, d, J = 7.2 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.09 (1H, dt, J = 7.2, 15.6 Hz) , 6.97 (1H, d, J = 15.6 Hz), 6.98 (1H, s), 8.37 (2H, d, J = 6.9 Hz), 8.91 (2H, d, J = 6.9 Hz).
IR (KBr) cm"1: 3420, 3055, 2982, 2160, 1762, 1605, 1561, 1533, 1457, 1367, 1301,
1200, 1150, 1122, 1036, 1001. IR (KBr) cm " 1 : 3420, 3055, 2982, 2160, 1762, 1605, 1561, 1533, 1457, 1367, 1301, 1200, 1150, 1122, 1036, 1001.
MS(ESI): 605+ (M + H)+ MS (ESI): 605+ (M + H) +
元素分析 C H N NaO S - 3.6 H O Elemental analysis C H N NaO S-3.6 H O
計算値: C,43.06; H,4.25; N, 16.74; S,9.58; Na,3.43 (%) Calculated values: C, 43.06; H, 4.25; N, 16.74; S, 9.58; Na, 3.43 (%)
実験値: C,43.09; H,4.22; N, 16.73; S,9.48; Na,3.64 (%) Experimental value: C, 43.09; H, 4.22; N, 16.73; S, 9.48; Na, 3.64 (%)
実施例 84 Example 84
[化 129] [Chemical 129]
(1) 20→63 (1) 20 → 63
化合物 20(1.62, 10 mmol)のテトラヒドロフラン (20 mL)懸濁液にジフヱニルジァゾメタ ン( 2.14 g, 11 mmol)をカ卩ぇ 3時間還流した。室温まで冷却後テトラヒドロフランを減圧 留去し、残渣にジェチルエーテル、へキサンを加えて沈殿を濾取、減圧乾燥した。化 合物 63(2.70 g,収率 82%)を得た。 Diphenyldiazomethane (2.14 g, 11 mmol) was refluxed for 3 hours in a suspension of compound 20 (1.62, 10 mmol) in tetrahydrofuran (20 mL). After cooling to room temperature, tetrahydrofuran was distilled off under reduced pressure. To the residue was added jetyl ether and hexane, and the precipitate was collected by filtration and dried under reduced pressure. Compound 63 (2.70 g, yield 82%) was obtained.
'H-NMR (CDC1 ) δ 7.14 (1H, s), 7.27 - 7.46 (11H, m), 7.55 (1H, s), 7.76 (1H, d, 'H-NMR (CDC1) δ 7.14 (1H, s), 7.27-7.46 (11H, m), 7.55 (1H, s), 7.76 (1H, d,
J = 8.4 Hz), 8.58 (1H, brs), 9.11 (1H, brs). J = 8.4 Hz), 8.58 (1H, brs), 9.11 (1H, brs).
(2) 46+63→64 (2) 46 + 63 → 64
化合物 46(1.24 g)と化合物 63(493 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 64(487 mg,収率 46%)を得た。 Using Compound 46 (1.24 g) and Compound 63 (493 mg), Compound 64 (487 mg, Yield 46%) was obtained in the same manner as in Example 79, (3).
'H-NMR (D O) δ: 1.29 (3H, t, J = 7.2 Hz), 3.62 (2H, s), 4.24 (2H, q, J = 7.2 Hz), 'H-NMR (D O) δ: 1.29 (3H, t, J = 7.2 Hz), 3.62 (2H, s), 4.24 (2H, q, J = 7.2 Hz),
5.23 (1H, d, J = 4.8 Hz), 5.45 (2H, d, J = 6.6 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.15 (1 H, dt, J = 6.6, 15.9 Hz), 6.83 (1H, d, J = 15.9 Hz), 6.96 (1H, s), 7.23 (1H, brs), 7.6 8 (1H, dd, J = 5.7, 8.4 Hz), 8.50 (1H, d, J = 8.4 Hz), 8.58 (1H, d, J = 5.7).
IR (KBr) cm : 3407, 1763, 1604, 1532, 1460, 1390, 1336, 1201, 1161, 1123, 1035.5.23 (1H, d, J = 4.8 Hz), 5.45 (2H, d, J = 6.6 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.15 (1 H, dt, J = 6.6, 15.9 Hz) , 6.83 (1H, d, J = 15.9 Hz), 6.96 (1H, s), 7.23 (1H, brs), 7.6 8 (1H, dd, J = 5.7, 8.4 Hz), 8.50 (1H, d, J = 8.4 Hz), 8.58 (1H, d, J = 5.7). IR (KBr) cm: 3407, 1763, 1604, 1532, 1460, 1390, 1336, 1201, 1161, 1123, 1035.
MS(ESI): 620+ (M + H)+ MS (ESI): 620+ (M + H) +
元素分析 C H N NaO S -4.8 H O Elemental analysis C H N NaO S -4.8 H O
計算値: C,42.53; H,4.51; N, 13.89; S,9.08; Na,3.26 (%) Calculated value: C, 42.53; H, 4.51; N, 13.89; S, 9.08; Na, 3.26 (%)
実験値: C,42.49; H,4.25; N, 14.01; S,8.80; Na,3.29 (%) Experimental value: C, 42.49; H, 4.25; N, 14.01; S, 8.80; Na, 3.29 (%)
実施例 85 Example 85
[化 130] [Chem 130]
(1) 65→66 (1) 65 → 66
化合物 65(832 mg, 4.0 mmol)の DMF(10 mL)溶液にメタノール (2 mL)、酢酸パラジゥ ム (11)、 dppp(412 mg, 1.0 mmol),トリェチルァミン (5.6 mL, 40 mmol)を加え一酸化炭 素雰囲気下 80°Cで 14時間撹拌した。反応液は室温まで冷却後酢酸ェチル (100 mL) 、水 (20 mL)を加え抽出し、有機層を水で 3回、飽和食塩水で 1回洗浄した。無水硫 酸マグネシウムで乾燥し、濃縮した。残渣をシリカゲルカラムクロマトグラフィーで精製 した。化合物 66(621 mg,収率 83%)を結晶として得た。 dppp:l,3-Bis(diphenyl phospino )propane To a solution of compound 65 (832 mg, 4.0 mmol) in DMF (10 mL), add methanol (2 mL), palladium acetate (11), dppp (412 mg, 1.0 mmol), and triethylamine (5.6 mL, 40 mmol). The mixture was stirred at 80 ° C for 14 hours under a carbon oxide atmosphere. The reaction mixture was cooled to room temperature, extracted with ethyl acetate (100 mL) and water (20 mL), and the organic layer was washed three times with water and once with saturated brine. The extract was dried over anhydrous magnesium sulfate and concentrated. The residue was purified by silica gel column chromatography. Compound 66 (621 mg, yield 83%) was obtained as crystals. dppp: l, 3-Bis (diphenyl phospino) propane
JH-NMR (CDC1 ) δ 4.03 (3H, s), 7.66 (1H, dd, J = 7.5, 8.4 Hz), 8.18 (1H, m), 8.4 J H-NMR (CDC1) δ 4.03 (3H, s), 7.66 (1H, dd, J = 7.5, 8.4 Hz), 8.18 (1H, m), 8.4
6 (1H, dd, J = 1.5, 7.5 Hz), 8.65 (1H, d, J = 6.3 Hz), 8.78 (1H, m), 9.302 (1H, s).6 (1H, dd, J = 1.5, 7.5 Hz), 8.65 (1H, d, J = 6.3 Hz), 8.78 (1H, m), 9.302 (1H, s).
(2) 66→67 (2) 66 → 67
化合物 66(620 mg)から実施例 75の (3)と同様の方法で化合物 67(544 mg, 75%)を粉 末として得た。 Compound 67 (544 mg, 75%) was obtained as a powder from compound 66 (620 mg) in the same manner as in Example 75, (3).
(3) 46+67→68
化合物 46(830 mg)と化合物 67(219 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 68(49 mg,収率 6%)を得た。 (3) 46 + 67 → 68 Compound 68 (49 mg, 6% yield) was obtained in the same manner as in Example 79, (3), using Compound 46 (830 mg) and Compound 67 (219 mg).
'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.67 (2H, s), 4.24 (2H, q, J = 6.9 Hz), 'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.67 (2H, s), 4.24 (2H, q, J = 6.9 Hz),
5.27 (1H, d, J = 4.8 Hz), 5.44 (2H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.17 (1 H, dt, J = 6.9, 15.6 Hz), 6.96 (1H, s), 7.04 (1H, d, J = 15.6 Hz), 8.01 (1H, t, J = 7. 8 Hz), 8.45 - 8.48 (2H, m), 8.54 (1H, d, J = 7.2 Hz), 8.95 (1H, d, J = 7.2 Hz), 9.73 (1H, s). 5.27 (1H, d, J = 4.8 Hz), 5.44 (2H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.17 (1 H, dt, J = 6.9, 15.6 Hz) , 6.96 (1H, s), 7.04 (1H, d, J = 15.6 Hz), 8.01 (1H, t, J = 7.8 Hz), 8.45-8.48 (2H, m), 8.54 (1H, d, J = 7.2 Hz), 8.95 (1H, d, J = 7.2 Hz), 9.73 (1H, s).
IR (KBr) cm—1: 3418, 2984, 2162, 1763, 1607, 1535, 1474, 1456, 1390, 1365, 1293, 1243, 1202, 1168, 1133, 1090, 1037, 1001. IR (KBr) cm— 1 : 3418, 2984, 2162, 1763, 1607, 1535, 1474, 1456, 1390, 1365, 1293, 1243, 1202, 1168, 1133, 1090, 1037, 1001.
MS(ESI): 655+ (M + H)+ MS (ESI): 655+ (M + H) +
元素分析 c H N NaO S - 2.8 H O - 0.6 NaHCO Elemental analysis c H N NaO S-2.8 H O-0.6 NaHCO
計算値: C,45.47; H,3.90; N, 14.83; S,8.49; Na,4.87 (%) Calculated values: C, 45.47; H, 3.90; N, 14.83; S, 8.49; Na, 4.87 (%)
実験値: C,45.36; Η,4· 11; Ν, 15.01; S,8.91; Na,4.73 (%) Experimental value: C, 45.36; Η, 4.11; Ν, 15.01; S, 8.91; Na, 4.73 (%)
実施例 86 Example 86
[化 131] [Chemical 131]
(1) 69→71
アミノビリジン 69(1.15g, 12.2 mmol)の酢酸 (11 mL)溶液に化合物 70(2.0 g, 11.1 mmo(1) 69 → 71 Compound 70 (2.0 g, 11.1 mmo) was added to a solution of aminoviridine 69 (1.15 g, 12.2 mmol) in acetic acid (11 mL).
1)を加え、 3時間還流した。反応液を室温まで冷却後酢酸を減圧留去し飽和重曹水 をカ卩えて酢酸ェチルで抽出した。有機層は飽和食塩水で洗浄後、無水硫酸マグネ シゥムで乾燥し減圧濃縮した。残渣をシリカゲルカラムクロマトグラフィーで精製し、化 合物 71(964 mg,収率 46%)を淡黄色結晶として得た。 1) was added and refluxed for 3 hours. The reaction mixture was cooled to room temperature, acetic acid was distilled off under reduced pressure, saturated aqueous sodium hydrogen carbonate was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain compound 71 (964 mg, yield 46%) as pale yellow crystals.
'H-NMR (CDC1 ) δ 6.88 (1H, m), 7.24 (1H, m), 7.38 (2H, dd, J = 1.8, 4.8 Hz), 7. 'H-NMR (CDC1) δ 6.88 (1H, m), 7.24 (1H, m), 7.38 (2H, dd, J = 1.8, 4.8 Hz), 7.
3 Three
82 (1H, m), 8.72 (2H, dd, J = 1.8, 4.8 Hz), 9.90 (1H, s). 82 (1H, m), 8.72 (2H, dd, J = 1.8, 4.8 Hz), 9.90 (1H, s).
(2) 71→72 (2) 71 → 72
NaCIO (1.39g, 12.3 mmol)と NH SO H(1.19g, 12.3 mmol)を水 (13 mL)に溶角军し氷浴 NaCIO (1.39 g, 12.3 mmol) and NH 2 SO H (1.19 g, 12.3 mmol) are melted into water (13 mL) and ice bathed.
2 2 3 2 2 3
にて冷去 P、撹拌下、化合物 71(960 mg, 5.58 mmol)のメタノール (13 mL)溶液を滴下し た。氷浴にて 1.5時間撹拌した後 NaCIO (315 mg)及び NH SO H(271 mg)を追加してさ The solution of compound 71 (960 mg, 5.58 mmol) in methanol (13 mL) was added dropwise with stirring and cooling. After stirring in an ice bath for 1.5 hours, add NaCIO (315 mg) and NH 2 SO H (271 mg).
2 2 3 2 2 3
らに 1時間撹拌した。 Na2S2〇3 ' 5H20(4.15 g)をカ卩え、さらに 20分撹拌後メタノールを 減圧留去し 1N塩酸をカ卩えて pHを 3付近に調整した。沈殿を濾取し減圧乾燥して化合 物 72(1.07 g,収率 100%)を淡黄色粉末として得た。 The mixture was further stirred for 1 hour. Na2S203'5H20 (4.15 g) was added, and the mixture was further stirred for 20 minutes. Methanol was distilled off under reduced pressure, and 1N hydrochloric acid was added to adjust the pH to around 3. The precipitate was collected by filtration and dried under reduced pressure to obtain Compound 72 (1.07 g, yield 100%) as a pale yellow powder.
H-NMR (d -DMSO) δ 6.67 (1H, m), 7.71 (1H, m), 7.82 (2H, d, J = 6.3 Hz), 8.22 ( H-NMR (d-DMSO) δ 6.67 (1H, m), 7.71 (1H, m), 7.82 (2H, d, J = 6.3 Hz), 8.22 (
6 6
1H, m), 8.64 (1H, d, J = 6.3 Hz). 1H, m), 8.64 (1H, d, J = 6.3 Hz).
(3) 72→73 (3) 72 → 73
実施例 74の (2)と同様の方法で行い、化合物 72(1.06 g)力 化合物 73(1.20 g,収率 1 00%)を白色粉末として得た。 In the same manner as in Example 74 (2), compound 72 (1.06 g) was obtained as compound 73 (1.20 g, yield 100%) as a white powder.
H-NMR (d -DMSO) δ 6.84 (1H, m), 7.74 - 7.78 (3H, m), 8.38 (1H, m), 8.67 (2H, H-NMR (d -DMSO) δ 6.84 (1H, m), 7.74-7.78 (3H, m), 8.38 (1H, m), 8.67 (2H,
6 6
d, J = 6.3 Hz). d, J = 6.3 Hz).
(4) 73→74→75 (4) 73 → 74 → 75
化合物 73(212 mg, 1.0 mmol)の DMF(3.0 mL)懸濁液に N, O-ピストリメチルシリルァ セトアミド (0.49 mL, 2.0 mL)をカ卩えて激しく撹拌し溶液とした。この溶液に化合物 46(8 30 mg, 1.0 mmol, f = 0.89)、臭化ナトリウム (309 mg, 3.0 mmol)を加え室温で 8時間撹 拌した。 DMF(3 mL)を加えて希釈し、氷冷撹拌下の 5%食塩水 (80 mL)中に注加した。 同温で 20分間撹拌後沈殿を濾取し、減圧下五酸化リンを用いて乾燥して黄土色粉 末状の粗成生物 74(996 mg)を得た。この粗生成物を塩化メチレン (15 mL)に溶解し、
窒素雰囲気下ァニソール(0.65 mL, 6.0 mmol)を加え- 40°Cに冷却した。 _40°C下、塩 化チタニウム (IV) (2.0M塩化メチレン溶液, 3.0 mL, 6.0 mmol)を滴下した後、 - 20°C で 1時間攪拌した。この反応液を氷浴撹拌下の水(50 mL)に注ぎ、ジイソプロピルェ 一テル (60 mL)をカ卩えた。析出物を吸引濾取して得られた沈殿を重曹水で溶解させ〇 DSカラムクロマトグラフィーに付して集めた分画 (水一ァセトニトリル)を減圧濃縮し、凍 結乾燥した。化合物 75 (263 mg,収率 34%)を粉末として得た。 N, O-pistrimethylsilylacetamide (0.49 mL, 2.0 mL) was added to a suspension of compound 73 (212 mg, 1.0 mmol) in DMF (3.0 mL), and the mixture was vigorously stirred to obtain a solution. Compound 46 (8 30 mg, 1.0 mmol, f = 0.89) and sodium bromide (309 mg, 3.0 mmol) were added to this solution, and the mixture was stirred at room temperature for 8 hours. DMF (3 mL) was added for dilution, and the mixture was poured into 5% brine (80 mL) with ice-cooling and stirring. After stirring at the same temperature for 20 minutes, the precipitate was collected by filtration and dried using phosphorus pentoxide under reduced pressure to obtain an ocherous powdery crude product 74 (996 mg). This crude product was dissolved in methylene chloride (15 mL) Under an atmosphere of nitrogen, anisole (0.65 mL, 6.0 mmol) was added and cooled to -40 ° C. Titanium (IV) chloride (2.0M methylene chloride solution, 3.0 mL, 6.0 mmol) was added dropwise at _40 ° C, followed by stirring at -20 ° C for 1 hour. The reaction mixture was poured into water (50 mL) under ice bath stirring, and diisopropyl ether (60 mL) was added. The precipitate obtained by suction filtration was dissolved in aqueous sodium bicarbonate, and the fraction (water-acetonitrile) collected by DS column chromatography was concentrated under reduced pressure and freeze-dried. Compound 75 (263 mg, yield 34%) was obtained as a powder.
'H-NMR (D O) δ: 1.28 (3H, t, J = 6.9 Hz), 3.65 and 3.73 (2H, ABq, J = 17.4 Hz), 'H-NMR (D O) δ: 1.28 (3H, t, J = 6.9 Hz), 3.65 and 3.73 (2H, ABq, J = 17.4 Hz),
4.22 (2H, q, J = 6.9 Hz), 5.21 (2H, d, J = 7.2 Hz), 5.26 (1H, d, J = 4.8 Hz), 5.80 (1 H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 7.2, 15.9 Hz), 6.60 (1H, m), 6.93 (1H, s), 6.97 ( 1H, d, J = 15.9 Hz), 7.42 (1H, m), 7.97 (2H, d, J = 7.2 Hz), 8.73 (2H, d, J = 7.2 Hz) 4.22 (2H, q, J = 6.9 Hz), 5.21 (2H, d, J = 7.2 Hz), 5.26 (1H, d, J = 4.8 Hz), 5.80 (1 H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 7.2, 15.9 Hz), 6.60 (1H, m), 6.93 (1H, s), 6.97 (1H, d, J = 15.9 Hz), 7.42 (1H, m), 7.97 (2H, d, J = 7.2 Hz), 8.73 (2H, d, J = 7.2 Hz)
IR (KBr) cm"1: 3418, 2983, 2154, 1762, 1639, 1587, 1558, 1529, 1496, 1389, 1333,IR (KBr) cm " 1 : 3418, 2983, 2154, 1762, 1639, 1587, 1558, 1529, 1496, 1389, 1333,
1254, 1215, 1160, 1089, 1037, 1002. 1254, 1215, 1160, 1089, 1037, 1002.
MS(ESI): 670+ (M + H)+ MS (ESI): 670 + (M + H) +
元素分析 C H N NaO S - 5.3 H O Elemental analysis C H N NaO S-5.3 H O
計算値: C,43.95; Η,4·56; Ν, 16.48; S,8.38; Na,3.00 (%) Calculated value: C, 43.95; Η, 4.56; Ν, 16.48; S, 8.38; Na, 3.00 (%)
実験値: C,44.00; Η,4·60; Ν, 16.57; S,8.27; Na,3.10 (%) Experimental value: C, 44.00; Η, 4.60; Ν, 16.57; S, 8.27; Na, 3.10 (%)
実施例 87 Example 87
[化 132]
[Chemical 132]
(1) 76→77 (1) 76 → 77
実施例 91の (1)と同様の方法で、 76(4.74 mL)から化合物 77(8· 15 g)を得た。 Compound 77 (8 · 15 g) was obtained from 76 (4.74 mL) in the same manner as in Example 91, (1).
'H-NMR (CDC1 ) δ: 5.24 (2Η, s), 7.29 (1H, dd, J = 1.2, 4.8 Hz), 7.33 (1H, dd, J = 'H-NMR (CDC1) δ: 5.24 (2Η, s), 7.29 (1H, dd, J = 1.2, 4.8 Hz), 7.33 (1H, dd, J =
3 Three
1.2, 4.8 Hz), 7.42 - 7.44 (1H, m), 7.72 - 7.76 (2H, m), 7.78 - 7.82 (2H, m). 1.2, 4.8 Hz), 7.42-7.44 (1H, m), 7.72-7.76 (2H, m), 7.78-7.82 (2H, m).
( 2) 77→79 (2) 77 → 79
実施例 91の (2)と同様の方法で、化合物 77(11.2 g)と化合物 78(12.7 g)から化合物 79 (14.3 g)を得た。 Compound 79 (14.3 g) was obtained from Compound 77 (11.2 g) and Compound 78 (12.7 g) in the same manner as in Example 91 (2).
'H-NMR (CDC1 ) δ: 1.54 (9H, s), 5.26 (2H, s), 7.09 (1H, dd, J = 1.2, 4.8 Hz), 7.22 'H-NMR (CDC1) δ: 1.54 (9H, s), 5.26 (2H, s), 7.09 (1H, dd, J = 1.2, 4.8 Hz), 7.22
3 Three
一 7.25 (1H, m), 7.29 - 7.33 (2H, m). 7.25 (1H, m), 7.29-7.33 (2H, m).
(3) 79→81 (3) 79 → 81
実施例 91の (3)と同様の方法で、化合物 79(3.07 g)と化合物 80(3.82 g)から化合物 81 (5.71 g)を得た。 Compound 81 (5.71 g) was obtained from Compound 79 (3.07 g) and Compound 80 (3.82 g) in the same manner as in Example 91, (3).
'H-NMR (CDC1 ) δ 1.53 (9H, s), 3.45 (2H, s), 4.01 (2H, d, J = 6.9 Hz), 5.06 (1H, 'H-NMR (CDC1) δ 1.53 (9H, s), 3.45 (2H, s), 4.01 (2H, d, J = 6.9 Hz), 5.06 (1H,
3 Three
d, J = 5.1 Hz), 5.32 (2H, t- like), 5.91 - 6.01 (2H, m), 6.93 (1H, d, J = 15.9 Hz), 7.0 0 (1H, s), 7.13 (1H, d, J = 5.1 Hz), 7.22 - 7.45 (13H, m).
(4) 81+57→82 d, J = 5.1 Hz), 5.32 (2H, t-like), 5.91-6.01 (2H, m), 6.93 (1H, d, J = 15.9 Hz), 7.0 0 (1H, s), 7.13 (1H, d, J = 5.1 Hz), 7.22-7.45 (13H, m). (4) 81 + 57 → 82
化合物 81(888 mg)と化合物 57(169 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 82(212 mg)を得た。 Compound 82 (212 mg) was obtained in the same manner as in Example 79, (3), using Compound 81 (888 mg) and Compound 57 (169 mg).
'H-NMR (D O) δ: 3.50 and 3.57 (2H, ABq, J = 17.4 Hz), 5.18 (1H, d, J = 4.8 Hz), 'H-NMR (D O) δ: 3.50 and 3.57 (2H, ABq, J = 17.4 Hz), 5.18 (1H, d, J = 4.8 Hz),
5.30 (2H, d, J = 6.9 Hz), 5.37 (2H, s), 5.73 (1H, d, J = 4.8 Hz), 6.02 (1H, dt, J = 6. 9, 15.9 Hz), 6.94 - 7.04 (3H, m), 7.19 (1H, d, J = 2.4 Hz), 7.43 (1H, d, J = 5.1 Hz): 8.32 (2H, d, J = 6.9 Hz), 8.86 (2H, d, J = 6.9 Hz). 5.30 (2H, d, J = 6.9 Hz), 5.37 (2H, s), 5.73 (1H, d, J = 4.8 Hz), 6.02 (1H, dt, J = 6.9, 15.9 Hz), 6.94-7.04 (3H, m), 7.19 (1H, d, J = 2.4 Hz), 7.43 (1H, d, J = 5.1 Hz): 8.32 (2H, d, J = 6.9 Hz), 8.86 (2H, d, J = 6.9 Hz).
IR (KBr) cm—1: 3418, 2159, 1764, 1667, 1604, 1561, 1533, 1457, 1368, 1302, 1198,IR (KBr) cm— 1 : 3418, 2159, 1764, 1667, 1604, 1561, 1533, 1457, 1368, 1302, 1198,
1148, 1060, 1047. 1148, 1060, 1047.
MS(ESI): 673+ (M + H)+ MS (ESI): 673+ (M + H) +
元素分析 C H N NaO S - 3.5 H O Elemental analysis C H N NaO S-3.5 H O
計算値: C,44.08; H,3.84; N, 15.23; S, 13.07; Na,3.12 (%) Calculated value: C, 44.08; H, 3.84; N, 15.23; S, 13.07; Na, 3.12 (%)
実験値: C,43.98; Η,3·69; Ν, 15.49; S, 12.81; Na,3.18 (%) Experimental value: C, 43.98; Η, 3.69; Ν, 15.49; S, 12.81; Na, 3.18 (%)
実施例 88 Example 88
[化 133] [Chemical 133]
化合物 81(888 mg)と化合物 5(236 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 83(253 mg)を得た。 Compound 83 (253 mg) was obtained in the same manner as in Example 79, (3), using Compound 81 (888 mg) and Compound 5 (236 mg).
'H-NMR (D O) δ: 3.50 and 3.58 (2H, ABq, J = 17.1 Hz), 5.16 (1H, d, J = 4.8 Hz), 'H-NMR (D O) δ: 3.50 and 3.58 (2H, ABq, J = 17.1 Hz), 5.16 (1H, d, J = 4.8 Hz),
5.31 (3H, m), 5.70 (1H, d, J = 4.8 Hz), 6.00 (1H, dt, J = 7.2, 15.6 Hz), 6.85 (1H, s) , 7.15 (1H, m), 7.38 - 7.42 (2H, m), 8.67 (2H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 H z). 5.31 (3H, m), 5.70 (1H, d, J = 4.8 Hz), 6.00 (1H, dt, J = 7.2, 15.6 Hz), 6.85 (1H, s), 7.15 (1H, m), 7.38-7.42 (2H, m), 8.67 (2H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 H z).
IR (KBr) cm—1: 3420, 2170, 1764, 1608, 1561, 1532, 1474, 1438, 1357, 1300, 1257, 1199, 1149, 1059. IR (KBr) cm— 1 : 3420, 2170, 1764, 1608, 1561, 1532, 1474, 1438, 1357, 1300, 1257, 1199, 1149, 1059.
MS(ESI): 740+ (M + H)+
元素分析 C H N NaO S -4.1 H O MS (ESI): 740 + (M + H) + Elemental analysis CHN NaO S -4.1 HO
計算値: C,44.29; H,3.74; N, 15.49; S, 11.82; Na,2.83 (%) Calculated values: C, 44.29; H, 3.74; N, 15.49; S, 11.82; Na, 2.83 (%)
実験値: C,44.16; Η,3·68; Ν, 15.49; S, 12.18; Na,2.83 (%) Experimental value: C, 44.16; Η, 3.68; Ν, 15.49; S, 12.18; Na, 2.83 (%)
実施例 89 Example 89
[化 134] [Chemical 134]
(1) 26→84 (1) 26 → 84
化合物 26(2.0 g, 9.6 mmol)の THF(15 mL)溶液に 5N NaOH水溶液(3.9 mL, 19.5 m mol)をカ卩ぇ室温にて撹拌した。 1時間後 5N NaOH7]溶液 (8.0 mL)を追加しさらに室 温にて 2時間撹拌した。 THFを減圧留去し 5N塩酸をカ卩えて pHを 1.5に調整した。析出 した沈殿を濾取し、減圧乾燥して化合物 84(1.60 g,収率 92%)を得た。 A solution of compound 26 (2.0 g, 9.6 mmol) in THF (15 mL) was stirred with 5N NaOH aqueous solution (3.9 mL, 19.5 mmol) at room temperature. After 1 hour, 5N NaOH7] solution (8.0 mL) was added, and the mixture was further stirred at room temperature for 2 hours. THF was distilled off under reduced pressure, and 5N hydrochloric acid was added to adjust the pH to 1.5. The deposited precipitate was collected by filtration and dried under reduced pressure to obtain Compound 84 (1.60 g, yield 92%).
(2) 84→85 (2) 84 → 85
化合物 84(1.47 g, 8.17 mmol)の塩化メチレン (15 mL)溶液にジフヱニルジァゾメタン ( 1.62 g, 8.32 mmol),メタノール (5 mL)、 THF(15 mL)を加え 70°Cで 1時間撹拌した。ジ フエニルジァゾメタン (1.08 g)を追加し 70°Cでさらに 1時間撹拌した。室温めで冷却後 減圧濃縮して、残渣をシリカゲルカラムクロマトグラフィーにより精製し、化合物 85(2.7 5 g,収率 97%)を得た。 Diphenyldiazomethane (1.62 g, 8.32 mmol), methanol (5 mL) and THF (15 mL) were added to a solution of compound 84 (1.47 g, 8.17 mmol) in methylene chloride (15 mL) at 70 ° C. Stir for 1 hour. Diphenyl diazomethane (1.08 g) was added, and the mixture was further stirred at 70 ° C for 1 hour. After cooling to room temperature, the mixture was concentrated under reduced pressure, and the residue was purified by silica gel column chromatography to give compound 85 (2.75 g, yield 97%).
(3) 81+85→86 (3) 81 + 85 → 86
化合物 81(888 mg)と化合物 85(346 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 86(265 mg)を得た。 Compound 86 (265 mg) was obtained in the same manner as in Example 79, (3), using Compound 81 (888 mg) and Compound 85 (346 mg).
'H-NMR (D O) δ: 3.52 and 3.60 (2H, ABq, J = 17.7 Hz), 5.18 (1H, d, J = 4.8 Hz), 'H-NMR (D O) δ: 3.52 and 3.60 (2H, ABq, J = 17.7 Hz), 5.18 (1H, d, J = 4.8 Hz),
5.35 (2H, s), 5.43 (2H, d, J = 6.9 Hz), 5.72 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6.
9, 15.6 Hz), 6.89 (IH, s), 7.00 - 7.05 (2H, m), 7.18 (IH, m), 7.42 (IH, m), 8.60 (1 H, d, J = 6.9 Hz), 8.63 (1H, d, J = 6.9 Hz), 9.66 (1H, s). 5.35 (2H, s), 5.43 (2H, d, J = 6.9 Hz), 5.72 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6. 9, 15.6 Hz), 6.89 (IH, s), 7.00-7.05 (2H, m), 7.18 (IH, m), 7.42 (IH, m), 8.60 (1 H, d, J = 6.9 Hz), 8.63 (1H, d, J = 6.9 Hz), 9.66 (1H, s).
IR (KBr) cm—1: 3417, 1764, 1637, 1532, 1506, 1465, 1362, 1303, 1197, 1118, 1058.IR (KBr) cm— 1 : 3417, 1764, 1637, 1532, 1506, 1465, 1362, 1303, 1197, 1118, 1058.
MS(ESI): 684+ (M - Na + 2H)+ MS (ESI): 684+ (M-Na + 2H) +
元素分析 C H N NaO S -4.4 H O Elemental analysis C H N NaO S -4.4 H O
計算値: C,41.31; H,3.70; N, 12.49; S, 16.34; Na,2.93 (%) Calculated values: C, 41.31; H, 3.70; N, 12.49; S, 16.34; Na, 2.93 (%)
実験値: C41.23; H,3.64; N, 12.56; S, 16.45; Na,3.13 (%) Experimental value: C41.23; H, 3.64; N, 12.56; S, 16.45; Na, 3.13 (%)
実施例 90 Example 90
[0113] [化 135] [0113] [Chemical 135]
化合物 81(888 mg)と化合物 27(226 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 87(171 mg)を得た。 Compound 87 (171 mg) was obtained in the same manner as in Example 79, (3), using Compound 81 (888 mg) and Compound 27 (226 mg).
'H-NMR (D O) δ: 3.51 and 3.58 (2H, ABq, J = 17.4 Hz), 5.15 (IH, d, J = 4.5 Hz), 'H-NMR (D O) δ: 3.51 and 3.58 (2H, ABq, J = 17.4 Hz), 5.15 (IH, d, J = 4.5 Hz),
5.29 (2H, s), 5.42 (2H, d, J = 6.9 Hz), 5.69 (1H, d, J = 4.5 Hz), 6.07 (1H, dt, J = 6. 9, 15.6 Hz), 6.82 (IH, s), 6.96 - 6.99 (IH, m), 7.06 (IH, d, J = 15.6 Hz), 7.14 (IH, m), 7.36 - 7.38 (1H, m), 8.57 (IH, d, J = 6.6 Hz), 8.63 (IH, d, J = 6.6 Hz), 9.66 (1 H, s). 5.29 (2H, s), 5.42 (2H, d, J = 6.9 Hz), 5.69 (1H, d, J = 4.5 Hz), 6.07 (1H, dt, J = 6.9, 15.6 Hz), 6.82 (IH , s), 6.96-6.99 (IH, m), 7.06 (IH, d, J = 15.6 Hz), 7.14 (IH, m), 7.36-7.38 (1H, m), 8.57 (IH, d, J = 6.6 Hz), 8.63 (IH, d, J = 6.6 Hz), 9.66 (1 H, s).
IR (KBr) cm"1: 3420, 3111, 2178, 1763, 1606, 1532, 1465, 1363, 1196, 1171, 1123,IR (KBr) cm " 1 : 3420, 3111, 2178, 1763, 1606, 1532, 1465, 1363, 1196, 1171, 1123,
1082, 1062. 1082, 1062.
MS(ESI): 730+ (M + H)+ MS (ESI): 730 + (M + H) +
元素分析 C H N NaO S -4.1 H O Elemental analysis C H N NaO S -4.1 H O
計算値: C,41.85; Η,3·54; Ν, 15.69; S, 15.96; Na,2.86 (%) Calculated value: C, 41.85; Η, 3 · 54; Ν, 15.69; S, 15.96; Na, 2.86 (%)
実験値: C,41.80; Η,3·40; Ν, 15.76; S, 15.79; Na,2.41 (%) Experimental value: C, 41.80; Η, 3.40; Ν, 15.76; S, 15.79; Na, 2.41 (%)
実施例 91 Example 91
(1) 88→89 (1) 88 → 89
化合物 88(2.36 g, 20 mmol)の THF(35 mL)溶液に N_ヒドロキシフタルイミド (3.26g, 20 mmol),トリフエニルホスフィン (5.25 g)を加えて氷浴にて冷却撹拌した。この溶液に D EADのトルエン溶液 (11.1 mL)を滴下し、室温まで昇温後同温で 3時間撹拌した。 TH Fを減圧留去し、トルエンを加えて不溶物を濾去した。トルエンを減圧留去し残渣をシ リカゲルカラムクロマーにより精製しィ匕合物 89(4.42 g,収率 84%)を結晶で得た。 N_hydroxyphthalimide (3.26 g, 20 mmol) and triphenylphosphine (5.25 g) were added to a solution of compound 88 (2.36 g, 20 mmol) in THF (35 mL), and the mixture was cooled and stirred in an ice bath. To this solution was added DEAD in toluene (11.1 mL) dropwise, and the mixture was warmed to room temperature and stirred at the same temperature for 3 hours. THF was distilled off under reduced pressure, toluene was added and insolubles were removed by filtration. Toluene was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography to obtain Compound 89 (4.42 g, yield 84%) as crystals.
'H-NMR (CDCl ) δ 2.04 - 2.15 (2Η, m), 2.23 - 2.32 (2H, m), 2.52 - 2.61 (2H, m) 'H-NMR (CDCl) δ 2.04-2.15 (2Η, m), 2.23-2.32 (2H, m), 2.52-2.61 (2H, m)
3 Three
, 2.96 - 3.03 (2H, m), 4.22 - 4.28 (1H, m), 7.74 - 7.79 (2H, m), 7.81 - 7.86 (2H, m )· , 2.96-3.03 (2H, m), 4.22-4.28 (1H, m), 7.74-7.79 (2H, m), 7.81-7.86 (2H, m)
(2) 78→90 (2) 78 → 90
化合物 89(4.42g, 16.8 mmol)の塩化メチレン (30 mL)溶液を氷冷し、メチルヒドラジン (0.89 mL, 16.8 mmol)をカ卩えた。同温で 1.5時間撹拌し析出した沈殿を濾去した。塩 化メチレンを約 20 mLまで減圧留去し、メタノールを加え氷冷した。この溶液に化合物 78(4.57 g, 16.8 mmol)を加え室温まで昇温後 2時間撹拌した。メタノールを減圧留去 し、酢酸ェチル (120 mL)を加え、 0.2N塩酸、水、飽和食塩水の順に洗浄した。無水
硫酸マグネシウムで乾燥し濃縮した。ジェチルエーテルとへキサンをカ卩えて析出した 沈殿を濾取し、減圧乾燥して化合物 90(4.95 g,収率 76%)を得た。 A solution of compound 89 (4.42 g, 16.8 mmol) in methylene chloride (30 mL) was ice-cooled to obtain methyl hydrazine (0.89 mL, 16.8 mmol). The mixture was stirred at the same temperature for 1.5 hours, and the deposited precipitate was removed by filtration. Methylene chloride was distilled off under reduced pressure to about 20 mL, methanol was added and the mixture was ice-cooled. Compound 78 (4.57 g, 16.8 mmol) was added to this solution, and the mixture was warmed to room temperature and stirred for 2 hours. Methanol was distilled off under reduced pressure, ethyl acetate (120 mL) was added, and the mixture was washed with 0.2N hydrochloric acid, water, and saturated brine in this order. anhydrous It was dried over magnesium sulfate and concentrated. The precipitate formed by collecting the jetyl ether and hexane was collected by filtration and dried under reduced pressure to obtain Compound 90 (4.95 g, yield 76%).
'H-NMR (CDC1 ) δ 1.98 - 2.09 (2Η, m), 2.16 - 2.25 (2H, m), 2.46 - 2.54 (2H, m) 'H-NMR (CDC1) δ 1.98-2.09 (2Η, m), 2.16-2.25 (2H, m), 2.46-2.54 (2H, m)
, 2.77 - 2.86 (2H, m), 4.37 (1H, m), 7.33 (1H, s). , 2.77-2.86 (2H, m), 4.37 (1H, m), 7.33 (1H, s).
(3) 90→91 (3) 90 → 91
化合物 90(2.32g, 6.0 mmol)の塩化メチレン (30 mL)溶液を _30°Cに冷却し化合物 80( 2.86 g, 6.0 mmol),フエ二ルリン酸ジクロライド (1.08 mL, 7.2 mmol), N_メチルモルホリ ン (1.98 mL)を順に加え- 20°Cで 2時間撹拌した。 10%クェン酸水溶液 (30 mL)を加え 室温まで昇温した後、塩ィ匕メチレンを約 20mLまで濃縮した。酢酸ェチル (100 mL)を 加えて抽出し、有機層を飽和重曹水、飽和食塩水で洗浄した後、無水硫酸マグネシ ゥムで乾燥した。濃縮によって得られた残渣をシリカゲルカラムクロマトグラフィーで精 製し、化合物 91(2.88 g,収率 56%)を淡褐色泡状で得た。 A solution of compound 90 (2.32 g, 6.0 mmol) in methylene chloride (30 mL) was cooled to _30 ° C and compound 80 (2.86 g, 6.0 mmol), phenylphosphoric dichloride (1.08 mL, 7.2 mmol), N_methylmorpholine (1.98 mL) was added in order, and the mixture was stirred at −20 ° C. for 2 hours. A 10% aqueous citrate solution (30 mL) was added and the mixture was warmed to room temperature, and then concentrated to about 20 mL of sodium chloride. Ethyl acetate (100 mL) was added for extraction, and the organic layer was washed with saturated aqueous sodium hydrogen carbonate and saturated brine, and then dried over anhydrous magnesium sulfate. The residue obtained by concentration was purified by silica gel column chromatography to obtain Compound 91 (2.88 g, yield 56%) as a light brown foam.
'H-NMR (CDC1 ) δ 1.54 (9Η, s), 1.92 - 2.05 (2H, m), 2.26 - 2.34 (2H, m), 2.56 - 'H-NMR (CDC1) δ 1.54 (9Η, s), 1.92-2.05 (2H, m), 2.26-2.34 (2H, m), 2.56-
2.65 (2H, m), 2.78 - 2.88 (2H, m), 3.56 and 3.68 (2H, ABq, J = 17.8 Hz), 4.00 (2H , d, J = 7.3 Hz), 4.36 (1H, m), 5.12 (1H, d, J = 4.8 Hz), 5.96 - 6.06 (2H, m), 6.91 ( 1H, d, J = 15.9 Hz), 7.02 (1H, s), 7.13 (1H, d, J = 8.7 Hz), 7.29 - 7.45 (11H, m).2.65 (2H, m), 2.78-2.88 (2H, m), 3.56 and 3.68 (2H, ABq, J = 17.8 Hz), 4.00 (2H, d, J = 7.3 Hz), 4.36 (1H, m), 5.12 (1H, d, J = 4.8 Hz), 5.96-6.06 (2H, m), 6.91 (1H, d, J = 15.9 Hz), 7.02 (1H, s), 7.13 (1H, d, J = 8.7 Hz) , 7.29-7.45 (11H, m).
(4) 91→92 (4) 91 → 92
化合物 91(863 mg)と化合物 27(226 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 92(382 mg,収率 47%)を得た。 Compound 92 (382 mg, 47% yield) was obtained in the same manner as in Example 79, (3), using Compound 91 (863 mg) and Compound 27 (226 mg).
'H-NMR (D O) 5: 1.91 - 1.97 (2Η, m), 2.11 - 2.21 (2H, m), 2.53 - 2.60 (2H, m), 2 'H-NMR (D O) 5: 1.91-1.97 (2Η, m), 2.11-2.21 (2H, m), 2.53-2.60 (2H, m), 2
.78 - 2.84 (2H, m), 3.64 and 3.72 (2H, ABq, J = 17.7 Hz), 4.29 (1H, m), 5.27 (1H, d, J = 4.8 Hz), 5.47 (2H, d, J = 6.9 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.17 (1H, dt, J = 6.9, 15.6 Hz), 6.89 (1H, s), 7.05 (1H, d, J = 15.6 Hz), 8.66 (1H, d, J = 6.9 Hz), 8.7 4 (1H, d, J = 6.9 Hz), 9.71 (1H, s). .78-2.84 (2H, m), 3.64 and 3.72 (2H, ABq, J = 17.7 Hz), 4.29 (1H, m), 5.27 (1H, d, J = 4.8 Hz), 5.47 (2H, d, J = 6.9 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.17 (1H, dt, J = 6.9, 15.6 Hz), 6.89 (1H, s), 7.05 (1H, d, J = 15.6 Hz), 8.66 (1H, d, J = 6.9 Hz), 8.7 4 (1H, d, J = 6.9 Hz), 9.71 (1H, s).
IR (KBr) cm—1: 3410, 2940, 2178, 1764, 1604, 1531, 1362, 1190, 1122, 1081, 1061, 1022. IR (KBr) cm— 1 : 3410, 2940, 2178, 1764, 1604, 1531, 1362, 1190, 1122, 1081, 1061, 1022.
MS(ESI): 712+ (M - Na + 2H)+ MS (ESI): 712+ (M-Na + 2H) +
元素分析 C H N NaO S -4.7 H O
計算値: C,41.09; Η,4· 11; Ν, 15.40; S, 15.67; Na,2.81 (%) Elemental analysis CHN NaO S -4.7 HO Calculated value: C, 41.09; Η, 4.11; Ν, 15.40; S, 15.67; Na, 2.81 (%)
実験値: C,40.91; Η,3·98; Ν, 15.34; S, 15.77; Na,3.11 (%) Experimental value: C, 40.91; Η, 3.98; Ν, 15.34; S, 15.77; Na, 3.11 (%)
実施例 92 Example 92
[0115] [化 137] [0115] [Chemical 137]
(1) 91→93 (1) 91 → 93
化合物 91(863 mg)と化合物 85(341 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 9 3(259 mg,収率 32%)を得た。 Compound 93 (259 mg, 32% yield) was obtained in the same manner as in Example 79, (3), using Compound 91 (863 mg) and Compound 85 (341 mg).
'H-NMR (D O) δ: 1.95 - 2.04 (2Η, m), 2.12 - 2.22 (2H, m), 2.53 - 2.62 (2H, m), 2 'H-NMR (D O) δ: 1.95-2.04 (2Η, m), 2.12-2.22 (2H, m), 2.53-2.62 (2H, m), 2
.80 - 2.88 (2H, m), 3.64 and 3.71 (2H, ABq, J = 17.7 Hz), 4.29 - 4.35 (1H, m), 5.2 8 (1H, d, J = 4.8 Hz), 5.46 (2H, d, J = 6.9 Hz), 5.83 (1H, d, J = 4.8 Hz), 6.16 (1H, dt, J = 6.9, 15.6 Hz), 6.94 (1H, s), 7.02 (1H, d, J = 15.6 Hz), 8.66 (1H, d, J = 6.9 H z), 8.71 (1H, d, J = 6.9 Hz), 9.69 (1H, s). .80-2.88 (2H, m), 3.64 and 3.71 (2H, ABq, J = 17.7 Hz), 4.29-4.35 (1H, m), 5.2 8 (1H, d, J = 4.8 Hz), 5.46 (2H, d, J = 6.9 Hz), 5.83 (1H, d, J = 4.8 Hz), 6.16 (1H, dt, J = 6.9, 15.6 Hz), 6.94 (1H, s), 7.02 (1H, d, J = 15.6 Hz), 8.66 (1H, d, J = 6.9 Hz), 8.71 (1H, d, J = 6.9 Hz), 9.69 (1H, s).
IR (KBr) cm"1: 3399, 2938, 1765, 1636, 1531, 1362, 1191, 1118, 1058, 1022. IR (KBr) cm " 1 : 3399, 2938, 1765, 1636, 1531, 1362, 1191, 1118, 1058, 1022.
MS(ESI): 688+ (M - Na + 2H)+ MS (ESI): 688 + (M-Na + 2H) +
元素分析 C H N NaO S -4.1 H O - 0.3 NaHCO Elemental analysis C H N NaO S -4.1 H O-0.3 NaHCO
計算値: C,40.54; Η,4·05; Ν, 12.12; S, 15.86; Na,3.70 (%) Calculated value: C, 40.54; Η, 4.05; Ν, 12.12; S, 15.86; Na, 3.70 (%)
実験値: C,40.52; Η,4·03; Ν, 11.99; S, 15.90; Na,3.66 (%) Experimental value: C, 40.52; Η, 4.03; Ν, 11.99; S, 15.90; Na, 3.66 (%)
実施例 93 Example 93
[0116] [化 138] [0116] [Chemical 138]
化合物 91(863 mg)と化合物 57(169 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 94(272 mg,収率 36%)を得た。 Compound 94 (272 mg, 36% yield) was obtained in the same manner as in Example 79, (3), using Compound 91 (863 mg) and Compound 57 (169 mg).
'H-NMR (D O) 5: 1.94 - 2.05 (2Η, m), 2.13 - 2.23 (2H, m), 2.54 - 2.62 (2H, m), 2 'H-NMR (D O) 5: 1.94-2.05 (2Η, m), 2.13-2.23 (2H, m), 2.54-2.62 (2H, m), 2
2 2
• 80 - 2.87 (2H, m), 3.62 and 3.69 (2H, ABq, J = 17.4 Hz), 4.30 - 4.37 (1H, m), 5.2 7 (1H, d, J = 4.5 Hz), 5.33 (2H, d, J = 6.9 Hz), 5.83 (1H, d, J = 4.5 Hz), 6.09 (1H, dt, J = 6.9, 15.9 Hz), 6.95 - 6.99 (2H, m), 8.36 (2H, d, J = 6.9 Hz), 8.91 (1H, d, J = 6.9 Hz). • 80-2.87 (2H, m), 3.62 and 3.69 (2H, ABq, J = 17.4 Hz), 4.30-4.37 (1H, m), 5.2 7 (1H, d, J = 4.5 Hz), 5.33 (2H, d, J = 6.9 Hz), 5.83 (1H, d, J = 4.5 Hz), 6.09 (1H, dt, J = 6.9, 15.9 Hz), 6.95-6.99 (2H, m), 8.36 (2H, d, J = 6.9 Hz), 8.91 (1H, d, J = 6.9 Hz).
IR (KBr) cm—1: 3410, 3055, 2940, 2159, 1764, 1667, 1604, 1561, 1532, 1455, 1365, 1240, 1196, 1146, 1060, 1022. IR (KBr) cm— 1 : 3410, 3055, 2940, 2159, 1764, 1667, 1604, 1561, 1532, 1455, 1365, 1240, 1196, 1146, 1060, 1022.
MS(ESI): 677+ (M + H)+ MS (ESI): 677 + (M + H) +
元素分析 c H N NaO S -4.0 H O - 0.1 NaHCO Elemental analysis c H N NaO S -4.0 H O-0.1 NaHCO
27 25 8 6 3 2 3 27 25 8 6 3 2 3
計算値: C,42.99; H,4.41; N, 14.80; S, 12.70; Na,3.34 (%) Calculated values: C, 42.99; H, 4.41; N, 14.80; S, 12.70; Na, 3.34 (%)
実験値: C,42.74; H,4.26; N, 14.79; S, 12.98; Na,3.47 (%) Experimental value: C, 42.74; H, 4.26; N, 14.79; S, 12.98; Na, 3.47 (%)
実施例 94 Example 94
[化 139] [Chem 139]
(1) 41→95 (1) 41 → 95
実施例 74の (1)と同様の方法で化合物 41(2.34 g)力 化合物 95(1.92 g,収率 93%)を 得た。 Compound 41 (2.34 g) force Compound 95 (1.92 g, yield 93%) was obtained in the same manner as in Example 74, (1).
H-NMR (d -DMSO) δ 7.96 (2Η, dd, J = 1.8, 4.8 Hz), 8.68 (2H, d, J = 6.0 Hz), 8.7 H-NMR (d-DMSO) δ 7.96 (2Η, dd, J = 1.8, 4.8 Hz), 8.68 (2H, d, J = 6.0 Hz), 8.7
6 6
8 (1H, s). 8 (1H, s).
(2) 95→96 (2) 95 → 96
実施例 84の (1)と同様の方法で化合物 95(1.92 g)から化合物 96(3.08 g,収率 88%)を
得た。 Compound 96 (3.08 g, yield 88%) was converted from compound 95 (1.92 g) in the same manner as in Example 84, (1). Obtained.
'H-NMR (CDCl ) δ 7.20 (1H, s), 7.31 - 7.49 (10H, m), 7.92 (2H, d, J = 6.0 Hz), 8 'H-NMR (CDCl) δ 7.20 (1H, s), 7.31-7.49 (10H, m), 7.92 (2H, d, J = 6.0 Hz), 8
.02 (1H, s), 8.72 (2H, d, J = 4.8 Hz). .02 (1H, s), 8.72 (2H, d, J = 4.8 Hz).
(3) 81+96→97 (3) 81 + 96 → 97
化合物 81(888 mg)と化合物 96(372 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 97(145 mg,収率 18%)を得た。 Compound 97 (145 mg, yield 18%) was obtained in the same manner as in Example 79, (3), using Compound 81 (888 mg) and Compound 96 (372 mg).
'H-NMR (D O) δ: 3.46 and 3.57 (2H, ABq, J = 17.1 Hz), 5.15 - 5.20 (3H, m), 5.33 and 5.38 (2H, ABq, J = 13.2 Hz), 5.69 (1H, d, J = 4.5 Hz), 5.95 (1H, dt, J = 6.9, 1 5.6 Hz), 6.81 (1H, s), 6.97 - 7.02 (2H, m), 7.13 (2H, d, J = 2.7 Hz), 7.39 (1H, dd, J = 1.2, 5.1 Hz), 8.33 (2H, d, J = 6.6 Hz), 8.54 (1H, s), 8.67 (2H, d, J = 6.6 Hz). IR (KBr) cm"1: 3408, 1763, 1635, 1532, 1487, 1458, 1367, 1292, 1200, 1156, 1109, 1064. 'H-NMR (DO) δ: 3.46 and 3.57 (2H, ABq, J = 17.1 Hz), 5.15-5.20 (3H, m), 5.33 and 5.38 (2H, ABq, J = 13.2 Hz), 5.69 (1H, d, J = 4.5 Hz), 5.95 (1H, dt, J = 6.9, 1 5.6 Hz), 6.81 (1H, s), 6.97-7.02 (2H, m), 7.13 (2H, d, J = 2.7 Hz) , 7.39 (1H, dd, J = 1.2, 5.1 Hz), 8.33 (2H, d, J = 6.6 Hz), 8.54 (1H, s), 8.67 (2H, d, J = 6.6 Hz). IR (KBr) cm " 1 : 3408, 1763, 1635, 1532, 1487, 1458, 1367, 1292, 1200, 1156, 1109, 1064.
M S(ESI): 710+ (M - Na + 2H)+ MS (ESI): 710 + (M-Na + 2H) +
元素分析 C H N NaO S -4.4 H O Elemental analysis C H N NaO S -4.4 H O
計算値: C,42.95; Η,3·83; Ν, 12.09; S, 15.81; Na,2.83 (%) Calculated value: C, 42.95; Η, 3.83; Ν, 12.09; S, 15.81; Na, 2.83 (%)
実験値: C,42.74; Η,3·65; Ν, 11.80; S, 15.72; Na,2.74 (%) Experimental value: C, 42.74; Η, 3.65; Ν, 11.80; S, 15.72; Na, 2.74 (%)
実施例 95 Example 95
[化 140]
[Chemical 140]
(1) 98→99 (1) 98 → 99
実施例 91の (1)と同様の方法で化合物 98(2.28g)から化合物 99(2.06g,収率 57%)を得 た。 Compound 99 (2.06 g, yield 57%) was obtained from compound 98 (2.28 g) in the same manner as in Example 91, (1).
'H-NMR (CDC1 ) δ 5.24 (2Η, s), 7.29 (1H, dd, J = 1.2, 4.8 Hz), 7.33 (1H, dd, J = 'H-NMR (CDC1) δ 5.24 (2Η, s), 7.29 (1H, dd, J = 1.2, 4.8 Hz), 7.33 (1H, dd, J =
1.2, 4.8 Hz), 7.42 - 7.44 (1H, m), 7.72 - 7.76 (2H, m), 7.78 - 7.82 (2H, m). 1.2, 4.8 Hz), 7.42-7.44 (1H, m), 7.72-7.76 (2H, m), 7.78-7.82 (2H, m).
(2) 78→100 (2) 78 → 100
実施例 91の (2)と同様の方法で化合物 93(2.95 g)と化合物 78(3.25 g)から化合物 100( 4.33 g,収率 99%)を得た。 Compound 100 (4.33 g, yield 99%) was obtained from compound 93 (2.95 g) and compound 78 (3.25 g) in the same manner as in Example 91, (2).
'H-NMR (CDC1 ) δ: 1.54 (9H, s), 5.26 (2H, s), 7.09 (1H, dd, J = 1.2, 4.8 Hz), 7.2 'H-NMR (CDC1) δ: 1.54 (9H, s), 5.26 (2H, s), 7.09 (1H, dd, J = 1.2, 4.8 Hz), 7.2
2 - 7.25 (1H, m), 7.29 - 7.33 (2H, m). 2-7.25 (1H, m), 7.29-7.33 (2H, m).
(3) 100→101 (3) 100 → 101
実施例 91の (3)と同様の方法で化合物 100(4.33 g)と化合物 80(5.39 g)から化合物 10 1(7.92 g,収率 81%)を得た。 Compound 101 (7.92 g, yield 81%) was obtained from compound 100 (4.33 g) and compound 80 (5.39 g) in the same manner as in Example 91, (3).
'H-NMR (CDC1 ) δ 1.53 (9H, s), 3.45 (2H, s), 4.01 (2H, d, J = 6.9 Hz), 5.06 (1H, d, J = 5.1 Hz), 5.32 (2H, t- like), 5.91 - 6.01 (2H, m), 6.93 (1H, d, J = 15.9 Hz), 7.0 0 (1H, s), 7.13 (1H, d, J = 5.1 Hz), 7.22 - 7.45 (13H, m).
(4) 101+96→102 'H-NMR (CDC1) δ 1.53 (9H, s), 3.45 (2H, s), 4.01 (2H, d, J = 6.9 Hz), 5.06 (1H, d, J = 5.1 Hz), 5.32 (2H, t-like), 5.91-6.01 (2H, m), 6.93 (1H, d, J = 15.9 Hz), 7.0 0 (1H, s), 7.13 (1H, d, J = 5.1 Hz), 7.22-7.45 ( 13H, m). (4) 101 + 96 → 102
化合物 101(860 mg)と化合物 96(372 mg)を用いて、実施例 79の (3)と同様の方法で 化合物 102(315 mg,収率 39%)を得た。 Compound 102 (315 mg, yield 39%) was obtained in the same manner as in Example 79, (3), using Compound 101 (860 mg) and Compound 96 (372 mg).
'Η -NMR (D O) δ: 3.46 and 3.55 (2H, ABq, J = 17.4 Hz), 5.15 (1H, d, J = 9.5 Hz), 'Η-NMR (D O) δ: 3.46 and 3.55 (2H, ABq, J = 17.4 Hz), 5.15 (1H, d, J = 9.5 Hz),
2 2
5.17 (2H, s), 5.22 (2H, d, J = 6.9 Hz), 5.70 (1H, d, J = 4.5 Hz), 5.99 (1H, dt, J = 6. 9, 15.6 Hz), 6.82 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 7.16 (1H, m), 7.37 (1H, m), 7.4 4 (1H, m), 8.36 (2H, d, J = 6.9 Hz), 8.55 (1H, s), 8.70 (2H, d, J = 6.9 Hz). 5.17 (2H, s), 5.22 (2H, d, J = 6.9 Hz), 5.70 (1H, d, J = 4.5 Hz), 5.99 (1H, dt, J = 6.9, 15.6 Hz), 6.82 (1H , s), 6.99 (1H, d, J = 15.6 Hz), 7.16 (1H, m), 7.37 (1H, m), 7.4 4 (1H, m), 8.36 (2H, d, J = 6.9 Hz), 8.55 (1H, s), 8.70 (2H, d, J = 6.9 Hz).
IR (KBr) cm—1: 3399, 1764, 1635, 1531, 1487, 1458, 1365, 1199, 1155, 1109, 1063, 1001. IR (KBr) cm— 1 : 3399, 1764, 1635, 1531, 1487, 1458, 1365, 1199, 1155, 1109, 1063, 1001.
MS(ESI): 710+ (M -Na + 2H)+ MS (ESI): 710+ (M -Na + 2H) +
元素分析 C H N NaO S -4.5 H O Elemental analysis C H N NaO S -4.5 H O
29 22 7 7 4 2 29 22 7 7 4 2
計算値: C,42.85; H,3.84; N, 12.06; S, 15.78; Na,2.83 (%) Calculated values: C, 42.85; H, 3.84; N, 12.06; S, 15.78; Na, 2.83 (%)
実験値: C,42.69; Η,3·49; Ν, 12.24; S, 15.79; Na,2.95 (%) Experimental value: C, 42.69; Η, 3.49; Ν, 12.24; S, 15.79; Na, 2.95 (%)
実施例 96 Example 96
[化 141] [Chem 141]
【化 1 4 2 [Chemical 1 4 2
(1) 36→103 (1) 36 → 103
実施例 74の (1)と同様の方法で化合物 36(5.21 g)から化合物 103(4.47 g,収率 97%)を
得た。 Compound 103 (4.47 g, yield 97%) was converted from compound 36 (5.21 g) in the same manner as in Example 74 (1). Obtained.
H-NMR (d -DMSO) δ 7.76 (2H, dd, J = 1.5, 4.8 Hz) , 8.46 (1H, s), 8.57 (2H, d, J H-NMR (d -DMSO) δ 7.76 (2H, dd, J = 1.5, 4.8 Hz), 8.46 (1H, s), 8.57 (2H, d, J
= 1.5, 4.8 Hz). = 1.5, 4.8 Hz).
(2) 103→104 (2) 103 → 104
実施例 84の (1)と同様の方法で化合物 103(2.06 g)から化合物 104(3.49 g,収率 94%) を得た。 Compound 104 (3.49 g, yield 94%) was obtained from compound 103 (2.06 g) in the same manner as in Example 84, (1).
'H-NMR (CDC1 ) δ 7.18 (1H, s), 7.25 - 7.47 (10H, m), 7.94 (2H, dd, J = 1.8, 4.5 'H-NMR (CDC1) δ 7.18 (1H, s), 7.25-7.47 (10H, m), 7.94 (2H, dd, J = 1.8, 4.5
Hz), 8.37 (1H, s), 8.75 (2H, dd, J = 1.8, 4.5 Hz). Hz), 8.37 (1H, s), 8.75 (2H, dd, J = 1.8, 4.5 Hz).
(3) 101+104→105 (3) 101 + 104 → 105
化合物 101(860 mg)と化合物 104(372 mg)を用いて、実施例 79の (3)と同様の方法で 化合物 105(329 mg,収率 40%)を得た。 Compound 105 (329 mg, yield 40%) was obtained in the same manner as in Example 79, (3), using Compound 101 (860 mg) and Compound 104 (372 mg).
'H-NMR (D O) δ: 3.49 and 3.57 (2H, ABq, J = 17.1 Hz), 5.17 (1H, d, J = 4.8 Hz), 'H-NMR (D O) δ: 3.49 and 3.57 (2H, ABq, J = 17.1 Hz), 5.17 (1H, d, J = 4.8 Hz),
5.20 (2H, s), 5.28 (2H, d, J = 6.9 Hz), 5.72 (1H, d, J = 4.8 Hz), 6.02 (1H, dt, J = 6. 9, 15.6 Hz), 6.87 (1H, s), 7.00 (1H, d, J = 15.6 Hz), 7.19 (1H, dd, J = 1.2, 5.1 Hz), 7.40 (1H, dd, J = 3.0, 5.1 Hz), 7.46 (1H, m), 8.37 (1H, s), 8.45 (2H, d, J = 6.9 Hz), 8.82 (2H, d, J = 6.9 Hz). 5.20 (2H, s), 5.28 (2H, d, J = 6.9 Hz), 5.72 (1H, d, J = 4.8 Hz), 6.02 (1H, dt, J = 6.9, 15.6 Hz), 6.87 (1H , s), 7.00 (1H, d, J = 15.6 Hz), 7.19 (1H, dd, J = 1.2, 5.1 Hz), 7.40 (1H, dd, J = 3.0, 5.1 Hz), 7.46 (1H, m) 8.37 (1H, s), 8.45 (2H, d, J = 6.9 Hz), 8.82 (2H, d, J = 6.9 Hz).
IR (KBr) cm"1: 3399, 1763, 1634, 1599, 1531, 1466, 1437, 1357, 1294, 1199, 1155, 1060, 1011. IR (KBr) cm " 1 : 3399, 1763, 1634, 1599, 1531, 1466, 1437, 1357, 1294, 1199, 1155, 1060, 1011.
MS(ESI): 710+ (M + H)+ MS (ESI): 710 + (M + H) +
元素分析 C H N NaO S -4.3 H O - 0.2 NaHCO Elemental analysis C H N NaO S -4.3 H O-0.2 NaHCO
計算値: C,42.46; H,3.76; N, 11.87; S, 15.53; Na,3.34 (%) Calculated values: C, 42.46; H, 3.76; N, 11.87; S, 15.53; Na, 3.34 (%)
実験値: C,42.42; H,3.72; N, 11.68; S, 15.60; Na,3.34 (%) Experimental value: C, 42.42; H, 3.72; N, 11.68; S, 15.60; Na, 3.34 (%)
実施例 97 Example 97
【化 1 4 2 [Chemical 1 4 2
化合物 81(1.05 g)と化合物 104(440 mg)を用いて実施例 79の (3)と同様の方法で化 合物 106(230 mg,収率 23%)を得た。 Compound 106 (230 mg, 23% yield) was obtained in the same manner as in Example 79, (3), using Compound 81 (1.05 g) and Compound 104 (440 mg).
'H-NMR (D O) δ: 3.51 and 3.59 (2H, ABq, J = 17.4 Hz), 5.18 (1H, d, J = 4.8 Hz), 'H-NMR (D O) δ: 3.51 and 3.59 (2H, ABq, J = 17.4 Hz), 5.18 (1H, d, J = 4.8 Hz),
2 2
5.27 (2H, d, J = 6.9 Hz), 5.34 (2H, s), 5.72 (1H, d, J = 4.8 Hz), 6.02 (1H, dt, J = 6. 9, 15.6 Hz), 6.89 (1H, s), 6.98 - 7.04 (2H, m), 7.18 (2H, d, J = 3.0), 7.43 (1H, dd, J = 1.2, 5.1 Hz), 8.38 (1H, s), 8.44 (2H, d, J = 6.9 Hz), 8.81 (2H, d, J = 6.9 Hz). IR (KBr) cm"1: 3408, 1763, 1633, 1602, 1531, 1467, 1436, 1358, 1295, 1200, 1156, 1061, 1010. 5.27 (2H, d, J = 6.9 Hz), 5.34 (2H, s), 5.72 (1H, d, J = 4.8 Hz), 6.02 (1H, dt, J = 6.9, 15.6 Hz), 6.89 (1H , s), 6.98-7.04 (2H, m), 7.18 (2H, d, J = 3.0), 7.43 (1H, dd, J = 1.2, 5.1 Hz), 8.38 (1H, s), 8.44 (2H, d , J = 6.9 Hz), 8.81 (2H, d, J = 6.9 Hz). IR (KBr) cm " 1 : 3408, 1763, 1633, 1602, 1531, 1467, 1436, 1358, 1295, 1200, 1156, 1061 , 1010.
MS(ESI): 710+ (M - Na + 2H)+ MS (ESI): 710 + (M-Na + 2H) +
元素分析 C H N NaO S - 5.2 H O - 0.1 NaHCO Elemental analysis C H N NaO S-5.2 H O-0.1 NaHCO
29 22 7 7 4 2 3 29 22 7 7 4 2 3
計算値: C,41.91; H,3.93; N, 11.76; S, 15.38; Na,3.03 (%) Calculated values: C, 41.91; H, 3.93; N, 11.76; S, 15.38; Na, 3.03 (%)
実験値: C41.86; H,3.70; N, 11.94; S, 15.38; Na,3.12 (%) Experimental value: C41.86; H, 3.70; N, 11.94; S, 15.38; Na, 3.12 (%)
実施例 99 Example 99
(1) 110→111 (1) 110 → 111
アルデヒド体 110(3.87 g, 34.2 mmol)のエタノール (40 mL)溶液に氷冷撹拌下、 NaB H4(92%w/w, 1.41g, 34.2 mmol)を加え、室温まで昇温した。同温で 1時間撹拌した後 水 (50 mL)を加えてクロ口ホルムで 4回抽出し、有機層は無水硫酸マグネシウムで乾 燥後、減圧濃縮、減圧乾燥した。化合物 111(2.96 g,収率 99%)を油状物質として得た NaB H4 (92% w / w, 1.41 g, 34.2 mmol) was added to an ethanol (40 mL) solution of the aldehyde 110 (3.87 g, 34.2 mmol) with stirring under ice cooling, and the temperature was raised to room temperature. After stirring at the same temperature for 1 hour, water (50 mL) was added and the mixture was extracted four times with Kuroguchi Form. Compound 111 (2.96 g, 99% yield) was obtained as an oily substance.
'H-NMR (CDC1 ) δ: 4.98 (2Η, s), 7.34 (1H, d, J = 3.3 Hz), 7.76 (1H, d, J = 3.3 Hz'H-NMR (CDC1) δ: 4.98 (2Η, s), 7.34 (1H, d, J = 3.3 Hz), 7.76 (1H, d, J = 3.3 Hz)
)· )
(2) 111→112 (2) 111 → 112
実施例 91の (1)と同様の方法で化合物 lll(3.90g)から化合物 112(6.98g,収率 79%) を得た。 Compound 112 (6.98 g, yield 79%) was obtained from compound lll (3.90 g) in the same manner as in Example 91, (1).
'H-NMR (CDC1 ) δ 5.49 (2H, s), 7.49 (1H, d, J = 3.3 Hz), 7.73 - 7.83 (5H, m). 'H-NMR (CDC1) δ 5.49 (2H, s), 7.49 (1H, d, J = 3.3 Hz), 7.73-7.83 (5H, m).
(3) 112→113 (3) 112 → 113
実施例 91の (2)と同様の方法で化合物 112(3.12 g)と化合物 78(3.43 g)から化合物 11 3(5.24 g,収率 99%)を得た。
JH-NMR (CDC1 ) δ 1.53 (9H, s), 5.62 (2H, s), 7.36 (1H, d, J = 3.3 Hz), 7.40 (1H, Compound 113 (5.24 g, yield 99%) was obtained from Compound 112 (3.12 g) and Compound 78 (3.43 g) in the same manner as in Example 91, (2). J H-NMR (CDC1) δ 1.53 (9H, s), 5.62 (2H, s), 7.36 (1H, d, J = 3.3 Hz), 7.40 (1H,
3 Three
s), 7.76 (1H, d, J = 3.3 Hz). s), 7.76 (1H, d, J = 3.3 Hz).
[0123] (4) 113→114 [0123] (4) 113 → 114
実施例 91の (3)と同様の方法で化合物 113(5.24 g)と化合物 80(5.69 g)から化合物 11 4(7.94 g,収率 78%)を得た。 Compound 114 (7.94 g, yield 78%) was obtained from compound 113 (5.24 g) and compound 80 (5.69 g) in the same manner as in Example 91, (3).
'H-NMR (CDC1 ) δ 1.52 (9H, s), 3.50 and 3.58 (2H, ABq, J = 17.6 Hz), 4.00 (2H, 'H-NMR (CDC1) δ 1.52 (9H, s), 3.50 and 3.58 (2H, ABq, J = 17.6 Hz), 4.00 (2H,
3 Three
d, J = 6.9 Hz), 5.13 (1H, d, J = 4.9 Hz), 5.64 and 5.71 (2H, ABq, J = 15.3 Hz), 5.9 2 - 6.02 (2H, m), 6.88 (1H, d, J = 15.6 Hz), 7.01 (1H, s), 7.25 - 7.46 (12H, m), 7.6 9 (1H, d, J = 3.4 Hz), 9.59 (1H, d, J = 8.1 Hz). d, J = 6.9 Hz), 5.13 (1H, d, J = 4.9 Hz), 5.64 and 5.71 (2H, ABq, J = 15.3 Hz), 5.9 2-6.02 (2H, m), 6.88 (1H, d, J = 15.6 Hz), 7.01 (1H, s), 7.25-7.46 (12H, m), 7.6 9 (1H, d, J = 3.4 Hz), 9.59 (1H, d, J = 8.1 Hz).
[0124] (5) 114+96→115 [0124] (5) 114 + 96 → 115
化合物 114(857 mg)と化合物 96(372 mg)を用いて実施例 79の (3)と同様の方法で化 合物 115(408mg,収率 50%)を得た。 Compound 115 (408 mg, yield 50%) was obtained in the same manner as in Example 79, (3), using Compound 114 (857 mg) and Compound 96 (372 mg).
'H-NMR (D O) δ: 3.57 (2H, brs), 5.20 (1H, d, J = 4.8 Hz), 5.25 (2H, d, J = 6.6 Hz 'H-NMR (D O) δ: 3.57 (2H, brs), 5.20 (1H, d, J = 4.8 Hz), 5.25 (2H, d, J = 6.6 Hz
2 2
), 5.47 (2H, s), 5.76 (1H, d, J = 4.8 Hz), 6.06 (1H, dt, J = 6.6, 15.6 Hz), 6.95 (1H, s), 6.98 (1H, d, J = 15.6 Hz), 7.57 (1H, d, J = 3.3 Hz), 7.75 (1H, d, J = 3.3 Hz), 8.4 ), 5.47 (2H, s), 5.76 (1H, d, J = 4.8 Hz), 6.06 (1H, dt, J = 6.6, 15.6 Hz), 6.95 (1H, s), 6.98 (1H, d, J = 15.6 Hz), 7.57 (1H, d, J = 3.3 Hz), 7.75 (1H, d, J = 3.3 Hz), 8.4
2 (2H, d, J = 7.2 Hz), 8.59 (1H, s), 8.77 (2H, d, J = 7.2 Hz). 2 (2H, d, J = 7.2 Hz), 8.59 (1H, s), 8.77 (2H, d, J = 7.2 Hz).
IR (KBr) cm"1: 3408, 1764, 1635, 1533, 1488, 1458, 1366, 1293, 1200, 1153, 1110,IR (KBr) cm " 1 : 3408, 1764, 1635, 1533, 1488, 1458, 1366, 1293, 1200, 1153, 1110,
1064, 1023, 1001. 1064, 1023, 1001.
MS(ESI): 711+ (M -Na + 2H)+ MS (ESI): 711 + (M -Na + 2H) +
元素分析 C H N NaO S - 5.0 H O Elemental analysis C H N NaO S-5.0 H O
28 21 8 7 4 2 28 21 8 7 4 2
計算値: C,40.87; Η,3·80; Ν, 13.62; S, 15.59; Na,2.79 (%) Calculated value: C, 40.87; Η, 3.80; Ν, 13.62; S, 15.59; Na, 2.79 (%)
実験値: C40.79; H,3.64; N, 13.71; S, 15.59; Na,2.94 (%) Experimental value: C40.79; H, 3.64; N, 13.71; S, 15.59; Na, 2.94 (%)
実施例 101 Example 101
[0125] [化 146]
[0125] [Chemical 146]
(1)化合物 117(721 mg)と化合物 57(169 mg)を用いて実施例 79の (3)と同様の方法で 化合物 118(127mg,収率 18%)を得た。 (1) Compound 118 (127 mg, 18% yield) was obtained in the same manner as in Example 79, (3), using Compound 117 (721 mg) and Compound 57 (169 mg).
'H-NMR (D O) δ: 1.05 (3H, t, J = 7.5 Hz), 2.23 (2H, m), 3.64 (2H, s), 5.26 (1H, d 'H-NMR (D O) δ: 1.05 (3H, t, J = 7.5 Hz), 2.23 (2H, m), 3.64 (2H, s), 5.26 (1H, d
, J = 4.8 Hz), 5.34 (2H, d, J = 7.2 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.09 (1H, dt, J = 7. 2, 15.9 Hz), 6.35 (1H, d, J = 8.1 Hz), 6.48 (1H, s), 6.96 (1H, d, J = 15.9 Hz), 8.37 ( 2H, d, J = 6.9 Hz), 8.91 (2H, d, J = 6.9 Hz). , J = 4.8 Hz), 5.34 (2H, d, J = 7.2 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.09 (1H, dt, J = 7.2, 15.9 Hz), 6.35 (1H , d, J = 8.1 Hz), 6.48 (1H, s), 6.96 (1H, d, J = 15.9 Hz), 8.37 (2H, d, J = 6.9 Hz), 8.91 (2H, d, J = 6.9 Hz) ).
IR (KBr) cm"1: 3418, 3056, 2967, 2160, 1761, 1607, 1562, 1528, 1456, 1368, 1145, 1063, 1003. IR (KBr) cm " 1 : 3418, 3056, 2967, 2160, 1761, 1607, 1562, 1528, 1456, 1368, 1145, 1063, 1003.
MS(ESI): 588+ (M + H)+ MS (ESI): 588 + (M + H) +
元素分析 C H N NaO S - 3.7 H O - 0.4 NaHCO Elemental analysis C H N NaO S-3.7 H O-0.4 NaHCO
計算値: C,44.35; H,4.37; N, 14.25; S,9.32; Na,4.68 (%) Calculated values: C, 44.35; H, 4.37; N, 14.25; S, 9.32; Na, 4.68 (%)
実験値: C,44.35; Η,4· 16; Ν, 14.08; S,9.53; Na,5.01 (%) Experimental value: C, 44.35; Η, 4.16; Ν, 14.08; S, 9.53; Na, 5.01 (%)
実施例 103 Example 103
[化 148]
[Chemical 148]
(1) 125→126 (1) 125 → 126
化合物 125(589 mg, 3.0 mmol)のメタノーノレ (3.0 mL)溶液にシァナミド (126 mg, 3.0 m mol)を加え氷冷し、 IN NaOMe(3.0 mL)を滴下した。室温まで昇温後、同温にて 2時 間撹拌しメタノールを減圧留去した。水 (6 mL)をカ卩えて氷冷し 5N塩酸、 1N塩酸を用 いて pHを 3.5付近に調整した。析出した沈殿を濾取し、五酸化リンを用いて減圧乾燥 して化合物 126(535 mg,収率 93%)を淡黄色固体として得た。 Cyanamide (126 mg, 3.0 mmol) was added to a methanol (3.0 mL) solution of compound 125 (589 mg, 3.0 mmol), and the mixture was ice-cooled, and IN NaOMe (3.0 mL) was added dropwise. After raising the temperature to room temperature, the mixture was stirred at the same temperature for 2 hours, and methanol was distilled off under reduced pressure. Water (6 mL) was added and ice-cooled, and the pH was adjusted to around 3.5 using 5N hydrochloric acid and 1N hydrochloric acid. The deposited precipitate was collected by filtration and dried under reduced pressure using phosphorus pentoxide to obtain Compound 126 (535 mg, yield 93%) as a pale yellow solid.
H-NMR (d -DMSO) δ 7.76 (1H, s), 8.08 (1H, s), 9.74 (1H, s). H-NMR (d-DMSO) δ 7.76 (1H, s), 8.08 (1H, s), 9.74 (1H, s).
(2) 46→127 (2) 46 → 127
化合物 46(803 mg)と化合物 126(192 mg)を用いて、実施例 86の (4)と同様の方法で化 合物 127(195 mg,収率 33%)を得た。 Compound 127 (195 mg, 33% yield) was obtained in the same manner as in Example 86, (4), using Compound 46 (803 mg) and Compound 126 (192 mg).
'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.66 (2H, s), 4.25 (2H, q, J = 6.9 Hz), 'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.66 (2H, s), 4.25 (2H, q, J = 6.9 Hz),
5.11 (2H, d, J = 6.6 Hz), 5.40 (1H, d, J = 4.5 Hz), 5.81 (1H, d, J = 4.5 Hz), 6.09 (1 H, dt, J = 6.6, 15.9 Hz), 6.88 (1H, d, J = 15.9 Hz), 6.97 (1H, s), 7.72 (1H, d, J = 1. 5 Hz), 8.12 (1H, s), 9.69 (1H, d, J = 1.5 Hz). 5.11 (2H, d, J = 6.6 Hz), 5.40 (1H, d, J = 4.5 Hz), 5.81 (1H, d, J = 4.5 Hz), 6.09 (1 H, dt, J = 6.6, 15.9 Hz) , 6.88 (1H, d, J = 15.9 Hz), 6.97 (1H, s), 7.72 (1H, d, J = 1.5 Hz), 8.12 (1H, s), 9.69 (1H, d, J = 1.5 Hz).
IR (KBr) cm—1: 3426, 2980, 2167, 1763, 1606, 1576, 1534, 1369, 1311, 1237, 1163,IR (KBr) cm— 1 : 3426, 2980, 2167, 1763, 1606, 1576, 1534, 1369, 1311, 1237, 1163,
1111, 1092, 1036. 1111, 1092, 1036.
MS(ESI): 628+ (M + H)+ MS (ESI): 628+ (M + H) +
元素分析 C H N NaO S -4.8 H O Elemental analysis C H N NaO S -4.8 H O
計算値: C,39.16; H,4.05; N, 17.12; S, 13.07; Na,3.12 (%) Calculated values: C, 39.16; H, 4.05; N, 17.12; S, 13.07; Na, 3.12 (%)
実験値: C39.08; H,3.55; N, 17.21; S, 12.88; Na,3.30 (%) Experimental value: C39.08; H, 3.55; N, 17.21; S, 12.88; Na, 3.30 (%)
実施例 104
[化 149] Example 104 [Chemical 149]
(1) 128→130 (1) 128 → 130
化合物 128(19.9 g, 133 mmol)の DMF(40 mL)溶液を氷冷し,水素化ナトリウム (60%w/ w, 5.3g, 132 mmol)を加えた。一方、化合物 129(6.2 g, 44.2 mmol)の DMF(30 mL)溶 液は氷冷し、水素化ナトリウム (60%w/w, 1.77g, 44.2 mmol)を加え氷冷で 30分撹拌し た後、先の溶液に加えた。反応液は 130°Cに加熱し 8時間撹拌した。室温まで冷却後 、 DMFを減圧留去し、水をカ卩えて酢酸ェチルで抽出した。有機層を水、飽和食塩水 で洗浄後、無水硫酸マグネシウムで乾燥して減圧濃縮した。残渣をシリカゲルカラム クロマトグラフィーで精製し、化合物 130(1.34g,収率 14%)を淡黄色結晶として得た。 'H-NMR (CDC1 ) δ 1.44 (3H, t, J = 7.2 Hz), 4.46 (2H, q, J = 7.2 Hz), 7.05 (1H, d A solution of compound 128 (19.9 g, 133 mmol) in DMF (40 mL) was ice-cooled, and sodium hydride (60% w / w, 5.3 g, 132 mmol) was added. On the other hand, a DMF (30 mL) solution of Compound 129 (6.2 g, 44.2 mmol) was ice-cooled, sodium hydride (60% w / w, 1.77 g, 44.2 mmol) was added, and the mixture was stirred with ice-cooling for 30 minutes. Later added to the previous solution. The reaction solution was heated to 130 ° C and stirred for 8 hours. After cooling to room temperature, DMF was distilled off under reduced pressure, and water was collected and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain compound 130 (1.34 g, yield 14%) as pale yellow crystals. 'H-NMR (CDC1) δ 1.44 (3H, t, J = 7.2 Hz), 4.46 (2H, q, J = 7.2 Hz), 7.05 (1H, d
, J = 2.7 Hz), 7.76 (2H, dd, J = 1.5, 4.5 Hz), 8.72 (2H, d, J = 2.7 Hz), 8.72 (1H, d, J = 5.4 Hz). , J = 2.7 Hz), 7.76 (2H, dd, J = 1.5, 4.5 Hz), 8.72 (2H, d, J = 2.7 Hz), 8.72 (1H, d, J = 5.4 Hz).
(2) 130→131 (2) 130 → 131
実施例 74の (1)と同様の方法で化合物 130(1.34 g)から化合物 131(1.36 g,収率 99%) を得た。 Compound 131 (1.36 g, yield 99%) was obtained from compound 130 (1.34 g) in the same manner as in Example 74, (1).
H-NMR (d -DMSO) δ 7.03 (1H, d, J = 2.7 Hz), 7.94 (2H, dd, J = 1.8, 4.8 Hz), 8.7 H-NMR (d-DMSO) δ 7.03 (1H, d, J = 2.7 Hz), 7.94 (2H, dd, J = 1.8, 4.8 Hz), 8.7
6 (2H, dd, J = 1.8, 4.8 Hz), 8.81 (1H, d, J = 2.7 Hz). 6 (2H, dd, J = 1.8, 4.8 Hz), 8.81 (1H, d, J = 2.7 Hz).
(3) 131→132 (3) 131 → 132
実施例 74の (2)と同様の方法で行い、化合物 131(1.36 g)から化合物 132(1.50 g,収
率 98%)を得た。 In the same manner as in Example 74, (2), compound 131 (1.36 g) to compound 132 (1.50 g, yield) Rate 98%).
H-NMR (d -DMSO) δ 7.17 (1Η, d, J = 2.7 Hz), 8.05 (2H, dd, J = 1.5, 4.8 Hz), 8.7 H-NMR (d-DMSO) δ 7.17 (1Η, d, J = 2.7 Hz), 8.05 (2H, dd, J = 1.5, 4.8 Hz), 8.7
6 6
8 (2H, dd, J = 1.8, 4.8 Hz), 8.90 (1H, d, J = 2.7 Hz). 8 (2H, dd, J = 1.8, 4.8 Hz), 8.90 (1H, d, J = 2.7 Hz).
(4) 46→133 (4) 46 → 133
化合物 46(803 mg)と化合物 132(213 mg)を用いて、実施例 86の (4)と同様の方法で 化合物 133(215 mg,収率 27%)を得た。 Compound 133 (215 mg, 27% yield) was obtained in the same manner as in Example 86, (4), using Compound 46 (803 mg) and Compound 132 (213 mg).
'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.67 (2H, s), 4.23 (2H, q, J = 6.9 Hz), 'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.67 (2H, s), 4.23 (2H, q, J = 6.9 Hz),
2 2
5.26 - 5.28 (3H, m), 5.81 (1H, d, J = 4.5 Hz), 6.07 - 6.17 (1H, m), 6.95 - 6.99 (3H, m), 8.31 (2H, d, J = 7.2 Hz), 8.49 (1H, d, J = 2.7 Hz), 8.85 (2H, d, J = 7.2 Hz). IR (KBr) cm—1: 3420, 2981, 2162, 1764, 1638, 1599, 1536, 1475, 1446, 1384, 1332, 1203, 1158, 1036. 5.26-5.28 (3H, m), 5.81 (1H, d, J = 4.5 Hz), 6.07-6.17 (1H, m), 6.95-6.99 (3H, m), 8.31 (2H, d, J = 7.2 Hz) , 8.49 (1H, d, J = 2.7 Hz), 8.85 (2H, d, J = 7.2 Hz). IR (KBr) cm— 1 : 3420, 2981, 2162, 1764, 1638, 1599, 1536, 1475, 1446 , 1384, 1332, 1203, 1158, 1036.
MS(ESI): 649+ (M - Na + 2H)+ MS (ESI): 649 + (M-Na + 2H) +
元素分析 C H N NaO S - 6.5 H O Elemental analysis C H N NaO S-6.5 H O
27 23 10 6 3 2 27 23 10 6 3 2
計算値: C,41.17; Η,4·61; Ν, 17.78; S,8.14; Na,2.92 (%) Calculated value: C, 41.17; Η, 4.61; Ν, 17.78; S, 8.14; Na, 2.92 (%)
実験値: C,41.04; Η,4·09; Ν, 17.77; S,8.31; Na,3.06 (%) Experimental value: C, 41.04; Η, 4.09; Ν, 17.77; S, 8.31; Na, 3.06 (%)
実施例 105 Example 105
[化 150] [Chemical 150]
(1) 134→137 (1) 134 → 137
化合物 134(1.46 g, 10 mmol)の THF(50 mL)溶液を- 70。Cに冷却し n_ブチルリ (1.58 Mへキサン溶液, 6.96 mL, 11 mmol)を滴下した。同温で 1時間撹拌後、ェチル シァノホルメート (0.87 mL, 11 mmol)を滴下し- 70°Cで 1時間撹拌後室温まで昇温した
。飽和塩化アンモニゥム水溶液 (20 mL)を加えてタエンチし、水を加え酢酸ェチルで 抽出した。有機層は無水硫酸マグネシウムで乾燥し、減圧濃縮、減圧乾燥して化合 物 135と化合物 134の混合物 (1.94 g)として得た。この残渣はそのまま次の反応に使用 した。 A solution of compound 134 (1.46 g, 10 mmol) in THF (50 mL) -70. After cooling to C, n_butyl (1.58 M hexane solution, 6.96 mL, 11 mmol) was added dropwise. After stirring at the same temperature for 1 hour, ethyl cyanoformate (0.87 mL, 11 mmol) was added dropwise, and the mixture was stirred at -70 ° C for 1 hour and then warmed to room temperature. . Saturated aqueous ammonium chloride solution (20 mL) was added to the mixture, water was added, and the mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate, concentrated under reduced pressure, and dried under reduced pressure to obtain a mixture (1.94 g) of Compound 135 and Compound 134. This residue was used as such for the next reaction.
この混合物をメタノール (20 mL)に溶かして、氷冷下 2N NaOH水溶液 (9.5 mL)をカロ えて、 1.5時間撹拌した。 5N塩酸をカ卩えて中和した。メタノールを減圧留去して氷冷下 、 1N塩酸で pHを 3.5付近に調整した。析出した沈殿を濾取し減圧乾燥して化合物 136 と化合物 134の混合物 (1.25 g)として得た。 This mixture was dissolved in methanol (20 mL), and 2N NaOH aqueous solution (9.5 mL) was added under ice-cooling and stirred for 1.5 hours. 5N hydrochloric acid was added to neutralize. Methanol was distilled off under reduced pressure, and the pH was adjusted to around 3.5 with 1N hydrochloric acid under ice cooling. The deposited precipitate was collected by filtration and dried under reduced pressure to obtain a mixture (1.25 g) of Compound 136 and Compound 134.
この混合物の DMF(15 mL)懸濁液にカルボニルジイミダゾール (1.59 g, 9.86 mmol) を加えて終夜で撹拌した。シアナミド (690 mg, 16.4 mmol)の DMF(10 mL)溶液に氷冷 撹拌下水素化ナトリウム (60%w/w, 526 mg, 13.1 mmol)を加え同温で 30分撹拌した。こ の溶液を先の反応液に氷冷下加え、室温まで昇温して 2時間撹拌した。 DMFを減圧 留去し水 (20 mL)をカ卩ぇ 1N塩酸を用いて pHを 3.5付近に調整した。析出した沈殿を濾 取し五酸化リンを用いて減圧乾燥しィヒ合物 137(1.19 g, 134より収率 56%)を黄土色粉 末として得た。 Carbonyldiimidazole (1.59 g, 9.86 mmol) was added to a DMF (15 mL) suspension of this mixture, and the mixture was stirred overnight. Sodium hydride (60% w / w, 526 mg, 13.1 mmol) was added to a DMF (10 mL) solution of cyanamide (690 mg, 16.4 mmol) under ice-cooling and stirring, and the mixture was stirred at the same temperature for 30 min. This solution was added to the previous reaction solution under ice cooling, and the mixture was warmed to room temperature and stirred for 2 hours. DMF was distilled off under reduced pressure, water (20 mL) was added, and the pH was adjusted to around 3.5 using 1N hydrochloric acid. The deposited precipitate was collected by filtration and dried under reduced pressure using phosphorous pentoxide to obtain a compound 137 (1.19 g, yield 56% from 134) as an ocher powder.
H-NMR (d -DMSO) δ 8.04 (2Η, d, J = 6.6 Hz), 8.27 (1H, s), 8.83 (2H, d, J = 6.6 H-NMR (d-DMSO) δ 8.04 (2Η, d, J = 6.6 Hz), 8.27 (1H, s), 8.83 (2H, d, J = 6.6
Hz). Hz).
(2) 137→138 (2) 137 → 138
化合物 46(803 mg)と化合物 137(214 mg)を用いて、実施例 86の (4)と同様の方法で 化合物 138(246 mg,収率 31%)を得た。 Compound 138 (246 mg, yield 31%) was obtained in the same manner as in Example 86, (4), using Compound 46 (803 mg) and Compound 137 (214 mg).
H-NMR (D O) δ: 1.28 (3H, t, J = 7.2 Hz), 3.66 (2H, s), 4.22 (1H, d, J = 7.2 Hz), H-NMR (D O) δ: 1.28 (3H, t, J = 7.2 Hz), 3.66 (2H, s), 4.22 (1H, d, J = 7.2 Hz),
5.26 (1H, d, J = 4.8 Hz), 5.29 (2H, d, J = 6.9 Hz), 5.79 (1H, d, J = 4.8 Hz), 6.10 (1 H, dt, J = 6.9, 15.6 Hz), 6.92 (1H, s), 6.98 (1H, d, J = 15.6 Hz), 8.17 (1H, s), 8.29 (2H, d, J = 6.9 Hz), 8.85 (2H, d, J = 6.9 Hz). 5.26 (1H, d, J = 4.8 Hz), 5.29 (2H, d, J = 6.9 Hz), 5.79 (1H, d, J = 4.8 Hz), 6.10 (1 H, dt, J = 6.9, 15.6 Hz) , 6.92 (1H, s), 6.98 (1H, d, J = 15.6 Hz), 8.17 (1H, s), 8.29 (2H, d, J = 6.9 Hz), 8.85 (2H, d, J = 6.9 Hz) .
IR (KBr) cm—1: 3424, 2981, 2169, 1764, 1637, 1607, 1531, 1496, 1463, 1382, 1334,IR (KBr) cm— 1 : 3424, 2981, 2169, 1764, 1637, 1607, 1531, 1496, 1463, 1382, 1334,
1291, 1201, 1146, 1035,. 1291, 1201, 1146, 1035,.
MS(ESI): 650+ (M - Na + 2H)+ MS (ESI): 650+ (M-Na + 2H) +
元素分析 C H N NaO S - 6.1 H O
計算値: C,41.49; Η,4·41; Ν, 16.13; S,8.21; Na,2.94 (%) Elemental analysis CHN NaO S-6.1 HO Calculated value: C, 41.49; Η, 4.41; Ν, 16.13; S, 8.21; Na, 2.94 (%)
実験値: C,41.38; Η,4·86; Ν, 16.35; S,8.21; Na,3.08 (%) Experimental value: C, 41.38; Η, 4.86; Ν, 16.35; S, 8.21; Na, 3.08 (%)
実施例 107 Example 107
[0130] [化 152] [0130] [Chemical 152]
(1) 144→146 (1) 144 → 146
化合物 144(986 mg)と化合物 104(372 mg)を用いて、実施例 79の (3)と同様の方法で 化合物 146(172 mg,収率 19%)を得た。 Compound 146 (172 mg, 19% yield) was obtained in the same manner as in Example 79, (3), using Compound 144 (986 mg) and Compound 104 (372 mg).
'H-NMR (D O) δ: 3.59 and 3.66 (2H, ABq, J = 17.7 Hz), 5.10 (2H, s), 5.21 (1H, d, 'H-NMR (D 2 O) δ: 3.59 and 3.66 (2H, ABq, J = 17.7 Hz), 5.10 (2H, s), 5.21 (1H, d,
2 2
J = 4.8 Hz), 5.31 (2H, d, J = 6.6 Hz), 5.78 (1H, d, J = 4.8 Hz), 5.82 (1H, s), 6.13 ( 1H, dt, J = 6.6, 15.9 Hz), 6.97 (1H, d, J = 15.9 Hz), 7.01 (1H, s), 8.39 (1H, s), 8.52 (2H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 Hz). J = 4.8 Hz), 5.31 (2H, d, J = 6.6 Hz), 5.78 (1H, d, J = 4.8 Hz), 5.82 (1H, s), 6.13 (1H, dt, J = 6.6, 15.9 Hz) , 6.97 (1H, d, J = 15.9 Hz), 7.01 (1H, s), 8.39 (1H, s), 8.52 (2H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 Hz) .
IR (KBr) cm—1: 3419, 1762, 1631, 1522, 1468, 1359, 1295, 1200, 1156, 1062, 1011. MS(ESI): 711+ (M + H)+ IR (KBr) cm— 1 : 3419, 1762, 1631, 1522, 1468, 1359, 1295, 1200, 1156, 1062, 1011. MS (ESI): 711 + (M + H) +
元素分析 c H N Na O S - 5.8 H O - 0.3 NaHCO Elemental analysis c H N Na O S-5.8 H O-0.3 NaHCO
28 20 8 2 9 3 2 3 28 20 8 2 9 3 2 3
計算値: C,38.43; Η,3·64; Ν, 12.67; S, 10.88; Na,5.98 (%) Calculated value: C, 38.43; Η, 3.64; Ν, 12.67; S, 10.88; Na, 5.98 (%)
実験値: C,38.61; Η,3·51; Ν, 12.85; S, 10.58; Na,6.19 (%) Experimental value: C, 38.61; Η, 3 · 51; Ν, 12.85; S, 10.58; Na, 6.19 (%)
実施例 108 Example 108
[0131] [化 153] [0131] [Chemical 153]
147 147
(1) 144→147
化合物 144(986 mg)と化合物 27(226 mg)を用いて、実施例 79の (3)と同様の方法で 化合物 147(394 mg,収率 43%)を得た。 (1) 144 → 147 Compound 147 (394 mg, yield 43%) was obtained in the same manner as in Example 79, (3), using Compound 144 (986 mg) and Compound 27 (226 mg).
'H-NMR (D O) δ: 3.59 and 3.66 (2H, ABq, J = 17.4 Hz), 5.09 (2H, s), 5.20 (1H, d, 'H-NMR (D O) δ: 3.59 and 3.66 (2H, ABq, J = 17.4 Hz), 5.09 (2H, s), 5.20 (1H, d,
2 2
J = 4.8 Hz), 5.47 (2H, d, J = 6.6 Hz), 5.78 (1H, d, J = 4.8 Hz), 5.81 (1H, s), 6.18 ( 1H, dt, J = 6.6, 15.9 Hz), 6.98 - 7.03 (2H, m), 8.67 (1H, d, J = 6.6 Hz), 8.72 (1H, d , J = 6.6 Hz), 9.72 (1H, s). J = 4.8 Hz), 5.47 (2H, d, J = 6.6 Hz), 5.78 (1H, d, J = 4.8 Hz), 5.81 (1H, s), 6.18 (1H, dt, J = 6.6, 15.9 Hz) , 6.98-7.03 (2H, m), 8.67 (1H, d, J = 6.6 Hz), 8.72 (1H, d, J = 6.6 Hz), 9.72 (1H, s).
IR (KBr) cm—1: 3419, 2182, 1763, 1610, 1510, 1363, 1120, 1028, 1001. IR (KBr) cm— 1 : 3419, 2182, 1763, 1610, 1510, 1363, 1120, 1028, 1001.
MS(ESI): 709+ (M + H)+ MS (ESI): 709 + (M + H) +
元素分析 C H N Na O S - 9.0 H O - 0.1 NaHCO Elemental analysis C H N Na O S-9.0 H O-0.1 NaHCO
27 18 10 2 8 3 2 3 27 18 10 2 8 3 2 3
計算値: C,35.26; H,3.94; N, 15.17; S, 10.42; Na,5.23 (%) Calculated values: C, 35.26; H, 3.94; N, 15.17; S, 10.42; Na, 5.23 (%)
実験値: C, 34.99; H,3.13; N, 15.08; S, 10.17; Na,5.38 (%) Experimental values: C, 34.99; H, 3.13; N, 15.08; S, 10.17; Na, 5.38 (%)
実施例 109 Example 109
[化 154] [Chemical 154]
(1) 148→149 (1) 148 → 149
化合物 148(2.07 g, 10 mmol)の THF(20 mL)溶液にジフヱニルジァゾメタン (2.33 g, 1 2 mmol)を加え室温で 30分撹拌した。ジフエニルジァゾメタン (388 mg)を追加しさらに 1時間撹拌した。 THFを減圧留去しへキサンを加えて析出物を濾取、減圧乾燥し、化 合物 149(790 mg,収率 21%)を得た。さらに濾液を濃縮し残渣をシリカゲルカラムクロマ トグラフィ一で精製し化合物 149(合計 2.95 g,収率 79%)を得た。 Diphenyldiazomethane (2.33 g, 12 mmol) was added to a THF (20 mL) solution of compound 148 (2.07 g, 10 mmol), and the mixture was stirred at room temperature for 30 minutes. Diphenyl diazomethane (388 mg) was added, and the mixture was further stirred for 1 hr. THF was distilled off under reduced pressure, hexane was added, and the precipitate was collected by filtration and dried under reduced pressure to obtain Compound 149 (790 mg, yield 21%). The filtrate was further concentrated, and the residue was purified by silica gel column chromatography to obtain compound 149 (total 2.95 g, yield 79%).
'H-NMR (CDC1 ) δ: 7.03 (1H, s), 7.09 (1H, d, J = 3.9 Hz), 7.29 - 7.41 (10H, m), 'H-NMR (CDC1) δ: 7.03 (1H, s), 7.09 (1H, d, J = 3.9 Hz), 7.29-7.41 (10H, m),
3 Three
7.62 (1H, d, J = 3.9 Hz). 7.62 (1H, d, J = 3.9 Hz).
(2) 149→150
化合物 149(1.87 g, 5.0 mmol)のトルエン (50 mL)溶液に、 4_アミノビリジン (565 mg, 6 .0 mmol), BINAP(311 mg, 0.5 mmol),炭酸セシウム (2.28 g, 7.0 mmol)を加えた。脱 気、窒素置換の後、酢酸パラジウム (IIX112 mg, 0.5 mmol)を加えて 110°Cで 15時間撹 拌した。室温まで冷却後セライトを通してろ過し、濾液を減圧濃縮して得られた残渣 をシリカゲルカラムクロマトグラフィーで精製した。化合物 150(291 mg,収率 15%)を与 えた。 (2) 149 → 150 To a solution of compound 149 (1.87 g, 5.0 mmol) in toluene (50 mL), 4_aminoviridine (565 mg, 6.0 mmol), BINAP (311 mg, 0.5 mmol), cesium carbonate (2.28 g, 7.0 mmol) Was added. After deaeration and substitution with nitrogen, palladium acetate (IIX112 mg, 0.5 mmol) was added and the mixture was stirred at 110 ° C for 15 hours. After cooling to room temperature, the mixture was filtered through celite. The filtrate was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography. Compound 150 (291 mg, yield 15%) was given.
'H-NMR (CDC1 ) δ 7.03 - 7.46 (15H, m), 7.62 (1H, d, J = 4.2 Hz). 'H-NMR (CDC1) δ 7.03-7.46 (15H, m), 7.62 (1H, d, J = 4.2 Hz).
3 Three
(3) 150→151 (3) 150 → 151
化合物 46(605 mg)と化合物 150(291 mg)を用いて、実施例 79の (3)と同様の方法で 化合物 151(350 mg,収率 62%)を得た。 Compound 151 (350 mg, 62% yield) was obtained in the same manner as in Example 79, (3), using Compound 46 (605 mg) and Compound 150 (291 mg).
'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.63 (2H, s), 4.25 (2H, q, J = 6.9 Hz), 'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.63 (2H, s), 4.25 (2H, q, J = 6.9 Hz),
2 2
4.91 (2H, d, J = 6.3 Hz), 5.24 (1H, d, J = 4.8 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.03 (1 H, dt, J = 6.9, 15.9 Hz), 6.79 (1H, d, J = 15.9 Hz), 6.97 (1H, m), 7.18 (2H, d, J = 7. 2 Hz), 7.45 (1H, d, J = 3.9 Hz), 8.15 (2H, d, J = 7.2 Hz). 4.91 (2H, d, J = 6.3 Hz), 5.24 (1H, d, J = 4.8 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.03 (1 H, dt, J = 6.9, 15.9 Hz) , 6.79 (1H, d, J = 15.9 Hz), 6.97 (1H, m), 7.18 (2H, d, J = 7.2 Hz), 7.45 (1H, d, J = 3.9 Hz), 8.15 (2H, d, J = 7.2 Hz).
IR (KBr) cm"1: 3409, 2978, 1763, 1645, 1602, 1528, 1461, 1361, 1209, 1167, 1034"IR (KBr) cm " 1 : 3409, 2978, 1763, 1645, 1602, 1528, 1461, 1361, 1209, 1167, 1034"
MS(ESI): 656+ (M - Na + 2H)+ MS (ESI): 656+ (M-Na + 2H) +
元素分析 C H N NaO S -4.1 H O Elemental analysis C H N NaO S -4.1 H O
27 24 7 7 3 2 27 24 7 7 3 2
計算値: C,43.15; H,4.32; N, 13.05; S, 12.80; Na,3.06 (%) Calculated values: C, 43.15; H, 4.32; N, 13.05; S, 12.80; Na, 3.06 (%)
実験値: C,43.16; H,4.25; N, 13.11; S, 12.71; Na,3.21 (%) Experimental value: C, 43.16; H, 4.25; N, 13.11; S, 12.71; Na, 3.21 (%)
実施例 110 Example 110
[化 155] [Chemical 155]
(1) 152→153
チォゥレア体 152(2.30 g, 15 mmol)のエタノール (30 mL)溶液にブロモピルビン酸ェ チルエステル (90%w/w, 2.92 mL, 16.5 mmol)を加え 1.5時間還流した。エタノールを減 圧留去し、ジェチルエーテルを加えて析出してくる沈殿を濾取し、減圧乾燥して化合 物 153(3.83 g,収率 77%)を得た。 (1) 152 → 153 Bromopyruvate ethyl ester (90% w / w, 2.92 mL, 16.5 mmol) was added to a solution of thiourea 152 (2.30 g, 15 mmol) in ethanol (30 mL) and refluxed for 1.5 hours. Ethanol was distilled off under reduced pressure, and the resulting precipitate was collected by filtration and collected by filtration and dried under reduced pressure to obtain Compound 153 (3.83 g, yield 77%).
H-NMR (d -DMSO) δ 1.30 (3Η, t, J = 7.2 Hz), 4.32 (2H, q, J = 7.2 Hz), 8.05 (2H H-NMR (d -DMSO) δ 1.30 (3Η, t, J = 7.2 Hz), 4.32 (2H, q, J = 7.2 Hz), 8.05 (2H
, brs), 8.18 (1H, s), 8.66 (2H, d, J = 7.2 Hz), 12.1 (1H, brs). , Brs), 8.18 (1H, s), 8.66 (2H, d, J = 7.2 Hz), 12.1 (1H, brs).
(2) 153→154 (2) 153 → 154
実施例 74の (1)と同様の方法で化合物 153(3.83 g)から化合物 154(2.58 g,収率 100 In the same manner as in Example 74, (1), compound 153 (3.83 g) to compound 154 (2.58 g, yield 100)
%)を得た。 %).
H-NMR (d -DMSO) δ 7.62 (2Η, dd, J = 1.5, 4.8 Hz), 8.40 (2H, dd, J = 1.5, 4.8 H z). H-NMR (d-DMSO) δ 7.62 (2Η, dd, J = 1.5, 4.8 Hz), 8.40 (2H, dd, J = 1.5, 4.8 H z).
(3) 154→155 (3) 154 → 155
化合物 154(1.11 g, 5.0 mmol)の DMF(10 mL)溶液にカルボニルジイミダゾール (973 mg, 6.0 mmol)を加え室温で 2時間撹拌した。カルボニルジイミダゾール (639 mg)を追 加しさらに 1時間撹拌した。 t-ブタノール (2.4 mL)、 KOBu (56 mg)を加えて室温で 1時 間撹拌後さらに ΚΟΒι (560 mg)を追加した。 30分間撹拌の後、飽和塩化アンモニゥム をカ卩ぇ酢酸ェチルで抽出した。有機層を水、飽和食塩水で洗浄し、無水硫酸マグネ シゥムで乾燥後、減圧濃縮して得られた析出物をへキサンと酢酸ェチルを用いて濾 取した。減圧乾燥の後、化合物 155(258 mg,収率 19%)を得た。 Carbonyldiimidazole (973 mg, 6.0 mmol) was added to a DMF (10 mL) solution of compound 154 (1.11 g, 5.0 mmol), and the mixture was stirred at room temperature for 2 hours. Carbonyldiimidazole (639 mg) was added, and the mixture was further stirred for 1 hr. t-Butanol (2.4 mL) and KOBu (56 mg) were added, and the mixture was stirred at room temperature for 1 hour, and further ΚΟΒι (560 mg) was added. After stirring for 30 minutes, saturated ammonium chloride was extracted with ketyl acetate. The organic layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure, and the resulting precipitate was collected by filtration using hexane and ethyl acetate. After drying under reduced pressure, Compound 155 (258 mg, yield 19%) was obtained.
H-NMR (CDC1 ) δ 1.60 (9Η, s), 7.49 (2H, d, J = 6.6 Hz), 7.60 (1H, s), 8.42 (1H, d, J = 6.6 Hz). H-NMR (CDC1) δ 1.60 (9Η, s), 7.49 (2H, d, J = 6.6 Hz), 7.60 (1H, s), 8.42 (1H, d, J = 6.6 Hz).
(4) 46→156 (4) 46 → 156
化合物 46(746 mg)と化合物 155(258 mg)を用いて、実施例 79の (3)と同様の方法で 化合物 156(101 mg,収率 13%)を得た。 Compound 156 (101 mg, 13% yield) was obtained in the same manner as in Example 79, (3), using Compound 46 (746 mg) and Compound 155 (258 mg).
'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.65 (2H, brs), 4.24 (2H, q, J = 6.9 Hz) 'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9 Hz), 3.65 (2H, brs), 4.24 (2H, q, J = 6.9 Hz)
, 5.02 (2H, d, J = 6.9 Hz), 5.25 (1H, d, J = 4.5 Hz), 5.81 (1H, d, J = 4.5 Hz), 6.07 ( 1H, dt, J = 6.9, 15.9 Hz), 6.84 (1H, d, J = 15.9 Hz), 6.97 (1H, s), 7.70 (1H, s), 7.97 (2H, brs), 8.37 (2H, d, J = 7.8 Hz).
IR (KBr) cm : 3417, 2979, 1763, 1642, 1604, 1517, 1440, 1385, 1281, 1177, 1118 1037,. , 5.02 (2H, d, J = 6.9 Hz), 5.25 (1H, d, J = 4.5 Hz), 5.81 (1H, d, J = 4.5 Hz), 6.07 (1H, dt, J = 6.9, 15.9 Hz) , 6.84 (1H, d, J = 15.9 Hz), 6.97 (1H, s), 7.70 (1H, s), 7.97 (2H, brs), 8.37 (2H, d, J = 7.8 Hz). IR (KBr) cm: 3417, 2979, 1763, 1642, 1604, 1517, 1440, 1385, 1281, 1177, 1118 1037,.
MS(ESI): 657+ (M - Na + 2H)+ MS (ESI): 657 + (M-Na + 2H) +
元素分析 C H N NaO S - 7.0 H O Elemental analysis C H N NaO S-7.0 H O
計算値: C,38.80; Η,4·63; Ν,13·92; S,11.95; Na,2.86 (%) Calculated value: C, 38.80; Η, 4.63; Ν, 13.92; S, 11.95; Na, 2.86 (%)
実験値: C38.68; Η,3·94; Ν,13·85; S,12.03; Na,2.95 (%) Experimental value: C38.68; Η, 3.94; Ν, 13.85; S, 12.03; Na, 2.95 (%)
実施例 111 Example 111
[化 156] [Chemical 156]
,NH2 OH , NH 2 OH
HO H HO H
NH2 0 - 、f N NH 2 0-, f N
157 158 159 160 157 158 159 160
(1) 157→159 (1) 157 → 159
ジァミノピリジン 157(20.23 g, 185 mmol)とグリコール酸 (31g, 407 mmol)を混合し 150 °Cで 64時間撹拌した。室温まで冷却後、重曹水を加えて CHC1 -MeOH-THF(10:l:2) の混合液で洗浄してた水層は減圧下濃縮乾固した.残渣に水を加えて不溶性の結 晶を濾取し、減圧乾燥して化合物 159(19.2 g,収率 70%)を得た。 Diaminopyridine 157 (20.23 g, 185 mmol) and glycolic acid (31 g, 407 mmol) were mixed and stirred at 150 ° C. for 64 hours. After cooling to room temperature, the aqueous layer washed with a mixture of sodium bicarbonate and CHC1-MeOH-THF (10: l: 2) was concentrated to dryness under reduced pressure. Was collected by filtration and dried under reduced pressure to obtain Compound 159 (19.2 g, yield 70%).
H-NMR (d -DMSO) δ 4.71 (2Η, s), 7.17 (1H, dd, J = 4.2, 7.2 Hz), 7.88 (1H, dd, J H-NMR (d-DMSO) δ 4.71 (2Η, s), 7.17 (1H, dd, J = 4.2, 7.2 Hz), 7.88 (1H, dd, J
= 1.5, 7.2 Hz), 8.27 (1H, dd, J = 1.5, 4.2 Hz). = 1.5, 7.2 Hz), 8.27 (1H, dd, J = 1.5, 4.2 Hz).
(2) 159→160 (2) 159 → 160
過マンガン酸カリウム (9 g)の水 (190 mL)溶液を沸騰させ、この溶液に化合物 159(5 g )と炭酸ナトリウム (3.8 g)の沸騰水 (120 mL)溶液をカ卩えた。 5時間還流後 60°Cまで冷却 しセライトを通して濾過した。濾液に濃塩酸を加えて pH2とし、析出物を濾取、減圧乾
燥して化合物 160(3.49 g,収率 64%)を得た。 A solution of potassium permanganate (9 g) in water (190 mL) was boiled, and a solution of compound 159 (5 g) and sodium carbonate (3.8 g) in boiling water (120 mL) was added to this solution. After refluxing for 5 hours, the mixture was cooled to 60 ° C and filtered through celite. Concentrated hydrochloric acid is added to the filtrate to pH 2. The precipitate is collected by filtration and dried under reduced pressure. Drying gave compound 160 (3.49 g, yield 64%).
H-NMR (d -DMSO) δ 7.37 (1H, dd, J = 4.8, 8.1 Hz), 8.10 (1H, d, J = 8.1 Hz), 8.5 H-NMR (d-DMSO) δ 7.37 (1H, dd, J = 4.8, 8.1 Hz), 8.10 (1H, d, J = 8.1 Hz), 8.5
6 6
2 (1H, d, J = 4.8 Hz). 2 (1H, d, J = 4.8 Hz).
(3) 160→161 (3) 160 → 161
実施例 74の (1)と同様の方法で行レ、、化合物 160(1.63 g)力 化合物 161(2.03 g,収 率 100%)を得た。 In the same manner as in (1) of Example 74, Compound 160 (1.63 g) strength Compound 161 (2.03 g, yield 100%) was obtained.
H-NMR (d -DMSO) δ 7.57 (1H, dd, J = 4.8, 8.1 Hz), 8.17 (1H, d, J = 8.1 Hz), 8.6 H-NMR (d-DMSO) δ 7.57 (1H, dd, J = 4.8, 8.1 Hz), 8.17 (1H, d, J = 8.1 Hz), 8.6
6 6
4 (1H, d, J = 4.8 Hz). 4 (1H, d, J = 4.8 Hz).
(4) 161→162 (4) 161 → 162
化合物 161(2.18g, 11.6 mmol)のメタノーノレ (100 mL)懸濁液に 1.0 M NaOMe/MeOH (11 mL)を室温滴下しメタノールを減圧濃縮した。化合物 162(2.2 g,収率 95%)を得た。 H-NMR (d -DMSO) δ 7.21 (1H, dd, J = 4.5, 7.8 Hz), 7.89 (1H, brs Hz), 8.35 (1H 1.0 M NaOMe / MeOH (11 mL) was added dropwise to a methanol (100 mL) suspension of compound 161 (2.18 g, 11.6 mmol) at room temperature, and methanol was concentrated under reduced pressure. Compound 162 (2.2 g, yield 95%) was obtained. H-NMR (d-DMSO) δ 7.21 (1H, dd, J = 4.5, 7.8 Hz), 7.89 (1H, brs Hz), 8.35 (1H
6 6
, d, J = 4.5Hz). , d, J = 4.5Hz).
(5) 162→163 (5) 162 → 163
化合物 46(2.28 g)と化合物 162(627 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 163(229 mg,収率 10%)を得た。 Compound 163 (229 mg, yield 10%) was obtained in the same manner as in Example 79, (3), using Compound 46 (2.28 g) and Compound 162 (627 mg).
'H-NMR (d -DMSO) δ: 1.21 (3Η, t, J = 6.9), 3.37 and 3.48 (2H, ABq, J = 16.8 Hz) 'H-NMR (d-DMSO) δ: 1.21 (3Η, t, J = 6.9), 3.37 and 3.48 (2H, ABq, J = 16.8 Hz)
6 6
, 4.07 (2H, q, J = 6.9 Hz), 5.01 (1H, d, J = 5.1 Hz), 5.28 (1H, dd, J = 6.6, 14.7 Hz), 5.49 - 5.61 (2H, m), 5.85 (1H, m), 6.70 (1H, s), 7.25 - 7.35 (4H, m), 8.29 (1H, d, J = 7.2 Hz), 9.51 (1H, d, J = 8.5 Hz),. , 4.07 (2H, q, J = 6.9 Hz), 5.01 (1H, d, J = 5.1 Hz), 5.28 (1H, dd, J = 6.6, 14.7 Hz), 5.49-5.61 (2H, m), 5.85 ( 1H, m), 6.70 (1H, s), 7.25-7.35 (4H, m), 8.29 (1H, d, J = 7.2 Hz), 9.51 (1H, d, J = 8.5 Hz) ,.
IR (KBr) cm—1: 3418, 2981, 2341, 2260, 2168, 1762, 1585, 1532, 1482, 1440, 1370,IR (KBr) cm— 1 : 3418, 2981, 2341, 2260, 2168, 1762, 1585, 1532, 1482, 1440, 1370,
1300, 1201, 1162, 1121, 1090, 1036. 1300, 1201, 1162, 1121, 1090, 1036.
MS(ESI): 667+ (M + H)+ MS (ESI): 667+ (M + H) +
元素分析 C H N Na O S - 6.7 H O Elemental analysis C H N Na O S-6.7 H O
25 20 10 2 6 2 2 25 20 10 2 6 2 2
計算値: C,38.14; H,4.28; N, 17.79; S,8.15; Na,5.84 (%) Calculated values: C, 38.14; H, 4.28; N, 17.79; S, 8.15; Na, 5.84 (%)
実験値: C38.10; H,3.94; N, 17.75; S,8.34; Na,5.98 (%) Experimental value: C38.10; H, 3.94; N, 17.75; S, 8.34; Na, 5.98 (%)
実施例 112 Example 112
[化 157]
- OH 0' O O Na+ [Chemical 157] -OH 0 'OO Na +
EtO、 一 EtO, one
OEt ^— C02Et OEt ^ — C0 2 Et
NH2 EtO" NH 2 EtO "
OEt 、N OEt, N
164a 173 164 165 164a 173 164 165
(1) 164a→164 (1) 164a → 164
化合物 164a(3.0 g, 27.2 mmol)と化合物 173(24 g, 109 mmol)を混合し 100°Cで 30時 間撹拌した。室温まで冷却後酢酸ェチルを加え不溶物を濾去し、濾液を水洗した後 硫酸ナトリウムで乾燥して濃縮した。残渣をシリカゲルカラムクロマトグラフィーで精製 して化合物 164(748 mg,収率 14%)を得た。 Compound 164a (3.0 g, 27.2 mmol) and compound 173 (24 g, 109 mmol) were mixed and stirred at 100 ° C for 30 hours. After cooling to room temperature, ethyl acetate was added and insolubles were removed by filtration. The filtrate was washed with water, dried over sodium sulfate and concentrated. The residue was purified by silica gel column chromatography to obtain compound 164 (748 mg, yield 14%).
'H-NMR (CDC1 ) δ 1.52 (3Η, t, J = 6.9 Hz), 4.59 (2H,d, J = 6.9 Hz), 7.66 (1H, dd 'H-NMR (CDC1) δ 1.52 (3Η, t, J = 6.9 Hz), 4.59 (2H, d, J = 6.9 Hz), 7.66 (1H, dd
, J = 1.2, 5.7 Hz), 8.74 (1H, d, J = 5.7 Hz), 9.26 (1H, d, J = 1.2 Hz). , J = 1.2, 5.7 Hz), 8.74 (1H, d, J = 5.7 Hz), 9.26 (1H, d, J = 1.2 Hz).
(2) 164→165 (2) 164 → 165
化合物 164(430 mg)から実施例 75の (3)と同様の方法で化合物 165(385 mg)を得た。 H-NMR (d -DMSO) δ 7.85 (1H, dd, J = 1.2, 5.7), 8.60 (1H, d, J = 5.7 Hz), 9.09 ( Compound 165 (385 mg) was obtained from compound 164 (430 mg) in the same manner as in Example 75, (3). H-NMR (d-DMSO) δ 7.85 (1H, dd, J = 1.2, 5.7), 8.60 (1H, d, J = 5.7 Hz), 9.09 (
1H, d, J = 1.2 Hz). (1H, d, J = 1.2 Hz).
(3) 165→166 (3) 165 → 166
化合物 46(1.35 g)と化合物 165(385 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 166(89 mg,収率 26%)を得た。 Compound 166 (89 mg, 26% yield) was obtained in the same manner as in Example 79, (3), using Compound 46 (1.35 g) and Compound 165 (385 mg).
'H-NMR (d -DMSO) δ: 1.22 (3Η, t, J = 6.9 Hz), 3.42 and 3.49 (2H, ABq, J = 17.4 'H-NMR (d-DMSO) δ: 1.22 (3Η, t, J = 6.9 Hz), 3.42 and 3.49 (2H, ABq, J = 17.4
Hz), 4.09 (2H, q, J = 6.9 Hz), 5.04 (1H, d, J = 5.1 Hz), 5.40 (2H, d, J = 6.9 Hz), 5. 60 (1H, dd, J = 5.1, 8.4 Hz), 5.91 (1H, m), 6.71 (1H, s), 7.21 (2H, brs), 7.30 (1H, d , J = 15.9 Hz), 8.58 (1H, d, J = 6.9 Hz), 9.05 (1H, dd, J = 1.2, 6.9 Hz), 9.52 (1H, d, J = 8.1 Hz), 9.88 (1H, brs). Hz), 4.09 (2H, q, J = 6.9 Hz), 5.04 (1H, d, J = 5.1 Hz), 5.40 (2H, d, J = 6.9 Hz), 5. 60 (1H, dd, J = 5.1 , 8.4 Hz), 5.91 (1H, m), 6.71 (1H, s), 7.21 (2H, brs), 7.30 (1H, d, J = 15.9 Hz), 8.58 (1H, d, J = 6.9 Hz), 9.05 (1H, dd, J = 1.2, 6.9 Hz), 9.52 (1H, d, J = 8.1 Hz), 9.88 (1H, brs).
IR (KBr) cm—1: 3426, 2174, 1762, 1615, 1532, 1474, 1442, 1369, 1286, 1255, 1187, 1151, 1118, 1092, 1036, 1002. IR (KBr) cm— 1 : 3426, 2174, 1762, 1615, 1532, 1474, 1442, 1369, 1286, 1255, 1187, 1151, 1118, 1092, 1036, 1002.
MS(ESI): 624+ (M - Na + 2H)+
元素分析 C H N NaO S 5.8 H O MS (ESI): 624 + (M-Na + 2H) + Elemental analysis CHN NaO S 5.8 HO
: :
計算値: C,40.03; H,4.25 N, 16.81; S,8.55 Na,3.06 (%) Calculated value: C, 40.03; H, 4.25 N, 16.81; S, 8.55 Na, 3.06 (%)
実験値: C,39.90 H,3.86 N, 16.61; S,8.26 Na,3.00 (%) Experimental value: C, 39.90 H, 3.86 N, 16.61; S, 8.26 Na, 3.00 (%)
実施例 113 Example 113
[0136] [化 158] [0136] [Chemical 158]
(1) 85→167 (1) 85 → 167
化合物 46(599 mg)と化合物 85(281 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 167(281 mg,収率 14%)を得た。 Compound 167 (281 mg, 14% yield) was obtained in the same manner as in Example 79, (3), using Compound 46 (599 mg) and Compound 85 (281 mg).
'H-NMR (d -DMSO) δ: 1.22 (3Η, t, J = 6.9 Hz), 3.42 and 3.50 (2H, ABq, J = 16.8 'H-NMR (d-DMSO) δ: 1.22 (3Η, t, J = 6.9 Hz), 3.42 and 3.50 (2H, ABq, J = 16.8
Hz), 4.09 (2H, q, J = 6.9), 5.02 - 5.05 (IH, m), 5.40 (2H, d, J = 6.3 Hz), 5.57 - 5.6 2 (IH, m), 5.87 - 5.96 (1H, m), 6.72 (IH, s), 7.21 (2H, brs), 7.32 (IH, d, J = 15.9 Hz), 8.76 - 8.82 (2H, m), 9.53 (IH, d, J = 8.1 Hz), 9.88 (IH, s). Hz), 4.09 (2H, q, J = 6.9), 5.02-5.05 (IH, m), 5.40 (2H, d, J = 6.3 Hz), 5.57-5.6 2 (IH, m), 5.87-5.96 (1H , M), 6.72 (IH, s), 7.21 (2H, brs), 7.32 (IH, d, J = 15.9 Hz), 8.76-8.82 (2H, m), 9.53 (IH, d, J = 8.1 Hz) , 9.88 (IH, s).
IR (KBr) cm—1: 3418, 2158, 1763, 1638, 1533, 1506, 1363, 1303, 1200, 1166, 1119, 1036, 1002. IR (KBr) cm— 1 : 3418, 2158, 1763, 1638, 1533, 1506, 1363, 1303, 1200, 1166, 1119, 1036, 1002.
MS(ESI): 616+ (M - Na + 2H)+ MS (ESI): 616+ (M-Na + 2H) +
元素分析 C H N NaO S -4.7 H O Elemental analysis C H N NaO S -4.7 H O
計算値: C,39.91; H,4.10; N, 13.57; S, 13.32; Na,3.18 (%) Calculated values: C, 39.91; H, 4.10; N, 13.57; S, 13.32; Na, 3.18 (%)
実験値: C39.87; H,3.99; N, 13.69; S,13.13; Na,3.29 (%) Experimental value: C39.87; H, 3.99; N, 13.69; S, 13.13; Na, 3.29 (%)
実施例 114 Example 114
(1) 168→169 (1) 168 → 169
実施例 74の (1)と同様の方法で行レ、、化合物 168(942 mg, 5.77 mmol)力、ら化合物 16 9(1.02 g,収率 95%)を得た。 In the same manner as in Example 74, (1), Gyre, Compound 168 (942 mg, 5.77 mmol), et al. Compound 16 9 (1.02 g, yield 95%) was obtained.
H-NMR (d -DMSO) δ 7.90 (1H, d, J = 6.3 Hz), 8.51 (1H, d, J = 6.3 Hz), 9.34 (1H H-NMR (d-DMSO) δ 7.90 (1H, d, J = 6.3 Hz), 8.51 (1H, d, J = 6.3 Hz), 9.34 (1H
, brs). , Brs).
(2) 169→170 (2) 169 → 170
化合物 169(1.02 g, 5.46 mmol)のメタノール (50 mL)懸濁液に IN NaOMe/MeOH(5.5 mL)を加え濃縮乾固後、イソプロパノール、エタノールを加えて不溶の沈殿を濾取、 減圧乾燥した。化合物 170(1.08 g,収率 87%)を得た。 IN NaOMe / MeOH (5.5 mL) was added to a suspension of compound 169 (1.02 g, 5.46 mmol) in methanol (50 mL), concentrated to dryness, isopropanol and ethanol were added, and the insoluble precipitate was collected by filtration and dried under reduced pressure. . Compound 170 (1.08 g, yield 87%) was obtained.
H-NMR (d - DMSO) δ: 7.39 (1H, d, J = 5.4 Hz), 8.08 (1H, d, J = 5.4 Hz), 8.79 (1 H-NMR (d-DMSO) δ: 7.39 (1H, d, J = 5.4 Hz), 8.08 (1H, d, J = 5.4 Hz), 8.79 (1
H, brs). H, brs).
(3) 170→171 (3) 170 → 171
化合物 46(2.21 mg)と化合物 170(679 mg)を用いて、実施例 79の (3)と同様の方法で 化合物 171 (70 mg,収率 4%)を得た。 Compound 171 (70 mg, yield 4%) was obtained in the same manner as in Example 79, (3), using Compound 46 (2.21 mg) and Compound 170 (679 mg).
'H-NMR (d -DMSO) δ: 1.21 (3Η, t, J = 7.2 Hz), 3.42 and 3.49 (2H, ABq, J = 17.4 'H-NMR (d-DMSO) δ: 1.21 (3Η, t, J = 7.2 Hz), 3.42 and 3.49 (2H, ABq, J = 17.4
Hz), 4.08 (2H, q, J = 7.2 Hz), 5.03 (1H, d, J = 5.1 Hz), 5.23 (2H, d, J = 6.3 Hz), 5. 59 (1H, dd, J = 4.8, 8.4 Hz), 5.89 (1H, m), 6.71 (1H, s), 7.20 - 7.25 (3H, m), 7.86 ( 1H, d, J = 6.6 Hz), 8.27 (1H, d, J = 6.6 Hz), 9.17 (1H, s), 9.52 (1H, d, J = 8.1 Hz). IR (KBr) cm—1: 3433, 2170, 1761, 1617, 1532, 1473, 1364, 1313, 1243, 1201, 1160, 1120, 1035. Hz), 4.08 (2H, q, J = 7.2 Hz), 5.03 (1H, d, J = 5.1 Hz), 5.23 (2H, d, J = 6.3 Hz), 5.59 (1H, dd, J = 4.8 , 8.4 Hz), 5.89 (1H, m), 6.71 (1H, s), 7.20-7.25 (3H, m), 7.86 (1H, d, J = 6.6 Hz), 8.27 (1H, d, J = 6.6 Hz ), 9.17 (1H, s), 9.52 (1H, d, J = 8.1 Hz). IR (KBr) cm— 1 : 3433, 2170, 1761, 1617, 1532, 1473, 1364, 1313, 1243, 1201, 1160 , 1120, 1035.
MS(ESI): 645+ (M + H)+ MS (ESI): 645+ (M + H) +
元素分析 Q.6(C H N NaO S ) - 0.4(C H N NaO S ) - 6.0 H O
計算値: C,39.43; H,4.32; N, 18.39; S,8.42; Na,4.23 (%) Elemental analysis Q.6 (CHN NaO S)-0.4 (CHN NaO S)-6.0 HO Calculated value: C, 39.43; H, 4.32; N, 18.39; S, 8.42; Na, 4.23 (%)
実験値: C,39.34; Η,3·94; Ν, 18.20; S,8.48; Na,4.53 (%) Experimental value: C, 39.34; Η, 3.94; Ν, 18.20; S, 8.48; Na, 4.53 (%)
実施例 115 Example 115
[化 160] [Chemical 160]
(1) 172→174 (1) 172 → 174
化合物 172(7.76 g, 63 mmol)に化合物 173(41.63 g, 189 mmol)を加え 100°Cで 7時間 加熱した。室温まで冷却し水を加えて酢酸ェチルで抽出した。有機層を硫酸ナトリウ ムで乾燥し、濃縮後の残渣をシリカゲルカラムクロマトグラフィーで精製した。化合物 1 74(900 mg,収率 7%)を得た。 Compound 173 (41.63 g, 189 mmol) was added to compound 172 (7.76 g, 63 mmol) and heated at 100 ° C. for 7 hours. After cooling to room temperature, water was added and extracted with ethyl acetate. The organic layer was dried over sodium sulfate, and the concentrated residue was purified by silica gel column chromatography. Compound 1 74 (900 mg, yield 7%) was obtained.
'H-NMR (CDC1 ) δ 1.51 (3H, t, J = 6.9 Hz), 3.70 (3H,s), 4.59 (2H, q, J = 6.9 Hz), 'H-NMR (CDC1) δ 1.51 (3H, t, J = 6.9 Hz), 3.70 (3H, s), 4.59 (2H, q, J = 6.9 Hz),
7.15 (1H, d, J = 5.7 Hz), 8.52 (1H, d, J = 5.7 Hz), 8.85 (1H, s). 7.15 (1H, d, J = 5.7 Hz), 8.52 (1H, d, J = 5.7 Hz), 8.85 (1H, s).
(2) 174→175 (2) 174 → 175
化合物 174(884 mg, 4.3 mmol)のメタノール (8 mL)溶液に NaNHCN(296 mg, 4.53mm ol)を加えて 50°Cで 14時間撹拌した。室温まで冷却後沈殿を濾取した。得られた固体 を水に懸濁させ 6N塩酸で pHを 2付近に調整した。析出した沈殿を濾取し、減圧乾燥 によって化合物 175(539 mg,収率 62%)を得た。 NaNHCN (296 mg, 4.53 mmol) was added to a solution of compound 174 (884 mg, 4.3 mmol) in methanol (8 mL), and the mixture was stirred at 50 ° C. for 14 hours. After cooling to room temperature, the precipitate was collected by filtration. The obtained solid was suspended in water and the pH was adjusted to around 2 with 6N hydrochloric acid. The deposited precipitate was collected by filtration and dried under reduced pressure to obtain Compound 175 (539 mg, yield 62%).
H-NMR (d -DMSO) δ 3.53 (3Η, s), 7.48 (1H, d, J = 5.7 Hz), 8.38 (1H, d, J = 5.7 H-NMR (d-DMSO) δ 3.53 (3Η, s), 7.48 (1H, d, J = 5.7 Hz), 8.38 (1H, d, J = 5.7
Hz), 8.59 (1H, brs). Hz), 8.59 (1H, brs).
(3) 175→176 (3) 175 → 176
化合物 46(738 mg)と化合物 175(201 mg)を用いて、実施例 86の (4)と同様の方法で 化合物 176(370mg,収率 25%)を得た。
Ή-NMR (d -DMSO) δ: 1.22 (3H, t, J = 6.9 Hz), 3.40 and 3.48 (2H, ABq, J = 17.1Compound 176 (370 mg, 25% yield) was obtained in the same manner as in Example 86, (4), using Compound 46 (738 mg) and Compound 175 (201 mg). NMR-NMR (d-DMSO) δ: 1.22 (3H, t, J = 6.9 Hz), 3.40 and 3.48 (2H, ABq, J = 17.1
6 6
Hz), 3.55 (3H, s), 4.09 (2H, q, J = 6.9), 5.04 (1H, d, J = 4.8 Hz), 5.14 (1H, d, J = 6. 6 Hz), 5.58 (1H, dd, J = 4.5, 8.1 Hz), 5.82 - 5.92 (1H, m), 6.71 (1H, s), 7.21 (2H, b rs), 7.25 (1H, d, J = 16.5 Hz), 7.69 (1H, d, J = 6.6 Hz), 8.34 (1H, d, J = 6.6 Hz), 8. 71 (1H, brs), 9.52 (1H, d, J = 8.1 Hz). Hz), 3.55 (3H, s), 4.09 (2H, q, J = 6.9), 5.04 (1H, d, J = 4.8 Hz), 5.14 (1H, d, J = 6.6 Hz), 5.58 (1H , Dd, J = 4.5, 8.1 Hz), 5.82-5.92 (1H, m), 6.71 (1H, s), 7.21 (2H, b rs), 7.25 (1H, d, J = 16.5 Hz), 7.69 (1H , D, J = 6.6 Hz), 8.34 (1H, d, J = 6.6 Hz), 8. 71 (1H, brs), 9.52 (1H, d, J = 8.1 Hz).
IR (KBr) cm—1: 3417, 2983, 2151, 1763, 1683, 1626, 1570, 1517, 1485, 1394, 1291,IR (KBr) cm— 1 : 3417, 2983, 2151, 1763, 1683, 1626, 1570, 1517, 1485, 1394, 1291,
1185, 1143, 1084, 1034, 1002. 1185, 1143, 1084, 1034, 1002.
MS(ESI): 659+ (M + H)+ MS (ESI): 659+ (M + H) +
元素分析 C H N NaO S - 4.5 H O Elemental analysis C H N NaO S-4.5 H O
26 23 10 6 2 2 26 23 10 6 2 2
計算値: C,42.22; H,4.36; N, 18.94; S,8.67; Na,3.11 (%) Calculated value: C, 42.22; H, 4.36; N, 18.94; S, 8.67; Na, 3.11 (%)
実験値: C42.25; H,4.40; N, 18.98; S,8.83; Na,3.13 (%) Experimental value: C42.25; H, 4.40; N, 18.98; S, 8.83; Na, 3.13 (%)
実施例 116 Example 116
[化 161] [Chemical 161]
(1) 177→178 (1) 177 → 178
化合物 177(2.50 g, 21.2 mmol)の塩化メチレン (40mL)溶液にベンジルトリェチルアン モニゥムクロライド (0.13g, 0.55 mmol)を加え氷浴にて冷却した。この溶液に NaOH(po wder, 2.54g)、ベンゼンスルホユルク口ライド (3.4 mL)を加え氷浴で 15分間攪拌した後 、更に室温で 2.5時間撹拌した。反応液中の不溶物ををセライトを通して濾去した。濾 液は濃縮し、析出してきた結晶をへキサン—酢酸ェチルを用いて濾取した。減圧乾
燥して化合物 178(4.58g,収率 84%)を得た。 To a solution of compound 177 (2.50 g, 21.2 mmol) in methylene chloride (40 mL) was added benzyltriethyl ammonium chloride (0.13 g, 0.55 mmol) and cooled in an ice bath. To this solution were added NaOH (powder, 2.54 g) and benzenesulfuryl chloride (3.4 mL), and the mixture was stirred in an ice bath for 15 minutes, and further stirred at room temperature for 2.5 hours. Insoluble matter in the reaction solution was filtered off through celite. The filtrate was concentrated, and the precipitated crystals were collected by filtration using hexane-ethyl acetate. Vacuum drying Drying gave compound 178 (4.58 g, 84% yield).
'H-NMR (CDC1 ) δ 6.59 (1H, d, J = 3.9 Hz), 7.17 (1H, dd, J = 4.8, 7.8 Hz), 7.44 'H-NMR (CDC1) δ 6.59 (1H, d, J = 3.9 Hz), 7.17 (1H, dd, J = 4.8, 7.8 Hz), 7.44
- 7.59 (3H, m), 7.72 (1H, d, J = 3.9 Hz), 7.84 (1H, dd, J = 1.2, 7.8 Hz), 8.17 - 8.20 (2H, m), 8.42 (1H, dd, J = 1.2, 4.8). -7.59 (3H, m), 7.72 (1H, d, J = 3.9 Hz), 7.84 (1H, dd, J = 1.2, 7.8 Hz), 8.17-8.20 (2H, m), 8.42 (1H, dd, J = 1.2, 4.8).
(2) 178→179 (2) 178 → 179
ジイソプロピルアミン (4.9 mL)の THF(10 mL)溶液を氷冷し、窒素雰囲気下 n_ブチル リチウム (1.6 Mへキサン溶液, 19.8 mL)を 15分かけて滴下した後、同温で 40分間撹拌 した。この溶液は窒素雰囲気下、予め _70°Cに冷却された化合物 178(4.55 g)の THF( 35 mL)溶液中に滴下した。 _70°Cで 1.5時間撹拌後、ドライアイス力ら COガス発生さ せ 10分間反応液に吹き込んだ。 -5°Cまで昇温後 2N HC1(9 mL)をカ卩えた。 THFを減 圧留去し残渣に 2N塩酸をカ卩えて pHを 4付近に調整した。酢酸ェチルを加えて抽出し 、有機層を飽和食塩水で洗浄後、無水硫酸マグネシウムで乾燥した。濃縮して得ら れた結晶性の固体にジェチルエーテルを加えて洗浄、濾取して化合物 179(4.19g, 収率 79%)を得た。 A solution of diisopropylamine (4.9 mL) in THF (10 mL) is ice-cooled, and n_butyllithium (1.6 M hexane solution, 19.8 mL) is added dropwise over 15 minutes under a nitrogen atmosphere, followed by stirring at the same temperature for 40 minutes. did. This solution was added dropwise to a THF (35 mL) solution of compound 178 (4.55 g) that had been cooled to _70 ° C. in a nitrogen atmosphere. After stirring at _70 ° C for 1.5 hours, CO gas was generated from dry ice and blown into the reaction solution for 10 minutes. After raising the temperature to -5 ° C, 2N HC1 (9 mL) was added. THF was removed under reduced pressure, and 2N hydrochloric acid was added to the residue to adjust the pH to around 4. Ethyl acetate was added for extraction, and the organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The crystalline solid obtained by concentration was washed by adding jetyl ether and collected by filtration to obtain Compound 179 (4.19 g, yield 79%).
'H-NMR (CDC1 ) δ 7.11 (1H, s), 7.25 (1H, dd, J = 4.8, 7.8 Hz), 7.51 - 7.64 (3H, m), 7.92 (1H, dd, J = 1.8, 7.8 Hz), 8.40 - 8.43 (2H, m), 8.55 (1H, dd, J = 1.8, 4.8 H z). 'H-NMR (CDC1) δ 7.11 (1H, s), 7.25 (1H, dd, J = 4.8, 7.8 Hz), 7.51-7.64 (3H, m), 7.92 (1H, dd, J = 1.8, 7.8 Hz ), 8.40-8.43 (2H, m), 8.55 (1H, dd, J = 1.8, 4.8 H z).
(3) 179→180 (3) 179 → 180
実施例 74の (1)と同様の方法で行い、化合物 179(1.56 g, 5.0 mmol)から化合物 180( 1.44 g,収率 88%)を得た。 In the same manner as in Example 74, (1), Compound 180 (1.44 g, yield 88%) was obtained from Compound 179 (1.56 g, 5.0 mmol).
H-NMR (CDC1 ) δ: 7.08 (1H, s), 7.21 (1H, dd, J = 4.2, 7.8 Hz), 7.45 - 7.57 (3H, m), 7.85 (1H, d, J = 7.8 Hz), 8.24 (2H, d, J = 7.5 Hz), 8.52 (1H, d, J = 4.2 Hz). H-NMR (CDC1) δ: 7.08 (1H, s), 7.21 (1H, dd, J = 4.2, 7.8 Hz), 7.45-7.57 (3H, m), 7.85 (1H, d, J = 7.8 Hz), 8.24 (2H, d, J = 7.5 Hz), 8.52 (1H, d, J = 4.2 Hz).
(4) 180→181 (4) 180 → 181
化合物 180(1.41 g)のエタノール (14 mL)溶液に 2N (^水溶液(10.8 mL)を加え室 温で 4時間撹拌した。氷浴にて冷却し 2N塩酸 (14 mL)をカ卩え、析出した沈殿を濾取し た。減圧乾燥して化合物 181(567 mg,収率 70%)を得た。 To a solution of compound 180 (1.41 g) in ethanol (14 mL) was added 2N (^ aqueous solution (10.8 mL) and stirred at room temperature for 4 hours. Cooled in an ice bath, and 2N hydrochloric acid (14 mL) was added to precipitate. The resulting precipitate was collected by filtration and dried under reduced pressure to give compound 181 (567 mg, yield 70%).
H-NMR (d -DMSO) δ 7.20 (1H, dd, J = 4.5, 7.8 Hz), 7.33 (1H, s) , 8.20 (1H, dd, H-NMR (d-DMSO) δ 7.20 (1H, dd, J = 4.5, 7.8 Hz), 7.33 (1H, s), 8.20 (1H, dd,
J = 1.8, 7.8 Hz), 8.44 (1H, brd, J = 4.5 Hz).
(5) 181→182 J = 1.8, 7.8 Hz), 8.44 (1H, brd, J = 4.5 Hz). (5) 181 → 182
化合物 1 81(448 mg)のメタノール (9 mL)懸濁液に IN NaOMe/MeOH(2.4 mL)を加え 濃縮乾固して化合物 182(552 mg)を得た。 IN NaOMe / MeOH (2.4 mL) was added to a suspension of compound 1 81 (448 mg) in methanol (9 mL) and concentrated to dryness to give compound 182 (552 mg).
H-NMR (d -DMSO) δ 6.76 (1H, s), 7.03 (1H, dd, J = 4.5, 7.8 Hz), 7.94 (1H, d, J H-NMR (d-DMSO) δ 6.76 (1H, s), 7.03 (1H, dd, J = 4.5, 7.8 Hz), 7.94 (1H, d, J
6 6
= 7.8 Hz), 8.22 (1H, d, J = 4.5 Hz), 11.6 (1H, brs). = 7.8 Hz), 8.22 (1H, d, J = 4.5 Hz), 11.6 (1H, brs).
(6) 182→183 (6) 182 → 183
化合物 46(1.52 g)と化合物 182(460 mg)を用いて、実施例 79の (3)と同様の方法で化 合物 183 (120mg,収率 7%)を得た。 Compound 183 (120 mg, yield 7%) was obtained in the same manner as in Example 79, (3), using Compound 46 (1.52 g) and Compound 182 (460 mg).
'H-NMR (d -DMSO) δ: 1.21 (3Η, t, J = 6.9 Hz), 4.08 (2H, q, J = 6.9 Hz), 5.01 (1 'H-NMR (d-DMSO) δ: 1.21 (3Η, t, J = 6.9 Hz), 4.08 (2H, q, J = 6.9 Hz), 5.01 (1
6 6
H, d, J = 5.1 Hz), 5.24 (1H, dd, J = 6.3, 14.4 Hz), 5.52 - 5.62 (2H, m), 5.90 (1H, m H, d, J = 5.1 Hz), 5.24 (1H, dd, J = 6.3, 14.4 Hz), 5.52-5.62 (2H, m), 5.90 (1H, m
), 6.71 (1H, s), 7.02 - 7.07 (2H, m), 7.21 (2H, brs), 7.31 (1H, d, J = 15.6 Hz), 8.18), 6.71 (1H, s), 7.02-7.07 (2H, m), 7.21 (2H, brs), 7.31 (1H, d, J = 15.6 Hz), 8.18
(1H, d, J = 6.3 Hz), 8.28 (1H, d, J = 7.8 Hz), 9.53 (1H, d, J = 7.8 Hz). (1H, d, J = 6.3 Hz), 8.28 (1H, d, J = 7.8 Hz), 9.53 (1H, d, J = 7.8 Hz).
IR (KBr) cm"1: 3409, 2981, 2286, 2153, 1762, 1611, 1533, 1475, 1456, 1394, 1365,IR (KBr) cm " 1 : 3409, 2981, 2286, 2153, 1762, 1611, 1533, 1475, 1456, 1394, 1365,
1301, 1259, 1200, 1163, 1122, 1089, 1037. 1301, 1259, 1200, 1163, 1122, 1089, 1037.
MS(ESI): 622+ (M - 2Na + 3H)+ MS (ESI): 622 + (M-2Na + 3H) +
元素分析 C H N Na O S - 4.7 H O Elemental analysis C H N Na O S-4.7 H O
26 21 9 2 6 2 2 26 21 9 2 6 2 2
計算値: C,41.62; Η,4·08; Ν, 16.08; S,8.55; Na,6.13 (%) Calculated value: C, 41.62; Η, 4.08; Ν, 16.08; S, 8.55; Na, 6.13 (%)
実験値: C,41.47; H,3.75; N, 16.86; S,8.52; Na,6.18 (%) Experimental value: C, 41.47; H, 3.75; N, 16.86; S, 8.52; Na, 6.18 (%)
実施例 117 Example 117
[化 162]
[Chemical 162]
(1) 184→185 (1) 184 → 185
実施例 78の (1)と同様の方法で化合物 184(4.06 g)から化合物 185(7.45 g,収率 84%) を得た。 Compound 185 (7.45 g, yield 84%) was obtained from compound 184 (4.06 g) in the same manner as in Example 78, (1).
H-NMR (d -DMSO) δ: 1 .86 (3H, d, J = 6.3 Hz), 5.92 (2H, q, J = 5.9 Hz), 8.26 (2 H-NMR (d-DMSO) δ: 1.86 (3H, d, J = 6.3 Hz), 5.92 (2H, q, J = 5.9 Hz), 8.26 (2
6 6
H, d, J = 6.3 Hz), 9.06 (2H, brs). H, d, J = 6.3 Hz), 9.06 (2H, brs).
(2) 185→186 (2) 185 → 186
実施例 78の (2)と同様の方法で化合物 185(6.78 g)力 化合物 186(4.41 g,収率 77%) を得た。 Compound 185 (6.78 g) force Compound 186 (4.41 g, yield 77%) was obtained in the same manner as in Example 78, (2).
H-NMR (CDC1 ) δ: 1.45 (3Η, t, J = 7.2 Hz), 2.70 (3H, s), 4.49 (2H, q, J = 7.2 Hz), H-NMR (CDC1) δ: 1.45 (3Η, t, J = 7.2 Hz), 2.70 (3H, s), 4.49 (2H, q, J = 7.2 Hz),
3 Three
7.64 (2H, dd, J = 1.5, 4.8 Hz), 8.72 (2H, brs). 7.64 (2H, dd, J = 1.5, 4.8 Hz), 8.72 (2H, brs).
(3) 186→187a (3) 186 → 187a
実施例 78の (3)と同様の方法で化合物 186(2.20 g)から化合物 187a(703 mg,収率 30 In the same manner as in Example 78, (3), compound 186 (2.20 g) to compound 187a (703 mg, yield 30)
%)を得た。 %).
H-NMR (d -DMSO) δ 2.61 (3Η, s), 7.69 (2H, dd, J = 1.5, 4.2 Hz), 8.64 (2H, dd, J H-NMR (d-DMSO) δ 2.61 (3Η, s), 7.69 (2H, dd, J = 1.5, 4.2 Hz), 8.64 (2H, dd, J
6 6
= 1.5, 4.2 Hz).
(4) 187a→187b = 1.5, 4.2 Hz). (4) 187a → 187b
化合物 187a(455 mg, 1.71mmol)を水 6mlに溶かし 2N_塩酸で 0.86ml(1.71mmol)を加 える.析出晶を濾取し、乾燥する.得られた結晶はメタノール 7mlに懸濁させ、 1M -テ トラメチルダァニジンのメタノール溶液を加えて PH6.2に調整した.反応液は十分に減 圧下、乾固して化合物 187b(681mg)を得て、そのまま次の反応に用いた。 Dissolve compound 187a (455 mg, 1.71 mmol) in 6 ml of water and add 0.86 ml (1.71 mmol) with 2N hydrochloric acid. The precipitated crystals are collected by filtration and dried. The crystals obtained are suspended in 7 ml of methanol. A methanol solution of 1M-tetramethyldanidine was added to adjust the pH to 6.2. The reaction solution was sufficiently dried under reduced pressure to obtain compound 187b (681 mg), which was directly used in the next reaction.
(5) 187b→189(ATZァミン free、 TFA脱保護法) (5) 187b → 189 (ATZ amine free, TFA deprotection method)
化合物 188(1.15g、 lJlmmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナ トリウム水溶液 (216mg、 2.57mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかに化合物 187b(663mg、 1.71mmol) を加えて、ジメチルスルホキシド (5ml)に溶解し、ヨウ化ナトリウム (769mg、 5.13mmol)を 加えて、室温で 3時間攪拌した。反応液を 5%食塩水 (80ml)攪拌中に注加し、析出し た沈殿を濾取した。沈殿を減圧乾燥して 4級塩を無定形粉末として得た。これを塩化 メチレン (10ml)、ァニソール (1.6ml)に溶解し、 0°Cに冷却し、 TFA 5mlを加えた。混合 液を 0°Cで 1時間攪拌した後、 IPA50mlに氷冷下で攪拌しながら注加した。析出した沈 殿物を濾取し、飽和 NaHCO水で溶解させた。溶液を HP-20SSカラムクロマトグラフィ 一に付し、水-ァセトニトリルで溶離した。所望の化合物を含むフラクションを減圧下 濃縮し、濃縮液を凍結乾燥して化合物 189を粉末として得た。収量 145mg(9%) 'H-NMR (D20): 1.27 (3H, t, J = 6.8 Hz), 2.70 (3H, s), 3.73, 3.99 (2H, ABq, J = 17 .3 Hz), 4.21 (2H, q, J = 6.8 Hz), 5.26 (1H, d, J = 4.8 Hz), 5.27-5.30 (2H, m), 5.79 ( 1H, d, J = 4.8 Hz), 6.14 (1H, dt, J = 15.5, 7.2 Hz), 6.89 (1H, s), 7.04 (1H, d, J = 15 .5 Hz), 8.25 (2H, d, J = 6.8 Hz), 8.80 (2H, d, J = 6.8 Hz). Compound 188 (1.15 g, lJlmmol) is suspended in dichloromethane (10 ml), and an aqueous sodium hydrogen carbonate solution (216 mg, 2.57 mmol is dissolved in 10 ml of water) is added under ice cooling, extracted with dichloromethane, and dried over magnesium sulfate. did. After the solvent was distilled off, compound 187b (663 mg, 1.71 mmol) was quickly added and dissolved in dimethyl sulfoxide (5 ml). Sodium iodide (769 mg, 5.13 mmol) was added, and the mixture was stirred at room temperature for 3 hours. The reaction solution was poured into 5% brine (80 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain a quaternary salt as an amorphous powder. This was dissolved in methylene chloride (10 ml) and anisole (1.6 ml), cooled to 0 ° C., and 5 ml of TFA was added. The mixture was stirred at 0 ° C for 1 hour and then poured into 50 ml of IPA with stirring under ice cooling. The deposited precipitate was collected by filtration and dissolved with saturated aqueous NaHCO 3 solution. The solution was subjected to HP-20SS column chromatography and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 189 as a powder. Yield 145 mg (9%) 'H-NMR (D20): 1.27 (3H, t, J = 6.8 Hz), 2.70 (3H, s), 3.73, 3.99 (2H, ABq, J = 17.3 Hz), 4.21 (2H, q, J = 6.8 Hz), 5.26 (1H, d, J = 4.8 Hz), 5.27-5.30 (2H, m), 5.79 (1H, d, J = 4.8 Hz), 6.14 (1H, dt, J = 15.5, 7.2 Hz), 6.89 (1H, s), 7.04 (1H, d, J = 15.5 Hz), 8.25 (2H, d, J = 6.8 Hz), 8.80 (2H, d, J = 6.8 Hz).
IR (KBr) cm—1: 3408, 2981, 2153, 1763, 1635, 1598, 1530, 1463, 1366, 1295, 1200,IR (KBr) cm— 1 : 3408, 2981, 2153, 1763, 1635, 1598, 1530, 1463, 1366, 1295, 1200,
1148, 1090, 1035, 1002. 1148, 1090, 1035, 1002.
MS(ESI): 702+ (M + H)+ MS (ESI): 702 + (M + H) +
元素分析 C H N NaO S - 5.2 H O Elemental analysis C H N NaO S-5.2 H O
計算値: C,42.28; H,4.36; N, 15.85; S, 12.09; Na,2.89 (%) Calculated values: C, 42.28; H, 4.36; N, 15.85; S, 12.09; Na, 2.89 (%)
実験値: C,42.17; H,4.17; N, 15.85; S, 12.07; Na,3.24 (%) Experimental value: C, 42.17; H, 4.17; N, 15.85; S, 12.07; Na, 3.24 (%)
実施例 118
[化 163] Example 118 [Chemical 163]
(1) 186→190 (1) 186 → 190
実施例 74の (1)と同様の方法で化合物 186(825 mg)から化合物 190(661 mg,収率 10 0%)を得た。 Compound 190 (661 mg, yield 100%) was obtained from compound 186 (825 mg) in the same manner as in Example 74, (1).
H-NMR (D 0-DC1) δ: 2.88 (3Η, s), 8.39 (2H, dd, J = 1.2, 5.4 Hz), 8.87 (2H, d, J H-NMR (D 0-DC1) δ: 2.88 (3Η, s), 8.39 (2H, dd, J = 1.2, 5.4 Hz), 8.87 (2H, d, J
= 1.2, 5.4 Hz). = 1.2, 5.4 Hz).
(2) 19 0→191 (2) 19 0 → 191
化合物 190(230 mg)のメタノール (2 mL)溶液に 1.0M NaOMe/MeOH(1.0 mL)を加え 室温にて撹拌後濃縮乾固して化合物 191(250mg)を得た。 To a solution of compound 190 (230 mg) in methanol (2 mL) was added 1.0M NaOMe / MeOH (1.0 mL), and the mixture was stirred at room temperature and concentrated to dryness to give compound 191 (250 mg).
(3) 191→192(ATZァミン free、 TFA脱保護法) (3) 191 → 192 (ATZ amine free, TFA deprotection law)
化合物 188(702 mg)と化合物 191(250 mg)を用いて、実施例 117の (5)と同様の方法 で化合物 192 (114 mg,収率 13%)を得た。 Using compound 188 (702 mg) and compound 191 (250 mg), compound 192 (114 mg, 13% yield) was obtained in the same manner as in Example 117, (5).
'H-NMR (d -DMSO): 1.22 (3H, t, J = 6.9 Hz), 2.73 (3H, s), 3.45—3.53 (2H, m), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9 Hz), 2.73 (3H, s), 3.45—3.53 (2H, m), 4.0
9 (2H, q, J = 6.9 Hz), 5.05 (1H, d, J = 5.1 Hz), 5.29 (2H, d, J = 6.6 Hz), 5.60 (1H, dd, J = 5.1, 8.4 Hz), 5.87 (1H, dt, J = 15.6, 6.6 Hz), 6.72 (1H, s), 7.23 (2H, s), 7.29 (1H, d, J = 15.6 Hz ), 8.38 (2H, d, J = 6.9 Hz), 8.99 (2H, d, J = 6.9 Hz), 9.55 (1H, d, J = 8.4 Hz). 9 (2H, q, J = 6.9 Hz), 5.05 (1H, d, J = 5.1 Hz), 5.29 (2H, d, J = 6.6 Hz), 5.60 (1H, dd, J = 5.1, 8.4 Hz), 5.87 (1H, dt, J = 15.6, 6.6 Hz), 6.72 (1H, s), 7.23 (2H, s), 7.29 (1H, d, J = 15.6 Hz), 8.38 (2H, d, J = 6.9 Hz ), 8.99 (2H, d, J = 6.9 Hz), 9.55 (1H, d, J = 8.4 Hz).
IR (KBr) cm—1: 3410, 2982, 1763, 1635, 1531, 1458, 1371, 1298, 1200, 1152, 1115, 1037. IR (KBr) cm— 1 : 3410, 2982, 1763, 1635, 1531, 1458, 1371, 1298, 1200, 1152, 1115, 1037.
MS(ESI): 700+ (M + Na)+ MS (ESI): 700 + (M + Na) +
元素分析 c H N NaO S - 6.6 H O - 0.4NaHCO
計算値: C,39.64; Η,4·56; Ν, 11.81; S, 11.59; Na,3.88 (%) Elemental analysis c HN NaO S-6.6 HO-0.4 NaHCO Calculated value: C, 39.64; Η, 4.56; Ν, 11.81; S, 11.59; Na, 3.88 (%)
実験値: C,39.33; Η,4·18; Ν, 12.05; S, 11.98; Na,4.08 (%) Experimental value: C, 39.33; Η, 4.18; Ν, 12.05; S, 11.98; Na, 4.08 (%)
実施例 119 Example 119
193 194 195 196 193 194 195 196
(1) 193, 194→195 (1) 193, 194 → 195
化合物 194(6.66g, 50 mmol)のエタノール (50 mL)溶液に氷冷撹拌下、ブロモアセト ン 193(4.25 mL, 50.5 mmol)を加え 50°Cに加温して 1時間撹拌した。ブロモアセトン (0. 85 mL)を追加しさらに 1時間撹拌した後室温まで冷却した。この反応液を 10%炭酸ナ トリウム水溶液 (100 mL)に注加しエタノールを減圧留去して酢酸ェチルで抽出した。 有機層を水で洗浄後、無水硫酸マグネシウムで乾燥し濃縮した。減圧乾燥して化合 物 195(8.60 g,収率 100%)を得た。 Bromoacetone 193 (4.25 mL, 50.5 mmol) was added to a solution of compound 194 (6.66 g, 50 mmol) in ethanol (50 mL) with ice cooling and stirring, and the mixture was heated to 50 ° C. and stirred for 1 hr. Bromoacetone (0.85 mL) was added, and the mixture was further stirred for 1 hour, and then cooled to room temperature. The reaction solution was poured into a 10% aqueous sodium carbonate solution (100 mL), ethanol was distilled off under reduced pressure, and the mixture was extracted with ethyl acetate. The organic layer was washed with water, dried over anhydrous magnesium sulfate and concentrated. Compound 195 (8.60 g, yield 100%) was obtained by drying under reduced pressure.
H-NMR (CDC1 ) δ: 1.44 (3Η, t, J = 6.9 Hz), 2.55 (3H, s), 4.48 (2H, q, J = 6.9 Hz) H-NMR (CDC1) δ: 1.44 (3Η, t, J = 6.9 Hz), 2.55 (3H, s), 4.48 (2H, q, J = 6.9 Hz)
3 Three
7.19 (1H, s). 7.19 (1H, s).
(2) 195→19 6 (2) 195 → 19 6
化合物 195(8.60g, 50 mmol)の四塩化炭素 (80 mL)溶液に鉄粉 (279 mg, 5.0 mmol),
臭素 (6.41 mL, 125 mmol)を加え窒素雰囲気下室温で 21時間撹拌した。 1M Na S 0 水溶液 (500 mL)に反応液を加え酢酸ェチルで抽出した。有機層を飽和重曹水、飽 和食塩水で洗浄し無水硫酸マグネシウムで乾燥後濃縮した。残渣をシリカゲルカラ ムクロマトグラフィーで精製し、化合物 196(4.07g,収率 33%)を得た。 Compound 195 (8.60 g, 50 mmol) in carbon tetrachloride (80 mL) was added to iron powder (279 mg, 5.0 mmol), Bromine (6.41 mL, 125 mmol) was added and stirred at room temperature for 21 hours under a nitrogen atmosphere. The reaction solution was added to 1M Na 2 S 0 aqueous solution (500 mL) and extracted with ethyl acetate. The organic layer was washed with saturated aqueous sodium bicarbonate and saturated Japanese brine, dried over anhydrous magnesium sulfate and concentrated. The residue was purified by silica gel column chromatography to obtain compound 196 (4.07 g, yield 33%).
H-NMR (CDC1 ) δ: 1.44 (3Η, t, J = 7.2 Hz), 2.50 (3H, s), 4.47 (2H, q, J = 7.2 Hz).H-NMR (CDC1) δ: 1.44 (3Η, t, J = 7.2 Hz), 2.50 (3H, s), 4.47 (2H, q, J = 7.2 Hz).
(3) 196→198 (3) 196 → 198
化合物 196(1.97 g, 7.89 mmol)のトルエン (70 mL)溶液に化合物 197(2.29 g, 9.47 m mol)、テトラキストリフエニルホスフィンパラジウム (913 mg, 0.79 mmol)を加え 120°Cで 2 4時間撹拌した。室温まで冷却後、反応液を濃縮し、残渣をシリカゲルカラムクロマト グラフィ一で精製しィ匕合物 198(2.17 g)を得た。 Compound 197 (2.29 g, 9.47 mmol) and tetrakistriphenylphosphine palladium (913 mg, 0.79 mmol) were added to a solution of compound 196 (1.97 g, 7.89 mmol) in toluene (70 mL) and stirred at 120 ° C for 24 hours. did. After cooling to room temperature, the reaction solution was concentrated, and the residue was purified by silica gel column chromatography to obtain Compound 198 (2.17 g).
H-N MR (CDC1 ) δ 1.35 (3Η, t, J = 7.2 Hz), 2.58 (3H, s), 4.40 (2H, q, J = 7.2 Hz) H-N MR (CDC1) δ 1.35 (3Η, t, J = 7.2 Hz), 2.58 (3H, s), 4.40 (2H, q, J = 7.2 Hz)
, 7.62 (2H, dd, J = ), 8.71 (2H, dd, J = 1.8, 4.8 Hz). 7.62 (2H, dd, J =), 8.71 (2H, dd, J = 1.8, 4.8 Hz).
(4) 198→199 (4) 198 → 199
実施例 74の (1)と同様の方法で化合物 198(825 mg)から化合物 199(757 mg)を得た。 H-NMR (D 0-DC1) δ: 8.25 (2Η, d, J = 6.9 Hz), 8.87 (2H, d, J = 6.9 Hz). Compound 199 (757 mg) was obtained from compound 198 (825 mg) in the same manner as in Example 74 (1). H-NMR (D 0-DC1) δ: 8.25 (2Η, d, J = 6.9 Hz), 8.87 (2H, d, J = 6.9 Hz).
(5) 199→200 (5) 199 → 200
化合物 199(379 mg)のメタノール (3 mL)溶液に 1.0M NaOMe/MeOH(1.5 mL)を加え 室温にて撹拌後濃縮乾固して化合物 200(364mg)を得た。 To a solution of compound 199 (379 mg) in methanol (3 mL) was added 1.0M NaOMe / MeOH (1.5 mL), and the mixture was stirred at room temperature and concentrated to dryness to give compound 200 (364 mg).
(6) 200→201 (6) 200 → 201
化合物 188(1.01 g)と化合物 200(364 mg)を用いて、実施例 117の (5)と同様の方法で 化合物 201 (77 mg,収率 6%)を得た。 Compound 201 (77 mg, yield 6%) was obtained in the same manner as in Example 117, (5), using Compound 188 (1.01 g) and Compound 200 (364 mg).
'H-NMR (d -DMSO): 1.22 (3H, t, J = 6.9 Hz), 2.62 (3H, s), 3.42 - 3.47 (2H, m), 4 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9 Hz), 2.62 (3H, s), 3.42-3.47 (2H, m), 4
• 09 (2H, q, J = 6.9 Hz), 5.04 (1H, d, J = 5.1 Hz), 5.27 (2H, d, J = 6.6 Hz), 5.60 (1H , dd, J = 5.1, 8.4 Hz), 5.86 (1H, dt, J = 15.9, 6.6 Hz), 6.71 (1H, s), 7.22 (2H, s), 7. 30 (1H, d, 15.9 Hz), 8.19 (2H, d, J = 6.6 Hz), 8.95 (2H, d, J = 6.6Hz), 9.55 (1H, d, J = 8.4 Hz). • 09 (2H, q, J = 6.9 Hz), 5.04 (1H, d, J = 5.1 Hz), 5.27 (2H, d, J = 6.6 Hz), 5.60 (1H, dd, J = 5.1, 8.4 Hz) , 5.86 (1H, dt, J = 15.9, 6.6 Hz), 6.71 (1H, s), 7.22 (2H, s), 7.30 (1H, d, 15.9 Hz), 8.19 (2H, d, J = 6.6 Hz), 8.95 (2H, d, J = 6.6Hz), 9.55 (1H, d, J = 8.4 Hz).
IR (KBr) cm—1: 3409, 2982, 1762, 1632, 1531, 1434, 1361, 1298, 1200, 1160, 1120, 1037.
MS(ESI): 656+ (M - Na + 2H)+ IR (KBr) cm— 1 : 3409, 2982, 1762, 1632, 1531, 1434, 1361, 1298, 1200, 1160, 1120, 1037. MS (ESI): 656+ (M-Na + 2H) +
元素分析 C H N NaO S -8.0 H O - O. lNaHCO Elemental analysis C H N NaO S -8.0 H O-O. lNaHCO
計算値: C,39.20; H,4.87; N, 11.81; S, 11.59; Na,3.05 (%) Calculated values: C, 39.20; H, 4.87; N, 11.81; S, 11.59; Na, 3.05 (%)
実験値: C38.94; H,5.55; N,12.18; S,11.65; Na,3.02 (%) Experimental value: C38.94; H, 5.55; N, 12.18; S, 11.65; Na, 3.02 (%)
実施例 120 Example 120
[化 165] [Chemical 165]
206 206
(1) 202→203 (1) 202 → 203
化合物 202(3.40 g, 15.5 mmol)のジォキサン (100 mL)溶液に化合物 197(3.18 g, 15. 5 mmol), K Ρ〇 (16.5 g, 77.5 mmol),テトラキストリフエニルホスフィンパラジウム (896 mg, 0.775 mmol)を加え窒素雰囲気下 100°Cで 1時間撹拌した。反応液を氷冷撹拌下 の 5%クェン酸水溶液 (200 mL)中に加え、酢酸ェチルで 3回抽出した。有機層を飽和 食塩水で洗浄後、無水硫酸マグネシウムで乾燥し、濾過、濃縮した。得られた残渣を シリカゲルカラムクロマトグラフィーで精製しィ匕合物 203(3.43 g,収率 96%)を得た。 H-NMR (d -DMSO) δ 3.90 (3Η, s), 7.80 - 7.91 (4H, m), 8.03 (1H, t, J = 8.1 Hz), Compound 202 (3.40 g, 15.5 mmol) in dioxane (100 mL) was added to compound 197 (3.18 g, 15.5 mmol), K Ρ〇 (16.5 g, 77.5 mmol), tetrakistriphenylphosphine palladium (896 mg, 0.775 mmol) was added, and the mixture was stirred at 100 ° C for 1 hour under a nitrogen atmosphere. The reaction mixture was added to a 5% aqueous citrate solution (200 mL) with stirring on ice, and extracted three times with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, filtered and concentrated. The resulting residue was purified by silica gel column chromatography to obtain Compound 203 (3.43 g, yield 96%). H-NMR (d -DMSO) δ 3.90 (3Η, s), 7.80-7.91 (4H, m), 8.03 (1H, t, J = 8.1 Hz),
8.71 (2H, dd, J = 1.8, 4.8 Hz). 8.71 (2H, dd, J = 1.8, 4.8 Hz).
(2) 203→204 (2) 203 → 204
実施例 74の (1)と同様の方法で化合物 203(1.39 g)から化合物 204(938 mg)を得た。 H-NMR (d -DMSO) δ 7.74 - 7.91(4H, m), 7.84 (1H, m), 7.98 (1H, t, J = 7.8 Hz),
8.70 (2H, brs). Compound 204 (938 mg) was obtained from Compound 203 (1.39 g) in the same manner as in Example 74, (1). H-NMR (d -DMSO) δ 7.74-7.91 (4H, m), 7.84 (1H, m), 7.98 (1H, t, J = 7.8 Hz), 8.70 (2H, brs).
(3) 204→205 (3) 204 → 205
実施例 84の (1)と同様の方法で化合物 204(938 mg)力 化合物 205(1.45 g,収率 88% Compound 204 (938 mg) compound 205 (1.45 g, yield 88%) in the same manner as in Example 84 (1)
)を得た。 )
H-NMR (d -DMSO) δ 7.09 (1H, s), 7.29 - 7.34 (2H, m), 7.40 (1H, t, J = 7.5 Hz), H-NMR (d -DMSO) δ 7.09 (1H, s), 7.29-7.34 (2H, m), 7.40 (1H, t, J = 7.5 Hz),
7.54 (4H, d, J = 7.5 Hz), 7.83 (2H, dd, J = 2.1, 3.6 Hz), 7.92 (1H, d, J = 12.6 Hz), 8.15 (1H, t, J = 8.1 Hz), 8.72 (2H, dd, J = 2.1, 3.6 Hz). 7.54 (4H, d, J = 7.5 Hz), 7.83 (2H, dd, J = 2.1, 3.6 Hz), 7.92 (1H, d, J = 12.6 Hz), 8.15 (1H, t, J = 8.1 Hz), 8.72 (2H, dd, J = 2.1, 3.6 Hz).
(4) 205→206 (4) 205 → 206
化合物 188(1.88 g)と化合物 205(1.07 g)を用いて、実施例 117の (5)と同様の方法で 化合物 206 (724 mg,収率 33%)を得た。 Compound 206 (724 mg, 33% yield) was obtained in the same manner as in Example 117, (5), using Compound 188 (1.88 g) and Compound 205 (1.07 g).
'H-NMR (d -DMSO): 1.21 (3H, t, J = 6.9Hz), 3.46 (2H, Abq, J = 16.5 Hz), 4.09 (2 'H-NMR (d-DMSO): 1.21 (3H, t, J = 6.9Hz), 3.46 (2H, Abq, J = 16.5 Hz), 4.09 (2
H, q, J = 6.9Hz), 5.04 (1H, d, J = 4.8Hz), 5.28 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 4.8, 7.8Hz), 5.88 (1H, dt, J = 15.9, 6.9 Hz), 6.71 (1H, s), 7.24 (2H, s), 7.30 (1H, d , 15.9 Hz), 7.61-7.83 (3H, m) 8.50 (2H, d, J = 6.9Hz), 9.03 (2H, d, J = 6.9 Hz), 9.5 4 (1H, d, J = 7.8Hz). H, q, J = 6.9Hz), 5.04 (1H, d, J = 4.8Hz), 5.28 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 4.8, 7.8Hz), 5.88 ( 1H, dt, J = 15.9, 6.9 Hz), 6.71 (1H, s), 7.24 (2H, s), 7.30 (1H, d, 15.9 Hz), 7.61-7.83 (3H, m) 8.50 (2H, d, J = 6.9Hz), 9.03 (2H, d, J = 6.9 Hz), 9.5 4 (1H, d, J = 7.8Hz).
IR (KBr) cm"1: 3399, 2982, 1763, 1601, 1530, 1463, 1376, 1306, 1200, 1157, 1110, 1036. IR (KBr) cm " 1 : 3399, 2982, 1763, 1601, 1530, 1463, 1376, 1306, 1200, 1157, 1110, 1036.
MS(ESI): 653+ (M - Na + 2H)+ MS (ESI): 653+ (M-Na + 2H) +
元素分析 C H FN NaO S -4.7 H O - 0.2NaHCO Elemental analysis C H FN NaO S -4.7 H O-0.2NaHCO
計算値: C,45.19; Η,4·36; Ν, 10.83; S,8.26; F,2.45; Na,3.55 (%) Calculated value: C, 45.19; Η, 4.36; Ν, 10.83; S, 8.26; F, 2.45; Na, 3.55 (%)
実験値: C,44.96; Η,4·06; Ν, 10.96; S,8.55; F,2.27; Na,3.77 (%) Experimental value: C, 44.96; Η, 4.06; Ν, 10.96; S, 8.55; F, 2.27; Na, 3.77 (%)
実施例 121 Example 121
[化 166]
[Chemical 166]
209 209
(1) 198→207 (1) 198 → 207
実施例 78の (3)と同様の方法で化合物 198(877 mg)から化合物 207(458 mg,収率 49 In the same manner as in Example 78, (3), compound 198 (877 mg) to compound 207 (458 mg, yield 49)
%)を得た。 %).
H-NMR (d -DMSO) δ 2.50 (3Η, s), 7.53 (2H, dd, J = 1.5, 4.5 Hz), 8.64 (2H, dd, J H-NMR (d-DMSO) δ 2.50 (3Η, s), 7.53 (2H, dd, J = 1.5, 4.5 Hz), 8.64 (2H, dd, J
6 6
= 1.5, 4.5 Hz). = 1.5, 4.5 Hz).
(2) 207→208 (2) 207 → 208
化合物 207(455 mg, 1.71 mmol)の水 (6 mL)懸濁液に 2N塩酸 (0.86 mし, 1.71 mmol) をカ卩ぇ析出した沈殿を濾取した。この固体にメタノール (7 mL)を加え 1Mのテトラメチ ルグァ二ジンのメタノール溶液を (1.71 mL)加えた。この反応液を濃縮し化合物 208(6 81 mg)を得た。 A precipitate in which 2N hydrochloric acid (0.86 m, 1.71 mmol) was precipitated in a suspension of compound 207 (455 mg, 1.71 mmol) in water (6 mL) was collected by filtration. Methanol (7 mL) was added to the solid, and 1M tetramethylguanidine in methanol (1.71 mL) was added. The reaction solution was concentrated to obtain Compound 208 (681 mg).
H-NMR (d -DMSO) δ 2.51 (3Η, s), 2.89 (12H, s), 3.37 (3H, s), 7.54 (2H, brs), 7. H-NMR (d-DMSO) δ 2.51 (3Η, s), 2.89 (12H, s), 3.37 (3H, s), 7.54 (2H, brs), 7.
6 6
79 (2H, brs), 8.66 (2H, brs). 79 (2H, brs), 8.66 (2H, brs).
(3) 208→209 (3) 208 → 209
化合物 188(1.15 g)と化合物 208(663 mg)を用いて、実施例 117の (5)と同様の方法で 化合物 209 (145 mg,収率 9%)を得た。 Compound 209 (145 mg, 9% yield) was obtained in the same manner as in Example 117, (5), using Compound 188 (1.15 g) and Compound 208 (663 mg).
'H-NMR (d -DMSO): 1.22 (3H, t, J = 7.2 Hz), 2.63 (3H, s), 3.46 (2H, ABq, J = 16. 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2 Hz), 2.63 (3H, s), 3.46 (2H, ABq, J = 16.
6 6
5 Hz), 4.09 (2H, q, J = 7.2 Hz), 5.04 (1H, d, J = 5.1 Hz), 5.28 (2H, d, J = 6.9 Hz), 5.60 (1H, dd, J=5.1, 8.1 Hz), 5.86 (1H, dt, J = 16.2, 6.9 Hz), 6.72 (1H, s), 7.22 (2H , s), 7.30 (1H, d, J = 16.2 Hz), 8.25 (2H, d, J = 6.6 Hz), 8.98 (2H, d, J = 6.6 Hz), 9 .54 (1H, d, J = 8.1Hz). 5 Hz), 4.09 (2H, q, J = 7.2 Hz), 5.04 (1H, d, J = 5.1 Hz), 5.28 (2H, d, J = 6.9 Hz), 5.60 (1H, dd, J = 5.1, 8.1 Hz), 5.86 (1H, dt, J = 16.2, 6.9 Hz), 6.72 (1H, s), 7.22 (2H, s), 7.30 (1H, d, J = 16.2 Hz), 8.25 (2H, d, J = 6.6 Hz), 8.98 (2H, d, J = 6.6 Hz), 9.54 (1H, d, J = 8.1 Hz).
IR (KBr) cm"1: 3425, 2982, 2163, 1763, 1632, 1530, 1442, 1358, 1200, 1160, 1090,
1036, 1001. IR (KBr) cm " 1 : 3425, 2982, 2163, 1763, 1632, 1530, 1442, 1358, 1200, 1160, 1090, 1036, 1001.
MS(ESI): 680+ (M - Na + 2H)+ MS (ESI): 680+ (M-Na + 2H) +
元素分析 C H N NaO S - 6.0 H O - 1.0NaHCO Elemental analysis C H N NaO S-6.0 H O-1.0 NaHCO
28 24 9 6 3 2 3 28 24 9 6 3 2 3
計算値: C,38.97; H,4.17; N, 14.10; S, 10.76; Na,5.15 (%) Calculated values: C, 38.97; H, 4.17; N, 14.10; S, 10.76; Na, 5.15 (%)
実験値: C,38.87; H,3.82; N, 14.11; S, 10.92; Na,4.94 (%) Experimental value: C, 38.87; H, 3.82; N, 14.11; S, 10.92; Na, 4.94 (%)
実施例 122 Example 122
[化 167] [Chemical 167]
(1) 3→4 (1) 3 → 4
化合物 3(2.17g, 10.0mmol)を 28%アンモニア水(25ml)に懸濁させ、 60°Cに加熱し、 8 時間攪拌した。固体をろ取し 4を固体として得た。収量 1.41g(75%)。 Compound 3 (2.17 g, 10.0 mmol) was suspended in 28% aqueous ammonia (25 ml), heated to 60 ° C., and stirred for 8 hours. The solid was collected by filtration to give 4 as a solid. Yield 1.41 g (75%).
'H-NMR (d -DMSO): 7.36(1H, s),7.50(lH, bs),7,73(2H, d, J = 4.5Hz),7.87(lH, bs), 'H-NMR (d-DMSO): 7.36 (1H, s), 7.50 (lH, bs), 7,73 (2H, d, J = 4.5Hz), 7.87 (lH, bs),
6 6
8.63(2H, d, J = 4.5Hz). 8.63 (2H, d, J = 4.5Hz).
(2) 4→5 (2) 4 → 5
化合物 4(188mg,lmmol)をテトラヒドロフラン 5mlに懸濁させ、無水トリフルォロ酢酸 (14 1 μ L,lmmol)とピリジン (81 a L, lmmol)を滴下し一夜攪拌し減圧留去した。精製水を
加え、炭酸水素ナトリウムで中和して 5を固体として得た。収量 170mg Compound 4 (188 mg, 1 mmol) was suspended in 5 ml of tetrahydrofuran, trifluoroacetic anhydride (141 μL, 1 mmol) and pyridine (81 a L, 1 mmol) were added dropwise, and the mixture was stirred overnight and evaporated under reduced pressure. Purified water In addition, neutralization with sodium bicarbonate gave 5 as a solid. Yield 170mg
'H-NMR (d -DMSO): 7.70(1H, s),7.80(2H, d, J = 5.4Hz), 8.71(2H, d, J = 5.4Hz). 'H-NMR (d-DMSO): 7.70 (1H, s), 7.80 (2H, d, J = 5.4Hz), 8.71 (2H, d, J = 5.4Hz).
(3) 5→6 (3) 5 → 6
化合物 5(492mg,2.89mmol)、アジ化ナトリウム (207mg、 3.18mmol)、塩化アンモニゥム (170mg、 3.18mmol)をジメチルホルムアミド (5ml)中に懸濁させ、 115°Cにて 1時間 35分 攪拌した。室温に冷却後水をカ卩えて、 2N HC1で pH=3.5とし、析出物をろ過して、化合 物 6を無色結晶として得た。収量 553mg(90%)。 Compound 5 (492 mg, 2.89 mmol), sodium azide (207 mg, 3.18 mmol) and ammonium chloride (170 mg, 3.18 mmol) were suspended in dimethylformamide (5 ml) and stirred at 115 ° C for 1 hour and 35 minutes. . Water was added after cooling to room temperature, pH was adjusted to 3.5 with 2N HC1, and the precipitate was filtered to obtain Compound 6 as colorless crystals. Yield 553 mg (90%).
'H-NMR (d -DMSO): 7.59(1H, s), 7.89(2H, d, J = 4.4Hz), 8.71(2H, d, J = 4.4Hz),l 'H-NMR (d-DMSO): 7.59 (1H, s), 7.89 (2H, d, J = 4.4Hz), 8.71 (2H, d, J = 4.4Hz), l
4.4(1H, br s). 4.4 (1H, br s).
(4) 6→7 (4) 6 → 7
化合物 2(1.387g、 2.06mmol)をジクロロメタン (20ml)に懸濁させ、氷冷下炭酸水素ナ トリウム水溶液 (259mg、 3.08mmolを水 20mlに溶解)を加え、ジクロロメタンで抽出し、硫 酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (4ml)に溶 解し、化合物 6(438mg、 1.20mmol)と混合し、さらにジメチルスルホキシド (3ml)、次いで 臭化ナトリウム (635mg、 6.17mmol)を加えて、室温で 5時間攪拌した。反応液を 5%食 塩水 (60ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して化合物 7 を無定形粉末として得た。収量 1.799g(107%)。 Compound 2 (1.387 g, 2.06 mmol) is suspended in dichloromethane (20 ml), an aqueous sodium hydrogen carbonate solution (259 mg, 3.08 mmol dissolved in 20 ml of water) is added under ice cooling, extracted with dichloromethane, and magnesium sulfate is added. Dried. After distilling off the solvent, quickly dissolve in dimethylformamide (4 ml), mix with compound 6 (438 mg, 1.20 mmol), add dimethyl sulfoxide (3 ml) and then sodium bromide (635 mg, 6.17 mmol). And stirred at room temperature for 5 hours. The reaction solution was poured into 5% saline (60 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 7 as an amorphous powder. Yield 1.799 g (107%).
'H-NMR (d -DMSO): 1.23(3H, t, J = 7.1Hz), 3.66, 3.91(2H, ABq, J = 18.2Hz), 4.1 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.1Hz), 3.66, 3.91 (2H, ABq, J = 18.2Hz), 4.1
0(2H, q, J = 7.1Hz), 5.28(2H, d, J = 7.7Hz), 5.29(1H, d, J = 4.8Hz), 5.93(1H, dd, J = 8.1, 4.8Hz), 6.44(1H, dt, J = 15.3, 7.7Hz), 6.75(1H, s), 6.91(1H, d, J = 15.3Hz), 6.93(1H, s), 7.20-7.55(m, 12H), 8. 00(1H, br s), 8.60(2H, m), 9.02(2H, m), 9.66(1H , d, J = 7.7Hz). 0 (2H, q, J = 7.1Hz), 5.28 (2H, d, J = 7.7Hz), 5.29 (1H, d, J = 4.8Hz), 5.93 (1H, dd, J = 8.1, 4.8Hz), 6.44 (1H, dt, J = 15.3, 7.7Hz), 6.75 (1H, s), 6.91 (1H, d, J = 15.3Hz), 6.93 (1H, s), 7.20-7.55 (m, 12H), 8 00 (1H, br s), 8.60 (2H, m), 9.02 (2H, m), 9.66 (1H, d, J = 7.7Hz).
(5) 7→1 (5) 7 → 1
化合物 7(1.782g,2.19mmol)を塩化メチレン (11ml)とァニソール (1.78ml)に溶解し、 0 °Cに冷却し、無水トリフルォロ酢酸 5.3mlを加えた。混合液を 0°Cで 55分攪拌した後、 イソプロパノール 80mlに氷冷下で攪拌しながら注加した。析出した沈殿物を濾取し、 飽和 NaHCO水で溶解させた。溶液を HP-20SSカラムクロマトグラフィーに付し、水- ァセトニトリルで溶離した。所望の化合物を含むフラクションを減圧下濃縮し、濃縮液
を凍結乾燥して化合物 1を粉末として得た。収量 133mg(8%) Compound 7 (1.782 g, 2.19 mmol) was dissolved in methylene chloride (11 ml) and anisole (1.78 ml), cooled to 0 ° C., and 5.3 ml of trifluoroacetic anhydride was added. The mixture was stirred at 0 ° C for 55 minutes, and then poured into 80 ml of isopropanol with stirring under ice cooling. The deposited precipitate was collected by filtration and dissolved with saturated aqueous NaHCO. The solution was subjected to HP-20SS column chromatography and eluted with water-acetonitrile. Concentrate the fraction containing the desired compound under reduced pressure and concentrate Was lyophilized to obtain Compound 1 as a powder. Yield 133 mg (8%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.1Hz), 3.43, 3.51(2H, ABq, J = 16.8Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.1Hz), 3.43, 3.51 (2H, ABq, J = 16.8Hz), 4.0
9(2H, q, J = 7.1 Hz), 5.05(1H, d, J = 5.0Hz), 5.24(2H, d, J = 6.8Hz), 5.60(1H, dd, J = 8.0, 5.0Hz), 5.86(1H, dt, J = 16.1, 6.8Hz), 6.72(1H, s), 7.23(2H, s), 7.30(1H, d, J = 16.1Hz), 7.51(1H, s), 8.52(2H, d, J = 7.1Hz), 8.93(2H, d, J = 7.1Hz), 9.54(1H, d , J = 8.0Hz), 14.2(1H, br s). 9 (2H, q, J = 7.1 Hz), 5.05 (1H, d, J = 5.0Hz), 5.24 (2H, d, J = 6.8Hz), 5.60 (1H, dd, J = 8.0, 5.0Hz), 5.86 (1H, dt, J = 16.1, 6.8Hz), 6.72 (1H, s), 7.23 (2H, s), 7.30 (1H, d, J = 16.1Hz), 7.51 (1H, s), 8.52 (2H , D, J = 7.1Hz), 8.93 (2H, d, J = 7.1Hz), 9.54 (1H, d, J = 8.0Hz), 14.2 (1H, br s).
IR (KBr) cm_1:3408, 1763, 1636, 1535, 13899, 1369, 1036, 970. IR (KBr) cm _1 : 3408, 1763, 1636, 1535, 13899, 1369, 1036, 970.
MS(ESI): 649+ (M-Na+2H)+ MS (ESI): 649 + (M-Na + 2H) +
元素分析 C H N O S Na- 5.2H O -O.lNaHCO Elemental analysis C H N O S Na- 5.2H O -O.lNaHCO
計算値: C,40.57; H,4.37; N,21.75; S,8.30; Na,3.27 (%) Calculated value: C, 40.57; H, 4.37; N, 21.75; S, 8.30; Na, 3.27 (%)
実験値: C40.60; H,4.34; N,21.50; S,8.45; Na,3.26 (%) Experimental value: C40.60; H, 4.34; N, 21.50; S, 8.45; Na, 3.26 (%)
実施例 123 Example 123
[化 168] [Chemical 168]
10 Ten
(1) 9→10 (1) 9 → 10
化合物 9(4.69g,20.0mmol)を 28%アンモニア水(71ml)に懸濁させ、 60°Cに加熱し、 1 時間 30分攪拌した。固体をろ取し 10を固体として得た。収量 3.1g(76%)。 Compound 9 (4.69 g, 20.0 mmol) was suspended in 28% aqueous ammonia (71 ml), heated to 60 ° C., and stirred for 1 hour 30 minutes. The solid was collected by filtration to give 10 as a solid. Yield 3.1 g (76%).
'H-NMR (d -DMSO): 7.74(1H, br),8.01(3H, dd, J = 1.8, 4.8Hz), 8.45(1H, s), 8.75('H-NMR (d-DMSO): 7.74 (1H, br), 8.01 (3H, dd, J = 1.8, 4.8Hz), 8.45 (1H, s), 8.75 (
2H, dd, J = 1.8, 4.8Hz).
(2) 10→11 (2H, dd, J = 1.8, 4.8Hz). (2) 10 → 11
化合物 10(3.0g,14.6mmol)をピリジン (36.5mL)に溶解させ、無水トリフルォロ酢酸 (6.7 5g, 32.1mmol)を滴下した。 60°Cで 2時間攪拌後、トルエン (35ml)を加えピリジンを減圧 留去した。精製水を加え、クロ口ホルムで抽出した。有機層を精製水、飽和食塩水に より洗浄し、無水硫酸ナトリウムで乾燥させた。溶媒を減圧留居し、粗生成物をジイソ プロピルエーテルで洗浄し 11を褐色固体として得た。収量 2.50g(92%) Compound 10 (3.0 g, 14.6 mmol) was dissolved in pyridine (36.5 mL), and trifluoroacetic anhydride (6.7 5 g, 32.1 mmol) was added dropwise. After stirring at 60 ° C for 2 hours, toluene (35 ml) was added and pyridine was distilled off under reduced pressure. Purified water was added and extracted with black mouth form. The organic layer was washed with purified water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the crude product was washed with diisopropyl ether to obtain 11 as a brown solid. Yield 2.50 g (92%)
'H-NMR (d -DMSO): 7.96(2H, dd, J = 1.5, 4.5Hz),8.77(2H, dd, J = 1.5, 4.5Hz), 9. 'H-NMR (d-DMSO): 7.96 (2H, dd, J = 1.5, 4.5Hz), 8.77 (2H, dd, J = 1.5, 4.5Hz), 9.
07(1H, s). 07 (1H, s).
(3) 11→12 (3) 11 → 12
化合物 ll(562mg,3.00mmol)、アジ化ナトリウム (215mg, 3.30mmol)と塩化アンモニゥ ム (177mg, 3.30mmol)をジメチルホルムアミド (6.00mL)に溶解させ、 110°Cで 2時間攪 拌した。 0°Cに冷却後、精製水 (10ml)をカ卩え, 2M塩酸により pHを 3.5とした。析出した 固体をろ取し、 12を黄白色固体として得た。収量 669mg(97%) Compound ll (562 mg, 3.00 mmol), sodium azide (215 mg, 3.30 mmol) and ammonium chloride (177 mg, 3.30 mmol) were dissolved in dimethylformamide (6.00 mL) and stirred at 110 ° C. for 2 hours. After cooling to 0 ° C, purified water (10 ml) was added, and the pH was adjusted to 3.5 with 2M hydrochloric acid. The precipitated solid was collected by filtration to obtain 12 as a pale yellow solid. Yield 669 mg (97%)
'H-NMR (d -DMSO): 8.02(2H, dd, J = 1.8, 4.5Hz), 8.74 (1H, s), 8.81(2H, dd, J = 1 'H-NMR (d-DMSO): 8.02 (2H, dd, J = 1.8, 4.5Hz), 8.74 (1H, s), 8.81 (2H, dd, J = 1
.8, 4.5Hz), 9.07(1H, s). .8, 4.5Hz), 9.07 (1H, s).
(4) 12→8 (4) 12 → 8
実施例 122の化合物 2(1.68g、 2.50mmol)をジクロロメタン (20ml)に懸濁させ、氷冷下 炭酸水素ナトリウム水溶液 (315mg、 3.75mmolを水 20mlに溶解)を加え、ジクロロメタン で抽出し、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルスルホキ シド (10ml)に溶解し、化合物 12(576mg,2.50mmol)と混合し、ヨウ化ナトリウム (1.10g、 7. 50mmol)を加えて、室温で 4時間半攪拌した。反応液を冷却下、 5%食塩水 (100ml)攪 拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して無定形粉末 (2.48g)を 得た。無定形粉末 (2.48g)をジクロロメタン (25.0ml)に溶解し、ァニソール (2.50ml)を加 え、 -30°Cに冷却した。 2M四塩化チタン(ジクロロメタン溶液 5.24ml)を滴下し、混合 液を _20°Cで 2時間 15分攪拌した。水(120ml)に氷冷下で攪拌しながら注加した後、 ジイソプロピルエーテル 120mlを加えて、析出した沈殿物を濾過した。濾取物を水中 に懸濁させ、飽和重曹水を加えて pH=7.5とし、さらにァセトニトリルをカ卩えて不溶物を 濾去した。得られた濾液に HP-20SSを加えて減圧濃縮し、 HP-20SSカラムクロマトダラ
フィ一に付して、水 -ァセトニトリルで溶離した。所望の化合物を含むフラクションを減 圧下濃縮し、濃縮液を凍結乾燥して化合物 8を粉末として得た。収量 103mg(4.9% in 2 steps) Compound 2 of Example 122 (1.68 g, 2.50 mmol) was suspended in dichloromethane (20 ml), and an aqueous sodium hydrogen carbonate solution (315 mg, 3.75 mmol was dissolved in 20 ml of water) was added under ice cooling, followed by extraction with dichloromethane and sulfuric acid. Dried with magnesium. After distilling off the solvent, quickly dissolve in dimethyl sulfoxide (10 ml), mix with compound 12 (576 mg, 2.50 mmol), add sodium iodide (1.10 g, 7.50 mmol), and at room temperature for 4 hours. Half stirred. The reaction mixture was poured into 5% brine (100 ml) with stirring under cooling, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain an amorphous powder (2.48 g). Amorphous powder (2.48 g) was dissolved in dichloromethane (25.0 ml), and anisole (2.50 ml) was added and cooled to -30 ° C. 2M titanium tetrachloride (dichloromethane solution 5.24 ml) was added dropwise, and the mixture was stirred at _20 ° C for 2 hours and 15 minutes. The mixture was poured into water (120 ml) with stirring under ice-cooling, 120 ml of diisopropyl ether was added, and the deposited precipitate was filtered. The filtered product was suspended in water, saturated aqueous sodium hydrogen carbonate was added to adjust the pH to 7.5, and acetonitrile was further added to remove insolubles. HP-20SS was added to the obtained filtrate and concentrated under reduced pressure. The sample was eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 8 as a powder. Yield 103mg (4.9% in 2 steps)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.43, 3.51(2H, ABq, J = 17.1Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.43, 3.51 (2H, ABq, J = 17.1Hz), 4.0
6 6
9(2H, q, 6.9Hz), 5.06(1H, d, J = 4.8Hz), 5.33(2H, d, J = 6.9Hz), 5.60(1H, dd, J = 8. 7, 4.8Hz), 5.86(1H, dt, J = 15.9, 6.9Hz), 6.72(1H, s), 7.23(2H, s), 7.27(1H, d, J = 1 5.9Hz), 7.44(1H, d, J = 8.1Hz), 8.37(1H, s), 8.63(2H, d, J = 6.9Hz), 9.09 (2H, d, J = 6.9Hz), 9.55(1H, d, J = 8.7Hz). 9 (2H, q, 6.9Hz), 5.06 (1H, d, J = 4.8Hz), 5.33 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 8.7, 4.8Hz), 5.86 (1H, dt, J = 15.9, 6.9Hz), 6.72 (1H, s), 7.23 (2H, s), 7.27 (1H, d, J = 1 5.9Hz), 7.44 (1H, d, J = 8.1 Hz), 8.37 (1H, s), 8.63 (2H, d, J = 6.9Hz), 9.09 (2H, d, J = 6.9Hz), 9.55 (1H, d, J = 8.7Hz).
IR (KBr) cm_1:3408, 1761, 1634, 1532 IR (KBr) cm _1 : 3408, 1761, 1634, 1532
MS(ESI): 667+ (M-Na+2H)+ MS (ESI): 667 + (M-Na + 2H) +
元素分析 C H N O S Na- 5.7 H O - 0.5(NaHCO ) Elemental analysis C H N O S Na- 5.7 H O-0.5 (NaHCO)
26 22 11 5 3 2 3 26 22 11 5 3 2 3
計算値: C, 38.24; H, 4.10; N, 18.51 ; S, 11.56; Na, 4.14 (%) Calculated values: C, 38.24; H, 4.10; N, 18.51; S, 11.56; Na, 4.14 (%)
実験値: C, 38.27; H, 4.13; N, 18.36; S, 11.50; Na, 4.27 (%) Experimental values: C, 38.27; H, 4.13; N, 18.36; S, 11.50; Na, 4.27 (%)
実施例 124 Example 124
[化 169]
[Chemical 169]
(1) 14→15 (1) 14 → 15
化合物 14(562mg,3.00mmol)をピリジン (6.8ml)に懸濁させ、トリフルォロ酢酸無水物( 0.847ml,6.00mmol)を加えて 60°Cにて 4時間攪拌した。トルエンを加えて減圧濃縮し、 水、酢酸ェチルを加え、酢酸ェチルで抽出した。水層を 2N Na〇Hでアルカリ性とし、 酢酸ェチルで抽出した。全ての有機層を併せて、水、飽和食塩水で洗浄し、無水硫 酸ナトリウムで乾燥した。溶媒を減圧留去し、残渣をジイソプロピルエーテルで洗浄し て、化合物 15を淡褐色結晶として得た。収量 264mg(52%)。 Compound 14 (562 mg, 3.00 mmol) was suspended in pyridine (6.8 ml), trifluoroacetic anhydride (0.847 ml, 6.00 mmol) was added, and the mixture was stirred at 60 ° C. for 4 hours. Toluene was added and the mixture was concentrated under reduced pressure, water and ethyl acetate were added, and extraction was performed with ethyl acetate. The aqueous layer was made alkaline with 2N NaOH and extracted with ethyl acetate. All organic layers were combined, washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was washed with diisopropyl ether to obtain Compound 15 as light brown crystals. Yield 264 mg (52%).
'H-NMR (d -DMSO): 7.56(1H, t, J = 1.8Hz), 7.62(2H, d, J = 6.3Hz), 7.91(1H, dd, 'H-NMR (d-DMSO): 7.56 (1H, t, J = 1.8Hz), 7.62 (2H, d, J = 6.3Hz), 7.91 (1H, dd,
J = 3.0, 1.8Hz), 8.50(2H, d, J = 6.3Hz), 12.4(1H, br s). J = 3.0, 1.8Hz), 8.50 (2H, d, J = 6.3Hz), 12.4 (1H, br s).
(2) 15→16 (2) 15 → 16
化合物 15(346mg,2.05mmol)、アジ化ナトリウム (146mg、 2.25mmol)、塩化アンモニゥ ム (120mg、 2.25mmol)より、実施例 122(3)と同様の手法にて化合物 16を無色結晶とし て得た。収量 346mg(80%)。 Compound 16 was obtained as colorless crystals from compound 15 (346 mg, 2.05 mmol), sodium azide (146 mg, 2.25 mmol), and ammonium chloride (120 mg, 2.25 mmol) in the same manner as in Example 122 (3). It was. Yield 346 mg (80%).
'H-NMR (d -DMSO): 7.47(1H, t, J = 1.8Hz), 7.93(2H, d, J = 6.6Hz), 8.06(1H, dd,
J = 3.0, 1.8Hz), 8.63(2H, d, J = 6.6Hz), 12.8(1H, br s). 'H-NMR (d-DMSO): 7.47 (1H, t, J = 1.8Hz), 7.93 (2H, d, J = 6.6Hz), 8.06 (1H, dd, J = 3.0, 1.8Hz), 8.63 (2H, d, J = 6.6Hz), 12.8 (1H, br s).
(3) 16+2→17 (3) 16 + 2 → 17
実施例 122の化合物 2(1.082g、 1.60mmol)をジクロロメタン (15ml)に懸濁させ、氷冷 下、炭酸水素ナトリウム水溶液 (202mg、 2.41mmolを水 15mlに溶解)を加え、ジクロロメ タンで抽出し、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルスル ホキシド (6ml)に溶解し、化合物 16(340mg、 1.60mmol)と混合し、次いでヨウ化ナトリウ ム (720mg、 4.81mmol)をカ卩えて、室温で 4時間攪拌した。反応液を 5%食塩水 (50ml)攪 拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して化合物 17を無定形粉 末として得た。収量 1.544g。 Compound 2 of Example 122 (1.082 g, 1.60 mmol) was suspended in dichloromethane (15 ml), and an aqueous sodium hydrogen carbonate solution (202 mg, 2.41 mmol dissolved in 15 ml of water) was added under ice cooling, followed by extraction with dichloromethane. And dried over magnesium sulfate. After distilling off the solvent, quickly dissolve in dimethyl sulfoxide (6 ml), mix with compound 16 (340 mg, 1.60 mmol), then add sodium iodide (720 mg, 4.81 mmol) and stir at room temperature for 4 hours. did. The reaction solution was poured into 5% brine (50 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 17 as an amorphous powder. Yield 1.544g.
'H-NMR (d -DMSO): 1.23(3H, t, J = 7.2Hz), 3.65, 3.91(2H, ABq, J = 18.0Hz), 4.1 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.2Hz), 3.65, 3.91 (2H, ABq, J = 18.0Hz), 4.1
1(2H, q, J = 7.2Hz), 5.16(2H, d, J = 6.0Hz), 5.29(1H, d, J = 4.8Hz), 5.92(1H, dd, J = 8.4, 4.8Hz), 6.41(1H, dt, J = 15.5, 6.0Hz), 6.75(1H, s), 6.86(1H, d, J = 15.5Hz), 6.92(1H, s), 7.25-7.60(m, 12H), 8.21(1H, m) , 8.25(2H, d, J = 6.9Hz), 8.32(1H, m), 8.74(2H, d, J = 6.9Hz), 9.76(1H, d, J = 8.4Hz), 13.1(1H, brs). 1 (2H, q, J = 7.2Hz), 5.16 (2H, d, J = 6.0Hz), 5.29 (1H, d, J = 4.8Hz), 5.92 (1H, dd, J = 8.4, 4.8Hz), 6.41 (1H, dt, J = 15.5, 6.0Hz), 6.75 (1H, s), 6.86 (1H, d, J = 15.5Hz), 6.92 (1H, s), 7.25-7.60 (m, 12H), 8.21 (1H, m), 8.25 (2H, d, J = 6.9Hz), 8.32 (1H, m), 8.74 (2H, d, J = 6.9Hz), 9.76 (1H, d, J = 8.4Hz), 13.1 (1H, brs).
(4) 17→13 (4) 17 → 13
化合物 17(1.532g,1.882mmol)を塩化メチレン (15ml)とァニソール (1.53ml)に溶解し、 -30°Cに冷却し、 2M四塩ィヒチタンジクロロメタン溶液 7.5mlを加えた。混合液を- 30°C で 15分攪拌した後、ニトロメタン (6ml)を加えて、さらに 45分撹拌後、水 (40ml)に氷冷 下で攪拌しながら注加した。ジイソプロピルエーテル 40mlを加えて、析出した沈殿物 を濾過した。濾取物を水中に懸濁させ、飽和重曹水をカ卩えて pH=7.5とし、さらにァセ トニトリルを加えて不溶物を濾過した。得られた濾液に HP-20SSを加えて減圧濃縮し 、 HP-20SSカラムクロマトグラフィーに付して、水-ァセトニトリルで溶離した。所望の化 合物を含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥して化合物 13を粉末とし て得た。収量 308mg(2より通算 25%) Compound 17 (1.532 g, 1.882 mmol) was dissolved in methylene chloride (15 ml) and anisole (1.53 ml), cooled to −30 ° C., and 7.5 ml of 2M tetrasalt titanium titanium dichloromethane solution was added. The mixture was stirred at −30 ° C. for 15 minutes, nitromethane (6 ml) was added, and the mixture was further stirred for 45 minutes, and then poured into water (40 ml) with stirring under ice cooling. 40 ml of diisopropyl ether was added, and the deposited precipitate was filtered. The filtered product was suspended in water, saturated aqueous sodium hydrogen carbonate was added to adjust the pH to 7.5, and acetonitrile was further added to filter insoluble matters. HP-20SS was added to the obtained filtrate, and the filtrate was concentrated under reduced pressure, subjected to HP-20SS column chromatography, and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 13 as a powder. Yield 308mg (25% from 2)
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.1Hz), 3.42, 3.56(2H, ABq, J = 16.8Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.1Hz), 3.42, 3.56 (2H, ABq, J = 16.8Hz), 4.0
9(2H, q, J = 7.1 Hz), 5.04(1H, d, J = 5.1Hz), 5.09(2H, d, J = 7.5Hz), 5.59(1H, dd, J = 8.1, 5.1Hz), 5.83(1H, dt, J = 15.6, 7.5Hz), 6.72(1H, s), 7.11(1H, d, J = 1.8Hz), 7 • 23(2H, s), 7.25(1H, d, J = 15.6Hz), 7.95(1H, d, J = 1.8Hz), 8.20(2H, d, J = 6.9Hz),
8.63(2H, d, J = 6.9Hz), 9.54(1H, d, J = 8.1Hz), 12.3(1H, br s). 9 (2H, q, J = 7.1 Hz), 5.04 (1H, d, J = 5.1 Hz), 5.09 (2H, d, J = 7.5 Hz), 5.59 (1H, dd, J = 8.1, 5.1 Hz), 5.83 (1H, dt, J = 15.6, 7.5Hz), 6.72 (1H, s), 7.11 (1H, d, J = 1.8Hz), 7 • 23 (2H, s), 7.25 (1H, d, J = 15.6Hz), 7.95 (1H, d, J = 1.8Hz), 8.20 (2H, d, J = 6.9Hz), 8.63 (2H, d, J = 6.9Hz), 9.54 (1H, d, J = 8.1Hz), 12.3 (1H, br s).
1R (KBr) cm— 3398, 1762, 1634, 1612, 1549, 1385, 1357, 1166, 1143, 1035. 1R (KBr) cm— 3398, 1762, 1634, 1612, 1549, 1385, 1357, 1166, 1143, 1035.
MS(ESI): 648+ (M_Na+2H)+ MS (ESI): 648+ (M_Na + 2H) +
元素分析 C H N O S Na- 5.0H O - 0.2NaHCO Elemental analysis C H N O S Na- 5.0H O-0.2NaHCO
27 24 11 5 2 2 3 27 24 11 5 2 2 3
計算値: C,42.07; H,4.44; N, 19.84; S,8.24; Na,3.55 (%) Calculated value: C, 42.07; H, 4.44; N, 19.84; S, 8.24; Na, 3.55 (%)
実験値: C42.08; H,4.46; N, 19.64; S,8.44; Na,3.61 (%) Experimental value: C42.08; H, 4.46; N, 19.64; S, 8.44; Na, 3.61 (%)
実施例 125 Example 125
[化 170] [Chemical 170]
23 twenty three
(1) 5→20 (1) 5 → 20
塩化ヒドロキシアンモユウム(2.78g, 40.0mmol)をジメチルスルホキシド (8ml)に溶解 し、トリェチルァミン (4.04g, 40.0mmol)を加えた。不溶物を濾去し、化合物 5を加え、 75 °Cで一晩攪拌した。精製水を加え、 pHを 5.1に調整し、析出物をろ取し 20を褐色粉末 として得た。収量 (1.20g, 68%) Hydroxyammonium chloride (2.78 g, 40.0 mmol) was dissolved in dimethyl sulfoxide (8 ml), and triethylamine (4.04 g, 40.0 mmol) was added. The insoluble material was removed by filtration, compound 5 was added, and the mixture was stirred at 75 ° C overnight. Purified water was added to adjust the pH to 5.1, and the precipitate was collected by filtration to obtain 20 as a brown powder. Yield (1.20g, 68%)
(2) 20→21 (2) 20 → 21
化合物 20(610mg, 3. OOmmol)をジメチルホルムアミド (6ml)に懸濁させ、チォカルボ二 ルジイミダゾール (588mg, 3.30mmol)を加え、 1時間半攪拌し、精製水(10mL)を加え た。析出した固体をろ取し、 21を得た。収量 (723mg, 77%)
(3) 21→22 Compound 20 (610 mg, 3.OOmmol) was suspended in dimethylformamide (6ml), thiocarbodiimidazole (588mg, 3.30mmol) was added, stirred for 1.5 hours, and purified water (10mL) was added. The precipitated solid was collected by filtration to obtain 21. Yield (723mg, 77%) (3) 21 → 22
化合物 21(723mg, 2.3111111101)をジメチルホルムァミド(7.51111)に懸濁させ、三フッ化ホ ゥ素エーテル錯体 (1.64g, 11.2mmol)を滴下し、室温で 6時間攪拌後、 60°Cで 1時間攪 拌した。反応液に精製水(7.5ml)を加え、 pHを 3.5とし、析出した固体をろ取し 22を得 た。収量 (353mg, 62%) Compound 21 (723 mg, 2.3111111101) was suspended in dimethylformamide (7.51111), and a fluorine trifluoride ether complex (1.64 g, 11.2 mmol) was added dropwise thereto, followed by stirring at room temperature for 6 hours, and then at 60 ° C. Stir for 1 hour. Purified water (7.5 ml) was added to the reaction solution to adjust the pH to 3.5, and the precipitated solid was collected by filtration to obtain 22. Yield (353mg, 62%)
(4) 22+19→23 (4) 22 + 19 → 23
化合物 19(1.24g、 1.31mmol)と化合物 22(328mg, 1.34mmol)をジメチルスルホキシドズ 2.6ml)に溶解させ、ヨウ化ナトリウム (601mg, 4.01mmol)を加え、遮光下、室温で 6時間 半攪拌した。反応液を冷却下、 5%食塩水 (30ml)攪拌中に注加し、析出した沈殿を濾 取した。沈殿を減圧乾燥して無定形粉末として 23を得た (1.27g)。 Compound 19 (1.24 g, 1.31 mmol) and Compound 22 (328 mg, 1.34 mmol) are dissolved in dimethyl sulfoxides 2.6 ml), sodium iodide (601 mg, 4.01 mmol) is added, and the mixture is stirred at room temperature for 6 hours and a half for 6 hours. did. The reaction mixture was poured into 5% brine (30 ml) with stirring under cooling, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain 23 as an amorphous powder (1.27 g).
'H-NMR (d -DMSO): 1.25(3H, t, J = 7.2Hz), 1.45(9H, s), 3.66, 3.91(2H, ABq, J ='H-NMR (d-DMSO): 1.25 (3H, t, J = 7.2Hz), 1.45 (9H, s), 3.66, 3.91 (2H, ABq, J =
18.0Hz), 4.14(2H, q, J = 7.2Hz), 5.26_5.31(3H, m), 5.95(1H, dd, J = 8.1, 4.8Hz), 6. 42(1H, dt, J = 15.1, 6.6Hz), 6.92(1H, s), 7.29-7.50(13H, m).7.86(lH, s), 8.46(1H, br), 9.05(2H, d, J = 7.1Hz), 9.73(1H, d, J = 8.1Hz). 18.0Hz), 4.14 (2H, q, J = 7.2Hz), 5.26_5.31 (3H, m), 5.95 (1H, dd, J = 8.1, 4.8Hz), 6. 42 (1H, dt, J = 15.1, 6.6Hz), 6.92 (1H, s), 7.29-7.50 (13H, m) .7.86 (lH, s), 8.46 (1H, br), 9.05 (2H, d, J = 7.1Hz), 9.73 ( (1H, d, J = 8.1Hz).
(5) 23→18 (5) 23 → 18
無定形粉末 23(1.24g)をジクロロメタン (12.5ml)に溶解し、ァニソール (1.25ml)を加え、 -30°Cに冷却した。 2M四塩ィ匕チタン (ジクロロメタン溶液)を滴下し (5.24ml)、実施例 1 23(3)と同じ方法で化合物 18を粉末として得た。収量 273mg(25% in 2 steps) Amorphous powder 23 (1.24 g) was dissolved in dichloromethane (12.5 ml), anisole (1.25 ml) was added, and the mixture was cooled to -30 ° C. 2M Tetrachloride-titanium (dichloromethane solution) was added dropwise (5.24 ml), and Compound 18 was obtained as a powder in the same manner as in Example 1 23 (3). Yield 273 mg (25% in 2 steps)
JH-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 3.44, 3.51(2H, ABq, J = 17.1Hz), 4.0JH-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 3.44, 3.51 (2H, ABq, J = 17.1Hz), 4.0
9(2H, q, J = 7.2Hz), 5.05(1H, d, J = 4.8Hz), 5.23(2H, d, J = 7.2Hz), 5.60(1H, dd, J = 8.1, 4.8Hz), 5.86(1H, dt, J = 15.6, 7.2Hz), 6.72(1H, s), 7.23(2H, s), 7.30(1H, d, J = 15.6Hz), 7.48(1H, s), 8.48(2H, d, J = 6.6Hz), 8.92 (2H, d, J = 6.6Hz), 9.54(1H, d, J = 8.1Hz). 9 (2H, q, J = 7.2Hz), 5.05 (1H, d, J = 4.8Hz), 5.23 (2H, d, J = 7.2Hz), 5.60 (1H, dd, J = 8.1, 4.8Hz), 5.86 (1H, dt, J = 15.6, 7.2Hz), 6.72 (1H, s), 7.23 (2H, s), 7.30 (1H, d, J = 15.6Hz), 7.48 (1H, s), 8.48 (2H , d, J = 6.6Hz), 8.92 (2H, d, J = 6.6Hz), 9.54 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3397, 1761, 1636, 1603, 1535, 1391 IR (KBr) cm _1 : 3397, 1761, 1636, 1603, 1535, 1391
MS( ESI): 681+ (M-Na+2H)+ MS (ESI): 681 + (M-Na + 2H) +
元素分析 C H N O S Na-4.4 H O -0.5(NaHCO ) Elemental analysis C H N O S Na-4.4 H O -0.5 (NaHCO)
計算値: C, 40.08; H, 3.95; N, 17.00; S, 11.67; Na, 4.19 (%) Calculated values: C, 40.08; H, 3.95; N, 17.00; S, 11.67; Na, 4.19 (%)
実験値: C, 40.09; H, 4.10; N, 17.17; S, 11.52; Na, 4.26 (%)
実施例 126 Experimental values: C, 40.09; H, 4.10; N, 17.17; S, 11.52; Na, 4.26 (%) Example 126
[化 171] [Chemical 171]
2S 2S
(1) 25→26 (1) 25 → 26
化合物 25(1.17g,5.0mmol)をエタノール (12ml)に懸濁させ、ヒドラジン一水和物 (1.30g , 25.0mmol)を加え、 1時間攪拌した。析出物をろ取し 26を固体として得た。収量 890m g(81%)。 Compound 25 (1.17 g, 5.0 mmol) was suspended in ethanol (12 ml), hydrazine monohydrate (1.30 g, 25.0 mmol) was added, and the mixture was stirred for 1 hour. The precipitate was collected by filtration to obtain 26 as a solid. Yield 890 mg (81%).
JH-NMR (d -DMSO): 8·04(2Η, d, J = 6·0Ηζ),8.69(2Η, d, J = 6.0Hz), 8.72(1H, s). J H-NMR (d-DMSO): 8.04 (2Η, d, J = 6.0 6ζ), 8.69 (2Η, d, J = 6.0Hz), 8.72 (1H, s).
6 6
(2) 26→27 (2) 26 → 27
化合物 26(853mg,3.89mmol)をテトラヒドロフラン (100ml)に懸濁させ、トリェチルァミン (433mg, 4.28mmol)を加え、 0°Cに冷却した。反応液にカルボニルジイミダゾール(883 mg, 5.44mmol)をカ卩ぇ室温で 4時間半攪拌した。テトラヒドロフランを 90ml留去し、精製 水を加え pHを 3.5とし、析出した固体をろ取し、 27を得た。収量 901mg(94%)。 Compound 26 (853 mg, 3.89 mmol) was suspended in tetrahydrofuran (100 ml), triethylamine (433 mg, 4.28 mmol) was added, and the mixture was cooled to 0 ° C. To the reaction solution, carbonyldiimidazole (883 mg, 5.44 mmol) was stirred at room temperature for 4 and a half hours. 90 ml of tetrahydrofuran was distilled off, purified water was added to adjust the pH to 3.5, and the precipitated solid was collected by filtration to obtain 27. Yield 901 mg (94%).
'H-NMR (d -DMSO): 7.97(2H, d, J = 4.5Hz),8.70(2H, d, J = 4.5Hz), 8.77(1H, s). 'H-NMR (d-DMSO): 7.97 (2H, d, J = 4.5Hz), 8.70 (2H, d, J = 4.5Hz), 8.77 (1H, s).
6 6
(3) 27→28 (3) 27 → 28
実施例 122の化合物 2(1.01g、 1.50mmol)をジクロロメタン (10ml)に懸濁させ、氷冷下 炭酸水素ナトリウム水溶液 (189mg、 3.75mmolを水 10mlに溶解)を加え、ジクロロメタン で抽出し、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルスルホキ
シド (6ml)に溶解し、化合物 27(369mg,1.50mmol)と混合し、ヨウ化ナトリウム (675mg、 4. 50mmol)を加えて、室温で 5時間半攪拌した。反応液を冷却下、 5%食塩水 (45ml)攪 拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して無定形粉末として 28( 1.21g)を得た。 Compound 2 of Example 122 (1.01 g, 1.50 mmol) was suspended in dichloromethane (10 ml), and an aqueous sodium hydrogen carbonate solution (189 mg, 3.75 mmol was dissolved in 10 ml of water) was added under ice cooling, followed by extraction with dichloromethane and sulfuric acid. Dried with magnesium. Immediately after distilling off the solvent, dimethylsulfoxide It was dissolved in side (6 ml), mixed with compound 27 (369 mg, 1.50 mmol), sodium iodide (675 mg, 4.50 mmol) was added, and the mixture was stirred at room temperature for 5 and a half hours. The reaction solution was poured into 5% brine (45 ml) with stirring under cooling, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain 28 (1.21 g) as an amorphous powder.
'H-NMR (d -DMSO): 1.23(3H, t, J = 7.2Hz), 3.65, 3.90(2H, ABq, J = 17.7Hz), 4.1 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.2Hz), 3.65, 3.90 (2H, ABq, J = 17.7Hz), 4.1
0(2H, q, J = 7.2Hz), 5.29(1H, d, J = 5.1), 5·839_5·941(1Η, m), 6.43(1H, m), 6.75—7. 50(14H, m), 7.97(1H, d, J = 6.0Hz), 8.70(1H, d, J = 6.0Hz), 8.76(1H, s), 9.63(1H, d , J = 8.1Hz). 0 (2H, q, J = 7.2Hz), 5.29 (1H, d, J = 5.1), 5 · 839_5 · 941 (1Η, m), 6.43 (1H, m), 6.75-7.50 (14H, m ), 7.97 (1H, d, J = 6.0Hz), 8.70 (1H, d, J = 6.0Hz), 8.76 (1H, s), 9.63 (1H, d, J = 8.1Hz).
(4) 28→24 (4) 28 → 24
化合物 28(1.21g)をジクロロメタン (7.20ml)に溶解し、ァニソール (1.21ml)を加え、 -30 °Cに冷却した。トリフルォロ酢酸 (3.6ml)を滴下し、実施例 123(3)と同じ方法で化合物 24を粉末として得た。収量 184mg(15.0% in 2steps) Compound 28 (1.21 g) was dissolved in dichloromethane (7.20 ml), anisole (1.21 ml) was added, and the mixture was cooled to -30 ° C. Trifluoroacetic acid (3.6 ml) was added dropwise to give Compound 24 as a powder in the same manner as in Example 123 (3). Yield 184mg (15.0% in 2steps)
JH-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.43, 3.51(2H, ABq, J = 16.5Hz), 4.0 J H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.43, 3.51 (2H, ABq, J = 16.5Hz), 4.0
9(2H, q, J = 6.9Hz), 5.05(1H, d, J = 5.1Hz), 5.27(2H, d, J = 6.0Hz), 5.59(1H, dd, J = 8.4, 5.1Hz), 5.87(1H, dt, J = 16.2, 6.9Hz), 6.72(1H, s), 7.27(2H, s), 7.30(1H, d, J = 16.2Hz), 8.58(2H, d, J = 6.0Hz), 8.92(1H, s), 9.03 (2H, d, J = 6.0Hz), 9.54(1H, d, J = 8.4Hz). 9 (2H, q, J = 6.9Hz), 5.05 (1H, d, J = 5.1Hz), 5.27 (2H, d, J = 6.0Hz), 5.59 (1H, dd, J = 8.4, 5.1Hz), 5.87 (1H, dt, J = 16.2, 6.9Hz), 6.72 (1H, s), 7.27 (2H, s), 7.30 (1H, d, J = 16.2Hz), 8.58 (2H, d, J = 6.0Hz ), 8.92 (1H, s), 9.03 (2H, d, J = 6.0Hz), 9.54 (1H, d, J = 8.4Hz).
IR (KBr) cm"1:3419, 1762, 1667, 1634, 1531, 1387 IR (KBr) cm " 1 : 3419, 1762, 1667, 1634, 1531, 1387
MS(ESI): 682+ (M-Na+2H)+ MS (ESI): 682 + (M-Na + 2H) +
元素分析 C H N O S Na-4.8 H O - 0.3(NaHCO ) Elemental analysis C H N O S Na-4.8 H O-0.3 (NaHCO)
計算値: C, 40.21; H, 3.94; N, 15.46; S, 11.80; Na, 3.67 (%) Calculated values: C, 40.21; H, 3.94; N, 15.46; S, 11.80; Na, 3.67 (%)
実験値: C, 40.40; H, 3.99; N, 15.39; S, 11.50; Na, 3.61 (%) Experimental values: C, 40.40; H, 3.99; N, 15.39; S, 11.50; Na, 3.61 (%)
実施例 127 Example 127
[化 172]
[Chemical 172]
31 31
(1) 6+30→31 (1) 6 + 30 → 31
化合物 30(802mg、 1.07mmol)と化合物 6(227mg, 1.07mmol)をジメチルスルホキシド (1 • 5ml)とジメチルホルムアミド (2. Oml)に溶解させ、臭化化ナトリウム (269mg, 3.20mmol) を加え、室温で一昼夜攪拌した。反応液を冷却下、 5%食塩水 (30ml)攪拌中に注カロ し、析出した沈殿を濾取した。沈殿を減圧乾燥して無定形粉末として 31を得た (959m g)。 Compound 30 (802 mg, 1.07 mmol) and compound 6 (227 mg, 1.07 mmol) are dissolved in dimethyl sulfoxide (1 • 5 ml) and dimethylformamide (2. Oml), sodium bromide (269 mg, 3.20 mmol) is added, Stir at room temperature overnight. While cooling, the reaction solution was poured into 5% brine (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain 31 as an amorphous powder (959 mg).
JH-NMR (d -DMSO): 1.24(6H, m), 3.66, 3.92(2H, ABq, J = 18.0Hz), 4.35(2H, m, J J H-NMR (d-DMSO): 1.24 (6H, m), 3.66, 3.92 (2H, ABq, J = 18.0Hz), 4.35 (2H, m, J
= 6.3Hz), 5.23(1H, d, J = 6.3Hz), 5.31(2H, d, J = 5.1Hz), 5.95(1H, dd, J = 8.4, 5.1 Hz), 6.43(1H, m), 6.93(2H, s), 7.28- 7.48(14H, m), 8.52(2H, d, 6.9Hz), 8.89(2H, d, J = 6.9Hz), 9.69(1H, d, J =8.4Hz), 11.81(1H, s). = 6.3Hz), 5.23 (1H, d, J = 6.3Hz), 5.31 (2H, d, J = 5.1Hz), 5.95 (1H, dd, J = 8.4, 5.1 Hz), 6.43 (1H, m), 6.93 (2H, s), 7.28-7.48 (14H, m), 8.52 (2H, d, 6.9Hz), 8.89 (2H, d, J = 6.9Hz), 9.69 (1H, d, J = 8.4Hz), 11.81 (1H, s).
(2) 31→29 (2) 31 → 29
化合物 31(959mg)をジクロロメタン (10.0ml)に溶解し、ァニソール (1.00ml)を加え、 -30 °Cに冷却した。四塩ィ匕チタン (2Mジクロロメタン溶液, 4.1ml)を加え、実施例 123(3) と同じ方法で化合物 29を粉末として得た。収量 (248mg, 29.0% in 2 steps) Compound 31 (959 mg) was dissolved in dichloromethane (10.0 ml), anisole (1.00 ml) was added, and the mixture was cooled to -30 ° C. Tetrachloride-titanium (2M dichloromethane solution, 4.1 ml) was added to obtain compound 29 as a powder in the same manner as in Example 123 (3). Yield (248mg, 29.0% in 2 steps)
'Η- NMR (d -DMSO): 1.20(6H, m), 3.43, 3.51(2H, ABq, J = 16.8Hz), 4.30(1H, m,'Η-NMR (d-DMSO): 1.20 (6H, m), 3.43, 3.51 (2H, ABq, J = 16.8Hz), 4.30 (1H, m,
J = 6.3Hz), 5.05(1H, d, J = 5.1Hz), 5.23(2H, d, J = 7.2Hz), 5.60(1H, dd, J = 8.1, 6. 3Hz), 5.89(1H, dt, J = 15.9, 5.1Hz), 6.70(1H, s), 7.22(2H, s), 7.30(1H, d, J = 15.9H z), 8.50(2H, d, J = 6.9Hz), 8.92(2H, d, J = 6.9Hz), 9.47(1H, d, J = 8.1Hz). J = 6.3Hz), 5.05 (1H, d, J = 5.1Hz), 5.23 (2H, d, J = 7.2Hz), 5.60 (1H, dd, J = 8.1, 6.3Hz), 5.89 (1H, dt , J = 15.9, 5.1Hz), 6.70 (1H, s), 7.22 (2H, s), 7.30 (1H, d, J = 15.9Hz), 8.50 (2H, d, J = 6.9Hz), 8.92 ( 2H, d, J = 6.9Hz), 9.47 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3408, 1761, 1636, 1535, 1371 IR (KBr) cm _1 : 3408, 1761, 1636, 1535, 1371
MS(ESI): 663+ (M-Na+2H)+
元素分析 C H N O S Na- 5.2 H O - 0.3(NaHCO ) MS (ESI): 663 + (M-Na + 2H) + Elemental analysis CHNOS Na- 5.2 HO-0.3 (NaHCO)
計算値: C, 40.80; H, 4.48; N, 20.92; S, 7.98; Na, 3.72 (%) Calculated: C, 40.80; H, 4.48; N, 20.92; S, 7.98; Na, 3.72 (%)
実験値: C, 40.89; H, 4.55; N, 20.65; S, 8.21 ; Na, 3.78 (%) Experimental values: C, 40.89; H, 4.55; N, 20.65; S, 8.21; Na, 3.78 (%)
実施例 128 Example 128
[化 173] [Chemical 173]
38 38
35 35
(1) 3→36 (1) 3 → 36
化合物 3(869mg、 4.00mmol)をエタノール (9ml)に懸濁させ、ヒドラジン一水和物 (0.62 3ml、 20.0 mmol)をカ卩えて室温で 5時間、次いで 70°Cにて 17時間 40分攪拌した。氷冷 し、析出物を濾過して、化合物 36を無色粉末として得た。収量 715mg(88%)。 Compound 3 (869 mg, 4.00 mmol) was suspended in ethanol (9 ml), and hydrazine monohydrate (0.62 3 ml, 20.0 mmol) was added and stirred at room temperature for 5 hours, then at 70 ° C for 17 hours and 40 minutes. did. The mixture was cooled on ice, and the precipitate was filtered to obtain Compound 36 as a colorless powder. Yield 715 mg (88%).
'H-NMR (d -DMSO): 4.51(2H, br s), 7.34(s, 1H), 7.72(2H, d, J = 6.0Hz), 8.63(2H, d, J = 6.0Hz), 9.73(1H, br s), 13.9(1H, br s). 'H-NMR (d-DMSO): 4.51 (2H, br s), 7.34 (s, 1H), 7.72 (2H, d, J = 6.0Hz), 8.63 (2H, d, J = 6.0Hz), 9.73 (1H, br s), 13.9 (1H, br s).
(2) 36→37 (2) 36 → 37
化合物 36(699mg,3.44mmol)をテトラヒドロフラン (7ml)に懸濁させ、トリェチルァミン (0.
671ml、 4.82mmol)、 1,1, -カルボニルジイミダゾール (803mg、 3.78mmol)を加えた。室 温にて 2時間 50分、 60°Cにて 15分攪拌し、室温に冷却後水を加え、 2N HC1で pH=3.5 に調整した。析出物をろ過し、化合物 37を淡褐色結晶として得た。収量 739mg(93%)。 'H-NMR (d -DMSO): 7.50(1H, s), 7.89(2H, m), 8.69(2H, d, J = 6.3Hz), 12.6(1H, b Compound 36 (699 mg, 3.44 mmol) was suspended in tetrahydrofuran (7 ml) and triethylamine (0. 671 ml, 4.82 mmol), 1,1, -carbonyldiimidazole (803 mg, 3.78 mmol) were added. The mixture was stirred at room temperature for 2 hours and 50 minutes, and at 60 ° C for 15 minutes. After cooling to room temperature, water was added and the pH was adjusted to 3.5 with 2N HC1. The precipitate was filtered to obtain Compound 37 as light brown crystals. Yield 739 mg (93%). 'H-NMR (d-DMSO): 7.50 (1H, s), 7.89 (2H, m), 8.69 (2H, d, J = 6.3Hz), 12.6 (1H, b
6 6
r s), 14.4(1H, br s). r s), 14.4 (1H, br s).
(3) 37+20→38 (3) 37 + 20 → 38
化合物 20(1.698g、 2.00mmol)、化合物 37(458mg、 2.00mmol)をジメチルホルムアミド( 6ml)に溶解し、臭化ナトリウム (617mg,6.00mmol)をカ卩えて、室温で 4時間 35分攪拌した 。反応液を 5%食塩水 (60ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧 乾燥して化合物 38を無定形粉末として得た。収量 2.107g。 Compound 20 (1.698 g, 2.00 mmol) and compound 37 (458 mg, 2.00 mmol) were dissolved in dimethylformamide (6 ml), sodium bromide (617 mg, 6.00 mmol) was added, and the mixture was stirred at room temperature for 4 hours and 35 minutes. . The reaction solution was poured into 5% brine (60 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 38 as an amorphous powder. Yield 2.107g.
'H-NMR (d -DMSO): 1.24(3H, t, J = 7.2Hz), 3.66, 3.79(2H, ABq, J = 17.6Hz), 4.1 'H-NMR (d-DMSO): 1.24 (3H, t, J = 7.2Hz), 3.66, 3.79 (2H, ABq, J = 17.6Hz), 4.1
6 6
7(2H, q, J = 7.2Hz), 5.28(2H, d, J = 8.1Hz), 5.31(1H, d, J = 5.0Hz), 5.95(1H, dd, J = 8.1, 5.0Hz), 6.43(1H, dt, J = 16.5, 8.1Hz), 6.90(1H, d, J = 16.5Hz), 6.92(1H, s), 7.28— 7.54(m, 10H), 7.29(s, 1H), 8.58(2H, m), 8.97(2H, m), 9.75(1H, d, J = 8.1Hz), 11.8(1H, br s). 7 (2H, q, J = 7.2Hz), 5.28 (2H, d, J = 8.1Hz), 5.31 (1H, d, J = 5.0Hz), 5.95 (1H, dd, J = 8.1, 5.0Hz), 6.43 (1H, dt, J = 16.5, 8.1Hz), 6.90 (1H, d, J = 16.5Hz), 6.92 (1H, s), 7.28—7.54 (m, 10H), 7.29 (s, 1H), 8.58 (2H, m), 8.97 (2H, m), 9.75 (1H, d, J = 8.1Hz), 11.8 (1H, br s).
(4) 38→35 (4) 38 → 35
化合物 38(2.098g,2.253mmol)を塩化メチレン (21ml)とァニソール (2.10ml)に溶解し、 -30°Cに冷却し、 2M四塩ィヒチタンジクロロメタン溶液 11.3mlを加えた。混合液を- 30°C で 45分攪拌した後、氷冷下にて水 80mlに注加し、実施例 123(3)と同様の手法にて化 合物 35を粉末として得た。収量 129mg(20より通算 7%)。 Compound 38 (2.098 g, 2.253 mmol) was dissolved in methylene chloride (21 ml) and anisole (2.10 ml), cooled to −30 ° C., and 11.3 ml of a 2M tetrasalt titanium titanium dichloromethane solution was added. The mixture was stirred at −30 ° C. for 45 minutes and then poured into 80 ml of water under ice cooling to obtain Compound 35 as a powder in the same manner as in Example 123 (3). Yield 129 mg (7% from 20).
'H-NMR (d -DMSO): 1.23(3H, t, J = 7.2Hz), 3.43, 3.51(2H, ABq, J = 16.8Hz), 4.0 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.2Hz), 3.43, 3.51 (2H, ABq, J = 16.8Hz), 4.0
6 6
9(2H, q, J = 7.2 Hz), 5.04(1H, d, J = 5.1Hz), 5.08(2H, d, J = 7.5Hz), 5.60(1H, dd, J = 8.3, 5.1Hz), 5.84(1H, dt, J = 15.6, 7.5Hz), 6.72(1H, s), 7.18(1H, s), 7.22(2H, s), 7.27(1H, d, J = 15.6Hz), 8.24(2H, d, J = 6.8Hz), 8.60(2H, d, J = 6.8Hz), 9.54(1H, d , J = 8.3Hz). 9 (2H, q, J = 7.2 Hz), 5.04 (1H, d, J = 5.1 Hz), 5.08 (2H, d, J = 7.5 Hz), 5.60 (1H, dd, J = 8.3, 5.1 Hz), 5.84 (1H, dt, J = 15.6, 7.5Hz), 6.72 (1H, s), 7.18 (1H, s), 7.22 (2H, s), 7.27 (1H, d, J = 15.6Hz), 8.24 (2H , d, J = 6.8Hz), 8.60 (2H, d, J = 6.8Hz), 9.54 (1H, d, J = 8.3Hz).
IR (KBr) cm_1:3418, 1762, 1633, 1535, 1389, 1164, 1037. IR (KBr) cm _1 : 3418, 1762, 1633, 1535, 1389, 1164, 1037.
MS(ESI): 665+ (M-Na+2H)+ MS (ESI): 665 + (M-Na + 2H) +
元素分析 C H N O S Na- 6.2H O -0.9NaHCO
計算値: C,38.34; H,4.19; N,16.03; S,7.34; Na,5.00 (%) Elemental analysis CHNOS Na- 6.2HO -0.9NaHCO Calculated value: C, 38.34; H, 4.19; N, 16.03; S, 7.34; Na, 5.00 (%)
実験値: C,38.27; H,4.34; N,15.85; S,7.89; Na,4.93 (%) Experimental value: C, 38.27; H, 4.34; N, 15.85; S, 7.89; Na, 4.93 (%)
実施例 129 Example 129
[化 174] [Chemical 174]
(1) 9→40 (1) 9 → 40
化合物 9(937mg、 4.00mmol)をエタノール (9ml)に懸濁させ、ヒドラジン一水和物 (0.62 3ml、 20.0 mmol)を加えて室温で 2時間、次いで 70°Cにて 2時間攪拌した。氷冷し、析 出物を濾取して、化合物 40を無色粉末として得た。収量 7 98mg(91%)。 Compound 9 (937 mg, 4.00 mmol) was suspended in ethanol (9 ml), hydrazine monohydrate (0.62 3 ml, 20.0 mmol) was added, and the mixture was stirred at room temperature for 2 hours and then at 70 ° C. for 2 hours. The mixture was cooled on ice, and the precipitate was collected by filtration to obtain Compound 40 as a colorless powder. Yield 7 98 mg (91%).
'H-NMR (d -DMSO): 4.61(2H, brs), 8·02(2Η, d, J = 6.2Hz), 8.44(s, 1H), 8.75(2H, 'H-NMR (d-DMSO): 4.61 (2H, brs), 8 · 02 (2Η, d, J = 6.2Hz), 8.44 (s, 1H), 8.75 (2H,
6 6
d, J = 6.2Hz), 9.88(1H, brs). d, J = 6.2Hz), 9.88 (1H, brs).
(2) 40→41 (2) 40 → 41
化合物 40(786mg,3.57mmol)をテトラヒドロフラン (8ml)に懸濁させ、氷冷下にてトリエ チルァミン (0.700ml、 4.99mmol)、 1, -カルボニルジイミダゾール (833mg、 3.92mmol) をカロえた。室温にて 2時間 45分攪拌し、氷冷下にて水を加え、 2N HC1で pH=3.5に調 整した。析出物をろ過し、化合物 41を淡褐色結晶として得た。収量 739mg(93%)。
Ή-NMR (d -DMSO): 7.95(2H, d, J = 6.0Hz), 8.56(1H, s), 8.77(2H, d, J = 6.0Hz),Compound 40 (786 mg, 3.57 mmol) was suspended in tetrahydrofuran (8 ml), and triethylamine (0.700 ml, 4.99 mmol) and 1, -carbonyldiimidazole (833 mg, 3.92 mmol) were obtained under ice cooling. The mixture was stirred at room temperature for 2 hours and 45 minutes, water was added under ice cooling, and the pH was adjusted to 3.5 with 2N HC1. The precipitate was filtered to obtain compound 41 as light brown crystals. Yield 739 mg (93%). NMR-NMR (d-DMSO): 7.95 (2H, d, J = 6.0Hz), 8.56 (1H, s), 8.77 (2H, d, J = 6.0Hz),
6 6
12.8(1H, brs). 12.8 (1H, brs).
(3) 41+19→42 (3) 41 + 19 → 42
ィ匕合物 19(1.698g、 2.00mmol)、化合物 41(492mg、 2.00mmol)をジメチルホルムアミド( 6.8ml)に溶解し、臭化ナトリウム (617mg,6.00mmol)をカ卩えて、室温で 9時間 35分攪拌し た。反応液を 5%食塩水 (50ml)攪拌中に注カ卩し、析出した沈殿を濾取した。沈殿を減 圧乾燥して化合物 42を無定形粉末として得た。収量 2.078g。 Compound 19 (1.698 g, 2.00 mmol), Compound 41 (492 mg, 2.00 mmol) was dissolved in dimethylformamide (6.8 ml), sodium bromide (617 mg, 6.00 mmol) was added, and the mixture was stirred at room temperature for 9 hours. Stir for 35 minutes. The reaction solution was poured into 5% brine (50 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was reduced-pressure dried to obtain Compound 42 as an amorphous powder. Yield 2.078g.
'H-NMR (d -DMSO): 1.24(3H, t, J = 7.0Hz), 3.66, 3.91(2H, ABq, J = 17.7Hz), 4.1 'H-NMR (d-DMSO): 1.24 (3H, t, J = 7.0Hz), 3.66, 3.91 (2H, ABq, J = 17.7Hz), 4.1
6 6
4(2H, q, J = 7.0Hz), 5.31(1H, d, J = 4.8Hz), 5.37(2H, d, J = 8.4Hz), 5.95(1H, dd, J = 8.1, 4.8Hz), 6.44(1H, dt, J = 16.1, 8.4Hz), 6.92(1H, d, J = 16.1Hz), 6.92(1H, s), 7.27-7.52(m, 10H), 8.68(2H, d, J = 7.1Hz), 8.84(s, 1H), 9 . l l(2H, d, J = 7.1Hz), 9. 74(1H, d, J = 8.1Hz), 11.9(1H, brs), 12.9(1H, brs). 4 (2H, q, J = 7.0Hz), 5.31 (1H, d, J = 4.8Hz), 5.37 (2H, d, J = 8.4Hz), 5.95 (1H, dd, J = 8.1, 4.8Hz), 6.44 (1H, dt, J = 16.1, 8.4Hz), 6.92 (1H, d, J = 16.1Hz), 6.92 (1H, s), 7.27-7.52 (m, 10H), 8.68 (2H, d, J = 7.1Hz), 8.84 (s, 1H), 9.ll (2H, d, J = 7.1Hz), 9.74 (1H, d, J = 8.1Hz), 11.9 (1H, brs), 12.9 (1H, brs).
(4) 42→39 (4) 42 → 39
化合物 42(2.066g,2.179mmol)を塩化メチレン (20ml)とァニソール (2.07ml)に溶解し、 -30°Cに冷却し、 2M四塩ィヒチタンジクロロメタン溶液 11.3mlを加えた。混合液を- 30°C で 45分攪拌した後、氷冷下にて水 80mlに注加し、実施例 123(3)と同様の手法にて化 合物 39を粉末として得た。収量 509mg(19より通算 31%)。 Compound 42 (2.066 g, 2.179 mmol) was dissolved in methylene chloride (20 ml) and anisole (2.07 ml), cooled to −30 ° C., and 11.3 ml of 2M tetrasalt-titanium dichloromethane solution was added. The mixture was stirred at −30 ° C. for 45 minutes, then poured into 80 ml of water under ice cooling, and compound 39 was obtained as a powder in the same manner as in Example 123 (3). Yield 509 mg (31% from 19).
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 3.42, 3.50(2H, ABq, J = 16.2Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 3.42, 3.50 (2H, ABq, J = 16.2Hz), 4.0
6 6
9(2H, q, J = 7.2 Hz), 5.05(1H, d, J = 5.0Hz), 5.33(2H, d, J = 6.9Hz), 5.60(1H, dd, J = 8.1, 5.0Hz), 5.87(1H, dt, J = 15.9, 7.5Hz), 6.72(1H, s), 7.22(2H, s), 7.32(1H, d, J = 15.9Hz), 8.25(1H, s), 8.61(2H, d, J = 6.9Hz), 9.09(2H, d, J = 6.9Hz), 9.54(1H, d , J = 8.1Hz). 9 (2H, q, J = 7.2 Hz), 5.05 (1H, d, J = 5.0 Hz), 5.33 (2H, d, J = 6.9 Hz), 5.60 (1H, dd, J = 8.1, 5.0 Hz), 5.87 (1H, dt, J = 15.9, 7.5Hz), 6.72 (1H, s), 7.22 (2H, s), 7.32 (1H, d, J = 15.9Hz), 8.25 (1H, s), 8.61 (2H , d, J = 6.9Hz), 9.09 (2H, d, J = 6.9Hz), 9.54 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3410, 1764, 1664, 1634, 1531, 1389, 1363, 1037. IR (KBr) cm _1 : 3410, 1764, 1664, 1634, 1531, 1389, 1363, 1037.
MS(ESI): 682+ (M-Na+2H)+ MS (ESI): 682 + (M-Na + 2H) +
元素分析 c H N O S Na- 5.3H O - 0.2NaHCO Elemental analysis c H N O S Na- 5.3H O-0.2NaHCO
27 22 9 7 3 2 3 27 22 9 7 3 2 3
計算値: C,40.04; H,4.05; N,15.45; S,11.79; Na,3.38 (%) Calculated value: C, 40.04; H, 4.05; N, 15.45; S, 11.79; Na, 3.38 (%)
実験値: C,40.04; H,4.10; N,15.47; S,11.86; Na,3.29 (%) Experimental value: C, 40.04; H, 4.10; N, 15.47; S, 11.86; Na, 3.29 (%)
実施例 130
[化 175] Example 130 [Chemical 175]
43 43
(1) 44→45 (1) 44 → 45
化合物 44(1.00g,4.27mmol)を 28%アンモニア水 (15ml)中に懸濁させ、実施例 122(2) と同様の手法にて化合物 45を淡橙色結晶として得た。収量 715mg(82%)。 Compound 44 (1.00 g, 4.27 mmol) was suspended in 28% aqueous ammonia (15 ml), and compound 45 was obtained as pale orange crystals in the same manner as in Example 122 (2). Yield 715 mg (82%).
'H-NMR (d -DMSO): 8·00(1Η, s), 8·03(2Η, d, J = 6.0Hz), 8.34(1H, s), 8.69(2H, d,'H-NMR (d-DMSO): 8 · 00 (1Η, s), 8 · 03 (2Η, d, J = 6.0Hz), 8.34 (1H, s), 8.69 (2H, d,
J = 6.0 Hz), 8.73(1H, s). J = 6.0 Hz), 8.73 (1H, s).
(2) 45→46 (2) 45 → 46
化合物 45(715mg,3.48mmol)をピリジン (8.5ml)に懸濁させ、トリフルォロ酢酸無水物 (0.984ml,6.91mmol)を加えて 60°Cにて 5時間攪拌した。トルエンを加えて減圧濃縮し、 水、酢酸ェチルをカ卩え、酢酸ェチルで抽出した。有機層を水、飽和食塩水で洗浄し 、無水硫酸ナトリウムで乾燥した。溶媒を減圧留去し、得られた粗結晶をジイソプロピ ルエーテルで洗浄して、化合物 46を黄褐色結晶として得た。収量 583mg(89%)。 Compound 45 (715 mg, 3.48 mmol) was suspended in pyridine (8.5 ml), trifluoroacetic anhydride (0.984 ml, 6.91 mmol) was added, and the mixture was stirred at 60 ° C. for 5 hours. Toluene was added and the mixture was concentrated under reduced pressure. Water and ethyl acetate were collected and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting crude crystals were washed with diisopropyl ether to obtain Compound 46 as tan crystals. Yield 583 mg (89%).
'H-NMR (d -DMSO): 7.98(2H, d, J = 6.3Hz), 8.71(2H, d, J = 6.3 Hz), 8.99(1H, s).'H-NMR (d-DMSO): 7.98 (2H, d, J = 6.3Hz), 8.71 (2H, d, J = 6.3 Hz), 8.99 (1H, s).
(3) 46→47 (3) 46 → 47
塩酸ヒドロキシルァミン (1.42g,20.4mmol)をジメチルスルホキシド (5m 1)に溶解し、室 温にてトリエチルァミン (2.85ml,20.4mmol)を滴下した。生じた析出物をろ過し、テトラヒ ドロフランで洗浄後、濾液中のテトラヒドロフランを減圧濃縮した。得られた溶液に化
合物 46(765mg,4.09mmol)を加え、 75°Cにて 13時間 30分攪拌し、室温に冷却後、水を 加え析出物を濾取し、次いで減圧乾燥して化合物 47を無色結晶として得た。収量 78 7mg(87%)。 Hydroxylamine hydrochloride (1.42 g, 20.4 mmol) was dissolved in dimethyl sulfoxide (5 ml), and triethylamine (2.85 ml, 20.4 mmol) was added dropwise at room temperature. The resulting precipitate was filtered and washed with tetrahydrofuran, and then the tetrahydrofuran in the filtrate was concentrated under reduced pressure. Convert to the resulting solution Compound 46 (765 mg, 4.09 mmol) was added, and the mixture was stirred at 75 ° C. for 13 hours and 30 minutes. After cooling to room temperature, water was added and the precipitate was collected by filtration and then dried under reduced pressure to give Compound 47 as colorless crystals. Obtained. Yield 78 7 mg (87%).
'H-NMR (d -DMSO): 6.14(2H, s), 8.01(2H, d, J = 6.3Hz), 8.44(1H, s), 8.66(2H, d, 'H-NMR (d-DMSO): 6.14 (2H, s), 8.01 (2H, d, J = 6.3Hz), 8.44 (1H, s), 8.66 (2H, d,
J = 6.3 Hz), 10.24(1H, s). J = 6.3 Hz), 10.24 (1H, s).
(4) 47→48 (4) 47 → 48
化合物 47(768mg,3.45mmol)をジメチルホルムアミド (6ml)に溶解し、氷冷下にてピリ ジン (0.31ml,3.8mmol)、クロ口ぎ酸 2_ェチルへキシル (0.75ml,3.8mmol)を加え 1時間攪 拌した。酢酸ェチル、水を加え酢酸ェチルで抽出し、水、飽和食塩水で洗浄後、無 水硫酸ナトリウムで乾燥した。溶媒を減圧留去後、キシレン (8ml)に溶解し、 150°Cにて 2時間攪拌した。室温に冷却後、析出物を濾取し、ジイソプロピルエーテルで洗浄し、 化合物 48を淡褐色粉末として得た。収量 717mg(84%)。 Compound 47 (768 mg, 3.45 mmol) was dissolved in dimethylformamide (6 ml), and pyridine (0.31 ml, 3.8 mmol) and 2-ethylhexyl chloroformate (0.75 ml, 3.8 mmol) were added under ice cooling. The mixture was stirred for 1 hour. Ethyl acetate and water were added, and the mixture was extracted with ethyl acetate, washed with water and saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, dissolved in xylene (8 ml), and stirred at 150 ° C. for 2 hours. After cooling to room temperature, the precipitate was collected by filtration and washed with diisopropyl ether to obtain Compound 48 as a light brown powder. Yield 717 mg (84%).
'H-NMR (d -DMSO): 8.02(2H, d, J = 6.2Hz), 8.72(2H, d, J = 6.2 Hz), 8.82(1H, s). 'H-NMR (d-DMSO): 8.02 (2H, d, J = 6.2 Hz), 8.72 (2H, d, J = 6.2 Hz), 8.82 (1H, s).
(5) 48+2→49→43 (5) 48 + 2 → 49 → 43
化合物 48(369mg,1.50mmol)をメタノール中に懸濁し、ナトリウムメトキシドメタノール 溶液を pH=7.8となるまで滴下して、得られた溶液を減圧濃縮して、 48のナトリウム塩を 得た。実施例 122の化合物 2(1.012g、 1.50mmol)をジクロロメタン (12ml)に懸濁させ、 氷冷下炭酸水素ナトリウム水溶液 (189mg、 2.25mmolを水 12mlに溶解)をカ卩え、ジクロ ロメタンで抽出し、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホ ルムアミド (3ml)に溶解し、 48のナトリウム塩と混合し、臭化ナトリウム (463mg、 4.50mmol )を加えて、室温で 2時間攪拌した。反応液を 5%食塩水 (40ml)攪拌中に注加し、析出 した沈殿を濾取した。沈殿を減圧乾燥して化合物 49の無定形粉末を得た。これを塩 化メチレン (6.6ml)、ァニソール (1.1ml)に溶解し、 0°Cに冷却し、トリフルォロ酢酸 3.3ml をカロえた。混合液を 0°Cで 45分攪拌した後、イソプロパノール 60mlに氷冷下で攪拌し ながら注加した。析出した沈殿物を濾取し、飽和 NaHCO水で溶解させた。溶液を HP Compound 48 (369 mg, 1.50 mmol) was suspended in methanol, a sodium methoxide methanol solution was added dropwise until pH = 7.8, and the resulting solution was concentrated under reduced pressure to obtain 48 sodium salts. Compound 2 of Example 122 (1.012 g, 1.50 mmol) was suspended in dichloromethane (12 ml), and an aqueous sodium hydrogen carbonate solution (189 mg, 2.25 mmol dissolved in 12 ml of water) was added under ice-cooling and extracted with dichloromethane. And dried over magnesium sulfate. After the solvent was distilled off, it was immediately dissolved in dimethylformamide (3 ml), mixed with 48 sodium salt, sodium bromide (463 mg, 4.50 mmol) was added, and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into 5% brine (40 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain an amorphous powder of Compound 49. This was dissolved in methylene chloride (6.6 ml) and anisole (1.1 ml), cooled to 0 ° C., and 3.3 ml of trifluoroacetic acid was added. The mixture was stirred at 0 ° C for 45 minutes and then poured into 60 ml of isopropanol while stirring under ice cooling. The deposited precipitate was collected by filtration and dissolved with saturated aqueous NaHCO. HP solution
-20SSカラムクロマトグラフィーに付し、水-ァセトニトリルで溶離した。所望の化合物を 含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥して化合物 43を粉末として得た 。収量 184mg(17%)。
Ή-NMR (d -DMSO): 1.22(3H, t, J = 7.1Hz), 3.43, 3.51(2H, ABq, J = 16.5 Hz), 4.-20SS column chromatography eluting with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 43 as a powder. Yield 184 mg (17%). Ή-NMR (d-DMSO): 1.22 (3H, t, J = 7.1Hz), 3.43, 3.51 (2H, ABq, J = 16.5 Hz), 4.
09(2H, q, J = 7.1 Hz), 5.05(1H, d, J = 5.0Hz), 5.28(2H, d, J = 6.9Hz), 5.60(1H, dd, J = 8.1, 5.0Hz), 5.87(1H, dt, J = 15.9, 6.9Hz), 6.72(1H, s), 7.23(2H, s), 7.30(1H, d J = 15.9Hz), 8.60(2H, d, J = 6.9Hz), 9.05(2H, d, J = 6.9Hz), 9.05(1H, s), 9.54(1H, d, J = 8.1Hz). 09 (2H, q, J = 7.1 Hz), 5.05 (1H, d, J = 5.0 Hz), 5.28 (2H, d, J = 6.9 Hz), 5.60 (1H, dd, J = 8.1, 5.0 Hz), 5.87 (1H, dt, J = 15.9, 6.9Hz), 6.72 (1H, s), 7.23 (2H, s), 7.30 (1H, d J = 15.9Hz), 8.60 (2H, d, J = 6.9Hz) , 9.05 (2H, d, J = 6.9Hz), 9.05 (1H, s), 9.54 (1H, d, J = 8.1Hz).
IR (KBr) cm— 3418, 1763, 1672, 1635, 1529, 1387, 1364, 1036. IR (KBr) cm— 3418, 1763, 1672, 1635, 1529, 1387, 1364, 1036.
MS(FAB): 704+ (M+H)+ MS (FAB): 704 + (M + H) +
元素分析 c H N O S Na-4.8 H O - 0.3NaHCO Elemental analysis c H N O S Na-4.8 H O-0.3NaHCO
計算値: C,40.21; H,3.94; N,15.46; S, 11.80; Na 3.67 (%) Calculated values: C, 40.21; H, 3.94; N, 15.46; S, 11.80; Na 3.67 (%)
実験値: C40.21; H,3.87; N,15.40; S, 11.75; Na 3.93 (%) Experimental value: C40.21; H, 3.87; N, 15.40; S, 11.75; Na 3.93 (%)
実施例 131 Example 131
[化 178] [Chemical 178]
(1) 3→4 (1) 3 → 4
化合物 3(5.19g,30mmol)をジメチルホルムアミド(30ml)に溶解して、炭酸カリウム(4.97 g, 36mmol)と臭化パラ-メトキシベンジル (4.76ml,3.3mmol.)を加え室温で一夜攪拌し た。反応液に水をカ卩ぇェチルエーテルで抽出し、水洗、乾燥した後、濃縮して 4を結 晶として得た。収量 6.47g(74%)。 Compound 3 (5.19 g, 30 mmol) was dissolved in dimethylformamide (30 ml), potassium carbonate (4.97 g, 36 mmol) and para-methoxybenzyl bromide (4.76 ml, 3.3 mmol.) Were added, and the mixture was stirred overnight at room temperature. . Water was extracted from the reaction solution with ketyl ether, washed with water, dried and concentrated to give 4 as crystals. Yield 6.47 g (74%).
'H-NMR (CDC13): 3·82(3Η, s), 5·31(2Η, s), 6.92(2Η, d, J = 8.7Hz), 7.37(2H, d, J = 8.7Hz), 7.68(1H, d, J = 5.1Hz), 7.85(1H, d, J = 5.1Hz).
(2) 4→5 'H-NMR (CDC13): 3 · 82 (3Η, s), 5 · 31 (2Η, s), 6.92 (2Η, d, J = 8.7Hz), 7.37 (2H, d, J = 8.7Hz), 7.68 (1H, d, J = 5.1Hz), 7.85 (1H, d, J = 5.1Hz). (2) 4 → 5
化合物 4(6.42g,22mmol)を EtOH200mlに溶解して、塩化アンモニゥム (3.5g,66mmol)の 水溶液(10ml)を加え還流した。次いで鉄粉 (l lg, 198mmol)を少量づつに分けて加え 、 4.5時間還流した。不溶物を濾去して濃縮した。残渣に水を加え酢酸ェチルで抽出 し、水洗、乾燥して 4NHC1の酢酸ェチル溶液 (6.7ml)をカ卩え,濃縮して 5を結晶として 得た。収量 4.04g(62%)。 Compound 4 (6.42 g, 22 mmol) was dissolved in 200 ml of EtOH, and an aqueous solution (10 ml) of ammonium chloride (3.5 g, 66 mmol) was added and refluxed. Next, iron powder (l lg, 198 mmol) was added in small portions and refluxed for 4.5 hours. The insoluble material was filtered off and concentrated. Water was added to the residue, and the mixture was extracted with ethyl acetate, washed with water and dried to obtain 4NHC1 in ethyl acetate (6.7 ml) and concentrated to give 5 as crystals. Yield 4.04 g (62%).
'H-NMR (d -DMSO): 3.75(3H, s), 5.11(2H, s), 5.89(1H, d, J = 3.9Hz), 6.93(2H, d, 'H-NMR (d-DMSO): 3.75 (3H, s), 5.11 (2H, s), 5.89 (1H, d, J = 3.9Hz), 6.93 (2H, d,
J = 8.7Hz), 7.33(2H, d,J = 9.0Hz), 7.35(1H, d, J = 4.2Hz). J = 8.7Hz), 7.33 (2H, d, J = 9.0Hz), 7.35 (1H, d, J = 4.2Hz).
( 3) 5+6→7 (3) 5 + 6 → 7
化合物 5(1.80g, 6mmol)をジメチルホルムアミド(5ml)に溶解して、トリェチルァミン (0.9 lml, 6.5mmol)と化合物 6(601mg, 5mmol)を加えて室温で 1.5時間攪拌した。反応液に 酢酸ェチルと水を加えて抽出し、水洗、乾燥、濃縮して 7を結晶として得た。収量 965 mg(50% Compound 5 (1.80 g, 6 mmol) was dissolved in dimethylformamide (5 ml), triethylamine (0.9 lml, 6.5 mmol) and compound 6 (601 mg, 5 mmol) were added, and the mixture was stirred at room temperature for 1.5 hours. The reaction mixture was extracted with ethyl acetate and water, washed with water, dried and concentrated to give 7 as crystals. Yield 965 mg (50%
)。 ).
'H-NMR (d -DMSO): 3.76(3H, s), 5.20(2H, s), 6.66(1H, d, J = 4.2Hz) ,6.96(2H, d, 'H-NMR (d-DMSO): 3.76 (3H, s), 5.20 (2H, s), 6.66 (1H, d, J = 4.2Hz), 6.96 (2H, d,
J = 8.7Hz), 7.37(2H, d, J = 8.7Hz), 7.46(2H, d, J =6.3Hz), 7.59(1H, d, J = 4.2Hz), 8.39(2H, d, J = 6.3Hz), 9.45(1H, bs), 10.51(1H, bs). J = 8.7Hz), 7.37 (2H, d, J = 8.7Hz), 7.46 (2H, d, J = 6.3Hz), 7.59 (1H, d, J = 4.2Hz), 8.39 (2H, d, J = 6.3Hz), 9.45 (1H, bs), 10.51 (1H, bs).
(4) 7 + 2→8 (4) 7 + 2 → 8
化合物 7(383mg、 lmmol)と化合物 2(738mg、 lmmol)をジメチルホルムアミド (2ml)に溶 解した。次いで NaBr(309mg、 3mmol)を加えて、室温で 6時間攪拌した。反応液を酢 酸ェチルと水の混合液に注加した。有機層を水洗、乾燥、濃縮して化合物 8(969mg) を粉末として得た。 Compound 7 (383 mg, 1 mmol) and Compound 2 (738 mg, 1 mmol) were dissolved in dimethylformamide (2 ml). Then NaBr (309 mg, 3 mmol) was added and stirred at room temperature for 6 hours. The reaction solution was poured into a mixed solution of ethyl acetate and water. The organic layer was washed with water, dried and concentrated to give Compound 8 (969 mg) as a powder.
(5) 8→1 (5) 8 → 1
化合物 8(957mg)を塩化メチレン (10ml)とァニソール (0.82ml)に溶解し、 _30°Cに冷却し た。 1MA1C1のニトロメタン溶液 (8.2ml)をカ卩ぇ 40分間攪拌した。反応液を希塩酸-ァ セトニトリルの混合液に氷冷下で攪拌しながら注カ卩した。水層をイソプロピルエーテル —へキサン混合液で洗浄した後、 HP-20SSカラムクロマトグラフィーに付し、希 NaHC 〇水 -ァセトニトリルで溶離した。所望の化合物を含むフラクションを減圧下濃縮し、 2
NHC1で中和して析出物を濾取した。析出物は希 NaOH水溶液に溶解し、凍結乾燥 して化合物 1を粉末として得た。収量 367mg(48%) Compound 8 (957 mg) was dissolved in methylene chloride (10 ml) and anisole (0.82 ml) and cooled to -30 ° C. A nitromethane solution (8.2 ml) of 1MA1C1 was stirred for 40 minutes. The reaction solution was poured into a dilute hydrochloric acid-acetonitrile mixture with stirring under ice cooling. The aqueous layer was washed with an isopropyl ether-hexane mixture, then subjected to HP-20SS column chromatography and eluted with dilute NaHC 0 water-acetonitrile. Concentrate the fraction containing the desired compound under reduced pressure, 2 The mixture was neutralized with NHC1 and the precipitate was collected by filtration. The precipitate was dissolved in a dilute aqueous NaOH solution and freeze-dried to obtain Compound 1 as a powder. Yield 367 mg (48%)
'H-NMR (D O): 1.25(3H, t, J = 7.2Hz), 3.61, 3.68(2H, ABq, J = 17.8Hz), 4.19(2H, 'H-NMR (D 2 O): 1.25 (3H, t, J = 7.2Hz), 3.61, 3.68 (2H, ABq, J = 17.8Hz), 4.19 (2H,
2 2
q, J = 7.2 Hz), 4.91(2H, m), 5.23(1H, d, J = 4.8Hz), 5.78(1H, d J = 5.1Hz), 6.01(1 H, m), 6.45(1H, m), 6.81(1H, d, J = 15.6Hz), 6.91(1H, s), 7.16(1H, m), 7.65(2H, d J = 5.1Hz), 8.20(2H, d, J = 7.2Hz). q, J = 7.2 Hz), 4.91 (2H, m), 5.23 (1H, d, J = 4.8Hz), 5.78 (1H, d J = 5.1Hz), 6.01 (1 H, m), 6.45 (1H, m), 6.81 (1H, d, J = 15.6Hz), 6.91 (1H, s), 7.16 (1H, m), 7.65 (2H, d J = 5.1Hz), 8.20 (2H, d, J = 7.2Hz ).
IR (KBr) cm—1: 3407, 2981, 1763, 1715, 1609, 1531, 1459, 1374, 1304. IR (KBr) cm— 1 : 3407, 2981, 1763, 1715, 1609, 1531, 1459, 1374, 1304.
MS(ESI): 699+ (M+H)+ MS (ESI): 699+ (M + H) +
元素分析 c H N O S Na- l. lNaCl-0.4NaHCO -6H O Elemental analysis c H N O S Na- l. LNaCl-0.4NaHCO -6H O
28 25 8 8 3 3 2 28 25 8 8 3 3 2
計算値: C, 36.81; H,4.07; N,12.09; S, 10.38; Cl,4.21; Na,6.20 (%) Calculated values: C, 36.81; H, 4.07; N, 12.09; S, 10.38; Cl, 4.21; Na, 6.20 (%)
実験値: C, 36.83; H,4.08; N,12.32; S, 10.63; Cl,4.25; Na,6.11 (%) Experimental value: C, 36.83; H, 4.08; N, 12.32; S, 10.63; Cl, 4.25; Na, 6.11 (%)
実施例 132 Example 132
[化 179] [Chemical 179]
(6) 10→11 (6) 10 → 11
化合物 10(5.73g,30mmol)をトルエン (50ml)に溶解してエチレングリコール (10ml)と p-ト ルエンスルホン酸 (571mg, 3mmol)を加え、 6.5時間還流した。反応液を水洗、乾燥後 濃縮して 11を得た。収量 7.08g。
JH-NMR (CDC1 ): 3.97— 4·13(4Η, m), 6.02(1H, s), 6.90(1H, d, J = 4.5Hz), 6.93(1H, d, J = 3.6Hz). Compound 10 (5.73 g, 30 mmol) was dissolved in toluene (50 ml), ethylene glycol (10 ml) and p-toluenesulfonic acid (571 mg, 3 mmol) were added, and the mixture was refluxed for 6.5 hours. The reaction solution was washed with water, dried and concentrated to obtain 11. Yield 7.08g. J H-NMR (CDC1): 3.97—4 · 13 (4Η, m), 6.02 (1H, s), 6.90 (1H, d, J = 4.5Hz), 6.93 (1H, d, J = 3.6Hz).
(7) 11 + 12→13 (7) 11 + 12 → 13
化合物 l l(3.53g,15mmol)をテトラヒドロフラン (30ml)に溶解する。 _78。Cにて 2.7Nn_ブ チルリチウム-へキサン溶液 (5.8ml)をカ卩えて 30分間攪拌して、予め _78°Cに冷却され た化合物 12(1.86ml,19.5mmol)のテトラヒドロフラン (30ml)溶液の中に注加した。同温 で 45分間攪拌した後、塩ィ匕アンモニゥム水溶液、次いで酢酸ェチルを加えて抽出し た。有機層を水洗、乾燥、濃縮して 13を結晶として得た。収量 1.79g(45%) Compound l l (3.53 g, 15 mmol) is dissolved in tetrahydrofuran (30 ml). _78. Add 2.7Nn_butyllithium-hexane solution (5.8ml) in C and stir for 30 minutes, then precooled to _78 ° C in solution of Compound 12 (1.86ml, 19.5mmol) in tetrahydrofuran (30ml) Added to the inside. After stirring at the same temperature for 45 minutes, the solution was extracted by adding an aqueous salt ammonium solution and then ethyl acetate. The organic layer was washed with water, dried and concentrated to give 13 as crystals. Yield 1.79 g (45%)
'H-NMR (CDCl ): 3.97-4.13(4H, m), 6·01(1Η, s), 6·03(1Η, s), 6.85(1H, d, J = 4.2'H-NMR (CDCl): 3.97-4.13 (4H, m), 6 · 01 (1Η, s), 6 · 03 (1Η, s), 6.85 (1H, d, J = 4.2
Hz), 7.02(1H, d, J = 4.2Hz) , 7.41(2H, d, J = 6.9Hz), 8.54(1H, d, J = 6.0Hz). Hz), 7.02 (1H, d, J = 4.2Hz), 7.41 (2H, d, J = 6.9Hz), 8.54 (1H, d, J = 6.0Hz).
(8) 13→14 (8) 13 → 14
化合物 13(1.77g、 6.7mmol)をクロ口ホルム (30ml)に懸濁させ、二酸化マンガン(5.84g、 67mmol)を加え、室温で 2.5時間攪拌した。反応液中の不溶物を濾去し、濃縮して化 合物 14(1.74g)を結晶として得た。 Compound 13 (1.77 g, 6.7 mmol) was suspended in black mouth form (30 ml), manganese dioxide (5.84 g, 67 mmol) was added, and the mixture was stirred at room temperature for 2.5 hours. The insoluble material in the reaction solution was removed by filtration and concentrated to obtain Compound 14 (1.74 g) as crystals.
'H-NMR (CDCl ): 4.04-4.18(4H, m), 6.16(1H, s), 7.22(1H, d, J = 4.5Hz), 7.54(1H, d, J = 3.9Hz) , 7.66(2H, d, J = 6.0Hz), 8.82(2H, d, J = 6.0Hz). 'H-NMR (CDCl): 4.04-4.18 (4H, m), 6.16 (1H, s), 7.22 (1H, d, J = 4.5Hz), 7.54 (1H, d, J = 3.9Hz), 7.66 ( 2H, d, J = 6.0Hz), 8.82 (2H, d, J = 6.0Hz).
(9) 14→15 (9) 14 → 15
化合物 14(1.66g,6.4mmol.)を 2NHCl(9.5ml)を加えて、室温で 2時間攪拌した。反応液 を NaHCOで中和して、酢酸ェチルで抽出して化合物 15を結晶として得た。収量 1.33 g(96%) To compound 14 (1.66 g, 6.4 mmol) was added 2NHCl (9.5 ml), and the mixture was stirred at room temperature for 2 hours. The reaction solution was neutralized with NaHCO and extracted with ethyl acetate to obtain Compound 15 as crystals. Yield 1.33 g (96%)
'H-NMR (CDCl ): 7.69(2H, d, J = 6.0Hz), 7.72(1H, d, J = 3.9Hz), 7.82(1H, d, J = 'H-NMR (CDCl): 7.69 (2H, d, J = 6.0Hz), 7.72 (1H, d, J = 3.9Hz), 7.82 (1H, d, J =
3.9Hz), 8.87(2H, d, J = 6.0Hz), 10.04(1H, s). 3.9Hz), 8.87 (2H, d, J = 6.0Hz), 10.04 (1H, s).
(10) 15→16 (10) 15 → 16
硝酸銀 (2.93g)を水 (6ml)に溶解して、 8NNaOH(3.5ml)をカ卩えて攪拌した。反応液を氷 冷して化合物 15(1.22g,5.6mmol.)を加えて 2時間攪拌した。不溶物を濾去し、 6NHC1 で中和して、析出物を濾取、乾燥して化合物 16を得た。収量 265mg(20%) Silver nitrate (2.93 g) was dissolved in water (6 ml), and 8N NaOH (3.5 ml) was added and stirred. The reaction mixture was ice-cooled, compound 15 (1.22 g, 5.6 mmol) was added, and the mixture was stirred for 2 hr. The insoluble material was removed by filtration, neutralized with 6NHC1, and the precipitate was collected by filtration and dried to give compound 16. Yield 265mg (20%)
'H-NMR (d -DMSO): 7.76-7.82(4H, m), 8.86(2H, d, J = 7.5Hz). 'H-NMR (d-DMSO): 7.76-7.82 (4H, m), 8.86 (2H, d, J = 7.5Hz).
(12) 16→17
化合物 16(265mg,l. lmmol.)をジメチルホルムアミド (2ml)に溶解して、カルボニルジイミ ダゾール (370mg,2.2mmol.)を加えて 30分間攪拌した。次いで tーブタノール (0.55ml)と t—ブトキシカリウム (265mg,0.1mmol.)を加えて、 50°Cで 30分間攪拌した。反応液を冷 却して塩化アンモニゥム水溶液、次いで酢酸ェチルをカ卩えて抽出した。有機層を水 洗、乾燥、濃縮して 17を結晶として得た。収量 201mg(63%) (12) 16 → 17 Compound 16 (265 mg, l.lmmol.) Was dissolved in dimethylformamide (2 ml), carbonyldiimidazole (370 mg, 2.2 mmol.) Was added, and the mixture was stirred for 30 minutes. Subsequently, t-butanol (0.55 ml) and t-butoxypotassium (265 mg, 0.1 mmol.) Were added, and the mixture was stirred at 50 ° C. for 30 minutes. The reaction solution was cooled and extracted by adding ammonium chloride aqueous solution and then ethyl acetate. The organic layer was washed with water, dried and concentrated to give 17 as crystals. Yield 201 mg (63%)
'H-NMR (CDCl ): 1·60(9Η, s), 7.58(1H, d, J = 3.9Hz), 7.69(2H, d, J = 6.0Hz), 7.7 'H-NMR (CDCl): 1 · 60 (9Η, s), 7.58 (1H, d, J = 3.9Hz), 7.69 (2H, d, J = 6.0Hz), 7.7
3(1H, d, J = 3.9Hz), 8.85(2H, d, J = 5.7Hz). 3 (1H, d, J = 3.9Hz), 8.85 (2H, d, J = 5.7Hz).
(13) 17 + 2→18 (13) 17 + 2 → 18
化合物 17(199mg、 0.69mmol)と化合物 2(509mg、 0.69mmol)から(4)と同様して化合物 18(663mg)を粉末として得た。 Compound 18 (663 mg) was obtained as a powder from Compound 17 (199 mg, 0.69 mmol) and Compound 2 (509 mg, 0.69 mmol) in the same manner as (4).
(14) 18→9 (14) 18 → 9
化合物 18(957mg)から(5)と同様して化合物 9を粉末として得た。収量 247mg(52%) 'H-NMR (D O): 1.29(3H, t, J = 7.2Hz), 3.67(2H, bs), 4.25(2H, q, J = 7.2 Hz), 5.2Compound 9 was obtained as a powder in the same manner as Compound (5) from Compound 18 (957 mg). Yield 247 mg (52%) 'H-NMR (DO): 1.29 (3H, t, J = 7.2 Hz), 3.67 (2H, bs), 4.25 (2H, q, J = 7.2 Hz), 5.2
7(1H, d, J = 4.5Hz), 5.43(2H, d, J = 7.2Hz), 5.82(1H, d J =4.8Hz), 6.14(1H, dt, J = 15.6, 7.2Hz), 6.97(1H, s), 7.02(1H, d, J = 15.6Hz), 7.58(1H, d, J = 3.9Hz), 7.67(2 H, d, J = 4.2Hz), 8.39(2H, d, J = 6.6Hz) , 9.10(2H, d, J = 6.6Hz). 7 (1H, d, J = 4.5Hz), 5.43 (2H, d, J = 7.2Hz), 5.82 (1H, d J = 4.8Hz), 6.14 (1H, dt, J = 15.6, 7.2Hz), 6.97 (1H, s), 7.02 (1H, d, J = 15.6Hz), 7.58 (1H, d, J = 3.9Hz), 7.67 (2H, d, J = 4.2Hz), 8.39 (2H, d, J = 6.6Hz), 9.10 (2H, d, J = 6.6Hz).
IR (KBr) cm"1: 3410, 2982, 1765, 1603, 1532, 1454, 1365, 1333. IR (KBr) cm " 1 : 3410, 2982, 1765, 1603, 1532, 1454, 1365, 1333.
MS: 669+ (M+H)+ MS: 669 + (M + H) +
元素分析 C H N O S Na-0.3NaHCO -4H O Elemental analysis C H N O S Na-0.3NaHCO -4H O
計算値: C,43.14; H,4.00; N,10.67; S,12.21; Na,3.79 (%) Calculated value: C, 43.14; H, 4.00; N, 10.67; S, 12.21; Na, 3.79 (%)
実験値: C,43.42; H,3.95; N,10.32; S, 12.39; Na,3.81 (%) Experimental value: C, 43.42; H, 3.95; N, 10.32; S, 12.39; Na, 3.81 (%)
実施例 133 Example 133
[化 180]
[Chemical 180]
24 twenty four
(15) 20→21 (15) 20 → 21
化合物 20(5.35g,29mmol)を塩化メチレン(50ml)に溶解して、ジフヱニルジァゾメタン を加え室温で攪拌した。反応液を濃縮して 21を得た。収量 10.5g Compound 20 (5.35 g, 29 mmol) was dissolved in methylene chloride (50 ml), diphenyldiazomethane was added, and the mixture was stirred at room temperature. The reaction mixture was concentrated to give 21. Yield 10.5g
'H-NMR (CDCl ): 7.16(1H, s), 7.29- 7·47(11Η, m), 8.39- 8·44(1Η, m), 8.88-8.91(1 'H-NMR (CDCl): 7.16 (1H, s), 7.29-7 · 47 (11Η, m), 8.39-8 · 44 (1Η, m), 8.88-8.91 (1
3 Three
H, m). H, m).
(16) 21→22 (16) 21 → 22
化合物 21(10.5g,29mmol)を(2)と同様にして 22を結晶として得た。収量 6.28g(68%)。 'H-NMR (CDCl ): 6.95-7.09(2H, m), 7·08(1Η, s), 7.23— 7.45(10H, m), 7.52-7.55(1 Compound 21 (10.5 g, 29 mmol) was obtained in the same manner as (2) to obtain 22 as crystals. Yield 6.28 g (68%). 'H-NMR (CDCl): 6.95-7.09 (2H, m), 7 · 08 (1Η, s), 7.23-7.45 (10H, m), 7.52-7.55 (1
3 Three
H, m). H, m).
(17) 22+6→23 (17) 22 + 6 → 23
化合物 22(1.93g, 6mmol)を(3)と同様にして 23を得た。収量 1.66g(75%) Compound 22 (1.93 g, 6 mmol) was obtained in the same manner as (3) to give 23. Yield 1.66 g (75%)
'H-NMR (CDCl ): 7.01-7.07(2H, m), 7· 18_7·43(10Η, m), 7.50(2H, d, J = 6.6Hz), 7 'H-NMR (CDCl): 7.01-7.07 (2H, m), 7 · 18_7 · 43 (10Η, m), 7.50 (2H, d, J = 6.6Hz), 7
3 Three
• 70(1H, m), 7.91(1H, m), 8.20(2H, d, J = 6.3Hz), 8.58(1H, bs), 9.20(1H, bs). • 70 (1H, m), 7.91 (1H, m), 8.20 (2H, d, J = 6.3Hz), 8.58 (1H, bs), 9.20 (1H, bs).
(18) 23 + 2→24 (18) 23 + 2 → 24
化合物 23(383mg、 Immol)と化合物 2(738mg、 Immol)力、ら(4)と同様して化合物 24(1 .18g)を粉末として得た。 Compound 24 (1.18 g) was obtained as a powder in the same manner as Compound 23 (383 mg, Immol) and Compound 2 (738 mg, Immol) force, et al. (4).
(19) 24→19 (19) 24 → 19
化合物 24(1.16g)から(5)と同様して化合物 19を粉末として得た。収量 530mg(56%) 'H-NMR (D O): 1.27(3H, t, J = 7.2Hz), 3.63(2H, m), 4.22(2H, q, J = 6.9Hz), 5.02(
2H, d, J = 6.6Hz), 5.25(1H, d, J = 4.5Hz), 5.80(1H, d J = 4.8Hz), 6.03(1H, dt, J = 1 6.2, 6.6Hz), 6.83(1H, d, J = 15.3Hz), 6.94(1H, s), 7.10(1H, m), 7.44-7.53(2H, m), 7 .79(2H, d, J = 6.6Hz), 8.37(2H, d, J = 6.9Hz). Compound 19 was obtained as a powder in the same manner as Compound (5) from Compound 24 (1.16 g). Yield 530mg (56%) 'H-NMR (DO): 1.27 (3H, t, J = 7.2Hz), 3.63 (2H, m), 4.22 (2H, q, J = 6.9Hz), 5.02 ( 2H, d, J = 6.6Hz), 5.25 (1H, d, J = 4.5Hz), 5.80 (1H, d J = 4.8Hz), 6.03 (1H, dt, J = 16.2, 6.6Hz), 6.83 ( 1H, d, J = 15.3Hz), 6.94 (1H, s), 7.10 (1H, m), 7.44-7.53 (2H, m), 7.79 (2H, d, J = 6.6Hz), 8.37 (2H , d, J = 6.9Hz).
IR (KBr) cm—1: 3407, 2980, 1764, 1725, 1609, 1530, 1490, 1374, 1313. IR (KBr) cm— 1 : 3407, 2980, 1764, 1725, 1609, 1530, 1490, 1374, 1313.
MS: 711+ (M+H)+ MS: 711 + (M + H) +
元素分析 c H F N O S Na- 2.6NaCl- 6H O Elemental analysis c H F N O S Na- 2.6NaCl-6H O
30 26 1 8 8 2 2 30 26 1 8 8 2 2
計算値: C, 36.30; Η,3·86; Ν,11·29; S,6.46; F,1.91; Cl,9.29; Na,8.34 (%) Calculated values: C, 36.30; Η, 3.86; Ν, 11.29; S, 6.46; F, 1.91; Cl, 9.29; Na, 8.34 (%)
実験値: C, 36.31; H,3.69; N,11.33; S,6.49; F,1.80; Cl,9.15; Na,8.64 (%) Experimental values: C, 36.31; H, 3.69; N, 11.33; S, 6.49; F, 1.80; Cl, 9.15; Na, 8.64 (%)
実施例 134 Example 134
[化 181] [Chem 181]
(20) 26→27 (20) 26 → 27
化合物 26(6.31g,50mmol)を酢酸 (50ml)に溶解して臭素 (3.07ml)の酢酸 (25ml)溶液を 滴加 Compound 26 (6.31 g, 50 mmol) was dissolved in acetic acid (50 ml) and a solution of bromine (3.07 ml) in acetic acid (25 ml) was added dropwise.
した後、一夜攪拌した。反応液を濃縮して、ェチルエーテルと水をカ卩え、有機層を水 洗、乾燥、濃縮して化合物 27を結晶として得た。収量 5.86g(57%)。 And stirred overnight. The reaction mixture was concentrated to obtain ethyl ether and water, and the organic layer was washed with water, dried and concentrated to obtain compound 27 as crystals. Yield 5.86 g (57%).
'H-NMR (CDCl ): 2.49(3H, s), 7.59(1H, s), 9.77(1H, s). 'H-NMR (CDCl 3): 2.49 (3H, s), 7.59 (1H, s), 9.77 (1H, s).
3 Three
(21) 27→28 (21) 27 → 28
硝酸銀 (11.47g)を水に溶解して、 NaOH(5.4g)をカ卩えて攪拌した。反応液を氷冷して 化合物 27(5.13g,25mmol.)をカ卩えて 3時間攪拌した。不溶物を濾去し、 HC1で中和して
、析出物を濾取、乾燥して化合物 28を得た。収量 265mg(57%) Silver nitrate (11.47 g) was dissolved in water and NaOH (5.4 g) was added and stirred. The reaction mixture was ice-cooled, compound 27 (5.13 g, 25 mmol.) Was added, and the mixture was stirred for 3 hr. Insoluble material is filtered off and neutralized with HC1 The precipitate was collected by filtration and dried to obtain Compound 28. Yield 265mg (57%)
'H-NMR (CDCl ): 2.46(3H, s), 7.69(1H, s). 'H-NMR (CDCl): 2.46 (3H, s), 7.69 (1H, s).
3 Three
(22) 28→29 (22) 28 → 29
化合物 28(3.07g,13.9mmol.)を(15)と同様にして化合物 29を結晶として得た。収量 4. 14g(77%) Compound 28 (3.07 g, 13.9 mmol.) Was obtained in the same manner as (15) to give compound 29 as crystals. Yield 4.14 g (77%)
'H-NMR (CDCl ): 2.44(3H, s), 7.02(1H, s), 7.25— 7.41(10H, m), 7.68(1H, s). 'H-NMR (CDCl): 2.44 (3H, s), 7.02 (1H, s), 7.25-7.41 (10H, m), 7.68 (1H, s).
3 Three
(23) 29 + 30→31 (23) 29 + 30 → 31
化合物 29(3.87g,10mmol.)と化合物 30(2.05g,10mmol.)をジォキサン (80ml)に溶解する 。 K PO (10.61g,50mmol.)と Pd(PPh )を加えて、 100°Cで 5時間攪拌する。反応液は冷Compound 29 (3.87 g, 10 mmol.) And compound 30 (2.05 g, 10 mmol.) Are dissolved in dioxane (80 ml). Add K 3 PO 4 (10.61 g, 50 mmol.) And Pd (PPh 3) and stir at 100 ° C for 5 hours. The reaction solution is cold
3 4 3 4 3 4 3 4
却して不溶物を濾去した後、濃縮する。残渣をカラムクロマトで精製して化合物 31を 得た。収量 3.57g(85%) On the contrary, the insoluble material is removed by filtration and then concentrated. The residue was purified by column chromatography to give compound 31. Yield 3.57g (85%)
'H-NMR (CDCl ): 2.59(3H, s), 7.07(1H, s), 7.16— 7.43(12H, m), 7.84(1H, s), 8.67(2 'H-NMR (CDCl): 2.59 (3H, s), 7.07 (1H, s), 7.16-7.43 (12H, m), 7.84 (1H, s), 8.67 (2
3 Three
H, d, J = 5.4Hz). (H, d, J = 5.4Hz).
(24) 31 + 33→32 (24) 31 + 33 → 32
化合物 31(340mg、 0.88mmol)と化合物 33(662mg、 0.88mmol)から(4)と同様して化合 物 32(1.0g)を粉末として得た。 Compound 32 (1.0 g) was obtained as a powder from compound 31 (340 mg, 0.88 mmol) and compound 33 (662 mg, 0.88 mmol) in the same manner as (4).
(25) 32→25 (25) 32 → 25
化合物 32(957mg)から(5)と同様して化合物 25を粉末として得た。収量 334mg(48%) 'H-NMR (D O): 1.28(6H, bd, J = 6.0Hz), 2.63(3H, s), 3.67(2H, m), 4.47(1H, m), 5. Compound 25 was obtained as a powder from Compound 32 (957 mg) in the same manner as in (5). Yield 334 mg (48%) 'H-NMR (D 2 O): 1.28 (6H, bd, J = 6.0 Hz), 2.63 (3H, s), 3.67 (2H, m), 4.47 (1H, m), 5.
2 2
21-5.27(3H, m), 5.79(1H, d J = 4.5Hz), 6.11(1H, m) , 6.90(1H, s), 6.98(1H, d, J = 1 5.6Hz), 7.66(1H, s),8.02(2H, bd, J = 5.1Hz), 8.73(2H, bd, J = 5.7Hz). 21-5.27 (3H, m), 5.79 (1H, d J = 4.5Hz), 6.11 (1H, m), 6.90 (1H, s), 6.98 (1H, d, J = 1 5.6Hz), 7.66 (1H , s), 8.02 (2H, bd, J = 5.1Hz), 8.73 (2H, bd, J = 5.7Hz).
IR (KBr) cm—1: 3399, 2976, 1762, 1634, 1596, 1537, 1437, 1386, 1356. IR (KBr) cm— 1 : 3399, 2976, 1762, 1634, 1596, 1537, 1437, 1386, 1356.
MS: 669+ (M+H)+ MS: 669+ (M + H) +
元素分析 c H N O S Na-0.5NaHCO -4.7H O Elemental analysis c H N O S Na-0.5NaHCO -4.7H O
29 27 6 7 3 3 2 29 27 6 7 3 3 2
計算値: C,43.36; H,4.51; N,10.29; S,11.77; Na,4.22 (%) Calculated values: C, 43.36; H, 4.51; N, 10.29; S, 11.77; Na, 4.22 (%)
実験値: C43.53; H,4.54; Ν,ΙΟ.01; S,11.17; Na,4.39 (%) Experimental value: C43.53; H, 4.54; Ν, ΙΟ.01; S, 11.17; Na, 4.39 (%)
実施例 135 Example 135
(26) 35→36 (26) 35 → 36
化合物 35(946mg,5mmol)をジメチルホルムアミド (10ml)に溶解して p—メトキシベンジ ルアルコール (0.62ml,5mmol)を加えた後、ェチルジメチルァミノプロピルカルボジイミ ド塩酸塩 (1.15g,6mmol)と 4-ジメチルァミノピリジン (183mg,0.15mmol)を加えて室温か ら 50°Cで 3.5時間攪拌した。反応液に酢酸ェチル -水を加え、有機層を水洗、乾燥後 、濃縮して 36を結晶として得た。収量 878mg(57%)。 Compound 35 (946 mg, 5 mmol) was dissolved in dimethylformamide (10 ml), p-methoxybenzyl alcohol (0.62 ml, 5 mmol) was added, and then ethyldimethylaminopropylcarbodiimide hydrochloride (1.15 g, 6 mmol) and 4-dimethylaminopyridine (183 mg, 0.15 mmol) were added, and the mixture was stirred at room temperature at 50 ° C for 3.5 hours. Ethyl acetate-water was added to the reaction solution, and the organic layer was washed with water, dried and concentrated to obtain 36 as crystals. Yield 878 mg (57%).
'H-NMR (CDCl ): 3·82(3Η, s), 5.33(2H, s), 6.92(2H, d, J = 8.7Hz), 7.25(1H, s), 7. 'H-NMR (CDCl): 3 · 82 (3Η, s), 5.33 (2H, s), 6.92 (2H, d, J = 8.7Hz), 7.25 (1H, s), 7.
39(2H, d, J = 8.7Hz), 7.75(2H, d, J = 6.0Hz), 8.70(2H, d, J = 6.3Hz). 39 (2H, d, J = 8.7Hz), 7.75 (2H, d, J = 6.0Hz), 8.70 (2H, d, J = 6.3Hz).
(27) 36 + 33→37 (27) 36 + 33 → 37
化合物 36(309mg、 Immol)と化合物 33(752mg、 Immol)から(4)と同様して化合物 37(1 .0g)を粉末として得た。 Compound 37 (1.0 g) was obtained as a powder in the same manner as Compound (4) from Compound 36 (309 mg, Immol) and Compound 33 (752 mg, Immol).
( 28) 37→34 (28) 37 → 34
化合物 37(1.0g)から(5)と同様して化合物 34を粉末として得た。収量 374mg(54%) 'H-NMR (D O): 1.28(6H, d, J = 6.0Hz), 3.65, 3.68(2H, ABq, J = 17.3Hz), 4.47(1H, m), 5.26(3H, m), 5.80(1H, d J = 4.5Hz), 6.11(1H, dt, J = 7.2, 15.6Hz), 6.90(1H, s) , 6.98(1H, d, J = 15.9Hz), 7.28(1H, s), 8.28(2H, d, J = 6.0Hz), 8.75(2H, d, J = 5.7H z). Compound 34 was obtained as a powder in the same manner as Compound (5) from Compound 37 (1.0 g). Yield 374mg (54%) 'H-NMR (DO): 1.28 (6H, d, J = 6.0Hz), 3.65, 3.68 (2H, ABq, J = 17.3Hz), 4.47 (1H, m), 5.26 (3H , m), 5.80 (1H, d J = 4.5Hz), 6.11 (1H, dt, J = 7.2, 15.6Hz), 6.90 (1H, s), 6.98 (1H, d, J = 15.9Hz), 7.28 ( 1H, s), 8.28 (2H, d, J = 6.0Hz), 8.75 (2H, d, J = 5.7H z).
IR (KBr) cm"1: 3409, 2977, 1763, 1635, 1604, 1532, 1472, 1438, 1398, 1347, 1301. MS: 639+ (M+H)+ IR (KBr) cm " 1 : 3409, 2977, 1763, 1635, 1604, 1532, 1472, 1438, 1398, 1347, 1301. MS: 639 + (M + H) +
元素分析 C H N O S Na- 0.3NaHCO -4.7H O Elemental analysis C H N O S Na- 0.3NaHCO -4.7H O
計算値: C,42.56; H,4.54; N, 14.54; S,8.32; Na,3.88 (%)
実験値: C,42.53; H,4.67; N,14.56; S,8.30; Na,3.70 (%) Calculated value: C, 42.56; H, 4.54; N, 14.54; S, 8.32; Na, 3.88 (%) Experimental value: C, 42.53; H, 4.67; N, 14.56; S, 8.30; Na, 3.70 (%)
実施例 136 Example 136
[化 183] [Chemical 183]
(29) 39→40 (29) 39 → 40
化合物 39(1.37g,10mmol)をテトラヒドロフラン (30ml)に溶解してトリェチルァミン (1.67ml ,12mmol)を加えた後、。 :θ。ΟΟΒι (1.8^,11πΐΓηο1)を加えて 5時間還流した。反応液 に酢酸ェチル -水を加え、有機層を水洗、乾燥後、濃縮して、析出晶をイソプロピル エーテルとへキサン混液で洗浄して 40を結晶として得た。収量 1.54g(62%)。 Compound 39 (1.37 g, 10 mmol) was dissolved in tetrahydrofuran (30 ml) and triethylamine (1.67 ml, 12 mmol) was added. : θ. ΟΟΒι (1.8 ^, 11πΐΓηο1) was added and refluxed for 5 hours. Ethyl acetate-water was added to the reaction solution, and the organic layer was washed with water, dried and concentrated. The precipitated crystals were washed with a mixture of isopropyl ether and hexane to obtain 40 as crystals. Yield 1.54 g (62%).
'H-NMR (CDCl ): 1·69(9Η, s), 8.05(2H, d, J = 5.7Hz), 8.82(2H, d, J = 6.0Hz). 'H-NMR (CDCl): 1 · 69 (9Η, s), 8.05 (2H, d, J = 5.7Hz), 8.82 (2H, d, J = 6.0Hz).
3 Three
(30) 40 + 33→41 (30) 40 + 33 → 41
化合物 40(247mg、 Immol)と化合物 33(752mg、 Immol)から(4)と同様して化合物 41(0· 91g)を粉末として得た。 Compound 41 (0 · 91 g) was obtained as a powder from Compound 40 (247 mg, Immol) and Compound 33 (752 mg, Immol) in the same manner as (4).
(31) 41→38 (31) 41 → 38
化合物 41(0.91g)から(5)と同様して化合物 38を粉末として得た。収量 189mg(28%) 'H-NMR (D O): 1.28(6H, d, J = 6.0Hz), 3.67(2H, m), 4.48(1H, m), 5.27(1H, d, J = Compound 38 was obtained as a powder in the same manner as Compound (5) from Compound 41 (0.91 g). Yield 189 mg (28%) 'H-NMR (D 2 O): 1.28 (6H, d, J = 6.0Hz), 3.67 (2H, m), 4.48 (1H, m), 5.27 (1H, d, J =
2 2
4.5Hz), 5.40(2H, d, J = 6.3Hz), 5.81(1H, d J = 4.8Hz), 6.13(1H, dt, J = 6.9, 15.6Hz ) , 6.93(1H, s), 7.02(1H, d, J = 15.3Hz), 8.65(2H, d, J = 6.9Hz), 9.06(2H, d, J = 6.6 Hz). 4.5Hz), 5.40 (2H, d, J = 6.3Hz), 5.81 (1H, d J = 4.8Hz), 6.13 (1H, dt, J = 6.9, 15.6Hz), 6.93 (1H, s), 7.02 ( 1H, d, J = 15.3Hz), 8.65 (2H, d, J = 6.9Hz), 9.06 (2H, d, J = 6.6 Hz).
IR (KBr) cm—1: 3410, 2978, 2935, 2170, 1764, 1669, 1610, 1533, 1456, 1384, 1347. MS: 641+ (M+H)+ IR (KBr) cm— 1 : 3410, 2978, 2935, 2170, 1764, 1669, 1610, 1533, 1456, 1384, 1347. MS: 641 + (M + H) +
元素分析 c H N O S Na-0.3NaHCO -4.3H O
計算値: C,41.20; H,4.20; N, 14.64; S,8.38; Na,3.91 (%) Elemental analysis c HNOS Na-0.3NaHCO -4.3HO Calculated values: C, 41.20; H, 4.20; N, 14.64; S, 8.38; Na, 3.91 (%)
実験値: C,41.26; H,4.29; N, 14.78; S,8.57; Na,3.84 (%) Experimental value: C, 41.26; H, 4.29; N, 14.78; S, 8.57; Na, 3.84 (%)
実施例 137 Example 137
[化 184] [Chemical 184]
(32) 43 + 45→44 (32) 43 + 45 → 44
化合物 43(291mg、 0.78mmol)と化合物 45(618mg、 0.78mmol)から(4)と同様して化合 物 44を粉末として得た。 Compound 44 was obtained as a powder from Compound 43 (291 mg, 0.78 mmol) and Compound 45 (618 mg, 0.78 mmol) in the same manner as (4).
(33) 44→42 (33) 44 → 42
化合物 44から(5)と同様して化合物 42を粉末として得た。収量 204mg(31%) Compound 42 was obtained as a powder from Compound 44 in the same manner as (5). Yield 204 mg (31%)
'H-NMR (D O): 3·66(2Η, m), 4.64-4.72(1Η, m), 5.26(3Η, m), 5.79(1Η, d J = 3.9Hz 'H-NMR (D O): 3.66 (2Η, m), 4.64-4.72 (1Η, m), 5.26 (3Η, m), 5.79 (1Η, d J = 3.9Hz
2 2
), 6.11(1H, dt, J = 8.1, 15.0Hz), 7.00(1H, d, J = 15.6Hz), 7.02(1H, s), 8.43(2H, d, J = 6.3Hz), 8.60(1H, s), 8.79(2H, d, J = 5.7Hz). ), 6.11 (1H, dt, J = 8.1, 15.0Hz), 7.00 (1H, d, J = 15.6Hz), 7.02 (1H, s), 8.43 (2H, d, J = 6.3Hz), 8.60 (1H , s), 8.79 (2H, d, J = 5.7Hz).
IR (KBr) cm"1: 3408, 1764, 1636, 1533, 1488, 1458, 1368, 1301. IR (KBr) cm " 1 : 3408, 1764, 1636, 1533, 1488, 1458, 1368, 1301.
MS: 696+ (M+H)+ MS: 696+ (M + H) +
元素分析 C H F N O S Na- 0.2NaHCO - 5.5H O Elemental analysis C H F N O S Na- 0.2NaHCO-5.5H O
26 19 3 7 7 3 3 2 26 19 3 7 7 3 3 2
計算値: C,37.75; Η,3·65; Ν,11·76; S, 11.54; F,6.84; Na,3.31 (%) Calculated value: C, 37.75; Η, 3.65; Ν, 11.76; S, 11.54; F, 6.84; Na, 3.31 (%)
実験値: C,37.71; H,3.23; N,11.50; S,11.16; F,6.46; Na,3.23 (%) Experimental value: C, 37.71; H, 3.23; N, 11.50; S, 11.16; F, 6.46; Na, 3.23 (%)
実施例 138 Example 138
[化 185]
[Chemical 185]
(34) 47→48 (34) 47 → 48
化合物 47(8.24g,50mmol)をジメチルホルムアミド (50ml)に溶解してトリフヱニルホスフ イン (13.2g,50mmol)を加え 80°Cにて 1時間攪拌した。反応液に酢酸ェチルを加え析 出晶を濾取して 48を得た。収量 14.9g(69%)。 Compound 47 (8.24 g, 50 mmol) was dissolved in dimethylformamide (50 ml), triphenylphosphine (13.2 g, 50 mmol) was added, and the mixture was stirred at 80 ° C. for 1 hour. Ethyl acetate was added to the reaction mixture, and the precipitated crystals were collected by filtration to give 48. Yield 14.9 g (69%).
'H-NMR (d -DMSO) : 5·69(2Η, d, J=17.1Hz), 7.47(2H, d, J = 6.6Hz), 7.76-7.97(15 'H-NMR (d-DMSO): 5 · 69 (2Η, d, J = 17.1Hz), 7.47 (2H, d, J = 6.6Hz), 7.76-7.97 (15
H, m), 8.70(2H, d, J = 6.3Hz). H, m), 8.70 (2H, d, J = 6.3Hz).
(35) 48 + 49→50 (35) 48 + 49 → 50
化合物 48(1. lg、 2.6mmol)と化合物 49(647mg、 2mmol)をジメチルホルムアミド (10ml)に 溶解する。 DBU(0.9ml、 6mmol)を加えて、室温で 1時間攪拌した。反応液に酢酸ェチ ルをカ卩ぇ水洗、乾燥、濃縮した後カラムクロマト精製して 50(E/Z混合物)を得た。収量 402mg(48%)o Compound 48 (1. lg, 2.6 mmol) and compound 49 (647 mg, 2 mmol) are dissolved in dimethylformamide (10 ml). DBU (0.9 ml, 6 mmol) was added and stirred at room temperature for 1 hour. The reaction solution was washed with water, dried, concentrated, and purified by column chromatography to obtain 50 (E / Z mixture). Yield 402 mg (48%) o
(36) 50→51 (36) 50 → 51
化合物 50(391mg,0.94mmol)を塩化メチレン (5ml)に溶解する。 2,2 ' -ァゾビス (2,4-ジメ チルバレロニトリル) (117mg,0.47mmol)と 4_クロロチオフエノーノレ (68mg,0.47mmol)を 加えて 5時間還流した。反応液に少量の活性炭を加えて、濾過した。濾液を濃縮した 後カラムクロマト精製して化合物 51を得た。収量 156mg(40%) Compound 50 (391 mg, 0.94 mmol) is dissolved in methylene chloride (5 ml). 2,2′-Azobis (2,4-dimethylvaleronitrile) (117 mg, 0.47 mmol) and 4_chlorothiophenol (68 mg, 0.47 mmol) were added and refluxed for 5 hours. A small amount of activated carbon was added to the reaction solution and filtered. The filtrate was concentrated and purified by column chromatography to give compound 51. Yield 156 mg (40%)
'H-NMR (CDCl ) : 7.17-7.57(16H, m), 8· 59(2Η, d, J = 5.1Hz). 'H-NMR (CDCl 3): 7.17-7.57 (16H, m), 8 · 59 (2Η, d, J = 5.1 Hz).
(37) 51 + 2→52 (37) 51 + 2 → 52
化合物 51(156mg、 0.38mmol)と化合物 2(281mg、 0.38mmol)から(4)と同様して化合物
52を粉末として得た。 Compound 51 (156 mg, 0.38 mmol) and compound 2 (281 mg, 0.38 mmol) to compound similar to (4) 52 was obtained as a powder.
(38) 52→46 (38) 52 → 46
化合物 52から(5)と同様して化合物 46を粉末として得た。収量 127mg(41%) The compound 46 was obtained as a powder in the same manner as the compound 52 to (5). Yield 127 mg (41%)
'H-NMR (D O): 1.27(3H, t, J = 7.2Hz), 3.66(2H, m), 4.22(2H, q, J = 7.2Hz) , 5.19( 'H-NMR (D 2 O): 1.27 (3H, t, J = 7.2Hz), 3.66 (2H, m), 4.22 (2H, q, J = 7.2Hz), 5.19 (
2H, d, J = 6.6Hz), 5.26(1H, d, J = 5.1Hz), 5.80(1H, d J = 5.1Hz), 6.07(1H, dt, J = 7 • 5, 15.6Hz), 6.94(1H, s), 6.95(1H, d, J = 15.9Hz), 7.41(1H, d, J = 16.2Hz), 7.69(1 H, d, J = 15.9Hz), 7.89(lH,s), 8.00(2H, d, J = 6.3Hz), 8.61(2H, d, J = 6.3Hz). 2H, d, J = 6.6Hz), 5.26 (1H, d, J = 5.1Hz), 5.80 (1H, d J = 5.1Hz), 6.07 (1H, dt, J = 7 • 5, 15.6Hz), 6.94 (1H, s), 6.95 (1H, d, J = 15.9Hz), 7.41 (1H, d, J = 16.2Hz), 7.69 (1 H, d, J = 15.9Hz), 7.89 (lH, s), 8.00 (2H, d, J = 6.3Hz), 8.61 (2H, d, J = 6.3Hz).
IR (KBr) cm—1: 3408, 2981, 1763, 1621, 1532, 1470, 1367. IR (KBr) cm— 1 : 3408, 2981, 1763, 1621, 1532, 1470, 1367.
MS: 668+ (M+H)+ MS: 668+ (M + H) +
元素分析 C H N O S Na-0.2NaHCO -6H〇 Elemental analysis C H N O S Na-0.2NaHCO -6H
計算値: C,41.58; H,4.48; N,12.04; S,11.81; Na,3.39 (%) Calculated value: C, 41.58; H, 4.48; N, 12.04; S, 11.81; Na, 3.39 (%)
実験値: C41.18; H,4.38; N,11.96; S,11.82; Na,3.33 (%) Experimental value: C41.18; H, 4.38; N, 11.96; S, 11.82; Na, 3.33 (%)
実施例 139 Example 139
[化 186] [Chemical 186]
(39) 54 + 55→56 (39) 54 + 55 → 56
化合物 54(1.78g,10mmol)を塩化メチレン (20ml)に溶解して化合物 55(1.29ml, 10mmol) をカロえ、次いでピリジン (1.71111,2111111101)を加ぇて氷冷下1時間攪拌した。さらに室温で 1時間攪拌した後、反応液に酢酸ュチルを加え、水洗、乾燥、濃縮した。析出晶をィ ソプロピルエーテルで洗浄しながら濾取して 56を得た。収量 2.07g(81%)。 Compound 54 (1.78 g, 10 mmol) was dissolved in methylene chloride (20 ml) to remove compound 55 (1.29 ml, 10 mmol), pyridine (1.71111, 2111111101) was added, and the mixture was stirred under ice-cooling for 1 hour. After further stirring at room temperature for 1 hour, utyl acetate was added to the reaction solution, washed with water, dried and concentrated. The precipitated crystals were collected by filtration while washing with isopropyl ether to obtain 56. Yield 2.07 g (81%).
'H-NMR (CDCl ): 3·99(3Η, s), 7.19(1H, m), 7.64(1H, m),7.92(2H, d, J = 6.9Hz), 8.
12(1H, m), 8.85(2H, d, J = 6.0Hz), 8.90(1H, d, J = 8.4Hz). 'H-NMR (CDCl): 3.99 (3Η, s), 7.19 (1H, m), 7.64 (1H, m), 7.92 (2H, d, J = 6.9Hz), 8. 12 (1H, m), 8.85 (2H, d, J = 6.0Hz), 8.90 (1H, d, J = 8.4Hz).
(40) 56→57→58 (40) 56 → 57 → 58
化合物 56(1.99g、 7.8mmol)をメタノール (10ml)に溶解して、 2NNaOH(8.5ml)を加えて、 室温で 45分間攪拌した。反応液を 2NHCl(8.5ml)で中和して、析出晶を濾取して 57を 得た。 Compound 56 (1.99 g, 7.8 mmol) was dissolved in methanol (10 ml), 2NNaOH (8.5 ml) was added, and the mixture was stirred at room temperature for 45 minutes. The reaction solution was neutralized with 2N HCl (8.5 ml), and the precipitated crystals were collected by filtration to obtain 57.
次いでクロ口ホルム (30ml)に溶解してジフヱニルジァゾメタンを加えて化合物 58を結 晶として得た。収量 3.08g(97%)。 Subsequently, it was dissolved in black mouth form (30 ml), and diphenyldiazomethane was added to obtain Compound 58 as crystals. Yield 3.08 g (97%).
'H-NMR (CDCl ): 7.18— 7.46(12H, m), 7·66(1Η, m), 7.86(2H, d, J = 6.0Hz), 8.32(1 'H-NMR (CDCl): 7.18— 7.46 (12H, m), 7.66 (1Η, m), 7.86 (2H, d, J = 6.0 Hz), 8.32 (1
H, m), 8.82(2H, d, J = 6.3Hz), 8.90(1H, d, J = 8.7Hz). H, m), 8.82 (2H, d, J = 6.3Hz), 8.90 (1H, d, J = 8.7Hz).
(41) 58 + 2→59 (41) 58 + 2 → 59
化合物 58(613mg、 1.5mmol)と化合物 2(l.llg、 1.5mmol)から(4)と同様して化合物 59 を粉末として得た。 Compound 59 was obtained as a powder from Compound 58 (613 mg, 1.5 mmol) and Compound 2 (l.llg, 1.5 mmol) in the same manner as (4).
(42) 59→53 (42) 59 → 53
化合物 59から(5)と同様して化合物 53を粉末として得た。収量 127mg(41%) Compound 53 was obtained as a powder in the same manner as in Compound 59 to (5). Yield 127 mg (41%)
'H-NMR (D O): 1.29(3H, t, J = 7.2Hz), 3.68(2H, m), 4.24(2H, q, J = 7.2Hz) , 5.28( 'H-NMR (D 2 O): 1.29 (3H, t, J = 7.2Hz), 3.68 (2H, m), 4.24 (2H, q, J = 7.2Hz), 5.28 (
1H, d, J = 4.8Hz), 5.35(2H, d, J = 6.3Hz), 5.83(1H, d, J = 4.8Hz), 6.10(1H, dt, J = 6.9, 15.9Hz), 6.96(1H, s), 7.04(1H, d, J = 15.6Hz), 7.22(1H, m), 7.50(1H, m), 7.92 (1H, m), 8.31(2H, d , J = 6.9Hz), 8.33(1H, m), 8.98(2H, d, J = 6.9Hz). 1H, d, J = 4.8Hz), 5.35 (2H, d, J = 6.3Hz), 5.83 (1H, d, J = 4.8Hz), 6.10 (1H, dt, J = 6.9, 15.9Hz), 6.96 ( 1H, s), 7.04 (1H, d, J = 15.6Hz), 7.22 (1H, m), 7.50 (1H, m), 7.92 (1H, m), 8.31 (2H, d, J = 6.9Hz), 8.33 (1H, m), 8.98 (2H, d, J = 6.9Hz).
IR (KBr) cm"1: 3408, 3055, 2981, 1765, 1668, 1586, 1505, 1439, 1371, 1307. IR (KBr) cm " 1 : 3408, 3055, 2981, 1765, 1668, 1586, 1505, 1439, 1371, 1307.
MS: 678+ (M+H)+ MS: 678+ (M + H) +
元素分析 C H N O S Na-0.6NaHCO -2H O Elemental analysis C H N O S Na-0.6NaHCO -2H O
計算値: C,46.75; Η,3·92; N,12.47; S,8.16; Na,4.68 (%) Calculated value: C, 46.75; Η, 3.92; N, 12.47; S, 8.16; Na, 4.68 (%)
実験値: C47.86; H,4.31; N,11.86; S,5.93; Na,4.56 (%) Experimental value: C47.86; H, 4.31; N, 11.86; S, 5.93; Na, 4.56 (%)
実施例 140 Example 140
[化 187]
[Chemical 187]
(43) 61→62 (43) 61 → 62
化合物 61(1.83g,10mmol)をジメチルホルムアミド (30ml)に溶解して炭酸カリウム(3.45g , 25mmol)と臭化 P-メトキシベンジル (3.03ml,21mmol)を加え室温で一夜攪拌した。反 応液に水を加え酢酸ェチルで抽出し、水洗、乾燥した後、濃縮して 62を結晶として得 た。収量 1.58g (37%)。 Compound 61 (1.83 g, 10 mmol) was dissolved in dimethylformamide (30 ml), potassium carbonate (3.45 g, 25 mmol) and P-methoxybenzyl bromide (3.03 ml, 21 mmol) were added, and the mixture was stirred overnight at room temperature. Water was added to the reaction solution, and the mixture was extracted with ethyl acetate, washed with water, dried and concentrated to obtain 62 as crystals. Yield 1.58 g (37%).
'H-NMR (d -DMSO): 3.75(3H, s), 3.77(3H, s), 5.24(2H, s), 5.27(2H, s), 6.89(2H, d 'H-NMR (d-DMSO): 3.75 (3H, s), 3.77 (3H, s), 5.24 (2H, s), 5.27 (2H, s), 6.89 (2H, d
, J = 8.7Hz) , 6.93(2H, d, J = 9.0Hz), 7.31(2H, d, J = 8.7Hz), 7.37(2H, d, J = 8.7H z), 7.49(1H, d, J = 9.6Hz), 8.41(1H, dd, J = 3.0, 9.3Hz), 8.47(1H, d, J = 2.7Hz)., J = 8.7Hz), 6.93 (2H, d, J = 9.0Hz), 7.31 (2H, d, J = 8.7Hz), 7.37 (2H, d, J = 8.7H z), 7.49 (1H, d, J = 9.6Hz), 8.41 (1H, dd, J = 3.0, 9.3Hz), 8.47 (1H, d, J = 2.7Hz).
(44) 62→63 (44) 62 → 63
化合物 62(1.56g,3.68mmol)を(2)と同様にして 63を結晶として得た。収量 1.50g 'H-NMR (CDCl ): 3·80(6Η, s), 4.97(2H, s), 5.25(2H, s), 6.77(1H, dd, J = 2.4, 8.4H z), 6.85(5H, m) , 7.16(1H, d, J = 2.7Hz) , 7.31(4H, m). Compound 62 (1.56 g, 3.68 mmol) was obtained in the same manner as (2) to give 63 as crystals. Yield 1.50g 'H-NMR (CDCl): 3.80 (6Η, s), 4.97 (2H, s), 5.25 (2H, s), 6.77 (1H, dd, J = 2.4, 8.4H z), 6.85 (5H, m), 7.16 (1H, d, J = 2.7Hz), 7.31 (4H, m).
(45) 54 + 63→64 (45) 54 + 63 → 64
化合物 54(765mg,10mmol)と化合物 63(1.46g,3.6mmol)を(39)と同様にして 64を得た 。収量 1.57g(88%)。 Compound 54 (765 mg, 10 mmol) and compound 63 (1.46 g, 3.6 mmol) were obtained in the same manner as (39) to give 64. Yield 1.57g (88%).
'H-NMR (CDCl ): 3.80(3H, s), 3.81(3H, s), 5.08(2H, s), 5.25(2H, s), 6.83— 6.88(4H 'H-NMR (CDCl): 3.80 (3H, s), 3.81 (3H, s), 5.08 (2H, s), 5.25 (2H, s), 6.83-6.88 (4H
, m), 7.04(1H, d, J = 9.0Hz), 7.29- 7.35(4H, m), 7.69(2H, d, J = 5.7Hz), 7.83(1H, d, J = 3.0Hz) , 7.97(2H, m), 8.77(2H, d, J = 5.7Hz). , M), 7.04 (1H, d, J = 9.0Hz), 7.29-7.35 (4H, m), 7.69 (2H, d, J = 5.7Hz), 7.83 (1H, d, J = 3.0Hz), 7.97 (2H, m), 8.77 (2H, d, J = 5.7Hz).
(46) 64 + 2→65
化合物 64(748mg、 1.5mmol)と化合物 2(l. l lg、 1.5mmol)から(4)と同様して化合物 65 を粉末として得た。 (46) 64 + 2 → 65 Compound 65 was obtained as a powder in the same manner as (4) from compound 64 (748 mg, 1.5 mmol) and compound 2 (l. L lg, 1.5 mmol).
(47) 65→60 (47) 65 → 60
化合物 65から(5)と同様して化合物 60を粉末として得た。収量 618mg(50%) Compound 60 was obtained as a powder in the same manner as Compound (5) from Compound 65. Yield 618mg (50%)
'H-NMR (D O): 1.29(3H, t, J = 7.2Hz), 3.66(2H, m), 4.24(2H, q, J = 7.2Hz) , 5.26( 'H-NMR (DO): 1.29 (3H, t, J = 7.2Hz), 3.66 (2H, m), 4.24 (2H, q, J = 7.2Hz), 5.26 (
2 2
1H, d, J = 4.5Hz), 5.38(2H, d, J = 6.9Hz), 5.82(1H, d, J = 4.5Hz), 6.11(1H, dt, J = 6.9, 15.6Hz), 6.90(1H, d, J = 9.0Hz), 6.97(1H, s), 7.00(1H, d, J = 15.3Hz), 7.60(1H , dd, J = 2.7, 8.7Hz), 7.87(1H, d, J = 2.7Hz), 8.33(2H, d, J = 6 .6Hz), 8.99(2H, d, J = 6.9Hz). 1H, d, J = 4.5Hz), 5.38 (2H, d, J = 6.9Hz), 5.82 (1H, d, J = 4.5Hz), 6.11 (1H, dt, J = 6.9, 15.6Hz), 6.90 ( 1H, d, J = 9.0Hz), 6.97 (1H, s), 7.00 (1H, d, J = 15.3Hz), 7.60 (1H, dd, J = 2.7, 8.7Hz), 7.87 (1H, d, J = 2.7Hz), 8.33 (2H, d, J = 6.6Hz), 8.99 (2H, d, J = 6.9Hz).
IR (KBr) cm—1: 3420, 3056, 2982, 1764, 1633, 1538, 1492, 1436, 1377, 1316. IR (KBr) cm— 1 : 3420, 3056, 2982, 1764, 1633, 1538, 1492, 1436, 1377, 1316.
MS: 694+ (M+H)+ MS: 694 + (M + H) +
元素分析 c H N O S Na- 0.3NaHCO - 5H O Elemental analysis c H N O S Na- 0.3NaHCO-5H O
30 26 7 9 2 3 2 30 26 7 9 2 3 2
計算値: C,43.88; H,4.41; N, 11.82; S,7.73; Na,3.60 (%) Calculated value: C, 43.88; H, 4.41; N, 11.82; S, 7.73; Na, 3.60 (%)
実験値: C,43.98; H,4.33; N,11.60; S,7.15; Na,3.59 (%) Experimental value: C, 43.98; H, 4.33; N, 11.60; S, 7.15; Na, 3.59 (%)
実施例 141 Example 141
[化 188] [Chemicalization 188]
(48) 67→68 (48) 67 → 68
化合物 67(2.21g,10mmol)をテトラヒドロフラン (50ml)に溶解してジフエニルジァゾメタン を加えて攪拌した後、濃縮して 68を結晶として得た。収量 3.99g
Ή-NMR (CDC1 ): 7.15(1H, s), 7.31— 7·44(10Η, m), 8.13(2H d, J = 8.7Hz), 8.36(2H, d, J = 9.0Hz). Compound 67 (2.21 g, 10 mmol) was dissolved in tetrahydrofuran (50 ml), diphenyldiazomethane was added and stirred, and then concentrated to obtain 68 as crystals. Yield 3.99g Ή-NMR (CDC1): 7.15 (1H, s), 7.31—7.44 (10Η, m), 8.13 (2H d, J = 8.7Hz), 8.36 (2H, d, J = 9.0Hz).
(49) 68→69 (49) 68 → 69
4—ァミノピリジン (1.24g, 13.2mmol)をピリジンに溶解して、化合物 68(3.41g,8.8mmol)を 加えて 50°Cで 1時間攪拌した。反応液を濃縮した後、水を加えて酢酸ェチルで抽出 し、水洗、乾燥した後、濃縮した。残渣をカラムクロマトで精製して 69を結晶として得 た。収量 645mg (16%)。 4-Aminopyridine (1.24 g, 13.2 mmol) was dissolved in pyridine, compound 68 (3.41 g, 8.8 mmol) was added, and the mixture was stirred at 50 ° C. for 1 hr. The reaction mixture was concentrated, water was added, and the mixture was extracted with ethyl acetate, washed with water, dried and concentrated. The residue was purified by column chromatography to obtain 69 as crystals. Yield 645 mg (16%).
'H-NMR (d -DMSO): 6.93(2H, d, J = 7.2Hz), 7.05(1H, s), 7.27- 7.53(10H, m), 7.95 'H-NMR (d-DMSO): 6.93 (2H, d, J = 7.2Hz), 7.05 (1H, s), 7.27-7.53 (10H, m), 7.95
(4H, m), 8.20(2H, d, J = 8.4Hz). (4H, m), 8.20 (2H, d, J = 8.4Hz).
(50) 69 + 2→70 (50) 69 + 2 → 70
化合物 69(595mg、 0.98mmol)と化合物 2(724mg、 0.98mmol)から(4)と同様して化合 物 70を粉末として得た。 Compound 70 was obtained as a powder from Compound 69 (595 mg, 0.98 mmol) and Compound 2 (724 mg, 0.98 mmol) in the same manner as (4).
(51) 70→66 (51) 70 → 66
化合物 70から(5)と同様して化合物 66を粉末として得た。収量 171mg(20%) Compound 66 was obtained as a powder in the same manner as Compound (7) from Compound 70. Yield 171 mg (20%)
'H-NMR (D O): 1.29(3H, t, J = 7.2Hz), 3.60(2H, m), 4.26(2H, q, J = 7.2Hz), 4.82('H-NMR (D 2 O): 1.29 (3H, t, J = 7.2Hz), 3.60 (2H, m), 4.26 (2H, q, J = 7.2Hz), 4.82 (
2H, d, J = 6.6Hz), 5.24(1H, d, J = 4.2Hz), 5.82(1H, d, J = 5.4Hz), 5.95(1H, dt, J = 6.9, 16.5Hz), 6.80(1H, d, J = 16.2Hz), 6.99(1H, s), 7.05(2H, d, J = 6.3Hz), 7.94(4H , s), 8.00(2H, d, J = 6.6Hz). 2H, d, J = 6.6Hz), 5.24 (1H, d, J = 4.2Hz), 5.82 (1H, d, J = 5.4Hz), 5.95 (1H, dt, J = 6.9, 16.5Hz), 6.80 ( 1H, d, J = 16.2Hz), 6.99 (1H, s), 7.05 (2H, d, J = 6.3Hz), 7.94 (4H, s), 8.00 (2H, d, J = 6.6Hz).
IR (ATR) cm—1: 3333, 2324, 2050, 1759, 1635, 1596, 1531, 2504, 1380, 1353. IR (ATR) cm— 1 : 3333, 2324, 2050, 1759, 1635, 1596, 1531, 2504, 1380, 1353.
MS: 714+ (M+H)+ MS: 714 + (M + H) +
元素分析 C H N O S Na - 7H O Elemental analysis C H N O S Na-7H O
計算値: C,39.37; H,4.57; N,11.08; S, 10.87; Na,5.20 (%) Calculated value: C, 39.37; H, 4.57; N, 11.08; S, 10.87; Na, 5.20 (%)
実験値: C,49.19; H,4.31; N,11.21; S, 10.71; Na,5.21 (%) Experimental value: C, 49.19; H, 4.31; N, 11.21; S, 10.71; Na, 5.21 (%)
実施例 142 Example 142
[化 189]
[Chemical 189]
(1) 3→4 (1) 3 → 4
化合物 3(886mg,5mmol)をジメチルホルムアミド(10ml)に溶解して、モノ- 1_ブチルマロ ン酸エステル (927mg, 5.5mmol)とェチルジメチルァミノプロピルカルボジイミド塩酸塩( 1.15g,6mmol)を加えて室温で一夜攪拌した。反応液を 5%食塩水に注加して、析出し た沈殿を濾取した。沈殿を減圧乾燥して化合物 4を粉末として得た。収量 1.37g(86%) 'H-NMR (CDCl ): 1.54 (9H, s), 3.52 (2H,s),7.43 (1H, s), 7.79 (2H, dd, J = 1.8, 4.8 Dissolve compound 3 (886 mg, 5 mmol) in dimethylformamide (10 ml) and add mono-1-butylmalonate (927 mg, 5.5 mmol) and ethyldimethylaminopropylcarbodiimide hydrochloride (1.15 g, 6 mmol). And stirred at room temperature overnight. The reaction solution was poured into 5% brine, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 4 as a powder. Yield 1.37 g (86%) 'H-NMR (CDCl): 1.54 (9H, s), 3.52 (2H, s), 7.43 (1H, s), 7.79 (2H, dd, J = 1.8, 4.8
3 Three
Hz), 8.65 (2H, dd, J = 1.8, 4.8 Hz), 11.0 (1H, s). Hz), 8.65 (2H, dd, J = 1.8, 4.8 Hz), 11.0 (1H, s).
( 2) 4 + 2→5 (2) 4 + 2 → 5
化合物 4(479mg、 1.5mmol)をジメチルホルムアミド (5ml)に溶解した。次いで化合物 2( 1.20g、 1.5mmol)と NaBr(463mg、 4.5mmol)を加えて、室温で一夜攪拌した。反応液を 5 %食塩水攪拌下にて注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して化合物 5(1.60g)を粉末として得た。 Compound 4 (479 mg, 1.5 mmol) was dissolved in dimethylformamide (5 ml). Compound 2 (1.20 g, 1.5 mmol) and NaBr (463 mg, 4.5 mmol) were then added and stirred overnight at room temperature. The reaction solution was poured under stirring with 5% saline, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 5 (1.60 g) as a powder.
(3) 5→1 (3) 5 → 1
化合物 5(1.60g)を塩化メチレン (20ml)、ァニソール (0.98ml)に溶解し、 _40°Cに冷却し た。 2MTiClの塩化メチレン溶液 (4.5ml)をカ卩えた後、氷冷下、 45分間攪拌した。反応 Compound 5 (1.60 g) was dissolved in methylene chloride (20 ml) and anisole (0.98 ml) and cooled to _40 ° C. After 2 MTiCl in methylene chloride (4.5 ml) was added, the mixture was stirred for 45 minutes under ice cooling. Reaction
4 Four
液に 2NHC1 (5ml) -イソプロピールエーテル (60ml)を加えて攪拌した。反応液を静置 して後、上澄み液を傾斜して、さらにイソプロピールエーテルで沈殿物を洗浄した。 沈殿物は 0.5NHC1—ァセトニトリルに溶解して HP-20SSカラムクロマトグラフィーに付 し、水 -ァセトニトリルで溶離した。溶離液はさらに 0.2NNaOHで中和し濃縮した後、 0 DSカラムクロマトに付し、水 -ァセトニトリルで溶離した。所望の化合物を含むフラクシ
ヨンを減圧下濃縮し、濃縮液を凍結乾燥して化合物 1を粉末として得た。収量 515mg( 41%) 2NHC1 (5 ml) -isopropyl ether (60 ml) was added to the solution and stirred. After allowing the reaction solution to stand, the supernatant was decanted and the precipitate was further washed with isopropyl ether. The precipitate was dissolved in 0.5NHC1-acetonitrile, subjected to HP-20SS column chromatography and eluted with water-acetonitrile. The eluent was further neutralized with 0.2N NaOH and concentrated, then subjected to 0 DS column chromatography and eluted with water-acetonitrile. Fluxi containing the desired compound Yon was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 1 as a powder. Yield 515mg (41%)
'H-NMR (D O) δ: 1.26 (3Η, t, J = 7.2 Hz), 3.50 (2H, brs), 3.66 (2H, brs), 4.20 (2 'H-NMR (D O) δ: 1.26 (3Η, t, J = 7.2 Hz), 3.50 (2H, brs), 3.66 (2H, brs), 4.20 (2
2 2
H, q, J = 7.2 Hz), 5.22 - 5.26 (3H, m), 5.78 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6. 9, 15.6 Hz), 6.90 (1H, s), 6.97 (1H, d, J = 15.6 Hz), 8.13 (1H, s), 8.32 (2H, d, J = 6 • 9 Hz), 8.73 (2H, d, J = 6.9 Hz). H, q, J = 7.2 Hz), 5.22-5.26 (3H, m), 5.78 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6. 9, 15.6 Hz), 6.90 (1H , s), 6.97 (1H, d, J = 15.6 Hz), 8.13 (1H, s), 8.32 (2H, d, J = 6 • 9 Hz), 8.73 (2H, d, J = 6.9 Hz).
IR (KBr) cm—1 : 3309, 2324, 1756, 1634, 1593, 1538, 1458, 1371, 1216, 1154, 1034. MS(ESI): 699+ (M + H)+ IR (KBr) cm— 1 : 3309, 2324, 1756, 1634, 1593, 1538, 1458, 1371, 1216, 1154, 1034. MS (ESI): 699+ (M + H) +
元素分析 c H N NaO S -6.9 H O - 0.1 NaHCO Elemental analysis c H N NaO S -6.9 H O-0.1 NaHCO
28 25 8 8 3 2 3 28 25 8 8 3 2 3
計算値: C,39.55 ; H,4.59 ; N,13.13 ; S,11.27 ; Na,2.96 (%) Calculated values: C, 39.55; H, 4.59; N, 13.13; S, 11.27; Na, 2.96 (%)
実験値: C39.54 ; H,4.23 ; N, 13.23 ; S, 10.96 ; Na,3.09 (%) Experimental value: C39.54; H, 4.23; N, 13.23; S, 10.96; Na, 3.09 (%)
実施例 143 Example 143
[化 190] [Chemical 190]
(4) 7→8 (4) 7 → 8
化合物 7(1.03g, 5mmol)をジメチルホルムアミド (10ml)に溶解して、グリシン- 1_ブチノレ エステル (923mg,5.5mmol)、ェチルジメチルァミノプロピルカルボジイミド塩酸塩 (1.15g ,6mmol)とトリエチルァミン (0.77ml, 5.5mmol)を加え、 0°C〜室温で一夜攪拌した。反 応液に水-酢酸ェチルを加えて抽出した。有機層を水洗、乾燥、濃縮後、カラムクロ マト精製して 8を得た。収量 548mg(34%) Compound 7 (1.03 g, 5 mmol) was dissolved in dimethylformamide (10 ml), and glycine-1-butynole ester (923 mg, 5.5 mmol), ethyldimethylaminopropyl carbodiimide hydrochloride (1.15 g, 6 mmol) and triethylamine were dissolved. Min (0.77 ml, 5.5 mmol) was added and stirred overnight at 0 ° C. to room temperature. The reaction solution was extracted by adding water-ethyl acetate. The organic layer was washed with water, dried and concentrated, and purified by column chromatography to obtain 8. Yield 548 mg (34%)
'H-NMR (CDCl ): 1.53 (9H, s), 4.19 (2H,d, J = 5.4 Hz), 7.79 (1H, brs), 7.86 (2H, d
, J = 6.3 Hz), 7.97 (lH,s), 8.71 (2H, d, J = 6.3 Hz). 'H-NMR (CDCl): 1.53 (9H, s), 4.19 (2H, d, J = 5.4 Hz), 7.79 (1H, brs), 7.86 (2H, d , J = 6.3 Hz), 7.97 (lH, s), 8.71 (2H, d, J = 6.3 Hz).
(5) 8 + 2→9 (5) 8 + 2 → 9
ィ匕合物 2(1.20g,1.5mmol)と化合物 8(479mg,1.5mmol)力も(2)と同様にして 9を得た。 収量 1.70g Compound 2 (1.20 g, 1.5 mmol) and compound 8 (479 mg, 1.5 mmol) were also obtained in the same manner as (2). Yield 1.70g
(6) 9→6 (6) 9 → 6
化合物 9(1.70g)を塩化メチレン (20ml)、ァニソール (0.98ml)に溶解し、 _40°Cに冷却し た。 2MTiClの塩化メチレン溶液 (4.5ml)をカ卩えた後、氷冷下、 45分間攪拌した。反応 液に 2NHCl (5ml) -イソプロピールエーテル (60ml)をカ卩えて攪拌した。反応液を静置 して後、上澄み液を傾斜して、さらにイソプロピールエーテルで沈殿物を洗浄した。 沈殿物は 0.5NHC1—ァセトニトリルに溶解して HP-20SSカラムクロマトグラフィーに付 し、水-ァセトニトリルで溶離した。所望の化合物を含むフラクションを減圧下濃縮し、 濃縮液を凍結乾燥して化合物 6を粉末として得た。収量 739mg(60%) Compound 9 (1.70 g) was dissolved in methylene chloride (20 ml) and anisole (0.98 ml) and cooled to _40 ° C. After 2 MTiCl in methylene chloride (4.5 ml) was added, the mixture was stirred for 45 minutes under ice cooling. 2NHCl (5 ml) -isopropyl ether (60 ml) was added to the reaction solution and stirred. After allowing the reaction solution to stand, the supernatant was decanted and the precipitate was further washed with isopropyl ether. The precipitate was dissolved in 0.5NHC1-acetonitrile, subjected to HP-20SS column chromatography, and eluted with water-acetonitrile. Fractions containing the desired compound were concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain compound 6 as a powder. Yield 739mg (60%)
'H-NMR (D O) δ: 1.27 (3Η, t, J = 6.9 Hz), 3.67 (2H, brs), 4.01 (2H, brs), 4.22 (2'H-NMR (D O) δ: 1.27 (3Η, t, J = 6.9 Hz), 3.67 (2H, brs), 4.01 (2H, brs), 4.22 (2
H, q, J = 6.9 Hz), 5.25 - 5.30 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6. 9, 15.9 Hz), 6.91 (1H, s), 6.98 (1H, d, J = 15.9 Hz), 8.50 (2H, d, J = 6.9 Hz), 8.76 ( 1H, s), 8.83 (2H, d, J = 6.9 Hz). H, q, J = 6.9 Hz), 5.25-5.30 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6. 9, 15.9 Hz), 6.91 (1H , s), 6.98 (1H, d, J = 15.9 Hz), 8.50 (2H, d, J = 6.9 Hz), 8.76 (1H, s), 8.83 (2H, d, J = 6.9 Hz).
IR (KBr) cm"1 : 3362, 29970, 1751, 1634, 1593, 1531, 1456, 1377, 1216, 1156, 1034 MS(ESI): 699+ (M + H)+ IR (KBr) cm " 1 : 3362, 29970, 1751, 1634, 1593, 1531, 1456, 1377, 1216, 1156, 1034 MS (ESI): 699+ (M + H) +
元素分析 C H N NaO S - 5.4 H O - 0.1 NaHCO Elemental analysis C H N NaO S-5.4 H O-0.1 NaHCO
計算値: C,40.84; Η,4·38; Ν, 13.56; S, 11.64; Na,3.06 (%) Calculated value: C, 40.84; Η, 4.38; Ν, 13.56; S, 11.64; Na, 3.06 (%)
実験値: C40.85; H,4.33; N, 13.67; S,11.36; Na,3.23 (%) Experimental value: C40.85; H, 4.33; N, 13.67; S, 11.36; Na, 3.23 (%)
実施例 144 Example 144
[化 191]
[Chemical 191]
(7) 7→11 (7) 7 → 11
化合物 7(1.03g, 5mmol)にチォニルクロリド (12ml)を加えて、 1時間加温還流した。反 応液にェチルエーテルをカ卩えて、析出晶を濾取した。この析出晶に塩化メチレン (15 ml)を加えて、ァラニン一 t_ブチルエステル塩酸塩 (999mg,5.5mmol)とピリジン (1.5ml, 15.5mmol)をカ卩えて、 0°Cで攪拌した。反応液に酢酸ェチルと水を加え、有機層を水 洗、乾燥、濃縮して結晶性残渣を得た。残渣にイソプロピルエーテルとへキサンをカロ えて濾取して 11を得た。収量 1.06g(64%) To compound 7 (1.03 g, 5 mmol) was added thionyl chloride (12 ml), and the mixture was heated to reflux for 1 hour. Ethyl ether was added to the reaction solution, and the precipitated crystals were collected by filtration. Methylene chloride (15 ml) was added to the precipitated crystals, and alanine mono-t_butyl ester hydrochloride (999 mg, 5.5 mmol) and pyridine (1.5 ml, 15.5 mmol) were added and stirred at 0 ° C. Ethyl acetate and water were added to the reaction solution, and the organic layer was washed with water, dried and concentrated to obtain a crystalline residue. The residue was filtered with isopropyl ether and hexane to obtain 11. Yield 1.06 g (64%)
'H-NMR (CDCl ): 1.52 (9H, s), 1.56 (3H, d, J = 6.9 Hz), 4.68 (1H, m), 7.89 (2H, d 'H-NMR (CDCl): 1.52 (9H, s), 1.56 (3H, d, J = 6.9 Hz), 4.68 (1H, m), 7.89 (2H, d
, J = 6.3 Hz), 7.98 (lH,s), 8.71 (2H, d, J = 6.3 Hz). , J = 6.3 Hz), 7.98 (lH, s), 8.71 (2H, d, J = 6.3 Hz).
(8) 11 + 2→12 (8) 11 + 2 → 12
ィ匕合物 2(1.20g,1.5mmol)と化合物 ll(500mg,1.5mmol)から(2)と同様にして 12を得 た。収量 1.67g Compound 12 (1.20 g, 1.5 mmol) and Compound ll (500 mg, 1.5 mmol) were used to obtain 12 in the same manner as (2). Yield 1.67g
(9) 12→10 (9) 12 → 10
化合物 12(1.67g)力も(6)と同様にして化合物 10を粉末として得た。収量 719mg(58%) 'H-NMR (D O) δ: 1.28 (3Η, t, J = 6.9 Hz), 1.51 (3H, d, J = 7.2 Hz), 3.67 (2H, brs)Compound 10 (1.67 g) was also obtained in the same manner as in (6). Yield 719mg (58%) 'H-NMR (D O) δ: 1.28 (3Η, t, J = 6.9 Hz), 1.51 (3H, d, J = 7.2 Hz), 3.67 (2H, brs)
, 4.22 (2H, q, J = 6.9 Hz), 5.25 - 5.30 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6.6, 15.6 Hz), 6.92 (1H, s), 6.98 (1H, d, J = 15.6 Hz), 8.51 (2H, d, J = 6.9 H z), 8.76 (1H, s), 8.83 (2H, d, J = 6.9 Hz). , 4.22 (2H, q, J = 6.9 Hz), 5.25-5.30 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6.6, 15.6 Hz), 6.92 ( 1H, s), 6.98 (1H, d, J = 15.6 Hz), 8.51 (2H, d, J = 6.9 Hz), 8.76 (1H, s), 8.83 (2H, d, J = 6.9 Hz).
IR (KBr) cm—1 : 3360, 2970, 1750, 1635, 1590, 1531, 1456, 1365, 1217, 1158, 1034. MS(ESI): 713+ (M + H)+
元素分析 C H N NaO S - 5.0 H O - 0.1 NaHCO IR (KBr) cm— 1 : 3360, 2970, 1750, 1635, 1590, 1531, 1456, 1365, 1217, 1158, 1034. MS (ESI): 713+ (M + H) + Elemental analysis CHN NaO S-5.0 HO-0.1 NaHCO
計算値: C,41.95; H,4.49; N, 13.45; S, 11.54; Na,3.04 (%) Calculated values: C, 41.95; H, 4.49; N, 13.45; S, 11.54; Na, 3.04 (%)
実験値: C,41.96; H,4.54; N, 13.51; S, 11.52; Na,3.05 (%) Experimental value: C, 41.96; H, 4.54; N, 13.51; S, 11.52; Na, 3.05 (%)
実施例 145 Example 145
[化 192] [Chemical 192]
(10) 14→15 (10) 14 → 15
化合物 14(2.16 g, 5mmol)から(4)と同様にして 15を結晶として得た。収量 1.77g(65%) 'H-NMR (CDCl ): 1.45 (9H, s), 3.39 (2H, d, J = 4.8 Hz), 5.77 (1H, t, J = 4.8 Hz),15 was obtained as crystals from compound 14 (2.16 g, 5 mmol) in the same manner as in (4). Yield 1.77 g (65%) 'H-NMR (CDCl): 1.45 (9H, s), 3.39 (2H, d, J = 4.8 Hz), 5.77 (1H, t, J = 4.8 Hz),
6.97 (1H, s), 7.16 - 7.33 (15H, m), 7.59 (2H, dd, J = 1.5, 4.5 Hz), 8.57 (2H, dd, J = 1.5, 4.5 Hz). 6.97 (1H, s), 7.16-7.33 (15H, m), 7.59 (2H, dd, J = 1.5, 4.5 Hz), 8.57 (2H, dd, J = 1.5, 4.5 Hz).
(11) 15 + 2→16 (11) 15 + 2 → 16
化合物 2(1.20g,1.5mmol)と化合物 15(817mg,1.5mmol)から(2)と同様にして 16を得 た。収量 1.91g 16 was obtained from Compound 2 (1.20 g, 1.5 mmol) and Compound 15 (817 mg, 1.5 mmol) in the same manner as (2). Yield 1.91g
(12) 16→13 (12) 16 → 13
化合物 16(931mg,5mmol)力、ら(6)と同様にして 13を粉末として得た。収量 512mg(41%) 'H-NMR (D O) δ: 1.28 (3Η, t, J = 7.2 Hz), 3.66 (2H, brs), 3.96 (2H, s), 4.23 (2H, q, J = 7.2 Hz), 5.23 - 5.26 (3H, m), 5.80 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6.6, 15.6 Hz), 6.93 (1H, s), 6.96 (1H, d, J = 15.6 Hz), 7.47 (1H, s), 8.28 (2H, d, J = 6.9 Hz), 8.73 (2H, d, J = 6.9 Hz).
IR (KBr) cm : 3323, 1755, 1634, 1587, 1532, 1474, 1385, 1295, 1216, 1154, 1034. MS(ESI): 682+ (M + H)+ Compound 16 (931 mg, 5 mmol), 13 was obtained as a powder in the same manner as in (6). Yield 512mg (41%) 'H-NMR (DO) δ: 1.28 (3Η, t, J = 7.2 Hz), 3.66 (2H, brs), 3.96 (2H, s), 4.23 (2H, q, J = 7.2 Hz), 5.23-5.26 (3H, m), 5.80 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6.6, 15.6 Hz), 6.93 (1H, s), 6.96 (1H, d , J = 15.6 Hz), 7.47 (1H, s), 8.28 (2H, d, J = 6.9 Hz), 8.73 (2H, d, J = 6.9 Hz). IR (KBr) cm: 3323, 1755, 1634, 1587, 1532, 1474, 1385, 1295, 1216, 1154, 1034. MS (ESI): 682+ (M + H) +
元素分析 C H N NaO S -4.8 H O - 0.4 NaHCO Elemental analysis C H N NaO S -4.8 H O-0.4 NaHCO
計算値: C41.41; H,4.40; N, 15.30; SJ.79; Na,3.91 (%) Calculated: C41.41; H, 4.40; N, 15.30; SJ.79; Na, 3.91 (%)
実験値: C41.20; H,4.59; N, 15.34; SJ.79; Na,4.21 (%) Experimental value: C41.20; H, 4.59; N, 15.34; SJ.79; Na, 4.21 (%)
実施例 146 Example 146
[化 193] [Chemical 193]
(13) 18→19 (13) 18 → 19
化合物 18(579mg,2.1mmol)とモノ- 1-ブチルマロン酸エステル (368mg, 2.3mmol)力、ら( 1)と同様にして化合物 19を得た。収量 612mg(72%) Compound 19 was obtained in the same manner as Compound 18 (579 mg, 2.1 mmol) and mono-1-butylmalonic ester (368 mg, 2.3 mmol), et al. (1). Yield 612mg (72%)
'H-NMR (CDCl ): 1.51 (9H, s), 3.37 (2H, s), 3.78 (3H, s), 5.33 (2H, s), 6.85 (2H, dd, J = 2.1, 6.6 Hz), 6.97 (1H, s), 7.24 (2H, dd, J = 2.1, 6.6 Hz), 7.81 (2H, dd, J = 1.5, 4.8 Hz), 8.60 (2H, dd, J = 1.5, 4.8 Hz), 9.94 (1H, brs). 'H-NMR (CDCl): 1.51 (9H, s), 3.37 (2H, s), 3.78 (3H, s), 5.33 (2H, s), 6.85 (2H, dd, J = 2.1, 6.6 Hz), 6.97 (1H, s), 7.24 (2H, dd, J = 2.1, 6.6 Hz), 7.81 (2H, dd, J = 1.5, 4.8 Hz), 8.60 (2H, dd, J = 1.5, 4.8 Hz), 9.94 (1H, brs).
(14) 19 + 2→20 (14) 19 + 2 → 20
ィ匕合物 2(1.20g,1.5mmol)と化合物 19(612mg,1.5mmol)力 (2)と同様にして 20を得 た。収量 1.70g Compound 20 (1.20 g, 1.5 mmol) and Compound 19 (612 mg, 1.5 mmol) 20 were obtained in the same manner as (2). Yield 1.70g
(15) 20→17 (15) 20 → 17
化合物 20(1.70g)から(6)と同様にして 17を粉末として得た。収量 271mg(23%)。 In the same manner as in (6), 17 was obtained as a powder from compound 20 (1.70 g). Yield 271 mg (23%).
'H-NMR (D O) 5: 1.27 (3Η, t, J = 6.9 Hz), 3.40 (2H, s), 3.66 (2H, s), 4.22 (2H, q,
J = 6.9 Hz), 5.23 - 5.28 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.09 (1H, dt, J = 6.9, 15 .6 Hz), 6.92 (1H, s), 6.96 (1H, d, J = 15.6 Hz), 8.22 (2H, d, J = 6.9 Hz), 8.75 (2H, d, J = 6.9 Hz). 'H-NMR (DO) 5: 1.27 (3Η, t, J = 6.9 Hz), 3.40 (2H, s), 3.66 (2H, s), 4.22 (2H, q, J = 6.9 Hz), 5.23-5.28 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.09 (1H, dt, J = 6.9, 15.6 Hz), 6.92 (1H, s), 6.96 (1H, d, J = 15.6 Hz), 8.22 (2H, d, J = 6.9 Hz), 8.75 (2H, d, J = 6.9 Hz).
IR (KBr) cm—1 : 3291, 1752, 1636, 1586, 1533, 1475, 1373, 1216, 1155, 1034. IR (KBr) cm— 1 : 3291, 1752, 1636, 1586, 1533, 1475, 1373, 1216, 1155, 1034.
MS(ESI): 682+ (M + H)+ MS (ESI): 682+ (M + H) +
元素分析 c H N NaO S -4.6 H O - 0.1 NaHCO Elemental analysis c H N NaO S -4.6 H O-0.1 NaHCO
計算値: C,42.46; H,4.48; N, 15.86; S,8.07; Na,3.18 (%) Calculated values: C, 42.46; H, 4.48; N, 15.86; S, 8.07; Na, 3.18 (%)
実験値: C42.48; H,4.55; N, 15.69; SJ.96; Na,3.43 (%) Experimental value: C42.48; H, 4.55; N, 15.69; SJ.96; Na, 3.43 (%)
実施例 147 Example 147
[化 194] [Chemical 194]
(16) 22→23 (16) 22 → 23
化合物 22(1.21g,3mmol)を塩化メチレン (12ml)に溶解して、氷冷下でピリジン (0.26ml,3 .15mmol)と t_ブチル蓚酸クロリド (518mg, 3.15mmol)を加えて、 1時間攪拌した。反応 液に酢酸ェチルと水を加え、有機層を水洗、乾燥、濃縮して結晶性残渣を得た。残 渣にイソプロピルエーテルを加えて濾取して 23を粉末として得た。収量 1.37g(86%) 'H-NMR (d -DMSO): 1.29 (9H, s), 7.13 - 7.16 (6H, m), 7.23 (1H, s), 7.36 - 7.44 (Compound 22 (1.21 g, 3 mmol) was dissolved in methylene chloride (12 ml), and pyridine (0.26 ml, 3.15 mmol) and t_butyl succinate chloride (518 mg, 3.15 mmol) were added under ice-cooling for 1 hour. Stir. Ethyl acetate and water were added to the reaction solution, and the organic layer was washed with water, dried and concentrated to obtain a crystalline residue. Isopropyl ether was added to the residue and collected by filtration to obtain 23 as a powder. Yield 1.37g (86%) 'H-NMR (d-DMSO): 1.29 (9H, s), 7.13-7.16 (6H, m), 7.23 (1H, s), 7.36-7.44 (
9H, m), 7.54 (2H, d, J = 5.7 Hz), 8.26 (1H, brs), 8.58 (2H, d, J = 5.7 Hz). 9H, m), 7.54 (2H, d, J = 5.7 Hz), 8.26 (1H, brs), 8.58 (2H, d, J = 5.7 Hz).
(17) 23 + 2→24 (17) 23 + 2 → 24
化合物 2(1.20g,1.5mmol)と化合物 23(796mg,1.5mmol)から(2)と同様にして 24を得 た。収量 1.86g
(18) 24→21 24 was obtained from Compound 2 (1.20 g, 1.5 mmol) and Compound 23 (796 mg, 1.5 mmol) in the same manner as (2). Yield 1.86g (18) 24 → 21
化合物 24(1.86g)力も(6)と同様にして 21を粉末として得た。収量 291mg(16%)。 Compound 24 (1.86 g) was also obtained as a powder in the same manner as (6). Yield 291 mg (16%).
'H-NMR (D O) δ: 1.28 (3Η, t, J = 6.9 Hz), 3.66 (2H, brs), 4.22 (2H, q, J = 6.9 Hz)'H-NMR (D O) δ: 1.28 (3Η, t, J = 6.9 Hz), 3.66 (2H, brs), 4.22 (2H, q, J = 6.9 Hz)
, 5.25 (3H, m), 5.80 (1H, d, J = 4.5 Hz), 6.10 (1H, dt, J = 6.6, 15.9 Hz), 6.93 (1H, s), 6.96 (1H, d, J = 15.9 Hz), 8.24 (2H, d, J = 6.9 Hz), 8.77 (2H, d, J = 6.9 Hz). IR (KBr) cm—1 : 3284, 1753, 1636, 1595, 1531, 1366, 1205, 1154, 1033. , 5.25 (3H, m), 5.80 (1H, d, J = 4.5 Hz), 6.10 (1H, dt, J = 6.6, 15.9 Hz), 6.93 (1H, s), 6.96 (1H, d, J = 15.9 Hz), 8.24 (2H, d, J = 6.9 Hz), 8.77 (2H, d, J = 6.9 Hz). IR (KBr) cm— 1 : 3284, 1753, 1636, 1595, 1531, 1366, 1205, 1154 , 1033.
MS(ESI): 668+ (M + H)+ MS (ESI): 668+ (M + H) +
元素分析 C H N NaO S -6.8 H O Elemental analysis C H N NaO S -6.8 H O
計算値: C,39.93; H,4.67; N, 15.52; SJ.90; Na,2.83 (%) Calculated values: C, 39.93; H, 4.67; N, 15.52; SJ.90; Na, 2.83 (%)
実験値: C39.95; H,4.38; N, 15.39; SJ.83; Na,3.12 (%) Experimental value: C39.95; H, 4.38; N, 15.39; SJ.83; Na, 3.12 (%)
実施例 148 Example 148
[化 195] [Chem 195]
(19) 26 + 2→27 (19) 26 + 2 → 27
ィ匕合物 2(1.20g,1.5mmol)と化合物 26(463mg,1.5mmol)から(2)と同様にして 27を得 た。収量 1.70g 27 was obtained from Compound 2 (1.20 g, 1.5 mmol) and Compound 26 (463 mg, 1.5 mmol) in the same manner as (2). Yield 1.70g
(20) 27→25 (20) 27 → 25
化合物 27(1.70g)力も(6)と同様にして 25を粉末として得た。収量 250mg(34%)。 Compound 27 (1.70 g) force was also obtained in the same manner as (6) to obtain 25 as a powder. Yield 250 mg (34%).
'H-NMR (D O) δ: 1.29 (3Η, t, J = 6.9 Hz), 3.67 (2H, brs), 4.24 (2H, q, J = 6.9 Hz)'H-NMR (D O) δ: 1.29 (3Η, t, J = 6.9 Hz), 3.67 (2H, brs), 4.24 (2H, q, J = 6.9 Hz)
, 5.26 (1H, d, J = 4.5 Hz), 5.32 (2H, d, J = 7.2 Hz), 5.81 (1H, d, J = 4.5 Hz), 6.12 ( 1H, dt, J = 7.2, 15.9 Hz), 6.95 (1H, s), 6.99 (1H, d, J = 15.9 Hz), 8.38 (1H, s), 8.52 (2H, d, J = 6.9 Hz), 8.75 (2H, d, J = 6.9 Hz).
IR (KBr) cm : 3309, 1752, 1590, 1523, 1466, 1352, 1216, 1156, , 5.26 (1H, d, J = 4.5 Hz), 5.32 (2H, d, J = 7.2 Hz), 5.81 (1H, d, J = 4.5 Hz), 6.12 (1H, dt, J = 7.2, 15.9 Hz) , 6.95 (1H, s), 6.99 (1H, d, J = 15.9 Hz), 8.38 (1H, s), 8.52 (2H, d, J = 6.9 Hz), 8.75 (2H, d, J = 6.9 Hz) . IR (KBr) cm: 3309, 1752, 1590, 1523, 1466, 1352, 1216, 1156,
MS(ESI): 642+ (M + H)+ MS (ESI): 642+ (M + H) +
元素分析 C H N NaO S -4.1 H O - O. l NaHCO Elemental analysis C H N NaO S -4.1 H O-O. l NaHCO
計算値: C,42.02; H,4.09; N,13.14; S, 12.90; Na,3.39 (%) Calculated value: C, 42.02; H, 4.09; N, 13.14; S, 12.90; Na, 3.39 (%)
実験値: C41.95; H,4.15; N,13.18; S, 12.97; Na,3.72 (%) Experimental value: C41.95; H, 4.15; N, 13.18; S, 12.97; Na, 3.72 (%)
実施例 149 Example 149
[化 196] [Chem 196]
(37) 48+49→50 (37) 48 + 49 → 50
化合物 48(6.59g,70mmol)と化合物 49(16.6g,77mmol)を混合して、 110°Cにて 3時間加 温攪拌した。生成したエタノールを留去し、残渣をカラムクロマト精製して 50を結晶と して得た。収量 17.9g(97%) Compound 48 (6.59 g, 70 mmol) and compound 49 (16.6 g, 77 mmol) were mixed and stirred while heating at 110 ° C. for 3 hours. The ethanol produced was distilled off, and the residue was purified by column chromatography to obtain 50 as crystals. Yield 17.9g (97%)
'H-NMR (CDCl ): 1.32 - 1.41 (6H, m), 4.24 - 4.36 (4H, m), 7.02 (2H, dd, J = 1.5, 'H-NMR (CDCl): 1.32-1.41 (6H, m), 4.24-4.36 (4H, m), 7.02 (2H, dd, J = 1.5,
4.5 Hz), 8.49 - 8.54 (3H, m), 10.9 (1H, d, J = 13.2 Hz). 4.5 Hz), 8.49-8.54 (3H, m), 10.9 (1H, d, J = 13.2 Hz).
(38) 50→51 (38) 50 → 51
化合物 50(5.29g,20mmol)をジフヱニルエーテル (20ml)と共に 240°Cにて 20分間加温 攪拌した。反応液にイソプロピルエーテルを加えて、析出物として 51を得た。収量 990 mg Compound 50 (5.29 g, 20 mmol) was stirred with diphenyl ether (20 ml) at 240 ° C. for 20 minutes with heating. Isopropyl ether was added to the reaction solution to obtain 51 as a precipitate. Yield 990 mg
1H-NMR (CDCl ): 1.28 (3H, t, J = 7.2 Hz), 4.22 (2H, q, J = 7.2 Hz), 7.51 (2H, d, J 1H-NMR (CDCl): 1.28 (3H, t, J = 7.2 Hz), 4.22 (2H, q, J = 7.2 Hz), 7.51 (2H, d, J
= 5.4 Hz), 8.63 - 8.65 (2H, m), 9.24 (1H, s). = 5.4 Hz), 8.63-8.65 (2H, m), 9.24 (1H, s).
(39) 51→52
化合物 51(1.0g,4.5mmol)をエタノール (10ml)に溶解して、 2NNaOH(6.5ml)を加えて、 7 0°Cにて 1.5時間攪拌した。反応液を 6NHC1で中和した後エタノールを留去した。水溶 液の残渣を PH2.6に調製して析出物を濾取、乾燥して化合物 52を得た。収量 544mg( 64%) (39) 51 → 52 Compound 51 (1.0 g, 4.5 mmol) was dissolved in ethanol (10 ml), 2N NaOH (6.5 ml) was added, and the mixture was stirred at 70 ° C. for 1.5 hours. The reaction solution was neutralized with 6NHC1, and ethanol was distilled off. The residue of the aqueous solution was adjusted to PH 2.6, and the precipitate was collected by filtration and dried to obtain Compound 52. Yield 544 mg (64%)
'H-NMR (d -DMSO): 7.72 (1H, d, J = 6.0 Hz), 8.84 (1H, d, J = 6.0 Hz), 9.01 (1H, s), 9.46 (1H, s), 13.5 (1H, brs), 14.7 (1H, brs). 'H-NMR (d-DMSO): 7.72 (1H, d, J = 6.0 Hz), 8.84 (1H, d, J = 6.0 Hz), 9.01 (1H, s), 9.46 (1H, s), 13.5 ( 1H, brs), 14.7 (1H, brs).
(40) 52→53 (40) 52 → 53
化合物 52(544mg,2.9mmol)をテトラヒドロフラン (10ml)に溶解して、ジフヱニルジァゾメ タン (1.95g)をカ卩えて還流攪拌した。反応液を濃縮して、残渣にイソプロピルエーテル を加えて析出晶を濾取、乾燥して化合物 53を得た。収量 654mg(64%) Compound 52 (544 mg, 2.9 mmol) was dissolved in tetrahydrofuran (10 ml), and diphenyldiazomethane (1.95 g) was added thereto and stirred at reflux. The reaction mixture was concentrated, isopropyl ether was added to the residue, and the precipitated crystals were collected by filtration and dried to give compound 53. Yield 654mg (64%)
'H-NMR (d -DMSO): 7.00 (1H, s), 7.24 - 7.60 (11H, m), 7.19 (1H, d, J = 6.0 Hz),'H-NMR (d-DMSO): 7.00 (1H, s), 7.24-7.60 (11H, m), 7.19 (1H, d, J = 6.0 Hz),
8.74 (1H, s), 9.32 (1H, s). 8.74 (1H, s), 9.32 (1H, s).
(41) 53 + 2→54 (41) 53 + 2 → 54
ィ匕合物 2(1.20g,1.5mmol)と化合物 54(535mg,1.5mmol)から(2)と同様にして 54を得 た。収量 1.67g 54 was obtained in the same manner as (2) from Compound 2 (1.20 g, 1.5 mmol) and Compound 54 (535 mg, 1.5 mmol). Yield 1.67g
(42) 54→47 (42) 54 → 47
化合物 54(1.67g)力も(6)と同様にして 47を粉末として得た。収量 241mg(21%)。 Compound 54 (1.67 g) force was also obtained as 47 in the same manner as (6). Yield 241 mg (21%).
'H-NMR (D O) δ: 1.30 (3Η, t, J = 7.8 Hz), 3.66 (2H, brs), 4.25 (2H, q, J = 7.8 Hz)'H-NMR (D O) δ: 1.30 (3Η, t, J = 7.8 Hz), 3.66 (2H, brs), 4.25 (2H, q, J = 7.8 Hz)
, 5.23 - 5.27 (3H, m), 5.82 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6.9, 13.8 Hz), 6.9 6 (1H, d, J = 13.8 Hz), 6.99 (1H, s), 7.83 (1H, d, J = 7.2 Hz), 8.33 (1H, dd, J = 1.5, 7.2 Hz), 8.70 (1H, s), 9.39 (1H, d, J = 1.5 Hz). , 5.23-5.27 (3H, m), 5.82 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6.9, 13.8 Hz), 6.9 6 (1H, d, J = 13.8 Hz), 6.99 (1H, s), 7.83 (1H, d, J = 7.2 Hz), 8.33 (1H, dd, J = 1.5, 7.2 Hz), 8.70 (1H, s), 9.39 (1H, d, J = 1.5 Hz) .
IR (KBr) cm—1 : 3315, 1750, 1650, 1587, 1536, 1474, 1366, 1314, 1201, 1173, 1114, 1034. IR (KBr) cm— 1 : 3315, 1750, 1650, 1587, 1536, 1474, 1366, 1314, 1201, 1173, 1114, 1034.
MS(ESI): 626+ (M + H)+ MS (ESI): 626+ (M + H) +
元素分析 c H N Na O S - 4.5 H O - 0.1 NaHCO Elemental analysis c H N Na O S-4.5 H O-0.1 NaHCO
計算値: C,41.30; H,4.00; N, 12.92; S,8.45; Na,6.36 (%) Calculated values: C, 41.30; H, 4.00; N, 12.92; S, 8.45; Na, 6.36 (%)
実験値: C41.33; H,3.91; N, 12.76; S,8.40; Na,6.52 (%) Experimental value: C41.33; H, 3.91; N, 12.76; S, 8.40; Na, 6.52 (%)
実施例 150
[化 197] Example 150 [Chemical 197]
(1) 3+4→5 (1) 3 + 4 → 5
化合物 4(1.63g,10.8mmol)をジメチルホルムアミド(9ml)に溶解して、化合物 3(1.08g, 9 mmol)をカ卩えて室温にて 1時間攪拌後、一夜放置した。反応液に水を加え酢酸ェチ ルで抽出し、水洗、乾燥した後、シリカゲルクロマトで精製して 5を結晶として得た。収 量 1.8g(74%)。 Compound 4 (1.63 g, 10.8 mmol) was dissolved in dimethylformamide (9 ml), and compound 3 (1.08 g, 9 mmol) was collected and stirred at room temperature for 1 hour, and then left overnight. Water was added to the reaction solution, extracted with ethyl acetate, washed with water, dried and purified by silica gel chromatography to obtain 5 as crystals. Yield 1.8g (74%).
'H-NMR (d -DMSO): 3.69(3H, s),7.25— 7.31(2H,m),7.4_7.5(2H, m),8.03(lH, m), 'H-NMR (d-DMSO): 3.69 (3H, s), 7.25—7.31 (2H, m), 7.4_7.5 (2H, m), 8.03 (lH, m),
8.18-8.21(2H, m),8.99(lH, bs). 8.18-8.21 (2H, m), 8.99 (lH, bs).
( 2) 5→6 (2) 5 → 6
化合物 5(1.76g,6.5mmol)を EtOHlOml懸濁させ、 2N NaOH 7mlを滴下し 4.5時間攪 拌した。反応液に 2N HC1 7mlで中和した後、さらに水 40mlを追加した。析出物を濾取 、乾燥して 6を固体として得た。収量(1.75g) Compound 5 (1.76 g, 6.5 mmol) was suspended in EtOHlOml, and 7 ml of 2N NaOH was added dropwise and stirred for 4.5 hours. The reaction solution was neutralized with 7 ml of 2N HC1, and then 40 ml of water was added. The precipitate was collected by filtration and dried to obtain 6 as a solid. Yield (1.75g)
( 3) 6→7 (3) 6 → 7
化合物 6(1.75g,6.5mmol)にジメチルホルムアミド (10ml)溶解した後、カルボニルジイミ ダゾール (2.1g,13mmol)を加えて 40°Cで 30分間攪拌した。次いでプレニルアルコール 6.7ml、 4ージメチルァミノピリジン 5mgを加えて、 60°Cで 3.5時間攪拌した。反応液を冷 却後、酢酸ェチルと水を加えて抽出した。有機層を重炭酸ナトリウム水溶液、水で洗 浄後、乾燥して濃縮して得られた残渣をシリカゲルクロマトで精製して 7を得た。収量
l. lg(52%)。 After dissolving dimethylformamide (10 ml) in compound 6 (1.75 g, 6.5 mmol), carbonyldiimidazole (2.1 g, 13 mmol) was added and stirred at 40 ° C. for 30 minutes. Next, 6.7 ml of prenyl alcohol and 5 mg of 4-dimethylaminopyridine were added and stirred at 60 ° C. for 3.5 hours. The reaction mixture was cooled, and extracted by adding ethyl acetate and water. The organic layer was washed with an aqueous sodium bicarbonate solution and water, then dried and concentrated. The residue obtained was purified by silica gel chromatography to obtain 7. yield l. lg (52%).
'H-NMR (d -DMSO): 1.75(6H, m), 4.79(2H,d,J=7.2Hz), 5.44(1H, m),7.4-7.47(2H, m), 7.6-7.7.7(2H, m), 8.15(H, m), 8.36- 7·38(2Η, m) 9.19(1H, bs). 'H-NMR (d-DMSO): 1.75 (6H, m), 4.79 (2H, d, J = 7.2Hz), 5.44 (1H, m), 7.4-7.47 (2H, m), 7.6-7.7.7 (2H, m), 8.15 (H, m), 8.36-7 · 38 (2Η, m) 9.19 (1H, bs).
(4) 7 + 2→8 (4) 7 + 2 → 8
化合物 2(674mg、 lmmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナトリウ ム水溶液 (126mg、 1.5mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、硫酸ナト リウムで乾燥した。溶媒を留去後、速やかにジメチルホルムアミド (2ml)に溶解し、化合 物 7(325mg、 l.Ommol)と混合し、臭化ナトリウム (309mg、 3mmol)を加えて、室温で 4時 間攪拌した。反応液を 5%食塩水 (40ml)攪拌下にて注加し、析出した沈殿を濾取した 。沈殿を減圧乾燥して化合物 8(896mg)を粉末として得た。 Compound 2 (674 mg, lmmol) was suspended in dichloromethane (10 ml), and an aqueous sodium hydrogen carbonate solution (126 mg, 1.5 mmol dissolved in 10 ml of water) was added under ice cooling, extracted with dichloromethane, and dried over sodium sulfate. . After distilling off the solvent, quickly dissolved in dimethylformamide (2 ml), mixed with compound 7 (325 mg, l.Ommol), added sodium bromide (309 mg, 3 mmol), and stirred at room temperature for 4 hours. . The reaction solution was poured under stirring with 5% brine (40 ml), and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 8 (896 mg) as a powder.
(5) 8→1 (5) 8 → 1
化合物 8(896mg)を塩化メチレン (5ml)とァニソール (0.8ml)に溶解し、 0°Cに冷却し、 TF A 2.4mlを加えた。混合液を 0°Cで 2時間攪拌した後、イソプロピールエーテル 50ml に氷冷下で攪拌しながら注加した。析出した沈殿物を濾取し、飽和 NaHCO水で溶 解させた。溶液を HP-20SSカラムクロマトグラフィーに付し、水-ァセトニトリルで溶離し た。所望の化合物を含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥して化合物 1を粉末として得た。収量 361mg(45%) Compound 8 (896 mg) was dissolved in methylene chloride (5 ml) and anisole (0.8 ml), cooled to 0 ° C., and 2.4 ml of TFA was added. The mixture was stirred at 0 ° C for 2 hours and then poured into 50 ml of isopropyl ether with stirring under ice cooling. The deposited precipitate was collected by filtration and dissolved with saturated NaHCO 3 aqueous solution. The solution was subjected to HP-20SS column chromatography and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 1 as a powder. Yield 361 mg (45%)
'H-NMR (D O): 1·16(3Η, t, J = 7.2Hz), 3.52(2H, ABq, J = 18.3Hz), 4.11(2H, q, J = 'H-NMR (D O): 1 · 16 (3Η, t, J = 7.2Hz), 3.52 (2H, ABq, J = 18.3Hz), 4.11 (2H, q, J =
7.2 Hz), 4.89(2H, d, J = 6.6Hz), 5.13(1H, d, J = 4.8Hz), 5.69(1H, d J =4.8Hz), 5.97.2 Hz), 4.89 (2H, d, J = 6.6Hz), 5.13 (1H, d, J = 4.8Hz), 5.69 (1H, d J = 4.8Hz), 5.9
1(1H, dt, J = 15.9, 6.6Hz), 6.70(1H, d, J = 15.9Hz) 6.84(1H, s), 7.29(1H, m), 7.4-7.1 (1H, dt, J = 15.9, 6.6Hz), 6.70 (1H, d, J = 15.9Hz) 6.84 (1H, s), 7.29 (1H, m), 7.4-7.
5(2H, m), 7.64(lH,m),7.68(2H, d, J = 7.2Hz), 8.24(2H, d, J = 7.2Hz). 5 (2H, m), 7.64 (lH, m), 7.68 (2H, d, J = 7.2Hz), 8.24 (2H, d, J = 7.2Hz).
IR (KBr) cm—1: 1766, 1725, 1614, 1522. IR (KBr) cm— 1 : 1766, 1725, 1614, 1522.
MS: 693+ (M-Na+2H)+ MS: 693+ (M-Na + 2H) +
元素分析 C H N O S Na-4.5H O Elemental analysis C H N O S Na-4.5H O
計算値: C,45.28; H,4.56; N,14.08; S,8.06; Na,2.87 (%) Calculated value: C, 45.28; H, 4.56; N, 14.08; S, 8.06; Na, 2.87 (%)
実験値: C,45.43; H,4.46; N,14.04; S,8.15; Na,3.28 (%) Experimental value: C, 45.43; H, 4.46; N, 14.04; S, 8.15; Na, 3.28 (%)
実施例 151 Example 151
[化 198]
[Chemical 198]
14 14
(6) 3+10→l l (6) 3 + 10 → l l
化合物 10(1.63g,10.8mmol)と化合物 3(1.08g, 9mmol)から(1)と同様にして 11を結晶と して得た。収量 1.76g(72%)。 11 was obtained as crystals from compound 10 (1.63 g, 10.8 mmol) and compound 3 (1.08 g, 9 mmol) in the same manner as (1). Yield 1.76 g (72%).
'H-NMR (d -DMSO): 3.38(3H, s), 7.42-7.44(2H, m),7,58(2H, d, J =9Hz), 7,89(2H, 'H-NMR (d-DMSO): 3.38 (3H, s), 7.42-7.44 (2H, m), 7, 58 (2H, d, J = 9Hz), 7, 89 (2H,
6 6
d, J =9Hz)8.35-8.37(2H,m), 9.25(1H, bs) , 9.29(1H, bs). d, J = 9Hz) 8.35-8.37 (2H, m), 9.25 (1H, bs), 9.29 (1H, bs).
(7) 11→12 (7) 11 → 12
化合物 l l(1.48g,5.5mmol)から(2)と同様にして 12を固体として得た。収量(1.30g)In the same manner as in (2), 12 was obtained as a solid from compound l 1 (1.48 g, 5.5 mmol). Yield (1.30g)
(8) 12→13 (8) 12 → 13
化合物 12(1.2g,4.6mmol)を(3)と同様にして 13を得た。収量 1.18g(72%)。 Compound 12 (1.2 g, 4.6 mmol) was obtained in the same manner as (3) to give 13. Yield 1.18 g (72%).
'H-NMR (d -DMSO): 1.74(6H, m), 4.75(2H,d,J=7.2Hz), 5.43(1H, m),7.44-7.46(2H, 'H-NMR (d-DMSO): 1.74 (6H, m), 4.75 (2H, d, J = 7.2Hz), 5.43 (1H, m), 7.44-7.46 (2H,
6 6
m), 7.59(2H, J=8.7Hz), 7.89(2H, J=8.7Hz), 8.36- 7·38(2Η, m) 9.27(2H, bs). m), 7.59 (2H, J = 8.7Hz), 7.89 (2H, J = 8.7Hz), 8.36-7.38 (2mm, m) 9.27 (2H, bs).
(9) 13 + 2→14 (9) 13 + 2 → 14
化合物 2(674mg、 lmmol)と化合物 13(325mg、 l.Ommol)から(4)と同様にして化合物 1 4(914mg)を得た。 Compound 14 (914 mg) was obtained from Compound 2 (674 mg, lmmol) and Compound 13 (325 mg, l.Ommol) in the same manner as (4).
(10) 14→9 (10) 14 → 9
化合物 14(914mg)を(5)と同様にして化合物 9を粉末として得た。収量 410mg(51%) 'H-NMR (D O): 1.27(3H, t, J = 6.9Hz), 3.65(2H, bs), 4.21(2H, q, J = 6.9 Hz), 5.00 Compound 14 (914 mg) was obtained in the same manner as (5) to give Compound 9 as a powder. Yield 410 mg (51%) 'H-NMR (D 2 O): 1.27 (3H, t, J = 6.9 Hz), 3.65 (2H, bs), 4.21 (2H, q, J = 6.9 Hz), 5.00
2 2
(2H, d, J = 6.9Hz), 5.25(1H, d, J = 4.2Hz), 5.81(1H, d J =4.8Hz), 6.05(1H, dt, J = 1
6.2, 6·9Ηζ), 6.80(1H, d, J = 16.2Hz) 6.95(1H, s), 7.41(1H, bd, J=8.1Hz), 7.78(4H, b d+bd, J= 6.9Hz ,8.1Hz),8.35(2H, d, J = 6.9Hz). (2H, d, J = 6.9Hz), 5.25 (1H, d, J = 4.2Hz), 5.81 (1H, d J = 4.8Hz), 6.05 (1H, dt, J = 1 6.2, 6.9Ηζ), 6.80 (1H, d, J = 16.2Hz) 6.95 (1H, s), 7.41 (1H, bd, J = 8.1Hz), 7.78 (4H, b d + bd, J = 6.9Hz , 8.1Hz), 8.35 (2H, d, J = 6.9Hz).
IR (KBr) cm—1: 1765, 1601, 1518. IR (KBr) cm— 1 : 1765, 1601, 1518.
MS: 693+ (M-Na+2H)+ MS: 693 + (M-Na + 2H) +
元素分析 C H N O S Na-4.6H O Elemental analysis C H N O S Na-4.6H O
計算値: C,45.18; H,4.57; N,14.05; S,8.04; Na,2.88 (%) Calculated values: C, 45.18; H, 4.57; N, 14.05; S, 8.04; Na, 2.88 (%)
実験値: C,44.94; H,4.38; N,14.14; SJ.98; Na,3.19 (%) Experimental value: C, 44.94; H, 4.38; N, 14.14; SJ.98; Na, 3.19 (%)
実施例 152 Example 152
[化 199] [Chemical 199]
(11) 16+4→17 (11) 16 + 4 → 17
化合物 16(1.23g,l lmmol)をジメチルホルムアミド(10ml)に懸濁して、カルボニルジイミ ダゾール (1.62g,10mmol)を加えて攪拌する。次いで化合物 4(1.69g,llmmol)を加え室 温で 1時間攪拌した。反応液に酢酸ェチル-水-重炭酸ナトリウムを加え攪拌した。析 出物を濾取、乾燥して 17を得た。収量 0.70g(27%)。 Compound 16 (1.23 g, l mmol) is suspended in dimethylformamide (10 ml), carbonyldiimidazole (1.62 g, 10 mmol) is added and stirred. Compound 4 (1.69 g, llmmol) was then added and stirred at room temperature for 1 hour. Ethyl acetate-water-sodium bicarbonate was added to the reaction solution and stirred. The precipitate was collected by filtration and dried to obtain 17. Yield 0.70 g (27%).
'H-NMR (d -DMSO): 3.88(3H, s),7.54(lH, t),7.74(lH, d),7.89(2H, m), 8.07(1H, m) 'H-NMR (d-DMSO): 3.88 (3H, s), 7.54 (lH, t), 7.74 (lH, d), 7.89 (2H, m), 8.07 (1H, m)
,8.46(1H, m),8.8l(2H, m). , 8.46 (1H, m), 8.8l (2H, m).
(12) 17→18 (12) 17 → 18
化合物 17(927mg,3.62mmol)力も(2)と同様にして 18を得た。収量 813mg(93%)。
(13) 18→19 Compound 18 (927 mg, 3.62 mmol) was also obtained in the same manner as (2). Yield 813 mg (93%). (13) 18 → 19
化合物 18(813mg,3.36mmol)を(3)と同様にして 19を得た。収量 926mg(90%)。 Compound 18 (813 mg, 3.36 mmol) was obtained in the same manner as (3) to give 19. Yield 926 mg (90%).
'H-NMR (d -DMSO): 1.76(6H, m), 4.81(2H,d,J=7.2Hz), 5.45(1H, m),7.53(lH, m)'H-NMR (d-DMSO): 1.76 (6H, m), 4.81 (2H, d, J = 7.2Hz), 5.45 (1H, m), 7.53 (lH, m)
7.72(1H, m), 7.89(2H, m), 8.09(1H, m), 8.40(1H, m) 8.80(2H, m). 7.72 (1H, m), 7.89 (2H, m), 8.09 (1H, m), 8.40 (1H, m) 8.80 (2H, m).
(14) 19 + 2→20 (14) 19 + 2 → 20
化合物 2(674mg、 lmmol)と化合物 19(310mg、 l.Ommol)から(4)と同様にして化合物 2 0(918mg)を粉末として得た。 Compound 20 (918 mg) was obtained as a powder from Compound 2 (674 mg, lmmol) and Compound 19 (310 mg, l.Ommol) in the same manner as in (4).
(15) 20→15 (15) 20 → 15
化合物 20(918mg)を(5)と同様にして化合物 15を粉末として得た。収量 175mg(20%) 'H-NMR (D O): 1.18(3H, t, J =7.2Hz), 3.54(2H, bs), 4.13(2H, q, J = 7.2 Hz), 5.15(Compound 15 (918 mg) was obtained in the same manner as (5) to give compound 15 as a powder. Yield 175 mg (20%) 'H-NMR (D 2 O): 1.18 (3H, t, J = 7.2Hz), 3.54 (2H, bs), 4.13 (2H, q, J = 7.2 Hz), 5.15 (
1H, d, J = 4.8Hz), 5.28(2H, d, J = 6.6Hz), 5.70(1H, d J =4.8Hz), 6.00(1H, dt, J = 11H, d, J = 4.8Hz), 5.28 (2H, d, J = 6.6Hz), 5.70 (1H, d J = 4.8Hz), 6.00 (1H, dt, J = 1
5.6, 6.6Hz), 6.85(1H, d, J = 15.6Hz) 6.86(1H, s), 7.41(1H, m), 7.62— 7.68(4H, m),8.5.6, 6.6Hz), 6.85 (1H, d, J = 15.6Hz) 6.86 (1H, s), 7.41 (1H, m), 7.62-7.68 (4H, m), 8.
32(2H, d, J = 6.9Hz), 8.93(2H, d, J = 6.9Hz). 32 (2H, d, J = 6.9Hz), 8.93 (2H, d, J = 6.9Hz).
IR (KBr) cm"1: 1765, 1667, 1608, 1557. IR (KBr) cm " 1 : 1765, 1667, 1608, 1557.
MS: 678+ (M_Na+2H)+ MS: 678+ (M_Na + 2H) +
元素分析 C H N O S Na-4.5H O Elemental analysis C H N O S Na-4.5H O
計算値: C,46.15; H,4.52; N,12.56; S,8.21; Na,2.94 (%) Calculated values: C, 46.15; H, 4.52; N, 12.56; S, 8.21; Na, 2.94 (%)
実験値: C,45.94; H,4.24; N,12.58; S,8.04; Na,3.48 (%) Experimental value: C, 45.94; H, 4.24; N, 12.58; S, 8.04; Na, 3.48 (%)
実施例 153 Example 153
[化 200] [Chemical 200]
窒素雰囲気下、ジォキサン 45mlに Pd(dba) 169mg、 l,3-Bis(2,6-diisopripylphenyl) imi dazolium chloride 126mg、カリウム t—ブトオキサイド 166mg、炭酸セシウム 9.64g 加えた後、化合物 22(1.68g,14.8mmol)と化合物 4(2.68g,17.7mmol)を加えて 100°Cで 8 時間攪拌した。反応液を冷却後、 1NHC1 30mlと水、酢酸ェチルを加えて抽出した。 有機層を水洗後、乾燥して濃縮して得られた残渣をシリカゲルクロマトで精製して 23 を結晶として得た。収量 1.04g(31%)。 In a nitrogen atmosphere, Pd (dba) 169 mg, l, 3-Bis (2,6-diisopripylphenyl) imi dazolium chloride 126 mg, potassium t-butoxide 166 mg, cesium carbonate 9.64 g were added to 45 ml of dioxane, and then compound 22 (1.68 g , 14.8 mmol) and compound 4 (2.68 g, 17.7 mmol) were added, and the mixture was stirred at 100 ° C for 8 hours. The reaction solution was cooled, and extracted by adding 30 ml of 1NHC1, water and ethyl acetate. The organic layer was washed with water, dried and concentrated, and the resulting residue was purified by silica gel chromatography to give 23 as crystals. Yield 1.04 g (31%).
'H-NMR (d -DMSO): 3.86(3H, s),6.93(2H, m),7.48(2H, m),7.59(lH, m), 7.75(1H, m),8.23(2H, m),9.01(lH, s). 'H-NMR (d-DMSO): 3.86 (3H, s), 6.93 (2H, m), 7.48 (2H, m), 7.59 (lH, m), 7.75 (1H, m), 8.23 (2H, m ), 9.01 (lH, s).
(17) 23→24 (17) 23 → 24
化合物 23( 1.04g,4.5mmol)から(2)と同様にして 24を得た。収量 949mg(98%)。 24 was obtained from Compound 23 (1.04 g, 4.5 mmol) in the same manner as in (2). Yield 949 mg (98%).
(18) 24→25 (18) 24 → 25
化合物 24(914mg,4.3mmol)を(3)と同様にして 25を得た。収量 803mg(67%)。 Compound 24 (914 mg, 4.3 mmol) was obtained in the same manner as (3) to give 25. Yield 803 mg (67%).
'H-NMR (d -DMSO): 1.73(6H, m), 4.77(2H,d,J=7.2Hz), 5.42(1H, m), 6.91(2H, m),'H-NMR (d-DMSO): 1.73 (6H, m), 4.77 (2H, d, J = 7.2Hz), 5.42 (1H, m), 6.91 (2H, m),
7.46(2H, m),7.56(lH, m), 7.71(1H, m),8.21(2H, m),8.99(lH, s). 7.46 (2H, m), 7.56 (lH, m), 7.71 (1H, m), 8.21 (2H, m), 8.99 (lH, s).
(19) 25 + 2→26 (19) 25 + 2 → 26
化合物 2(675mg、 lmmol)と化合物 25(282mg、 l.Ommol)から(4)と同様にして化合物 2 6(873mg)を粉末として得た。 Compound 26 (873 mg) was obtained as a powder from Compound 2 (675 mg, lmmol) and Compound 25 (282 mg, l.Ommol) in the same manner as (4).
(20) 26→21 (20) 26 → 21
化合物 26(873mg)を(5)と同様にして化合物 21を粉末として得た。収量 307mg(32%) 'H-NMR (D O): 1·18(3Η, t, J =6·9Ηζ), 3.51(2H, ABq, J = 18.5Hz), 4.13(2H, q, J =Compound 26 (873 mg) was obtained in the same manner as (5) to give compound 21 as a powder. Yield 307mg (32%) 'H-NMR (D O): 1 · 18 (3Η, t, J = 6 · 9Ηζ), 3.51 (2H, ABq, J = 18.5Hz), 4.13 (2H, q, J =
6.9Hz), 4.75(2H, d, J = 6.3Hz), 5.12(1H, d, J = 4.8Hz), 5.69(1H, d J =4.8Hz), 5.90(6.9Hz), 4.75 (2H, d, J = 6.3Hz), 5.12 (1H, d, J = 4.8Hz), 5.69 (1H, d J = 4.8Hz), 5.90 (
1H, m), 6.65(1H, d, J = 15.6Hz), 6.86(1H, s), 6.97(2H, J = 7.5Hz), 7.33(1H, m), 7.41H, m), 6.65 (1H, d, J = 15.6Hz), 6.86 (1H, s), 6.97 (2H, J = 7.5Hz), 7.33 (1H, m), 7.4
0(lH,m), 7.65(2H,m),7.95(2H, d, J = 7.5Hz). 0 (lH, m), 7.65 (2H, m), 7.95 (2H, d, J = 7.5Hz).
IR (KBr) cm—1: 1763, 1647, 1606, 1541. IR (KBr) cm— 1 : 1763, 1647, 1606, 1541.
MS: 650+ (M-Na+2H)+ MS: 650+ (M-Na + 2H) +
元素分析 C H N O S Na-4H O Elemental analysis C H N O S Na-4H O
計算値: C,46.83; H,4.61; N,13.18; S,8.62; Na,3.09 (%)
実験値: C,46.81; H,4.54; N,13.31; S,8.80; Na,3.35 (%) Calculated value: C, 46.83; H, 4.61; N, 13.18; S, 8.62; Na, 3.09 (%) Experimental value: C, 46.81; H, 4.54; N, 13.31; S, 8.80; Na, 3.35 (%)
実施例 154 Example 154
[化 201] [Chemical 201]
32 32
(21) 3+28→29 (21) 3 + 28 → 29
化合物 28(1.78g,10.8mmol)と化合物 3(1.08g, 9mmol)から(1)と同様にしてして 29を結 晶として得た。収量 565mg(81%)。 29 was obtained as a crystal from compound 28 (1.78 g, 10.8 mmol) and compound 3 (1.08 g, 9 mmol) in the same manner as in (1). Yield 565 mg (81%).
'H-NMR (d -DMSO): 2.35(3H, s),3.82(3H, s),7.27(lH, m),7.42(2H, m),7.46(lH, m) 'H-NMR (d-DMSO): 2.35 (3H, s), 3.82 (3H, s), 7.27 (lH, m), 7.42 (2H, m), 7.46 (lH, m)
,7.84(1H, m),8.30(lH, bs), 8.34(2H, m),9.43(lH, bs). 7.84 (1H, m), 8.30 (lH, bs), 8.34 (2H, m), 9.43 (lH, bs).
(22) 29→30 (22) 29 → 30
化合物 29(2.07g,7.3mmol)力 (2)と同様にして 30を得た。収量 1.79g(91%)。 Compound 29 (2.07 g, 7.3 mmol) force 30 was obtained in the same manner as (2). Yield 1.79 g (91%).
(23) 30→31 (23) 30 → 31
ィ匕合物 30(1.79g,6.6mmol)を(3)と同様にして 31を得た。収量 1.88g(84%)。 Compound 30 (1.79 g, 6.6 mmol) was obtained in the same manner as (3) to give 31. Yield 1.88 g (84%).
'H-NMR (CDCl ): 1.76(6H, m), 2.41(1H, s),4.77(2H,d,J=6.9Hz), 5.43(1H, m),'H-NMR (CDCl 3): 1.76 (6H, m), 2.41 (1H, s), 4.77 (2H, d, J = 6.9Hz), 5.43 (1H, m),
7.23(lH,m), 7.43(2H, m),7.47(lH,bs),7.63(lH,m),7.72(lH, m), 8.33(2H, m),8.77(lH , s). 7.23 (lH, m), 7.43 (2H, m), 7.47 (lH, bs), 7.63 (lH, m), 7.72 (lH, m), 8.33 (2H, m), 8.77 (lH, s).
(24) 31 + 2→32 (24) 31 + 2 → 32
化合物 2(675mg、 lmmol)と化合物 31(339mg、 l.Ommol)から(4)と同様にして化合物 3 2(936mg)を粉末として得た。
(25) 32→27 Compound 3 2 (936 mg) was obtained as a powder from Compound 2 (675 mg, lmmol) and Compound 31 (339 mg, l.Ommol) in the same manner as (4). (25) 32 → 27
化合物 32(936mg)を(5)と同様にして化合物 27を粉末として得た。収量 437mg(51%) H-NMR (D 0): 1·30(3Η, t, J=7.2Hz),2.26(3H,s), 3.64(2H, bs), 4.25(2H, q, J =7.2Compound 32 (936 mg) was obtained in the same manner as (5) to give compound 27 as a powder. Yield 437mg (51%) H-NMR (D 0): 1 · 30 (3Η, t, J = 7.2Hz), 2.26 (3H, s), 3.64 (2H, bs), 4.25 (2H, q, J = 7.2
Hz), 5.06(2H, d, J = 6.6Hz), 5.25(1H, d, J = 4.8Hz), 5.81(1H, d J =4.8Hz), 6.06(1H: m), 6.83(1H, d, J = 15.6Hz), 6.99(1H, s),7.25— 7.38(3H, m), 7.88(2H, d,J=7.2Hz), 8 .44(2H, d, J = 7.2Hz). Hz), 5.06 (2H, d, J = 6.6Hz), 5.25 (1H, d, J = 4.8Hz), 5.81 (1H, d J = 4.8Hz), 6.06 (1H: m), 6.83 (1H, d , J = 15.6Hz), 6.99 (1H, s), 7.25—7.38 (3H, m), 7.88 (2H, d, J = 7.2Hz), 8.44 (2H, d, J = 7.2Hz).
I R (KBr) cm—1: 1765, 1723, 1604, 1519. IR (KBr) cm— 1 : 1765, 1723, 1604, 1519.
MS: 707+ (M-Na+2H)+ MS: 707 + (M-Na + 2H) +
元素分析 C H N O S Na-4H O Elemental analysis C H N O S Na-4H O
計算値: C,46.50; H,4.66; N,13.99; S,8.01 ; Na,2.87 (%) Calculated values: C, 46.50; H, 4.66; N, 13.99; S, 8.01; Na, 2.87 (%)
実験値: C46.47; H,4.56; N, 13.97; SJ.71 ; Na,3.24 (%) Experimental value: C46.47; H, 4.56; N, 13.97; SJ.71; Na, 3.24 (%)
実施例 155 Example 155
[化 202] [Chemical 202]
(26) 22+10→34 (26) 22 + 10 → 34
化合物 22(897mg,7.9mmol)と化合物 10(1.43g,9.5mmol)から(16)と同様にして 34を結 晶として得た。収量 1.06g(59%)。 34 was obtained as a crystal from compound 22 (897 mg, 7.9 mmol) and compound 10 (1.43 g, 9.5 mmol) in the same manner as in (16). Yield 1.06 g (59%).
'H-NMR (d -DMSO): 3.82(3H, s),7.06(2H, m),7.27(2H, d, J =8.7Hz), 7.90(2H, d, J 'H-NMR (d-DMSO): 3.82 (3H, s), 7.06 (2H, m), 7.27 (2H, d, J = 8.7Hz), 7.90 (2H, d, J
=8.7Hz),8.30(2H,m), 9.25(1H, bs), 9.27(1H, bs). = 8.7Hz), 8.30 (2H, m), 9.25 (1H, bs), 9.27 (1H, bs).
(27) 34→35
化合物 34(1.05g,4.6mmol)力 (2)と同様にして 3 5を得た。収量 824mg(84%)。 (27) 34 → 35 Compound 34 (1.05 g, 4.6 mmol) force 35 was obtained in the same manner as (2). Yield 824 mg (84%).
(28) 35→36 (28) 35 → 36
化合物 35(817mg,3.8mmol)を(3)と同様にして 36を得た。収量 772mg(72%)。 Compound 35 (817 mg, 3.8 mmol) was obtained in the same manner as (3) to give 36. Yield 772 mg (72%).
'H-NMR (d -DMSO): 1.74(6H, m), 4.75(2H,d,J=6.9Hz), 5.43(1H, m),7.06(2H, m),'H-NMR (d-DMSO): 1.74 (6H, m), 4.75 (2H, d, J = 6.9Hz), 5.43 (1H, m), 7.06 (2H, m),
7.27(2H, J=9Hz), 7.89(2H, J=9Hz), 8.30(2H, m) 9.27(1H, bs). 7.27 (2H, J = 9Hz), 7.89 (2H, J = 9Hz), 8.30 (2H, m) 9.27 (1H, bs).
(29) 36 + 2→37 (29) 36 + 2 → 37
化合物 2(675mg,lmmol)と化合物 36(282mg,1.0mmol)から(4)と同様にして化合物 37( 859mg)を粉末として得た。 Compound 37 (859 mg) was obtained as a powder from Compound 2 (675 mg, lmmol) and Compound 36 (282 mg, 1.0 mmol) in the same manner as in (4).
(30) 37→33 (30) 37 → 33
化合物 37(859mg)を(5)と同様にして化合物 33を粉末として得た。収量 351mg(43%) 'H-NMR (D O): 1.29(3H, t, J = 6.9Hz), 3.64(2H, bs), 4.25(2H, q, J = 6.9 Hz), 4.88Compound 37 (859 mg) was obtained in the same manner as (5) to give compound 33 as a powder. Yield 351 mg (43%) 'H-NMR (D 2 O): 1.29 (3H, t, J = 6.9 Hz), 3.64 (2H, bs), 4.25 (2H, q, J = 6.9 Hz), 4.88
(2H,dJ=6Hz),5.24(lH, d, J = 4.8Hz), 5.80(1H, d, J = 4.8Hz), 6.03(1H, m,), 6.77(1H(2H, dJ = 6Hz), 5.24 (lH, d, J = 4.8Hz), 5.80 (1H, d, J = 4.8Hz), 6.03 (1H, m,), 6.77 (1H
, d,J=15.6Hz), 6.97(1H, s), 7.16(2H, d, J = 6Hz), 7.36(2H, d, J = 8.4Hz), 7.92(2H, d, D, J = 15.6Hz), 6.97 (1H, s), 7.16 (2H, d, J = 6Hz), 7.36 (2H, d, J = 8.4Hz), 7.92 (2H, d
, J = 8.4Hz), 8.09(1H, d, J =7Hz). , J = 8.4Hz), 8.09 (1H, d, J = 7Hz).
IR (KBr) cm"1: 1762, 1648, 1602, 1536. IR (KBr) cm " 1 : 1762, 1648, 1602, 1536.
MS: 650+ (M_Na+2H)+ MS: 650+ (M_Na + 2H) +
元素分析 C H N O S Na-4.5H O Elemental analysis C H N O S Na-4.5H O
計算値: C,46.27; H,4.69; N,13.03; S,8.52; Na,3.05 (%) Calculated: C, 46.27; H, 4.69; N, 13.03; S, 8.52; Na, 3.05 (%)
実験値: C,46.14; H,4.58; N,13.08; S,8.60; Na,3.06 (%) Experimental value: C, 46.14; H, 4.58; N, 13.08; S, 8.60; Na, 3.06 (%)
実施例 156 Example 156
[化 203]
[Chemical 203]
(31) 4+39→40 (31) 4 + 39 → 40
化合物 4(1.51g,10mmol)を酢酸ェチル(30ml)に懸濁して、トリェチルァミン 3. lmlを加 え、次いで化合物 39(1.78g, 10mmol)を加え室温で攪拌した。一夜放置後、反応液に さらに酢酸ェチルを加えて水-重炭酸ナトリウムで洗浄した。有機層を乾燥、濃縮して 得られた残渣をシリカゲルクロマトで精製して 40を結晶として得た。収量 1.05g(41%)。 'H-NMR (d -DMSO): 3.88(3H,s),7.54(lH, m),7.59(lH, m),7.72(lH, m),8.07(lH, m)Compound 4 (1.51 g, 10 mmol) was suspended in ethyl acetate (30 ml), 3. lml of triethylamine was added, then compound 39 (1.78 g, 10 mmol) was added, and the mixture was stirred at room temperature. After standing overnight, the reaction mixture was further added with ethyl acetate and washed with water-sodium bicarbonate. The organic layer was dried and concentrated, and the resulting residue was purified by silica gel chromatography to obtain 40 as crystals. Yield 1.05 g (41%). 'H-NMR (d-DMSO): 3.88 (3H, s), 7.54 (lH, m), 7.59 (lH, m), 7.72 (lH, m), 8.07 (lH, m)
, 8.32(1H, m),8.47(lH,m),8.78(lH,m),9.14(lH,m), 10.66(lH,bs). , 8.32 (1H, m), 8.47 (lH, m), 8.78 (lH, m), 9.14 (lH, m), 10.66 (lH, bs).
(32) 40→41 (32) 40 → 41
ィ匕合物 40(1.05g,4.1mmol)を(2)と同様にして 41を得た。収量 898mg(91%)。 Compound 40 (1.05 g, 4.1 mmol) was obtained in the same manner as (2) to obtain 41. Yield 898 mg (91%).
(33) 41→42 (33) 41 → 42
化合物 41(898mg,3.7mmol)を(3)と同様にして 42を得た。収量 1.13g(93%)。 Compound 41 (898 mg, 3.7 mmol) was obtained in the same manner as (3) to give 42. Yield 1.13 g (93%).
'H-NMR (d -CDC1 ): 1.78(6H, m), 4.82(2H,d,J=6.6Hz), 5.47(1H, m), 7.47(1H, m),'H-NMR (d-CDC1): 1.78 (6H, m), 4.82 (2H, d, J = 6.6Hz), 5.47 (1H, m), 7.47 (1H, m),
7.51(1H, m),7.86(lH, m),8.10(lH, m),8.16(lH, m),8.30(lH, m),8.33(lH,bs), 8.79(lH,m),9.21(lH,bs). 7.51 (1H, m), 7.86 (lH, m), 8.10 (lH, m), 8.16 (lH, m), 8.30 (lH, m), 8.33 (lH, bs), 8.79 (lH, m), 9.21 (lH, bs).
(34) 42 + 2→43 (34) 42 + 2 → 43
化合物 2(675mg、 lmmol)と化合物 42(310mg、 l.Ommol)から(4)と同様にして化合物 4 3(882mg)を粉末として得た。 Compound 43 (882 mg) was obtained as a powder from Compound 2 (675 mg, lmmol) and Compound 42 (310 mg, l.Ommol) in the same manner as (4).
(35) 43→38
化合物 43(882mg)を(5)と同様にして化合物 38を粉末として得た。収量 292mg(36%) 'H-NMR (D O): 1.29(3H, t, J = 6.9Hz), 3·66(2Η, bs), 4.24(2H, q, J = 6.9Hz), 5.26((35) 43 → 38 Compound 43 (882 mg) was obtained in the same manner as (5) to give Compound 38 as a powder. Yield 292mg (36%) 'H-NMR (DO): 1.29 (3H, t, J = 6.9Hz), 3.66 (2Η, bs), 4.24 (2H, q, J = 6.9Hz), 5.26 (
1H, d, J = 4.5Hz), 5.42(2H, d, J = 6.6Hz), 5.81(1H, d, J = 4.5Hz),6.14(lH, m), 6.991H, d, J = 4.5Hz), 5.42 (2H, d, J = 6.6Hz), 5.81 (1H, d, J = 4.5Hz), 6.14 (lH, m), 6.99
(1H, s), 6.98(1H, d,J=15.9Hz), 7.52(1H, m),7.7— 7.8(2H, m), 7.96(lH,m), 8.21(1H, m), 8.97-9.04(2H, m), 9.39(1H, bs). (1H, s), 6.98 (1H, d, J = 15.9Hz), 7.52 (1H, m), 7.7—7.8 (2H, m), 7.96 (lH, m), 8.21 (1H, m), 8.97- 9.04 (2H, m), 9.39 (1H, bs).
IR (KBr) cm—1: 1765, 1670, 1609, 1559. IR (KBr) cm— 1 : 1765, 1670, 1609, 1559.
MS: 678+ (M-Na+2H)+ MS: 678 + (M-Na + 2H) +
元素分析 C H N O S Na-4.5H O Elemental analysis C H N O S Na-4.5H O
計算値: C,46.15; H,4.52; N,12.56; S,8.21; Na,2.94 (%) Calculated value: C, 46.15; H, 4.52; N, 12.56; S, 8.21; Na, 2.94 (%)
実験値: C46.29; H,4.37; N,12.73; S,8.21; Na,3.29 (%) Experimental value: C46.29; H, 4.37; N, 12.73; S, 8.21; Na, 3.29 (%)
実施例 157 Example 157
[化 204] [Chemical 204]
(36) 45+4→46 (36) 45 + 4 → 46
化合物 45(0.96ml,10mmol)と化合物 4 (1.81g,12mmol)を(16)と同様にして 46を結晶と して得た。収量 375mg(16%)。 Compound 45 (0.96 ml, 10 mmol) and compound 4 (1.81 g, 12 mmol) were obtained in the same manner as (16) as 46. Yield 375 mg (16%).
'H-NMR (d -DMSO): 3.84(3H,s),7.27-7.53(4H, m),7.65(lH, m),8.10(lH, m), 8.38(1 'H-NMR (d-DMSO): 3.84 (3H, s), 7.27-7.53 (4H, m), 7.65 (lH, m), 8.10 (lH, m), 8.38 (1
H, m), 8.62(1H, s). H, m), 8.62 (1H, s).
(37) 46→47 (37) 46 → 47
化合物 46(372mg,1.6mmol)力ら(2)と同様にして 47を得た。収量 338mg(97%)。
(38) 47→48 Compound 46 (372 mg, 1.6 mmol) 47 was obtained in the same manner as the force (2). Yield 338 mg (97%). (38) 47 → 48
化合物 47(338mg,1.6mmol)を(3)と同様にして 48を得た。収量 406mg(91%)。 Compound 47 (338 mg, 1.6 mmol) was obtained in the same manner as (3) to give 48. Yield 406 mg (91%).
'H-NMR (d -CDC1 ): 1·79(6Η, m), 4.81(2H,d,J=7.2Hz), 5.46(1H, m), 6.01(lH,bs),'H-NMR (d -CDC1): 1 · 79 (6Η, m), 4.81 (2H, d, J = 7.2Hz), 5.46 (1H, m), 6.01 (lH, bs),
7.20-7.48(3H, m),7.66(lH, m),7.74(lH, m),8.20(lH, m),8.42(lH, m). 7.20-7.48 (3H, m), 7.66 (lH, m), 7.74 (lH, m), 8.20 (lH, m), 8.42 (lH, m).
(39) 48 + 2→49 (39) 48 + 2 → 49
化合物 2(675mg、 lmmol)と化合物 48(282mg、 l.Ommol)から(4)と同様にして化合物 4 9(878mg)を粉末として得た。 Compound 49 (878 mg) was obtained as a powder from Compound 2 (675 mg, lmmol) and Compound 48 (282 mg, l.Ommol) in the same manner as (4).
(40) 49→44 (40) 49 → 44
化合物 49(878mg)を(5)と同様にして化合物 44を粉末として得た。収量 352mg(44%) 'H-NMR (D O): 1.30(3H, t, J = 7.2Hz), 3.63(2H, bs), 4.25(2H, q, J = 7.2Hz), 5.14(Compound 49 (878 mg) was obtained in the same manner as (5) to give Compound 44 as a powder. Yield 352 mg (44%) 'H-NMR (D 2 O): 1.30 (3H, t, J = 7.2Hz), 3.63 (2H, bs), 4.25 (2H, q, J = 7.2Hz), 5.14 (
2H,d,J=7.2Hz),5.26(lH, d, J = 4.8Hz), 5.82(1H, d, J = 4.8Hz),6.07(lH, m), 6.86(1H2H, d, J = 7.2Hz), 5.26 (lH, d, J = 4.8Hz), 5.82 (1H, d, J = 4.8Hz), 6.07 (lH, m), 6.86 (1H
,d,J=15.9Hz), 6.99(1H, s), 7.38(lH,m),7.48(lH, m), 7.64—7.75(2H, m), 7.96(1H, m),, D, J = 15.9Hz), 6.99 (1H, s), 7.38 (lH, m), 7.48 (lH, m), 7.64-7.75 (2H, m), 7.96 (1H, m),
8.11(lH,m),8.30(lH,bs). 8.11 (lH, m), 8.30 (lH, bs).
I R (KBr) cm"1: 1764, 1565, 1509. IR (KBr) cm " 1 : 1764, 1565, 1509.
MS: 650+ (M_Na+2H)+ MS: 650+ (M_Na + 2H) +
元素分析 C H N O S Na-4H O Elemental analysis C H N O S Na-4H O
計算値: C,46.83; H,4.61; N,13.18; S,8.62; Na,3.09 (%) Calculated values: C, 46.83; H, 4.61; N, 13.18; S, 8.62; Na, 3.09 (%)
実験値: C,46.78; H,4,46; N,13.31; S,8.79; Na,3.31 (%) Experimental value: C, 46.78; H, 4,46; N, 13.31; S, 8.79; Na, 3.31 (%)
実施例 158 Example 158
[化 205]
[Chemical 205]
(41) 10+39→51 (41) 10 + 39 → 51
化合物 10(1.51g,10mmol)と化合物 39(1.78g,10mmol)を(31)と同様にして 51を得た。 収量 885mg(35%)。 Compound 10 (1.51 g, 10 mmol) and compound 39 (1.78 g, 10 mmol) were obtained in the same manner as (31) to give 51. Yield 885 mg (35%).
'H-NMR (d -DMSO): 3.85(3H,s),7.59(lH,m),7.96(2H, m),8.31(lH, m),8.79(lH, m), 'H-NMR (d-DMSO): 3.85 (3H, s), 7.59 (lH, m), 7.96 (2H, m), 8.31 (lH, m), 8.79 (lH, m),
9.12(1H, m). 9.12 (1H, m).
(42) 51→52 (42) 51 → 52
化合物 51(881mg,3.4mmol)を(2)と同様にして 52を得た。収量 777mg(93%)。 Compound 51 (881 mg, 3.4 mmol) was obtained in the same manner as (2) to give 52. Yield 777 mg (93%).
(43) 52→53 (43) 52 → 53
化合物 52(777mg,3.2mmol)を(3)と同様にして 53を得た。収量 675g(63%)。 Compound 52 (777 mg, 3.2 mmol) was obtained in the same manner as (3) to give 53. Yield 675 g (63%).
'H-NMR (d -DMSO): 1.74(6H, m), 4.78(2H,d,J=7.2Hz), 5.44(1H, m), 7.59(lH,m),'H-NMR (d-DMSO): 1.74 (6H, m), 4.78 (2H, d, J = 7.2Hz), 5.44 (1H, m), 7.59 (lH, m),
7.95(4H, m),8.31(lH, m),8.78(lH, m),9.12(lH, m). 7.95 (4H, m), 8.31 (lH, m), 8.78 (lH, m), 9.12 (lH, m).
(44) 53 + 2→54 (44) 53 + 2 → 54
化合物 2(675mg,lmmol)と化合物 53(310mg、 l.Ommol)力 (4)と同様にして化合物 54 (896mg)を粉末として得た。 Compound 54 (896 mg) was obtained as a powder in the same manner as Compound 2 (675 mg, lmmol) and Compound 53 (310 mg, l.Ommol) force (4).
(45) 54→50 (45) 54 → 50
化合物 54(896mg)を(5)と同様にして化合物 50を粉末として得た。収量 316mg(40%) 'H-NMR (D O): 1.28(3H, t, J = 6.9Hz), 3.66(2H, ABq,J=19.4,17.6Hz), 4.22(2H, q,Compound 54 (896 mg) was obtained in the same manner as (5) to give compound 50 as a powder. Yield 316mg (40%) 'H-NMR (D 2 O): 1.28 (3H, t, J = 6.9Hz), 3.66 (2H, ABq, J = 19.4, 17.6Hz), 4.22 (2H, q,
J = 6.9Hz), 5.26(1H, d, J = 4.8Hz), 5.41(2H,dJ=6.6Hz), 5.81(1H, d, J = 4.8Hz),6.1 4(1H, m), 6.96(1H, s), 6.99(lH,d,J=12.9Hz), 7.64(2H, d,J=8.1Hz),7.87(2H, d,J=8.1
Hz), 8.19(lH,m), 8.94(1H, d,J=8.1Hz) ,9.03(lH,d,J=6Hz), 9.36(lH,bs). J = 6.9Hz), 5.26 (1H, d, J = 4.8Hz), 5.41 (2H, dJ = 6.6Hz), 5.81 (1H, d, J = 4.8Hz), 6.1 4 (1H, m), 6.96 ( 1H, s), 6.99 (lH, d, J = 12.9Hz), 7.64 (2H, d, J = 8.1Hz), 7.87 (2H, d, J = 8.1) Hz), 8.19 (lH, m), 8.94 (1H, d, J = 8.1Hz), 9.03 (lH, d, J = 6Hz), 9.36 (lH, bs).
IR (KBr) cm—1: 1765, 1669, 1603, 1532. IR (KBr) cm— 1 : 1765, 1669, 1603, 1532.
MS: 678+ (M_Na+2H)+ MS: 678+ (M_Na + 2H) +
元素分析 C H N O S Na- 5.5H O Elemental analysis C H N O S Na- 5.5H O
計算値: C,45.11; H,4.67; N,12.27; S,8.03; Na,2.88 (%) Calculated values: C, 45.11; H, 4.67; N, 12.27; S, 8.03; Na, 2.88 (%)
実験値: C,45.15; H,4.44; N,12.44; S,8.28; Na,3.34 (%) Experimental value: C, 45.15; H, 4.44; N, 12.44; S, 8.28; Na, 3.34 (%)
実施例 159 Example 159
[化 206] [Chemical 206]
(46) 56→57 (46) 56 → 57
化合物 56(1.38g,10mmol)にジメチルホルムアミド (15ml)溶解した後、カルボニルジイミ ダゾール (1.95g,12mmol)を加えて 55°Cで 30分間攪拌した。次いでプレニルアルコー ル 10mlを加えて、 55°Cで 8時間攪拌した。反応液を冷却後、酢酸ェチルと水をカ卩えて 抽出した。有機層を重炭酸ナトリウム水溶液、水で洗浄後、乾燥して濃縮して得られ た残渣をシリカゲルクロマトで精製して 57を得た。収量 1.48g(72%)。 After dissolving dimethylformamide (15 ml) in compound 56 (1.38 g, 10 mmol), carbonyldiimidazole (1.95 g, 12 mmol) was added, and the mixture was stirred at 55 ° C. for 30 minutes. Next, 10 ml of prenyl alcohol was added and stirred at 55 ° C. for 8 hours. After cooling the reaction solution, extraction was performed with cetyl acetate and water. The organic layer was washed with an aqueous sodium bicarbonate solution and water, then dried and concentrated. The residue obtained was purified by silica gel chromatography to obtain 57. Yield 1.48 g (72%).
'H-NMR (CDCl ): 1.79(6H, m), 4.78(2H, d, J = 7.8Hz), 5.45(1H, m),6.48(lH, d, J'H-NMR (CDCl): 1.79 (6H, m), 4.78 (2H, d, J = 7.8Hz), 5.45 (1H, m), 6.48 (lH, d, J
= 8.4Hz), 8.03(1H, dd, J = 2.4,8.4Hz),8.72(lH, d, J = 2.4Hz). = 8.4Hz), 8.03 (1H, dd, J = 2.4, 8.4Hz), 8.72 (lH, d, J = 2.4Hz).
(47) 3+57→58 (47) 3 + 57 → 58
化合物 57(1.24g,6mmol)と化合物 3(720mg, 6mmol)から(1)と同様にして 58を結晶と して得た。収量 620mg(32%)。
Ή-NMR (d -DMSO): 1.74(6H, m), 4.79(2H,d,J=7.2Hz), 5.44(1H, m), 7.53(2H,m),58 was crystallized from Compound 57 (1.24 g, 6 mmol) and Compound 3 (720 mg, 6 mmol) in the same manner as (1). Yield 620 mg (32%). NMR-NMR (d-DMSO): 1.74 (6H, m), 4.79 (2H, d, J = 7.2Hz), 5.44 (1H, m), 7.53 (2H, m),
7.73(1H, d, J = 8.7Hz), 8.24(1H, dd, J = 2.4,8.7Hz), 8.41(2H,m),8.84(lH, dd, J = 0. 6,2.4Hz). 7.73 (1H, d, J = 8.7Hz), 8.24 (1H, dd, J = 2.4, 8.7Hz), 8.41 (2H, m), 8.84 (lH, dd, J = 0.6, 2.4Hz).
(48) 58 + 2→59 (48) 58 + 2 → 59
化合物 2(674mg,lmmol)と化合物 58(326mg, lmmol)から(4)と同様にして化合物 59(94 4mg)を得た。 Compound 59 (94 4 mg) was obtained from Compound 2 (674 mg, lmmol) and Compound 58 (326 mg, lmmol) in the same manner as in (4).
(49) 59→55 (49) 59 → 55
化合物 59(944mg)を(5)と同様にして化合物 55を粉末として得た。収量 290mg(36%) 'H-NMR (D O): 1.27(3H, t, J = 7.2Hz), 3.66(2H, bs), 4.21(2H, q, J = 7.2 Hz), 5.08Compound 59 (944 mg) was obtained in the same manner as (5) to give compound 55 as a powder. Yield 290 mg (36%) 'H-NMR (D 2 O): 1.27 (3H, t, J = 7.2 Hz), 3.66 (2H, bs), 4.21 (2H, q, J = 7.2 Hz), 5.08
(2H, d, J = 6.9Hz),5.25(lH, d, J = 4.5Hz), 5.81(1H, d, J = 4.5Hz), 6.07(1H, m), 6.8(2H, d, J = 6.9Hz), 5.25 (lH, d, J = 4.5Hz), 5.81 (1H, d, J = 4.5Hz), 6.07 (1H, m), 6.8
8(1H, d, J = 15.6Hz), 6.94(1H, s), 7.30(1H, d, J =9.3Hz), 7.93(2H, d, J =7Hz), 8.12(8 (1H, d, J = 15.6Hz), 6.94 (1H, s), 7.30 (1H, d, J = 9.3Hz), 7.93 (2H, d, J = 7Hz), 8.12 (
1H, d, J = 8.7Hz), 8.47(2H, d, J = 7Hz), 8.67(1H, br s). 1H, d, J = 8.7Hz), 8.47 (2H, d, J = 7Hz), 8.67 (1H, br s).
IR (KBr) cm"1: 1766, 1590, 1516. IR (KBr) cm " 1 : 1766, 1590, 1516.
MS: 694+ (M_Na+2H)+ MS: 694+ (M_Na + 2H) +
元素分析 C H N O S Na- 5H O Elemental analysis C H N O S Na- 5H O
計算値: C,43.23; H,4.50; N,15.64; S,7.96; Na,2.85 (%) Calculated values: C, 43.23; H, 4.50; N, 15.64; S, 7.96; Na, 2.85 (%)
実験値: C,43.35; H,4.40; N,15.75; S,8.12; Na,3.49 (%) Experimental value: C, 43.35; H, 4.40; N, 15.75; S, 8.12; Na, 3.49 (%)
実施例 160 Example 160
[化 207]
[Chemical 207]
(50) 56-1 + 57- 1→58- 1 (50) 56-1 + 57- 1 → 58- 1
化合物 57-l(1.8g,10mmol)をジメチルホルムアミド(15ml)に懸濁して、カルボエルジイ ミダゾール (1.63g, 10mmol)を加えて攪拌する。次いで化合物 56-l(940mg, 10mmol)を 加え 100°Cで 9時間攪拌した。反応液に酢酸ェチル -水を加えた。有機層を水洗、乾 燥後濃縮して 58-1を得た。収量 1.21g(47%)。 Compound 57-l (1.8 g, 10 mmol) is suspended in dimethylformamide (15 ml), carbodiimidazole (1.63 g, 10 mmol) is added and stirred. Next, Compound 56-l (940 mg, 10 mmol) was added and stirred at 100 ° C. for 9 hours. Ethyl acetate-water was added to the reaction solution. The organic layer was washed with water, dried and concentrated to give 58-1. Yield 1.21 g (47%).
'H-NMR (d -DMSO): 3.91(3H,s),7.42(lH,m),8.11(4H, m),8.20(lH, m),8.34(lH, dd, 'H-NMR (d-DMSO): 3.91 (3H, s), 7.42 (lH, m), 8.11 (4H, m), 8.20 (lH, m), 8.34 (lH, dd,
),8.93(1H, d,J=2.4Hz). ), 8.93 (1H, d, J = 2.4Hz).
(51) 58- 1→59-1 (51) 58-1 → 59-1
化合物 58-1(1.21g,4.7mmol)力 (2)と同様にして 59_1を得た。収量 1.08g(95%)。Compound 58-1 (1.21 g, 4.7 mmol) force 59_1 was obtained in the same manner as in (2). Yield 1.08 g (95%).
(52) 59-1→60-1 (52) 59-1 → 60-1
化合物 59-1(1.08g,4.5mmol)を(3)と同様にして 60-1を得た。収量 1.23g(84%)。 Compound 59-1 (1.08 g, 4.5 mmol) was obtained in the same manner as (3) to give 60-1. Yield 1.23 g (84%).
'H-NMR (d -DMSO): 1.76(6H, m), 4.80(2H,d), 5.46(1H, m),7.42(lH,m),8.09(4H, m'H-NMR (d-DMSO): 1.76 (6H, m), 4.80 (2H, d), 5.46 (1H, m), 7.42 (lH, m), 8.09 (4H, m
),8.19(1H, m),8.33(lH, dd),8.92(lH, dd,). ), 8.19 (1H, m), 8.33 (lH, dd), 8.92 (lH, dd,).
(53) 60-1 + 2→61-1 (53) 60-1 + 2 → 61-1
化合物 2(675mg、 lmmol)と化合物 60_l(310mg、 l.Ommol)力 (4)と同様にして化合 物 61-l(916mg)を粉末として得た。 Compound 61-l (916 mg) was obtained as a powder in the same manner as Compound 2 (675 mg, lmmol) and Compound 60_l (310 mg, l.Ommol) force (4).
(54) 61- 1→55_1 (54) 61- 1 → 55_1
化合物 61-l(916mg)を(5)と同様にして化合物 55_1を粉末として得た。収量 346mg(44
%) Compound 61-l (916 mg) was obtained in the same manner as (5) to give compound 55_1 as a powder. Yield 346 mg (44 %)
'H-NMR (D O): 1.27(3H, t, J = 7.2Hz), 3.67(2H, ABq, J = 17.4,20.4Hz), 4.21(2H, q, J = 7.2 Hz), 5.26(1H, d, J = 4.5Hz), 5.32(2H, d, J = 6.9Hz), 5.80(1H, d, J = 4.5H z), 6.13(1H, m), 6.95(1H, s), 7.99(1H, dd), 8.55(1H, d), 8.60(1H, d), 9.35(lH,s). IR (KBr) cm—1: 1765, 1669, 1594, 1552, 1506. 'H-NMR (DO): 1.27 (3H, t, J = 7.2Hz), 3.67 (2H, ABq, J = 17.4, 20.4Hz), 4.21 (2H, q, J = 7.2 Hz), 5.26 (1H, d, J = 4.5Hz), 5.32 (2H, d, J = 6.9Hz), 5.80 (1H, d, J = 4.5H z), 6.13 (1H, m), 6.95 (1H, s), 7.99 (1H , dd), 8.55 (1H, d), 8.60 (1H, d), 9.35 (lH, s). IR (KBr) cm— 1 : 1765, 1669, 1594, 1552, 1506.
MS: 678+ (M-Na+2H)+元素分析 C H N O S Na- 5H O MS: 678+ (M-Na + 2H) + elemental analysis C H N O S Na-5 H O
計算値: C,45.62; H,4.59; N,12.41; S,8.12; Na,2.91 (%) Calculated value: C, 45.62; H, 4.59; N, 12.41; S, 8.12; Na, 2.91 (%)
実験値: C45.59; H,4,53; N,12.55; S,8.26; Na,3.27 (%) Experimental value: C45.59; H, 4, 53; N, 12.55; S, 8.26; Na, 3.27 (%)
実施例 161 Example 161
[化 208] [Chemical 208]
(55) 22+61→62 (55) 22 + 61 → 62
化合物 22(947mg,8.3mmol)と化合物 61(1.58g,9.6mmol)から(16)と同様にして 62を結 晶として得た。収量 1.33g(66%)。 62 was obtained as a crystal from Compound 22 (947 mg, 8.3 mmol) and Compound 61 (1.58 g, 9.6 mmol) in the same manner as in (16). Yield 1.33 g (66%).
'H-NMR (d -DMSO): 2.28(3H,s),3.83(3H,s),6.90(2H,m),7.40(lH,d,J=8.4Hz),7.77(l 'H-NMR (d-DMSO): 2.28 (3H, s), 3.83 (3H, s), 6.90 (2H, m), 7.40 (lH, d, J = 8.4Hz), 7.77 (l
H, dd,J=2.1,8.4Hz),7.86(lH, d,J=1.5Hz),8.23(2H, m),8.41(lH,s). H, dd, J = 2.1, 8.4Hz), 7.86 (lH, d, J = 1.5Hz), 8.23 (2H, m), 8.41 (lH, s).
(56) 62→63 (56) 62 → 63
化合物 62(1.32g,5.5mmol)力 (2)と同様にして 63を得た。収量 1.19g(96%)。 Compound 62 (1.32 g, 5.5 mmol) force 63 was obtained in the same manner as (2). Yield 1.19 g (96%).
(57) 63→64
ィ匕合物 35(1.19g,5.2mmol)を(3)と同様にして 64を得た。収量 1.3g(84%)。 (57) 63 → 64 Compound 35 (1.19 g, 5.2 mmol) was obtained in the same manner as (3) to give 64. Yield 1.3 g (84%).
'H-NMR (CDCl ): 1.79(6H, m), 2.31(3H,s), 4.81(2H,dJ=7.2Hz), 5.47(1H, m),'H-NMR (CDCl): 1.79 (6H, m), 2.31 (3H, s), 4.81 (2H, dJ = 7.2Hz), 5.47 (1H, m),
6.12(lH,bs),6.83(2H,m),7.37(lH,d,J=8.4Hz),7.89(lH,m),7.94(lH,bs)8.32(2H, m).6.12 (lH, bs), 6.83 (2H, m), 7.37 (lH, d, J = 8.4Hz), 7.89 (lH, m), 7.94 (lH, bs) 8.32 (2H, m).
(58) 64 + 2→65 (58) 64 + 2 → 65
化合物 2(675mg,lmmol)と化合物 64(310mg,1.0mmol)から(4)と同様にして化合物 65( 827mg)を粉末として得た。 Compound 65 (827 mg) was obtained as a powder from Compound 2 (675 mg, lmmol) and Compound 64 (310 mg, 1.0 mmol) in the same manner as in (4).
(59) 65→60 (59) 65 → 60
化合物 65(827mg)を(5)と同様にして化合物 60を粉末として得た。収量 339mg(44%) 'H-NMR (D O): 1.29(3H, t, J = 6.9Hz), 3.63(2H, bs), 4.26(2H, q, J = 6.9 Hz), 4.9(Compound 65 (827 mg) was obtained in the same manner as (5) to give Compound 60 as a powder. Yield 339 mg (44%) 'H-NMR (DO): 1.29 (3H, t, J = 6.9Hz), 3.63 (2H, bs), 4.26 (2H, q, J = 6.9 Hz), 4.9 (
2H,d,J=6Hz),5.26(lH, d, J = 4.2Hz), 5.80(1H, d, J = 4.2Hz), 6.02(1H, m,), 6.77(1H, d,J=15.6Hz), 6.92(2H, bd), 6.99(1H, s), 7.35(lH,d, J = 8.1Hz), 7.76(1H, d, J = 8.1 Hz), 7.85(lH,bs)8.06(lH, d, J =6.6Hz). 2H, d, J = 6Hz), 5.26 (lH, d, J = 4.2Hz), 5.80 (1H, d, J = 4.2Hz), 6.02 (1H, m,), 6.77 (1H, d, J = 15.6 Hz), 6.92 (2H, bd), 6.99 (1H, s), 7.35 (lH, d, J = 8.1Hz), 7.76 (1H, d, J = 8.1 Hz), 7.85 (lH, bs) 8.06 (lH , d, J = 6.6Hz).
IR (KBr) cm"1: 1765, 1647, 1536. IR (KBr) cm " 1 : 1765, 1647, 1536.
MS: 664+ (M_Na+2H)+ MS: 664+ (M_Na + 2H) +
元素分析 C H N O S Na-4.5H O Elemental analysis C H N O S Na-4.5H O
計算値: C,46.99; H,4.86; N,12.79; S,8.36; Na,3.00 (%) Calculated value: C, 46.99; H, 4.86; N, 12.79; S, 8.36; Na, 3.00 (%)
実験値: C,46.77; H,4.81; N,12.84; S,8.21; Na,3.27 (%) Experimental value: C, 46.77; H, 4.81; N, 12.84; S, 8.21; Na, 3.27 (%)
実施例 162 Example 162
[化 209]
[Chemical 209]
(60) 67→68 (60) 67 → 68
化合物 67(7.55g,50mmol)を(3)と同様にして 68を得た。収量 9.4g(88%)。 Compound 67 (7.55 g, 50 mmol) was obtained in the same manner as in (3) to give 68. Yield 9.4g (88%).
'H-NMR (CDCl ): 1.78(6H, m),2.19(3H,s), 4.76(2H, d, J = 7.2Hz), 5.45(1H, m),6.6 'H-NMR (CDCl): 1.78 (6H, m), 2.19 (3H, s), 4.76 (2H, d, J = 7.2Hz), 5.45 (1H, m), 6.6
5(1H, d, J = 8.4Hz), 7.75(1H, dd, J = 2.1,8.4Hz),7.76(lH, bs). 5 (1H, d, J = 8.4Hz), 7.75 (1H, dd, J = 2.1, 8.4Hz), 7.76 (lH, bs).
(61) 16+68→69 (61) 16 + 68 → 69
化合物 16(369mg,3mmol)をジメチルホルムアミド(3ml)に懸濁して、カルボニルジイミ ダゾール (486mg,3mmol)を加えて攪拌する。次レ、で化合物 68(788mg,3.6mmol)を加え 120°Cで加温攪拌した。反応液に酢酸ェチルを加え水洗、乾燥、濃縮後シリカゲルク 口マトで精製して 69を得た。収量 348mg(36%)。 Suspend compound 16 (369 mg, 3 mmol) in dimethylformamide (3 ml), add carbonyldiimidazole (486 mg, 3 mmol) and stir. Next, compound 68 (788 mg, 3.6 mmol) was added and heated and stirred at 120 ° C. Ethyl acetate was added to the reaction solution, which was washed with water, dried, concentrated, and purified by silica gel chromatography to obtain 69. Yield 348 mg (36%).
'H-NMR (d -DMSO): 1.75(6H, m),,2.33(3H,s) 4.79(2H, d, J = 6.9Hz), 5.45(1H, m) 'H-NMR (d-DMSO): 1.75 (6H, m), 2.33 (3H, s) 4.79 (2H, d, J = 6.9Hz), 5.45 (1H, m)
,7.61(1H, d, J = 8.4Hz), 7.83(1H, dd, J = 1.8,8.4Hz),7.88(lH, bs). 7.88(2H, m ), 8.8 0(2H, m). , 7.61 (1H, d, J = 8.4Hz), 7.83 (1H, dd, J = 1.8, 8.4Hz), 7.88 (lH, bs). 7.88 (2H, m), 8.8 0 (2H, m).
(62) 69 + 2→70 (62) 69 + 2 → 70
化合物 2(675mg,lmmol)と化合物 69(324mg,1.0mmol)から(4)と同様にして化合物 70( 922mg)を粉末として得た。 Compound 70 (922 mg) was obtained as a powder from Compound 2 (675 mg, 1 mmol) and Compound 69 (324 mg, 1.0 mmol) in the same manner as in (4).
(63) 70→66 (63) 70 → 66
化合物 70(827mg)を(5)と同様にして化合物 66を粉末として得た。収量 272mg(33%)
H-NMR (D O): 1.30(3H, t, J = 7.1Hz), 2.33(3H,s),3.43, 3.66(2H, bs), 4.25(2H, q,Compound 70 (827 mg) was obtained in the same manner as (5) to give Compound 66 as a powder. Yield 272mg (33%) H-NMR (DO): 1.30 (3H, t, J = 7.1Hz), 2.33 (3H, s), 3.43, 3.66 (2H, bs), 4.25 (2H, q,
J = 7.1 Hz), 5.27(1H, d, J = 5.1Hz), 5.42(2H, d, J = 6.3Hz), 5.83(1H, d, J = 5.1Hz), 6.13(1H, m),6.98(lH,d,J=15.3Hz), 6.99(1H, s), 7.42(1H, d, J = 8.1Hz), 7.75(lH,dd J=1.2,8.1Hz),7.82(lH, bs), 8.48(2H, m), 8.99(2H, m). J = 7.1 Hz), 5.27 (1H, d, J = 5.1Hz), 5.42 (2H, d, J = 6.3Hz), 5.83 (1H, d, J = 5.1Hz), 6.13 (1H, m), 6.98 (lH, d, J = 15.3Hz), 6.99 (1H, s), 7.42 (1H, d, J = 8.1Hz), 7.75 (lH, dd J = 1.2,8.1Hz), 7.82 (lH, bs), 8.48 (2H, m), 8.99 (2H, m).
IR (KBr) cm_1:1765, 1666, 1594, 1532. IR (KBr) cm _1 : 1765, 1666, 1594, 1532.
MS: 692+ (M-Na+2H)+ MS: 692+ (M-Na + 2H) +
元素分析 C H N O S Na- 5.5H O Elemental analysis C H N O S Na- 5.5H O
計算値: C,45.81; H,4.84; N,12.06; SJ.89; Na,2.83 (%) Calculated value: C, 45.81; H, 4.84; N, 12.06; SJ.89; Na, 2.83 (%)
実験値: C,45.52; H,4.71; N,12.20; S,8.25; Na,3.48 (%) Experimental value: C, 45.52; H, 4.71; N, 12.20; S, 8.25; Na, 3.48 (%)
実施例 163 Example 163
[化 210] [Chemical 210]
(64) 22+72→73 (64) 22 + 72 → 73
化合物 22(908mg,8mmol)と化合物 72(1.78g,9.6mmol)から(16)と同様にして 73を得た 。収量 357mg(17%)。 73 was obtained from Compound 22 (908 mg, 8 mmol) and Compound 72 (1.78 g, 9.6 mmol) in the same manner as (16). Yield 357 mg (17%).
'H-NMR (d -DMSO): 3.85(3H,s),7.06(2H, m),7.56(lH, d,J=8.7Hz),7.86(2H, dd, J = 'H-NMR (d-DMSO): 3.85 (3H, s), 7.06 (2H, m), 7.56 (lH, d, J = 8.7Hz), 7.86 (2H, dd, J =
2.1,8.4Hz), 8.00(1H, d,J=2.1Hz), 8.31(2H, m),8.78(lH,bs). 2.1,8.4Hz), 8.00 (1H, d, J = 2.1Hz), 8.31 (2H, m), 8.78 (lH, bs).
(65) 73→74 (65) 73 → 74
化合物 73(349mg,1.3mmol)力 (2)と同様にして 74を得た。収量 257mg(78%)。
(66) 74→75 Compound 73 (349 mg, 1.3 mmol) force 74 was obtained in the same manner as (2). Yield 257 mg (78%). (66) 74 → 75
化合物 74(257mg,1.0mmol)を(3)と同様にして 75を得た。収量 257mg(79%)。 Compound 74 (257 mg, 1.0 mmol) was obtained in the same manner as (3) to give 75. Yield 257 mg (79%).
'H-NMR (d -DMSO): 1.75(6H, m),4.78(2H, d, J = 7.2Hz), 5.43(1H, m), 'H-NMR (d-DMSO): 1.75 (6H, m), 4.78 (2H, d, J = 7.2Hz), 5.43 (1H, m),
7.05(2H, m),7.56(lH, d,J=8.7Hz),7.84(2H, dd, J = 2.1,8.7Hz),7.98(lH, d,J=2.1Hz), 8.30(2H, m),8.78(lH,bs). 7.05 (2H, m), 7.56 (lH, d, J = 8.7Hz), 7.84 (2H, dd, J = 2.1, 8.7Hz), 7.98 (lH, d, J = 2.1Hz), 8.30 (2H, m ), 8.78 (lH, bs).
(67) 75 + 2→76 (67) 75 + 2 → 76
化合物 2(540mg,0.8mmol)と化合物 75(257mg,0.8mmol)から(4)と同様にして化合物 7 6(718mg)を粉末として得た。 Compound 76 (718 mg) was obtained as a powder from Compound 2 (540 mg, 0.8 mmol) and Compound 75 (257 mg, 0.8 mmol) in the same manner as (4).
(68) 76→71 (68) 76 → 71
化合物 76(827mg)を(5)と同様にして化合物 71を粉末として得た。収量 239mg(38%) 'H-NMR (D O): 1.29(3H, t, J = 7.2Hz), 3.64(2H, bs), 4.25(2H, q, J = 7.2 Hz), 4.91Compound 76 (827 mg) was obtained in the same manner as (5) to give Compound 71 as a powder. Yield 239 mg (38%) 'H-NMR (D 2 O): 1.29 (3H, t, J = 7.2 Hz), 3.64 (2H, bs), 4.25 (2H, q, J = 7.2 Hz), 4.91
(2H, d, J = 6.6Hz), 5.24(1H, d, J = 5.4Hz), 5.81(1H, d, J = 5.4Hz), 5.03(1H, m), 6.7(2H, d, J = 6.6Hz), 5.24 (1H, d, J = 5.4Hz), 5.81 (1H, d, J = 5.4Hz), 5.03 (1H, m), 6.7
8(1H, d, J = 15.3Hz), 6.99(lH,bs),7.06(2H, d, J = 7.2Hz), 7.53(1H, d, J = 8.1Hz), 7.8 (1H, d, J = 15.3Hz), 6.99 (lH, bs), 7.06 (2H, d, J = 7.2Hz), 7.53 (1H, d, J = 8.1Hz), 7.
85(1H, d, J = 8.1Hz), 8.02(lH,bs),7.86 (2H, d, J = 7.2Hz). 85 (1H, d, J = 8.1Hz), 8.02 (lH, bs), 7.86 (2H, d, J = 7.2Hz).
IR (KBr) cm"1: 1764, 1647, 1597, 1534. IR (KBr) cm " 1 : 1764, 1647, 1597, 1534.
MS: 684+ (M_Na+2H)+ MS: 684+ (M_Na + 2H) +
元素分析 C H N O S Na-4.5H O Elemental analysis C H N O S Na-4.5H O
計算値: C,44.25; H,4.35; N,12.46; Cl,4.50 S,8.15; Na,3.27 (%) Calculated: C, 44.25; H, 4.35; N, 12.46; Cl, 4.50 S, 8.15; Na, 3.27 (%)
実験値: C,44.11; H,4.31; N,12.46; Cl,4.44 S,8.24; Na,2.92 (%) Experimental value: C, 44.11; H, 4.31; N, 12.46; Cl, 4.44 S, 8.24; Na, 2.92 (%)
実施例 164 Example 164
[化 211]
[Chemical 211]
(69) 16+57→78 (69) 16 + 57 → 78
化合物 16(492mg,4mmol)と化合物 57(824mg,4mmol)から(61)と同様にして 78を得た。 収量 772mg(62%)。 78 was obtained from Compound 16 (492 mg, 4 mmol) and Compound 57 (824 mg, 4 mmol) in the same manner as (61). Yield 772 mg (62%).
'H-NMR (CDCl ): 1.79(6H,m),4.85(2H,d,J=7.2Hz),5.48(lH,m),7.79(2H,m), 8.38—8. 'H-NMR (CDCl 3): 1.79 (6H, m), 4.85 (2H, d, J = 7.2Hz), 5.48 (lH, m), 7.79 (2H, m), 8.38-8.
47 (2H, m), 8.86(2H, m),8.95(lH, m). 47 (2H, m), 8.86 (2H, m), 8.95 (lH, m).
( 70) 78 + 2→79 (70) 78 + 2 → 79
化合物 2(675mg,lmmol)と化合物 78(311mg,1.0mmol)から(4)と同様にして化合物 79( 887mg)を粉末として得た。 Compound 79 (887 mg) was obtained as a powder from Compound 2 (675 mg, lmmol) and Compound 78 (311 mg, 1.0 mmol) in the same manner as in (4).
(71) 79→77 (71) 79 → 77
化合物 79(887mg)を(5)と同様にして化合物 77を粉末として得た。収量 119mg(15%) 'H-NMR (D O): 1.28(3H, t, J = 7.2Hz), 3.65(2H, bs), 4.22(2H, q, J = 7.2 Hz), 5.26Compound 77 (887 mg) was obtained in the same manner as (5) to give Compound 77 as a powder. Yield 119 mg (15%) 'H-NMR (D 2 O): 1.28 (3H, t, J = 7.2 Hz), 3.65 (2H, bs), 4.22 (2H, q, J = 7.2 Hz), 5.26
(1H, d, J = 4.5Hz), 5.42(2H, d, J = 6.6Hz), 5.51(1H, d, J = 4.5Hz), 6.12(1H, m), 6. 95(lH,bs),6.99(lH, d, J = 15.9Hz), 8.00(1H, d, J = 8.4Hz), 8.31(1H, d, J = 8.4Hz), 8.47(2H, d,J=6.3Hz), 8.79(lH,bs),9.08(2H, d, J = 6.3Hz). (1H, d, J = 4.5Hz), 5.42 (2H, d, J = 6.6Hz), 5.51 (1H, d, J = 4.5Hz), 6.12 (1H, m), 6.95 (lH, bs) , 6.99 (lH, d, J = 15.9Hz), 8.00 (1H, d, J = 8.4Hz), 8.31 (1H, d, J = 8.4Hz), 8.47 (2H, d, J = 6.3Hz), 8.79 (lH, bs), 9.08 (2H, d, J = 6.3Hz).
IR (KBr) cm"1: 1765, 1670, 1607, 1532. IR (KBr) cm " 1 : 1765, 1670, 1607, 1532.
MS: 679+ (M_Na+2H)+
元素分析 C H N O S Na- 5H O MS: 679+ (M_Na + 2H) + Elemental analysis CHNOS Na- 5H O
計算値: C,44.05; H,4.46; N,14.17; S,8.11; Na,3.29 (%) Calculated: C, 44.05; H, 4.46; N, 14.17; S, 8.11; Na, 3.29 (%)
実験値: C,44.26; H,4.36; N,14.24; S,8.07; Na,3.48 (%) Experimental value: C, 44.26; H, 4.36; N, 14.24; S, 8.07; Na, 3.48 (%)
実施例 165 Example 165
[化 212] [Chemical 212]
(72) 56-l+81→82 (72) 56-l + 81 → 82
化合物 81(1.58g,8.1mmol)をジメチルホルムアミド(8ml)に懸濁して、 56_l(762mg,8.1 mmol)を加えた。次いでェチルジメチルァミノプロピルカルボジイミド塩酸塩 (1.56g,8.1 mmol)をカ卩えて 5時間攪拌した。反応液に酢酸ェチル-水をカ卩え、有機層を水洗、乾 燥後濃縮して 82を得た。収量 1.87g(85%)。 Compound 81 (1.58 g, 8.1 mmol) was suspended in dimethylformamide (8 ml), and 56_l (762 mg, 8.1 mmol) was added. Next, ethyldimethylaminopropylcarbodiimide hydrochloride (1.56 g, 8.1 mmol) was added and stirred for 5 hours. Ethyl acetate-water was added to the reaction solution, and the organic layer was washed with water, dried and concentrated to obtain 82. Yield 1.87 g (85%).
'H-NMR (d -DMSO): 1.37(3H,t,J=6.9Hz),4.41(2H,qJ=6.9Hz),7.40-7.44(lH, m), 'H-NMR (d-DMSO): 1.37 (3H, t, J = 6.9Hz), 4.41 (2H, qJ = 6.9Hz), 7.40-7.44 (lH, m),
8.29-8.36(3H,m),8.55(2H, dd, J = 2.1,8.1Ηζ),9·08(1Η, m), 9.19(lH,m). 8.29-8.36 (3H, m), 8.55 (2H, dd, J = 2.1,8.1Ηζ), 9.08 (1Η, m), 9.19 (lH, m).
(73) 82→83 (73) 82 → 83
化合物 82(1.87g,6.9mmol)力 (2)と同様にして 83を得た。収量 1.55g(93%)。 Compound 82 (1.87 g, 6.9 mmol) force 83 was obtained in the same manner as (2). Yield 1.55 g (93%).
(74) 83→84 (74) 83 → 84
化合物 83(1.55g,6.4mmol)をジメチルホルムアミド (10ml)溶解した後、プレニルアルコ ール lmlを加えた。次レ、でェチルジメチルァミノプロピルカルボジイミド塩酸塩 (1.46g, 7.6mmol)と 4ージメチルァミノピリジン 233mgを加えて、室温で 5.5時間攪拌した。反応
液に酢酸ェチルと水を加えて抽出した。有機層を水洗後、乾燥、濃縮して得られた 残渣をシリカゲルクロマトで精製して 84を得た。収量 1.55g(73%)。 Compound 83 (1.55 g, 6.4 mmol) was dissolved in dimethylformamide (10 ml), and 1 ml of prenyl alcohol was added. Next, ethyldimethylaminopropylcarbodiimide hydrochloride (1.46 g, 7.6 mmol) and 233 mg of 4-dimethylaminopyridine were added, and the mixture was stirred at room temperature for 5.5 hours. reaction The solution was extracted with ethyl acetate and water. The organic layer was washed with water, dried and concentrated. The residue obtained was purified by silica gel chromatography to obtain 84. Yield 1.55 g (73%).
'H-NMR (CDCl ): 1.81(6H,m),4.90(2H,d,J=7.2Hz),5.49(lH,m),7.38(lH,dd,J=5.1,8. 'H-NMR (CDCl 3): 1.81 (6H, m), 4.90 (2H, d, J = 7.2Hz), 5.49 (lH, m), 7.38 (lH, dd, J = 5.1,8.
4Hz), 8.35-8.55 (3H, m), 8.86(1H, m),9.22(lH, m). 4Hz), 8.35-8.55 (3H, m), 8.86 (1H, m), 9.22 (lH, m).
(75) 84 + 2→85 (75) 84 + 2 → 85
化合物 2(675mg、 lmmol)と化合物 84(311mg、 l.Ommol)から(4)と同様にして化合物 8 5(894mg)を粉末として得た。 Compound 85 (894 mg) was obtained as a powder from Compound 2 (675 mg, lmmol) and Compound 84 (311 mg, l.Ommol) in the same manner as (4).
(76) 85→80 (76) 85 → 80
化合物 85(916mg)を(5)と同様にして化合物 80を粉末として得た。収量 162mg(21%) 'H-NMR (D O): 1.24(3H, t, J = 7.2Hz), 3.68(2H, bs),3.98(2H, q, J = 7.2 Hz), 5.26(Compound 85 (916 mg) was obtained in the same manner as (5) to give Compound 80 as a powder. Yield 162 mg (21%) 'H-NMR (D 2 O): 1.24 (3H, t, J = 7.2Hz), 3.68 (2H, bs), 3.98 (2H, q, J = 7.2 Hz), 5.26 (
1H, d, J = 4.8Hz), 5.35(2H, d, J = 6.3Hz), 5.80(1H, d, J = 4.8Hz), 6.34(1H, m), 6.81H, d, J = 4.8Hz), 5.35 (2H, d, J = 6.3Hz), 5.80 (1H, d, J = 4.8Hz), 6.34 (1H, m), 6.8
9(1H, s),7.02(lH, d, J = 15.3Hz), 8.02(1H, dd,), 8.13(1H, d, J = 8.4Hz), 8.32(2H, d,9 (1H, s), 7.02 (lH, d, J = 15.3Hz), 8.02 (1H, dd,), 8.13 (1H, d, J = 8.4Hz), 8.32 (2H, d,
J=8.1Hz), 8.63(2H,m),9.00(lH,bs),9.49(lH,bs). J = 8.1Hz), 8.63 (2H, m), 9.00 (lH, bs), 9.49 (lH, bs).
IR (KBr) cm"1: 1765, 1668, 1604, 1532. IR (KBr) cm " 1 : 1765, 1668, 1604, 1532.
MS: 679+ (M_Na+2H)+ MS: 679+ (M_Na + 2H) +
元素分析 C H N O S Na-4.5H O Elemental analysis C H N O S Na-4.5H O
計算値: C,44.56; H,4.38; N,14.33; S,8.20; Na,2.94 (%) Calculated: C, 44.56; H, 4.38; N, 14.33; S, 8.20; Na, 2.94 (%)
実験値: C,44.44; H,4,17; N,14.36; S,8.45; Na,3.31 (%) Experimental value: C, 44.44; H, 4,17; N, 14.36; S, 8.45; Na, 3.31 (%)
実施例 166 Example 166
[化 213]
[Chemical 213]
(1) 3→4 (1) 3 → 4
化合物 3(4.7g,20mmol)をジメチルホルムアミド(30ml)に溶解して、炭酸ナトリウム(3.0 4g, 22mmol)をカ卩えて攪拌して、臭化パラ-メトキシベンジノレを加え室温で 1.5時間攪 拌した。反応液に水を加え酢酸ェチルで抽出し、水洗、乾燥して 4を得た。収量 8.4g Compound 3 (4.7 g, 20 mmol) is dissolved in dimethylformamide (30 ml), sodium carbonate (3.04 g, 22 mmol) is added and stirred, and para-methoxybenzenole bromide is added and stirred at room temperature for 1.5 hours. did. Water was added to the reaction solution, extracted with ethyl acetate, washed with water and dried to obtain 4. Yield 8.4g
'H-NMR (d -DMSO) : 3.77(3H, s), 5.34(2H, s), 6·95_6·98(2Η, m), 7.40-7.43(2H, m'H-NMR (d-DMSO): 3.77 (3H, s), 5.34 (2H, s), 6.95_6 · 98 (2Η, m), 7.40-7.43 (2H, m
), 8.12(1H, d, J=8.4 Hz), 8.54(1H, d, J=2.4 Hz), 8.61(1H, dd, J=8.4, 2.4 Hz). ), 8.12 (1H, d, J = 8.4 Hz), 8.54 (1H, d, J = 2.4 Hz), 8.61 (1H, dd, J = 8.4, 2.4 Hz).
(2) 4→5 (2) 4 → 5
化合物 4(8.4g,20mmol)をエタノール 160mlに溶解して、塩化アンモニゥム (3.2g,60mmo 1)の水溶液(14ml)をカ卩えた。次いで鉄粉 (10.1g, 180mmol)を加えた後 1.5時間還流し た。不溶物を濾去して濃縮した。残渣に水をカ卩ぇ酢酸ェチルで抽出し、水洗、乾燥し て 5を得た。収量 7.3g。 Compound 4 (8.4 g, 20 mmol) was dissolved in 160 ml of ethanol to prepare an aqueous solution (14 ml) of ammonium chloride (3.2 g, 60 mmo 1). Next, iron powder (10.1 g, 180 mmol) was added and refluxed for 1.5 hours. The insoluble material was filtered off and concentrated. Water was extracted from the residue with ketyl acetate, washed with water and dried to obtain 5. Yield 7.3g.
'H-NMR (d -DMSO) : 3.76(3H, s), 5· 17(2Η, s), 6.32(2H, s), 6.76(2H, dd, J=8.7, 2.1 'H-NMR (d-DMSO): 3.76 (3H, s), 5 · 17 (2Η, s), 6.32 (2H, s), 6.76 (2H, dd, J = 8.7, 2.1
Hz), 6.92-6.97(2H, m), 6.99(1H, d, J=2.1 Hz), 7.34- 7.39(2H, m), 7.68(1H, d, J=8. 7 Hz). Hz), 6.92-6.97 (2H, m), 6.99 (1H, d, J = 2.1 Hz), 7.34-7.39 (2H, m), 7.68 (1H, d, J = 8.7 Hz).
(3) 5+6→7 (3) 5 + 6 → 7
化合物 5(1.83g, 5mmol)を塩化メチレン (15ml)に溶解した後、化合物 6(1.18g, 6.6mmo 1)、ピリジン (1.05ml, 13mmol)をカ卩えて 0°Cで 2時間攪拌した。反応液を濃縮後、酢酸ェ チルと水を加えて抽出し、水洗、乾燥して 7を得た。収量 2.25g。
Ή-NMR (d -DMSO): 3.77(3H, s), 5.28(2H, s), 6.97(2H, d, J=8.4 Hz), 7.41(2H, d,Compound 5 (1.83 g, 5 mmol) was dissolved in methylene chloride (15 ml), and then compound 6 (1.18 g, 6.6 mmol 1) and pyridine (1.05 ml, 13 mmol) were added and stirred at 0 ° C. for 2 hours. The reaction mixture was concentrated, extracted with ethyl acetate and water, washed with water, and dried to give 7. Yield 2.25g. Ή-NMR (d-DMSO): 3.77 (3H, s), 5.28 (2H, s), 6.97 (2H, d, J = 8.4 Hz), 7.41 (2H, d,
6 6
J=8.4 Hz), 7.88-7.90(2H, m), 7.95(1H, d, J=8.7 Hz), 8.20(1H, dd, J=8.7, 1.5 Hz), 8. 36(1H, d, J=1.5 Hz), 8.82- 8.84(2H, m), 11.00(1H, s). J = 8.4 Hz), 7.88-7.90 (2H, m), 7.95 (1H, d, J = 8.7 Hz), 8.20 (1H, dd, J = 8.7, 1.5 Hz), 8. 36 (1H, d, J = 1.5 Hz), 8.82-8.84 (2H, m), 11.00 (1H, s).
(4) 7 + 2→8 (4) 7 + 2 → 8
化合物 7(646mg、 1.5mmol)をジメチルホルムアミド (5ml)に溶解した。次いで化合物 2( 1.28g、 1.5mmol)と NaBr(463mg、 4.5mmol)を加えて、室温で 18時間攪拌した。反応液 を 5%食塩水攪拌下にて注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して化 合物 8(1.91g)を粉末として得た。 Compound 7 (646 mg, 1.5 mmol) was dissolved in dimethylformamide (5 ml). Compound 2 (1.28 g, 1.5 mmol) and NaBr (463 mg, 4.5 mmol) were then added and stirred at room temperature for 18 hours. The reaction solution was poured under stirring with 5% brine, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 8 (1.91 g) as a powder.
(5) 8→1 (5) 8 → 1
化合物 8(1.88g)を塩化メチレン (19ml)、ニトロメタン (9ml)とァニソール (1.88ml)に溶解し 、 -30°Cに冷却した。 2MTiClの塩ィ匕メチレン溶液(6ml)をカ卩ぇ 1時間攪拌した。反応 Compound 8 (1.88g) was dissolved in methylene chloride (19ml), nitromethane (9ml) and anisole (1.88ml) and cooled to -30 ° C. A salt solution of 2MTiCl in methylene chloride (6 ml) was stirred for 1 hour. Reaction
4 Four
液を水(40ml) -イソプロピールエーテル (50ml)に氷冷下で攪拌しながら注カ卩した。析 出した沈殿物を濾取し、 NaHCO水で溶解して HP-20SSカラムクロマトグラフィーに付 The solution was poured into water (40 ml) -isopropyl ether (50 ml) with stirring under ice cooling. The precipitated precipitate is collected by filtration, dissolved in NaHCO aqueous solution, and subjected to HP-20SS column chromatography.
3 Three
し、水-ァセトニトリルで溶離した。所望の化合物を含むフラクションを減圧下濃縮し、 濃縮液を凍結乾燥して化合物 1を粉末として得た。収量 490mg(37%) And eluted with water-acetonitrile. Fractions containing the desired compound were concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 1 as a powder. Yield 490 mg (37%)
'H-NMR (d -DMSO): 1.23(3H, t, J=7.2 Hz), 3.50(2H, m), 4.10(2H, q, J=7.2 Hz), 5. 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.2 Hz), 3.50 (2H, m), 4.10 (2H, q, J = 7.2 Hz), 5.
6 6
05(1H, d, J=5.1Hz), 5.38(2H, d, J=8.7 Hz), 5.63(1H, dd, J=8.1, 5.1 Hz), 5.92(1H, d t, J=15.9, 8.7 Hz), 6.72(1H, s), 7.23(1H, s), 7.29(1H, d, J=15.9 Hz), 7.45_7.50(1H, m), 7.89-7.9K1H, m), 8.18(1H, m), 8.63(2H, d, J=6.3 Hz), 9.21(2H, d, J=6.3Hz), 9. 56(1H, d, J=8.1 Hz), 10.87(1H, s). 05 (1H, d, J = 5.1Hz), 5.38 (2H, d, J = 8.7 Hz), 5.63 (1H, dd, J = 8.1, 5.1 Hz), 5.92 (1H, dt, J = 15.9, 8.7 Hz ), 6.72 (1H, s), 7.23 (1H, s), 7.29 (1H, d, J = 15.9 Hz), 7.45_7.50 (1H, m), 7.89-7.9K1H, m), 8.18 (1H, m), 8.63 (2H, d, J = 6.3 Hz), 9.21 (2H, d, J = 6.3 Hz), 9.56 (1H, d, J = 8.1 Hz), 10.87 (1H, s).
IR (KBr) cm—1: 3298, 1761, 1588, 1534, 1381, 1320, 1118, 1035. IR (KBr) cm— 1 : 3298, 1761, 1588, 1534, 1381, 1320, 1118, 1035.
MS: 746+ (M+H)+ MS: 746 + (M + H) +
元素分析 c H F N O S Na- 5.4H O - 0.3NaHCO Elemental analysis c H F N O S Na- 5.4H O-0.3NaHCO
31 25 3 7 8 2 2 3 31 25 3 7 8 2 2 3
計算値: C,42.23; H,4.09; F,6.40; Ν,ΙΙ.01; SJ.20; Na,3.36 (%) Calculated value: C, 42.23; H, 4.09; F, 6.40; Ν, ΙΙ.01; SJ.20; Na, 3.36 (%)
実験値: C,42.02; H,4.00; F,6.15; N,11.31; SJ.48; Na,3.33 (%) Experimental value: C, 42.02; H, 4.00; F, 6.15; N, 11.31; SJ.48; Na, 3.33 (%)
実施例 167 Example 167
[化 214]
[Chemical 214]
(6) 5→10 (6) 5 → 10
CuBr (1.34g,6mmol)をァセトニトリル (7ml)に溶解して、亜硝酸 t_ブチル (891 μ 1,7.5mm ol)と化合物 5(1.83g, 5mmol)を加え、 0°Cで 2時間攪拌した。氷水中に反応液を加え、 酢酸ェチルで抽出した。水洗、乾燥後濃縮して 10を得た。収量 1.94g。 Dissolve CuBr (1.34 g, 6 mmol) in acetonitrile (7 ml), add t_butyl nitrite (891 μ 1,7.5 mmol) and compound 5 (1.83 g, 5 mmol), and stir at 0 ° C for 2 hours. did. The reaction solution was added to ice water and extracted with ethyl acetate. Washed with water, dried and concentrated to give 10. Yield 1.94g.
'H-NMR (d -DMSO): 3.77(3H, s), 5.28(2H, s), 6.94_6.98(2H, m), 7.37- 7.42(2H, m 'H-NMR (d-DMSO): 3.77 (3H, s), 5.28 (2H, s), 6.94_6.98 (2H, m), 7.37-7.42 (2H, m
), 7.78(1H, d, J=8.1 Hz), 8.03(1H, dd, J=8.1, 2.1 Hz), 8.07(1H, d, J=2.1 Hz). ), 7.78 (1H, d, J = 8.1 Hz), 8.03 (1H, dd, J = 8.1, 2.1 Hz), 8.07 (1H, d, J = 2.1 Hz).
(7) 10 + 11→12 (7) 10 + 11 → 12
化合物 10(1.91g,4.9mmol)と化合物 l l(1.31g,6.38mmol)をジォキサン (20ml)に溶解す る。 K PO (3.12g, 14.7mmol)と Pd(PPh ) (289mg,0.25mmol)を加えて室温で 1時間後、 1Compound 10 (1.91 g, 4.9 mmol) and Compound l l (1.31 g, 6.38 mmol) are dissolved in dioxane (20 ml). K PO (3.12 g, 14.7 mmol) and Pd (PPh) (289 mg, 0.25 mmol) were added and after 1 hour at room temperature, 1
10°Cで 3時間攪拌した。さらに Pd(PPh ) (289mg,0.25mmol)を加えて 120°Cで 1時間攪 拌した。反応液を水に注加して、酢酸ェチルで抽出、水洗、乾燥、濃縮後、カラムク 口マト精製して 12を得た。収量 1.43g(75%) The mixture was stirred at 10 ° C for 3 hours. Further, Pd (PPh 3) (289 mg, 0.25 mmol) was added and stirred at 120 ° C. for 1 hour. The reaction solution was poured into water, extracted with ethyl acetate, washed with water, dried and concentrated, and purified by column chromatography. Yield 1.43g (75%)
'H-NMR (d -DMSO): 3.77(3H, s), 5.32(2H, s), 6·96_6·99(2Η, m), 7.41-7.44(2H, m 'H-NMR (d-DMSO): 3.77 (3H, s), 5.32 (2H, s), 6.96_6 · 99 (2Η, m), 7.41-7.44 (2H, m
), 7.84-7.86(2H, m), 7.98(1H, d, J=8.7 Hz), 8.20-8.23(2H, m), 8.71— 8.73(2H, m).), 7.84-7.86 (2H, m), 7.98 (1H, d, J = 8.7 Hz), 8.20-8.23 (2H, m), 8.71-8.73 (2H, m).
(8) 12 + 13→14 (8) 12 + 13 → 14
化合物 13(1.01g、 1.5mmol)を酢酸ェチル (9ml)に懸濁させ、炭酸水素ナトリウム水溶 液 (252mg、 3mmolを水 16mlに溶解)を加え、酢酸ェチルで抽出し、硫酸ナトリウムで乾 燥した。溶媒を留去後、速やかにジメチルホルムアミド (2ml)に溶解し、化合物 12(581
mg、 1.5mmol)と混合し、臭化ナトリウム (309mg、 3mmol)を加えて、室温で 7時間攪拌し た。反応液を 5%食塩水 (70ml)攪拌下にて注加し、析出した沈殿を濾取した。沈殿を 減圧乾燥して化合物 14(1.43g)を粉末として得た。 Compound 13 (1.01 g, 1.5 mmol) was suspended in ethyl acetate (9 ml), aqueous sodium hydrogen carbonate solution (252 mg, 3 mmol dissolved in 16 ml of water) was added, extracted with ethyl acetate, and dried over sodium sulfate. . After distilling off the solvent, it was immediately dissolved in dimethylformamide (2 ml) to give compound 12 (581 mg, 1.5 mmol), sodium bromide (309 mg, 3 mmol) was added, and the mixture was stirred at room temperature for 7 hours. The reaction solution was poured under stirring with 5% brine (70 ml), and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 14 (1.43 g) as a powder.
(9) 14→9 (9) 14 → 9
化合物 14(1.42g)を(5)と同様にして化合物 9を粉末として得た。収量 301mg(25%) 'H-NMR (d -DMSO): 1.22(3H, t, J=6.9 Hz), 3.33, 3.35(2H, ABq, J=16.8 Hz), 4.09( Compound 14 (1.42 g) was obtained in the same manner as (5) to give Compound 9 as a powder. Yield 301 mg (25%) 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9 Hz), 3.33, 3.35 (2H, ABq, J = 16.8 Hz), 4.09 (
6 6
2H, q, J=6.9 Hz), 5.05(1H, d, J=4.8 Hz), 5.30(2H, m), 5.60(1H, dd, J=8.1, 4.8 Hz), 5.88(1H, dt, J=15.6, 7.2 Hz), 6.71(1H, s), 7.23(1H, s), 7.32(1H, d, 15.6 Hz), 7.54(1 H, d, J=8.4 Hz), 8.15-8.17(2H, m), 8.55(2H, d, J=6.9 Hz), 9.04(2H, d, J=6.9 Hz), 9. 53(1H, d, J=8.1 Hz). 2H, q, J = 6.9 Hz), 5.05 (1H, d, J = 4.8 Hz), 5.30 (2H, m), 5.60 (1H, dd, J = 8.1, 4.8 Hz), 5.88 (1H, dt, J = 15.6, 7.2 Hz), 6.71 (1H, s), 7.23 (1H, s), 7.32 (1H, d, 15.6 Hz), 7.54 (1 H, d, J = 8.4 Hz), 8.15-8.17 (2H, m), 8.55 (2H, d, J = 6.9 Hz), 9.04 (2H, d, J = 6.9 Hz), 9.53 (1H, d, J = 8.1 Hz).
IR (KBr) cm"1: 3330, 1758, 1592, 1529, 1379, 1331, 1261, 1128, 1038. IR (KBr) cm " 1 : 3330, 1758, 1592, 1529, 1379, 1331, 1261, 1128, 1038.
MS: 703+ (M+H)+ MS: 703 + (M + H) +
元素分析 C H F N O S Na- 4.5H O Elemental analysis C H F N O S Na- 4.5H O
30 24 3 6 7 2 2 30 24 3 6 7 2 2
計算値: C,44.72; H,4.13; F,7.07; N, 10.43; SJ.96; Na,2.85 (%) Calculated: C, 44.72; H, 4.13; F, 7.07; N, 10.43; SJ.96; Na, 2.85 (%)
実験値: C,44.93; H,4.16; F,6.78; N, 10.67; S,8.12; Na,3.12 (%) Experimental value: C, 44.93; H, 4.16; F, 6.78; N, 10.67; S, 8.12; Na, 3.12 (%)
実施例 168 Example 168
[化 215] [Chemical 215]
(10) 16→17
化合物 16(9.55g,50mmol)とヒドロキシルァミン塩酸塩 (6.25g,90mmol)を N—メチルピロ リジン (70ml)に溶解する。 110°Cで 7時間攪拌した。反応液を水に注加して、酢酸ェチ ルで抽出、水洗、乾燥、濃縮後、カラムクロマト精製して 17を得た。収量 7.75g(82%) 'H-NMR (d -DMSO): 8.09-8.10(1H, m), 8.18— 8.19(1H, m). (10) 16 → 17 Compound 16 (9.55 g, 50 mmol) and hydroxylamine hydrochloride (6.25 g, 90 mmol) are dissolved in N-methylpyrrolidine (70 ml). The mixture was stirred at 110 ° C for 7 hours. The reaction solution was poured into water, extracted with ethyl acetate, washed with water, dried, concentrated, and purified by column chromatography to obtain 17. Yield 7.75 g (82%) 'H-NMR (d-DMSO): 8.09-8.10 (1H, m), 8.18-8.19 (1H, m).
(11) 17+11→18 (11) 17 + 11 → 18
化合物 17(1.88g,10mmol)と化合物 l l(2.67g,13mmol)をジォキサン (30ml)に溶解する。 K PO (6.37g,30mmol)と Pd(PPh ) (578mg,0. 5mmol)を加えて室温で 30分間攪拌した 後、 120°Cで 30分間攪拌した。反応液を水に注加して、酢酸ェチルで抽出、水洗、乾 燥、濃縮後、カラムクロマト精製して 18を得た。収量 1.91g Compound 17 (1.88 g, 10 mmol) and compound l l (2.67 g, 13 mmol) are dissolved in dioxane (30 ml). K 3 PO 4 (6.37 g, 30 mmol) and Pd (PPh 3) (578 mg, 0.5 mmol) were added and stirred at room temperature for 30 minutes, and then stirred at 120 ° C. for 30 minutes. The reaction solution was poured into water, extracted with ethyl acetate, washed with water, dried, concentrated, and purified by column chromatography to obtain 18. Yield 1.91g
'H-NMR (d -DMSO): 7.77-7.79(2H, m), 8.60— 8.61(2H, m), 8.64— 8.68(2H, m). 'H-NMR (d-DMSO): 7.77-7.79 (2H, m), 8.60—8.61 (2H, m), 8.64—8.68 (2H, m).
(12) 18→19 (12) 18 → 19
化合物 18(93 lmg,5mmol)をジメチルホルムアミド (7ml)に溶解して、 NaN (488mg,7.5mm ol)と塩化アンモニゥム (401mg,7.5mmol)を加えて 115°Cで 2時間攪拌した。反応液を冷 却後水 (10ml)をカ卩え、次いで 2NHC1で中和して析出物を濾取、乾燥して 19を得た。 収量 923mg(81%)。 Compound 18 (93 lmg, 5 mmol) was dissolved in dimethylformamide (7 ml), NaN (488 mg, 7.5 mmol) and ammonium chloride (401 mg, 7.5 mmol) were added, and the mixture was stirred at 115 ° C for 2 hours. After cooling the reaction solution, water (10 ml) was added, then neutralized with 2NHC1, and the precipitate was collected by filtration and dried to obtain 19. Yield 923 mg (81%).
'H-NMR (d -DMSO): 7.80-7.82(2H, m), 8.31(1H, d, J=1.8 Hz), 8.52(1H, d, J=1.8 'H-NMR (d-DMSO): 7.80-7.82 (2H, m), 8.31 (1H, d, J = 1.8 Hz), 8.52 (1H, d, J = 1.8
Hz), 8.66-8.68(2H, m). Hz), 8.66-8.68 (2H, m).
(13) 19+13→20 (13) 19 + 13 → 20
ィ匕合物 13(1.01g,1.5mmol)と化合物 19(344mg,1.5mmol)から(8)と同様にして 20を得 た。収量 1.45g 20 was obtained in the same manner as (8) from Compound 13 (1.01 g, 1.5 mmol) and Compound 19 (344 mg, 1.5 mmol). Yield 1.45g
'H-NMR (d -DMSO): 1.23(3H, t, J=7.2 Hz), 3.66, 3.91(2H, ABq, J=18.0 Hz), 4.10( 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.2 Hz), 3.66, 3.91 (2H, ABq, J = 18.0 Hz), 4.10 (
2H, q, J=7.2 Hz), 5·27_5·30(3Η, m), 5.92(2H, dd, J=8.4, 4.8 Hz), 6.45(1H, dt, J=16 • 5, 6.6 Hz), 6.75(1H, s), 6.89(1H, d, J=16.5 Hz), 6.92(1H, s), 7·29_7·50(10Η, m), 8. 49-8.53(2H, m), 8.74 (1H, m), 9.00— 9.02(3H, m), 9.65(1H, d, J=8.4 Hz). 2H, q, J = 7.2 Hz), 5.27_5.30 (3 mm, m), 5.92 (2H, dd, J = 8.4, 4.8 Hz), 6.45 (1H, dt, J = 16 • 5, 6.6 Hz) , 6.75 (1H, s), 6.89 (1H, d, J = 16.5 Hz), 6.92 (1H, s), 7 · 29_7 · 50 (10Η, m), 8. 49-8.53 (2H, m), 8.74 (1H, m), 9.00—9.02 (3H, m), 9.65 (1H, d, J = 8.4 Hz).
(14) 20→15 (14) 20 → 15
化合物 20(1.45g)をトリフロロ酢酸 (7.3ml)とァニソール (1.5ml)に溶解し、 0°Cで 1時間 攪拌した。反応液をイソプロピールエーテル 30mlに氷冷下で攪拌しながら注加した。 析出した沈殿物を濾取し、飽和 NaHCO水で溶解させた。溶液を HP-20SSカラムクロ
マトグラフィ一に付し、水-ァセトニトリルで溶離した。所望の化合物を含むフラクション を減圧下濃縮し、濃縮液を凍結乾燥して化合物 15を粉末として得た。収量 321mg(27 %) Compound 20 (1.45 g) was dissolved in trifluoroacetic acid (7.3 ml) and anisole (1.5 ml) and stirred at 0 ° C. for 1 hour. The reaction solution was poured into 30 ml of isopropyl ether with stirring under ice cooling. The deposited precipitate was collected by filtration and dissolved with saturated aqueous NaHCO. HP-20SS column chromatography Subjected to matography and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 15 as a powder. Yield 321 mg (27%)
'H-NMR (d -DMSO): 1.22(3H, t, J=7.2 Hz), 3.43, 3.52(2H, ABq, J=17.1 Hz), 4.09( 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2 Hz), 3.43, 3.52 (2H, ABq, J = 17.1 Hz), 4.09 (
6 6
2H, q, J=7.2 Hz),5.05(lH, d, J=4.8 Hz), 5.23(2H, d, J=6.9 Hz), 5.60(2H, dd, J=8.1, 4.8 Hz), 5.88(1H, dt, J=15.3, 6.9 Hz), 6.72(1H, s), 7.23(2H, s), 7.30(1H, d, J=15.3 Ηζ),8· 15(1Η, m), 8.52(2H, d, J=7.2 Hz), 8.61 (1H, m), 8.95(2H, d, J=7.2 Hz), 9.54( 1H, d, J=8.1 Hz). 2H, q, J = 7.2 Hz), 5.05 (lH, d, J = 4.8 Hz), 5.23 (2H, d, J = 6.9 Hz), 5.60 (2H, dd, J = 8.1, 4.8 Hz), 5.88 ( 1H, dt, J = 15.3, 6.9 Hz), 6.72 (1H, s), 7.23 (2H, s), 7.30 (1H, d, J = 15.3 Ηζ), 8.15 (1 Η, m), 8.52 (2H , d, J = 7.2 Hz), 8.61 (1H, m), 8.95 (2H, d, J = 7.2 Hz), 9.54 (1H, d, J = 8.1 Hz).
IR (KBr) cm—1: 3326, 1759, 1633, 1599, 1530, 1386, 1297, 1157, 1034. IR (KBr) cm— 1 : 3326, 1759, 1633, 1599, 1530, 1386, 1297, 1157, 1034.
MS: 665+ (M+H)+ MS: 665+ (M + H) +
元素分析 C H N O S Na- 6.2H O - O. lNaHCO Elemental analysis C H N O S Na- 6.2H O-O. lNaHCO
27 23 10 5 3 2 3 27 23 10 5 3 2 3
計算値: C ,40.34; H,4.43; N, 17.36; S,11.92; Na,3.13 (%) Calculated values: C, 40.34; H, 4.43; N, 17.36; S, 11.92; Na, 3.13 (%)
実験値: C,40.32; H,4.45; N,17.33; S, 12.07; Na,3.23 (%) Experimental value: C, 40.32; H, 4.45; N, 17.33; S, 12.07; Na, 3.23 (%)
実施例 169 Example 169
[化 216] [Chemical 216]
(15) 22→23 (15) 22 → 23
化合物 22(4.78 g,25mmol)力 (10)と同様にして 23を得た。収量 3.79g(81%)Compound 23 (4.78 g, 25 mmol) was obtained in the same manner as (10). Yield 3.79 g (81%)
H-NMR (d -DMSO): 7.46(1H, d, J=4.2 Hz), 7.85(1H, d, J=4.2 Hz). H-NMR (d-DMSO): 7.46 (1H, d, J = 4.2 Hz), 7.85 (1H, d, J = 4.2 Hz).
6
(16) 23+11→24 6 (16) 23 + 11 → 24
化合物 23(1.88g,10mmol)力 (11)と同様にして 24を得た。収量 1.69g(91%)Compound 23 (1.88 g, 10 mmol) was obtained in the same manner as (11). Yield 1.69 g (91%)
H-NMR (d -DMSO): 7.75_7.77(2H, m), 7.97(1H, d, J=3.9 Hz), 8.09(1H, d, J=3.9 H-NMR (d-DMSO): 7.75_7.77 (2H, m), 7.97 (1H, d, J = 3.9 Hz), 8.09 (1H, d, J = 3.9
Hz), 8.67-8.69(2H, m). Hz), 8.67-8.69 (2H, m).
(17) 24→25 (17) 24 → 25
化合物 24(931mg,5mmol)力、ら(12)と同様にして 25を得た。収量 l. llg(97%)。 Compound 24 (931 mg, 5 mmol) force 25 was obtained in the same manner as in (12). Yield l. Llg (97%).
'H-NMR (d -DMSO): 7.78-7.80(2H, m), 7.86(1H, d, J=3.9 Hz), 7.98(1H, d, J=3.9'H-NMR (d-DMSO): 7.78-7.80 (2H, m), 7.86 (1H, d, J = 3.9 Hz), 7.98 (1H, d, J = 3.9
Hz), 8.65-8.67(2H, m). Hz), 8.65-8.67 (2H, m).
(18) 25→26 (18) 25 → 26
化合物 25(688mg,3mmol)をジメチルホルムアミド (10ml)に溶解する。氷冷下、水素化 ナトリウム (203mg,5mmol)を加えて攪拌した。次レ、でべンジルォキシメチルクロリド (B〇 M-Cl)(0.42ml,3mmol)を加え、室温で 1.5時間攪拌した。反応液を水中に注加して、 酢酸ェチルで抽出、水洗、乾燥、濃縮して 26を得た。収量 424mg(40%) Compound 25 (688 mg, 3 mmol) is dissolved in dimethylformamide (10 ml). Under ice-cooling, sodium hydride (203 mg, 5 mmol) was added and stirred. Next, benzyloxymethyl chloride (B 0 M-Cl) (0.42 ml, 3 mmol) was added and stirred at room temperature for 1.5 hours. The reaction mixture was poured into water, extracted with ethyl acetate, washed with water, dried and concentrated to give 26. Yield 424 mg (40%)
'H-NMR (d -DMSO): 4.72(2H, s), 6· 16(2Η, s), 7.30- 7.36(5H, m), 7.75- 7.77(2H, m'H-NMR (d-DMSO): 4.72 (2H, s), 6 · 16 (2Η, s), 7.30-7.36 (5H, m), 7.75-7.77 (2H, m
), 7.91(1H, d, J=3.9 Hz), 7.95(1H, d, J=3.9 Hz), 8.63_8·65(2Η, m). ), 7.91 (1H, d, J = 3.9 Hz), 7.95 (1H, d, J = 3.9 Hz), 8.63_8 · 65 (2 mm, m).
(19) 26+13→27 (19) 26 + 13 → 27
化合物 13(810mg,1.2mmol)と化合物 26(420mg,1.2mmol)から(8)と同様にして 27を得 た。収量 1.45g In the same manner as in (8), 27 was obtained from compound 13 (810 mg, 1.2 mmol) and compound 26 (420 mg, 1.2 mmol). Yield 1.45g
'H-NMR (d -DMSO): 1.23(3H, t, J=6.9 Hz), 3.65, 3.91(2H, ABq, J=17.7 Hz), 4.11( 'H-NMR (d-DMSO): 1.23 (3H, t, J = 6.9 Hz), 3.65, 3.91 (2H, ABq, J = 17.7 Hz), 4.11 (
2H, q, J=6.9 Hz), 4.73(2H, s), 5.27— 5.31(3H, m), 5.93(2H, dd, J=8.4, 4.8 Hz), 6.20( 2H, s), 6.44(1H, dt,』=15.9, 6.3 Hz), 6.81(1H, s), 6.90(1H, d, J=15.9 Hz), 6.93(1H, s), 7.28-7.5K15H, m), 8.09(1H, d, J=3.9 Hz), 8.41(1H, d, J= 3.9 Hz), 8.51(2H, d, J =7.2 Hz), 8.97(2H, d, J=7.2 Hz), 9.66(1H, d, J=8.4Hz). 2H, q, J = 6.9 Hz), 4.73 (2H, s), 5.27- 5.31 (3H, m), 5.93 (2H, dd, J = 8.4, 4.8 Hz), 6.20 (2H, s), 6.44 (1H , dt, ”= 15.9, 6.3 Hz), 6.81 (1H, s), 6.90 (1H, d, J = 15.9 Hz), 6.93 (1H, s), 7.28-7.5K15H, m), 8.09 (1H, d , J = 3.9 Hz), 8.41 (1H, d, J = 3.9 Hz), 8.51 (2H, d, J = 7.2 Hz), 8.97 (2H, d, J = 7.2 Hz), 9.66 (1H, d, J = 8.4Hz).
(20) 27→21 (20) 27 → 21
化合物 27(1.13g)を(5)と同様にして化合物 21を粉末として得た。収量 268mg(28%) 'H-NMR (d -DMSO): 1.22(3H, t, J=6.9 Hz), 3.44, 3.51(2H, ABq, J=16.8 Hz), 4.09(Compound 27 (1.13 g) was obtained in the same manner as (5) to give compound 21 as a powder. Yield 268mg (28%) 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9 Hz), 3.44, 3.51 (2H, ABq, J = 16.8 Hz), 4.09 (
2H, q, J=6.9 Hz),5.05(lH, d, J=4.8 Hz), 5.18(2H, d, J=6.9 Hz), 5.60(2H, dd, J=8.1, 4.8 Hz), 5.86 (1H, dt, J=15.9, 6.9 Hz), 6.72(1H, s), 7.21(2H, s), 7.29(1H, d, J=15.9
Hz),7.62(lH, d, J=3.9 Hz), 8.21(1H, d, J=3.9 Hz), 8.31(2H, d, J=6.9 Hz), 8.83(2H d, J=6.9 Hz), 9.53(1H, d, J=8.1Hz). 2H, q, J = 6.9 Hz), 5.05 (lH, d, J = 4.8 Hz), 5.18 (2H, d, J = 6.9 Hz), 5.60 (2H, dd, J = 8.1, 4.8 Hz), 5.86 ( 1H, dt, J = 15.9, 6.9 Hz), 6.72 (1H, s), 7.21 (2H, s), 7.29 (1H, d, J = 15.9 Hz), 7.62 (lH, d, J = 3.9 Hz), 8.21 (1H, d, J = 3.9 Hz), 8.31 (2H, d, J = 6.9 Hz), 8.83 (2H d, J = 6.9 Hz), 9.53 (1H, d, J = 8.1Hz).
IR (KBr) cm—1: 3312, 1754, 1632, 1523, 1381, 1226, 1160, 1034. IR (KBr) cm— 1 : 3312, 1754, 1632, 1523, 1381, 1226, 1160, 1034.
MS: 665+ (M+H)+ MS: 665+ (M + H) +
元素分析 C H N O S Na- 5.2H O - 0.3NaHCO Elemental analysis C H N O S Na- 5.2H O-0.3NaHCO
27 23 10 5 3 2 3 27 23 10 5 3 2 3
計算値: C,40.70; H,4.22; N,17.39; S, 11.94; Na,3.71 (%) Calculated value: C, 40.70; H, 4.22; N, 17.39; S, 11.94; Na, 3.71 (%)
実験値: C,40.63; H,4.29; N,17.38; S, 12.21 ; Na,3.74 (%) Experimental value: C, 40.63; H, 4.29; N, 17.38; S, 12.21; Na, 3.74 (%)
実施例 170 Example 170
[化 217] [Chemical 217]
(1) 1→3 (1) 1 → 3
化合物 1(890 mg)の DMF(10 mL)溶液を氷冷し、化合物 2(1.50 g)、トリエチルァミン (2. 30 mL)をカ卩えた後、室温で 5時間攪拌した。反応液を酢酸ェチル、水で抽出し得ら れた有機層を無水硫酸マグネシウムで乾燥後濃縮した。得られた粗精製物をシリカ ゲルカラムクロマトグラフィーで精製し 3(191 mg)を淡茶色結晶で得た。 A solution of compound 1 (890 mg) in DMF (10 mL) was ice-cooled, and after compound 2 (1.50 g) and triethylamine (2.30 mL) were collected, the mixture was stirred at room temperature for 5 hours. The reaction solution was extracted with ethyl acetate and water, and the resulting organic layer was dried over anhydrous magnesium sulfate and concentrated. The obtained crude product was purified by silica gel column chromatography to obtain 3 (191 mg) as light brown crystals.
H-NMR (CDC13) δ 3.82 (3Η, s), 5.27 (2H, s), 6.78 (1H, d, J = 4.2 Hz), 6.91 (2H, d, J = 2.1, 8.7 Hz), 7.37 (2H, dd, J = 2.1, 8.7 Hz), 7.67 (1H, d, J = 4.2 Hz), 7.73 (2 H, d, J = 6.0 Hz), 8.77 (1H, brs), 8.84 (2H, d, J = 6.0 Hz). H-NMR (CDC13) δ 3.82 (3Η, s), 5.27 (2H, s), 6.78 (1H, d, J = 4.2 Hz), 6.91 (2H, d, J = 2.1, 8.7 Hz), 7.37 (2H , dd, J = 2.1, 8.7 Hz), 7.67 (1H, d, J = 4.2 Hz), 7.73 (2 H, d, J = 6.0 Hz), 8.77 (1H, brs), 8.84 (2H, d, J = 6.0 Hz).
(2) 4→5 (2) 4 → 5
化合物 3 (190 mg)の DMF(1.2 mL)溶液に 4(414 mg)、臭化ナトリウム (159 mg)を加えて
室温で 12時間撹拌した。 DMF(3 mL)を加えて希釈し氷冷撹拌下の 5%食塩水 (80 mL) に注加した。同温で 20分間撹拌後沈殿を濾取し、減圧乾燥した。得られた粗成生物 ( 594 mg)を塩化メチレン(8 mL)に溶解し、窒素雰囲気下ァニソール(0.34 mL)を加え- 40°Cに冷却した。 _40°C下、塩化チタニウム (IV) (2.0M塩化メチレン溶液, 1.56 mL)を 滴下した後、氷冷で 1時間攪拌した。この反応液を氷浴撹拌下の水(40 mL)に注ぎ、 ジイソプロピルエーテル (60 mL)をカ卩えた。析出物を吸引濾取して得られた沈殿を重 曹水で溶解させ HP20ssカラムクロマトグラフィーに付して集めた分画を減圧濃縮し、 再度 ODSカラムクロマトグラフィーに付して集めた分画を減圧濃縮し、凍結乾燥した。 化合物 5 (154 mg)を粉末として得た。 Add 4 (414 mg) and sodium bromide (159 mg) to a solution of compound 3 (190 mg) in DMF (1.2 mL). Stir at room temperature for 12 hours. DMF (3 mL) was added for dilution, and the mixture was poured into 5% brine (80 mL) under ice-cooling and stirring. After stirring at the same temperature for 20 minutes, the precipitate was collected by filtration and dried under reduced pressure. The obtained crude product (594 mg) was dissolved in methylene chloride (8 mL), and anisole (0.34 mL) was added under a nitrogen atmosphere, followed by cooling to -40 ° C. Titanium (IV) chloride (2.0M methylene chloride solution, 1.56 mL) was added dropwise at _40 ° C, followed by stirring with ice cooling for 1 hour. The reaction mixture was poured into water (40 mL) with stirring in an ice bath, and diisopropyl ether (60 mL) was added. Fractions collected by suction filtration of the precipitate were dissolved in aqueous sodium bicarbonate, and fractions collected by HP20ss column chromatography were concentrated under reduced pressure, and fractions collected by ODS column chromatography were collected again. Concentrated in vacuo and lyophilized. Compound 5 (154 mg) was obtained as a powder.
'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9), 3.62 and 3.68 (2H, ABq, J = 6.9 Hz), 4.25 'H-NMR (D O) δ: 1.29 (3H, t, J = 6.9), 3.62 and 3.68 (2H, ABq, J = 6.9 Hz), 4.25
(2H, q, J = 6.9), 5.26 (1H, d, J = 4.8 Hz), 5.32 (2H, d, J = 6.6 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6.6, 15.6 Hz), 6.90 (1H, d, J = 4.2 Hz), 6.97 (1H, s), 7.43(2H, q, J = 6.9), 5.26 (1H, d, J = 4.8 Hz), 5.32 (2H, d, J = 6.6 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6.6, 15.6 Hz), 6.90 (1H, d, J = 4.2 Hz), 6.97 (1H, s), 7.43
(1H, d, J = 4.2 Hz), 8.39 (2H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 Hz). (1H, d, J = 4.2 Hz), 8.39 (2H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 Hz).
IR (KBr) cm"1 : 3398, 1762, 1631, 1536, 1454, 1432, 1374, 1330, 1200, 1158, 1118,IR (KBr) cm " 1 : 3398, 1762, 1631, 1536, 1454, 1432, 1374, 1330, 1200, 1158, 1118,
1036, 1002. 1036, 1002.
MS(ESI): 684+ (M + H)+ MS (ESI): 684 + (M + H) +
元素分析 C H N Na O S - 6.2 H O Elemental analysis C H N Na O S-6.2 H O
計算値: C,40.06; H,4.25; N, 11.68; S, 11.46; Na,5.48 (%) Calculated values: C, 40.06; H, 4.25; N, 11.68; S, 11.46; Na, 5.48 (%)
実験値: C,40.02; H,4.02; N, 11.68; S, 11.61; Na,4.69 (%) Experimental value: C, 40.02; H, 4.02; N, 11.68; S, 11.61; Na, 4.69 (%)
実施例 171 Example 171
[化 218]
[Chemical 218]
(3) 6→8 (3) 6 → 8
ィ匕合物 6(1.78 g)の THF(20 mL)懸濁液を氷冷し、化合物 7(2.53 g)、トリエチノレアミン (8 .35 mL)をカ卩えた後、加熱還流下で 14時間攪拌した。反応液を酢酸ェチル、水で抽 出し得られた有機層を飽和食塩水で洗浄し無水硫酸マグネシウムで乾燥後ろ過、濃 縮して化合物 8(2.79 g)を淡茶色固体で得た。 A suspension of Compound 6 (1.78 g) in THF (20 mL) was ice-cooled, and after compound 7 (2.53 g) and triethylenoamine (8.35 mL) were prepared, the mixture was heated under reflux. Stir for 14 hours. The organic layer obtained by extracting the reaction solution with ethyl acetate and water was washed with saturated brine, dried over anhydrous magnesium sulfate, filtered and concentrated to obtain Compound 8 (2.79 g) as a light brown solid.
H-NMR (CDC13) δ 1.35 (3Η, t, J = 6.9 Hz), 4.29 (2H, d, J = 6.9 Hz), 7.88 (2H, d, J = 6.0 Hz), 7.91 (1H, s), 8.89 (2H, d, J = 6.0 Hz). H-NMR (CDC13) δ 1.35 (3Η, t, J = 6.9 Hz), 4.29 (2H, d, J = 6.9 Hz), 7.88 (2H, d, J = 6.0 Hz), 7.91 (1H, s), 8.89 (2H, d, J = 6.0 Hz).
(4) 8→9 (4) 8 → 9
ィ匕合物 8(2.79 g)のエタノール (30 mL)溶液を氷冷し、 2規定水酸化ナトリウム (10 mL)を 加え、同温で 1時間攪拌の後、室温で 1時間攪拌した。 2規定水酸化ナトリウム (5 mL) を追加して室温でー晚静置した。 5規定塩酸で中和しエタノールを減圧留去した。氷 冷下希塩酸で PH3.0にして析出した沈殿を吸引濾取した。得られた固体をイソプロパ ノール、ジェチルエーテル (1 : 1)の混液に懸濁させた後吸引濾取して減圧乾燥した。 ィ匕合物 9(2.60 g)を淡黄色固体として得た。 A solution of Compound 8 (2.79 g) in ethanol (30 mL) was ice-cooled, 2N sodium hydroxide (10 mL) was added, and the mixture was stirred at the same temperature for 1 hr and then at room temperature for 1 hr. 2N sodium hydroxide (5 mL) was added, and the mixture was allowed to stand at room temperature. The mixture was neutralized with 5N hydrochloric acid, and ethanol was distilled off under reduced pressure. Under ice-cooling, the pH was adjusted to pH 3.0 with dilute hydrochloric acid, and the deposited precipitate was collected by suction filtration. The obtained solid was suspended in a mixed solution of isopropanol and jetyl ether (1: 1), collected by suction filtration and dried under reduced pressure. Compound 9 (2.60 g) was obtained as a pale yellow solid.
H-NMR (d6-DMSO) δ: 8.06 (2H, d, J = 5.4 Hz), 8.11 (1H, s), 8.85 (2H, brs), 13.4 (1H, brs). H-NMR (d6-DMSO) δ: 8.06 (2H, d, J = 5.4 Hz), 8.11 (1H, s), 8.85 (2H, brs), 13.4 (1H, brs).
(5) 9→10
化合物 9(748 mg)の DMF(6 mL)懸濁液に p-メトキシベンジルアルコール (0.37 mL)、 W SCD(690 mg)、ジメチルァミノピリジン (110 mg)を加え室温で 3時間攪拌した。反応液 を水 (50 mL)に注加し析出した沈殿を吸引濾取した。減圧乾燥して化合物 10(907 mg) を淡桃色結晶として得た。 (5) 9 → 10 P-Methoxybenzyl alcohol (0.37 mL), W SCD (690 mg) and dimethylaminopyridine (110 mg) were added to a suspension of compound 9 (748 mg) in DMF (6 mL), and the mixture was stirred at room temperature for 3 hours. The reaction solution was poured into water (50 mL), and the deposited precipitate was collected by suction filtration. Drying under reduced pressure gave Compound 10 (907 mg) as pale pink crystals.
H-NMR (d6-DMSO) δ: 3.76 (3H, s), 5.23 (2H, s), 6.94 - 6.99 (2H, m), 7.38 - 7.4 2 (2H, m), 7.99 (2H, d, J = 6.0 Hz), 8.19 (1H, s), 8.81 (2H, d, J = 6.0 Hz), 13.3 (1H , brs). H-NMR (d6-DMSO) δ: 3.76 (3H, s), 5.23 (2H, s), 6.94-6.99 (2H, m), 7.38-7.4 2 (2H, m), 7.99 (2H, d, J = 6.0 Hz), 8.19 (1H, s), 8.81 (2H, d, J = 6.0 Hz), 13.3 (1H, brs).
(6) 4 + 10→l l (6) 4 + 10 → l l
化合物 10 (369 mg)の DMF(3.0 mL)溶液に 4(802 mg)、臭化ナトリウム (309 mg)を加え て室温で 14時間撹拌した。 DMF(3 mL)をカ卩えて希釈し氷冷撹拌下の 5%食塩水 (80 m L)に注加した。同温で 20分間撹拌後、沈殿を濾取し減圧乾燥した。得られた粗成生 物 (1.12 g)を塩化メチレン(15 mL)に溶解し、窒素雰囲気下ァニソール(0.65 mL)を 加え- 40°Cに冷却した。 -40°C下、塩化チタニウム (IV) (2.0M塩化メチレン溶液, 3.0 mL)を滴下した後、氷浴で 1時間攪拌した。この反応液を氷浴撹拌下の水(40 mL)に 注ぎ、ジイソプロピルエーテル (60 mL)を加えた。析出した沈殿を吸引濾取し、 1規定 塩酸、ァセトニトリルを用いて溶解し HP20ssを加えて濃縮した後、 HP20ssカラムクロマ トグラフィ一に付して集めた分画に攪拌下 0.2規定水酸化ナトリウムを滴下し pH9を超 えた時点で微量のドライアイスを投入した。濃縮後凍結乾燥して化合物 11 (227 mg) を粉末として得た。 4 (802 mg) and sodium bromide (309 mg) were added to a solution of compound 10 (369 mg) in DMF (3.0 mL), and the mixture was stirred at room temperature for 14 hours. DMF (3 mL) was added and diluted, and poured into 5% brine (80 mL) under ice-cooling and stirring. After stirring at the same temperature for 20 minutes, the precipitate was collected by filtration and dried under reduced pressure. The obtained crude product (1.12 g) was dissolved in methylene chloride (15 mL), and anisole (0.65 mL) was added under a nitrogen atmosphere, followed by cooling to -40 ° C. Titanium (IV) chloride (2.0 M methylene chloride solution, 3.0 mL) was added dropwise at −40 ° C., and the mixture was stirred in an ice bath for 1 hour. The reaction mixture was poured into water (40 mL) with stirring in an ice bath, and diisopropyl ether (60 mL) was added. The deposited precipitate was collected by suction filtration, dissolved in 1N hydrochloric acid and acetonitrile, added with HP20ss, concentrated, and 0.2N sodium hydroxide was added dropwise with stirring to the fraction collected by HP20ss column chromatography. When pH 9 was exceeded, a small amount of dry ice was added. Concentration and lyophilization gave Compound 11 (227 mg) as a powder.
1H-NMR (D O) δ: 1.29 (3Η, t, J = 6.9 Hz), 3.65 (2H, brs), 4.25 (2H, q, J = 6.9 Hz 1H-NMR (D O) δ: 1.29 (3Η, t, J = 6.9 Hz), 3.65 (2H, brs), 4.25 (2H, q, J = 6.9 Hz
2 2
), 5.02 (1H, d, J = 4.8 Hz), 5.32 (1H, d, J = 6.9 Hz), 5.83 (1H, d, J = 4.8 Hz), 6.10 ( 1H, dt, J = 6.9, 15.6 Hz), 6.98 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 7.66 (1H, s), 8.49 (2H, d, J = 6.6 Hz), 8.88 (2H, d, J = 6.6 Hz). ), 5.02 (1H, d, J = 4.8 Hz), 5.32 (1H, d, J = 6.9 Hz), 5.83 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6.9, 15.6 Hz) ), 6.98 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 7.66 (1H, s), 8.49 (2H, d, J = 6.6 Hz), 8.88 (2H, d, J = 6.6 Hz) ).
IR (KBr) cm—1 : 3398, 1763, 1586, 1538, 1454, 1382, 1290, 1197, 1157, 1123, 1036, 1001. IR (KBr) cm— 1 : 3398, 1763, 1586, 1538, 1454, 1382, 1290, 1197, 1157, 1123, 1036, 1001.
MS(ESI): 685+ (M + H)+ MS (ESI): 685+ (M + H) +
元素分析 c H N Na O S -4.4 H O -0.1(NaHCO ) Elemental analysis c H N Na O S -4.4 H O -0.1 (NaHCO)
27 22 8 2 8 3 2 3 27 22 8 2 8 3 2 3
計算値: C,39.87; H,3.82; N, 13.73; S,11.78; Na,5.91 (%)
実験値: C,39.95; Η,3·89; Ν, 13.61; S, 11.64; Na,6.11 (%) Calculated values: C, 39.87; H, 3.82; N, 13.73; S, 11.78; Na, 5.91 (%) Experimental value: C, 39.95; Η, 3.89; Ν, 13.61; S, 11.64; Na, 6.11 (%)
実施例 172 Example 172
[化 219] [Chemical 219]
(7) 13→14 (7) 13 → 14
ィ匕合物 12(1.88 g)の DMF(40 mL)溶液を氷冷し、化合物 13(4.56 g)、 WSCD(4.60 g)を 加えた後室温で 6時間攪拌した。 DMFを減圧留去し酢酸ェチル、水で抽出した。有 機層を水、飽和食塩水で洗浄後無水硫酸マグネシウムで乾燥し濃縮した。析出した 固体を酢酸ェチル-ジェチルエーテル混液で洗浄し減圧乾燥して化合物 14(5.09 g) を淡茶色結晶として得た。 A solution of Compound 12 (1.88 g) in DMF (40 mL) was ice-cooled, Compound 13 (4.56 g) and WSCD (4.60 g) were added, and the mixture was stirred at room temperature for 6 hr. DMF was distilled off under reduced pressure and extracted with ethyl acetate and water. The organic layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate and concentrated. The precipitated solid was washed with a mixed solution of ethyl acetate-jetyl ether and dried under reduced pressure to obtain Compound 14 (5.09 g) as light brown crystals.
H-NMR (d6-DMSO) δ: 7.41 (1H, d, J = 4.2 Hz), 7.74 (2H, dd, J = 1.5, 4.5 Hz), 7. 91 (1H, d, J = 4.2 Hz), 8.48 (2H, dd, J = 1.5, 4.5 Hz), 10.6 (1H, brs). H-NMR (d6-DMSO) δ: 7.41 (1H, d, J = 4.2 Hz), 7.74 (2H, dd, J = 1.5, 4.5 Hz), 7. 91 (1H, d, J = 4.2 Hz), 8.48 (2H, dd, J = 1.5, 4.5 Hz), 10.6 (1H, brs).
(8) 14→15 (8) 14 → 15
化合物 14(1.42 g)の DMF(10 mL)溶液に p-メトキシベンジルアルコール (1.25 mL)、 Pd( OAc)(225 mg)、 dppp(412 mg)、トリエチルァミン (5.58 mL)を加え一酸化炭素雰囲気下 80°Cで 7時間攪拌した。反応液を酢酸ェチル、水で抽出し有機層を水、飽和食塩水 で洗浄した。無水硫酸マグネシウムで乾燥後減圧濃縮して得られた粗精製物をシリ 力ゲルカラムクロマトグラフィーで精製し化合物 15(631 mg)を乳白色結晶で得た。 H-NMR (d6-DMSO) δ: 3.77 (3Η, s), 5.29 (2H, s), 6.97 (2H, d, J = 9.0 Hz), 7.42 (2
H, d, J = 9.0), 7.72 (2H, d, J = 6.3 Hz), 7.90 (1H, d, J = 3.9 Hz), 8.08 (1H, d, J = 3. 9 Hz), 8.49 (2H, d, J = 6.3 Hz), 10.8 (1H, brs). P-Methoxybenzyl alcohol (1.25 mL), Pd (OAc) (225 mg), dppp (412 mg), and triethylamine (5.58 mL) were added to a solution of compound 14 (1.42 g) in DMF (10 mL). The mixture was stirred at 80 ° C for 7 hours under a carbon atmosphere. The reaction solution was extracted with ethyl acetate and water, and the organic layer was washed with water and saturated brine. The crude product obtained by drying over anhydrous magnesium sulfate and concentrating under reduced pressure was purified by silica gel column chromatography to obtain Compound 15 (631 mg) as milky white crystals. H-NMR (d6-DMSO) δ: 3.77 (3Η, s), 5.29 (2H, s), 6.97 (2H, d, J = 9.0 Hz), 7.42 (2 H, d, J = 9.0), 7.72 (2H, d, J = 6.3 Hz), 7.90 (1H, d, J = 3.9 Hz), 8.08 (1H, d, J = 3.9 Hz), 8.49 (2H , D, J = 6.3 Hz), 10.8 (1H, brs).
(9) 4 + 15→16 (9) 4 + 15 → 16
化合物 15 (368 mg)、 化合物 4(802 mg)の DMF(3.0 mL)溶液に、臭化ナトリウム (309 m g)を加えて室温で 12時間撹拌した。 DMF(3 mL)を加えて希釈し氷冷撹拌下の 5%食塩 水 (80 mL)に注加した。同温で 20分間撹拌後、沈殿を濾取し減圧乾燥した。得られた 粗成生物 (1.16 g)を塩化メチレン(15 mL)に溶解し、窒素雰囲気下ァニソール(0.65 mL)をカ卩え- 40°Cに冷却した。 _40°C下、塩化チタニウム (IV) (2.0M塩化メチレン溶液, 3.0 mL)を滴下した後、氷浴で 1時間攪拌した。この反応液を氷浴撹拌下の水(40 m L)に注ぎ、ジイソプロピルエーテル (80 mL)を加えた。 1規定塩酸 (50 mL)—ァセトニトリ ル (50 mL)をカ卩えて分液し、有機層を 1規定塩酸、ァセトニトリル (1 : 1)で抽出した。合 わせた水層を HP20ssカラムクロマトグラフィーに付し、水-ァセトニトリル- NaHCOで溶 離して集めた分画を濃縮した。濃縮液を ODSカラムクロマトグラフィーに付し水-ァセト 二トリルで溶離して集めた分画を濃縮、凍結乾燥した。化合物 16 (492 mg)を粉末とし て得た。 Sodium bromide (309 mg) was added to a DMF (3.0 mL) solution of compound 15 (368 mg) and compound 4 (802 mg), and the mixture was stirred at room temperature for 12 hours. DMF (3 mL) was added for dilution, and the mixture was poured into 5% brine (80 mL) under ice-cooling and stirring. After stirring at the same temperature for 20 minutes, the precipitate was collected by filtration and dried under reduced pressure. The obtained crude product (1.16 g) was dissolved in methylene chloride (15 mL), and anisole (0.65 mL) was added under a nitrogen atmosphere and cooled to -40 ° C. Titanium (IV) chloride (2.0M methylene chloride solution, 3.0 mL) was added dropwise at _40 ° C, and the mixture was stirred for 1 hour in an ice bath. The reaction mixture was poured into water (40 mL) with stirring in an ice bath, and diisopropyl ether (80 mL) was added. 1N Hydrochloric acid (50 mL) —acetononitrile (50 mL) was added and separated, and the organic layer was extracted with 1N hydrochloric acid and acetonitrile (1: 1). The combined aqueous layer was subjected to HP20ss column chromatography, and the fraction collected by dissolution with water-acetonitrile-NaHCO was concentrated. The concentrated solution was subjected to ODS column chromatography and eluted with water-acetonitrile. The fraction collected was concentrated and lyophilized. Compound 16 (492 mg) was obtained as a powder.
'H-NMR (D O) δ: 1.26 (3H, t, J = 6.3 Hz), 3.62 and 3.69 (2H, ABq, J = 17.4 Hz), 'H-NMR (D O) δ: 1.26 (3H, t, J = 6.3 Hz), 3.62 and 3.69 (2H, ABq, J = 17.4 Hz),
4.20 (2H, q, J = 6.3 Hz), 5.13 (2H, d, J = 6.9 Hz), 5.25 (1H, d, J = 4.5 Hz), 5.79 (1 H, d, J = 4.5 Hz), 6.08 (1H, dt, J = 6.9, 15.6 Hz), 6.90 (1H, d, J = 15.6 Hz), 6.92 (1 H, s), 7.44 (1H, d, J = 4.2 Hz), 7.83 (1H, d, J = 4.2 Hz), 8.18 (2H, d, J = 7.2 Hz), 8.55 (2H, d, J = 7.2 Hz). 4.20 (2H, q, J = 6.3 Hz), 5.13 (2H, d, J = 6.9 Hz), 5.25 (1H, d, J = 4.5 Hz), 5.79 (1 H, d, J = 4.5 Hz), 6.08 (1H, dt, J = 6.9, 15.6 Hz), 6.90 (1H, d, J = 15.6 Hz), 6.92 (1 H, s), 7.44 (1H, d, J = 4.2 Hz), 7.83 (1H, d , J = 4.2 Hz), 8.18 (2H, d, J = 7.2 Hz), 8.55 (2H, d, J = 7.2 Hz).
IR (KBr) cm—1 : 3398, 1764, 1674, 1596, 1515, 1463, 1365, 1324, 1261, 1204, 1161, 1112, 1034. IR (KBr) cm— 1 : 3398, 1764, 1674, 1596, 1515, 1463, 1365, 1324, 1261, 1204, 1161, 1112, 1034.
MS(ESI): 684+ (M + H)+ MS (ESI): 684+ (M + H) +
元素分析 C H N NaO S - 5.7 H O Elemental analysis C H N NaO S-5.7 H O
計算値: C,41.60; H,4.41; N, 12.13; S, 11.90; Na,2.84 (%) Calculated values: C, 41.60; H, 4.41; N, 12.13; S, 11.90; Na, 2.84 (%)
実験値: C,41.62; H,4.11; N, 12.20; S, 11.78; Na,2.87 (%) Experimental value: C, 41.62; H, 4.11; N, 12.20; S, 11.78; Na, 2.87 (%)
実施例 173 Example 173
(10) 12→19 (10) 12 → 19
化合物 12(1.41 g)の DMF(30 mL)溶液に化合物 17(2.97 g)、 WSCD(3.45 g)を加え室温 で 12時間攪拌した。反応液を水 (160 mL)に注加し析出した沈殿を吸引濾取し、水及 びエーテルで洗浄して 18を得た。この粗製の 18をエタノール (40 mL)に懸濁させ、氷 冷下 2規定水酸化ナトリウム水溶液 (22.5 mL)をカ卩えて室温で 2時間攪拌後、 2規定水 酸化ナトリウム (20 mL)をカ卩えて室温で 6時間攪拌した。 5規定塩酸で pH3に調整し沈 殿を吸引濾取した。減圧乾燥の後化合物 19(3.1 g)を無色の固体として得た。 Compound 17 (2.97 g) and WSCD (3.45 g) were added to a solution of compound 12 (1.41 g) in DMF (30 mL), and the mixture was stirred at room temperature for 12 hours. The reaction solution was poured into water (160 mL), and the deposited precipitate was collected by suction filtration and washed with water and ether to obtain 18. Suspend this crude 18 in ethanol (40 mL), add 2N aqueous sodium hydroxide solution (22.5 mL) under ice-cooling and stir at room temperature for 2 hours, then add 2N sodium hydroxide (20 mL). The mixture was stirred for 6 hours at room temperature. The pH was adjusted to 3 with 5N hydrochloric acid, and the precipitate was collected by suction filtration. After drying under reduced pressure, compound 19 (3.1 g) was obtained as a colorless solid.
H-NMR (d6-DMSO) δ: 7.79 (2Η, d, J = 6.0 Hz), 8.05 (2H, d, J = 8.4 Hz), 8.10 (2 H, d, J = 8.4 Hz), 8.50 (2H, d, J = 6.0 Hz), 10.8 (1H, brs). H-NMR (d6-DMSO) δ: 7.79 (2Η, d, J = 6.0 Hz), 8.05 (2H, d, J = 8.4 Hz), 8.10 (2 H, d, J = 8.4 Hz), 8.50 (2H , d, J = 6.0 Hz), 10.8 (1H, brs).
(11) 19→20 (11) 19 → 20
化合物 19(3.10 g)の DMF(25 mL)懸濁液に p -メトキシベンジルアルコール (1.60 mL)、 WSCD(2.94 g)、ジメチルァミノピリジン (469 mg)をカ卩ぇ室温で 14時間攪拌した。反応 液を酢酸ェチル-水で抽出し有機層を水、食塩水で洗浄した。無水硫酸マグネシゥ ムで乾燥し減圧濃縮して得られた固体をエーテル-酢酸ェチルで洗浄、濾取した。減 圧乾燥後、化合物 20(3.17 g)を無色固体として得た。
H-NMR (CDC ) δ: 3.82 (3H, s), 5.33 (2H, s), 6.93 (2H, d, J = 8.7 Hz), 7.40 (2H, d, J = 8.7 Hz), 7.69 (2H, d, J = 5.4 Hz), 7.94 (2H, d, J = 8.1 Hz), 8.16 (2H, d, J = 8 .1 Hz), 8.25 (1H, brs), 8.55 (2H, d, J = 5.4 Hz). P-Methoxybenzyl alcohol (1.60 mL), WSCD (2.94 g), and dimethylaminopyridine (469 mg) were stirred in a DMF (25 mL) suspension of Compound 19 (3.10 g) at room temperature for 14 hours. . The reaction solution was extracted with ethyl acetate-water, and the organic layer was washed with water and brine. The solid obtained by drying over anhydrous magnesium sulfate and concentration under reduced pressure was washed with ether-ethyl acetate and collected by filtration. After reduced pressure drying, compound 20 (3.17 g) was obtained as a colorless solid. H-NMR (CDC) δ: 3.82 (3H, s), 5.33 (2H, s), 6.93 (2H, d, J = 8.7 Hz), 7.40 (2H, d, J = 8.7 Hz), 7.69 (2H, d, J = 5.4 Hz), 7.94 (2H, d, J = 8.1 Hz), 8.16 (2H, d, J = 8.1 Hz), 8.25 (1H, brs), 8.55 (2H, d, J = 5.4 Hz).
(12) 4 + 20→21 (12) 4 + 20 → 21
化合物 5と同様な方法で化合物 4(802 mg)と化合物 20(362 mg)から化合物 21(445 mg) を得た。 Compound 21 (445 mg) was obtained from Compound 4 (802 mg) and Compound 20 (362 mg) in the same manner as Compound 5.
1H-NMR (D O) δ: 1.29 (3Η, t, J = 6.9 Hz), 3.65 (2H, brs), 4.23 (2H, q, J = 6.9 Hz 1H-NMR (D O) δ: 1.29 (3Η, t, J = 6.9 Hz), 3.65 (2H, brs), 4.23 (2H, q, J = 6.9 Hz)
), 5.16 (2H, d, J = 6.9 Hz), 5.25 (1H, d, J = 4.8 Hz), 5.81 (1H, d, J = 4.8 Hz), 6.08 ( 1H, dt, J = 6.9, 15.6 Hz), 6.88 (1H, d, J = 15.6 Hz), 6.96 (1H, s), 7.95 (4H, s), 8.20 (2H, d, J = 7.2 Hz) , 8.61 (2H, d, J = 7.2 Hz). ), 5.16 (2H, d, J = 6.9 Hz), 5.25 (1H, d, J = 4.8 Hz), 5.81 (1H, d, J = 4.8 Hz), 6.08 (1H, dt, J = 6.9, 15.6 Hz) ), 6.88 (1H, d, J = 15.6 Hz), 6.96 (1H, s), 7.95 (4H, s), 8.20 (2H, d, J = 7.2 Hz), 8.61 (2H, d, J = 7.2 Hz) ).
IR (KBr) cm"1 : 3410, 1765, 1596, 1518, 1459, 1384, 1325, 1256, 1204, 1160, 1089. MS(ESI): 678+ (M + H)+ IR (KBr) cm " 1 : 3410, 1765, 1596, 1518, 1459, 1384, 1325, 1256, 1204, 1160, 1089. MS (ESI): 678 + (M + H) +
元素分析 C H N NaO S - 5.8 H O - 0.2(NaHCO ) Elemental analysis C H N NaO S-5.8 H O-0.2 (NaHCO)
計算値: C,44.18; Η,4·64; Ν, 11.94; SJ.81; Na,3.36 (%) Calculated value: C, 44.18; Η, 4.64; Ν, 11.94; SJ.81; Na, 3.36 (%)
実験値: C,44.06; H,4.47; N, 12.05; SJ.98; Na,3.40 (%) Experimental value: C, 44.06; H, 4.47; N, 12.05; SJ.98; Na, 3.40 (%)
実施例 174 Example 174
[化 221]
[Chem 221]
( 1 3) 22→24 (1 3) 22 → 24
化合物 22(2.05 g)の 1 ,4-ジォキサン (80 mL)溶液に化合物 23(1.99 g)、 K ΡΟ (10.6 g) Compound 23 (1.99 g), K ΡΟ (10.6 g) in a solution of compound 22 (2.05 g) in 1,4-dioxane (80 mL)
3 4 をカ卩えて脱気した後、 Pd(PPh ) (578 mg)を加えて 6時間攪拌した。反応液を室温まで After degassing by adding 34, Pd (PPh 3) (578 mg) was added and stirred for 6 hours. Bring the reaction solution to room temperature
3 4 3 4
冷却後セライトを用いて濾過し、濾液を減圧濃縮して得られた粗精製物をシリカゲル カラムクロマトグラフィーに付し、酢酸ェチルで溶離して化合物 24(2.03 g)を無色の結 晶として得た。 After cooling, the mixture was filtered through Celite, and the filtrate was concentrated under reduced pressure. The crude product obtained was subjected to silica gel column chromatography, and eluted with ethyl acetate to obtain Compound 24 (2.03 g) as a colorless crystal. .
H-NMR (CDC13) δ: 2.66 (3Η, s), 7.62 (2H, dd, J = 1.5, 4.8 Hz), 7.75 (2H, dd, J = 1.5, 6.0 Hz), 8.09 (2H, dd, J = 1.5, 6.0 Hz), 8.73 (2H, dd, J = 1.5, 4.8 Hz). H-NMR (CDC13) δ: 2.66 (3Η, s), 7.62 (2H, dd, J = 1.5, 4.8 Hz), 7.75 (2H, dd, J = 1.5, 6.0 Hz), 8.09 (2H, dd, J = 1.5, 6.0 Hz), 8.73 (2H, dd, J = 1.5, 4.8 Hz).
( 14) 24→25 (14) 24 → 25
化合物 24(1.02 g)の THF(20 mL)溶液を _70°Cに冷却し、リチウムへキサメチルジシラ ジド (1.0 M in THFX5.2 mL)を滴下しながら加えた。同温で 30分攪拌した後トリフルォ 口酢酸ェチル(0.68 mL)を加えて- 50°Cで 3時間攪拌した。 1規定塩酸 (5.2 mL)を加え て THFを減圧留去した。 1規定塩酸を用いて pH3に調整した後エーテルをカ卩えて析 出した沈殿を吸引濾取した。減圧乾燥して化合物 25(1. 13 g)を黄色粉末として得た。 H-NMR (DMSO) δ: 7.02 (1H, brs), 7.85 (2H, d, J = 5.4 Hz), 8.02 (2H, d, J = 8.7 Hz), 8.25 (2H, d, J = 8.4 Hz), 8.72 (2H, d, J = 5.4 Hz).
(15) 4 + 25→26 A solution of compound 24 (1.02 g) in THF (20 mL) was cooled to _70 ° C, and lithium hexamethyldisilazide (1.0 M in THFX5.2 mL) was added dropwise. After stirring at the same temperature for 30 minutes, trifluoroethyl acetate (0.68 mL) was added, and the mixture was stirred at −50 ° C. for 3 hours. 1N Hydrochloric acid (5.2 mL) was added, and THF was evaporated under reduced pressure. After adjusting the pH to 3 with 1N hydrochloric acid, ether was added and the precipitated precipitate was collected by suction filtration. Drying under reduced pressure gave Compound 25 (1.13 g) as a yellow powder. H-NMR (DMSO) δ: 7.02 (1H, brs), 7.85 (2H, d, J = 5.4 Hz), 8.02 (2H, d, J = 8.7 Hz), 8.25 (2H, d, J = 8.4 Hz) , 8.72 (2H, d, J = 5.4 Hz). (15) 4 + 25 → 26
化合物 25(293 mg)の DMF(2 mL)の懸濁液に N, 0_ビストリメチルシリルァセトアミド (0.4 9 mL)を加えて室温で 15分攪拌した。この反応液に化合物 4(802 mg)、 DMF(1 mL)、 臭化ナトリウム (309 mg)をカ卩えて 6時間攪拌した後、 DMF(3 mL)を加えて希釈し氷冷 攪拌下の 5 %食塩水 (80 mL)に注加した。同温で 20分攪拌した後吸引濾取して減圧 乾燥し淡茶色の固体 (1.07 g)を得た。この固体を塩化メチレン (15 mL)で溶解し、窒素 雰囲気下ァニソール (0.65 mL)を加え _40°Cに冷却した。 _40°C下、塩化チタニウム (I V) (2.0M塩化メチレン溶液, 3.0 mL)を滴下した後、氷浴で 1時間攪拌した。この反応 液を氷浴撹拌下の水(50 mL)に注ぎ、ジイソプロピルエーテル (60 mL)を加えた。析 出物を吸引濾取し重曹水で溶解させ ODSカラムクロマトグラフィー (水-ァセトニトリル) に付して集めた分画を減圧濃縮し、凍結乾燥した。化合物 26 (445 mg)を粉末として 得た。 To a suspension of compound 25 (293 mg) in DMF (2 mL) was added N, 0_bistrimethylsilylacetamide (0.4 9 mL), and the mixture was stirred at room temperature for 15 minutes. Compound 4 (802 mg), DMF (1 mL), and sodium bromide (309 mg) were added to the reaction mixture and stirred for 6 hours, and then diluted with DMF (3 mL). It was poured into% brine (80 mL). After stirring at the same temperature for 20 minutes, the solution was collected by suction filtration and dried under reduced pressure to obtain a light brown solid (1.07 g). This solid was dissolved in methylene chloride (15 mL), added with anisole (0.65 mL) under a nitrogen atmosphere, and cooled to _40 ° C. Titanium chloride (IV) (2.0M methylene chloride solution, 3.0 mL) was added dropwise at _40 ° C, and the mixture was stirred for 1 hour in an ice bath. The reaction mixture was poured into water (50 mL) with stirring in an ice bath, and diisopropyl ether (60 mL) was added. The precipitate was collected by suction filtration, dissolved in aqueous sodium hydrogen carbonate, and fractions collected by ODS column chromatography (water-acetonitrile) were concentrated under reduced pressure and lyophilized. Compound 26 (445 mg) was obtained as a powder.
'H-NMR (D O) δ: 1.28 (3H, t, J = 6.9 Hz), 3.65 (2H, brs), 4.22 (2H, q, J = 6.9 Hz) 'H-NMR (D O) δ: 1.28 (3H, t, J = 6.9 Hz), 3.65 (2H, brs), 4.22 (2H, q, J = 6.9 Hz)
, 5.24 - 5.28 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.05 - 6.15 (2H, m), 6.93 (1H, s), 6 .97 (1H, d, J = 15.6 Hz), 7.88 (4H, s), 8.26 (2H, d, J = 6.6 Hz), 8.78 (2H, d, J = 6. 6 Hz). , 5.24-5.28 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.05-6.15 (2H, m), 6.93 (1H, s), 6.97 (1H, d, J = 15.6 Hz ), 7.88 (4H, s), 8.26 (2H, d, J = 6.6 Hz), 8.78 (2H, d, J = 6.6 Hz).
IR (KBr) cm"1 : 3418, 2982, 1766, 1632, 1576, 1554, 1237, 1175, 1122, 1035, 1011. MS(ESI): 729+ (M + H)+ IR (KBr) cm " 1 : 3418, 2982, 1766, 1632, 1576, 1554, 1237, 1175, 1122, 1035, 1011. MS (ESI): 729 + (M + H) +
元素分析 C H F N NaO S - 4.5 H O - 0.2(NaHCO ) Elemental analysis C H F N NaO S-4.5 H O-0.2 (NaHCO)
計算値: C,45.58; Η,4· 18; F,6.72; N,9.90; SJ.56; Na,3.25 (%) Calculated value: C, 45.58; Η, 4.18; F, 6.72; N, 9.90; SJ.56; Na, 3.25 (%)
実験値: C,45.29; Η,3·89; F,6.44; N,9.98; SJ.65; Na,3.33 (%) Experimental value: C, 45.29; Η, 3.89; F, 6.44; N, 9.98; SJ.65; Na, 3.33 (%)
実施例 175 Example 175
[化 222]
[Chemical 222]
(16) 27→28 (16) 27 → 28
化合物 27(1.95 g)の DMF(30 mL)懸濁液にトリェチルァミン (1.58 mL)、 N_メトキシ _N_ メチルァミン塩酸塩 (1.11 g)を加え氷冷下 WSCD(2.18 g)を加え室温で 16時間攪拌し た。 DMFを減圧留去し酢酸ェチル -水で抽出し、有機層を水、食塩水で洗浄して無 水硫酸マグネシウムで乾燥した。濾過、濃縮後得られた固体にジイソプロピルエーテ ルを加えて不溶物を濾取し、減圧乾燥した。化合物 28(1.03 g)を淡茶色結晶として得 た。 To a suspension of compound 27 (1.95 g) in DMF (30 mL) was added triethylamine (1.58 mL), N_methoxy_N_methylamine hydrochloride (1.11 g), and WSCD (2.18 g) was added under ice cooling, followed by stirring at room temperature for 16 hours. did. DMF was distilled off under reduced pressure and extracted with ethyl acetate-water, and the organic layer was washed with water and brine and dried over anhydrous magnesium sulfate. Diisopropyl ether was added to the solid obtained after filtration and concentration, and the insoluble material was collected by filtration and dried under reduced pressure. Compound 28 (1.03 g) was obtained as light brown crystals.
H-NMR (CDC13) δ: 3.95 (3Η, s), 7.87 (2H, d, J = 5.4 Hz), 8.00 (1H, s), 8.70 (2H, brs). H-NMR (CDC13) δ: 3.95 (3Η, s), 7.87 (2H, d, J = 5.4 Hz), 8.00 (1H, s), 8.70 (2H, brs).
(17) 28→29 (17) 28 → 29
化合物 28(1.90 g)の THF(25 mL)懸濁液に氷冷攪拌下メチルマグネシウムクロライド (3To a suspension of compound 28 (1.90 g) in THF (25 mL) under stirring with ice cooling, methylmagnesium chloride (3
.0 M in THFX3.3 mL)を加えて、同温で 45分攪拌した。 2規定塩酸で中和したのち酢 酸ェチル-水で抽出した。有機層は飽和食塩水で洗浄し無水硫酸マグネシウムで乾 燥後濾過、濃縮した。得られた固体をへキサン-ジイソプロピルエーテルを用いて吸 引濾取し減圧乾燥して化合物 29(1.48 g)を淡茶色結晶として得た。 .0 M in THFX3.3 mL) was added, and the mixture was stirred at the same temperature for 45 minutes. The mixture was neutralized with 2N hydrochloric acid and extracted with ethyl acetate-water. The organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, filtered and concentrated. The obtained solid was collected by suction filtration using hexane-diisopropyl ether and dried under reduced pressure to obtain Compound 29 (1.48 g) as light brown crystals.
H-NMR (CDC13) δ 2.81 (3Η, s), 7.88 (2H, d, J = 6.0 Hz), 8.06 (1H, s), 8.74 (2H, brs). H-NMR (CDC13) δ 2.81 (3Η, s), 7.88 (2H, d, J = 6.0 Hz), 8.06 (1H, s), 8.74 (2H, brs).
(18) 29→30 (18) 29 → 30
化合物 29(1.48 g)の THF(20 mL)溶液を- 50°Cに冷却し、リチウムへキサメチルジシラ
ジド (8.0 mL)を滴下した。 -50°Cで 30分攪拌した後、トリフルォロ酢酸ェチル (2.13 mL) をカロえ氷冷で 1時間攪拌した。 1規定塩酸で中和した後 THFを減圧留去し 1規定塩酸 で pH3に調整した。エーテルをカ卩えて析出した沈殿を濾取し減圧乾燥して化合物 30( 1.62 g)を淡黄色固体として得た。 A solution of compound 29 (1.48 g) in THF (20 mL) was cooled to -50 ° C and lithium hexamethyldisiyl Zido (8.0 mL) was added dropwise. After stirring at −50 ° C. for 30 minutes, trifluoroethyl acetate (2.13 mL) was stirred with ice-cooling for 1 hour. After neutralizing with 1N hydrochloric acid, THF was distilled off under reduced pressure, and the pH was adjusted to 3 with 1N hydrochloric acid. The precipitate formed by adding ether was collected by filtration and dried under reduced pressure to obtain Compound 30 (1.62 g) as a pale yellow solid.
H-NMR (d6-DMSO) δ: 6.33 (1H, brs), 8.36 (2H, d, J = 5.7 Hz), 8.85 (2H, d, J = 5 • 7 Hz), 9.06 (1H, brs). H-NMR (d6-DMSO) δ: 6.33 (1H, brs), 8.36 (2H, d, J = 5.7 Hz), 8.85 (2H, d, J = 5 • 7 Hz), 9.06 (1H, brs).
(19) 4 + 30→31 (19) 4 + 30 → 31
化合物 26と同様な方法で化合物 4(802 mg)、化合物 30(300 mg)から化合物 31(162 mgCompound 4 (802 mg), Compound 30 (300 mg) to Compound 31 (162 mg) in the same manner as Compound 26
)を得た。 )
'H-NMR (D O) δ: 1.27 (3H, t, J = 7.2 Hz), 3.64 and 3.71 (2H, ABq, J = 17.4 Hz), 'H-NMR (D O) δ: 1.27 (3H, t, J = 7.2 Hz), 3.64 and 3.71 (2H, ABq, J = 17.4 Hz),
2 2
4.22 (2H, q, J = 7.2 Hz), 5.24 - 5.27 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.11 (1H, dt , J = 6.9, 15.6 Hz), 6.43 (1H, s), 6.91 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 8.38 (1H, d, J = 6.9 Hz), 8.60 (1H, s), 8.78 (2H, d, J = 6.9 Hz). 4.22 (2H, q, J = 7.2 Hz), 5.24-5.27 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.11 (1H, dt, J = 6.9, 15.6 Hz), 6.43 (1H , S), 6.91 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 8.38 (1H, d, J = 6.9 Hz), 8.60 (1H, s), 8.78 (2H, d, J = 6.9 Hz).
IR (KBr) cm"1 : 3480, 2982, 1633, 1516, 1388, 1392, 1206, 1180, 1131, 1036. IR (KBr) cm " 1 : 3480, 2982, 1633, 1516, 1388, 1392, 1206, 1180, 1131, 1036.
MS(ESI): 758+ (M + Na + H)+ MS (ESI): 758 + (M + Na + H) +
元素分析 C H F N NaO S - 6.1 H O - 0.2(NaHCO ) Elemental analysis C H F N NaO S-6.1 H O-0.2 (NaHCO)
29 23 3 7 7 2 2 3 29 23 3 7 7 2 2 3
計算値: C,39.65; Η,4·03; F,6.44; N, 11.09; S, 10.88; Na,3.12 (%) Calculated value: C, 39.65; Η, 4.03; F, 6.44; N, 11.09; S, 10.88; Na, 3.12 (%)
実験値: C,39.62; Η,3·40; F,6.20; N, 11.16; S, 10.86; Na,3.29 (%) Experimental value: C, 39.62; Η, 3.40; F, 6.20; N, 11.16; S, 10.86; Na, 3.29 (%)
実施例 176 Example 176
[化 223] [Chem. 223]
(20) 20 + 32→33
化合物 5と同様な方法で化合物 32(752 mg)と化合物 20(362 mg)から化合物 33(319 mg )を得た。 (20) 20 + 32 → 33 Compound 33 (319 mg) was obtained from Compound 32 (752 mg) and Compound 20 (362 mg) in the same manner as Compound 5.
'H-NMR (D O) δ: 1.26 - 1.29 (6Η, m), 3.62 and 3.68 (2H, ABq, J = 17.7 Hz), 4.47 'H-NMR (D O) δ: 1.26-1.29 (6Η, m), 3.62 and 3.68 (2H, ABq, J = 17.7 Hz), 4.47
(1H, m), 5.15 (2H, d, J = 7.2 Hz), 5.25 (1H, d, J = 4.5 Hz), 5.80 (1H, d, J = 4.5 H z), 6.08 (1H, dt, J = 7.2, 15.6 Hz), 6.89 (1H, d, J = 15.6 Hz), 6.94 (1H, s), 7.94 (4H , s), 8.18 (2H, d, J = 7.2 Hz) , 8.60 (2H, d, J = 7.2 Hz). (1H, m), 5.15 (2H, d, J = 7.2 Hz), 5.25 (1H, d, J = 4.5 Hz), 5.80 (1H, d, J = 4.5 Hz), 6.08 (1H, dt, J = 7.2, 15.6 Hz), 6.89 (1H, d, J = 15.6 Hz), 6.94 (1H, s), 7.94 (4H, s), 8.18 (2H, d, J = 7.2 Hz), 8.60 (2H, d , J = 7.2 Hz).
IR (KBr) cm—1 : 3417, 2976, 1765, 1596, 1518, 1459, 1383, 1325, 1255, 1204, 1160, 1117, 1090, 1042, 1014. IR (KBr) cm— 1 : 3417, 2976, 1765, 1596, 1518, 1459, 1383, 1325, 1255, 1204, 1160, 1117, 1090, 1042, 1014.
MS(ESI): 692+ (M + H)+ MS (ESI): 692+ (M + H) +
元素分析 C H N NaO S -4.5 H O Elemental analysis C H N NaO S -4.5 H O
計算値: C,46.85; H,4.69; N, 12.34; S,8.07; Na,2.89 (%) Calculated values: C, 46.85; H, 4.69; N, 12.34; S, 8.07; Na, 2.89 (%)
実験値: C,46.64; H,4.39; N, 12.43; SJ.94; Na,3.13 (%) Experimental value: C, 46.64; H, 4.39; N, 12.43; SJ.94; Na, 3.13 (%)
実施例 177 Example 177
[化 224] [Chemical 224]
34 34
(21) 10 + 32→34 (21) 10 + 32 → 34
化合物 11と同様な方法で化合物 32(752 mg)と化合物 10(369 mg)から化合物 34(192 m g)を得た。 Compound 34 (192 mg) was obtained from Compound 32 (752 mg) and Compound 10 (369 mg) in the same manner as Compound 11.
'H-NMR (D O) δ: 1.27 - 1.31 (6Η, m), 3.54 (2H, brs), 4.37 (1H, m), 5.27 (1H, d, J 'H-NMR (D O) δ: 1.27-1.31 (6Η, m), 3.54 (2H, brs), 4.37 (1H, m), 5.27 (1H, d, J
= 6.9 Hz), 5.33 (2H, d, J = 4.8 Hz), 5.83 (1H, d, J = 4.8 Hz), 6.11 (1H, dt, J = 6.9, 15.6 Hz), 6.97 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 7.66 (1H, s), 8.49 (2H, d, J = 6.3 Hz), 8.89 (2H, d, J = 6. 3 Hz). = 6.9 Hz), 5.33 (2H, d, J = 4.8 Hz), 5.83 (1H, d, J = 4.8 Hz), 6.11 (1H, dt, J = 6.9, 15.6 Hz), 6.97 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 7.66 (1H, s), 8.49 (2H, d, J = 6.3 Hz), 8.89 (2H, d, J = 6.3 Hz).
IR (KBr) cm—1 : 3399, 2978, 1763, 1631, 1586, 1540, 1454, 1381, 1290, 1197, 1157,
1119, 1062, 1043. IR (KBr) cm— 1 : 3399, 2978, 1763, 1631, 1586, 1540, 1454, 1381, 1290, 1197, 1157, 1119, 1062, 1043.
MS(ESI): 699+ (M + H)+ MS (ESI): 699+ (M + H) +
元素分析 C H N Na O S - 3.3 H O - 0.2(NaHCO ) Elemental analysis C H N Na O S-3.3 H O-0.2 (NaHCO)
計算値: C,41.36; H,3.79; N, 13.68; S, 11.75; Na,6.18 (%) Calculated values: C, 41.36; H, 3.79; N, 13.68; S, 11.75; Na, 6.18 (%)
実験値: C,41.56; H,4.12; N, 13.75; S, 11.24; Na,6.25 (%) Experimental values: C, 41.56; H, 4.12; N, 13.75; S, 11.24; Na, 6.25 (%)
実施例 178 Example 178
[化 225] [Chemical 225]
32 + 35→36 32 + 35 → 36
化合物 11と同様な方法で化合物 32(752 mg)と化合物 35(310 mg)から化合物 36(260 m g)を得た。 Compound 36 (260 mg) was obtained from Compound 32 (752 mg) and Compound 35 (310 mg) in the same manner as Compound 11.
'H-NMR (D O) δ: 1.27 - 1.30 (6Η, m), 3.62 and 3.69 (2H, ABq, J = 17.7 Hz), 4.49 'H-NMR (D O) δ: 1.27-1.30 (6Η, m), 3.62 and 3.69 (2H, ABq, J = 17.7 Hz), 4.49
(1H, m), 5.27 (1H, d, J = 4.8 Hz), 5.40 (1H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 H z), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.96 (1H, s), 6.97(1H, d, J = 15.6 Hz), 7.67 (2H, d, J = 8.7 Hz), 8.43 (2H, d, J = 6.9 Hz) , 9.05 (2H, d, J = 6.9 Hz). (1H, m), 5.27 (1H, d, J = 4.8 Hz), 5.40 (1H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.96 (1H, s), 6.97 (1H, d, J = 15.6 Hz), 7.67 (2H, d, J = 8.7 Hz), 8.43 (2H, d, J = 6.9 Hz), 9.05 (2H, d, J = 6.9 Hz).
IR (KBr) cm—1 : 3418, 3055, 2976, 1765, 1668, 1604, 1532, 1455, 1381, 1326, 1201,IR (KBr) cm— 1 : 3418, 3055, 2976, 1765, 1668, 1604, 1532, 1455, 1381, 1326, 1201,
1175, 1117, 1041. 1175, 1117, 1041.
MS(ESI): 692+ (M + H)+ MS (ESI): 692+ (M + H) +
元素分析 c H N NaO S - 5.1 H O - 0.2 NaHCO Elemental analysis c H N NaO S-5.1 H O-0.2 NaHCO
計算値: C,45.57; H,4.71; N, 11.92; SJ.80; Na,3.35 (%) Calculated value: C, 45.57; H, 4.71; N, 11.92; SJ.80; Na, 3.35 (%)
実験値: C45.52; H,4.73; N, 12.05; SJ.81; Na,3.31 (%) Experimental value: C45.52; H, 4.73; N, 12.05; SJ.81; Na, 3.31 (%)
実施例 179
[化 226] Example 179 [Chem 226]
(23) 32 + 37→38 (23) 32 + 37 → 38
化合物 11と同様な方法で化合物 32(752 mg)と化合物 37(310 mg)から化合物 38(275 m g)を得た。 Compound 38 (275 mg) was obtained from Compound 32 (752 mg) and Compound 37 (310 mg) in the same manner as Compound 11.
'H-NMR (D O) δ: 1.27 - 1.31 (6Η, m), 3.66 (2H, brs), 4.49 (1H, m), 5.27 (1H, d, 'H-NMR (D 2 O) δ: 1.27-1.31 (6Η, m), 3.66 (2H, brs), 4.49 (1H, m), 5.27 (1H, d,
J = 4.8 Hz), 5.40 (1H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6.9 , 15.6 Hz), 6.96 (1H, s), 6.98 (1H, d, J = 15.6 Hz), 7.53 (1H, t, J = 7.8 Hz), 7.74 - 7.98 (2H, m) , 7.97 (1H, t, J = 1.8 Hz), 8.44 (2H, d, J = 7.2 Hz), 9.05 (2H, d, J = 7. 2 Hz). J = 4.8 Hz), 5.40 (1H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.96 (1H, s) , 6.98 (1H, d, J = 15.6 Hz), 7.53 (1H, t, J = 7.8 Hz), 7.74-7.98 (2H, m), 7.97 (1H, t, J = 1.8 Hz), 8.44 (2H, d, J = 7.2 Hz), 9.05 (2H, d, J = 7.2 Hz).
IR (KBr) cm"1 : 3409, 3057, 2977, 1765, 1669, 1610, 1559, 1455, 1431, 1382, 1300, 1201, 1162, 1118, 1041. IR (KBr) cm " 1 : 3409, 3057, 2977, 1765, 1669, 1610, 1559, 1455, 1431, 1382, 1300, 1201, 1162, 1118, 1041.
MS(ESI): 692+ (M + H)+ MS (ESI): 692+ (M + H) +
元素分析 C H N NaO S -4.3 H O - 0.2 NaHCO Elemental analysis C H N NaO S -4.3 H O-0.2 NaHCO
計算値: C,46.38; H,4.59; N, 12.13; SJ.94; Na,3.41 (%) Calculated value: C, 46.38; H, 4.59; N, 12.13; SJ.94; Na, 3.41 (%)
実験値: C,46.37; H,4.35; N, 12.02; SJ.74; Na,3.44 (%) Experimental value: C, 46.37; H, 4.35; N, 12.02; SJ.74; Na, 3.44 (%)
実施例 180 Example 180
(24) 39→40 (24) 39 → 40
ィ匕合物 39(10 g)の THF(50 mL)溶液にジフヱニルジァゾメタン (11.6 g)の THF(50 mL) 溶液を 30分かけて滴下した。反応液を室温で 30分攪拌し減圧濃縮、乾燥することに より化合物 40(20 g)を黄色油状物質として得た。 A solution of diphenyldiazomethane (11.6 g) in THF (50 mL) was added dropwise over 30 minutes to a THF (50 mL) solution of the compound 39 (10 g). The reaction solution was stirred at room temperature for 30 minutes, concentrated under reduced pressure, and dried to obtain Compound 40 (20 g) as a yellow oily substance.
H-NMR (CDC13) δ: 4.33 (2Η, s), 6.99 (1H, s), 7.30 - 7.41 (10H, m). H-NMR (CDC13) δ: 4.33 (2Η, s), 6.99 (1H, s), 7.30-7.41 (10H, m).
(25) 40→42 (25) 40 → 42
化合物 40(3.33 g)の THF(20 mL)溶液に化合物 41(95% w/w)(1.40 g)を加えて加熱還 流下 6時間攪拌した。室温まで冷却後酢酸ェチル、重曹水をカ卩えて抽出し、有機層 は食塩水で洗浄した。水層は酢酸ェチルで抽出し、集めた有機層は無水硫酸マグ ネシゥムで乾燥し、減圧濃縮して得られた粗精製物をシリカゲルカラムクロマトグラフ ィ一で精製しィ匕合物 42(1.67 g)をクリーム色の結晶として得た。 Compound 41 (95% w / w) (1.40 g) was added to a solution of compound 40 (3.33 g) in THF (20 mL), and the mixture was stirred for 6 hours while heating under reflux. After cooling to room temperature, extraction was performed with cetyl acetate and sodium bicarbonate water, and the organic layer was washed with brine. The aqueous layer was extracted with ethyl acetate, the collected organic layer was dried over anhydrous magnesium sulfate, and the crude product obtained by concentration under reduced pressure was purified by silica gel column chromatography to obtain Compound 42 (1.67 g ) Was obtained as cream crystals.
H-NMR (CDC13) δ 1.45 (3Η, t, J = 7.2 Hz), 4.49 (2H, q, J = 7.2 Hz), 7.17 (1H, s) , 7.26 - 7.45 (10H, m), 8.45 (1H, s). H-NMR (CDC13) δ 1.45 (3Η, t, J = 7.2 Hz), 4.49 (2H, q, J = 7.2 Hz), 7.17 (1H, s), 7.26-7.45 (10H, m), 8.45 (1H , s).
(26) 42→43 (26) 42 → 43
化合物 42(4.85 g)にァニソール (2.87 mL)、トリフルォロ酢酸 (20 mL)を加えて室温で 45 分間攪拌した。反応液にジェチルエーテルを加えて析出した沈殿を濾取し、減圧乾 燥することにより化合物 43(1.73 g)を無色の結晶として得た。
H-NMR (CDC ) δ 1.46 (3H, t, J = 7.2 Hz), 4.52 (2H, q, J = 7.2 Hz), 8.53 (1H, s) Anisole (2.87 mL) and trifluoroacetic acid (20 mL) were added to compound 42 (4.85 g), and the mixture was stirred at room temperature for 45 minutes. Jetyl ether was added to the reaction solution, and the deposited precipitate was collected by filtration and dried under reduced pressure to obtain Compound 43 (1.73 g) as colorless crystals. H-NMR (CDC) δ 1.46 (3H, t, J = 7.2 Hz), 4.52 (2H, q, J = 7.2 Hz), 8.53 (1H, s)
(27) 43→44 (27) 43 → 44
4-アミノピリジン (809 mg)の DMF(17 mL)溶液に化合物 43(1.73 g)を加えて氷冷した。 WSCD(1.98 g)を加えた後室温まで昇温し 12時間攪拌した。酢酸ェチル、水を加え不 溶物を濾取し、減圧乾燥することにより化合物 44(1.08 g)を無色の粉末として得た。先 の有機層は水、食塩水で洗浄し、無水硫酸マグネシウムで乾燥の後濾過、濃縮した 得られた固体状の残渣をエーテル-酢酸ェチルで洗浄、濾取し、減圧乾燥すること により化合物 44(340 mg)を無色の結晶として得た。 Compound 43 (1.73 g) was added to a solution of 4-aminopyridine (809 mg) in DMF (17 mL), and the mixture was ice-cooled. After adding WSCD (1.98 g), the mixture was warmed to room temperature and stirred for 12 hours. Ethyl acetate and water were added, insoluble matter was collected by filtration, and dried under reduced pressure to obtain Compound 44 (1.08 g) as a colorless powder. The organic layer was washed with water and brine, dried over anhydrous magnesium sulfate, filtered and concentrated. The resulting solid residue was washed with ether-ethyl acetate, filtered and dried under reduced pressure to give compound 44. (340 mg) was obtained as colorless crystals.
H-NMR (CDC13) δ 1.49 (3Η, t, J = 7.2 Hz), 4.54 (2H, q, J = 7.2 Hz), 7.79 (2H, d, J = 6.6 Hz), 8.53 (1H, s), 8.58 (2H, d, J = 6.6 Hz), 9.48 (1H, brs). H-NMR (CDC13) δ 1.49 (3Η, t, J = 7.2 Hz), 4.54 (2H, q, J = 7.2 Hz), 7.79 (2H, d, J = 6.6 Hz), 8.53 (1H, s), 8.58 (2H, d, J = 6.6 Hz), 9.48 (1H, brs).
(28) 44→45 (28) 44 → 45
化合物 44(1.42 g)のエタノール (10 mL)溶液を氷冷し、 2規定水酸化ナトリウム (5.1 mL) をカ卩えて同温で 1.5時間攪拌した。 2規定塩酸 (5.1 mL)を加えて中和し、エタノールを 減圧留去後析出した沈殿を濾取、減圧乾燥して化合物 45(1.29 g)を無色の固体とし て得た。 A solution of compound 44 (1.42 g) in ethanol (10 mL) was ice-cooled, 2N sodium hydroxide (5.1 mL) was added, and the mixture was stirred at the same temperature for 1.5 hr. 2N Hydrochloric acid (5.1 mL) was added for neutralization, ethanol was evaporated under reduced pressure, and the deposited precipitate was collected by filtration and dried under reduced pressure to give compound 45 (1.29 g) as a colorless solid.
H-NMR (d -DMSO) δ 7.91 (2Η, d, J = 5.4 Hz), 8.50 (2H, brs), 8.77 (1H, s), 10.7 H-NMR (d -DMSO) δ 7.91 (2Η, d, J = 5.4 Hz), 8.50 (2H, brs), 8.77 (1H, s), 10.7
6 6
(1H, brs). (1H, brs).
(29) 45→46 (29) 45 → 46
化合物 45(1.29 g)の DMF(10 mL)懸濁液に p-メトキシベンジルアルコール (0.70 mL)、 WSCD(1.18 g)、 N, N-ジメチルァミノピリジン (188 mg)を順次加えて、 DMF(10 mL)を 追加した後室温で 16時間攪拌した。反応液を氷冷攪拌下の水 (150 mL)に加えて 20 分間攪拌し、析出した不溶物を濾取、減圧乾燥することにより化合物 46(738 mg)を淡 茶色の固体として得た。 To a suspension of compound 45 (1.29 g) in DMF (10 mL), p-methoxybenzyl alcohol (0.70 mL), WSCD (1.18 g), N, N-dimethylaminopyridine (188 mg) were sequentially added, and DMF was added. (10 mL) was added, followed by stirring at room temperature for 16 hours. The reaction mixture was added to water (150 mL) with ice-cooling and stirred for 20 minutes, and the precipitated insoluble material was collected by filtration and dried under reduced pressure to give compound 46 (738 mg) as a pale brown solid.
H-NMR (d6-DMSO) δ: 3.75 (3H, s), 5.38 (2H, 2), 6.96 (2H, d, J = 8.7 Hz), 7.44 ( 2H, d, J = 8.7 Hz), 7.83 (2H, d, J = 6.6 Hz), 8.46 (2H, d, J = 6.6 Hz), 8.83 (1H, s). H-NMR (d6-DMSO) δ: 3.75 (3H, s), 5.38 (2H, 2), 6.96 (2H, d, J = 8.7 Hz), 7.44 (2H, d, J = 8.7 Hz), 7.83 ( 2H, d, J = 6.6 Hz), 8.46 (2H, d, J = 6.6 Hz), 8.83 (1H, s).
(30) 4 + 46→47 (30) 4 + 46 → 47
化合物 5と同様な方法で化合物 4(820 mg)と化合物 46(369 mg)から化合物 47(388 mg)
を得た。 Compound 4 (820 mg) and Compound 46 (369 mg) to Compound 47 (388 mg) in the same manner as Compound 5 Got.
Ή-NMR (D O) δ: 1.16 (3H, t, J = 6.9 Hz), 3.54 (2H, brs), 4.11 (2H, q, J = 6.9 Hz) NMR-NMR (D O) δ: 1.16 (3H, t, J = 6.9 Hz), 3.54 (2H, brs), 4.11 (2H, q, J = 6.9 Hz)
, 5.04 (2H, d, J = 7.2 Hz) 5.14 (1H, d, J = 4.5 Hz), 5.69 (1H, d, J = 4.5 Hz), 5.97 (1 H, dt, J = 7.2, 15.9 Hz), 6.80 (1H, d, J = 15.9 Hz), 6.83 (1H, s), 8.12 (2H, d, J = 7. 5 Hz), 8.46 (1H, s), 8.50 (2H, d, J = 7.5 Hz). , 5.04 (2H, d, J = 7.2 Hz) 5.14 (1H, d, J = 4.5 Hz), 5.69 (1H, d, J = 4.5 Hz), 5.97 (1 H, dt, J = 7.2, 15.9 Hz) , 6.80 (1H, d, J = 15.9 Hz), 6.83 (1H, s), 8.12 (2H, d, J = 7.5 Hz), 8.46 (1H, s), 8.50 (2H, d, J = 7.5 Hz).
IR (KBr) cm—1: 3412, 2979, 1765, 1631, 1521, 1461, 1363, 1328, 1120, 1161, 1111, 1035. IR (KBr) cm— 1 : 3412, 2979, 1765, 1631, 1521, 1461, 1363, 1328, 1120, 1161, 1111, 1035.
MS(ESI): 685+ (M + H)+ MS (ESI): 685+ (M + H) +
元素分析 c H N NaO S - 5.6 H O - 0.1 NaHCO Elemental analysis c H N NaO S-5.6 H O-0.1 NaHCO
計算値: C,39.89; H,4.24; N, 13.73; S,11.79; Na,3.10 (%) Calculated values: C, 39.89; H, 4.24; N, 13.73; S, 11.79; Na, 3.10 (%)
実験値: C39.86; H,4.04; N, 13.71; S,11.66; Na,3.20 (%) Experimental value: C39.86; H, 4.04; N, 13.71; S, 11.66; Na, 3.20 (%)
実施例 181 Example 181
[化 228] [Chemical 228]
(31) 48→51 (31) 48 → 51
化合物 49(19.8 g)のエタノール (80 mL)溶液に化合物 48(11.1 g)を加え加熱還流下 10 時間攪拌した。エタノールを減圧留去し酢酸ェチルをカ卩えて析出した沈殿を濾取、 乾燥し粗製の 50を得た。得られた 50にエタノール (80 mL)を加えて氷冷し 2規定水酸
化ナトリウム水溶液 (40 mL)をカ卩ぇ室温で 2時間攪拌後、 2規定水酸化ナトリウム水溶 液 (20 mL)を追加して 45°Cで 2時間攪拌した。反応液を氷冷下 5規定塩酸を用いて中 和し、エタノールを減圧留去後、希塩酸で pH2に調整して析出した沈殿を濾取、減圧 乾燥した。化合物 51(8.67 g)をクリーム色の固体として得た。 Compound 48 (11.1 g) was added to a solution of compound 49 (19.8 g) in ethanol (80 mL), and the mixture was stirred with heating under reflux for 10 hours. Ethanol was distilled off under reduced pressure and ethyl acetate was added to precipitate, and the deposited precipitate was collected by filtration and dried to obtain crude 50. Ethanol (80 mL) was added to the obtained 50 and cooled with ice. A sodium hydroxide aqueous solution (40 mL) was stirred at room temperature for 2 hours, 2N aqueous sodium hydroxide solution (20 mL) was added, and the mixture was stirred at 45 ° C for 2 hours. The reaction mixture was neutralized with 5N hydrochloric acid under ice-cooling, ethanol was distilled off under reduced pressure, pH was adjusted to 2 with dilute hydrochloric acid, and the deposited precipitate was collected by filtration and dried under reduced pressure. Compound 51 (8.67 g) was obtained as a cream solid.
H-NMR (d6-DMSO) δ: 2.71 (3H, s), 7.92 (2H, dd, J = 1.8, 4.8 Hz), 8.74 (2H, dd, J = 1.8, 4.8). H-NMR (d6-DMSO) δ: 2.71 (3H, s), 7.92 (2H, dd, J = 1.8, 4.8 Hz), 8.74 (2H, dd, J = 1.8, 4.8).
(32) 51→52 (32) 51 → 52
化合物 51(2.20 g)の THF(30 mL)懸濁液にジフヱニルジァゾメタン (2.33 g)を加え加熱 還流下 4時間攪拌した。室温まで冷却後溶媒を減圧留去し、ジイソプロピルエーテル -へキサンから再結晶して化合物 52(3.48 g)を得た。 Diphenyldiazomethane (2.33 g) was added to a suspension of compound 51 (2.20 g) in THF (30 mL), and the mixture was heated and refluxed for 4 hours. After cooling to room temperature, the solvent was distilled off under reduced pressure, and recrystallization from diisopropyl ether-hexane gave Compound 52 (3.48 g).
H-NMR (CDC13) δ 2.82 (3Η, s), 7.08 (1H, s), 7.29 - 7.44 (10H, m), 7.86 (2H, d, J = 6.0 Hz), 8.74 (2H, d, J = 6.0 Hz). H-NMR (CDC13) δ 2.82 (3Η, s), 7.08 (1H, s), 7.29-7.44 (10H, m), 7.86 (2H, d, J = 6.0 Hz), 8.74 (2H, d, J = 6.0 Hz).
(33) 4 + 52→53 (33) 4 + 52 → 53
化合物 52 (386 mg)、 化合物 4(820 mg)の DMF(3.0 mL)溶液に、臭化ナトリウム (3 09 mg)をカ卩えて室温で 7時間撹拌した。 DMF(3 mL)を加えて希釈し氷冷撹拌下の 5%食 塩水 (80 mL)に注加した。同温で 20分間撹拌後、沈殿を濾取し減圧乾燥した。得られ た粗成生物 (1.24 g)を塩化メチレン(15 mL)に溶解し、窒素雰囲気下ァニソール(0.6 5 mL)を加え- 40°Cに冷却した。 -40°C下、塩化チタニウム (IV) (2.0M塩化メチレン溶 液, 3.0 mL)を滴下した後、氷浴中で 1時間攪拌した。この反応液を氷冷撹拌下の水 (40 mL)に注ぎ、ジイソプロピルエーテル (80 mL)を加えた。 1規定塩酸 (50 mL)、ァセト 二トリル (50 mL)を加えて分液し、有機層を 1規定塩酸ーァセトニトリル (1 : 1)で抽出した 。合わせた水層を HP20ssカラムクロマトグラフィーに付し、水-ァセトニトリルで溶離し て集めた分画に 0.2規定水酸化ナトリウム水溶液を注意深く加え pH力 になった時 点でドライアイスを投入し濃縮後凍結乾燥した。化合物 53 (256 mg)を粉末として得た To a solution of compound 52 (386 mg) and compound 4 (820 mg) in DMF (3.0 mL) was added sodium bromide (309 mg), and the mixture was stirred at room temperature for 7 hours. DMF (3 mL) was added for dilution, and the mixture was poured into 5% brine (80 mL) with ice-cooling and stirring. After stirring at the same temperature for 20 minutes, the precipitate was collected by filtration and dried under reduced pressure. The resulting crude product (1.24 g) was dissolved in methylene chloride (15 mL), and anisole (0.65 mL) was added under a nitrogen atmosphere, followed by cooling to -40 ° C. Titanium (IV) chloride (2.0M methylene chloride solution, 3.0 mL) was added dropwise at -40 ° C, and the mixture was stirred in an ice bath for 1 hour. The reaction mixture was poured into water (40 mL) under ice-cooling and stirring, and diisopropyl ether (80 mL) was added. 1N Hydrochloric acid (50 mL) and acetonitryl (50 mL) were added for liquid separation, and the organic layer was extracted with 1N hydrochloric acid-acetonitrile (1: 1). The combined aqueous layer was subjected to HP20ss column chromatography, 0.2N aqueous sodium hydroxide solution was carefully added to the fraction collected by elution with water-acetonitrile, dry ice was added when the pH was reached, and the sample was frozen after concentration. Dried. Compound 53 (256 mg) was obtained as a powder
1H-NMR (D O) δ: 1.28 (3Η, t, J = 6.9 Hz), 2.69 (3H, s), 3.67 (2H, brs), 4.22 (2H, q, J = 6.9 Hz), 5.26 (1H, d, J = 4.8 Hz) 5.31 (2H, d, J = 6.6 Hz), 5.77 (1H, d, J = 4 • 8 Hz), 6.10 (1H, dt, J = 6.6, 15.6 Hz), 6.91 (1H, s), 7.00 (1H, d, J = 15.6 Hz), 8.3
9 (2H, d, J = 7.2 Hz), 8.88 (2H, d, J = 7.2 Hz). 1H-NMR (DO) δ: 1.28 (3Η, t, J = 6.9 Hz), 2.69 (3H, s), 3.67 (2H, brs), 4.22 (2H, q, J = 6.9 Hz), 5.26 (1H, d, J = 4.8 Hz) 5.31 (2H, d, J = 6.6 Hz), 5.77 (1H, d, J = 4 • 8 Hz), 6.10 (1H, dt, J = 6.6, 15.6 Hz), 6.91 (1H , s), 7.00 (1H, d, J = 15.6 Hz), 8.3 9 (2H, d, J = 7.2 Hz), 8.88 (2H, d, J = 7.2 Hz).
IR (KBr) cm—1 : 3426, 1765, 1632, 1602, 1530, 1465, 1360, 1297, 1208, 1156, 1033.IR (KBr) cm— 1 : 3426, 1765, 1632, 1602, 1530, 1465, 1360, 1297, 1208, 1156, 1033.
MS(ESI): 656+ (M + H)+ MS (ESI): 656+ (M + H) +
元素分析 C H N NaO S -4.7 H O Elemental analysis C H N NaO S -4.7 H O
27 24 7 7 3 2 27 24 7 7 3 2
計算値: C,42.54; H,4.42; N, 12.86; S, 12.62; Na,3.02 (%) Calculated value: C, 42.54; H, 4.42; N, 12.86; S, 12.62; Na, 3.02 (%)
実験値: C,42.55; H,4.35; N, 12.94; S, 12.59; Na,3.27 (%) Experimental value: C, 42.55; H, 4.35; N, 12.94; S, 12.59; Na, 3.27 (%)
実施例 182 Example 182
[化 229] [Chemical 229]
(34) 54→56 (34) 54 → 56
化合物 55(13.4 g)のエタノール (50 mL)溶液に化合物 54(6.91 g)を加え 80°Cで 6時間 攪拌した。室温まで冷却後エタノールを減圧留去し酢酸ェチル -重曹水で抽出した。 有機層を食塩水で洗浄し、無水硫酸マグネシウムで乾燥、濾過後減圧濃縮した。得 られた粗精製物をシリカゲルカラムクロマトグラフィーで精製し化合物 56を淡茶色の 結晶として得た。 Compound 54 (6.91 g) was added to a solution of compound 55 (13.4 g) in ethanol (50 mL), and the mixture was stirred at 80 ° C. for 6 hours. After cooling to room temperature, ethanol was distilled off under reduced pressure and extracted with ethyl acetate-sodium bicarbonate water. The organic layer was washed with brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The obtained crude product was purified by silica gel column chromatography to obtain compound 56 as light brown crystals.
H-NMR (CDC13) δ: 1.30 (3Η, t, J = 7.2 Hz), 2.46 (3H, s), 3.82 (2H, s), 4.22 (2H, q, J = 7.2 Hz), 7.77 (2H, dd, J = 1.8, 4.8 Hz), 8.67 (2H, dd, J = 1.8, 4.8 Hz). H-NMR (CDC13) δ: 1.30 (3Η, t, J = 7.2 Hz), 2.46 (3H, s), 3.82 (2H, s), 4.22 (2H, q, J = 7.2 Hz), 7.77 (2H, dd, J = 1.8, 4.8 Hz), 8.67 (2H, dd, J = 1.8, 4.8 Hz).
(35) 56→57 (35) 56 → 57
化合物 56(1.31 g)に 2規定水酸化ナトリウム水溶液 (5 mL)を加え室温で 2時間攪拌し
た。 2規定塩酸を用いて中和し pH2.7に調整した。氷浴中で 20分攪拌の後不溶物を 濾取、減圧乾燥し化合物 57(1.09 g)を無色の固体として得た。 Add 2N aqueous sodium hydroxide solution (5 mL) to compound 56 (1.31 g) and stir at room temperature for 2 hours. It was. The mixture was neutralized with 2N hydrochloric acid and adjusted to pH 2.7. After stirring in an ice bath for 20 minutes, the insoluble material was collected by filtration and dried under reduced pressure to obtain Compound 57 (1.09 g) as a colorless solid.
H-NMR (d6-DMSO) δ: 2.37 (3Η, s), 3.91 (2H, s), 7.81 (2H, dd, J = 1.5, 4.2 Hz), 8 • 67 (2H, dd, J = 1.5, 4.2). H-NMR (d6-DMSO) δ: 2.37 (3Η, s), 3.91 (2H, s), 7.81 (2H, dd, J = 1.5, 4.2 Hz), 8 • 67 (2H, dd, J = 1.5, 4.2).
(36) 57→58 (36) 57 → 58
化合物 57(1.09 g)の THF(14 mL)懸濁液にジフヱニルジァゾメタン (1.08 g)を加え加熱 還流下 2.5時間攪拌した。室温まで冷却後溶媒を減圧留去し残渣をジイソプロピルェ 一テル-へキサンから再結晶し、化合物 58(1.78 g)を淡茶色結晶として得た。 Diphenyldiazomethane (1.08 g) was added to a suspension of compound 57 (1.09 g) in THF (14 mL), and the mixture was heated and refluxed for 2.5 hours. After cooling to room temperature, the solvent was distilled off under reduced pressure, and the residue was recrystallized from diisopropyl ether-hexane to obtain Compound 58 (1.78 g) as light brown crystals.
H-NMR (CDC13) d:2.42 (3H, s), 3.93 (2H, s), 6.92 (1H, s), 7.27 - 7.37 (10H, m), 7. 75 (2H, dd, J = 1.8, 4.5 Hz), 8.67 (2H, dd, J = 1.8, 4.5 Hz). H-NMR (CDC13) d: 2.42 (3H, s), 3.93 (2H, s), 6.92 (1H, s), 7.27-7.37 (10H, m), 7.75 (2H, dd, J = 1.8, 4.5 Hz), 8.67 (2H, dd, J = 1.8, 4.5 Hz).
(37) 32 + 58→59 (37) 32 + 58 → 59
化合物 53と同様な方法で化合物 32(855 mg)と化合物 58(369 mg)から化合物 59(330 m g)を得た。 Compound 59 (330 mg) was obtained from Compound 32 (855 mg) and Compound 58 (369 mg) in the same manner as Compound 53.
'H-NMR (D O) 5: 1.27 - 1.30 (6Η, m), 2.43 (3H, s), 3.66 (2H, brs), 3.80 (2H, brs) 'H-NMR (D O) 5: 1.27-1.30 (6Η, m), 2.43 (3H, s), 3.66 (2H, brs), 3.80 (2H, brs)
, 4.48 (1H, m), 5.25 - 5.29 (3H, m) 5.80 (1H, d, J = 4.5 Hz), 6.10 (1H, dt, J = 6.9, 16.2 Hz), 6.92 (1H, s), 6.98 (1H, d, J = 16.2 Hz) , 8.34 (2H, d, J = 6.9 Hz), 8.81 (2 H, d, J = 6.9 Hz). , 4.48 (1H, m), 5.25-5.29 (3H, m) 5.80 (1H, d, J = 4.5 Hz), 6.10 (1H, dt, J = 6.9, 16.2 Hz), 6.92 (1H, s), 6.98 (1H, d, J = 16.2 Hz), 8.34 (2H, d, J = 6.9 Hz), 8.81 (2 H, d, J = 6.9 Hz).
IR (KBr) cm"1 : 3409, 2976, 2932, 1766, 1632, 1599, 1531, 1467, 1371, 1275, 1206, 1152, 1119, 1030. IR (KBr) cm " 1 : 3409, 2976, 2932, 1766, 1632, 1599, 1531, 1467, 1371, 1275, 1206, 1152, 1119, 1030.
MS(ESI): 684+ (M + H)+ MS (ESI): 684+ (M + H) +
元素分析 C H N NaO S - 3.8 H O - 0.3 NaHCO Elemental analysis C H N NaO S-3.8 H O-0.3 NaHCO
計算値: C,44.02; H,4.53; N, 12.26; S, 12.03; Na,3.74 (%) Calculated value: C, 44.02; H, 4.53; N, 12.26; S, 12.03; Na, 3.74 (%)
実験値: C,43.76; H,4.60; N, 12.29; S, 12.10; Na,4.04 (%) Experimental value: C, 43.76; H, 4.60; N, 12.29; S, 12.10; Na, 4.04 (%)
実施例 183 Example 183
(38) 4 + 58→60 (38) 4 + 58 → 60
化合物 53と同様な方法で化合物 4(869 mg)と化合物 58(400 mg)から化合物 60(317 mg )を得た。 In the same manner as in Compound 53, Compound 60 (317 mg) was obtained from Compound 4 (869 mg) and Compound 58 (400 mg).
1H-NMR (D O) δ: 1.28 (3Η, t, J = 6.9 Hz), 2.43 (3H, s), 3.66 (2H, brs), 3.80 (2H, 1H-NMR (D O) δ: 1.28 (3Η, t, J = 6.9 Hz), 2.43 (3H, s), 3.66 (2H, brs), 3.80 (2H,
2 2
s), 4.23 (2H, q, J = 6.9 Hz), 5.25 - 5.28 (3H, m) 5.80 (1H, d, J = 4.5 Hz), 6.10 (1H , dt, J = 6.9, 15.3 Hz), 6.92 (1H, s), 6.98 (1H, dt, J = 15.3 Hz), 8.34 (2H, d, J = 7.2 Hz), 8.80 (2H, d, J = 7.2 Hz). s), 4.23 (2H, q, J = 6.9 Hz), 5.25-5.28 (3H, m) 5.80 (1H, d, J = 4.5 Hz), 6.10 (1H, dt, J = 6.9, 15.3 Hz), 6.92 (1H, s), 6.98 (1H, dt, J = 15.3 Hz), 8.34 (2H, d, J = 7.2 Hz), 8.80 (2H, d, J = 7.2 Hz).
IR (KBr) cm"1 : 3419, 2980, 1765, 1632, 1599, 1532, 1467, 1373, 1276, 1205, 1156, 1090, 1032, 1000. IR (KBr) cm " 1 : 3419, 2980, 1765, 1632, 1599, 1532, 1467, 1373, 1276, 1205, 1156, 1090, 1032, 1000.
MS(ESI): 670+ (M + H)+ MS (ESI): 670 + (M + H) +
元素分析 C H N NaO S -4.5 H O - 0.1 NaHCO Elemental analysis C H N NaO S -4.5 H O-0.1 NaHCO
28 26 7 7 3 2 3 28 26 7 7 3 2 3
計算値: C,43.20; Η,4·53; Ν, 12.55; S, 12.31; Na,3.24 (%) Calculated value: C, 43.20; Η, 4 · 53; Ν, 12.55; S, 12.31; Na, 3.24 (%)
実験値: C,43.23; Η,4·51; Ν, 12.63; S, 12.04; Na,3.26 (%) Experimental value: C, 43.23; Η, 4.51; Ν, 12.63; S, 12.04; Na, 3.26 (%)
実施例 184 Example 184
(39) 32 + 52→61 (39) 32 + 52 → 61
化合物 53と同様な方法で化合物 32(855 mg)と化合物 52(309 mg)から化合物 61(330 m g)を得た。 Compound 61 (330 mg) was obtained from Compound 32 (855 mg) and Compound 52 (309 mg) in the same manner as Compound 53.
'H-NMR (D O) δ: 1.26 - 1.30 (6Η, m), 2.69 (3H, s), 3.63 and 3.70 (2H, ABq, J = 'H-NMR (D O) δ: 1.26-1.30 (6Η, m), 2.69 (3H, s), 3.63 and 3.70 (2H, ABq, J =
17.1 Hz), 4.47 (1H, m), 5.23 (1H, d, J = 4.8 Hz) 5.31 (2H, d, J = 7.2 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.11 (1H, dt, J = 7.2, 15.6 Hz), 6.91 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 8.39 (2H, d, J = 7.2 Hz), 8.88 (2H, d, J = 7.2 Hz). 17.1 Hz), 4.47 (1H, m), 5.23 (1H, d, J = 4.8 Hz) 5.31 (2H, d, J = 7.2 Hz), 5.80 (1H, d, J = 4.8 Hz), 6.11 (1H, dt, J = 7.2, 15.6 Hz), 6.91 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 8.39 (2H, d, J = 7.2 Hz), 8.88 (2H, d, J = 7.2 Hz).
IR (KBr) cm"1 : 3410, 2976, 1765, 1632, 1600, 1529, 1465, 1360, 1296, 1208, 1150, 1119, 1061, 1031. IR (KBr) cm " 1 : 3410, 2976, 1765, 1632, 1600, 1529, 1465, 1360, 1296, 1208, 1150, 1119, 1061, 1031.
MS(ESI): 670+ (M + H)+ MS (ESI): 670 + (M + H) +
元素分析 C H N NaO S -4.7 H O - 0.1 NaHCO Elemental analysis C H N NaO S -4.7 H O-0.1 NaHCO
計算値: C,43.00; Η,4·56; Ν, 12.49; S, 12.26; Na,3.22 (%) Calculated value: C, 43.00; Η, 4.56; Ν, 12.49; S, 12.26; Na, 3.22 (%)
実験値: C,42.92; Η,4·41; Ν, 12.41; S, 12.46; Na,3.38 (%) Experimental value: C, 42.92; Η, 4.41; Ν, 12.41; S, 12.46; Na, 3.38 (%)
実施例 185 Example 185
[化 232]
[Chemical 232]
62 62
(40) 32 + 3→62 (40) 32 + 3 → 62
化合物 11と同様な方法で化合物 32(855 mg)と化合物 3(368 mg)から化合物 62(148 mg )を得た。 Compound 62 (148 mg) was obtained from Compound 32 (855 mg) and Compound 3 (368 mg) in the same manner as Compound 11.
'H-NMR (D O) δ: 1.27 - 1.30 (6Η, m), 3.62 and 3.69 (2H, ABq, J = 17.4 Hz), 4.49 'H-NMR (D O) δ: 1.27-1.30 (6Η, m), 3.62 and 3.69 (2H, ABq, J = 17.4 Hz), 4.49
(1H, m), 5.26 (1H, d, J = 4.8 Hz) 5.32 (2H, d, J = 7.2 Hz), 5.82 (1H, d, J = 4.8 Hz) , 6.10 (1H, dt, J = 7.2, 15.6 Hz), 6.90 (1H, d, J = 4.2 Hz), 6.96 (1H, s), 6.97 (1H, d , 15.6 Hz), 7.41 (1H, d, J = 4.2 Hz), 8.38 (2H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 Hz). (1H, m), 5.26 (1H, d, J = 4.8 Hz) 5.32 (2H, d, J = 7.2 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 7.2 , 15.6 Hz), 6.90 (1H, d, J = 4.2 Hz), 6.96 (1H, s), 6.97 (1H, d, 15.6 Hz), 7.41 (1H, d, J = 4.2 Hz), 8.38 (2H, d, J = 6.9 Hz), 8.89 (2H, d, J = 6.9 Hz).
IR (KBr) cm"1 : 3398, 2977, 1763, 1631, 1536, 1454, 1433, 1373, 1330, 1201, 1156, 1117, 1038. IR (KBr) cm " 1 : 3398, 2977, 1763, 1631, 1536, 1454, 1433, 1373, 1330, 1201, 1156, 1117, 1038.
MS(ESI): 698+ (M + H)+ MS (ESI): 698+ (M + H) +
元素分析 C H N Na O S - 5.4 H O Elemental analysis C H N Na O S-5.4 H O
計算値: C,41.51; Η,4·30; Ν, 11.69; S, 11.47; Na,5.48 (%) Calculated value: C, 41.51; Η, 4.30; Ν, 11.69; S, 11.47; Na, 5.48 (%)
実験値: C,41.57; H,4.24; N, 11.52; S, 11.50; Na,5.14 (%) Experimental value: C, 41.57; H, 4.24; N, 11.52; S, 11.50; Na, 5.14 (%)
実施例 186 Example 186
[化 233]
[Chemical 233]
(41) 63→64 (41) 63 → 64
化合物 63(3.14 g)の THF(40 mL)溶液にジフヱニルジァゾメタン (4.27 g)を注意深く加 え室温で 30分攪拌した。溶媒を減圧留去し、析出した結晶をへキサン-ジイソプロピ ルエーテルで洗浄し、減圧乾燥して化合物 64(7.12 g)を得た。 Diphenyldiazomethane (4.27 g) was carefully added to a solution of compound 63 (3.14 g) in THF (40 mL), and the mixture was stirred at room temperature for 30 minutes. The solvent was distilled off under reduced pressure, and the precipitated crystals were washed with hexane-diisopropyl ether and dried under reduced pressure to obtain Compound 64 (7.12 g).
H-NMR (CDC13) d:7.12 (1H, s), 7.33 - 7.40 (10H, m), 7.50 (1H, s), 11.5 (1H, brs). H-NMR (CDC13) d: 7.12 (1H, s), 7.33-7.40 (10H, m), 7.50 (1H, s), 11.5 (1H, brs).
(42) 64→65 (42) 64 → 65
化合物 64(7.12 g)のエタノール (210 mL)溶液に NH4CK3.21 g)の水 (12 mL)溶液、鉄 粉 (10.1 g)を加えて加熱還流下 5時間攪拌した。室温まで冷却後セライト濾過し、濾液 を減圧濃縮した。酢酸ェチル -水を加えて抽出し、有機層を食塩水で洗浄の後無水 硫酸マグネシウムで乾燥、濾過、減圧濃縮した。残渣に酢酸ェチルを加え、 4規定塩 酸-酢酸ェチル (6 mL)を加えて析出した沈殿を濾取、減圧乾燥した。化合物 65(5.40 g)を無色の粉末で得た。 To a solution of compound 64 (7.12 g) in ethanol (210 mL) was added NH4CK3.21 g) in water (12 mL) and iron powder (10.1 g), and the mixture was stirred with heating under reflux for 5 hours. The mixture was cooled to room temperature and filtered through celite, and the filtrate was concentrated under reduced pressure. Ethyl acetate-water was added for extraction, and the organic layer was washed with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. Ethyl acetate was added to the residue, 4N hydrochloric acid-ethyl acetate (6 mL) was added, and the deposited precipitate was collected by filtration and dried under reduced pressure. Compound 65 (5.40 g) was obtained as a colorless powder.
H-NMR (d6-DMSO) d:6.56 (1H, s), 7.03 (1H, s), 7.27 - 7.41 (6H, m), 7.51 - 7.53 ( 4H, m). H-NMR (d6-DMSO) d: 6.56 (1H, s), 7.03 (1H, s), 7.27-7.41 (6H, m), 7.51-7.53 (4H, m).
(43) 65→66 (43) 65 → 66
化合物 6(890 mg)の塩ィ匕メチレン (10 mL)懸濁液を氷冷し、攪拌下、化合物 65(1.65 g) 、トリェチルァミン (2.23 mL)をカ卩えて室温まで昇温した。室温で 3時間攪拌した後酢 酸ェチル -水で抽出し、有機層は食塩水で洗浄後、無水硫酸マグネシウムで乾燥、
濾過し減圧濃縮した。残渣に塩化メチレン (20 mL)を加え氷冷攪拌下、 40%メチルアミ ン -メタノール溶液 (0.255 mL)を加え同温で 10分攪拌し、化合物 6(354 mg)、ピリジン (0 .49 mL)をカ卩えた。氷浴中で 2時間攪拌後、酢酸ェチル -水で抽出し有機層は食塩水 で洗浄し、無水硫酸マグネシウムで乾燥、濾過、減圧濃縮した。得られた結晶性残渣 をジイソプロピルエーテルで洗浄し、減圧乾燥の後、化合物 66(1.23 g)を淡黄色結晶 として得た。 A suspension of compound 6 (890 mg) in salt methylene chloride (10 mL) was ice-cooled, and with stirring, compound 65 (1.65 g) and triethylamine (2.23 mL) were collected and the temperature was raised to room temperature. The mixture was stirred at room temperature for 3 hours, extracted with ethyl acetate-water, and the organic layer was washed with brine and dried over anhydrous magnesium sulfate. Filter and concentrate under reduced pressure. Methylene chloride (20 mL) was added to the residue, 40% methylamine-methanol solution (0.255 mL) was added with stirring under ice cooling, and the mixture was stirred at the same temperature for 10 min.Compound 6 (354 mg), pyridine (0.49 mL) I got The mixture was stirred in an ice bath for 2 hours, extracted with ethyl acetate-water, and the organic layer was washed with brine, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The obtained crystalline residue was washed with diisopropyl ether and dried under reduced pressure to obtain Compound 66 (1.23 g) as pale yellow crystals.
H-NMR (d6-DMSO) d:7.06 (1H, s), 7.28 - 7.53 (6H, m), 7.53 - 7.55 (4H, m), 7.91 (2H, dd, J = 1.5, 4.2 Hz), 8.78 (2H, dd, J = 1.5, 4.2 Hz), 11.5 (1H, brs), 13.9 (1H, brs). H-NMR (d6-DMSO) d: 7.06 (1H, s), 7.28-7.53 (6H, m), 7.53-7.55 (4H, m), 7.91 (2H, dd, J = 1.5, 4.2 Hz), 8.78 (2H, dd, J = 1.5, 4.2 Hz), 11.5 (1H, brs), 13.9 (1H, brs).
(44) 4 + 66→67 (44) 4 + 66 → 67
化合物 11と同様な方法で化合物 4(869 mg)と化合物 66(398 mg)から化合物 67(201 mg )を得た。 Compound 67 (201 mg) was obtained from Compound 4 (869 mg) and Compound 66 (398 mg) in the same manner as Compound 11.
'H-NMR (D O) δ: 1.29 (3H, t, J = 7.2 Hz), 3.65 (2H, brs), 4.25 (2H, q, J = 7.2 Hz) 'H-NMR (D O) δ: 1.29 (3H, t, J = 7.2 Hz), 3.65 (2H, brs), 4.25 (2H, q, J = 7.2 Hz)
, 5.27 (1H, d, J = 4.8 Hz), 5.38 (2H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.12 ( 1H, dt, J = 6.9, 15.9 Hz), 6.82 (1H, brs), 6.97 (1H, dt, J = 15.9 Hz), 6.99 (lH,s), 8. 43 (2H, d, J = 6.6 H z), 9.01 (2H, d, J = 6.6 Hz). , 5.27 (1H, d, J = 4.8 Hz), 5.38 (2H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6.9, 15.9 Hz) , 6.82 (1H, brs), 6.97 (1H, dt, J = 15.9 Hz), 6.99 (lH, s), 8. 43 (2H, d, J = 6.6 H z), 9.01 (2H, d, J = (6.6 Hz).
IR (KBr) cm"1 : 3410, 1764, 1669, 1599, 1534, 1455, 1362, 1342, 1302, 1200, 1164, 1132, 1035. IR (KBr) cm " 1 : 3410, 1764, 1669, 1599, 1534, 1455, 1362, 1342, 1302, 1200, 1164, 1132, 1035.
MS(ESI): 668+ (M + H)+ MS (ESI): 668 + (M + H) +
元素分析 C H N NaO S -4.2 H O - 0.8 NaHCO Elemental analysis C H N NaO S -4.2 H O-0.8 NaHCO
計算値: C40. ll; H,4.02; N, 15.14; SJ.70; Na,4.97 (%) Calculated value: C40. Ll; H, 4.02; N, 15.14; SJ.70; Na, 4.97 (%)
実験値: C ,40.01; H,4.16; N,15.38; SJ.72; Na,5.09 (%) Experimental value: C, 40.01; H, 4.16; N, 15.38; SJ.72; Na, 5.09 (%)
実施例 187 Example 187
[化 234]
[Chemical 234]
(45) 32 + 66→68 (45) 32 + 66 → 68
化合物 11と同様な方法で化合物 32(855 mg)と化合物 66(398 mg)から化合物 68(216 m g)を得た。 Compound 68 (216 mg) was obtained from Compound 32 (855 mg) and Compound 66 (398 mg) in the same manner as Compound 11.
1H-NMR (D O) δ: 1.27 - 1.30 (6Η, m), 3.62 and 3.69 (2H, ABq, J = 17.4 Hz), 4.4 1H-NMR (D 2 O) δ: 1.27-1.30 (6Η, m), 3.62 and 3.69 (2H, ABq, J = 17.4 Hz), 4.4
9 (IH, m), 5.27 (1H, d, J = 4.8 Hz), 5.39 (2H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 H z), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.83 (1H, brs), 6.96 (IH, s), 6.98 (1H, d, J = 15. 6 Hz), 8.43 (2H, d, J = 6.9 Hz), 9.02 (2H, d, J = 6.9 Hz). 9 (IH, m), 5.27 (1H, d, J = 4.8 Hz), 5.39 (2H, d, J = 6.9 Hz), 5.82 (1H, d, J = 4.8 Hz), 6.12 (1H, dt, J = 6.9, 15.6 Hz), 6.83 (1H, brs), 6.96 (IH, s), 6.98 (1H, d, J = 15.6 Hz), 8.43 (2H, d, J = 6.9 Hz), 9.02 ( 2H, d, J = 6.9 Hz).
IR (KBr) cm—1 : 3408, 2978, 1766, 1596, 1533, 1456, 1397, 1342, 1304, 1200, 1119, 1041. IR (KBr) cm— 1 : 3408, 2978, 1766, 1596, 1533, 1456, 1397, 1342, 1304, 1200, 1119, 1041.
MS(ESI): 682+ (M + H)+ MS (ESI): 682+ (M + H) +
元素分析 C H N NaO S -4.5 H O - 0.8 NaHCO Elemental analysis C H N NaO S -4.5 H O-0.8 NaHCO
計算値: C,40.60; H,4.24; N, 14.80; SJ.53; Na,4.86 (%) Calculated value: C, 40.60; H, 4.24; N, 14.80; SJ.53; Na, 4.86 (%)
実験値: C,40.46; H,4.31; N, 14.79; SJ.82; Na,4.85 (%) Experimental value: C, 40.46; H, 4.31; N, 14.79; SJ.82; Na, 4.85 (%)
実施例 188 Example 188
[化 235]
[Chemical 235]
(46) 69→71 (46) 69 → 71
化合物 69(301 mg)の塩化メチレン (3 mL)溶液に氷冷攪拌下、ピリジン (0.144 mL)、化 合物 70(294 mg)の塩ィヒメチレン (2 mL)溶液を加え、同温で 3時間攪拌した。酢酸ェチ ル -水で抽出し有機層は食塩水で洗浄後、無水硫酸マグネシウムで乾燥し、濾過、 減圧濃縮した。得られた結晶性残渣をジイソプロピルエーテルで洗浄し、減圧乾燥 の後、化合物 71(470 mg)をクリーム色の粉末として得た。 To a solution of compound 69 (301 mg) in methylene chloride (3 mL) is added pyridine (0.144 mL) and compound 70 (294 mg) in salted methylene chloride (2 mL) with ice-cooling and stirring at the same temperature for 3 hours. Stir. The mixture was extracted with ethyl acetate-water, and the organic layer was washed with brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The obtained crystalline residue was washed with diisopropyl ether and dried under reduced pressure to obtain Compound 71 (470 mg) as a cream powder.
H-NMR (CDC13) d: 1.63 (9H, s), 7.53 (1H, s), 7.79 (2H, d, J = 6.0 Hz), 8.68 (1H, br s), 10.3 (1H, brs). H-NMR (CDC13) d: 1.63 (9H, s), 7.53 (1H, s), 7.79 (2H, d, J = 6.0 Hz), 8.68 (1H, br s), 10.3 (1H, brs).
(47) 4 + 71→72 (47) 4 + 71 → 72
化合物 71 (458 mg)の DMF(4.5 mL)溶液に 4(1.23 g)、臭化ナトリウム (463 mg)を加えて 室温で 8.5時間撹拌した。 DMF(4 mL)を加えて希釈し氷冷撹拌下の 5%食塩水 (100 m L)に注加した。同温で 20分間撹拌後、沈殿を濾取し減圧乾燥した。得られた粗成生 物 (1.62 g)を塩化メチレン(20 mL)に溶解し、窒素雰囲気下ァニソール(0.98 mL)を 加え- 40°Cに冷却した。 _40°C下、塩化チタニウム (IV) (2.0M塩化メチレン溶液, 4.5 mL)を滴下した後、氷浴で 1時間攪拌した。この反応液に 2規定塩酸 (5 mL)、ジィソプ 口ピルエーテル (40 mL)を加えて 10分攪拌後、デカントによって有機層を除いた。残 渣をジイソプロピルエーテル (20 mL)を用いてデカントにより 3回洗浄した。残渣に 1規 定塩酸、ァセトニトリルを用いて溶解し HP20ssをカ卩えて濃縮した後、 HP20ssカラムクロ
マトグラフィ一に付して集めた分画に攪拌下 0.2規定水酸化ナトリウムを滴下し pH9を 超えた時点で微量のドライアイスを投入した。濃縮後凍結乾燥して化合物 72 (453 mg )を粉末として得た。 4 (1.23 g) and sodium bromide (463 mg) were added to a solution of compound 71 (458 mg) in DMF (4.5 mL), and the mixture was stirred at room temperature for 8.5 hours. DMF (4 mL) was added for dilution, and the mixture was poured into 5% brine (100 mL) with ice-cooling and stirring. After stirring at the same temperature for 20 minutes, the precipitate was collected by filtration and dried under reduced pressure. The obtained crude product (1.62 g) was dissolved in methylene chloride (20 mL), and anisole (0.98 mL) was added under a nitrogen atmosphere, followed by cooling to -40 ° C. Titanium chloride (IV) (2.0M methylene chloride solution, 4.5 mL) was added dropwise at _40 ° C, followed by stirring in an ice bath for 1 hour. To this reaction solution were added 2N hydrochloric acid (5 mL) and di-sip pill ether (40 mL), and the mixture was stirred for 10 minutes, and then the organic layer was removed by decantation. The residue was washed 3 times by decantation with diisopropyl ether (20 mL). Dissolve the residue in 1N hydrochloric acid and acetonitrile, cover and concentrate HP20ss, and then use HP20ss column chromatography. 0.2N sodium hydroxide was added dropwise to the fraction collected by matography with stirring, and a small amount of dry ice was added when pH 9 was exceeded. Concentration and lyophilization gave Compound 72 (453 mg) as a powder.
'H-NMR (D O) δ: 1.26 (3H, t, J = 7.2 Hz), 3.63 and 3.70 (2H, ABq, J = 17.7 Hz), 'H-NMR (D O) δ: 1.26 (3H, t, J = 7.2 Hz), 3.63 and 3.70 (2H, ABq, J = 17.7 Hz),
4.19 (2H, q, J = 7.2 Hz), 5.22 - 5.26 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.11 (1H, dt , J = 6.9, 15.3 Hz), 6.89 (1H, s), 6.98 (1H, d, J = 15.3 Hz), 8.16 (1H, s), 8.31 (2H, d, J = 6.9 Hz), 8.73 (2H, d, J = 6.9 Hz). 4.19 (2H, q, J = 7.2 Hz), 5.22-5.26 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.11 (1H, dt, J = 6.9, 15.3 Hz), 6.89 (1H , S), 6.98 (1H, d, J = 15.3 Hz), 8.16 (1H, s), 8.31 (2H, d, J = 6.9 Hz), 8.73 (2H, d, J = 6.9 Hz).
IR (KBr) cm—1 : 3421, 1762, 1663, 1634, 1451, 1458, 1380, 1274, 1206, 1155, 1035, 1001. IR (KBr) cm— 1 : 3421, 1762, 1663, 1634, 1451, 1458, 1380, 1274, 1206, 1155, 1035, 1001.
MS(ESI): 685+ (M + H)+ MS (ESI): 685+ (M + H) +
元素分析 C H N NaO S -4.9 H O - 0.2 NaHCO Elemental analysis C H N NaO S -4.9 H O-0.2 NaHCO
計算値: C,40.24; H,4.10; N, 13.80; S, 11.85; Na,3.40 (%) Calculated values: C, 40.24; H, 4.10; N, 13.80; S, 11.85; Na, 3.40 (%)
実験値: C,40.28; Η,4· 10; Ν, 13.81; S, 11.64; Na,3.44 (%) Experimental value: C, 40.28; Η, 4 · 10; Ν, 13.81; S, 11.64; Na, 3.44 (%)
実施例 189 Example 189
[化 236]
[Chemical 236]
(48) 48→74, 75 (48) 48 → 74, 75
化合物 48(6.91 g)のエタノール (70 mL)溶液に化合物 73(11.6 g)のエタノール (30 mL) 溶液をカ卩ぇ加熱還流下 2時間攪拌した。室温まで冷却後エタノールを減圧留去し、 酢酸ェチル -重曹水を加えて抽出した。有機層は食塩水で洗浄し、無水硫酸マグネ シゥムで乾燥後、濃縮した。クロ口ホルムをカ卩えて不溶物を濾去し、再度濃縮して得ら れた残渣をシリカゲルカラムクロマトグラフィーで精製することにより化合物 74(2.54 g) 、化合物 75(4.17 g)をそれぞれ淡茶色結晶として得た。 To a solution of compound 48 (6.91 g) in ethanol (70 mL), a solution of compound 73 (11.6 g) in ethanol (30 mL) was stirred with heating under reflux for 2 hours. After cooling to room temperature, ethanol was distilled off under reduced pressure, and extraction was performed by adding ethyl acetate-aqueous sodium bicarbonate. The organic layer was washed with brine, dried over anhydrous magnesium sulfate and concentrated. The insoluble matter was removed by filtration, and the residue obtained by concentration again was purified by silica gel column chromatography to obtain Compound 74 (2.54 g) and Compound 75 (4.17 g) as pale brown Obtained as crystals.
74: H-NMR (CDC13) δ: 1.47 (3Η, t, J = 7.2 Hz), 2.68 (3H, s), 4.52 (2H, q, J = 7.2 Hz), 7.89 (2H, d, J = 6.0 Hz), 8.79 (2H, d, J = 6.0 Hz). 74: H-NMR (CDC13) δ: 1.47 (3Η, t, J = 7.2 Hz), 2.68 (3H, s), 4.52 (2H, q, J = 7.2 Hz), 7.89 (2H, d, J = 6.0 Hz), 8.79 (2H, d, J = 6.0 Hz).
75: H-NMR (CDC13) δ: 1.46 (3H, t, J = 7.2 Hz), 2.88 (3H, s), 4.46 (2H, q, J = 7.2 Hz), 7.97 (2H, d, J = 4.8 Hz), 8.78 (2H, d, J = 4.8 Hz). 75: H-NMR (CDC13) δ: 1.46 (3H, t, J = 7.2 Hz), 2.88 (3H, s), 4.46 (2H, q, J = 7.2 Hz), 7.97 (2H, d, J = 4.8 Hz), 8.78 (2H, d, J = 4.8 Hz).
(49) 74→77 (49) 74 → 77
化合物 56から化合物 58を得る方法と同様に、化合物 74(2.54 g)から化合物 77(2.15 g)
を得た。 Similar to the method for obtaining Compound 58 from Compound 56, Compound 74 (2.54 g) to Compound 77 (2.15 g) Got.
76: H-NMR (d6-DMSO) δ: 2.63 (3Η, s), 7.96 (2H, dd, J = 1.8, 4.5 Hz), 8.78 (2H, dd, J = 1.8, 4.5 Hz). 76: H-NMR (d6-DMSO) δ: 2.63 (3Η, s), 7.96 (2H, dd, J = 1.8, 4.5 Hz), 8.78 (2H, dd, J = 1.8, 4.5 Hz).
77: H-NMR (CDC13) δ: 2.45 (3H, s), 7.20 (1H, s), 7.30 - 7.49 (10H, m), 7.91 (2 H, d, J = 5.7 Hz), 8.80 (2H, brs). 77: H-NMR (CDC13) δ: 2.45 (3H, s), 7.20 (1H, s), 7.30-7.49 (10H, m), 7.91 (2 H, d, J = 5.7 Hz), 8.80 (2H, brs).
(50) 4 + 77→78 (50) 4 + 77 → 78
化合物 71と同様な方法で化合物 4(1.22 g)と化合物 77(623 mg)から化合物 78(546 mg) を得た。 Compound 78 (546 mg) was obtained from Compound 4 (1.22 g) and Compound 77 (623 mg) in the same manner as Compound 71.
'H-NMR (D O) δ: 1.29 (3H, t, J = 7.2 Hz), 2.70 (3H, s), 3.66 (2H, brs), 4.24 (2H, q, J = 7.2 Hz), 5.27 (1H, d, J = 4.8 Hz), 5.34 (1H, d, J = 7.2 Hz), 5.81 (1H, d, J = 4 • 8 Hz), 6.12 (1H, dt, J = 7.2, 15.6 Hz), 6.96 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 8.54 (2H, d, J = 7.2 Hz), 8.96 (2H, d, J = 7.2 Hz). 'H-NMR (DO) δ: 1.29 (3H, t, J = 7.2 Hz), 2.70 (3H, s), 3.66 (2H, brs), 4.24 (2H, q, J = 7.2 Hz), 5.27 (1H , d, J = 4.8 Hz), 5.34 (1H, d, J = 7.2 Hz), 5.81 (1H, d, J = 4 • 8 Hz), 6.12 (1H, dt, J = 7.2, 15.6 Hz), 6.96 (1H, s), 6.99 (1H, d, J = 15.6 Hz), 8.54 (2H, d, J = 7.2 Hz), 8.96 (2H, d, J = 7.2 Hz).
IR (KBr) cm"1 : 3410, 1763, 1633, 1530, 1463, 1359, 1289, 1210, 1153, 1032, 1000. MS(ESI): 684+ (M + H)+ IR (KBr) cm " 1 : 3410, 1763, 1633, 1530, 1463, 1359, 1289, 1210, 1153, 1032, 1000. MS (ESI): 684 + (M + H) +
元素分析 C H N NaO S - 3.1 H O - 0.1 NaHCO Elemental analysis C H N NaO S-3.1 H O-0.1 NaHCO
計算値: C,43.83; H,3.97; N, 12.73; S, 12.49; Na,3.28 (%) Calculated values: C, 43.83; H, 3.97; N, 12.73; S, 12.49; Na, 3.28 (%)
実験値: C,43.79; H,4.22; N, 12.87; S, 12.56; Na,3.30 (%) Experimental value: C, 43.79; H, 4.22; N, 12.87; S, 12.56; Na, 3.30 (%)
実施例 190 Example 190
[化 237]
[Chemical 237]
(51) 75→80 (51) 75 → 80
化合物 56から化合物 58を得る方法と同様に、化合物 75(4.17 g)から化合物 80(4.42 g) を得た。 Analogously to the method for obtaining compound 58 from compound 56, compound 80 (4.42 g) was obtained from compound 75 (4.17 g).
79: H-NMR (d6-DMSO) δ: 2.73 (3Η, s), 7.97 (2H, d, J = 6.0 Hz), 8.74 (2H, d, J = 6.0 Hz). 79: H-NMR (d6-DMSO) δ: 2.73 (3Η, s), 7.97 (2H, d, J = 6.0 Hz), 8.74 (2H, d, J = 6.0 Hz).
80: H-NMR (CDC13) δ: 2.84 (3H, s), 7.04 (1H, s), 7.30 - 7.47 (10H, m), 7.92 (2H , dd, J = 1.5, 4.8 Hz), 8.76 (2H, dd, J = J = 1.5, 4.8 Hz). 80: H-NMR (CDC13) δ: 2.84 (3H, s), 7.04 (1H, s), 7.30-7.47 (10H, m), 7.92 (2H, dd, J = 1.5, 4.8 Hz), 8.76 (2H , dd, J = J = 1.5, 4.8 Hz).
(52) 4 + 80→81 (52) 4 + 80 → 81
化合物 71と同様な方法で化合物 4(1.22 g)と化合物 80(623 mg)から化合物 81(133 mg) を得た。 Compound 81 (133 mg) was obtained from Compound 4 (1.22 g) and Compound 80 (623 mg) in the same manner as Compound 71.
'H-NMR (D O) δ: 1.27 (3H, t, J = 7.2 Hz), 2.76 (3H, s), 3.67 (2H, brs), 4.21 (2H, q, J = 7.2 Hz), 5.25 (1H, d, J = 4.8 Hz), 5.34 (1H, d, J = 7.2 Hz), 5.78 (1H, d, J = 4 • 8 Hz), 6.11 (1H, dt, J = 7.2, 16.2 Hz), 6.89 (1H, s), 7.01 (1H, d, J = 16.2 Hz), 8.50 (2H, d, J = 6.9 Hz), 8.94 (2H, d, J = 6.9 Hz). 'H-NMR (DO) δ: 1.27 (3H, t, J = 7.2 Hz), 2.76 (3H, s), 3.67 (2H, brs), 4.21 (2H, q, J = 7.2 Hz), 5.25 (1H , d, J = 4.8 Hz), 5.34 (1H, d, J = 7.2 Hz), 5.78 (1H, d, J = 4 • 8 Hz), 6.11 (1H, dt, J = 7.2, 16.2 Hz), 6.89 (1H, s), 7.01 (1H, d, J = 16.2 Hz), 8.50 (2H, d, J = 6.9 Hz), 8.94 (2H, d, J = 6.9 Hz).
IR (KBr) cm"1 : 3419, 2982, 1763, 1633, 1531, 1481, 1381, 1325, 1209, 1155, 1034. MS(ESI): 684+ (M + H)+ IR (KBr) cm " 1 : 3419, 2982, 1763, 1633, 1531, 1481, 1381, 1325, 1209, 1155, 1034. MS (ESI): 684 + (M + H) +
元素分析 C H N NaO S -4.9 H O - 0.3 NaHCO
計算値: C,41.49 ; H,4.20 ; N, 11.97 ; S, 11.74 ; Na,3.65 (%) Elemental analysis CHN NaO S -4.9 HO-0.3 NaHCO Calculated values: C, 41.49; H, 4.20; N, 11.97; S, 11.74; Na, 3.65 (%)
実験値: C,41.37 ; H,4.20 ; N, 12.23 ; S, 11.79 ; Na,3.77 (%) Experimental value: C, 41.37; H, 4.20; N, 12.23; S, 11.79; Na, 3.77 (%)
実施例 191 Example 191
[化 238] [Chemical 238]
(53) 82→89 (53) 82 → 89
化合物 46を得る方法と同様にして化合物 89を合成した。 Compound 89 was synthesized in the same manner as that for obtaining Compound 46.
83 : H-NMR (CDC13) δ : 1.81 (3Η, d, J = 6.9 Hz) 5.16 (2H, d, J = 6.9 Hz), 6.99 (1 H, s), 7.26 - 7.48 (10H, m). 83: H-NMR (CDC13) δ: 1.81 (3Η, d, J = 6.9 Hz) 5.16 (2H, d, J = 6.9 Hz), 6.99 (1 H, s), 7.26-7.48 (10H, m).
84 : H-NMR (CDC13) δ : 1.43 (3H, t, J = 7.2 Hz), 2.82 (3H, s), 4.46 (2H, q, J = 7.2 Hz), 7.14 (1H, s), 7.27 - 7.47 (10H, m). 84: H-NMR (CDC13) δ: 1.43 (3H, t, J = 7.2 Hz), 2.82 (3H, s), 4.46 (2H, q, J = 7.2 Hz), 7.14 (1H, s), 7.27- 7.47 (10H, m).
85 : H-NMR (CDC13) δ : 1.44 (3H, t, J = 6.9 Hz), 2.89 (3H, s), 4.48 (2H, q, J = 6.9 Hz). 85: H-NMR (CDC13) δ: 1.44 (3H, t, J = 6.9 Hz), 2.89 (3H, s), 4.48 (2H, q, J = 6.9 Hz).
87 : H-NMR (CDC13) δ : 1.36 (3H, t, J = 6.9 Hz), 2.84 (3H, s), 4.42 (2H, q, J = 6.9 Hz), 7.84 (2H, dd, J = 1.5, 4.8 Hz), 8.47 (2H, dd, J = 1.5, 4.8 Hz), 10.6 (1H, brs). 87: H-NMR (CDC13) δ: 1.36 (3H, t, J = 6.9 Hz), 2.84 (3H, s), 4.42 (2H, q, J = 6.9 Hz), 7.84 (2H, dd, J = 1.5 , 4.8 Hz), 8.47 (2H, dd, J = 1.5, 4.8 Hz), 10.6 (1H, brs).
88 : H-NMR (d6-DMS0) δ : 2.87 (3H, s), 8.47 (2H, d, J = 7.2 Hz), 8.79 (2H, d, J = 7.2 Hz)11.7 (1H, brs).
89: H-NMR (d6-DMSO) δ: 2.80 (3H, s), 3.75 (3H, s), 5.35 (2H, s), 6.96 (2H, dd, J = 2.1, 6.6 Hz), 7.41 (2H, dd, J = 2.1, 6.6 Hz), 7.80 (2H, dd, J = 1.5, 4.8 Hz), 8.44 (2H, dd, J = 1.5, 4.8 Hz), 10.6 (1H, brs). 88: H-NMR (d6-DMS0) δ: 2.87 (3H, s), 8.47 (2H, d, J = 7.2 Hz), 8.79 (2H, d, J = 7.2 Hz) 11.7 (1H, brs). 89: H-NMR (d6-DMSO) δ: 2.80 (3H, s), 3.75 (3H, s), 5.35 (2H, s), 6.96 (2H, dd, J = 2.1, 6.6 Hz), 7.41 (2H , dd, J = 2.1, 6.6 Hz), 7.80 (2H, dd, J = 1.5, 4.8 Hz), 8.44 (2H, dd, J = 1.5, 4.8 Hz), 10.6 (1H, brs).
(54) 4 + 89→90 (54) 4 + 89 → 90
化合物 5と同様な方法で化合物 4(1.27 g)と化合物 89(575 mg)から化合物 90(335 mg) を得た。 Compound 90 (335 mg) was obtained from Compound 4 (1.27 g) and Compound 89 (575 mg) in the same manner as Compound 5.
1H-NMR (D O) δ: 1.27 (3Η, t, J = 7.2 Hz), 2.77 (3H, s), 3.64 and 3.71 (2H, ABq, 1H-NMR (D O) δ: 1.27 (3Η, t, J = 7.2 Hz), 2.77 (3H, s), 3.64 and 3.71 (2H, ABq,
J = 17.4 Hz), 4.21 (2H, q, J = 7.2 Hz), 5.14 (2H, d, J = 6.6 Hz), 5.26 (1H, d, J = 4.8 Hz), 5.81 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6.6, 15.6 Hz), 6.91 - 6.96 (2H, m), 8.13 (2H, d, J = 7.5 Hz), 8.57 (2H, d, J = 7.5 Hz). J = 17.4 Hz), 4.21 (2H, q, J = 7.2 Hz), 5.14 (2H, d, J = 6.6 Hz), 5.26 (1H, d, J = 4.8 Hz), 5.81 (1H, d, J = 4.8 Hz), 6.10 (1H, dt, J = 6.6, 15.6 Hz), 6.91-6.96 (2H, m), 8.13 (2H, d, J = 7.5 Hz), 8.57 (2H, d, J = 7.5 Hz) .
IR (KBr) cm"1 : 3418, 2981, 1764, 1616, 1519, 1458, 1369, 1328, 1196, 1165, 1108, 1038. IR (KBr) cm " 1 : 3418, 2981, 1764, 1616, 1519, 1458, 1369, 1328, 1196, 1165, 1108, 1038.
MS(ESI): 699+ (M + H)+ MS (ESI): 699+ (M + H) +
元素分析 C H N NaO S - 5.2 H O Elemental analysis C H N NaO S-5.2 H O
計算値: C,41.29; Η,4·38; Ν, 13.76; S, 11.81; Na,2.82 (%) Calculated value: C, 41.29; Η, 4.38; Ν, 13.76; S, 11.81; Na, 2.82 (%)
実験値: C,41.10; H,4.47; N, 13.69; S, 12.11; Na,2.56 (%) Experimental value: C, 41.10; H, 4.47; N, 13.69; S, 12.11; Na, 2.56 (%)
実施例 192 Example 192
[化 239] [Chemical 239]
化合物 91(881 mg)の THF(15 mL)溶液に化合物 92(1.11 g)、カリウム- tert-ブトキシド( 617 mg)を加え室温で 1.5時間攪拌した。化合物 92(405 mg)、カリウム- tert-ブトキシド (224 mg)を追加しさらに 30分攪拌した後、 THFを減圧留去した。 2規定塩酸を加えて p H3.0に調整し、ジイソプロピルエーテルを加えて氷浴中で 15分攪拌した後不溶物を 濾取、減圧乾燥した。化合物 93(1.53 g)を淡茶色固体として得た。 Compound 92 (1.11 g) and potassium tert-butoxide (617 mg) were added to a solution of compound 91 (881 mg) in THF (15 mL), and the mixture was stirred at room temperature for 1.5 hours. Compound 92 (405 mg) and potassium tert-butoxide (224 mg) were added, and the mixture was further stirred for 30 minutes, and then THF was distilled off under reduced pressure. 2N Hydrochloric acid was added to adjust to pH 3.0, diisopropyl ether was added and the mixture was stirred in an ice bath for 15 minutes. The insoluble material was collected by filtration and dried under reduced pressure. Compound 93 (1.53 g) was obtained as a light brown solid.
H-NMR (d6-DMSO) δ: 1.54 (9H, s), 6.80 (1H, s), 7.92 (2H, dd, J = 1.8, 4.5 Hz), 8 .47 (1H, brs), 8.64 (2H, dd, J = 1.8, 4.5 Hz). H-NMR (d6-DMSO) δ: 1.54 (9H, s), 6.80 (1H, s), 7.92 (2H, dd, J = 1.8, 4.5 Hz), 8.47 (1H, brs), 8.64 (2H , dd, J = 1.8, 4.5 Hz).
(56) 4 + 93→94 (56) 4 + 93 → 94
化合物 93(457 mg)の DMF(4 mL)の懸濁液に N, 0_ビストリメチルシリルァセトアミド (0.3 7 mL)を加えて室温で 15分攪拌した。この反応液に化合物 4(1..22 g)、 DMF(0.5 mL)、 臭化ナトリウム (463 mg)をカ卩えて室温終夜で攪拌した後、 DMF(4 mL)を加えて希釈し 氷冷攪拌下の 5 %食塩水 (80 mL)に注加した。同温で 20分攪拌した後吸引濾取して 減圧乾燥し淡茶色の固体 (1.69 g)を得た。この固体を塩化メチレン (3 mL)で溶解し、 窒素雰囲気下ァニソール (0.98 mL)を加え氷冷し、トリフルォロ酢酸 (7.5 mL)を加えて 同温で 2時間攪拌した。 TFA(5 mL)を追カロしてさらに室温で 2.5時間攪拌した後、溶 媒を減圧留去し、残渣にジイソプロピルエーテルを加えて析出した沈殿を濾取した。 この固体をァセトニトリル、水、塩酸を用いて溶解し HP20ssを加えて濃縮後、 HP20ss カラムクロマトグラフィーに付し、集めた分画を濃縮した。濃縮液を pH8にし、 ODSカラ ムクロマトグラフィーに付して集めた分画を濃縮後凍結乾燥した。化合物 94 (208 mg) を粉末として得た。 N, 0_bistrimethylsilylacetamide (0.3 7 mL) was added to a suspension of compound 93 (457 mg) in DMF (4 mL), and the mixture was stirred at room temperature for 15 min. Compound 4 (1..22 g), DMF (0.5 mL), and sodium bromide (463 mg) were added to the reaction mixture and stirred at room temperature overnight, then diluted with DMF (4 mL) and ice-cooled. The mixture was poured into 5% brine (80 mL) with stirring. After stirring at the same temperature for 20 minutes, the solution was collected by suction filtration and dried under reduced pressure to obtain a light brown solid (1.69 g). This solid was dissolved in methylene chloride (3 mL), anisole (0.98 mL) was added under a nitrogen atmosphere, and the mixture was ice-cooled. Trifluoroacetic acid (7.5 mL) was added, and the mixture was stirred at the same temperature for 2 hr. After additional TFA (5 mL) was stirred and further stirred at room temperature for 2.5 hours, the solvent was distilled off under reduced pressure, diisopropyl ether was added to the residue, and the deposited precipitate was collected by filtration. This solid was dissolved in acetonitrile, water, and hydrochloric acid, concentrated by adding HP20ss, and then subjected to HP20ss column chromatography, and the collected fractions were concentrated. The concentrated solution was adjusted to pH 8, and fractions collected by ODS column chromatography were concentrated and lyophilized. Compound 94 (208 mg) was obtained as a powder.
'H-NMR (D O) δ: 1.24 - 1.29 (3Η, m), 3.65 - 3.67 (2H, m), 4.17 - 4.25 (2H, m), 5 'H-NMR (D O) δ: 1.24-1.29 (3Η, m), 3.65-3.67 (2H, m), 4.17-4.25 (2H, m), 5
.24 - 5.26 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.07 - 6.14 (1H, m), 6.89 - 7.02 (2H, m), 8.21 - 8.49 (3H, m), 8.71 - 8.77 (2H, m). .24-5.26 (3H, m), 5.79 (1H, d, J = 4.8 Hz), 6.07-6.14 (1H, m), 6.89-7.02 (2H, m), 8.21-8.49 (3H, m), 8.71 -8.77 (2H, m).
IR (KBr) cm—1 : 3408, 1763, 1634, 1605, 1532, 1457, 1389, 1207, 1156, 1090, 1036.IR (KBr) cm— 1 : 3408, 1763, 1634, 1605, 1532, 1457, 1389, 1207, 1156, 1090, 1036.
MS(ESI): 684+ (M + H)+ MS (ESI): 684+ (M + H) +
元素分析 C H N NaO S -4.9 H O Elemental analysis C H N NaO S -4.9 H O
計算値: C,42.36; H,4.29; N, 12.35; S, 12.12; Na,2.90 (%)
実験値: C,42.26; Η,4·33; Ν, 12.32; S, 12.33; Na,3.15 (%) Calculated values: C, 42.36; H, 4.29; N, 12.35; S, 12.12; Na, 2.90 (%) Experimental value: C, 42.26; Η, 4.33; Ν, 12.32; S, 12.33; Na, 3.15 (%)
実施例 193 Example 193
[化 240] [Chemical 240]
(5) 9→1 0 (5) 9 → 1 0
化合物 9(946mg,5mmol)をジメチルホルムアミド(8ml)に溶解して、カルボニルジイミダ ゾール(1.06g, 6.5mmol)を加えて 3時間攪拌した。次いでトリフロロメタンスルフアミド( 745mg, 5mmol)と DBU (0.75ml, 5mmol)を加えて 60°Cで 2時間攪拌した。反応液を氷 冷して 6N HC1で中和し、析出物を濾取、乾燥して化合物 10を得た。収量 1.33g(67%) 'H-NMR (d -DMSO): 7.53(1H, s), 8.44(2H, d, J=6.6Hz), 8.86(2H, d, J=6.6Hz).Compound 9 (946 mg, 5 mmol) was dissolved in dimethylformamide (8 ml), carbonyldiimidazole (1.06 g, 6.5 mmol) was added, and the mixture was stirred for 3 hours. Next, trifluoromethanesulfamide (745 mg, 5 mmol) and DBU (0.75 ml, 5 mmol) were added and stirred at 60 ° C. for 2 hours. The reaction solution was ice-cooled and neutralized with 6N HC1, and the precipitate was collected by filtration and dried to obtain Compound 10. Yield 1.33g (67%) 'H-NMR (d-DMSO): 7.53 (1H, s), 8.44 (2H, d, J = 6.6Hz), 8.86 (2H, d, J = 6.6Hz).
(6) 10→11 (6) 10 → 11
化合物 10(0.79g,2mmol)をメタノール 8ml懸濁して、 1Mナトリウムメチラート 1.8mlを加え た。反応液を濃縮して 11を得、このまま次の反応に用いた。収量 0.88g。 Compound 10 (0.79 g, 2 mmol) was suspended in 8 ml of methanol, and 1.8 ml of 1M sodium methylate was added. The reaction solution was concentrated to obtain 11, which was used in the next reaction as it was. Yield 0.88g.
(7) 11 +8→12 (7) 11 + 8 → 12
化合物 8(1.7g、 2mmol)をジメチルホルムアミド (6.5ml)に溶解し、化合物 11(0.88g、 2mm ol)と混合し、臭化ナトリウム (617mg、 6mmol)をカ卩えて、室温で 6時間攪拌した。反応液 を 5%食塩水 (60ml)攪拌下にて注加し、析出した沈殿を濾取した。沈殿を減圧乾燥し て化合物 12(2.32g)を粉末として得た。 Compound 8 (1.7 g, 2 mmol) is dissolved in dimethylformamide (6.5 ml), mixed with compound 11 (0.88 g, 2 mmol), sodium bromide (617 mg, 6 mmol) is added and stirred at room temperature for 6 hours. did. The reaction mixture was poured into 5% brine (60 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 12 (2.32 g) as a powder.
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 1.48(9H, s), 3.67, 3.92(2H, ABq, J =
18.0Hz), 4·15(2Η, q, J =7.2Hz), 5.26(2H, d, J=6.4Hz), 5.31(1H, d, J=5.2Hz), 5.95(1 H, dd, J =8.0, 5.2Hz), 6.44(1H, dt, J=15.6, 6.4Hz), 6.89(1H, d, J=15.6Hz), 6.93(1H , s), 7.27-7.52(11H, m), 7.96(1H, s), 8.51(2H, d, J=6.4Hz), 8.91(2H, d, J=6.4Hz), 9 • 74(1H, d, J= 8.0Hz). 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 1.48 (9H, s), 3.67, 3.92 (2H, ABq, J = 18.0Hz), 4.15 (2Η, q, J = 7.2Hz), 5.26 (2H, d, J = 6.4Hz), 5.31 (1H, d, J = 5.2Hz), 5.95 (1 H, dd, J = 8.0, 5.2Hz), 6.44 (1H, dt, J = 15.6, 6.4Hz), 6.89 (1H, d, J = 15.6Hz), 6.93 (1H, s), 7.27-7.52 (11H, m), 7.96 (1H, s), 8.51 (2H, d, J = 6.4Hz), 8.91 (2H, d, J = 6.4Hz), 9 • 74 (1H, d, J = 8.0Hz).
(8) 12→7 (8) 12 → 7
化合物 12(2.31g)を塩化メチレン (23ml)とァニソール (2.3ml)に溶解し、 -30°Cに冷却し た。 2MTiClの塩化メチレン溶液(11ml)をカ卩ぇ 1時間攪拌した。反応液を水-イソプロ ピールエーテルに氷冷下で攪拌しながら注カ卩した。析出した沈殿物を濾取し、 NaHC 〇水で溶解して HP-20SSカラムクロマトグラフィーに付し、水-ァセトニトリルで溶離し た。所望の化合物を含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥して化合物 7を粉末として得た。収量 0.94g(48%) Compound 12 (2.31 g) was dissolved in methylene chloride (23 ml) and anisole (2.3 ml) and cooled to -30 ° C. A solution of 2MTiCl in methylene chloride (11 ml) was stirred for 1 hour. The reaction mixture was poured into water-isopropyl ether with stirring under ice cooling. The deposited precipitate was collected by filtration, dissolved in NaHC 0 water, subjected to HP-20SS column chromatography, and eluted with water-acetonitrile. Fractions containing the desired compound were concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain compound 7 as a powder. Yield 0.94g (48%)
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.42, 3.50(2H, ABq, J = 16.5Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.42, 3.50 (2H, ABq, J = 16.5Hz), 4.0
9(2H, q, J =6.9Hz), 5.04(1H, d, J=4.8Hz), 5.22(2H, d, J=6.8Hz), 5.59(1H, dd, J =8. 1, 4.8Hz), 5.84(1H, dt, J=15.9, 6.8Hz), 6.72(1H, s), 7.22(2H, s), 7.29(1H, d, J=15.9 Hz), 7.52(1H, s), 8.49(2H, d, J=6.8Hz), 8.91(2H, d, J=6.8Hz), 9.53(1H, d, J=8.1Hz) 9 (2H, q, J = 6.9Hz), 5.04 (1H, d, J = 4.8Hz), 5.22 (2H, d, J = 6.8Hz), 5.59 (1H, dd, J = 8.1, 4.8Hz ), 5.84 (1H, dt, J = 15.9, 6.8Hz), 6.72 (1H, s), 7.22 (2H, s), 7.29 (1H, d, J = 15.9 Hz), 7.52 (1H, s), 8.49 (2H, d, J = 6.8Hz), 8.91 (2H, d, J = 6.8Hz), 9.53 (1H, d, J = 8.1Hz)
IR (KBr) cm"1: 3420, 1763, 1636, 1533, 1394, 1299, 1203, 1119, 1035, 963, 819, 60 8. IR (KBr) cm " 1 : 3420, 1763, 1636, 1533, 1394, 1299, 1203, 1119, 1035, 963, 819, 60 8.
MS(ESI): 756+ (M-Na+2H)+ MS (ESI): 756 + (M-Na + 2H) +
元素分析 C H F N O S Na'4.5H O ' O. lNaHCO Elemental analysis C H F N O S Na'4.5H O 'O. lNaHCO
計算値: C,37.53; H,3.73; N,14.54; F,6.57; S, 11.09; Na,2.92 (%) Calculated: C, 37.53; H, 3.73; N, 14.54; F, 6.57; S, 11.09; Na, 2.92 (%)
実験値: C37.45; H,3.84; N,14.56; F,6.40; S,11.36; Na,3.11 (%) Experimental value: C37.45; H, 3.84; N, 14.56; F, 6.40; S, 11.36; Na, 3.11 (%)
実施例 194 Example 194
[化 241]
[Chemical 241]
(14) 21→22 (14) 21 → 22
化合物 21(3.04g,15mmol)をジメチルホルムアミド (30ml)に懸濁して、カルボニルジイミ ダゾーノレ(3.51g, 21.7mmol)を加えて 2時間攪拌した。反応液を氷冷下で酢酸ェチル に注カ卩して、不溶物を濾去した後、 28%アンモニア水 (15ml)をカ卩えた。反応液に酢酸 ェチルを加え、水洗、乾燥、濃縮して 22を結晶として得た。収量 2.14g(70%) Compound 21 (3.04 g, 15 mmol) was suspended in dimethylformamide (30 ml), carbonyldiimidazole (3.51 g, 21.7 mmol) was added, and the mixture was stirred for 2 hours. The reaction mixture was poured into ethyl acetate under ice-cooling, insoluble material was removed by filtration, and 28% aqueous ammonia (15 ml) was added. Ethyl acetate was added to the reaction solution, washed with water, dried and concentrated to obtain 22 as crystals. Yield 2.14 g (70%)
'H-NMR (d -DMSO): 2.43(3H, s), 7.06(2H, brs), 7.30(1H, s), 7.41(2H, d, J=6.0Hz)'H-NMR (d-DMSO): 2.43 (3H, s), 7.06 (2H, brs), 7.30 (1H, s), 7.41 (2H, d, J = 6.0Hz)
, 8.50(2H, d, J=6.0Hz), 11.5(1H, brs). 8.50 (2H, d, J = 6.0Hz), 11.5 (1H, brs).
(15) 22→23 (15) 22 → 23
化合物 22(1.12g,5.6mmol)をピリジン (13ml)に溶解して、無水トリフロロ酢酸(0.91ml, 6. 7mmol)を加えて 1.5時間攪拌した。反応液を濃縮した後、酢酸ェチルと水の混合液を 加え、不溶物を濾去した後、母液を水洗、乾燥、濃縮して 23を結晶として得た。収量 0 .46g(45%) Compound 22 (1.12 g, 5.6 mmol) was dissolved in pyridine (13 ml), trifluoroacetic anhydride (0.91 ml, 6.7 mmol) was added, and the mixture was stirred for 1.5 hours. After concentrating the reaction solution, a mixed solution of ethyl acetate and water was added, insoluble materials were filtered off, and the mother liquor was washed with water, dried and concentrated to obtain 23 as crystals. Yield 0.46g (45%)
'H-NMR (d -DMSO): 2.35(3H, s), 7.06(2H, brs), 7.48(2H, d, J=6.2Hz), 7.63(1H, s) 'H-NMR (d-DMSO): 2.35 (3H, s), 7.06 (2H, brs), 7.48 (2H, d, J = 6.2Hz), 7.63 (1H, s)
, 8.54(2H, d, J=6.2Hz), 12.4(1H, brs). , 8.54 (2H, d, J = 6.2Hz), 12.4 (1H, brs).
(16) 23→24 (16) 23 → 24
化合物 23(971mg,5.3mmol)をジメチルホルムアミド (10ml)に溶解して、 NaN (379mg,5.8Compound 23 (971 mg, 5.3 mmol) was dissolved in dimethylformamide (10 ml) to give NaN (379 mg, 5.8
3mmol)と塩化アンモニゥム (312mg,5.83mmol)を加え、 4時間後にさらに NaN (379mg,5.3 mmol) and ammonium chloride (312 mg, 5.83 mmol), and after 4 hours, further NaN (379 mg, 5.
83mmol)と塩化アンモニゥム (312mg,5.83mmol)を加えて 115°Cで一夜攪拌した。反応 液を冷却後、 2N HC1で中和して析出物を濾取、乾燥して 24を結晶として得た。収量 8
70mg(73%)。 83 mmol) and ammonium chloride (312 mg, 5.83 mmol) were added and stirred overnight at 115 ° C. The reaction solution was cooled and neutralized with 2N HC1, and the precipitate was collected by filtration and dried to obtain 24 as crystals. Yield 8 70 mg (73%).
'H-NMR (d -DMSO): 2.48(3H, s), 7.50— 7.56(2H, m), 8.54(2H, d, J=6.3Hz), 11.9(1 'H-NMR (d-DMSO): 2.48 (3H, s), 7.50—7.56 (2H, m), 8.54 (2H, d, J = 6.3Hz), 11.9 (1
6 6
H, brs). H, brs).
(17) 24 + 8→25 (17) 24 + 8 → 25
化合物 8(1.527g、 1.8mmol)と化合物 24(407mg、 1.8mmol)をジメチルスルホキシド (9ml) に溶解して、ヨウ化ナトリウム (809mg、 5.4mmol)を加えて 5時間攪拌した。反応液を 5% 食塩水 (50ml)攪拌下にて注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して化 合物 25(2.23g)を粉末として得た。 Compound 8 (1.527 g, 1.8 mmol) and compound 24 (407 mg, 1.8 mmol) were dissolved in dimethyl sulfoxide (9 ml), sodium iodide (809 mg, 5.4 mmol) was added, and the mixture was stirred for 5 hours. The reaction solution was poured under stirring with 5% brine (50 ml), and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 25 (2.23 g) as a powder.
'H-NMR (d -DMSO): 1.24(3H, t, J = 6.9Hz), 1.47(9H, s), 2.54(3H, s), 3.66, 3.92(2 'H-NMR (d-DMSO): 1.24 (3H, t, J = 6.9Hz), 1.47 (9H, s), 2.54 (3H, s), 3.66, 3.92 (2
6 6
H, ABq, J = 17.3Hz), 4.14(2H, q, J =6.9Hz), 5.18(2H, d, J=6.6Hz), 5.30(1H, d, J=4. 8Hz), 5.95(1H, dd, J =8.3, 4,8Hz), 6.43(1H, dt, J=15.6, 6.9Hz), 6.87(1H, d, J=15.6 Hz), 6.92(1H, s), 7.25-7.54(l lH, m), 8.06(1H, s), 8.18(2H, d, J=7.1Hz), 8.71(2H, d , J=7.1Hz), 9.74(1H, d, J=8.3Hz), 11.80(1H, s), 12.6(1H, brs). H, ABq, J = 17.3Hz), 4.14 (2H, q, J = 6.9Hz), 5.18 (2H, d, J = 6.6Hz), 5.30 (1H, d, J = 4.8Hz), 5.95 (1H , dd, J = 8.3, 4,8Hz), 6.43 (1H, dt, J = 15.6, 6.9Hz), 6.87 (1H, d, J = 15.6 Hz), 6.92 (1H, s), 7.25-7.54 (l lH, m), 8.06 (1H, s), 8.18 (2H, d, J = 7.1Hz), 8.71 (2H, d, J = 7.1Hz), 9.74 (1H, d, J = 8.3Hz), 11.80 ( 1H, s), 12.6 (1H, brs).
( 18) 25→20 (18) 25 → 20
化合物 25(2.22g)を(8)と同様にして化合物 20を粉末として得た。収量 464 mg(28%) 'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 2.69(3H, s), 3.42, 3.51(2H, ABq, J = Compound 25 (2.22 g) was obtained in the same manner as (8) to give Compound 20 as a powder. Yield 464 mg (28%) 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 2.69 (3H, s), 3.42, 3.51 (2H, ABq, J =
6 6
16.5Hz), 4.09(2H, q, J =7.2Hz), 5.04(1H, d, J=5.1Hz), 5.11(2H, d, J=6.9Hz), 5.60(1 H, dd, J=8.1, 5.1Hz), 5.84(1H, dt, J=16.1, 6.9Hz), 6.72(1H, s), 7.23(2H, s), 7.27(1 H, d, J=16.1Hz), 7.80(1H, s), 8.13(2H, d, J=7.2Hz), 8.64(2H, d, J=7.2Hz), 9.54(1H, d, J=8.1Hz), 12.K1H, brs). 16.5Hz), 4.09 (2H, q, J = 7.2Hz), 5.04 (1H, d, J = 5.1Hz), 5.11 (2H, d, J = 6.9Hz), 5.60 (1 H, dd, J = 8.1 , 5.1Hz), 5.84 (1H, dt, J = 16.1, 6.9Hz), 6.72 (1H, s), 7.23 (2H, s), 7.27 (1 H, d, J = 16.1Hz), 7.80 (1H, s), 8.13 (2H, d, J = 7.2Hz), 8.64 (2H, d, J = 7.2Hz), 9.54 (1H, d, J = 8.1Hz), 12.K1H, brs).
IR (ATR) cm—1: 3308, 1758, 1633, 1602, 1537, 1385, 1150, 1033. IR (ATR) cm— 1 : 3308, 1758, 1633, 1602, 1537, 1385, 1150, 1033.
MS(ESI): 662+ (M-Na+2H)+ MS (ESI): 662 + (M-Na + 2H) +
元素分析 C H N O S Na- 5.0H O -O.lNaHCO Elemental analysis C H N O S Na- 5.0H O -O.lNaHCO
28 26 11 5 2 2 3 28 26 11 5 2 2 3
計算値: C,43.15; H,4.65; N,19.70; S,8.20; Na,3.23 (%) Calculated value: C, 43.15; H, 4.65; N, 19.70; S, 8.20; Na, 3.23 (%)
実験値: C,43.15; H,4.71; N,19.73; S,8.22; Na,3.28 (%) Experimental value: C, 43.15; H, 4.71; N, 19.73; S, 8.22; Na, 3.28 (%)
実施例 195 Example 195
[化 242]
[Chemical 242]
(19) 27→28 (19) 27 → 28
化合物 27(10.37g,71mmol)を酢酸 (12.4ml)に溶解して、氷冷下で亜硝酸ナトリウム (5.6 3g,82mmol)水溶液 (68ml)を滴加する。 1時間攪拌後、反応液にェチルエーテルをカロ えて水洗、乾燥、濃縮する。残渣をへキサンから結晶化させて 28を得た。収量 6.72g( 54%) Compound 27 (10.37 g, 71 mmol) is dissolved in acetic acid (12.4 ml), and an aqueous solution of sodium nitrite (5.6 3 g, 82 mmol) (68 ml) is added dropwise under ice cooling. After stirring for 1 hour, add ethyl ether to the reaction mixture, wash with water, dry and concentrate. The residue was crystallized from hexane to give 28. Yield 6.72 g (54%)
'H-NMR (CDCl ): 3.48(3H, s), 3.92(3H, s), 4.55(2H, s), 9.97(1H, brs). 'H-NMR (CDCl): 3.48 (3H, s), 3.92 (3H, s), 4.55 (2H, s), 9.97 (1H, brs).
(20) 28+29→30 (20) 28 + 29 → 30
化合物 28(5.5 ,31.511111101)と化合物29(3.1 ,2111111101)を酢酸(441111)に溶解して、亜鉛 末 (3.1g,47mmol)をカ卩える。 2時間攪拌後、反応液に酢酸ェチルと炭酸ナトリウム水溶 液をカ卩えた。不溶物を濾去し、有機層は水洗、乾燥、濃縮する。残渣をカラムクロマト で精製して 30を結晶として得た。収量 1.83g(35%) Compound 28 (5.5, 31.511111101) and compound 29 (3.1, 2111111101) are dissolved in acetic acid (441111) to obtain zinc powder (3.1 g, 47 mmol). After stirring for 2 hours, ethyl acetate and aqueous sodium carbonate solution were added to the reaction solution. The insoluble material is removed by filtration, and the organic layer is washed with water, dried and concentrated. The residue was purified by column chromatography to obtain 30 as crystals. Yield 1.83 g (35%)
'H-NMR (CDCl ): 3.47(3H, s), 3.93(3H, s), 4.68(2H, s), 7.20(1H, d, J=3.3Hz), 7.53 'H-NMR (CDCl): 3.47 (3H, s), 3.93 (3H, s), 4.68 (2H, s), 7.20 (1H, d, J = 3.3Hz), 7.53
(2H, d, J=6.2Hz), 8.60(2H, d, J=6.2Hz), 9.52(1H, brs). (2H, d, J = 6.2Hz), 8.60 (2H, d, J = 6.2Hz), 9.52 (1H, brs).
(21) 30→31 (21) 30 → 31
化合物 30(1.78g,7.23mmol)をエタノール (14ml)に溶解して、 2NNaOH(18ml)を加えて 7 0°Cで 1.5時間攪拌する。反応液を濃縮して水を加え冷却し、希 HC1で中和する。析 出晶を濾取、乾燥して 31を得た。収量 1.21g(72%) Compound 30 (1.78 g, 7.23 mmol) is dissolved in ethanol (14 ml), 2NNaOH (18 ml) is added, and the mixture is stirred at 70 ° C. for 1.5 hours. Concentrate the reaction, add water, cool, and neutralize with dilute HC1. The precipitated crystals were collected by filtration and dried to obtain 31. Yield 1.21 g (72%)
'H-NMR (d -DMSO): 3·30(3Η, s), 4·72(2Η, s), 7.67(1Η, d, J=3.3Hz), 7.81(2H, d, J 'H-NMR (d-DMSO): 3 · 30 (3Η, s), 4 · 72 (2Η, s), 7.67 (1Η, d, J = 3.3Hz), 7.81 (2H, d, J
=6.0Hz), 8.54-8.75(2H, m), 12.3(1H, brs).
(22) 31+8→32 = 6.0Hz), 8.54-8.75 (2H, m), 12.3 (1H, brs). (22) 31 + 8 → 32
化合物 31(348mg、 1.5mmol)をジメチルホルムアミド (5ml)に溶解して、 bis-トリメチルシ リルトリフロロァテトアミド(0.4ml、 1.5mmol)を加えて 1時間攪拌する。次いで化合物 8( 1.18g、 1.5mmol)と臭化ナトリウム (463mg、 4.5mmol)を加えて 6時間攪拌した。反応液 を 5%食塩水 (50ml)攪拌下にて注加し、析出した沈殿を濾取した。沈殿を減圧乾燥し て化合物 32(1.36g)を粉末として得、そのまま次の反応に用いた。 Compound 31 (348 mg, 1.5 mmol) is dissolved in dimethylformamide (5 ml), bis-trimethylsilyltrifluoroacetamide (0.4 ml, 1.5 mmol) is added and stirred for 1 hour. Then, compound 8 (1.18 g, 1.5 mmol) and sodium bromide (463 mg, 4.5 mmol) were added and stirred for 6 hours. The reaction solution was poured into 5% brine (50 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 32 (1.36 g) as a powder, which was directly used in the next reaction.
(23) 32→26 (23) 32 → 26
化合物 32(2.22g)を(8)と同様にして化合物 26を粉末として得た。収量 149mg(13%) 'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.27(3H, s), 3.41, 3.50(2H, ABq, J =Compound 32 (2.22 g) was obtained in the same manner as (8) to give Compound 26 as a powder. Yield 149mg (13%) 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.27 (3H, s), 3.41, 3.50 (2H, ABq, J =
16.8Hz), 4.09(2H, q, J =6.9Hz), 5.03(2H, s), 5.04(1H, d, J=5.1Hz), 5.08(2H, d, J=6. 9Hz), 5.59(1H, dd, J=8.1, 5.1Hz), 5.82(1H, dt, J=15.9, 6.9Hz), 6.72(1H, s), 7.23(2 H, s), 7.25(1H, d, J=15.9Hz), 7.67(1H, s), 8.12(2H, d, J=7.2Hz), 8.65(2H, d, J=7.2 Hz), 9.53(1H, d, J=8.1Hz). 16.8Hz), 4.09 (2H, q, J = 6.9Hz), 5.03 (2H, s), 5.04 (1H, d, J = 5.1Hz), 5.08 (2H, d, J = 6.9Hz), 5.59 ( 1H, dd, J = 8.1, 5.1Hz), 5.82 (1H, dt, J = 15.9, 6.9Hz), 6.72 (1H, s), 7.23 (2H, s), 7.25 (1H, d, J = 15.9 Hz), 7.67 (1H, s), 8.12 (2H, d, J = 7.2Hz), 8.65 (2H, d, J = 7.2Hz), 9.53 (1H, d, J = 8.1Hz).
IR (ATR) cm—1: 3300, 1760, 1633, 1581, 1537, 1393, 1335, 1152, 1034. IR (ATR) cm— 1 : 3300, 1760, 1633, 1581, 1537, 1393, 1335, 1152, 1034.
MS(ESI): 667+ (M-Na+2H)+ MS (ESI): 667 + (M-Na + 2H) +
元素分析 C H N O S Na- 5H O -O. lNa HPO Elemental analysis C H N O S Na- 5H O -O.lNa HPO
計算値: C,43.87; H,4.84; N,12.35; S,8.08; Na,3.47 (%) Calculated value: C, 43.87; H, 4.84; N, 12.35; S, 8.08; Na, 3.47 (%)
実験値: C,43.78; H,4.71; N,12.43; S,8.14; Na,3.42 (%) Experimental value: C, 43.78; H, 4.71; N, 12.43; S, 8.14; Na, 3.42 (%)
実施例 196 Example 196
[化 243]
[Chemical 243]
(24) 33→34 (24) 33 → 34
化合物 33(14.42g,100mmol)から(19)と同様にして 34を結晶として得た。収量 10.19g( 59%)34 was obtained as crystals from compound 33 (14.42 g, 100 mmol) in the same manner as (19). Yield 10.19 g (59%)
H-NMR (CDCl ): 1.13(3H, t, J=7.2Hz), 1.36(3H, t, J=7.2Hz), 2.82(2H, q, J=7.2Hz H-NMR (CDCl): 1.13 (3H, t, J = 7.2Hz), 1.36 (3H, t, J = 7.2Hz), 2.82 (2H, q, J = 7.2Hz
), 4.39(2H, q, J=7.2Hz), 9.09(1H, brs). ), 4.39 (2H, q, J = 7.2Hz), 9.09 (1H, brs).
(25) 34+29→35 (25) 34 + 29 → 35
化合物 34(6.49g,37.5mmol)と化合物 29(4.14g,25mmol)から(20)と同様にして 35を結 晶として得た。収量 1.35g(22%) 35 was obtained as a crystal from compound 34 (6.49 g, 37.5 mmol) and compound 29 (4.14 g, 25 mmol) in the same manner as (20). Yield 1.35 g (22%)
'H-NMR (CDCl ): 1·23(3Η, t, J=7.5Hz), 1.40(3H, t, J=7.4Hz), 2.93(2H, q, J=7.5Hz 'H-NMR (CDCl): 1 · 23 (3Η, t, J = 7.5Hz), 1.40 (3H, t, J = 7.4Hz), 2.93 (2H, q, J = 7.5Hz
), 4.38(2H, q, J=7.4Hz), 7.09(1H, d, J=3.0Hz), 7.35(2H, d, J=6.2Hz), 8.59(2H, d, J= 6.2Hz), 9.44(1H, brs). ), 4.38 (2H, q, J = 7.4Hz), 7.09 (1H, d, J = 3.0Hz), 7.35 (2H, d, J = 6.2Hz), 8.59 (2H, d, J = 6.2Hz), 9.44 (1H, brs).
(26) 35→36 (26) 35 → 36
化合物 35(1.30g,5.32mmol)から(21)と同様にして 36を結晶として得た。収量 0.84g(7336 was obtained as a crystal from compound 35 (1.30 g, 5.32 mmol) in the same manner as (21). Yield 0.84 g (73
%) %)
'H-NMR (d -DMSO): 1·13(3Η, t, J=7.5Hz), 2.92(2H, q, J=7.5Hz), 7.36(1H, d, J=3. 'H-NMR (d-DMSO): 1 · 13 (3Η, t, J = 7.5Hz), 2.92 (2H, q, J = 7.5Hz), 7.36 (1H, d, J = 3.
3Hz), 7.49(2H, d, J=6.2Hz), 8.54(2H, d, J=6.2Hz), 11.9(1H, brs), 12.4(1H, brs).3Hz), 7.49 (2H, d, J = 6.2Hz), 8.54 (2H, d, J = 6.2Hz), 11.9 (1H, brs), 12.4 (1H, brs).
(27) 36→37
化合物 36(0.83g,15mmol)力 (14)と同様にして 37を結晶として得た。収量 0.66g(80% ) (27) 36 → 37 Compound 36 (0.83 g, 15 mmol) force 37 was obtained as crystals in the same manner as in (14). Yield 0.66g (80%)
'H-NMR (d -DMSO): 1.10(3H, t, J=7.5Hz), 2.91(2H, q, J=7.5Hz), 7.05(2H, s), 7.2 'H-NMR (d-DMSO): 1.10 (3H, t, J = 7.5Hz), 2.91 (2H, q, J = 7.5Hz), 7.05 (2H, s), 7.2
5(1H, s), 7.38(2H, d, J=6.2Hz), 8.50(2H, d, J=6.2Hz), 11.4(1H, brs). 5 (1H, s), 7.38 (2H, d, J = 6.2Hz), 8.50 (2H, d, J = 6.2Hz), 11.4 (1H, brs).
(28) 37→38 (28) 37 → 38
化合物 37(652mg,3mmol)力、ら(15)と同様にして 38を結晶として得た。収量 529mg(89 %) Compound 37 (652 mg, 3 mmol) was obtained in the same manner as in (15), 38 as crystals. Yield 529 mg (89%)
'H-NMR (d -DMSO): 1.13(3H, t, J=7.5Hz), 2.77(2H, q, J=7.5Hz), 7.45(2H, d, J=5. 'H-NMR (d-DMSO): 1.13 (3H, t, J = 7.5Hz), 2.77 (2H, q, J = 7.5Hz), 7.45 (2H, d, J = 5.
9Hz), 7.55(1H, d, J=3.3Hz), 8.55(2H, d, J=5.9Hz), 12.5(1H, brs). 9Hz), 7.55 (1H, d, J = 3.3Hz), 8.55 (2H, d, J = 5.9Hz), 12.5 (1H, brs).
(29) 38→39 (29) 38 → 39
化合物 38(463mg,2.3mmol)をジメチルホルムアミド (5ml)に溶解して、 NaN (764mg,11.8 mmol)とトリエチルァミン塩酸塩 (1.62g,11.8mmol)を加え、 115°Cで 6時間攪拌した。反 応液を冷却後、 2N HC1で中和して析出物を濾取、乾燥して 39を結晶として得た。収 量 506mg(90%)。 Compound 38 (463 mg, 2.3 mmol) was dissolved in dimethylformamide (5 ml), NaN (764 mg, 11.8 mmol) and triethylamine hydrochloride (1.62 g, 11.8 mmol) were added, and the mixture was stirred at 115 ° C for 6 hours. . The reaction solution was cooled, neutralized with 2N HC1, and the precipitate was collected by filtration and dried to obtain 39 as crystals. Yield 506 mg (90%).
'H-NMR (d -DMSO): 1.11(3H, t, J=7.5Hz), 2.98(2H, q, J=7.5Hz), 7.47(1H, d, J=3. 'H-NMR (d-DMSO): 1.11 (3H, t, J = 7.5Hz), 2.98 (2H, q, J = 7.5Hz), 7.47 (1H, d, J = 3.
OHz), 7.50(2H, d, J=6.3Hz), 8.54(2H, d, J=6.3Hz), 11.9(1H, brs). OHz), 7.50 (2H, d, J = 6.3Hz), 8.54 (2H, d, J = 6.3Hz), 11.9 (1H, brs).
(30) 39 + 2→40 (30) 39 + 2 → 40
化合物 2(1.214g、 1.8mmol)を酢酸ェチル (20ml)に懸濁させ、炭酸水素ナトリウム水溶 液 (227mg、 2.7mmolを水 20mlに溶解)を加え、酢酸ェチルで抽出し、乾燥した。溶媒 を留去後、速やかにジメチルホルムアミド (5ml)に溶解し、化合物 39(432mg、 1.8mmol) と混合し、臭化ナトリウム (556mg、 5.4mmol)をカ卩えて、室温で 7.5時間攪拌した。反応 液を 5%食塩水 (50ml)攪拌下にて注加し、析出した沈殿を濾取した。沈殿を減圧乾燥 して化合物 40(1.492g)を粉末として得た。 Compound 2 (1.214 g, 1.8 mmol) was suspended in ethyl acetate (20 ml), aqueous sodium hydrogen carbonate solution (227 mg, 2.7 mmol dissolved in 20 ml of water) was added, extracted with ethyl acetate and dried. After the solvent was distilled off, it was immediately dissolved in dimethylformamide (5 ml), mixed with compound 39 (432 mg, 1.8 mmol), sodium bromide (556 mg, 5.4 mmol) was added, and the mixture was stirred at room temperature for 7.5 hours. The reaction solution was poured into 5% brine (50 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 40 (1.492 g) as a powder.
'H-NMR (d -DMSO): 1.17(3H, t, J=7.2Hz), 1·23(3Η, t, J=7.2Hz), 3.14(2H, q, J=7. 'H-NMR (d-DMSO): 1.17 (3H, t, J = 7.2Hz), 1.23 (3Η, t, J = 7.2Hz), 3.14 (2H, q, J = 7.
2Hz), 3.65, 3.92(2H, ABq, J=17.7Hz), 4.10(2H, q, J =7.2Hz), 5.18(2H, d, J=6.6Hz), 5.29(1H, d, J=4.8Hz), 5.92(1H, dd, J =8.3, 4,8Hz), 6.43(1H, dt, J=16.5, 6.6Hz), 6. 75(1H, s), 6.88(1H, d, J=16.5Hz), 6.92(1H, s), 7.20— 7.55(12H, m), 8.06(1H, d, J=3. 3Hz), 8.15(2H, d, J=6.6Hz), 8.73(2H, d, J=6.6Hz), 9.65(1H, d, J=8.3Hz), 12.7(1H,
brs). 2Hz), 3.65, 3.92 (2H, ABq, J = 17.7Hz), 4.10 (2H, q, J = 7.2Hz), 5.18 (2H, d, J = 6.6Hz), 5.29 (1H, d, J = 4.8 Hz), 5.92 (1H, dd, J = 8.3, 4,8Hz), 6.43 (1H, dt, J = 16.5, 6.6Hz), 6.75 (1H, s), 6.88 (1H, d, J = 16.5 Hz), 6.92 (1H, s), 7.20—7.55 (12H, m), 8.06 (1H, d, J = 3.3Hz), 8.15 (2H, d, J = 6.6Hz), 8.73 (2H, d, J = 6.6Hz), 9.65 (1H, d, J = 8.3Hz), 12.7 (1H, brs).
(31) 40→32-1 (31) 40 → 32-1
化合物 40(1.48g)を(8)と同様にして化合物 32-1を粉末として得た。収量 460mg(34%) 'H-NMR (d -DMSO): 1.15(3H, t, J=7.5Hz), 1.22(3H, t, J = 7.2Hz), 3.24(2H, q, J = Compound 40-1 (1.48 g) was obtained in the same manner as (8) to give compound 32-1 as a powder. Yield 460mg (34%) 'H-NMR (d-DMSO): 1.15 (3H, t, J = 7.5Hz), 1.22 (3H, t, J = 7.2Hz), 3.24 (2H, q, J =
6 6
7.5Hz), 3.43, 3.51(2H, ABq, J = 17.0Hz), 4.09(2H, q, J =7.2Hz), 5.04(1H, d, J=5.1 7.5Hz), 3.43, 3.51 (2H, ABq, J = 17.0Hz), 4.09 (2H, q, J = 7.2Hz), 5.04 (1H, d, J = 5.1
Hz), 5.11(1H, d, J=5.1Hz), 5.11(2H, d, J=7.2Hz), 5.59(1H, dd, J=8.1, 5.1Hz), 5.84(Hz), 5.11 (1H, d, J = 5.1Hz), 5.11 (2H, d, J = 7.2Hz), 5.59 (1H, dd, J = 8.1, 5.1Hz), 5.84 (
1H, dt, J=15.9, 7.2Hz), 6.72(1H, s), 7.22(2H, s), 7.27(1H, d, J=15.9Hz), 7.76(1H, s1H, dt, J = 15.9, 7.2Hz), 6.72 (1H, s), 7.22 (2H, s), 7.27 (1H, d, J = 15.9Hz), 7.76 (1H, s
), 8.08(2H, d, J=7.2Hz), 8.64(2H, d, J=7.2Hz), 9.53(1H, d, J=8.1Hz), 12.0(1H, brs).), 8.08 (2H, d, J = 7.2Hz), 8.64 (2H, d, J = 7.2Hz), 9.53 (1H, d, J = 8.1Hz), 12.0 (1H, brs).
IR (ATR) cm—1: 3299, 1758, 1632, 1599, 1533, 1354, 1149, 1033. IR (ATR) cm— 1 : 3299, 1758, 1632, 1599, 1533, 1354, 1149, 1033.
MS(ESI): 675+ (M-Na+2H)+ MS (ESI): 675 + (M-Na + 2H) +
元素分析 C H N O S Na- 0.1NaCl -4.2H O Elemental analysis C H N O S Na- 0.1NaCl -4.2H O
29 26 11 5 2 2 29 26 11 5 2 2
計算値: C,44.70; H,4.71; N, 19.77; S,8.23; Na,3.25 Cl,0.45(%) Calculated value: C, 44.70; H, 4.71; N, 19.77; S, 8.23; Na, 3.25 Cl, 0.45 (%)
実験値: C,44.75; H,4.61; N, 19.70; S,8.23; Na,3.24 Cl,0.63 (%) Experimental value: C, 44.75; H, 4.61; N, 19.70; S, 8.23; Na, 3.24 Cl, 0.63 (%)
実施例 197 Example 197
[化 244] [Chemical 244]
(32) 42→43 (32) 42 → 43
化合物 42(4.32g,20mmol)をテトラヒドロフラン (34ml)に溶解して、ジフエニルジァゾメタ ンを加えて、加温攪拌した。反応液に酢酸ェチルを加えて水洗、乾燥、濃縮する。残 渣をカラムクロマト精製して 43を得た。収量 6.25g(82%)Compound 42 (4.32 g, 20 mmol) was dissolved in tetrahydrofuran (34 ml), diphenyldiazomethane was added, and the mixture was heated and stirred. Ethyl acetate is added to the reaction solution, washed with water, dried and concentrated. The residue was purified by column chromatography to give 43. Yield 6.25 g (82%)
H-NMR (CDCl ): 5.7(2H, brs), 6·56(1Η, d, J=6.0Hz), 7.05(1H, s), 7.25- 7.45(11H,
m), 8· 12(1Η, d, J=2.4Hz). H-NMR (CDCl): 5.7 (2H, brs), 6 · 56 (1Η, d, J = 6.0Hz), 7.05 (1H, s), 7.25- 7.45 (11H, m), 8/12 (1Η, d, J = 2.4Hz).
(33) 43→44 (33) 43 → 44
化合物 43(1.5g,3.9mmol)を塩化メチレン (12ml)に溶解して、ピリジン (1.65ml)とメタンス ルフォユルクロリド (1.59ml)を分割して加えて還流下攪拌した。反応液に酢酸ェチルと 2N HC1をカ卩えた後、重曹水で中和して水洗、乾燥、濃縮する。結晶性残渣をへキサ ン-酢酸ェチルで洗浄して 44を結晶として得た。収量 1.56g(86%) Compound 43 (1.5 g, 3.9 mmol) was dissolved in methylene chloride (12 ml), pyridine (1.65 ml) and methanesulfur chloride (1.59 ml) were added in portions, and the mixture was stirred under reflux. After adding ethyl acetate and 2N HC1 to the reaction solution, neutralize with sodium bicarbonate water, wash with water, dry and concentrate. The crystalline residue was washed with hexane-ethyl acetate to give 44 as crystals. Yield 1.56g (86%)
'H-NMR (CDCl ): 3·00(3Η, s), 7.09(1H, s), 7.05(1H, s), 7.30-7.46(10H, m), 7.62-'H-NMR (CDCl): 3 · 00 (3Η, s), 7.09 (1H, s), 7.05 (1H, s), 7.30-7.46 (10H, m), 7.62-
7.70(2H, m), 8.29- 8.33(1H, m), 10.31(1H, s). 7.70 (2H, m), 8.29-8.33 (1H, m), 10.31 (1H, s).
(34) 44 + 45→46 (34) 44 + 45 → 46
化合物 44(1.40g,3mmol)と化合物 45(811mg,4mmol)をジォキサン (14ml)に溶解する。 K PO (1.93g,9mmol)と Pd(PPh ) (176mg,0.15mmol)を加えて 5時間還流する。反応液に 酢酸ェチルを加えて水洗、乾燥して濃縮する。残渣をカラムクロマトで精製して化合 物 46を結晶として得た。収量 688mg(49%) Compound 44 (1.40 g, 3 mmol) and compound 45 (811 mg, 4 mmol) are dissolved in dioxane (14 ml). Add K 3 PO 4 (1.93 g, 9 mmol) and Pd (PPh 3) (176 mg, 0.15 mmol) and reflux for 5 hours. Add ethyl acetate to the reaction mixture, wash with water, dry and concentrate. The residue was purified by column chromatography to obtain Compound 46 as crystals. Yield 688mg (49%)
'H-NMR (CDCl ): 3.07(3H, s), 7.15(1H, s), 7.30-7.46(10H, m), 7.49(2H, d, J=6,0H z), 7.81-7.9K2H, m), 8.48(1H, d, J=1.8Hz), 8.70(2H, d, J=6,0Hz),10.51(lH, s). 'H-NMR (CDCl): 3.07 (3H, s), 7.15 (1H, s), 7.30-7.46 (10H, m), 7.49 (2H, d, J = 6, 0Hz), 7.81-7.9K2H, m), 8.48 (1H, d, J = 1.8Hz), 8.70 (2H, d, J = 6,0Hz), 10.51 (lH, s).
(35) 46 + 2→47 (35) 46 + 2 → 47
化合物 2(919mg、 1.4mmol)と化合物 46(625mg、 1.4 mmol)から(30)と同様にして化合 物 47(1.492g)を粉末として得た。 Compound 47 (1.492 g) was obtained as a powder from Compound 2 (919 mg, 1.4 mmol) and Compound 46 (625 mg, 1.4 mmol) in the same manner as (30).
'H-NMR (d -DMSO): 1.23(3H, t, J=7.2Hz), 3.32(3H, s), 3.65, 3.91(2H, ABq, J=17. 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.2Hz), 3.32 (3H, s), 3.65, 3.91 (2H, ABq, J = 17.
6Hz), 4.10(2H, q, J =7.2Hz), 5.30(1H, d, J=4.8Hz), 5.32(2H, d, J=6.9Hz), 5.93(1H, dd, J =8.4, 4.8Hz), 6.45(1H, dt, J=15.5, 6.9Hz), 6.75(1H, s), 6.92(1H, s), 6.92(1H, d, J=15.5Hz), 7.12(1H, s), 7.23— 7.66(22H, m), 7.85(1H, d, J=9.0Hz), 8.35(1H, dd, J =9.0, 2.6Hz), 8.56(2H, d, J=6.9Hz), 8.70(1H, d, J=2.6Hz), 9.01(2H, d, J=6.9Hz), 9. 65(1H, d, J=8.4Hz), 10.4(1H, s) · 6Hz), 4.10 (2H, q, J = 7.2Hz), 5.30 (1H, d, J = 4.8Hz), 5.32 (2H, d, J = 6.9Hz), 5.93 (1H, dd, J = 8.4, 4.8 Hz), 6.45 (1H, dt, J = 15.5, 6.9Hz), 6.75 (1H, s), 6.92 (1H, s), 6.92 (1H, d, J = 15.5Hz), 7.12 (1H, s), 7.23— 7.66 (22H, m), 7.85 (1H, d, J = 9.0Hz), 8.35 (1H, dd, J = 9.0, 2.6Hz), 8.56 (2H, d, J = 6.9Hz), 8.70 (1H , d, J = 2.6Hz), 9.01 (2H, d, J = 6.9Hz), 9.65 (1H, d, J = 8.4Hz), 10.4 (1H, s) ·
(36) 47→41 (36) 47 → 41
化合物 47(1.5g)を塩化メチレン (8ml)とァニソール (1.5ml)に溶解し、 0°Cに冷却し、 TFA 7.5mlを加えた。混合液を 0°Cで攪拌した後、イソプロピールアルコール 40mlの混合 液に氷冷下で攪拌しながら注加した。析出した沈殿物を濾取し、飽和 NaHCO水で
溶解させた。溶液を HP-20SSカラムクロマトグラフィーに付し、水-ァセトニトリルで溶 離した。所望の化合物を含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥して化 合物 41を粉末として得た。収量 497mg(46%) Compound 47 (1.5 g) was dissolved in methylene chloride (8 ml) and anisole (1.5 ml), cooled to 0 ° C., and 7.5 ml of TFA was added. The mixture was stirred at 0 ° C., and then poured into a mixture of 40 ml of isopropyl alcohol with stirring under ice cooling. The deposited precipitate was collected by filtration and saturated NaHCO 3 aqueous solution. Dissolved. The solution was subjected to HP-20SS column chromatography and dissolved with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 41 as a powder. Yield 497mg (46%)
'H-NMR (d -DMSO): 1.22(3H, t, J=6.9Hz), 2.97(3H, s), 3.42, 3.50(2H, ABq, J=16. 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 2.97 (3H, s), 3.42, 3.50 (2H, ABq, J = 16.
6 6
8Hz), 4.09(2H, q, J=6.9Hz), 5.05(1H, d, J=5.0Hz), 5.22(2H, d, J=6.9Hz), 5.60(1H, dd, J =8.4, 5.0Hz), 5.85(1H, dt, J=15.9, 6.9Hz), 6.72(1H, s), 7.22(2H, s), 7.29(1H, d, J=15.9Hz), 7.57(1H, d, J=9.0Hz), 8.07(1H, dd, J=9.0, 2.6Hz), 8.40(2H, d, J=7.2H z), 8.59(1H, d, J=2.6Hz), 8.87(2H, d, J=7.2Hz), 9.53(1H, d, J=8.4Hz). 8Hz), 4.09 (2H, q, J = 6.9Hz), 5.05 (1H, d, J = 5.0Hz), 5.22 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 8.4, 5.0 Hz), 5.85 (1H, dt, J = 15.9, 6.9Hz), 6.72 (1H, s), 7.22 (2H, s), 7.29 (1H, d, J = 15.9Hz), 7.57 (1H, d, J = 9.0Hz), 8.07 (1H, dd, J = 9.0, 2.6Hz), 8.40 (2H, d, J = 7.2Hz), 8.59 (1H, d, J = 2.6Hz), 8.87 (2H, d, J = 7.2Hz), 9.53 (1H, d, J = 8.4Hz).
IR (ATR) cm—1: 3315, 1760, 1615, 1531, 1487, 1354, 1298, 1144, 1034, 969. IR (ATR) cm— 1 : 3315, 1760, 1615, 1531, 1487, 1354, 1298, 1144, 1034, 969.
MS(ESI): 727+ (M-Na+2H)+ MS (ESI): 727 + (M-Na + 2H) +
元素分析 c H N O S Na-O. lNaHCO -0. lNaCl- 3.6H O Elemental analysis c H N O S Na-O. LNaHCO -0. LNaCl- 3.6H O
30 28 7 9 3 3 2 30 28 7 9 3 3 2
計算値: C,43.62; H,4.29; N,11.83; S,11.61; Na,3.33 Cl,0.43(%) Calculated values: C, 43.62; H, 4.29; N, 11.83; S, 11.61; Na, 3.33 Cl, 0.43 (%)
実験値: C,43.39; H,4.35; N,11.93; S, 12.24; Na,3.16 Cl,0.54 (%) Experimental value: C, 43.39; H, 4.35; N, 11.93; S, 12.24; Na, 3.16 Cl, 0.54 (%)
実施例 198 Example 198
[化 245] [Chemical 245]
(37) 43→49 (37) 43 → 49
化合物 43(1.58g,4.1mmol)を塩化メチレン (13ml)に溶解して、ピリジン (0.5ml,6.2mmol) とァセチルクロリド (0.44ml,6.2mmol)を加えて、攪拌した。反応液に酢酸ェチルと水を 加えた後、中和して水洗、乾燥、濃縮する。結晶性残渣をへキサンで洗浄して 49を
結晶として得た。収量 1.56g(89%) Compound 43 (1.58 g, 4.1 mmol) was dissolved in methylene chloride (13 ml), pyridine (0.5 ml, 6.2 mmol) and acetyl chloride (0.44 ml, 6.2 mmol) were added and stirred. After adding ethyl acetate and water to the reaction solution, neutralize, wash with water, dry and concentrate. Wash the crystalline residue with hexane to remove 49 Obtained as crystals. Yield 1.56g (89%)
'H-NMR (CDCl ): 2.19(3H, s), 7.08(1H, s), 7.28-7.45(10H,m), 7.64(1H, dd, J=9.3, 'H-NMR (CDCl 3): 2.19 (3H, s), 7.08 (1H, s), 7.28-7.45 (10H, m), 7.64 (1H, dd, J = 9.3,
2.4Hz),8.29(lH, d, J=2.4Hz), 8.65(1H, d, J=9.3Hz), 10.90(1H, s). 2.4Hz), 8.29 (lH, d, J = 2.4Hz), 8.65 (1H, d, J = 9.3Hz), 10.90 (1H, s).
(38) 49 + 45→50 (38) 49 + 45 → 50
化合物 49(1.27g,3mmol)と化合物 45(801mg,4mmol)から(34)と同様にして化合物 50を 結晶として得た。収量 589mg(46%) Compound 50 was obtained as crystals from compound 49 (1.27 g, 3 mmol) and compound 45 (801 mg, 4 mmol) in the same manner as in (34). Yield 589mg (46%)
'H-NMR (CDCl ): 2.23(3H, s), 7.14(1H, s), 7.30— 7.47(10H, m), 7.50(2H, d, J=6.3H z), 7.84(1H, dd, J=8.9, 2.3Hz), 8.48(1H, d, J=2.3Hz), 8.68(2H, d, J=6.3Hz), 8.87(1 H, d, J=8.9Hz), 11.04(1H, s). 'H-NMR (CDCl): 2.23 (3H, s), 7.14 (1H, s), 7.30—7.47 (10H, m), 7.50 (2H, d, J = 6.3H z), 7.84 (1H, dd, J = 8.9, 2.3Hz), 8.48 (1H, d, J = 2.3Hz), 8.68 (2H, d, J = 6.3Hz), 8.87 (1 H, d, J = 8.9Hz), 11.04 (1H, s ).
(39) 50 + 2→51 (39) 50 + 2 → 51
化合物 2(857mg、 1.3mmol)と化合物 50(537mg、 1.3mmol)力 (30)と同様にして化合 物 51(1.723g)を粉末として得、そのまま次の反応に用いた。 Compound 51 (1.723 g) was obtained as a powder in the same manner as Compound 2 (857 mg, 1.3 mmol) and Compound 50 (537 mg, 1.3 mmol) (30), and used as it was in the next reaction.
(40) 51→48 (40) 51 → 48
化合物 51(1.72g)を(36)と同様にして化合物 48を粉末として得た。収量 419mg(33%) 'H-NMR (d -DMSO): 1.22(3H, t, J=6.9Hz), 2.11(3H, s), 3.42, 3.50(2H, ABq, J=16.Compound 51 (1.72 g) was obtained in the same manner as (36) to give Compound 48 as a powder. Yield 419mg (33%) 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 2.11 (3H, s), 3.42, 3.50 (2H, ABq, J = 16.
5Hz), 4.09(2H, q, J=6.9Hz), 5.05(1H, d, J=5.1Hz), 5.24(2H, d, J=6.8Hz), 5.59(1H, dd, J =8.0, 5.1Hz), 5.86(1H, dt, J=16.1, 6.8Hz), 6.72(1H, s), 7.23(2H, s), 7.30(1H, d, J=16.1Hz), 8.07(1H, dd, J=8.6, 2.7Hz), 8.42(2H, d, J=7.2Hz), 8.64(1H, d, J=8.6H z), 8.65(1H, d, J=2.7Hz), 8.91(2H, d, J=7.2Hz), 9.53(1H, d, J =8.0Hz), . 5Hz), 4.09 (2H, q, J = 6.9Hz), 5.05 (1H, d, J = 5.1Hz), 5.24 (2H, d, J = 6.8Hz), 5.59 (1H, dd, J = 8.0, 5.1 Hz), 5.86 (1H, dt, J = 16.1, 6.8Hz), 6.72 (1H, s), 7.23 (2H, s), 7.30 (1H, d, J = 16.1Hz), 8.07 (1H, dd, J = 8.6, 2.7Hz), 8.42 (2H, d, J = 7.2Hz), 8.64 (1H, d, J = 8.6H z), 8.65 (1H, d, J = 2.7Hz), 8.91 (2H, d, J = 7.2Hz), 9.53 (1H, d, J = 8.0Hz),.
IR (ATR) cm—1: 3313, 1763, 1584, 1499, 1370, 1288, 1161, 1035, 829. IR (ATR) cm— 1 : 3313, 1763, 1584, 1499, 1370, 1288, 1161, 1035, 829.
MS(ESI): 691+ (M-Na+2H)+ MS (ESI): 691 + (M-Na + 2H) +
元素分析 c H N O S Na-0.2NaHCO -4.2H O Elemental analysis c H N O S Na-0.2NaHCO -4.2H O
計算値: C,46.48; H,4.58; N,12.16; SJ.95; Na,3.42 (%) Calculated value: C, 46.48; H, 4.58; N, 12.16; SJ.95; Na, 3.42 (%)
実験値: C46.48; H,4.68; N,12.36; S,8.00; Na,3.35 (%) Experimental value: C46.48; H, 4.68; N, 12.36; S, 8.00; Na, 3.35 (%)
実施例 199 Example 199
[化 246]
[Chemical 246]
(1) 3→4 (1) 3 → 4
4-ブロモフタル酸 3(735mg, 3. OOmmol)をジメチルホルムアミド (7.50ml)に溶解し、炭酸 カリウム (912mg, 6.60mmol)とパラメトキシベンジルブロマイド (1.33g, 6.60mmol)をカロ え、 3時間撹拌した。精製水 (7.50ml)を加え、酢酸ェチルで有機層を抽出した。抽出 した有機層を精製水、及び飽和食塩水洗浄し、硫酸ナトリウムで脱水した。硫酸ナトリ ゥムをろ過し、溶媒を留去し、ジリカゲルクロマトグラフィーに付し、へキサン-酢酸ェ チル系で溶離し、化合物 4を得た。 775mg(53%)。 4-Bromophthalic acid 3 (735mg, 3.OOmmol) is dissolved in dimethylformamide (7.50ml), and potassium carbonate (912mg, 6.60mmol) and paramethoxybenzyl bromide (1.33g, 6.60mmol) are added and stirred for 3 hours. did. Purified water (7.50 ml) was added, and the organic layer was extracted with ethyl acetate. The extracted organic layer was washed with purified water and saturated brine, and dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, subjected to zirica gel chromatography, and eluted with hexane-ethyl acetate system to obtain compound 4. 775 mg (53%).
'H-NMR (CDCl ): 3.80 (6H, s), 5.15 (2H, s), 5.16(2H, s), 6.89(4H, m), 7.29 (4H, m 'H-NMR (CDCl): 3.80 (6H, s), 5.15 (2H, s), 5.16 (2H, s), 6.89 (4H, m), 7.29 (4H, m
), 7.61 (2H, m), 7.78(1H, m). ), 7.61 (2H, m), 7.78 (1H, m).
(2) 4→5 (2) 4 → 5
化合物 4を 1,4-ジォキサンに溶解させ、燐酸三カリウム(987mg, 4.65mmol)、 4_ピリジ ルボロン酸ピナコールエステル(414mg, 2.02mmol)及び、テトラキストリフエニルホスフ インパラジウム(89mg, 0.0775mmol)を加え、マイクロウエーブ照射下、 120°Cで 35分間 攪拌した。精製水を加え、酢酸ェチルにより水層力 抽出し、有機層を精製水、飽和 食塩水で洗浄後、硫酸ナトリウムで脱水した。硫酸ナトリウムをろ過し、溶媒を留去し 、シリカゲルクロマトグラフィーに付し、へキサン-酢酸ェチル系で溶離し、化合物 5を 得た。 501mg(67%)。 Compound 4 was dissolved in 1,4-dioxane, tripotassium phosphate (987 mg, 4.65 mmol), 4_pyridylboronic acid pinacol ester (414 mg, 2.02 mmol) and tetrakistriphenylphosphine palladium (89 mg, 0.0775 mmol). In addition, the mixture was stirred at 120 ° C for 35 minutes under microwave irradiation. Purified water was added, and the aqueous layer was extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and then dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, and the residue was subjected to silica gel chromatography, eluting with a hexane-ethyl acetate system to obtain Compound 5. 501 mg (67%).
'H-NMR (CDCl ): 3.80 (6H, s), 5.20 (4H, s), 6.89(4H, m), 7.30(4H, m), 7.29 (4H, m), 7.55 (2H, d, J = 5.1Hz), 7.76(1H, dd, J = 8.1, 1.5Hz), 7.86(1H, d, J = 8.1Hz),
7.95(1H, d, J = 1.5Hz). 'H-NMR (CDCl): 3.80 (6H, s), 5.20 (4H, s), 6.89 (4H, m), 7.30 (4H, m), 7.29 (4H, m), 7.55 (2H, d, J = 5.1Hz), 7.76 (1H, dd, J = 8.1, 1.5Hz), 7.86 (1H, d, J = 8.1Hz), 7.95 (1H, d, J = 1.5Hz).
(3) 5 + 2→6→l (3) 5 + 2 → 6 → l
化合物 2(1.38g、 2.04mmol)をジクロロメタン (10ml)に懸濁させ、氷冷下炭酸水素ナトリ ゥム水溶液 (257mg、 3.06mmolを水 10mlに溶解)を加え、ジクロロメタンで抽出し、飽和 食塩水で脱水後、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチル ホルムアミド (6ml)に溶解し、化合物 5(465mg,0.9634mmol)と混合し、臭化ナトリウム (29 7mg、 2.89mmol)をカ卩えて、室温で 4時間攪拌した。反応液を冷却下、 5%食塩水 (30m 1)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して無定形粉末化合 物 6(1.10g)を得た。化合物 6(1.10g)をジクロロメタン (6.0ml)に溶解し、ァニソール (1.00 ml)をカ卩え、 -30°Cに冷却した。トリフルォロ酢酸 (3ml)を滴下し、 1時間 15分攪拌した。 反応液をジイソプロピルエーテル /2-プロパノールの混合溶媒 (1/1, 40ml)に注カロし、 析出した固体をろ取した。この固体を精製水(40ml)に懸濁させ、飽和炭酸水素ナトリ ゥム水溶液にて、 pHを 7.2とした。この溶液をろ過し、 HP-20SSカラムクロマトグラフィ 一及び、 ODSクロマトグラフィーに付し水 -ァセトニトリルで溶離した。所望の化合物を 含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥して化合物 1を粉末として得た 。収量 273mg(34%)。 Compound 2 (1.38 g, 2.04 mmol) is suspended in dichloromethane (10 ml), and an aqueous sodium hydrogen carbonate solution (257 mg, 3.06 mmol is dissolved in 10 ml of water) is added under ice-cooling, followed by extraction with dichloromethane and saturated brine. And dried over magnesium sulfate. After distilling off the solvent, it was immediately dissolved in dimethylformamide (6 ml), mixed with compound 5 (465 mg, 0.9634 mmol), sodium bromide (29 7 mg, 2.89 mmol) was added, and the mixture was stirred at room temperature for 4 hours. . While cooling, the reaction solution was poured into 5% saline (30 ml) while stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain amorphous powder compound 6 (1.10 g). Compound 6 (1.10 g) was dissolved in dichloromethane (6.0 ml), and anisole (1.00 ml) was added and cooled to -30 ° C. Trifluoroacetic acid (3 ml) was added dropwise, and the mixture was stirred for 1 hour and 15 minutes. The reaction solution was poured into a mixed solvent of diisopropyl ether / 2-propanol (1/1, 40 ml), and the precipitated solid was collected by filtration. This solid was suspended in purified water (40 ml), and the pH was adjusted to 7.2 with a saturated aqueous solution of sodium hydrogen carbonate. This solution was filtered, subjected to HP-20SS column chromatography and ODS chromatography, and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 1 as a powder. Yield 273 mg (34%).
JH- NMR (D O): 1· 17(3Η, t, J = 6.9Hz), 3.54(2H, s), 4.13(2H, q, J = 6.9Hz), 5.15( J H-NMR (DO): 1 · 17 (3Η, t, J = 6.9Hz), 3.54 (2H, s), 4.13 (2H, q, J = 6.9Hz), 5.15 (
2 2
1H, d, J = 4.5Hz), 5.16(2H, d, J = 6.9Hz), 5.70(1H, d, J = 4.5Hz), 6.00(1H, dt, J = 17.1, 6.9Hz), 6.84(1H, s), 6.86(1H, d, J = 17.1Hz), 7.50(1H, d, J = 6.0Hz), 7.80(1H , d, J = 6.0Hz), 7.89(1H, s), 8.18(2H, d, J = 7.2Hz), 8.68(2H, d, J = 7.2Hz). 1H, d, J = 4.5Hz), 5.16 (2H, d, J = 6.9Hz), 5.70 (1H, d, J = 4.5Hz), 6.00 (1H, dt, J = 17.1, 6.9Hz), 6.84 ( 1H, s), 6.86 (1H, d, J = 17.1Hz), 7.50 (1H, d, J = 6.0Hz), 7.80 (1H, d, J = 6.0Hz), 7.89 (1H, s), 8.18 ( 2H, d, J = 7.2Hz), 8.68 (2H, d, J = 7.2Hz).
IR (KBr) cm— 3407, 2324, 1762, 1636, 1609, 1584, 1532, 1463, 1396, 1300. IR (KBr) cm— 3407, 2324, 1762, 1636, 1609, 1584, 1532, 1463, 1396, 1300.
MS(ESI): 679+ (M-2Na+4H)+ MS (ESI): 679 + (M-2Na + 4H) +
元素分析 c H N O S Na - 5.3H O -0.3(NaHCO ) Elemental analysis c H N O S Na-5.3H O -0.3 (NaHCO)
30 24 6 9 2 2 2 3 30 24 6 9 2 2 2 3
計算値: C, 43.15; H, 4.17; N, 9.97; S, 7.60; Na, 6.27 (%) Calculated values: C, 43.15; H, 4.17; N, 9.97; S, 7.60; Na, 6.27 (%)
実験値: C, 43.02; H, 4.35; N, 10.43; S, 7.75; Na, 5.92 (%) Experimental values: C, 43.02; H, 4.35; N, 10.43; S, 7.75; Na, 5.92 (%)
実施例 200 Example 200
[化 247]
[Chemical 247]
(4) 9→10 (4) 9 → 10
化合物 9(4.24g, 19.5mmol)をジメチルホルムアミド (42.0ml)に溶解し、炭酸カリウム (5.9 4g, 43.0mmol)とパラメトキシベンジルブロマイド (8.65g, 643.0mmol)を加え、一昼夜 撹拌した。精製水を加え、酢酸ェチルで水層から抽出した。抽出した有機層を精製 水、及び飽和食塩水洗浄し、硫酸ナトリウムで脱水した。硫酸ナトリウムをろ過し、溶 媒を留去し、ジリカゲルクロマトグラフィーに付し、へキサン-酢酸ェチル系で溶離し、 化合物 10を得た。 1.22g(53%)。 Compound 9 (4.24 g, 19.5 mmol) was dissolved in dimethylformamide (42.0 ml), potassium carbonate (5.9 4 g, 43.0 mmol) and paramethoxybenzyl bromide (8.65 g, 643.0 mmol) were added, and the mixture was stirred overnight. Purified water was added and extracted from the aqueous layer with ethyl acetate. The extracted organic layer was washed with purified water and saturated brine, and dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, the residue was subjected to zirica gel chromatography and eluted with a hexane-ethyl acetate system to obtain Compound 10. 1.22g (53%).
'H-NMR (CDCl ) :3.81 (3H, s), 3.82(3H, s), 5.05 (2H, s),5.24 (2H, s), 6.82-6.90(4 'H-NMR (CDCl): 3.81 (3H, s), 3.82 (3H, s), 5.05 (2H, s), 5.24 (2H, s), 6.82-6.90 (4
H, m), 7.11 (1H, dd, J = 1.8, 8.1Hz), 7.18(1H, d, J = 1.8Hz), 7.25-7.34(4H, m), 7.6 9(1H, d, J = 8.1Hz). H, m), 7.11 (1H, dd, J = 1.8, 8.1Hz), 7.18 (1H, d, J = 1.8Hz), 7.25-7.34 (4H, m), 7.6 9 (1H, d, J = 8.1 Hz).
(5) 10→11 (5) 10 → 11
化合物 10(1.22g, 2.67mmol)を 1,4-ジォキサン (12.0ml)に溶解させ、燐酸三カリウム(9 87mg, 4.65mmol)、 4-ピリジルボロン酸ピナコールエステル(1.22g, 2.67mmol)及び、 テトラキストリフエニルホスフィンパラジウム(154mg, 0.134mmol)を加え、 2時間加熱還 流した。精製水を加え、酢酸ェチルにより水層力 抽出し、有機層を精製水、飽和食 塩水で洗浄後、硫酸ナトリウムで脱水した。硫酸ナトリウムをろ過し、溶媒を留去し、シ リカゲルクロマトグラフィーに付し、へキサン-酢酸ェチル系で溶離し、化合物 11を得 た。 651mg(54%)。
Ή-NMR (CDC1 ) :3.81 (3H, s), 3.82(3H, s), 5.17 (2H, s),5.29 (2H, s), 6.86(2H, d, JCompound 10 (1.22 g, 2.67 mmol) was dissolved in 1,4-dioxane (12.0 ml), tripotassium phosphate (987 mg, 4.65 mmol), 4-pyridylboronic acid pinacol ester (1.22 g, 2.67 mmol), and Tetrakistriphenylphosphine palladium (154 mg, 0.134 mmol) was added and heated to reflux for 2 hours. Purified water was added, and the aqueous layer was extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and then dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, the residue was subjected to silica gel chromatography and eluted with a hexane-ethyl acetate system to obtain Compound 11. 651 mg (54%). Ή-NMR (CDC1): 3.81 (3H, s), 3.82 (3H, s), 5.17 (2H, s), 5.29 (2H, s), 6.86 (2H, d, J
3 Three
= 9.0Hz), 6.80 (2H, d, J = 9.0Hz), 7.24-7.27(2H, m), 7.32(2H, d, J = 9.0Hz), 7.36( 2H, d, J = 9.0Hz), 7.62(2H, d, J = 6.3Hz), 7.94(1H, d, J = 8.4Hz), 8.71(2H, d, J = 6 • 3Hz). = 9.0Hz), 6.80 (2H, d, J = 9.0Hz), 7.24-7.27 (2H, m), 7.32 (2H, d, J = 9.0Hz), 7.36 (2H, d, J = 9.0Hz), 7.62 (2H, d, J = 6.3Hz), 7.94 (1H, d, J = 8.4Hz), 8.71 (2H, d, J = 6 • 3Hz).
(6) 11 + 8→12→7 (6) 11 + 8 → 12 → 7
化合物 8(1.06g、 1.43mmol)と化合物 l l(652mg, 1.43mmol)をジメチルホルムアミド (4.5 ml)に溶解させ、臭化ナトリウム (442mg4.29mmol)をカ卩え、 6時間攪拌した。反応液を冷 却下、 5%食塩水 (45ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥 して無定形粉末として化合物 12 (1.80g)を得た。化合物 12(1.80g)をジクロロメタン (18. 0ml)に溶解し、ァニソール (1.80ml)を加え、 _30°Cに冷却した。 2M四塩化チタン(ジク ロロメタン溶液)を滴下し (5.70ml)、 50分攪拌した。反応液を精製水 (50ml)に注加し、 ジイソプロピルエーテル (50ml)をカ卩ぇ析出した固体をろ取した。この固体を精製水(50 ml)に懸濁させ、飽和炭酸水素ナトリウム水溶液にて pHを 7.3とし、 HP-20SSカラムクロ マトグラフィ一に付し、水 -ァセトニトリルで溶離した。所望の化合物を含むフラクション を減圧下濃縮し、濃縮液を凍結乾燥して化合物 7を粉末として得た。収量 284mg(26% )。 Compound 8 (1.06 g, 1.43 mmol) and Compound l l (652 mg, 1.43 mmol) were dissolved in dimethylformamide (4.5 ml), sodium bromide (442 mg 4.29 mmol) was added, and the mixture was stirred for 6 hours. The reaction solution was cooled and poured into 5% brine (45 ml) with stirring, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 12 (1.80 g) as an amorphous powder. Compound 12 (1.80 g) was dissolved in dichloromethane (18.0 ml), and anisole (1.80 ml) was added and cooled to -30 ° C. 2M titanium tetrachloride (dichloromethane solution) was added dropwise (5.70 ml), and the mixture was stirred for 50 minutes. The reaction solution was poured into purified water (50 ml), and a solid precipitated with diisopropyl ether (50 ml) was collected by filtration. This solid was suspended in purified water (50 ml), adjusted to pH 7.3 with saturated aqueous sodium hydrogen carbonate solution, subjected to HP-20SS column chromatography and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 7 as a powder. Yield 284 mg (26%).
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.42, 3.50(2H, ABq, J = 16.8Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.42, 3.50 (2H, ABq, J = 16.8Hz), 4.0
6 6
9(2H, q, J = 6.9Hz), 5.04(1H, d, J = 4.8Hz), 5.27(2H, d, J = 6.9Hz), 5.59(1H, dd, J = 4.8, 8.1Hz), 5.86(1H, dt, J = 15.3, 4.8Hz), 6.72(1H, s), 7.21(2H, s), 7.25(1H, dd, J = 1.8, 7.8Hz), 7.31(1H, d, J = 15.3Hz), 7.32(1H, d, 1.8Hz), 7.84(1H, d, J = 8.1H z), 8.46(2H, d, J = 6.9Hz), 8.97(2H, d, J = 6.9Hz), 9.52(1H, d, J = 8.1Hz). 9 (2H, q, J = 6.9Hz), 5.04 (1H, d, J = 4.8Hz), 5.27 (2H, d, J = 6.9Hz), 5.59 (1H, dd, J = 4.8, 8.1Hz), 5.86 (1H, dt, J = 15.3, 4.8Hz), 6.72 (1H, s), 7.21 (2H, s), 7.25 (1H, dd, J = 1.8, 7.8Hz), 7.31 (1H, d, J = 15.3Hz), 7.32 (1H, d, 1.8Hz), 7.84 (1H, d, J = 8.1Hz), 8.46 (2H, d, J = 6.9Hz), 8.97 (2H, d, J = 6.9Hz) , 9.52 (1H, d, J = 8.1Hz).
IR (KBr) cm— 3418, 2324, 1762, 1634, 1525, 1425, 1376. IR (KBr) cm— 3418, 2324, 1762, 1634, 1525, 1425, 1376.
MS(ESI): 651+ (M-Na+2H)+ MS (ESI): 651 + (M-Na + 2H) +
元素分析 c H N O S Na-4.3 H O - 0.2(NaHCO ) Elemental analysis c H N O S Na-4.3 H O-0.2 (NaHCO)
29 25 6 8 3 2 3 29 25 6 8 3 2 3
計算値: C, 45.73; H, 4.44; N, 10.96; S, 8.36; Na, 3.60 (%) Calculated values: C, 45.73; H, 4.44; N, 10.96; S, 8.36; Na, 3.60 (%)
実験値: C, 45.64; H, 4.42; N, 11.08; S, 8.64; Na, 3.53 (%) Experimental values: C, 45.64; H, 4.42; N, 11.08; S, 8.64; Na, 3.53 (%)
実施例 201 Example 201
[化 248]
[Chemical 248]
(7) 14→15 (7) 14 → 15
化合物 14(2.37g, lO.Ommol)をジメチルホルムアミド (25.0ml)に溶解し、炭酸カリウム (1. 52g, l l.Ommol)を加え、パラメトキシベンジルブロマイド (2.21g, ll.Ommol)を加え、 2 時間撹拌した。精製水 (25ml)をカ卩え、酢酸ェチルで水層から抽出した。抽出した有機 層を精製水、及び飽和食塩水洗浄し、硫酸ナトリウムで脱水した。硫酸ナトリウムをろ 過し、溶媒を留去し、得られた個体をジイソプロピルエーテルで洗浄し、化合物 15を 白色個体として得た。 2.51g(70%)。 Compound 14 (2.37 g, lO.Ommol) is dissolved in dimethylformamide (25.0 ml), potassium carbonate (1.52 g, l l.Ommol) is added, and paramethoxybenzyl bromide (2.21 g, ll.Ommol) is added. And stirred for 2 hours. Purified water (25 ml) was added and extracted from the aqueous layer with ethyl acetate. The extracted organic layer was washed with purified water and saturated brine, and dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, and the resulting solid was washed with diisopropyl ether to obtain Compound 15 as a white solid. 2.51 g (70%).
'H-NMR (CDCl ) :3.82 (3H, s), 5.32 (2H, s), 6.91 (1H, d, J = 8.7Hz), 7.14(1H, d, J 'H-NMR (CDCl): 3.82 (3H, s), 5.32 (2H, s), 6.91 (1H, d, J = 8.7Hz), 7.14 (1H, d, J
3 Three
= 7.2Hz), 7.37 (1H, d, J = 8.7Hz). = 7.2Hz), 7.37 (1H, d, J = 8.7Hz).
(8) 15→16 (8) 15 → 16
化合物 15(2.42g, 6.77mmol)を 1,4-ジォキサン (25. Oml)に溶解させ、燐酸三カリウム(4. 31g, 20.4mmol)、 4-ピリジルボロン酸ピナコールエステル(1.80g, 8.80mmol)及び、テ トラキストリフエニルホスフィンパラジウム(391mg, 0.339mmol)を加え、 3時間加熱還流 した。精製水 (25ml)をカ卩え、酢酸ェチルにより水層から抽出し、有機層を精製水、飽 和食塩水で洗浄後、硫酸ナトリウムで脱水した。硫酸ナトリウムをろ過し、溶媒を留去 し、シリカゲルクロマトグラフィーに付し、へキサン-酢酸ェチル系で溶離し、化合物 16 を黄白色ガム状物質として得た。 2.35g(98%)。 Compound 15 (2.42 g, 6.77 mmol) was dissolved in 1,4-dioxane (25. Oml), tripotassium phosphate (4.31 g, 20.4 mmol), 4-pyridylboronic acid pinacol ester (1.80 g, 8.80 mmol) Tetrakistriphenylphosphine palladium (391 mg, 0.339 mmol) was added, and the mixture was heated to reflux for 3 hours. Purified water (25 ml) was added and extracted from the aqueous layer with ethyl acetate, and the organic layer was washed with purified water and saturated Japanese saline, and then dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, and the residue was subjected to silica gel chromatography, eluting with hexane-ethyl acetate system to obtain Compound 16 as a pale yellow gum. 2.35g (98%).
'H-NMR (CDCl ) :3.82 (3H, s), 5.36 (2H, s),6.92 (2H, d, J = 8.7Hz), 7.12(2H, d, J
= 8.4Hz), 7.40 (2H, d, J = 8.7Hz), 7.45(2H, dd, J = 1.8, 4.5Hz), 8.72(2H, dd, J = 1. 8, 4.5Hz). 'H-NMR (CDCl): 3.82 (3H, s), 5.36 (2H, s), 6.92 (2H, d, J = 8.7Hz), 7.12 (2H, d, J = 8.4Hz), 7.40 (2H, d, J = 8.7Hz), 7.45 (2H, dd, J = 1.8, 4.5Hz), 8.72 (2H, dd, J = 1.8, 4.5Hz).
(9) 16 + 8→17→13 (9) 16 + 8 → 17 → 13
化合物 8(1.48g、 2.00mmol)と化合物 16(711mg, 2.00mmol)をジメチルホルムアミド (6.0 ml)に溶解させ、臭化ナトリウム (617mg, 6.00mmol)をカ卩え、 5時間攪拌した。反応液を 冷却下、 5%食塩水 (80ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾 燥して無定形粉末として化合物 17 (2.19g)を得た。化合物 17 (2.19g)をジクロロメタン( 22.0ml)に溶解し、ァニソール (2.20ml)を加え、 _30°Cに冷却した。 2M四塩化チタンの ジクロロメタン溶液 (8.00ml)を滴下し、 75分攪拌した。反応液を精製水 (80ml)に注加し 、ジイソプロピルエーテル (80ml)を加え析出した固体をろ取した。この固体を精製水( 20ml)に懸濁させ、飽和炭酸水素ナトリウム水溶液にて pHを 7.3とし、 HP-20SSカラム クロマトグラフィーに付し、水 -ァセトニトリルで溶離した。所望の化合物を含むフラクシ ヨンを減圧下濃縮し、濃縮液を凍結乾燥して化合物 13を粉末として得た。収量 274mg (17%)。 Compound 8 (1.48 g, 2.00 mmol) and compound 16 (711 mg, 2.00 mmol) were dissolved in dimethylformamide (6.0 ml), sodium bromide (617 mg, 6.00 mmol) was added, and the mixture was stirred for 5 hours. The reaction mixture was poured into 5% brine (80 ml) with stirring under cooling, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 17 (2.19 g) as an amorphous powder. Compound 17 (2.19 g) was dissolved in dichloromethane (22.0 ml), anisole (2.20 ml) was added, and the mixture was cooled to -30 ° C. A 2M titanium tetrachloride solution in dichloromethane (8.00 ml) was added dropwise and stirred for 75 minutes. The reaction solution was poured into purified water (80 ml), diisopropyl ether (80 ml) was added, and the precipitated solid was collected by filtration. This solid was suspended in purified water (20 ml), adjusted to pH 7.3 with saturated aqueous sodium hydrogen carbonate solution, subjected to HP-20SS column chromatography, and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 13 as a powder. Yield 274 mg (17%).
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.41, 3.49(2H, ABq, J = 16.8Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.41, 3.49 (2H, ABq, J = 16.8Hz), 4.0
9(2H, q, J = 6.9Hz), 5.04(1H, d, J = 5.1Hz), 5.27(2H, d, J = 6.9Hz), 5.59(1H, dd, J = 5.1, 8.1Hz), 5.86(1H, dt, J = 15.9, 4.8Hz), 6.72(1H, s), 7.22(2H, s), 7.30(1H, d, J = 15.9Hz), 8.53(2H, d, J = 7.2Hz), 9.05(2H, d, J = 7.2Hz), 9.53(1H, d, J = 8.1Hz). IR (KBr) cm_1:3408, 1763, 1611, 1531, 1411, 1375, 1032. 9 (2H, q, J = 6.9Hz), 5.04 (1H, d, J = 5.1Hz), 5.27 (2H, d, J = 6.9Hz), 5.59 (1H, dd, J = 5.1, 8.1Hz), 5.86 (1H, dt, J = 15.9, 4.8Hz), 6.72 (1H, s), 7.22 (2H, s), 7.30 (1H, d, J = 15.9Hz), 8.53 (2H, d, J = 7.2Hz ), 9.05 (2H, d, J = 7.2Hz), 9.53 (1H, d, J = 8.1Hz). IR (KBr) cm _1 : 3408, 1763, 1611, 1531, 1411, 1375, 1032.
MS(ESI): 671+ (M-Na+2H)+ MS (ESI): 671 + (M-Na + 2H) +
元素分析 C H F N O S Na' 5.2H O ' 0.1(NaHCO ) Elemental analysis C H F N O S Na '5.2H O' 0.1 (NaHCO)
計算値: C, 43.98; H, 4.25; N, 10.57; S, 8.07; Na, 3.18; F, 4.78 (%) Calculated values: C, 43.98; H, 4.25; N, 10.57; S, 8.07; Na, 3.18; F, 4.78 (%)
実験値: C, 43.83; H, 4.23; N, 10.57; S, 8.37; Na, 3.32; F, 4.71 (%) Experimental values: C, 43.83; H, 4.23; N, 10.57; S, 8.37; Na, 3.32; F, 4.71 (%)
実施例 202 Example 202
[化 249]
[Chemical 249]
(10) 18→19 (10) 18 → 19
化合物 18(4.98g, 30. Ommol)をジメチルホルムアミド (50. Oml)に溶解し、炭酸カリウム (9. 12g, 66.0mmol)とパラメトキシベンジルブロマイド (13.3g, 66.0mmol)を加え、一昼夜 撹拌した。精製水 (50.0ml)を加え、酢酸ェチルで水層から抽出した。有機層を精製水 、及び飽和食塩水洗浄し、硫酸ナトリウムで脱水した。硫酸ナトリウムをろ過し、溶媒 を留去し、得られた個体をジイソプロピルエーテルで洗浄し、化合物 19を白色個体と して得た。収量 3.22g(91%)。 Compound 18 (4.98 g, 30. Ommol) was dissolved in dimethylformamide (50. Oml), potassium carbonate (9.12 g, 66.0 mmol) and paramethoxybenzyl bromide (13.3 g, 66.0 mmol) were added, and the mixture was stirred overnight. . Purified water (50.0 ml) was added, and the aqueous layer was extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, and the resulting solid was washed with diisopropyl ether to obtain Compound 19 as a white solid. Yield 3.22 g (91%).
'H-NMR (d -DMSO) :3.78 (6H, s), 5.23 (4H, s), 6.88 (2H, d, J = 8.7Hz), 6.92(2H, d, J =8.7Hz), 7.31 (2H, d, J = 8.7Hz), 7.36 (2H, d, J = 8.7Hz), 7.46(1H, d, J = 8.7 Hz), 8.07(1H, dd, J = 2.1, 8.7Hz), 8.19(1H, d, J = 2.1Hz), 9.90(1H, s). 'H-NMR (d -DMSO): 3.78 (6H, s), 5.23 (4H, s), 6.88 (2H, d, J = 8.7Hz), 6.92 (2H, d, J = 8.7Hz), 7.31 ( 2H, d, J = 8.7Hz), 7.36 (2H, d, J = 8.7Hz), 7.46 (1H, d, J = 8.7Hz), 8.07 (1H, dd, J = 2.1, 8.7Hz), 8.19 ( 1H, d, J = 2.1Hz), 9.90 (1H, s).
(11) 19→20 (11) 19 → 20
化合物 19(7.84g, 19.3mmol)を 2-メチル -2-プロパノール (60.0ml)に懸濁し、 2_メチル- 2-ブテン (20.0ml)、精製水(25ml)を加えた。反応液を 0°Cに冷却し、亜塩素酸ナトリウ ムを 5分かけて滴下し、 24時間攪拌した。 1Mチォ硫酸ナトリウム水溶液(190ml, 190m mol)と酢酸ェチルをカ卩ぇ攪拌した。析出した固体をろ取し、化合物 20を白色固体とし て得た。収量 5.83g(13.8mmol). Compound 19 (7.84 g, 19.3 mmol) was suspended in 2-methyl-2-propanol (60.0 ml), and 2_methyl-2-butene (20.0 ml) and purified water (25 ml) were added. The reaction solution was cooled to 0 ° C., and sodium chlorite was added dropwise over 5 minutes, followed by stirring for 24 hours. A 1M aqueous sodium thiosulfate solution (190 ml, 190 mmol) and ethyl acetate were stirred. The precipitated solid was collected by filtration to obtain Compound 20 as a white solid. Yield 5.83 g (13.8 mmol).
'H-NMR (d -DMSO) :3.76 (6H, s), 5.18 (2H, s), 5.21(2H, s), 6.89 (2H, d, J = 8.7H z), 6.92(2H, d, J =8.7Hz), 7.31 (2H, d, J = 8.7Hz), 7.35 (1H, d, J = 9.0Hz), 7.36 (2 H, d, J = 8.7Hz), 7.46(1H, d, J = 8.7Hz), 8.06(1H, dd, J = 2.4, 9.0Hz), 8.21(1H, d,
J = 2.4Hz). 'H-NMR (d-DMSO): 3.76 (6H, s), 5.18 (2H, s), 5.21 (2H, s), 6.89 (2H, d, J = 8.7H z), 6.92 (2H, d, J = 8.7Hz), 7.31 (2H, d, J = 8.7Hz), 7.35 (1H, d, J = 9.0Hz), 7.36 (2 H, d, J = 8.7Hz), 7.46 (1H, d, J = 8.7Hz), 8.06 (1H, dd, J = 2.4, 9.0Hz), 8.21 (1H, d, J = 2.4Hz).
(12) 20→21 (12) 20 → 21
化合物 20(5.83g, 13.8mmol)、 4_アミノビリジン (1.30g, 13.8mmol)、 4_ジメチルァミノピリ ジン(193mg, 15.2mmol)をジクロロメタン(60. Oml)に懸濁させた。 1_ェチル _3_ (ジメチ ルァミノプロピル) -カルポジイミド塩酸塩 (2.91g, 15.2mmol)を加え、 2日間攪拌した。 精製水(60ml)を加え、ジクロロメタンを留去し、析出した固体をろ取し、化合物 21を白 色固体として得た。収量 (6.51g, 95%). Compound 20 (5.83 g, 13.8 mmol), 4-aminopyridine (1.30 g, 13.8 mmol), and 4-dimethylaminopyridine (193 mg, 15.2 mmol) were suspended in dichloromethane (60. Oml). 1_Ethyl _3_ (dimethylaminopropyl) -carpositimide hydrochloride (2.91 g, 15.2 mmol) was added and stirred for 2 days. Purified water (60 ml) was added, dichloromethane was distilled off, and the precipitated solid was collected by filtration to obtain Compound 21 as a white solid. Yield (6.51g, 95%).
'H-NMR (d -DMSO) :3.76 (6H, s), 5.20(2H, s), 5.23(2H, s), 6.88 (2H, d, J = 8.7Hz 'H-NMR (d -DMSO): 3.76 (6H, s), 5.20 (2H, s), 5.23 (2H, s), 6.88 (2H, d, J = 8.7Hz
), 6.91(2H, d, J =8.7Hz), 7.31 (2H, d, J = 8.7Hz), 7.36 (1H, d, J = 8.7Hz), 7.41 (1H , d, J = 9.0Hz), 7.76(2H, d, J = 6.3Hz), 8.17(1H, dd, J = 9.0, 2.1), 8.28(1H, d, J = 2 • lHz), 8.45(2H, d, J = 6.3Hz). ), 6.91 (2H, d, J = 8.7Hz), 7.31 (2H, d, J = 8.7Hz), 7.36 (1H, d, J = 8.7Hz), 7.41 (1H, d, J = 9.0Hz), 7.76 (2H, d, J = 6.3Hz), 8.17 (1H, dd, J = 9.0, 2.1), 8.28 (1H, d, J = 2 • lHz), 8.45 (2H, d, J = 6.3Hz).
(13) 21 + 2→22→17-1 (13) 21 + 2 → 22 → 17-1
化合物 2(2.02g、 3.00mmol)を酢酸ェチル (21ml)に懸濁させ、氷冷下炭酸水素ナトリウ ム水溶液 (378mg、 4.50mmolを水 21mlに溶解)を加え、酢酸ェチルで抽出し、飽和食 塩水で脱水後、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホ ルムアミド (9ml)に溶解し、化合物 21(1.45g,3.00mmol)と混合し、臭化ナトリウム (926mg 、 9.00mmol)を加えて、室温で 1時間攪拌した。反応液を冷却下、 5%食塩水 (100ml) 攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して無定形粉末として 化合物 22(3.38g)を得た。化合物 22 (3.38g)にァニソール (3.30ml)をカ卩え、 0°Cに冷却 した。トリフルォロ酢酸 (16.5ml)を滴下し、 2時間攪拌した。反応液を 2-プロパノール/ ジイソプロピルエーテルの混合溶媒 (1/1, 90ml)に注加し、析出した固体をろ取した。 この固体を精製水(20ml)に懸濁させ、飽和炭酸水素ナトリウム水溶液にて、 pHを 7.3 とした。この溶液をろ過し、 HP-20SSカラムクロマトグラフィーに付し、水-ァセトニトリル で溶離した。所望の化合物を含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥し て化合物 17-1を粉末として得た。収量 1.10g(46% in 2steps)0 Compound 2 (2.02 g, 3.00 mmol) was suspended in ethyl acetate (21 ml), and an aqueous sodium hydrogen carbonate solution (378 mg, 4.50 mmol dissolved in 21 ml of water) was added under ice cooling, followed by extraction with ethyl acetate and saturated food. After dehydrating with brine, it was dried over magnesium sulfate. After the solvent was distilled off, it was immediately dissolved in dimethylformamide (9 ml), mixed with compound 21 (1.45 g, 3.00 mmol), sodium bromide (926 mg, 9.00 mmol) was added, and the mixture was stirred at room temperature for 1 hour. The reaction solution was poured into 5% brine (100 ml) with stirring under cooling, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 22 (3.38 g) as an amorphous powder. Compound 22 (3.38 g) was charged with anisole (3.30 ml) and cooled to 0 ° C. Trifluoroacetic acid (16.5 ml) was added dropwise and stirred for 2 hours. The reaction mixture was poured into a mixed solvent of 2-propanol / diisopropyl ether (1/1, 90 ml), and the precipitated solid was collected by filtration. This solid was suspended in purified water (20 ml), and the pH was adjusted to 7.3 with a saturated aqueous solution of sodium bicarbonate. The solution was filtered, subjected to HP-20SS column chromatography and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 17-1 as a powder. Yield 1.10 g (46% in 2steps) 0
'H-NMR (d -DMSO): 1.23(3H, t, J = 7.2Hz), 3.42, 3.51(2H, ABq, J = 16.8Hz), 4.1 'H-NMR (d-DMSO): 1.23 (3H, t, J = 7.2Hz), 3.42, 3.51 (2H, ABq, J = 16.8Hz), 4.1
5(2H, q, J = 7.2Hz), 5.03(1H, d, J = 4.8Hz), 5.10(2H, d, J = 6.9Hz), 5.60(1H, dd, J = 4.8, 7.8Hz), 5.81(1H, dt, J = 15.0, 4.8Hz), 6.716(1H, d, J = 8.7Hz), 6.721(1H, s),
7.22(2H, s), 7.25(1H, d, J = 15.0Hz), 7.89(1H, dd, J = 8.7, 2.7Hz), 8.31(2H, d, J = 6.6Hz), 8.50(1H, d, J = 2.7Hz), 8.72(2H, d, J = 6.6Hz), 9.54(1H, d, J = 7.8Hz), 11. 52(1H, br). 5 (2H, q, J = 7.2Hz), 5.03 (1H, d, J = 4.8Hz), 5.10 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 4.8, 7.8Hz), 5.81 (1H, dt, J = 15.0, 4.8Hz), 6.716 (1H, d, J = 8.7Hz), 6.721 (1H, s), 7.22 (2H, s), 7.25 (1H, d, J = 15.0Hz), 7.89 (1H, dd, J = 8.7, 2.7Hz), 8.31 (2H, d, J = 6.6Hz), 8.50 (1H, d , J = 2.7Hz), 8.72 (2H, d, J = 6.6Hz), 9.54 (1H, d, J = 7.8Hz), 11.52 (1H, br).
IR (ATR) cm— 3566, 1749, 1594, 1514, 1375, 1203. IR (ATR) cm— 3566, 1749, 1594, 1514, 1375, 1203.
MS(ESI): 694+ (M-Na+2H)+ MS (ESI): 694 + (M-Na + 2H) +
元素分析 c H N O S Na- 3.8 H O - 0.1(NaHCO ) Elemental analysis c H N O S Na- 3.8 H O-0.1 (NaHCO)
30 26 7 9 2 2 3 30 26 7 9 2 2 3
計算値: C, 45.62; H, 4.29; N, 12.37; S, 8.09; Na, 3.19 (%) Calculated values: C, 45.62; H, 4.29; N, 12.37; S, 8.09; Na, 3.19 (%)
実験値: C, 45.63; H, 4.34; N, 12.53; S, 8.11; Na, 3.14 (%) Experimental values: C, 45.63; H, 4.34; N, 12.53; S, 8.11; Na, 3.14 (%)
実施例 203 Example 203
[化 250] [Chemical 250]
(14) 23→24 (14) 23 → 24
化合物 23(4.74g, 20.0mmol)をジメチルホルムアミド (47.0ml)に溶解し、炭酸カリウム (3. 04g, 22.0mmol)を加え、パラメトキシベンジルブロマイド (4.42g, 22.0mmol)を加え、 2 時間撹拌した。精製水 (50.0ml)を加え、酢酸ェチルで水層から抽出した。抽出した有 機層を精製水、及び飽和食塩水洗浄し、硫酸ナトリウムで脱水した。硫酸ナトリウムを ろ過し、溶媒を留去し、化合物 24を緑色油状物質として得た。収量 7.54g(quant.). 'H-NMR (CDCl ) :3.82 (3H, s), 3.88(3H, s), 5.14 (2H, s), 6.91 (2H, dd, J = 2.1, 6. Compound 23 (4.74 g, 20.0 mmol) is dissolved in dimethylformamide (47.0 ml), potassium carbonate (3.04 g, 22.0 mmol) is added, paramethoxybenzyl bromide (4.42 g, 22.0 mmol) is added, and the mixture is stirred for 2 hours. did. Purified water (50.0 ml) was added, and the aqueous layer was extracted with ethyl acetate. The extracted organic layer was washed with purified water and saturated brine, and dehydrated with sodium sulfate. Sodium sulfate was filtered and the solvent was distilled off to obtain Compound 24 as a green oily substance. Yield 7.54 g (quant.). 'H-NMR (CDCl): 3.82 (3H, s), 3.88 (3H, s), 5.14 (2H, s), 6.91 (2H, dd, J = 2.1, 6.
3 Three
6Hz), 7.39(1H, s), 7.45 (2H, dd, J = 2.1, 6.6Hz).
(15) 24→25 6Hz), 7.39 (1H, s), 7.45 (2H, dd, J = 2.1, 6.6Hz). (15) 24 → 25
化合物 24(7.54g, 21.1mmol)をメタノール (75. Oml)とテトラヒドロフラン (25.0ml)に溶解し 、 2規定水酸化ナトリウム水溶液(53ml, 105.5mmol)をカ卩え、室温で 2時間攪拌した。メ タノール及びテトラヒドロフランを留去し、水層を酢酸ェチルで洗浄した。水層の pHを 1とし、酢酸ェチルで水層から抽出し、精製水、飽和食塩水で洗浄後、硫酸ナトリウム で脱水した。硫酸ナトリウムをろ過し、溶媒を留去し、析出した固体をへキサンで洗浄 し、化合物 25黄色固体として得た。収量 6.20g(86%). Compound 24 (7.54 g, 21.1 mmol) was dissolved in methanol (75. Oml) and tetrahydrofuran (25.0 ml), 2N aqueous sodium hydroxide solution (53 ml, 105.5 mmol) was added, and the mixture was stirred at room temperature for 2 hours. Methanol and tetrahydrofuran were distilled off, and the aqueous layer was washed with ethyl acetate. The aqueous layer was adjusted to pH 1, extracted from the aqueous layer with ethyl acetate, washed with purified water and saturated brine, and dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, and the precipitated solid was washed with hexane to obtain Compound 25 as a yellow solid. Yield 6.20 g (86%).
'H-NMR (CDCl ) :3.82 (3H, s), 5.24 (2H, s), 6.91 (2H, d, J = 8.7Hz), 7.41(2H, d, J 'H-NMR (CDCl): 3.82 (3H, s), 5.24 (2H, s), 6.91 (2H, d, J = 8.7Hz), 7.41 (2H, d, J
= 8.7Hz), 7.52(1H, s). = 8.7Hz), 7.52 (1H, s).
(16) 25→26 (16) 25 → 26
化合物 2 5(6.20g, 18.2mmol)をジメチルホルムアミド (60.0ml)に溶解し、炭酸カリウム (2 • 76g, 20.0mmol)を加え、パラメトキシベンジルブロマイド (4.02g, 20.0mmol)を加え、 3 時間撹拌した。精製水 (60.0ml)を加え、酢酸ェチルで水層から抽出した。抽出した有 機層を精製水、及び飽和食塩水洗浄し、硫酸ナトリウムで脱水した。硫酸ナトリウムを ろ過し、溶媒を留去し、析出した固体をジイソプロピルエーテルで洗浄し化合物 26を 茶褐色の固体として得た。収量 4.87g(58%). Compound 25 (6.20 g, 18.2 mmol) is dissolved in dimethylformamide (60.0 ml), potassium carbonate (2 • 76 g, 20.0 mmol) is added, paramethoxybenzyl bromide (4.02 g, 20.0 mmol) is added, and 3 hours. Stir. Purified water (60.0 ml) was added, and the aqueous layer was extracted with ethyl acetate. The extracted organic layer was washed with purified water and saturated brine, and dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, and the precipitated solid was washed with diisopropyl ether to obtain Compound 26 as a brown solid. Yield 4.87 g (58%).
'H-NMR (d -DMSO) :3.75 (3H, s), 3.77(3H, s), 5.02(2H, s), 5.26(2H, s), 6.87 (2H, d, J = 8.7Hz), 6.96(2H, d, J =8.7Hz), 7.24 (2H, d, J = 8.7Hz), 7.40 (1H, d, J = 8.7 Hz), 8.04(1H, s). 'H-NMR (d-DMSO): 3.75 (3H, s), 3.77 (3H, s), 5.02 (2H, s), 5.26 (2H, s), 6.87 (2H, d, J = 8.7Hz), 6.96 (2H, d, J = 8.7Hz), 7.24 (2H, d, J = 8.7Hz), 7.40 (1H, d, J = 8.7Hz), 8.04 (1H, s).
(17) 26→27 (17) 26 → 27
化合物 26(2.32g, 5.00mmol)とトリメチル (4-ピリジル)チン (1.45g, 6.00mmol)をトルエン( 23.0ml)に懸濁させ、テトラキストリフエニルホスフィンパラジウム (578mg, 0.50mmol)を 加え、 5時間加熱還流した。溶媒を留去し、シリカゲルクロマトグラフィーに付し、化合 物 27を黄色油状物質として得た。収量 1.57g(68%). Compound 26 (2.32 g, 5.00 mmol) and trimethyl (4-pyridyl) tin (1.45 g, 6.00 mmol) were suspended in toluene (23.0 ml), tetrakistriphenylphosphine palladium (578 mg, 0.50 mmol) was added, and 5 Heated to reflux for hours. The solvent was distilled off, and the residue was subjected to silica gel chromatography to obtain Compound 27 as a yellow oily substance. Yield 1.57 g (68%).
'H-NMR (d -DMSO) :3.72 (3H, s), 3.77(3H, s), 4.91(2H, s), 5.28(2H, s), 6.78 (2H, d, J = 8.7Hz), 6.97(2H, d, J =8.7Hz), 7.05 (2H, d, J = 8.7Hz), 7.55 (2H, dd, J = 1. 8, 4.5Hz), 8.24(1H, s), 8.56(2H, dd, J = 1.8, 4.5Hz). 'H-NMR (d-DMSO): 3.72 (3H, s), 3.77 (3H, s), 4.91 (2H, s), 5.28 (2H, s), 6.78 (2H, d, J = 8.7Hz), 6.97 (2H, d, J = 8.7Hz), 7.05 (2H, d, J = 8.7Hz), 7.55 (2H, dd, J = 1.8, 4.5Hz), 8.24 (1H, s), 8.56 (2H , dd, J = 1.8, 4.5Hz).
(18) 27 + 2→28→22-l
化合物 2(1.35g、 2.00mmol)を酢酸ェチル (15ml)に懸濁させ、氷冷下炭酸水素ナトリウ ム水溶液 (252mg、 3.00mmolを水 15mlに溶解)を加え、酢酸ェチルで抽出し、飽和食 塩水で脱水後、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホ ルムアミド (6ml)に溶解し、化合物 27(923mg,2.00mmol)と混合し、臭化ナトリウム (617m g、 6.00mmol)をカ卩えて、室温で 6時間攪拌した。反応液を冷却下、 5%食塩水 (60ml) 攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して無定形粉末として 化合物 28(2.05g)を得た。化合物 28 (1.91g)にァニソール (2.00ml)を加え、 0°Cに冷却 した。トリフルォロ酢酸 (10.0ml)を滴下し、 1時間攪拌した。反応液を 2_プロパノール/ ジイソプロピルエーテルの混合溶媒 (1/1, 90ml)に注カ卩し、析出した固体をろ取した。 この固体を精製水(60ml)に懸濁させ、飽和炭酸水素ナトリウム水溶液にて、 pHを 7.3 とした。この溶液をろ過し、 HP-20SSカラムクロマトグラフィーに付し、水-ァセトニトリル で溶離した。所望の化合物を含むフラクションを減圧下濃縮し、濃縮液を凍結乾燥し て化合物 22-1を粉末として得た。収量 510mg(32%)。 (18) 27 + 2 → 28 → 22-l Compound 2 (1.35 g, 2.00 mmol) was suspended in ethyl acetate (15 ml), and an aqueous sodium hydrogen carbonate solution (252 mg, 3.00 mmol dissolved in 15 ml of water) was added under ice-cooling, followed by extraction with ethyl acetate and saturated food. After dehydrating with brine, it was dried over magnesium sulfate. After the solvent was distilled off, it was immediately dissolved in dimethylformamide (6 ml), mixed with compound 27 (923 mg, 2.00 mmol), sodium bromide (617 mg, 6.00 mmol) was added, and the mixture was stirred at room temperature for 6 hours. . The reaction solution was poured into 5% brine (60 ml) with stirring under cooling, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 28 (2.05 g) as an amorphous powder. Anisole (2.00 ml) was added to compound 28 (1.91 g) and cooled to 0 ° C. Trifluoroacetic acid (10.0 ml) was added dropwise and stirred for 1 hour. The reaction solution was poured into a mixed solvent (1/1, 90 ml) of 2_propanol / diisopropyl ether, and the precipitated solid was collected by filtration. This solid was suspended in purified water (60 ml), and the pH was adjusted to 7.3 with a saturated aqueous solution of sodium bicarbonate. The solution was filtered, subjected to HP-20SS column chromatography and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was lyophilized to obtain Compound 22-1 as a powder. Yield 510 mg (32%).
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 3.42, 3.50(2H, ABq, J = 16.8Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 3.42, 3.50 (2H, ABq, J = 16.8Hz), 4.0
9(2H, q, J = 7.2Hz), 5.04(1H, d, J = 4.8Hz), 5.16(2H, d, J = 6.6Hz), 5.59(1H, dd, J = 4.8, 8.1Hz), 5.81(1H, dt, J = 15.9, 6.6Hz), 6.71(1H, s), 7.21(2H, s), 7.26(1H, d, J9 (2H, q, J = 7.2Hz), 5.04 (1H, d, J = 4.8Hz), 5.16 (2H, d, J = 6.6Hz), 5.59 (1H, dd, J = 4.8, 8.1Hz), 5.81 (1H, dt, J = 15.9, 6.6Hz), 6.71 (1H, s), 7.21 (2H, s), 7.26 (1H, d, J
= 15.9Hz), 8.60(1H, s), 8.75(2H, d, J = 6.9Hz), 8.84(2H, d, J = 6.9Hz), 9.52(1H, d,= 15.9Hz), 8.60 (1H, s), 8.75 (2H, d, J = 6.9Hz), 8.84 (2H, d, J = 6.9Hz), 9.52 (1H, d,
J = 8.1Hz). J = 8.1Hz).
IR (ATR) cm_1:3324, 1759, 1633, 1599, 1566, 1538, 1384. IR (ATR) cm _1 : 3324, 1759, 1633, 1599, 1566, 1538, 1384.
MS(ESI): 656+ (M-Na+2H)+ MS (ESI): 656+ (M-Na + 2H) +
元素分析 C H N O S Na- 5.7 H O - 0.11(NaHCO ) Elemental analysis C H N O S Na- 5.7 H O-0.11 (NaHCO)
計算値: C, 41.18; H, 4.40; N, 10.63; S, 12.17; Na, 3.23 (%) Calculated values: C, 41.18; H, 4.40; N, 10.63; S, 12.17; Na, 3.23 (%)
実験値: C, 40.91; H, 4.47; N, 10.89; S, 12.45; Na, 3.51 (%) Experimental values: C, 40.91; H, 4.47; N, 10.89; S, 12.45; Na, 3.51 (%)
実施例 204 Example 204
[化 251]
[Chemical 251]
( 19) 30→31 (19) 30 → 31
化合物30(6.528,30.011111101)をジメチルホルムァミド(65.01111)に懸濁させ、 t-ブトキシカリ ゥム(4.04g, 36.0mmol)を加え、 25分間撹拌した。次いでヨウ化メチル(3.69g, 1.62ml) を加え、 1時間撹拌した。反応液に精製水 (65.0ml)をカ卩え、酢酸ェチルで有機層を抽 出した。抽出した有機層を精製水、及び飽和食塩水洗浄し、硫酸ナトリウムで脱水し た。硫酸ナトリウムをろ過し、溶媒を留去し、ジェチルエーテルで洗浄を行い、 31を白 色固体として得た。収量 4.13g(60%)。 Compound 30 (6.52 8, 30.011111101) was suspended in dimethylformamide § bromide (65.01111), t-Butokishikari © beam (4.04 g, 36.0 mmol) was added and stirred for 25 minutes. Next, methyl iodide (3.69 g, 1.62 ml) was added and stirred for 1 hour. Purified water (65.0 ml) was added to the reaction solution, and the organic layer was extracted with ethyl acetate. The extracted organic layer was washed with purified water and saturated brine, and dehydrated with sodium sulfate. Sodium sulfate was filtered off, the solvent was distilled off, and the residue was washed with jetyl ether to obtain 31 as a white solid. Yield 4.13g (60%).
'H-NMR (CDCl ) 4.39 (2H, q, J = 7.2Hz), 7.265(1H, s), 7.74 (2H, dd, J = 1.8, 4.8H 'H-NMR (CDCl) 4.39 (2H, q, J = 7.2Hz), 7.265 (1H, s), 7.74 (2H, dd, J = 1.8, 4.8H
3 Three
z),: 8.64 (2H, dd, J = 1.8, 4.8Hz). z) ,: 8.64 (2H, dd, J = 1.8, 4.8Hz).
(20) 31→32 (20) 31 → 32
化合物 31(3.50g, 15.1mmol)をテトラヒドロフラン (16.5ml)とメタノール(16.5ml)に溶解さ せ、水酸化ナトリウム水溶液 (2規定, 23.0ml)を加えて室温で 30分攪拌後、さらに加 熱還流した。反応液を冷却して、 pHを 5.0としテトラヒドロフランとメタノールを留去した 。析出した固体をろ取し、 32を白色固体として得た。収量 2.62g(85%)。 Compound 31 (3.50 g, 15.1 mmol) is dissolved in tetrahydrofuran (16.5 ml) and methanol (16.5 ml), aqueous sodium hydroxide solution (2N, 23.0 ml) is added, and the mixture is stirred at room temperature for 30 minutes and further heated. Refluxed. The reaction solution was cooled to pH 5.0 and tetrahydrofuran and methanol were distilled off. The precipitated solid was collected by filtration to obtain 32 as a white solid. Yield 2.62 g (85%).
'H-NMR (d -DMSO): 4.16 (3H, s), 7·50(1Η, s), 7.74 (2H, dd, J = 1.8, 4.8Hz), 8.60 'H-NMR (d-DMSO): 4.16 (3H, s), 7 · 50 (1Η, s), 7.74 (2H, dd, J = 1.8, 4.8Hz), 8.60
6 6
(2H, dd, J = 1.8, 4.8Hz).
(21) 32→33 (2H, dd, J = 1.8, 4.8Hz). (21) 32 → 33
化合物 32(2.36g, 11.6mmol)をジメチルホルムアミド (25.0ml)に懸濁させ、カルボ二ノレ ジイミダゾール (2.10g, 12.8mmolを加え室温で 70分間攪拌した。次いで 28% NH水溶 液(15.0ml)を加え、撹拌した後、精製水 (25ml)を加えた。析出した固体をろ取し、 33 を白色固体として得た。収量(2.0g, 86%)。 Compound 32 (2.36 g, 11.6 mmol) was suspended in dimethylformamide (25.0 ml), carboninodiimidazole (2.10 g, 12.8 mmol was added and stirred for 70 minutes at room temperature, then 28% aqueous NH (15.0 ml) ) And stirred, and purified water (25 ml) was added, and the precipitated solid was collected by filtration to give 33 as a white solid, yield (2.0 g, 86%).
'H-NMR (d -DMSO) : 4.13 (3H, s), 7.43(1H, s), 7.65 (1H, br), 7.69 (2H, dd, J = 1.5 'H-NMR (d-DMSO): 4.13 (3H, s), 7.43 (1H, s), 7.65 (1H, br), 7.69 (2H, dd, J = 1.5
, 4.5Hz), 8.05(1H, br), 8.61 (2H, dd, J = 1.5, 4.5Hz). , 4.5Hz), 8.05 (1H, br), 8.61 (2H, dd, J = 1.5, 4.5Hz).
(22) 33→34 (22) 33 → 34
化合物 33(1.93g, 9.54mmol)をテトラヒドロフラン (20.0ml)に懸濁させ、ピリジン (2.23g, 2 8.6mmol)とトリフルォロ酢酸無水物 (2.60g, 12.4mmol)を加え、室温で 30分間攪拌した 。精製水 (20.0ml)をカ卩え、酢酸ェチルにより水層から抽出した。有機層を精製水及び 、飽和食塩水で洗浄後、硫酸マグネシウムにより脱水した。硫酸マグネシウムをろ過 し、有機層を濃縮し、 34を得た。収量 (1.72g, 98%) Compound 33 (1.93 g, 9.54 mmol) was suspended in tetrahydrofuran (20.0 ml), pyridine (2.23 g, 2 8.6 mmol) and trifluoroacetic anhydride (2.60 g, 12.4 mmol) were added, and the mixture was stirred at room temperature for 30 minutes. . Purified water (20.0 ml) was added and extracted from the aqueous layer with ethyl acetate. The organic layer was washed with purified water and saturated brine, and then dehydrated with magnesium sulfate. Magnesium sulfate was filtered, and the organic layer was concentrated to obtain 34. Yield (1.72g, 98%)
'H-NMR (d -DMSO) : 4.10 (3H, s), 7.78 (2H, dd, J = 1.5, 4.8Hz), 7.84(1H, s), 8.64 'H-NMR (d-DMSO): 4.10 (3H, s), 7.78 (2H, dd, J = 1.5, 4.8Hz), 7.84 (1H, s), 8.64
(2H, dd, J = 1.5, 4.8Hz). (2H, dd, J = 1.5, 4.8Hz).
(23) 34→35 (23) 34 → 35
化合物 34(1.70g, 9.22mmol)、塩化アンモニゥム (543mg, lO. lmmol)とアジ化ナトリウム ( 660mg, 10.1mmol)をジメチルホルムアミ (17ml)に懸濁させ、 110°Cで 3時間半攪拌した 。精製水 20mlを加え、 pHを 4.3に調整した。析出した固体をろ取し化合物 35を得た。 収量 2.15g(quant.)。 Compound 34 (1.70 g, 9.22 mmol), ammonium chloride (543 mg, lO. Lmmol) and sodium azide (660 mg, 10.1 mmol) were suspended in dimethylformamime (17 ml) and stirred at 110 ° C for 3 and a half hours. . 20 ml of purified water was added to adjust the pH to 4.3. The precipitated solid was collected by filtration to obtain Compound 35. Yield 2.15 g (quant.).
'H-NMR (d -DMSO) : 4.28 (3H, s), 7.54 (1H, s), 7.95 (2H, d, J = 6.0Hz), 8.68 (2H, d, J = 6.0Hz). 'H-NMR (d-DMSO): 4.28 (3H, s), 7.54 (1H, s), 7.95 (2H, d, J = 6.0Hz), 8.68 (2H, d, J = 6.0Hz).
(24) 35→36 (24) 35 → 36
化合物 35(905mg, 4.00mmol)をジメチルホルムアミド (10ml)に溶解し、水素化ナトリウム (106mg,4.40mmol)を加え、 0°Cで攪拌した。次いでべンジルクロロメチルエーテル (689 mg, 4.40mmol)を加え、 3時間攪拌した。さらに水素化ナトリウム (192mg, 8.00mmol)と ベンジルクロロメチルエーテル (1.25g, 8.00mmol)を加え、 1時間半攪拌した。反応液 に精製水 (10.0ml)を加え、水層から酢酸ェチルで抽出した。有機層を精製水と飽和
食塩水で洗浄し、硫酸ナトリウムで脱水した。硫酸ナトリウムをろ過し、酢酸ェチルを 留去した。得られたガム状物質をへキサンで洗浄し、化合物 36を得た。収量 763mg(5 5%)。 Compound 35 (905 mg, 4.00 mmol) was dissolved in dimethylformamide (10 ml), sodium hydride (106 mg, 4.40 mmol) was added, and the mixture was stirred at 0 ° C. Subsequently, benzyl chloromethyl ether (689 mg, 4.40 mmol) was added and stirred for 3 hours. Further, sodium hydride (192 mg, 8.00 mmol) and benzyl chloromethyl ether (1.25 g, 8.00 mmol) were added and stirred for 1.5 hours. Purified water (10.0 ml) was added to the reaction mixture, and the aqueous layer was extracted with ethyl acetate. Saturate organic layer with purified water The extract was washed with brine and dehydrated with sodium sulfate. Sodium sulfate was filtered and ethyl acetate was distilled off. The obtained gum-like substance was washed with hexane to obtain Compound 36. Yield 763 mg (5 5%).
'H-NMR (d -DMSO) 'H-NMR (d-DMSO)
6 6
Major isomer :4.27(3H, s), 4.74(2H, s), 6.21(2H, s), 7.30-7.38 (5H, m), 7.66 (IH, s) , 7.89 (2H, dd, J = 6.0Hz), 8.63 (2H, dd, J = 1.2, 6.3Hz). Major isomer: 4.27 (3H, s), 4.74 (2H, s), 6.21 (2H, s), 7.30-7.38 (5H, m), 7.66 (IH, s), 7.89 (2H, dd, J = 6.0Hz ), 8.63 (2H, dd, J = 1.2, 6.3Hz).
Minor isomer: 4.15(3H, s), 4.69(2H, s), 6.05(2H, s), 7.30-7.38 (5H, m), 7.56 (IH, s ), 7.79 (2H, d, J = 4.8Hz), 8.65 (2H, d, J = 4.8Hz). Minor isomer: 4.15 (3H, s), 4.69 (2H, s), 6.05 (2H, s), 7.30-7.38 (5H, m), 7.56 (IH, s), 7.79 (2H, d, J = 4.8Hz ), 8.65 (2H, d, J = 4.8Hz).
(25) 36 + 2→37→29 (25) 36 + 2 → 37 → 29
化合物 2(1.38g、 2.04mmol)を酢酸ェチル (10ml)に懸濁させ、氷冷下炭酸水素ナトリウ ム水溶液 (257mg、 3.06mmolを水 10mlに溶解)を加え、酢酸ェチルで抽出し、飽和食 塩水で脱水後、硫酸マグネシウムで乾燥した。溶媒を留去後、速やかにジメチルホ ルムアミド (6ml)に溶解し、化合物 36(709mg,2.04mmol)と混合し、臭化ナトリウム (630m g、 6.12mmol)を加えて、室温で 2時間半攪拌した。反応液を冷却下、 5%食塩水 (100 ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾燥して無定形粉末とし て化合物 37 (1.89g)を得た。化合物 37 (1.88g)をジクロロメタン (20.0ml)に溶解し、ァニ ソール (2.00ml)を加え、 -30°Cに冷却した。 2M四塩化チタンのジクロロメタン溶液 (8.00 ml)を滴下し、 1時間 15分攪拌した。反応液を精製水 (60ml)に注加し、析出した固体を ろ取した。この固体を精製水(6ml)に懸濁させ、飽和炭酸水素ナトリウム水溶液にて、 pHを 7.3とした。この溶液をろ過し、 HP-20SSカラムクロマトグラフィーに付し、水-ァセ トニトリルで溶離した。所望の化合物を含むフラクションを減圧下濃縮し、濃縮液を凍 結乾燥して化合物 29を粉末として得た。収量 239mg(15%)。 Compound 2 (1.38 g, 2.04 mmol) is suspended in ethyl acetate (10 ml), aqueous sodium hydrogen carbonate solution (257 mg, 3.06 mmol dissolved in 10 ml of water) is added under ice-cooling, and the mixture is extracted with ethyl acetate. After dehydrating with brine, it was dried over magnesium sulfate. After the solvent was distilled off, it was immediately dissolved in dimethylformamide (6 ml), mixed with compound 36 (709 mg, 2.04 mmol), sodium bromide (630 mg, 6.12 mmol) was added, and the mixture was stirred at room temperature for 2.5 hours. . The reaction mixture was poured into 5% brine (100 ml) with stirring under cooling, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain Compound 37 (1.89 g) as an amorphous powder. Compound 37 (1.88 g) was dissolved in dichloromethane (20.0 ml), anisole (2.00 ml) was added, and the mixture was cooled to -30 ° C. 2M Titanium tetrachloride in dichloromethane (8.00 ml) was added dropwise and stirred for 1 hour and 15 minutes. The reaction solution was poured into purified water (60 ml), and the precipitated solid was collected by filtration. This solid was suspended in purified water (6 ml), and the pH was adjusted to 7.3 with a saturated aqueous solution of sodium bicarbonate. The solution was filtered, subjected to HP-20SS column chromatography and eluted with water-acetonitrile. The fraction containing the desired compound was concentrated under reduced pressure, and the concentrated solution was freeze-dried to obtain Compound 29 as a powder. Yield 239 mg (15%).
'H-NMR (d -DMSO): 1.21(3H, t, J = 6.9Hz), 3.41, 3.50(2H, ABq, J = 16.8Hz), 4.1 'H-NMR (d-DMSO): 1.21 (3H, t, J = 6.9Hz), 3.41, 3.50 (2H, ABq, J = 16.8Hz), 4.1
6 6
7(2H, q, J = 6.9Hz), 4.32(3H, s), 5.03(1H, d, J = 5.1Hz), 5.22(2H, d, J = 6.6Hz), 5. 57(1H, dd, J = 7.8, 5.1Hz), 5.85(1H, dt, J = 15.9, 5.1Hz), 6.71(1H, s), 7.21(2H, s), 7.28(1H, d, J = 15.9Hz), 7.57(1H, s), 8.48(2H, d, J = 6.0Hz), 8.92(2H, d, J = 6.0Hz) , 9.47(1H, d, J = 7.8Hz). 7 (2H, q, J = 6.9Hz), 4.32 (3H, s), 5.03 (1H, d, J = 5.1Hz), 5.22 (2H, d, J = 6.6Hz), 5.57 (1H, dd , J = 7.8, 5.1Hz), 5.85 (1H, dt, J = 15.9, 5.1Hz), 6.71 (1H, s), 7.21 (2H, s), 7.28 (1H, d, J = 15.9Hz), 7.57 (1H, s), 8.48 (2H, d, J = 6.0Hz), 8.92 (2H, d, J = 6.0Hz), 9.47 (1H, d, J = 7.8Hz).
IR (ATR) cm_1:3334, 2324, 1757, 1634, 1602, 1537, 1478, 1362.
MS(ESI): 662+ (M-Na+2H)+ IR (ATR) cm _1 : 3334, 2324, 1757, 1634, 1602, 1537, 1478, 1362. MS (ESI): 662 + (M-Na + 2H) +
元素分析 C H N O S Na- 6.6 H O -0.1(NaHCO ) Elemental analysis C H N O S Na- 6.6 H O -0.1 (NaHCO)
計算値: C, 40.09; H, 4.75; N, 20.70; S, 7.90; Na, 3.11 (%) Calculated values: C, 40.09; H, 4.75; N, 20.70; S, 7.90; Na, 3.11 (%)
実験値: C, 40.16; H, 4.60; N, 20.46; S, 8.14; Na, 3.28 (%) Experimental values: C, 40.16; H, 4.60; N, 20.46; S, 8.14; Na, 3.28 (%)
実施例 205 Example 205
[化 252] [Chemical 252]
(26) 39→40 (26) 39 → 40
化合物 39(4.69g,20mmol)を 28%アンモニア水 (70ml)に懸濁させ、 60°Cで 1.5時間加温 撹拌した。析出物を濾取、水洗、乾燥して 40を得た。収量 3.1g(76%)。 Compound 39 (4.69 g, 20 mmol) was suspended in 28% aqueous ammonia (70 ml), and heated and stirred at 60 ° C. for 1.5 hours. The precipitate was collected by filtration, washed with water and dried to obtain 40. Yield 3.1 g (76%).
'H-NMR (d -DMSO): 7.74(1H, br),8.01(3H, dd, J = 1.8, 4.8Hz), 8.45(1H, s), 8.75( 'H-NMR (d-DMSO): 7.74 (1H, br), 8.01 (3H, dd, J = 1.8, 4.8Hz), 8.45 (1H, s), 8.75 (
2H, dd, J = 1.8, 4.8Hz). 2H, dd, J = 1.8, 4.8Hz).
(27) 40—41 (27) 40-41
化合物 40(3.0g, 14.6mmol)をピリジン (36.5ml)に溶解させ、無水トリフロロ酢酸 (4.54ml, 32.1mmol)を滴加した。反応液を 60°Cで 2時間攪拌した後、濃縮した。反応液にクロ 口ホルムと水を加えて抽出した。有機層は水洗、乾燥、濃縮して残渣を得た。イソプロ パノールで洗浄し、固体をろ取して 41を得た。収量 2.50g(92%)。 Compound 40 (3.0 g, 14.6 mmol) was dissolved in pyridine (36.5 ml), and trifluoroacetic anhydride (4.54 ml, 32.1 mmol) was added dropwise. The reaction solution was stirred at 60 ° C. for 2 hours and then concentrated. The reaction mixture was extracted with chloroform and water. The organic layer was washed with water, dried and concentrated to give a residue. Washing with isopropanol and filtration of the solid gave 41. Yield 2.50 g (92%).
'H-N R (d -DMSO): 7.96(2H, dd, J = 1.5, 4.5Hz),8.77(2H, dd, J = 1.5, 4.5Hz), 9.'H-N R (d -DMSO): 7.96 (2H, dd, J = 1.5, 4.5Hz), 8.77 (2H, dd, J = 1.5, 4.5Hz), 9.
07(1H, s). 07 (1H, s).
(28) 41→42
化合物 41(562mg, 3mmol)から(23)と同様にして 42を得た。収量 (669mg, 97%) 'H-NMR (d -DMSO): 8.02(2H, dd, J = 1.8, 4.5Hz), 8.74 (1H, s), 8.81(2H, dd, J = 1 (28) 41 → 42 42 was obtained from Compound 41 (562 mg, 3 mmol) in the same manner as (23). Yield (669mg, 97%) 'H-NMR (d-DMSO): 8.02 (2H, dd, J = 1.8, 4.5Hz), 8.74 (1H, s), 8.81 (2H, dd, J = 1
6 6
.8, 4.5Hz), 9.07(1H, s). .8, 4.5Hz), 9.07 (1H, s).
(29) 42 + 2→43→38 (29) 42 + 2 → 43 → 38
化合物 2(1.68g、 2.5mmol)と化合物 42(576mg,2.5mmol)力、ら (25)と同様にして化合物Compound 2 (1.68 g, 2.5 mmol) and Compound 42 (576 mg, 2.5 mmol)
43 (2.48g)を得て、次いで化合物 38を粉末として得た。収量 103mg(5%)。 43 (2.48 g) was obtained, and then compound 38 was obtained as a powder. Yield 103 mg (5%).
'H-NMR (d -DMSO): 1.22(3H, t, J = 6.9Hz), 3.43, 3.51(2H, ABq, J = 17.1Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 6.9Hz), 3.43, 3.51 (2H, ABq, J = 17.1Hz), 4.0
6 6
9(2H, q, 6.9Hz), 5.06(1H, d, J = 4.8Hz), 5.33(2H, d, J = 6.9Hz), 5.60(1H, dd, J = 8. 7, 4.8Hz), 5.86(1H, dt, J = 15.9, 6.9Hz), 6.72(1H, s), 7.23(2H, s), 7.27(1H, d, J = 1 5.9Hz), 7.44(1H, d, J = 8 .1Hz), 8.37(1H, s), 8.63(2H, d, J = 6.9Hz), 9.09 (2H, d, J = 6.9Hz), 9.55(1H, d, J = 8.7Hz). 9 (2H, q, 6.9Hz), 5.06 (1H, d, J = 4.8Hz), 5.33 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 8.7, 4.8Hz), 5.86 (1H, dt, J = 15.9, 6.9Hz), 6.72 (1H, s), 7.23 (2H, s), 7.27 (1H, d, J = 1 5.9Hz), 7.44 (1H, d, J = 8 .1Hz), 8.37 (1H, s), 8.63 (2H, d, J = 6.9Hz), 9.09 (2H, d, J = 6.9Hz), 9.55 (1H, d, J = 8.7Hz).
IR (KBr) 001_1:3408, 1761, 1634, 1532 IR (KBr) 001 _1 : 3408, 1761, 1634, 1532
MS(ESI): 667+ (M-Na+2H)+ MS (ESI): 667 + (M-Na + 2H) +
元素分析 C H N O S Na- 5.7 H O - 0.5(NaHCO ) Elemental analysis C H N O S Na- 5.7 H O-0.5 (NaHCO)
26 22 11 5 3 2 3 26 22 11 5 3 2 3
計算値: C, 38.24; H, 4.10; N, 18.51 ; S, 11.56; Na, 4.14 (%) Calculated values: C, 38.24; H, 4.10; N, 18.51; S, 11.56; Na, 4.14 (%)
実験値: C, 38.27; H, 4.13; N, 18.36; S, 11.50; Na, 4.27 (%) Experimental values: C, 38.27; H, 4.13; N, 18.36; S, 11.50; Na, 4.27 (%)
実施例 206 Example 206
[化 253] [Chemical 253]
化合物 45(5.65g, 30mmol)をピリジン (60ml)に溶解させ、氷冷下、メタンスルホニルクロ リド (13.9ml, 180mmol)を滴加した。反応液を 60°Cで 2時間攪拌した後、濃縮した。反 応液に酢酸ェチルと水を加えて抽出した。有機層は水洗、乾燥、濃縮して残渣を得 た。へキサン-ェチルエーテルで洗浄し、固体をろ取して 46を得た。収量 3.38g(66%)。 'H-NMR (d -DMSO): 7.70(1H, s), 7.79(2H, dd, J = 1.8, 4.8Hz), 8.71(2H, dd, J = 1.Compound 45 (5.65 g, 30 mmol) was dissolved in pyridine (60 ml), and methanesulfonyl chloride (13.9 ml, 180 mmol) was added dropwise under ice cooling. The reaction solution was stirred at 60 ° C. for 2 hours and then concentrated. The reaction solution was extracted by adding ethyl acetate and water. The organic layer was washed with water, dried and concentrated to give a residue. Washing with hexane-ethyl ether and filtration of the solid gave 46. Yield 3.38 g (66%). 'H-NMR (d-DMSO): 7.70 (1H, s), 7.79 (2H, dd, J = 1.8, 4.8Hz), 8.71 (2H, dd, J = 1.
8, 4.8Hz), 14.8(1H, br). 8, 4.8Hz), 14.8 (1H, br).
(31) 46→47 (31) 46 → 47
ヒドロキシルァミン塩酸塩 (2.78g, 40mmol)をジメチルスルホキシド (8ml)に溶解し、トリ ェチルァミン (5.57ml, 40mmol)を加えて攪拌した。不溶物を濾去した母液に化合物 46 (1.36g, 8mmol)をカ卩えて、 75°Cで加温攪拌した。反応液に水をカ卩えて中和して、析出 物をろ取、乾燥して 47を得た。収量 1.2g(68%)。 Hydroxylamine hydrochloride (2.78 g, 40 mmol) was dissolved in dimethyl sulfoxide (8 ml), and tritylamine (5.57 ml, 40 mmol) was added and stirred. Compound 46 (1.36 g, 8 mmol) was added to the mother liquor from which insolubles had been filtered off, and the mixture was heated and stirred at 75 ° C. Water was added to the reaction solution for neutralization, and the precipitate was collected by filtration and dried to obtain 47. Yield 1.2g (68%).
'H-NMR (d -DMSO)ピークが非常にブロード状であり解読不能 'H-NMR (d -DMSO) peak is very broad and unreadable
(32) 47→48 (32) 47 → 48
化合物 47(610mg, 3mmol)をジメチルホルムアミド (6ml)に溶解し、チォカルボエルジイ ミダゾール (588mg, 3.3mmol)をカ卩えて室温で 1時間攪拌した。反応液に水を加えて、 析出物をろ取、乾燥して 48を得た。収量 773mg(77%)。 Compound 47 (610 mg, 3 mmol) was dissolved in dimethylformamide (6 ml), and thiocarbodiimidazole (588 mg, 3.3 mmol) was added thereto and stirred at room temperature for 1 hour. Water was added to the reaction solution, and the precipitate was collected by filtration and dried to obtain 48. Yield 773 mg (77%).
'H-NMR (d -DMSO)ピークが非常にブロード状であり解読不能 'H-NMR (d -DMSO) peak is very broad and unreadable
(33) 48→49 (33) 48 → 49
化合物 48(723mg, 2.3mmol)をテトラヒドロフラン (7.5ml)に溶解し、 BF ·Εΐ 0(1.45ml, 1Compound 48 (723 mg, 2.3 mmol) was dissolved in tetrahydrofuran (7.5 ml), and BF · Εΐ 0 (1.45 ml, 1
1.5mmol)をカ卩えて室温から 60°Cで 7時間攪拌した。反応液に水をカ卩えて、析出物を ろ取、乾燥して 49を得た。収量 353mg(62%)。 1.5 mmol) was added and stirred at room temperature to 60 ° C for 7 hours. Water was added to the reaction solution, and the precipitate was collected by filtration and dried to obtain 49. Yield 353 mg (62%).
'H-NMR (d -DMSO)ピークが非常にブロード状であり解読不能 'H-NMR (d -DMSO) peak is very broad and unreadable
(34) 49 + 8→50→44 (34) 49 + 8 → 50 → 44
化合物 8(987mg、 1.3mmol)と化合物 49(328mg,1.3mmol)から(9)と同様にして化合物Compound 8 (987 mg, 1.3 mmol) and compound 49 (328 mg, 1.3 mmol) to compound (9) in the same manner
50 (1.27g)を得て、次いで化合物 44を粉末として得た。収量 273mg(25%)。 50 (1.27 g) was obtained and then compound 44 was obtained as a powder. Yield 273 mg (25%).
'H-NMR (d -DMSO): 1.22(3H, t, J = 7.2Hz), 3.44, 3.51(2H, ABq, J = 17.1Hz), 4.0 'H-NMR (d-DMSO): 1.22 (3H, t, J = 7.2Hz), 3.44, 3.51 (2H, ABq, J = 17.1Hz), 4.0
9(2H, q, J = 7.2Hz), 5.05(1H, d, J = 4.8Hz), 5.23(2H, d, J = 7.2Hz), 5.60(1H, dd, J
= 8.1, 4·8Ηζ), 5.86(1H, dt, J = 15.6, 7.2Hz), 6.72(1H, s), 7.23(2H, s), 7.30(1H, d, J = 15.6Hz), 7.48(1H, s), 8.48(2H, d, J = 6.6Hz), 8.92 (2H, d, J = 6.6Hz), 9.54(1H, d, J = 8.1Hz). 9 (2H, q, J = 7.2Hz), 5.05 (1H, d, J = 4.8Hz), 5.23 (2H, d, J = 7.2Hz), 5.60 (1H, dd, J = 8.1, 4 · 8Ηζ), 5.86 (1H, dt, J = 15.6, 7.2Hz), 6.72 (1H, s), 7.23 (2H, s), 7.30 (1H, d, J = 15.6Hz), 7.48 ( 1H, s), 8.48 (2H, d, J = 6.6Hz), 8.92 (2H, d, J = 6.6Hz), 9.54 (1H, d, J = 8.1Hz).
IR (KBr) cm_1:3397, 1761, 1636, 1603, 1535, 1391 IR (KBr) cm _1 : 3397, 1761, 1636, 1603, 1535, 1391
MS(ESI): 681+ (M-Na+2H)+ MS (ESI): 681 + (M-Na + 2H) +
元素分析 C H N O S Na-4.4 H O -0.5(NaHCO ) Elemental analysis C H N O S Na-4.4 H O -0.5 (NaHCO)
計算値: C, 40.08; H, 3.95; N, 17.00; S, 11.67; Na, 4.19 (%) Calculated values: C, 40.08; H, 3.95; N, 17.00; S, 11.67; Na, 4.19 (%)
実験値: C, 40.09; H, 4.10; N, 17.17; S, 11.52; Na, 4.26 (%) Experimental values: C, 40.09; H, 4.10; N, 17.17; S, 11.52; Na, 4.26 (%)
実施例 207 Example 207
[化 254] [Chemical 254]
(42) 64→65 (42) 64 → 65
化合物 64(615mg, 3mmol)をジメチルホルムアミド (6ml)に懸濁して、カルボニルジイミ ダゾール (535mg, 3.3mmol)を加えた後、ナトリウムシアナミド (21 lmg, 3.3mmol)を加え て室温で 6.5時間攪拌した。反応液に水をカ卩えた後、希塩酸で中和した。析出物をろ 取、乾燥して 65を得た。収量 529mg(77%)。 Compound 64 (615 mg, 3 mmol) is suspended in dimethylformamide (6 ml), carbonyldiimidazole (535 mg, 3.3 mmol) is added, sodium cyanamide (21 lmg, 3.3 mmol) is added, and the mixture is stirred at room temperature for 6.5 hours. did. Water was added to the reaction solution and neutralized with dilute hydrochloric acid. The precipitate was collected by filtration and dried to obtain 65. Yield 529 mg (77%).
'H-NMR (d DMSO) - 7.25 (1H, dd, J = 5.1, 3.7 Hz), 7.75 (1H, dd, J = 5.1, 1.2 Hz), 'H-NMR (d DMSO)-7.25 (1H, dd, J = 5.1, 3.7 Hz), 7.75 (1H, dd, J = 5.1, 1.2 Hz),
7.79 (1H, dd, J = 3.7, 1.2 Hz), 8.52 (1H, t, J = 2.1 Hz), 8.95 (1H, d, J = 2.0 Hz), 9. 16 (1H, d, J = 2.1 Hz). 7.79 (1H, dd, J = 3.7, 1.2 Hz), 8.52 (1H, t, J = 2.1 Hz), 8.95 (1H, d, J = 2.0 Hz), 9. 16 (1H, d, J = 2.1 Hz) ).
(43) 65 + 2→66→63 (43) 65 + 2 → 66 → 63
化合物 2(1.35g、 2mmol)と化合物 65(459mg,2mmol)から(25)と同様にして化合物 66 ( 1.32g)を得て、次いで化合物 63を粉末として得た。収量 322mg(21%)。
Ή-NMR (d DMSO) - 1.22 (3H, t, J = 7.0 Hz), 3.44 (2H, ABq, J = 17.4 Hz), 4.08 (2Compound 66 (1.32 g) was obtained in the same manner as (25) from Compound 2 (1.35 g, 2 mmol) and Compound 65 (459 mg, 2 mmol), and then Compound 63 was obtained as a powder. Yield 322 mg (21%). Ή-NMR (d DMSO)-1.22 (3H, t, J = 7.0 Hz), 3.44 (2H, ABq, J = 17.4 Hz), 4.08 (2
H, q, J = 7.0 Hz), 5.04 (1H, d, J = 5.0 Hz), 5.38 (2H, d, J = 6.6 Hz), 5.58 (IH, dd, J = 8.1, 5.0 Hz), 5.90 (IH, dt, J = 15.6, 6.6 Hz), 6.71 (IH, s), 7.20 (2H, s), 7.29 (IH , dd, J = 3.7, 5.0 Hz), 7.31 (IH, d, J = 15.6Hz), 7.89 (1H, d d, J = 5.0, 1.0 Hz), 7.9 7 (IH, dd, J = 3.7, 1.0 Hz), 8.91 (1H, s), 9.24 (IH, s), 9.43 (IH, s), 9.52 (1H, d, J = 8.1 Hz). H, q, J = 7.0 Hz), 5.04 (1H, d, J = 5.0 Hz), 5.38 (2H, d, J = 6.6 Hz), 5.58 (IH, dd, J = 8.1, 5.0 Hz), 5.90 ( IH, dt, J = 15.6, 6.6 Hz), 6.71 (IH, s), 7.20 (2H, s), 7.29 (IH, dd, J = 3.7, 5.0 Hz), 7.31 (IH, d, J = 15.6 Hz ), 7.89 (1H, dd, J = 5.0, 1.0 Hz), 7.9 7 (IH, dd, J = 3.7, 1.0 Hz), 8.91 (1H, s), 9.24 (IH, s), 9.43 (IH, s ), 9.52 (1H, d, J = 8.1 Hz).
IR (ATR) cm_1:3325, 2164, 1751, 1582, 1530, 1373. IR (ATR) cm _1 : 3325, 2164, 1751, 1582, 1530, 1373.
MS(ESI): 664+ (M-Na+2H)+ MS (ESI): 664 + (M-Na + 2H) +
元素分析 C H N O S Na-4.4 H O Elemental analysis C H N O S Na-4.4 H O
計算値: C, 43.90; H, 4.18; N, 14.63; S, 12.56; Na, 3.00 (%) Calculated values: C, 43.90; H, 4.18; N, 14.63; S, 12.56; Na, 3.00 (%)
実験値: C, 43.92; H, 3.95; N, 14.66; S, 12.40; Na, 3.07 (%) Experimental values: C, 43.92; H, 3.95; N, 14.66; S, 12.40; Na, 3.07 (%)
実施例 208 Example 208
[化 255] [Chemical 255]
(44) 68→69 (44) 68 → 69
化合物 68(621mg, 3mmol)力 (42)と同様にして化合物 69を得た。収量 608mg(96%) 'H-NMR (d DMSO) - 6.37 (2H, t, J = 2.2 Hz), 7.56 (2H, t, J = 2.2 Hz), 8.44 (IH, d d, J = 2.6, 1.9 Hz), 8.88 (1H, d, J = 1.9 Hz), 9.14 (1H, d, J = 2.6 Hz). Compound 69 was obtained in the same manner as Compound 68 (621 mg, 3 mmol) force (42). Yield 608mg (96%) 'H-NMR (d DMSO)-6.37 (2H, t, J = 2.2 Hz), 7.56 (2H, t, J = 2.2 Hz), 8.44 (IH, dd, J = 2.6, 1.9 Hz), 8.88 (1H, d, J = 1.9 Hz), 9.14 (1H, d, J = 2.6 Hz).
(45) 69 + 2→70→67 (45) 69 + 2 → 70 → 67
化合物 2(1.35g、 2mmol)と化合物 69(424mg,2mmol)から(25)と同様にして化合物 70 ( 1.68g)を得て、次いで化合物 67を粉末として得た。収量 343mg(23%)。
H-NMR (d DMSO) -1.21 (3H, t, J = 7.0 Hz), 3.44 (2H, ABq, J = 16.8 Hz), 4.08 (2Compound 70 (1.68 g) was obtained in the same manner as (25) from compound 2 (1.35 g, 2 mmol) and compound 69 (424 mg, 2 mmol), and then compound 67 was obtained as a powder. Yield 343 mg (23%). H-NMR (d DMSO) -1.21 (3H, t, J = 7.0 Hz), 3.44 (2H, ABq, J = 16.8 Hz), 4.08 (2
H, q, J = 7.0 Hz), 5.04 (1H, d, J = 4.9 Hz), 5.35-5.37 (2H, m), 5.58 (1H, dd, J = 8.H, q, J = 7.0 Hz), 5.04 (1H, d, J = 4.9 Hz), 5.35-5.37 (2H, m), 5.58 (1H, dd, J = 8.
0, 4.9 Hz), 5.91 (1H, dt, J = 15.9, 7.0 Hz), 6.43 (2H, t, J = 2.1 Hz), 6.71 (1H, s), 7.0, 4.9 Hz), 5.91 (1H, dt, J = 15.9, 7.0 Hz), 6.43 (2H, t, J = 2.1 Hz), 6.71 (1H, s), 7.
20 (2H, s), 7.32 (1H, d, J = 15.9 Hz), 7.71 (2H, t, J = 2.1 Hz), 8.93 (1H, s), 9.21 (120 (2H, s), 7.32 (1H, d, J = 15.9 Hz), 7.71 (2H, t, J = 2.1 Hz), 8.93 (1H, s), 9.21 (1
H, s), 9.46 (1H, s), 9.52 (1H, d, J = 8.0 Hz). H, s), 9.46 (1H, s), 9.52 (1H, d, J = 8.0 Hz).
IR (ATR) cm_1:3336, 2167, 1754, 1584, 1530, 1505, 1375. IR (ATR) cm _1 : 3336, 2167, 1754, 1584, 1530, 1505, 1375.
MS(ESI): 648+ (M-Na+2H)+ MS (ESI): 648 + (M-Na + 2H) +
元素分析 c H N O S Na-4.60 H O-O.l(NaCl) Elemental analysis c H N O S Na-4.60 H O-O.l (NaCl)
28 24 9 6 2 2 28 24 9 6 2 2
計算値: C, 44.34; H, 4.41; N, 16.62; S, 8.46; Na, 3.33 (%) Calculated values: C, 44.34; H, 4.41; N, 16.62; S, 8.46; Na, 3.33 (%)
実験値: C, 44.36; H, 4.31; N, 16.39; S, 8.64; Na, 3.60 (%) Experimental values: C, 44.36; H, 4.31; N, 16.39; S, 8.64; Na, 3.60 (%)
実施例 209 Example 209
[化 256] [Chemical 256]
(1) 2 + 3→l (1) 2 + 3 → l
化合物 2(802mg, l.OOmmol)と化合物 3(339mg, l.OOmmol)をジメチルホルムアミド (2.0 ml)に溶解させ、臭化ナトリウム (309mg, 3.00mmol)を加え、 3時間攪拌した。反応液を 冷却下、 5%食塩水 (30ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾 燥して無定形粉末 (1.1 lg)を得た。無定形粉末 (1.10g)をジクロロメタン (8.0ml)に溶解さ せ、ァニソール (1.00ml)を加え、 -15°Cに冷却した。 2M四塩化チタン(ジクロロメタン 溶液, 4.90ml)をカ卩え、 1.5時間攪拌した。反応液を冷却下、 Et O(30ml)および 0.3N-Compound 2 (802 mg, l.OOmmol) and compound 3 (339 mg, l.OOmmol) were dissolved in dimethylformamide (2.0 ml), sodium bromide (309 mg, 3.00 mmol) was added, and the mixture was stirred for 3 hours. The reaction mixture was poured into 5% brine (30 ml) with stirring while cooling, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain an amorphous powder (1.1 lg). Amorphous powder (1.10 g) was dissolved in dichloromethane (8.0 ml), and anisole (1.00 ml) was added and cooled to -15 ° C. 2M titanium tetrachloride (dichloromethane solution, 4.90 ml) was added and stirred for 1.5 hours. While cooling the reaction mixture, Et O (30 ml) and 0.3 N-
2 2
HCl(30ml)の混合液に滴下し、析出した固体をろ取した。この固体に水、ァセトニトリ ル、 2N-HC1を加えて溶解させ、 HP-20SSを加え濃縮し、 HP-20SSカラムクロマトグラ
フィ一に付し、水 -ァセトニトリルで溶離した。所望の化合物を含むフラクションを集め 攪拌しながら 2N_NaOHを注意深く加え、 pHが 10を超えた時点でドライアイスを加え、 pHを 5以下にした。溶液を減圧下濃縮し、凍結乾燥して化合物 1を粉末として得た。 収量 138mg(19%)。 The mixture was added dropwise to a mixture of HCl (30 ml), and the precipitated solid was collected by filtration. Add water, acetonitrile, and 2N-HC1 to this solid and dissolve, add HP-20SS to concentrate, and then HP-20SS column chromatograph. The sample was eluted with water-acetonitrile. Fractions containing the desired compound were collected and 2N NaOH was carefully added with stirring. When the pH exceeded 10, dry ice was added to bring the pH to 5 or less. The solution was concentrated under reduced pressure and lyophilized to obtain Compound 1 as a powder. Yield 138 mg (19%).
'H-NMR (D O): 1.29(3H, t, J = 6.6Hz), 2.28(3H, s), 3.44, 3.53(2H, ABq, J = 17.7H z), 4.25(2H, q, J = 6.6Hz), 5.03(2H, d, J = 6.6Hz), 5.25(1H, d, J = 4.5Hz), 5.81(1H, d, J = 4.5Hz), 6.04(1H, dt, J = 14.1, 6.6Hz), 6.84(1H, d, J = 14.1Hz), 6.98(1H, s), 'H-NMR (DO): 1.29 (3H, t, J = 6.6Hz), 2.28 (3H, s), 3.44, 3.53 (2H, ABq, J = 17.7Hz), 4.25 (2H, q, J = 6.6Hz), 5.03 (2H, d, J = 6.6Hz), 5.25 (1H, d, J = 4.5Hz), 5.81 (1H, d, J = 4.5Hz), 6.04 (1H, dt, J = 14.1, 6.6Hz), 6.84 (1H, d, J = 14.1Hz), 6.98 (1H, s),
7.33(1H, d, J = 7.5Hz), 7.66(1H, d, J = 7.5Hz), 7.81(2H, d, J = 6.6Hz), 7.84(1H, s), 8.38( 2H, d, J = 6.6Hz). 7.33 (1H, d, J = 7.5Hz), 7.66 (1H, d, J = 7.5Hz), 7.81 (2H, d, J = 6.6Hz), 7.84 (1H, s), 8.38 (2H, d, J = 6.6Hz).
IR (KBr) cm_1:3387, 1764, 1611, 1530, 1382. IR (KBr) cm _1 : 3387, 1764, 1611, 1530, 1382.
MS(FAB): 729+ (M+Na+H)+ MS (FAB): 729 + (M + Na + H) +
元素分析 c H N O S Na- 5.5H O - 0.8NaHCO -0.3NaCl. Elemental analysis c H N O S Na- 5.5H O-0.8NaHCO -0.3NaCl.
計算値: C,41.85; H,4.51; N,12.28; S,7.03; Na,5.29; Cl,1.17 (%) Calculated value: C, 41.85; H, 4.51; N, 12.28; S, 7.03; Na, 5.29; Cl, 1.17 (%)
実験値: C,41.76; H,4.43; N,12.30; S,7.07; Na,5.40; Cl,1.18 (%) Experimental value: C, 41.76; H, 4.43; N, 12.30; S, 7.07; Na, 5.40; Cl, 1.18 (%)
実施例 210 Example 210
[化 257] [Chemical 257]
(2) 2 + 5→4 (2) 2 + 5 → 4
化合物 2(802mg, l.OOmmol)と化合物 5(310mg, l.OOmmol)から(1)と同様にして化合 物 4を粉末として得た。収量 170mg(24%, 2steps)0
Ή-NMR (D O): 1.29(3H, t, J = 7.2Hz), 3.65(2H, s), 4.24(2H, q, J = 7.2Hz), 5.26(1Compound 4 was obtained as a powder from Compound 2 (802 mg, l.OOmmol) and Compound 5 (310 mg, l.OOmmol) in the same manner as (1). Yield 170mg (24%, 2steps) 0 Ή-NMR (DO): 1.29 (3H, t, J = 7.2Hz), 3.65 (2H, s), 4.24 (2H, q, J = 7.2Hz), 5.26 (1
H, d, J = 4.5Hz), 5.40(2H, d, J = 6.9Hz), 5.82(1H, d, J = 4.5Hz), 6.12(1H, d, J = 15 .0, 6.9Hz), 6.97(1H, s), 6.97(1H, d, J = 15.0Hz), 7.66(2H, d, J = 8.1Hz), 7.90(2H, d , J = 8.1Hz), 8.42(2H, d, J = 5.4Hz), 9.04(2H, d, J = 5.4Hz). H, d, J = 4.5Hz), 5.40 (2H, d, J = 6.9Hz), 5.82 (1H, d, J = 4.5Hz), 6.12 (1H, d, J = 15.0, 6.9Hz), 6.97 (1H, s), 6.97 (1H, d, J = 15.0Hz), 7.66 (2H, d, J = 8.1Hz), 7.90 (2H, d, J = 8.1Hz), 8.42 (2H, d, J = 5.4Hz), 9.04 (2H, d, J = 5.4Hz).
IR (KBr) cm_1:3408, 1764, 1668, 1604, 1532, 1382. IR (KBr) cm _1 : 3408, 1764, 1668, 1604, 1532, 1382.
MS(FAB): 722+ (M+2Na)+ MS (FAB): 722 + (M + 2Na) +
元素分析 c H N O S Na-4.9H O - 0.1NaHCO -O. lNaCl. Elemental analysis c H N O S Na-4.9H O-0.1NaHCO -O.lNaCl.
計算値: C,45.07; H,4.51; N,12.22; SJ.99; Na,3.44; Cl,0.44 (%) Calculated value: C, 45.07; H, 4.51; N, 12.22; SJ.99; Na, 3.44; Cl, 0.44 (%)
実験値: C,45.15; H,4.45; N,12.28; SJ.64; Na,3.49; Cl,0.51 (%) Experimental value: C, 45.15; H, 4.45; N, 12.28; SJ.64; Na, 3.49; Cl, 0.51 (%)
実施例 211 Example 211
[化 258] [Chemical 258]
(3) 2 + 7→6 (3) 2 + 7 → 6
化合物 2(802mg, l.OOmmol)と化合物 7(360mg, l.OOmmol)から(1)と同様にして化合 物 6を粉末として得た。収量 459mg(61%, 2steps)0 Compound 6 was obtained as a powder from Compound 2 (802 mg, l.OOmmol) and Compound 7 (360 mg, l.OOmmol) in the same manner as (1). Yield 459mg (61%, 2steps) 0
JH-NMR (D O): 1.28(3H, t, J = 7.2Hz), 3.62, 3.66(2H, ABq, J = 16.8Hz), 4.23(2H, q, J = 7.2Hz), 4.96(2H, d, J = 6.9Hz), 5.24(1H, d, J = 4.8Hz), 5.80(1H, d, J = 4.8H z), 6.02(1H, dt, J = 15.0, 6.9Hz), 6.87(1H, d, J = 15.0Hz), 6.96(1H, s), 7.39(1H, d, J = 8.1Hz), 7.53(1H, d, J = 8.1Hz), 7.66(2H, d, J = 6.6Hz), 8.20(1H, s), 8.27(2H, d, J H-NMR (DO): 1.28 (3H, t, J = 7.2Hz), 3.62, 3.66 (2H, ABq, J = 16.8Hz), 4.23 (2H, q, J = 7.2Hz), 4.96 (2H, d, J = 6.9Hz), 5.24 (1H, d, J = 4.8Hz), 5.80 (1H, d, J = 4.8Hz), 6.02 (1H, dt, J = 15.0, 6.9Hz), 6.87 (1H , d, J = 15.0Hz), 6.96 (1H, s), 7.39 (1H, d, J = 8.1Hz), 7.53 (1H, d, J = 8.1Hz), 7.66 (2H, d, J = 6.6Hz ), 8.20 (1H, s), 8.27 (2H, d,
J = 6.6Hz).
IR (KBr) cm :3412, 1765, 1609, 1570, 1520, 1379, 1195, 1165. J = 6.6Hz). IR (KBr) cm: 3412, 1765, 1609, 1570, 1520, 1379, 1195, 1165.
MS(FAB): 749+ (M+Na+H)+ MS (FAB): 749+ (M + Na + H) +
元素分析 C H C1N O S Na-4.2H O - 0.3NaHCO . Elemental analysis C H C1N O S Na-4.2H O-0.3NaHCO.
計算値: C,42.81; H,4.11; N,13.18; SJ.54; Na,3.52; Cl,4.17 (%) Calculated values: C, 42.81; H, 4.11; N, 13.18; SJ.54; Na, 3.52; Cl, 4.17 (%)
実験値: C,42.86; H,4.12; N,13.25; SJ.45; Na,3.54; Cl,4.02 (%) Experimental value: C, 42.86; H, 4.12; N, 13.25; SJ.45; Na, 3.54; Cl, 4.02 (%)
実施例 212 Example 212
[化 259] [Chemical 259]
(4) 9→10 (4) 9 → 10
化合物 9(1.21g, lO.Ommol)に 30%HBr-AcOH(l lml)を加えて溶解させ、冷却下、臭素 ( 564 μ 1, ll.Ommol)を滴下した。室温まで昇温し、 1時間攪拌した。懸濁液をあらかじ め冷却しておいた Et O(60ml)にカ卩え、固体をろ取した。減圧乾燥し、化合物 10を得たCompound 9 (1.21 g, lO.Ommol) was dissolved by adding 30% HBr-AcOH (l lml), and bromine (564 μl, ll.Ommol) was added dropwise under cooling. The mixture was warmed to room temperature and stirred for 1 hour. The suspension was poured into precooled Et 2 O (60 ml) and the solid was collected by filtration. Drying under reduced pressure gave compound 10.
。収量 2.90g(quant)。 . Yield 2.90 g (quant).
'H-NMR (DMSO): 5.05(2H, s), 7.82(1H, dd, J = 7.8, 5.1Hz), 8.58(1H, d, J = 7.8Hz ), 8.94(1H, d, J = 5.1Hz), 9.28(1H, s) 'H-NMR (DMSO): 5.05 (2H, s), 7.82 (1H, dd, J = 7.8, 5.1Hz), 8.58 (1H, d, J = 7.8Hz), 8.94 (1H, d, J = 5.1 Hz), 9.28 (1H, s)
(5) 10→11 (5) 10 → 11
化合物 10(2.80g, lO.Ommol)とェチルチオォキサメート (1.40g, lO.Ommol)を EtOH(45m 1)に懸濁させ 95°Cで 1時間攪拌した後、減圧下濃縮した。残渣に飽和 NaHCO水を加 え、酢酸ェチルで抽出した。有機層を精製水、飽和食塩水により洗浄し、無水硫酸
マグネシウムで乾燥させた。溶媒を減圧留去し、シリカゲルクロマトグラフィーに付し、 酢酸ェチルで溶離し、化合物 11を得た。収量 2.06g(88%) Compound 10 (2.80 g, lO.Ommol) and ethylthioxamate (1.40 g, lO.Ommol) were suspended in EtOH (45 ml) and stirred at 95 ° C for 1 hour, and then concentrated under reduced pressure. Saturated aqueous NaHCO 3 was added to the residue, and the mixture was extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and anhydrous sulfuric acid Dry with magnesium. The solvent was distilled off under reduced pressure, subjected to silica gel chromatography, and eluted with ethyl acetate to obtain Compound 11. Yield 2.06g (88%)
'H-NMR (CDCl ): 1.48(3H, t, J = 7.2Hz), 4.53(2H, q, J = 7.2Hz), 7.42(1H, dd, J = 'H-NMR (CDCl): 1.48 (3H, t, J = 7.2Hz), 4.53 (2H, q, J = 7.2Hz), 7.42 (1H, dd, J =
3 Three
7.9, 5.0Hz), 7.87(1H, s), 8.33(1H, dd, J = 7.9, 2.1Hz), 8.63(1H, dd, J = 5.0, 2.1Hz), 9.16(1H, d, J = 2.1Hz). 7.9, 5.0Hz), 7.87 (1H, s), 8.33 (1H, dd, J = 7.9, 2.1Hz), 8.63 (1H, dd, J = 5.0, 2.1Hz), 9.16 (1H, d, J = 2.1 Hz).
(6) 11→12 (6) 11 → 12
化合物 l l(1.95g, 8.32mmol)をエタノール (40ml)に溶解させ、 2N_NaOH(8.3ml)を加え 、 65°Cで 30分間攪拌した。エタノールを留去した後に、 2N_HCl(8.3ml)をカ卩え、析出し たものをろ取し、減圧乾燥して、化合物 12を得た。収量 1.69g(99%) Compound 11 (1.95 g, 8.32 mmol) was dissolved in ethanol (40 ml), 2N_NaOH (8.3 ml) was added, and the mixture was stirred at 65 ° C. for 30 minutes. After distilling off ethanol, 2N_HCl (8.3 ml) was added, and the precipitated one was collected by filtration and dried under reduced pressure to obtain Compound 12. Yield 1.69 g (99%)
'H-NMR (DMSO): 7·53(1Η, m), 8.36(1H, ddd, J = 8.1, 2.4, 1.8Hz). 8.60(1H, dd, J = 4.8, 1.8Hz), 8.64(1H, s), 9.21(1H, dd, J = 2.4, 0.9Hz) 'H-NMR (DMSO): 7 · 53 (1Η, m), 8.36 (1H, ddd, J = 8.1, 2.4, 1.8Hz). 8.60 (1H, dd, J = 4.8, 1.8Hz), 8.64 (1H , s), 9.21 (1H, dd, J = 2.4, 0.9Hz)
(7) 12→13 (7) 12 → 13
化合物 12 (1.69g, 8.20mmol)をジメチルホルムアミド (12ml)に溶解させ、パラメトキシべ ンジルアルコール (1.02ml, 8.20mmol)、 WSCD(1.89g, 9.84mmol)、 4_ジメチルアミノビ リジン (301mg, 2.46mmol)を加え、室温で 29時間攪拌した。精製水を加え、酢酸ェチ ルで抽出した。有機層を精製水、飽和食塩水により洗浄し、無水硫酸マグネシウムで 乾燥させた。溶媒を減圧留去し、シリカゲルクロマトグラフィーに付し、酢酸ェチルー へキサン系で溶離し、化合物 13を得た。収量 1.59g(59%) Compound 12 (1.69 g, 8.20 mmol) was dissolved in dimethylformamide (12 ml), paramethoxybenzyl alcohol (1.02 ml, 8.20 mmol), WSCD (1.89 g, 9.84 mmol), 4_dimethylaminopyridine (301 mg, 2.46 mmol) was added and the mixture was stirred at room temperature for 29 hours. Purified water was added and extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, subjected to silica gel chromatography, and eluted with ethyl acetate-hexane system to obtain Compound 13. Yield 1.59 g (59%)
'H-NMR (CDCl ): 3.82(3H, s), 5.42(2H, s), 6.93(2H, d, J = 6.6Hz), 7.41— 7.47(1H, 'H-NMR (CDCl): 3.82 (3H, s), 5.42 (2H, s), 6.93 (2H, d, J = 6.6Hz), 7.41-7.47 (1H,
3 Three
m), 7.44(2H, d, J = 6.6Hz), 7.87(1H, s), 8.35(1H, d, J = 6.3Hz), 8.62(1H, d, J = 4.8 Hz), 9.16(1H, s). m), 7.44 (2H, d, J = 6.6Hz), 7.87 (1H, s), 8.35 (1H, d, J = 6.3Hz), 8.62 (1H, d, J = 4.8 Hz), 9.16 (1H, s).
(8) 2 + 13→8 (8) 2 + 13 → 8
化合物 2(722mg, 0.90mmol)と化合物 13(294mg, 0.90mmol)から(1)と同様にして化 合物 8を粉末として得た。収量 202mg(34%)。 Compound 8 was obtained as a powder from Compound 2 (722 mg, 0.90 mmol) and Compound 13 (294 mg, 0.90 mmol) in the same manner as (1). Yield 202 mg (34%).
'H-NMR (DMSO): 1.21(3H, t, J = 7.2Hz), 3.42, 3.52(2H, ABq, J = 17.4Hz), 4.08(2 H, q, J = 7.2Hz), 5.04(1H, d, J = 4.8Hz), 5.41(2H, d, J = 6.0Hz), 5.61(1H, dd, J = 8 •1, 4.8Hz), 5.98(1H, J = 15.3, 6.0Hz), 6.71(1H, s), 7.24(2H, s), 7.36(1H, d, J = 15.3 Hz), 8.19(1H, dd, J = 7.8, 5.4Hz), 8.53(1H, s), 8.98(1H, d, J = 5.4Hz), 9.03(1H, d,
J = 7.8Hz), 9.54(1H, d, J = 8.1Hz), 9.66(1H, s). 'H-NMR (DMSO): 1.21 (3H, t, J = 7.2Hz), 3.42, 3.52 (2H, ABq, J = 17.4Hz), 4.08 (2H, q, J = 7.2Hz), 5.04 (1H , d, J = 4.8Hz), 5.41 (2H, d, J = 6.0Hz), 5.61 (1H, dd, J = 8 • 1, 4.8Hz), 5.98 (1H, J = 15.3, 6.0Hz), 6.71 (1H, s), 7.24 (2H, s), 7.36 (1H, d, J = 15.3 Hz), 8.19 (1H, dd, J = 7.8, 5.4 Hz), 8.53 (1H, s), 8.98 (1H, d, J = 5.4Hz), 9.03 (1H, d, J = 7.8Hz), 9.54 (1H, d, J = 8.1Hz), 9.66 (1H, s).
IR (KBr) cm_1:3407, 1764, 1614, 1531, 1367. IR (KBr) cm _1 : 3407, 1764, 1614, 1531, 1367.
MS(FAB): 664+ (M+Na+H)+ MS (FAB): 664 + (M + Na + H) +
元素分析 c H N O S Na-4.2H O - 0.06NaHCO . Elemental analysis c H N O S Na-4.2H O-0.06 NaHCO.
26 22 7 7 3 2 3 26 22 7 7 3 2 3
計算値: C,42.05; H,4.12; N,13.17; S, 12.92; Na,3.27 (%) Calculated value: C, 42.05; H, 4.12; N, 13.17; S, 12.92; Na, 3.27 (%)
実験値: C,42.05; H,4.10; N,13.38; S, 12.87; Na,3.27 (%) Experimental value: C, 42.05; H, 4.10; N, 13.38; S, 12.87; Na, 3.27 (%)
実施例 213 Example 213
[化 260] [Chemical 260]
(9) 15→16 (9) 15 → 16
ジイソプロピルアミン (631 μ ΐ, 4.50mmol)を THF(6ml)に加え、 0。Cで n_BuLi(2.7Mへキ サン溶液, 1.70ml, 4.50mmol)を滴下し、 40分間攪拌した。 - 78°Cとし、上記反応液に 、化合物 15(485mg, 3.00mmol)の THF (6ml)溶液を加えた。 -78度で 20分攪拌した後、 ドライアイス粉をカ卩ぇ 0°Cまで昇温し 1時間攪拌した。酢酸ェチル、飽和重曹水を加え 、水層を分取した。水層に 2N-HC1をカ卩ぇ pH 2とした後、析出するまで減圧濃縮を行 つた。ろ取し、減圧下乾燥をすることで化合物 16を得た。収量 490mg(79%) Diisopropylamine (631 μΐ, 4.50 mmol) was added to THF (6 ml) and 0. In C, n_BuLi (2.7 M hexane solution, 1.70 ml, 4.50 mmol) was added dropwise and stirred for 40 minutes. −78 ° C., and a solution of compound 15 (485 mg, 3.00 mmol) in THF (6 ml) was added to the reaction solution. After stirring at -78 degrees for 20 minutes, the dry ice powder was heated to 0 ° C and stirred for 1 hour. Ethyl acetate and saturated aqueous sodium hydrogen carbonate were added, and the aqueous layer was separated. After 2N-HC1 was adjusted to pH 2 in the aqueous layer, it was concentrated under reduced pressure until precipitation. The compound 16 was obtained by filtering and drying under reduced pressure. Yield 490 mg (79%)
'H-NMR (DMSO): 7.54(1H, dd, J = 7.8, 5.0Hz), 8.46(1H, dd, J = 7.8, 1.8Hz), 8.54( 1H, s), 8.66(1H, dd, J = 5.0, 1.8Hz), 9.28(1H, d, J = 1.8Hz). 'H-NMR (DMSO): 7.54 (1H, dd, J = 7.8, 5.0Hz), 8.46 (1H, dd, J = 7.8, 1.8Hz), 8.54 (1H, s), 8.66 (1H, dd, J = 5.0, 1.8Hz), 9.28 (1H, d, J = 1.8Hz).
(10) 16→17 (10) 16 → 17
化合物 16(480mg, 2.33mmol)を DMF (5ml)に溶解させ、パラメトキシベンジルアルコー
ノレ (291 μ 1, 2.33mmol)、 WSCD(536mg, 2.80mmol)、 4_ジメチルァミノピリジン (85mg, 0. 70mmol)を加え、室温で 23時間攪拌した。精製水を加え、酢酸ェチルで抽出した。有 機層を精製水、飽和食塩水により洗浄し、無水硫酸マグネシウムで乾燥させた。溶媒 を減圧留去し、シリカゲルクロマトグラフィーに付し、酢酸ェチル—トルエン系で溶離 し、化合物 17を得た。収量 598mg(59%) Compound 16 (480 mg, 2.33 mmol) was dissolved in DMF (5 ml) and paramethoxybenzyl alcohol was dissolved. Nore (291 μ1, 2.33 mmol), WSCD (536 mg, 2.80 mmol), 4_dimethylaminopyridine (85 mg, 0.70 mmol) were added, and the mixture was stirred at room temperature for 23 hours. Purified water was added and extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, subjected to silica gel chromatography, and eluted with an ethyl acetate-toluene system to obtain Compound 17. Yield 598mg (59%)
'H-NMR (CDCl ) : 3· 83(3Η, s), 5.34(2H, s), 6.94(2H, d, J = 8.7Hz), 7.40(1H, d, J = 'H-NMR (CDCl): 3 · 83 (3Η, s), 5.34 (2H, s), 6.94 (2H, d, J = 8.7Hz), 7.40 (1H, d, J =
8.7Hz), 7.44(1H, ddd, J = 8.1, 4.8, 0.9Hz), 8.30(1H, ddd, J = 8.1, 2.1, 2.1Hz), 8.6 7(1H, dd, J = 4.8, 2.1Hz), 9.17(1H, dd, J = 2.1, 0.9Hz). 8.7Hz), 7.44 (1H, ddd, J = 8.1, 4.8, 0.9Hz), 8.30 (1H, ddd, J = 8.1, 2.1, 2.1Hz), 8.6 7 (1H, dd, J = 4.8, 2.1Hz) , 9.17 (1H, dd, J = 2.1, 0.9Hz).
(11) 2 + 17→14 (11) 2 + 17 → 14
化合物 2(722mg, 0.90mmol)と化合物 17(294mg, 0.90mmol)から(1)と同様にして化合 物 14を粉末として得た。収量 350mg(59%, 2st印 s)。 Compound 14 was obtained as a powder from Compound 2 (722 mg, 0.90 mmol) and Compound 17 (294 mg, 0.90 mmol) in the same manner as (1). Yield 350 mg (59%, 2st mark s).
JH-NMR (DMSO) : 1.22(3H, t, J = 7.2Hz), 3.43, 3.49(2H, ABq, J = 16.5Hz), 4.09(2 H, q, J = 7.2Hz), 5.04(1H, d, J = 4.8Hz), 5.38(2H, d, J = 6.9Hz), 5.60(1H, dd, J = 8 .1, 4.8Hz), 5.93(1H, dt, J = 15.6, 6.9Hz), 6.71(1H, s), 7.23(2H, s), 7.33(1H, d, J = 15.6Hz), 8.14(1H, s), 8.20(1H, dd, J = 8.1, 6.0Hz), 9.02(1H, d, J = 6.0Hz), 9.11(1H , d, J = 8.1Hz), 9.54(1H, d, J = 8.1Hz), 9.71(1H, s) J H-NMR (DMSO): 1.22 (3H, t, J = 7.2Hz), 3.43, 3.49 (2H, ABq, J = 16.5Hz), 4.09 (2H, q, J = 7.2Hz), 5.04 (1H , d, J = 4.8Hz), 5.38 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 8.1, 4.8Hz), 5.93 (1H, dt, J = 15.6, 6.9Hz) , 6.71 (1H, s), 7.23 (2H, s), 7.33 (1H, d, J = 15.6Hz), 8.14 (1H, s), 8.20 (1H, dd, J = 8.1, 6.0Hz), 9.02 ( 1H, d, J = 6.0Hz), 9.11 (1H, d, J = 8.1Hz), 9.54 (1H, d, J = 8.1Hz), 9.71 (1H, s)
IR (KBr) cm_1:3398, 1763, 1603, 1531, 1398, 1346. IR (KBr) cm _1 : 3398, 1763, 1603, 1531, 1398, 1346.
MS(FAB) : 686+ (M+2Na)+ MS (FAB): 686 + (M + 2Na) +
元素分析 C H N O S Na- 3.7H O - 0.21NaHCO . Elemental analysis C H N O S Na- 3.7H O-0.21
計算値: C,42.09; H,3.99; N,13.11; S, 12.86; Na,3.72 (%) Calculated values: C, 42.09; H, 3.99; N, 13.11; S, 12.86; Na, 3.72 (%)
実験値: C,42.00; H,4.05; N,13.39; S, 12.94; Na,3.73 (%) Experimental value: C, 42.00; H, 4.05; N, 13.39; S, 12.94; Na, 3.73 (%)
実施例 214 Example 214
23 24 23 24
(12) 20 + 21→22 (12) 20 + 21 → 22
化合物 20(4.10g, 20. Ommol),化合物 21(3.28g, 20. Ommol)にジォキサン (200ml)を加え 、燐酸カリウム (21.2g, lOOmmol), Pd(PPh ) (1.15g, l.OOmmol)を加え、 100でで2.5時 間攪拌した。反応液をろ過し、ろ液を減圧濃縮した。残渣を酢酸ェチル (70ml)に溶解 させ、無水硫酸マグネシウムをカ卩え、再度ろ過した。ろ液を濃縮し、シリカゲルクロマト グラフィ一に付し、酢酸ェチル—トルエン系で溶離し、化合物 22を得た。収量 2.17g(6 7%) Compound 20 (4.10 g, 20. Ommol), Compound 21 (3.28 g, 20. Ommol) were added with dioxane (200 ml), and potassium phosphate (21.2 g, lOOmmol), Pd (PPh) (1.15 g, l.OOmmol) And stirred at 100 for 2.5 hours. The reaction solution was filtered, and the filtrate was concentrated under reduced pressure. The residue was dissolved in ethyl acetate (70 ml), anhydrous magnesium sulfate was added and filtered again. The filtrate was concentrated, subjected to silica gel chromatography and eluted with an ethyl acetate-toluene system to give compound 22. Yield 2.17 g (6 7%)
'H-NMR (DMSO): 7.82(2H, d, J = 4.5Hz), 7.94(1H, d, J = 4.8Hz), 8.54(2H, d, J = 4.5Hz), 9.08(1H, d, J = 4.8Hz). 'H-NMR (DMSO): 7.82 (2H, d, J = 4.5Hz), 7.94 (1H, d, J = 4.8Hz), 8.54 (2H, d, J = 4.5Hz), 9.08 (1H, d, J = 4.8Hz).
( 13) 22→23 (13) 22 → 23
化合物 22(2.16g, 13.3mmol)の THF (25ml)から(9)と同様にして化合物 23を得た。収 量 2.29g(83%) Compound 23 was obtained in the same manner as (9) from THF (25 ml) of Compound 22 (2.16 g, 13.3 mmol). Yield 2.29 g (83%)
'H-NMR (DMSO): 8.08(2H, d, J = 4.5Hz), 8.60(1H, s), 8.74(2H, d, J = 4.5Hz). 'H-NMR (DMSO): 8.08 (2H, d, J = 4.5Hz), 8.60 (1H, s), 8.74 (2H, d, J = 4.5Hz).
(14) 23→24 (14) 23 → 24
化合物 23(2.28g, ll.lmmol)力 (10)と同様にして化合物 24を得た。収量 2.64g(73% ) Compound 23 (2.28 g, ll.lmmol) Compound (24) was obtained in the same manner as in (10). Yield 2.64g (73%)
'H-NMR (CDCl ): 3.83(3H, s), 5.34(2H, s), 6.93(2H, d, J = 8.9Hz), 7.40(2H, d, J = 'H-NMR (CDCl): 3.83 (3H, s), 5.34 (2H, s), 6.93 (2H, d, J = 8.9Hz), 7.40 (2H, d, J =
8.9Hz), 7.82(2H, d, J = 6.0Hz), 8.17(1H, s), 8.73(2H, d, J = 6.0Hz).
(15) 19 + 24→18 8.9Hz), 7.82 (2H, d, J = 6.0Hz), 8.17 (1H, s), 8.73 (2H, d, J = 6.0Hz). (15) 19 + 24 → 18
化合物 19(738mg, l.OOmmol)と化合物 24(326mg, l.OOmmol)から(1)と同様にして化 合物 18を粉末として得た。収量 265mg(39%, 2steps)0 Compound 18 was obtained as a powder from Compound 19 (738 mg, l.OOmmol) and Compound 24 (326 mg, l.OOmmol) in the same manner as in (1). Yield 265mg (39%, 2steps) 0
'H-NMR (DMSO): 1.21(3H, d, J = 5·7Ηζ),1.23(3Η, d, J = 5.7Hz), 3.43, 3.50(2H, A Bq, J = 16.2Hz), 4.30(lH,m), 5.05(1H, d, J = 4.8Hz), 5.29(2H, d, J = 6.9Hz), 5.61(1 H, dd, J = 8.1, 4.8Hz), 5.88(1H, dt, J = 15.0, 6.9Hz), 6.70(1H, s), 7.24(2H, s), 7.30 (1H, d, J = 15.0Hz), 8.25(1H, s), 8.67(2H, d, J = 6.6Hz), 9.06(2H, d, J = 6.6Hz), 9. 49(1H, d, J = 8.1H z). 'H-NMR (DMSO): 1.21 (3H, d, J = 5 · 7Ηζ), 1.23 (3Η, d, J = 5.7Hz), 3.43, 3.50 (2H, A Bq, J = 16.2Hz), 4.30 ( lH, m), 5.05 (1H, d, J = 4.8Hz), 5.29 (2H, d, J = 6.9Hz), 5.61 (1 H, dd, J = 8.1, 4.8Hz), 5.88 (1H, dt, J = 15.0, 6.9Hz), 6.70 (1H, s), 7.24 (2H, s), 7.30 (1H, d, J = 15.0Hz), 8.25 (1H, s), 8.67 (2H, d, J = 6.6 Hz), 9.06 (2H, d, J = 6.6Hz), 9. 49 (1H, d, J = 8.1H z).
IR (KBr) cm_1:3418, 1760, 1607, 1530, 1396, 1344. IR (KBr) cm _1 : 3418, 1760, 1607, 1530, 1396, 1344.
MS(FAB): 700+ (M+2Na)+ MS (FAB): 700 + (M + 2Na) +
元素分析 c H N O S Na-4.4H O - 0.2NaHCO -0.4NaCl. Elemental analysis c H N O S Na-4.4H O-0.2NaHCO -0.4NaCl.
26 22 7 7 3 2 3 26 22 7 7 3 2 3
計算値: C,40.18; Η,3·99; N,12.52; S, 12.28; Na,4.70; Cl,1.81 (%) Calculated value: C, 40.18; Η, 3.99; N, 12.52; S, 12.28; Na, 4.70; Cl, 1.81 (%)
実験値: C,40.49; H,4.26; N,12.13; S,11.77; Na,4.62; Cl,1.80 (%) Experimental value: C, 40.49; H, 4.26; N, 12.13; S, 11.77; Na, 4.62; Cl, 1.80 (%)
実施例 215 Example 215
[化 262] [Chemical 262]
(16) 2 + 24→25 (16) 2 + 24 → 25
化合物 2(738mg, l.OOmmol)と化合物 24(294mg, 0.90mmol)から(1)と同様にして化合 物 25を粉末として得た。収量 121mg(20%, 2st印 s)。 Compound 25 was obtained as a powder from Compound 2 (738 mg, l.OOmmol) and Compound 24 (294 mg, 0.90 mmol) in the same manner as (1). Yield 121 mg (20%, 2st mark s).
JH-NMR (DMSO): 1.22(3H, t, J = 7.2Hz), 3.43, 3.49(2H, ABq, J = 17.0Hz), 4.09(2 H, q, J = 7.2Hz), 5.05(1H, d, J = 4.8Hz), 5.29(2H, d, J = 6.9Hz), 5.60(1H, dd, J = 8 .1, 4.8Hz), 5.87(1H, dt, J = 15.6, 6.9Hz), 6.72(1H, s), 7.23(2H, s), 7.30(1H, d, J = 15.6Hz), 8.25(1H, s), 8.67(2H, d, J = 6.9Hz), 9.06(2H, d, J = 6.9Hz), 9.54(1H, d, J
= 8.1Hz) J H-NMR (DMSO): 1.22 (3H, t, J = 7.2Hz), 3.43, 3.49 (2H, ABq, J = 17.0Hz), 4.09 (2H, q, J = 7.2Hz), 5.05 (1H , d, J = 4.8Hz), 5.29 (2H, d, J = 6.9Hz), 5.60 (1H, dd, J = 8.1, 4.8Hz), 5.87 (1H, dt, J = 15.6, 6.9Hz) , 6.72 (1H, s), 7.23 (2H, s), 7.30 (1H, d, J = 15.6Hz), 8.25 (1H, s), 8.67 (2H, d, J = 6.9Hz), 9.06 (2H, d, J = 6.9Hz), 9.54 (1H, d, J = 8.1Hz)
IR (KBr) cm— 3398, 1763, 1605, 1530, 1395, 1343. IR (KBr) cm— 3398, 1763, 1605, 1530, 1395, 1343.
MS(FAB): 686+ (M+2Na)+ MS (FAB): 686 + (M + 2Na) +
元素分析 c H N O S Na-4.5H O - 0.55NaHCO -0.15NaCl. Elemental analysis c H N O S Na-4.5H O-0.55NaHCO -0.15NaCl.
計算値: C,39.87; Η,3·98; Ν,12·26; S, 12.03; Na,4.89; Cl,0.66 (%) Calculated value: C, 39.87; Η, 3.98; Ν, 12.26; S, 12.03; Na, 4.89; Cl, 0.66 (%)
実験値: C39.78; Η,3·90; Ν,12·36; S, 12.05; Na,4.92; Cl,0.78 (%) Experimental value: C39.78; Η, 3.90; Ν, 12.36; S, 12.05; Na, 4.92; Cl, 0.78 (%)
実施例 216 Example 216
[化 263] [Chemical 263]
( 17) 28→29 (17) 28 → 29
化合物 28(1.04g, 3.30mmol)に 2N_NaOH(2.5ml)を加え、室温で 1時間攪拌した。 2N_ HCl(2.5ml)を加え、析出した固体をろ取した。減圧乾燥して、化合物 29を得た。収量 6 65mg (97%) 2N_NaOH (2.5 ml) was added to compound 28 (1.04 g, 3.30 mmol), and the mixture was stirred at room temperature for 1 hour. 2N_HCl (2.5 ml) was added, and the precipitated solid was collected by filtration. Drying under reduced pressure gave Compound 29. Yield 6 65mg (97%)
'H-NMR (CDCl ): 8.27(2H, d, J = 6.0Hz), 8.85(2H, d, J = 6.0Hz), 9.04(1H, s). 'H-NMR (CDCl): 8.27 (2H, d, J = 6.0Hz), 8.85 (2H, d, J = 6.0Hz), 9.04 (1H, s).
( 18) 29→30 (18) 29 → 30
化合物 29(650mg, 3.20mmol)力 (10)と同様にして化合物 30を得た。収量 585mg(57Compound 30 (650 mg, 3.20 mmol) Compound 30 was obtained in the same manner as (10). Yield 585 mg (57
%) %)
'H-NMR (CDCl ): 3·82(3Η, s), 5.42(2H, s), 6.93(2H, d, J = 8.7Hz), 7.43(2H, d, J = 'H-NMR (CDCl): 3 · 82 (3Η, s), 5.42 (2H, s), 6.93 (2H, d, J = 8.7Hz), 7.43 (2H, d, J =
8.7Hz), 7.98(1H, s), 8.70(2H, d, J = 6.0Hz), 7.88(2H, d, J = 6.0Hz). 8.7Hz), 7.98 (1H, s), 8.70 (2H, d, J = 6.0Hz), 7.88 (2H, d, J = 6.0Hz).
( 19) 27 + 30→26 (19) 27 + 30 → 26
化合物 27(677mg, 0.90mmol)と化合物 30(294mg, 0.90mmolから(1)と同様にして化合 物 26を粉末として得た。収量 101mg(17%)。 Compound 26 was obtained as a powder from Compound 27 (677 mg, 0.90 mmol) and Compound 30 (294 mg, 0.90 mmol) in the same manner as (1) .Yield 101 mg (17%).
'H-NMR (DMSO): 0.88(3H, t, J = 7.5Hz), 1.63(2H, qt, J = 7.5, 6.6Hz), 3.43, 3.49(
2H, ABq, J = 17.1Hz), 3.99(2H, t, J = 6.6Hz), 5.05(1H, d, J = 4.8Hz), 5.25(2H, d, J = 7.2Hz), 5.60(1H, dd, J = 7.8, 4.8Hz), 5.88(1H, dt, J = 15.9, 7.2Hz), 6.70(1H, s),'H-NMR (DMSO): 0.88 (3H, t, J = 7.5Hz), 1.63 (2H, qt, J = 7.5, 6.6Hz), 3.43, 3.49 ( 2H, ABq, J = 17.1Hz), 3.99 (2H, t, J = 6.6Hz), 5.05 (1H, d, J = 4.8Hz), 5.25 (2H, d, J = 7.2Hz), 5.60 (1H, dd, J = 7.8, 4.8Hz), 5.88 (1H, dt, J = 15.9, 7.2Hz), 6.70 (1H, s),
7.23(2H, s), 7.29(1H, d, J = 15.9Hz), 8.56(2H, d, J = 6.6Hz), 8.90(1H, s), 9.01(2H, d, J = 6.6Hz), 9.54(1H, d, J = 7.8Hz). 7.23 (2H, s), 7.29 (1H, d, J = 15.9Hz), 8.56 (2H, d, J = 6.6Hz), 8.90 (1H, s), 9.01 (2H, d, J = 6.6Hz), 9.54 (1H, d, J = 7.8Hz).
IR (KBr) cm_1:3407, 1764, 1635, 1532, 1367. IR (KBr) cm _1 : 3407, 1764, 1635, 1532, 1367.
MS(FAB): 678+ (M+Na+H)+ MS (FAB): 678 + (M + Na + H) +
元素分析 c H N O S Na-4.8H O - 0.35NaHCO -0.25NaCl. Elemental analysis c H N O S Na-4.8H O-0.35 NaHCO -0.25NaCl.
27 24 7 7 3 2 3 27 24 7 7 3 2 3
計算値: C,40.65; H,4.23; N,12.13; S,11.90; Na,4.55; Cl,1.10 (%) Calculated values: C, 40.65; H, 4.23; N, 12.13; S, 11.90; Na, 4.55; Cl, 1.10 (%)
実験値: C,40.72; H,4.16; N,12.23; S,11.70; Na,4.60; Cl,1.02 (%) Experimental value: C, 40.72; H, 4.16; N, 12.23; S, 11.70; Na, 4.60; Cl, 1.02 (%)
実施例 217 Example 217
[化 264] [Chemical 264]
(20) 27 + 24→31 (20) 27 + 24 → 31
化合物 27(677mg, 0.90mmol)と化合物 24(294mg, 0.90mmol)から(1)と同様にして化 合物 31を粉末として得た。収量 228mg(37%, 2st印 s)。 Compound 31 was obtained as a powder from Compound 27 (677 mg, 0.90 mmol) and Compound 24 (294 mg, 0.90 mmol) in the same manner as in (1). Yield 228 mg (37%, 2st mark s).
'H-NMR (DMSO): 0·89(3Η, t, J = 7.5Hz), 1·63(2Η, qt, J = 7.5, 6.6Hz), 3.43, 3.49( 2H, ABq, J = 17.1Hz), 3.99(2H, t, J = 6.6Hz), 5.05(1H, d, J = 5.4Hz), 5.29(2H, d, J 'H-NMR (DMSO): 0 · 89 (3Η, t, J = 7.5Hz), 1 · 63 (2Η, qt, J = 7.5, 6.6Hz), 3.43, 3.49 (2H, ABq, J = 17.1Hz ), 3.99 (2H, t, J = 6.6Hz), 5.05 (1H, d, J = 5.4Hz), 5.29 (2H, d, J
= 7.5Hz), 5.60(1H, dd, J = 7.8, 5.4Hz), 5.88(1H, dt, J = 15.9, 7.5Hz), 6.71(1H, s), 7.24(2H, s), 7.30(1H, d, J = 15.9Hz), 8.26(1H, s), 8.68(2H, d, J = 6.3Hz), 9.06(2H, d, J = 6.3Hz), 9.54(1H, d, J = 7.8Hz). = 7.5Hz), 5.60 (1H, dd, J = 7.8, 5.4Hz), 5.88 (1H, dt, J = 15.9, 7.5Hz), 6.71 (1H, s), 7.24 (2H, s), 7.30 (1H , d, J = 15.9Hz), 8.26 (1H, s), 8.68 (2H, d, J = 6.3Hz), 9.06 (2H, d, J = 6.3Hz), 9.54 (1H, d, J = 7.8Hz ).
IR (KBr) cm_1:3409, 1763, 1605, 1530, 1395, 1343. IR (KBr) cm _1 : 3409, 1763, 1605, 1530, 1395, 1343.
MS(FAB): 678+ (M+Na+H)+
元素分析 C H N O S Na-4.7H O - O. lNaHCO -0.15NaCl. MS (FAB): 678 + (M + Na + H) + Elemental analysis CHNOS Na-4.7HO-O. lNaHCO -0.15NaCl.
計算値: C,41.75; H,4.33; N,12.58; S, 12.34; Na,3.69; Cl,0.68 (%) Calculated value: C, 41.75; H, 4.33; N, 12.58; S, 12.34; Na, 3.69; Cl, 0.68 (%)
実験値: C,41.76; H,4.10; N,12.78; S,12.18; Na,3.60; Cl,0.72 (%) Experimental value: C, 41.76; H, 4.10; N, 12.78; S, 12.18; Na, 3.60; Cl, 0.72 (%)
実施例 218 Example 218
[化 265] [Chemical 265]
(21) 33→34 (21) 33 → 34
化合物 33(5.73g, 30.0mmol)にトルエン (50ml)、エチレングリコール (4.0ml)、 TsOH(57 lmg, 3.00mmol)を加え 2時間加熱還流した。エチレングリコール (2.0ml)を追加し、さら に 2時間加熱還流した。 2%炭酸ナトリウム水溶液 (50ml)をカ卩え、ジェチルエーテル抽 出を行った。 Toluene (50 ml), ethylene glycol (4.0 ml) and TsOH (57 lmg, 3.00 mmol) were added to compound 33 (5.73 g, 30.0 mmol), and the mixture was heated to reflux for 2 hours. Ethylene glycol (2.0 ml) was added, and the mixture was further heated under reflux for 2 hours. A 2% aqueous sodium carbonate solution (50 ml) was added and extracted with jetyl ether.
有機層を精製水、飽和食塩水により洗浄し、無水硫酸マグネシウムで乾燥させた。溶 媒を減圧留去し、化合物 34を得た。収量 7.68g(quant) The organic layer was washed with purified water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain Compound 34. Yield 7.68g (quant)
'H-NMR (CDCl ): 4.00-4.16(4H, m), 6.02(1H, s), 6.91(1H, d, J = 3.6Hz), 6.94(1H, d, J = 3.6Hz). 'H-NMR (CDCl): 4.00-4.16 (4H, m), 6.02 (1H, s), 6.91 (1H, d, J = 3.6Hz), 6.94 (1H, d, J = 3.6Hz).
(22) 34 + 35→36 (22) 34 + 35 → 36
化合物 34(3.53g, 15.0mmol)を THF(30ml)に溶解させ- 78°Cで n-BuLi(1.54Mへキサン
溶液, 10.20ml, 15.8mmol)を滴下し、 30分間攪拌した。続いて反応液に化合物 35(1. 93g, 18.0mmol)の THF (lOml)溶液を加えた。 _78°Cで 1時間攪拌し、飽和塩化アンモ ニゥム水溶液を加え、酢酸ェチルで抽出した。有機層を精製水、飽和食塩水により 洗浄し、無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、化合物 36を得た。 収量 2.60g(66%) Compound 34 (3.53 g, 15.0 mmol) was dissolved in THF (30 ml) at -78 ° C and n-BuLi (1.54 M hexane Solution, 10.20 ml, 15.8 mmol) was added dropwise and stirred for 30 minutes. Subsequently, a THF (lOml) solution of compound 35 (1.93 g, 18.0 mmol) was added to the reaction solution. The mixture was stirred at _78 ° C for 1 hour, saturated aqueous ammonium chloride solution was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain Compound 36. Yield 2.60 g (66%)
'H-NMR (CDCl ) : 3.97-4.13(4H, m), 6·01(1Η, s), 6·03(1Η, s), 6.85(1H, d, J = 3.6 'H-NMR (CDCl): 3.97-4.13 (4H, m), 6.01 (1Η, s), 6 · 03 (1Η, s), 6.85 (1H, d, J = 3.6
Hz), 7.01(1H, d, J = 3.6Hz), 7.39(2H, d, J = 6.0Hz),8.54(2H, d, J = 6.0Hz). Hz), 7.01 (1H, d, J = 3.6Hz), 7.39 (2H, d, J = 6.0Hz), 8.54 (2H, d, J = 6.0Hz).
(23) 36→37 (23) 36 → 37
化合物 36(2.60g, 9.87mmol)をクロ口ホルム (45ml)に溶解させ、二酸化マンガン (12.87g , 148.1mmol)を加え、室温で 1.5時間攪拌した。反応液をセライトろ過し、ろ液を濃縮 し、化合物 37を得た。 2.60g(quant) Compound 36 (2.60 g, 9.87 mmol) was dissolved in black mouth form (45 ml), manganese dioxide (12.87 g, 148.1 mmol) was added, and the mixture was stirred at room temperature for 1.5 hours. The reaction solution was filtered through Celite, and the filtrate was concentrated to obtain Compound 37. 2.60g (quant)
(24) 37→38 (24) 37 → 38
化合物 37(2.60g, 9.87mol)に 2N-HCl(14.7ml)を加え室温で 2時間攪拌した。炭酸水素 ナトリウムを〉 pH 7となるまでカ卩え、酢酸ェチルで抽出した。有機層を精製水、飽和食 塩水により洗浄し、無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し、シリカ ゲルクロマトグラフィーに付し、酢酸ェチルートルエン系で溶離し、化合物 38を得た。 収量 2.09g(98%) 2N-HCl (14.7 ml) was added to Compound 37 (2.60 g, 9.87 mol), and the mixture was stirred at room temperature for 2 hours. Sodium bicarbonate was added to pH> 7 and extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, subjected to silica gel chromatography, and eluted with an ethyl acetate-toluene system to obtain Compound 38. Yield 2.09 g (98%)
'H-NMR (CDCl ) : 7.68-7.73(3H, m), 7.82(1H, d, J = 3.6Hz), 8.87(2H, d, J = 5.7Hz 'H-NMR (CDCl): 7.68-7.73 (3H, m), 7.82 (1H, d, J = 3.6Hz), 8.87 (2H, d, J = 5.7Hz
), 10.05(1H, s). ), 10.05 (1H, s).
(25) 38→39 (25) 38 → 39
NaCIO (2.39g, 21.1mmol)と NH SO H(2.05g, 21.1mmol)に精製水 (50ml)を加え、冷却 し攪拌を行った。化合物 38を加え、 1時間攪拌した。 Na SO (5.32g, 42.2mmol)の水溶 液 (25ml)を反応液にカ卩え、さらに 30分間攪拌した。ろ過し、減圧乾燥することで化合 物 39を得た。収量 1.40g(63%) Purified water (50 ml) was added to NaCIO (2.39 g, 21.1 mmol) and NH 2 SO 4 (2.05 g, 21.1 mmol), and the mixture was cooled and stirred. Compound 38 was added and stirred for 1 hour. An aqueous solution (25 ml) of Na 2 SO 4 (5.32 g, 42.2 mmol) was added to the reaction solution and stirred for another 30 minutes. The compound 39 was obtained by filtering and drying under reduced pressure. Yield 1.40 g (63%)
'H-NMR (DMSO) : 7.75-7.8K4H, m), 8.85(2H, d, J = 6.0Hz). 'H-NMR (DMSO): 7.75-7.8K4H, m), 8.85 (2H, d, J = 6.0Hz).
(26) 39→40 (26) 39 → 40
化合物 39(1.38g, 5.92mmol)をジメチルホルムアミド (10ml)に溶解させ、パラメトキシべ ンジノレアノレコーノレ (736 μ ΐ, 5.92mmol)、 WSCD(1.36g, 7.08mmol)、 4—ジメチルアミノビ
リジン (216mg, 1.77mmol)を加え、室温で 3.5時間攪拌した。精製水を加え、酢酸ェチ ルで抽出した。有機層を精製水、飽和食塩水により洗浄し、無水硫酸マグネシウムで 乾燥させた。溶媒を減圧留去し、シリカゲルクロマトグラフィーに付し、酢酸ェチルー トルエン系で溶離し、化合物 40を得た。収量 1.40g(67%) Compound 39 (1.38 g, 5.92 mmol) was dissolved in dimethylformamide (10 ml), paramethoxybenzenoleanolone (736 μΐ, 5.92 mmol), WSCD (1.36 g, 7.08 mmol), 4-dimethylaminobiphenyl. Lysine (216 mg, 1.77 mmol) was added, and the mixture was stirred at room temperature for 3.5 hours. Purified water was added and extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, subjected to silica gel chromatography, and eluted with ethyl acetate-toluene system to obtain Compound 40. Yield 1.40 g (67%)
'H-NMR (CDCl ): 3·82(3Η, s), 5.31(2H, s), 6.92(2H, d, J = 8.7Hz), 7.38(2H, d, J = 'H-NMR (CDCl): 3 · 82 (3Η, s), 5.31 (2H, s), 6.92 (2H, d, J = 8.7Hz), 7.38 (2H, d, J =
8.7Hz), 7.59(1H, d, J = 3.9Hz), 7.65(2H, d, J = 5.7Hz), 7.81(1H, d, J = 3.9Hz), 8.8 4(2H, d, J = 5.7Hz). 8.7Hz), 7.59 (1H, d, J = 3.9Hz), 7.65 (2H, d, J = 5.7Hz), 7.81 (1H, d, J = 3.9Hz), 8.8 4 (2H, d, J = 5.7 Hz).
(27) 19 + 40→32 (27) 19 + 40 → 32
化合物 19(855mg, l.OOmmol)と化合物 40(353mg, l.OOmmol)をジメチルホルムアミド (2. Oml)に溶解させ、臭化ナトリウム (309mg, 3.00mmol)をカ卩え、 5時間攪拌した。反応液を 冷却下、 5%食塩水 (30ml)攪拌中に注加し、析出した沈殿を濾取した。沈殿を減圧乾 燥して無定形粉末 (1.23g)を得た。無定形粉末 (1.22g)をジクロロメタン (12.0ml)に溶解 させ、ァニソール (1.0ml)を加え、 -30°Cに冷却した。 1M-塩化アルミ(ニトロメタン溶液 、 10ml)を加え、 _10°Cまで昇温させながら 1時間攪拌した。反応液を、 MeCN(50ml)お よび 0.3N_HCl(50ml)の溶液に氷冷下で攪拌しながら滴下した。 Et 0を加え、水層を 分取した。 HP-20SSを加え濃縮し、 HP-20SSカラムクロマトグラフィーに付し、水-ァセ トニトリルで溶離した。所望の化合物を含むフラクションを集め攪拌しながら 2N_NaOH を注意深く加え、 pHが 10を超えた時点でドライアイスを加え、 pHを 5以下にした。減圧 下濃縮し、凍結乾燥して化合物 32を粉末として得た。収量 284mg(40%, 2steps)0 'H-NMR (D O): 1.28(3H, d, J = 3.3Hz), 1.30(3H, d, J = 3.3Hz), 3.66, 3.66(2H, AB q, J = 19.5Hz), 4.49(1H, m), 5.27(1H, d, J = 4.5Hz), 5.44(2H, d, J = 6.9Hz), 5.81(1 H, d, J = 4.5Hz), 6.13(1H, dt, J = 15.3, 6.9Hz), 6.94(1H, s), 7.03(1H, d, J = 15.3Hz ), 7.58(1H, d, J = 3.3Hz), 7.66(1H, d, J = 3.3Hz), 8.38(2H, d, J = 5.4Hz), 9.10(2H, d, J = 5.4Hz). Compound 19 (855 mg, l.OOmmol) and compound 40 (353 mg, l.OOmmol) were dissolved in dimethylformamide (2. Oml), sodium bromide (309 mg, 3.00 mmol) was added, and the mixture was stirred for 5 hours. The reaction mixture was poured into 5% brine (30 ml) with stirring while cooling, and the deposited precipitate was collected by filtration. The precipitate was dried under reduced pressure to obtain an amorphous powder (1.23 g). Amorphous powder (1.22 g) was dissolved in dichloromethane (12.0 ml), anisole (1.0 ml) was added, and the mixture was cooled to -30 ° C. 1M-aluminum chloride (nitromethane solution, 10 ml) was added, and the mixture was stirred for 1 hour while raising the temperature to _10 ° C. The reaction solution was added dropwise to a solution of MeCN (50 ml) and 0.3N_HCl (50 ml) with stirring under ice cooling. Et 0 was added and the aqueous layer was separated. HP-20SS was added and concentrated, subjected to HP-20SS column chromatography and eluted with water-nitrile. Fractions containing the desired compound were collected and 2N_NaOH was carefully added with stirring, and when the pH exceeded 10, dry ice was added to bring the pH to 5 or less. Concentration under reduced pressure and lyophilization gave Compound 32 as a powder. Yield 284mg (40%, 2steps) 0 'H-NMR (DO): 1.28 (3H, d, J = 3.3Hz), 1.30 (3H, d, J = 3.3Hz), 3.66, 3.66 (2H, AB q, J = 19.5Hz), 4.49 (1H, m), 5.27 (1H, d, J = 4.5Hz), 5.44 (2H, d, J = 6.9Hz), 5.81 (1 H, d, J = 4.5Hz), 6.13 (1H, dt, J = 15.3, 6.9Hz), 6.94 (1H, s), 7.03 (1H, d, J = 15.3Hz), 7.58 (1H, d, J = 3.3Hz), 7.66 (1H, d , J = 3.3Hz), 8.38 (2H, d, J = 5.4Hz), 9.10 (2H, d, J = 5.4Hz).
IR (KBr) cm_1:3417, 1765, 1604, 1521, 1366, 1321, 1297. IR (KBr) cm _1 : 3417, 1765, 1604, 1521, 1366, 1321, 1297.
MS(FAB): 705+ (M+Na+H)+ MS (FAB): 705 + (M + Na + H) +
元素分析 c H N O S Na-4.4H O - 0.2NaHCO . Elemental analysis c H N O S Na-4.4H O-0.2NaHCO.
計算値: C,43.80; H,4.28; N,10.49; S,12.01; Na,3.45 (%)
実験値: C43.96; H,4.13; N,10.42; S,11.64; Na,3.47 (%) Calculated value: C, 43.80; H, 4.28; N, 10.49; S, 12.01; Na, 3.45 (%) Experimental value: C43.96; H, 4.13; N, 10.42; S, 11.64; Na, 3.47 (%)
実施例 219 Example 219
[化 266] [Chemical 266]
(28) 34 + 42→43→44→45 (28) 34 + 42 → 43 → 44 → 45
化合物 34(3.53g, 15.0mmol 42(1.84ml, 19.5mmol)から(22)、 (23)および(24)と同 様にして化合物 43、化合物 44を経て化合物 45を得た。収量 1.44g(44% from34) 'H-NMR (CDCl ): 7.50— 7·54(1Η, m), 7.73(1H, d, J = 3.9Hz), 7.83(1H, d, J = 3.9HzIn the same manner as (22), (23) and (24), compound 45 was obtained from compound 34 (3.53 g, 15.0 mmol 42 (1.84 ml, 19.5 mmol) via compound 43 and compound 44. Yield 1.44 g ( 44% from34) 'H-NMR (CDCl): 7.50— 7 · 54 (1Η, m), 7.73 (1H, d, J = 3.9Hz), 7.83 (1H, d, J = 3.9Hz
), 8.20(1H, ddd, J = 8.1, 2.1, 1.8Hz), 8.83(1H, br s), 9.12(1H, br s), 10.04(1H, s).), 8.20 (1H, ddd, J = 8.1, 2.1, 1.8Hz), 8.83 (1H, br s), 9.12 (1H, br s), 10.04 (1H, s).
(29) 45→46 (29) 45 → 46
化合物 45(1.43g, 6.58mmol)から (25)と同様にして化合物 46を得た収量 1.15g(75%)。 'H-NMR (CDCl ): 7·63(1Η, dd, J = 7.8, 5.0Hz), 7.78(1H, d, J = 3.9Hz), 7.81(1H, dCompound 45 (1.43 g, 6.58 mmol) was obtained in the same manner as (25) to give compound 46. Yield 1.15 g (75%). 'H-NMR (CDCl): 7 · 63 (1Η, dd, J = 7.8, 5.0Hz), 7.78 (1H, d, J = 3.9Hz), 7.81 (1H, d
, J = 3.9Hz), 8.25(1H, ddd, J = 7.8, 1.8, 2.1Hz), 8.86(1H, dd, J =5.1, 1.8Hz), 9.01(1 H, d, J = 2.1Hz). , J = 3.9Hz), 8.25 (1H, ddd, J = 7.8, 1.8, 2.1Hz), 8.86 (1H, dd, J = 5.1, 1.8Hz), 9.01 (1 H, d, J = 2.1Hz).
(30) 46→47 (30) 46 → 47
化合物 46(1.15g, 4.93mmol)力 (26)と同様にして化合物 47を得た。収量 1.14g(66% ) Compound 47 (1.15g, 4.93mmol) Compound 47 was obtained in the same manner as in (26). Yield 1.14g (66%)
'H-NMR (CDCl ): 3.83(3H, s), 5.32(2H, s), 6.92(2H, d, J = 9.0Hz), 7.39(2H, d, J = 'H-NMR (CDCl 3): 3.83 (3H, s), 5.32 (2H, s), 6.92 (2H, d, J = 9.0Hz), 7.39 (2H, d, J =
9.0Hz), 7.49(1H, dd, J = 7.8, 4.8Hz), 7.61(1H, d, J = 3.9Hz), 7.82(1H, d, J = 3.9H z), 8.17(1H, ddd, J = 7.8, 1.5, 1.2Hz), 8.85(1H, dd, J = 4.8, 1.2Hz), 9.09(1H, d, J =
1.5Hz). 9.0Hz), 7.49 (1H, dd, J = 7.8, 4.8Hz), 7.61 (1H, d, J = 3.9Hz), 7.82 (1H, d, J = 3.9H z), 8.17 (1H, ddd, J = 7.8, 1.5, 1.2Hz), 8.85 (1H, dd, J = 4.8, 1.2Hz), 9.09 (1H, d, J = 1.5Hz).
(31) 2 + 47→41 (31) 2 + 47 → 41
化合物 2(812mg、 l. lOmmol)と化合物 47(353mg, l.OOmmol)力 (27)と同様にして化 合物 41を粉末として得た。収量 307mg(44%, 2st印 s)。 Compound 41 was obtained as a powder in the same manner as Compound 2 (812 mg, l.lOmmol) and Compound 47 (353 mg, l.OOmmol) force (27). Yield 307 mg (44%, 2st mark s).
'H-NMR (D O): 1.29(3H, t, J = 7.2Hz), 3.65, 3.65 (2H, ABq, J = 18.3Hz), 4.21(2H 'H-NMR (D 2 O): 1.29 (3H, t, J = 7.2Hz), 3.65, 3.65 (2H, ABq, J = 18.3Hz), 4.21 (2H
, q, J = 7.2Hz), 5.26(1H, d, J = 4.8Hz), 5.44(2H, d, J = 7.2Hz), 5.80(1H, d, J = 4.8, q, J = 7.2Hz), 5.26 (1H, d, J = 4.8Hz), 5.44 (2H, d, J = 7.2Hz), 5.80 (1H, d, J = 4.8
Hz), 6.14(1H, dt, J = 15.0, 7.2Hz), 6.96(1H, s), 7.00(1H, d, J = 15.0Hz), 7.58(1H, dHz), 6.14 (1H, dt, J = 15.0, 7.2Hz), 6.96 (1H, s), 7.00 (1H, d, J = 15.0Hz), 7.58 (1H, d
, J = 4.2Hz), 7.70(1H, d, J = 4.2Hz), 8.26(1H, dd, J = 6.9, 5.7Hz), 8.95(1H, d, J = 6, J = 4.2Hz), 7.70 (1H, d, J = 4.2Hz), 8.26 (1H, dd, J = 6.9, 5.7Hz), 8.95 (1H, d, J = 6
• 9Hz), 9.10(1H, d, J = 5.7Hz), 9.34(1H, s). • 9Hz), 9.10 (1H, d, J = 5.7Hz), 9.34 (1H, s).
IR (KBr) cm— 3397, 1764, 1601, 1519, 1362, 1316. IR (KBr) cm— 3397, 1764, 1601, 1519, 1362, 1316.
MS(FAB): 713+ (M+2Na)+ MS (FAB): 713 + (M + 2Na) +
元素分析 c H N O S Na- 3.4H O - 0.2NaHCO . Elemental analysis c H N O S Na- 3.4 H O-0.2 NaHCO.
計算値: C,44.06; Η,3·93; N, 10.93; S,12.51; Na,3.59 (%) Calculated value: C, 44.06; Η, 3.93; N, 10.93; S, 12.51; Na, 3.59 (%)
実験値: C44.27; H,3.90; N,10.71; S, 12.08; Na,3.65 (%) Experimental value: C44.27; H, 3.90; N, 10.71; S, 12.08; Na, 3.65 (%)
実施例 220 Example 220
[化 267] [Chemical 267]
(32) 49 + 35→50→51 (32) 49 + 35 → 50 → 51
化合物 49(3.44g, 15.0mmol)を THF(30ml)と化合物 35(1.93g, 18.0mmol)力 (22)と同
様にして化合物 50を得た (4.69g)。 Compound 49 (3.44 g, 15.0 mmol) was mixed with THF (30 ml) and Compound 35 (1.93 g, 18.0 mmol) force (22). In this way compound 50 was obtained (4.69 g).
化合物 50 (4.69g)を(23)と同様にして化合物 51を得た。収量 2.24g(59%, 2steps) 'H-NMR (CDCl ) : 4.03— 4·17(4Η, m), 5.86(1Η, s), 7.55(1Η, dd, J = 7.8, 7.8Hz), 7.6Compound 51 (4.69 g) was obtained in the same manner as (23) to give compound 51. Yield 2.24g (59%, 2steps) 'H-NMR (CDCl): 4.03—4 · 17 (4Η, m), 5.86 (1Η, s), 7.55 (1Η, dd, J = 7.8, 7.8Hz), 7.6
0(2H, d, J = 6.0Hz), 7.77(1H, d, J = 7.8Hz), 7.82(1H, d, J = 7.8Hz), 7.93(1H, br s), 8.82(2H, d, J = 6.0Hz). 0 (2H, d, J = 6.0Hz), 7.77 (1H, d, J = 7.8Hz), 7.82 (1H, d, J = 7.8Hz), 7.93 (1H, br s), 8.82 (2H, d, J = 6.0Hz).
(33) 51→52 (33) 51 → 52
化合物 51(2.23g, 8.74mmol)を(24)と同様にして化合物 52を得た。収量 1.72g(93%) 'H-NMR (CDCl ) : 7·61(2Η, d, J = 5.7Hz), 7.73(1H, dd, J = 7.8, 7.8 Hz), 8.11(1H, d, J = 7.8Hz), 8.18(1H, d, J = 7.8Hz), 8.30(1H, s), 8.86(2H, d, J = 5.7Hz), 10.11(1H , s). Compound 52 (2.23 g, 8.74 mmol) was obtained in the same manner as (24) to give compound 52. Yield 1.72g (93%) 'H-NMR (CDCl): 7 · 61 (2Η, d, J = 5.7Hz), 7.73 (1H, dd, J = 7.8, 7.8 Hz), 8.11 (1H, d, J = 7.8Hz), 8.18 (1H, d, J = 7.8Hz), 8.30 (1H, s), 8.86 (2H, d, J = 5.7Hz), 10.11 (1H, s).
(34) 52→53 (34) 52 → 53
化合物 52(1.72g, 8.14mmol)を(25)と同様にして化合物 53を得た。収量 1.73g(93%)。 'H-NMR (DMSO) : 7.66(2H, d, J = 5.7Hz), 7.74(1H, d, J = 7.8Hz), 8.04(1H, d, J = 4.8Hz), 8.25-8.28(2H, m), 8.84(2H, d, J = 5.7Hz). Compound 53 (1.72 g, 8.14 mmol) was obtained in the same manner as (25) to give compound 53. Yield 1.73 g (93%). 'H-NMR (DMSO): 7.66 (2H, d, J = 5.7Hz), 7.74 (1H, d, J = 7.8Hz), 8.04 (1H, d, J = 4.8Hz), 8.25-8.28 (2H, m), 8.84 (2H, d, J = 5.7Hz).
(35) 53→54 (35) 53 → 54
化合物 53(1.72g, 7.57mmol)を(26)と同様にして化合物 54を得た。収量 1.25g(48%) 'H-NMR (CDCl ) : 3.82(3H, s), 5.33(2H, s), 6.91(2H, d, J = 6.6Hz), 7.38(2H, d, J =Compound 54 (1.72 g, 7.57 mmol) was obtained in the same manner as (26) to give compound 54. Yield 1.25g (48%) 'H-NMR (CDCl): 3.82 (3H, s), 5.33 (2H, s), 6.91 (2H, d, J = 6.6Hz), 7.38 (2H, d, J =
6.6Hz), 7.58-7.63(3H, m), 8.01(1H, d, J = 8.1Hz), 8.31(1H, d, J = 7.8Hz), 8.45(1H , s), 8.84(2H, d, J = 6.6Hz). 6.6Hz), 7.58-7.63 (3H, m), 8.01 (1H, d, J = 8.1Hz), 8.31 (1H, d, J = 7.8Hz), 8.45 (1H, s), 8.84 (2H, d, J = 6.6Hz).
(36) 2 + 54→48 (36) 2 + 54 → 48
化合物 2(886mg, 1.20mmol)と化合物 54(347mg, l.OOmmol)から(27)と同様にして化 合物 48を粉末として得た。収量 309mg(45%, 2st印 s)。 Compound 48 was obtained as a powder from Compound 2 (886 mg, 1.20 mmol) and Compound 54 (347 mg, l.OOmmol) in the same manner as in (27). Yield 309 mg (45%, 2st mark s).
'H-NMR (D O) : 1.30(3H, t, J = 6.9Hz), 3.67(2H, s), 4.25(2H, q, J = 6.9Hz), 5.27(1 'H-NMR (D O): 1.30 (3H, t, J = 6.9Hz), 3.67 (2H, s), 4.25 (2H, q, J = 6.9Hz), 5.27 (1
H, d, J = 4.5Hz), 5.44(2H, d, J = 7.2Hz), 5.83(1H, d, J = 4.5Hz), 6.15(1H, dt, J = 1 5.3, 7.2Hz), 6.98(1H, s), 7.03(1H, d, J = 15.3Hz), 7.67(1H, dd, J = 8.1, 7.8Hz), 7.9 9(1H, d, J = 8.1Hz), 8.22(1H, d, J = 7.8Hz), 8.23(lH,s), 8.33(2H, d, J = 5.1Hz), 9.0 9(2H, d, J = 5.1Hz). H, d, J = 4.5Hz), 5.44 (2H, d, J = 7.2Hz), 5.83 (1H, d, J = 4.5Hz), 6.15 (1H, dt, J = 1 5.3, 7.2Hz), 6.98 (1H, s), 7.03 (1H, d, J = 15.3Hz), 7.67 (1H, dd, J = 8.1, 7.8Hz), 7.9 9 (1H, d, J = 8.1Hz), 8.22 (1H, d , J = 7.8Hz), 8.23 (lH, s), 8.33 (2H, d, J = 5.1Hz), 9.0 9 (2H, d, J = 5.1Hz).
IR (KBr) cm_1:3399, 1765, 1668, 1605, 1564, 1533, 1383.
MS(FAB): 685 (M+Na+H) IR (KBr) cm _1 : 3399, 1765, 1668, 1605, 1564, 1533, 1383. MS (FAB): 685 (M + Na + H)
元素分析 C H N O S Na- 5.3H O - O. lNaHCO . Elemental analysis C H N O S Na- 5.3H O-O.lNaHCO.
30 25 6 8 2 2 3 30 25 6 8 2 2 3
計算値: C,45.85; H,4.56; N,10.66; S,8.13; Na,3.21 (%) Calculated: C, 45.85; H, 4.56; N, 10.66; S, 8.13; Na, 3.21 (%)
実験値: C45.86; H,4.37; N,10.78; SJ.97; Na,3.14 (%) Experimental value: C45.86; H, 4.37; N, 10.78; SJ.97; Na, 3.14 (%)
実施例 221 Example 221
[化 268] [Chemical 268]
(37) 56 + 57→58 (37) 56 + 57 → 58
化合物 56(1. llg, 7.49mmol)、化合物 57(1.79g, 11.24mmol)に酢酸 (15ml)を加えた。 浴冷却下、亜鉛 (1.84g, 28.1mmol)をゆっくり加え、室温で 30分間攪拌後、 45分間加 熱還流した。溶媒留去後、精製水、酢酸ェチルをカ卩えた後、炭酸ナトリウムを〉 pH 7と なるまで加えた。固形物をろ過により除き、ろ液を酢酸ェチルにより抽出した。有機層 を精製水、飽和食塩水により洗浄し、無水硫酸マグネシウムで乾燥させた。溶媒を減 圧留去し、残渣に Et 0を加えろ取し、化合物 58を得た。収量 1.00g(58%) Acetic acid (15 ml) was added to compound 56 (1. llg, 7.49 mmol) and compound 57 (1.79 g, 11.24 mmol). Zinc (1.84 g, 28.1 mmol) was slowly added under bath cooling, and the mixture was stirred at room temperature for 30 minutes and then heated to reflux for 45 minutes. After the solvent was distilled off, purified water and ethyl acetate were added, and sodium carbonate was added until pH> 7. The solid was removed by filtration and the filtrate was extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, Et 0 was added to the residue and filtered to obtain Compound 58. Yield 1.00g (58%)
2 2
'H-NMR (CDCl ) : 1·39(3Η, t, J = 7.0Hz), 2.51(3H, s), 4.37(2H, q, J = 7.0Hz), 7.12 'H-NMR (CDCl): 1 · 39 (3Η, t, J = 7.0Hz), 2.51 (3H, s), 4.37 (2H, q, J = 7.0Hz), 7.12
3 Three
(1H, d, J = 3.3Hz), 7.35(2H, d, J = 6.0Hz), 8.60(2H, d, J = 6.0Hz), 9.32(1H, br s). (1H, d, J = 3.3Hz), 7.35 (2H, d, J = 6.0Hz), 8.60 (2H, d, J = 6.0Hz), 9.32 (1H, br s).
(38) 58→59 (38) 58 → 59
化合物 58(1.00g, 4.34mmol)をエタノール (15ml)に溶解させ、 2N_NaOH(10.9ml)を加 え、 70°Cで 2時間攪拌した。エタノールを留去した後に、 2N- HCl(10.9ml)をカ卩え、析 出した固体をろ取し、減圧乾燥して、化合物 59を得た。収量 630 mg(72%)
Ή-NMR (CDC1 ): 2.46(3H, s), 7.35(1H, d, J = 3.3Hz), 7.45(2H, d, J = 6.0Hz), 8.51Compound 58 (1.00 g, 4.34 mmol) was dissolved in ethanol (15 ml), 2N_NaOH (10.9 ml) was added, and the mixture was stirred at 70 ° C. for 2 hours. After distilling off ethanol, 2N-HCl (10.9 ml) was added, and the precipitated solid was collected by filtration and dried under reduced pressure to obtain Compound 59. Yield 630 mg (72%) Ή-NMR (CDC1): 2.46 (3H, s), 7.35 (1H, d, J = 3.3Hz), 7.45 (2H, d, J = 6.0Hz), 8.51
3 Three
(2H, br s). (2H, br s).
(39) 19 + 59→55 (39) 19 + 59 → 55
化合物 19(855mg, l.OOmmol)と化合物 59(202mg, l.OOmmol)から(27)と同様にして 化合物 55を粉末として得た。収量 328mg(49%, 2steps)0 Compound 55 was obtained as a powder from Compound 19 (855 mg, l.OOmmol) and Compound 59 (202 mg, l.OOmmol) in the same manner as in (27). Yield 328mg (49%, 2steps) 0
'H-NMR (D O): 1.28(6H, d, J = 3.3Hz), 2.52(3H, s), 3.65, 3.65(2H, ABq, J = 19.5 'H-NMR (D 2 O): 1.28 (6H, d, J = 3.3Hz), 2.52 (3H, s), 3.65, 3.65 (2H, ABq, J = 19.5
2 2
Hz), 4.47(1H, m), 5.13(2H, m), 5.25(1H, m), 5.79(lH,m), 6.08(1H, m), 6.90(1H, s), 6.92(1H, d, J = 15.3Hz), 7.55(1H, s), 7.93(2H, br s), 8.47(2H, br s). Hz), 4.47 (1H, m), 5.13 (2H, m), 5.25 (1H, m), 5.79 (lH, m), 6.08 (1H, m), 6.90 (1H, s), 6.92 (1H, d , J = 15.3Hz), 7.55 (1H, s), 7.93 (2H, br s), 8.47 (2H, br s).
IR (KBr) cm_1:3388, 1763, 1633, 1566, 1534, 1403, 1334. IR (KBr) cm _1 : 3388, 1763, 1633, 1566, 1534, 1403, 1334.
MS(FAB): 674+ (M+Na+H)+ MS (FAB): 674 + (M + Na + H) +
元素分析 c H N O S Na- 5.1H O - 0.17NaHCO . Elemental analysis c H N O S Na- 5.1H O-0.17 NaHCO.
29 28 7 7 2 2 3 29 28 7 7 2 2 3
計算値: C,44.93; H,4.96; N,12.57; S,8.22; Na,3.45 (%) Calculated value: C, 44.93; H, 4.96; N, 12.57; S, 8.22; Na, 3.45 (%)
実験値: C,44.89; H,4.82; N,12.52; S,8.17; Na,3.41 (%) Experimental value: C, 44.89; H, 4.82; N, 12.52; S, 8.17; Na, 3.41 (%)
実施例 222 Example 222
[化 269] [Chemical 269]
(40) 61 + 57→62 (40) 61 + 57 → 62
化合物 61(5.28g, 30.0mmol)と化合物 57(7.17g, 45.0mmol)から(37)と同様にして化 合物 62を得た。収量 920mg(12%) Compound 62 was obtained from Compound 61 (5.28 g, 30.0 mmol) and Compound 57 (7.17 g, 45.0 mmol) in the same manner as in (37). Yield 920mg (12%)
'H-NMR (CDCl ): 1.40(3H, t, J = 7.2Hz), 2.67(3H, s), 4.39(2H, q, J = 7.2Hz), 7.19
(1H, d, J = 3.6Hz), 7.56(2H, d, J = 5.7Hz), 8.77(2H, d, J = 5.7Hz). 'H-NMR (CDCl): 1.40 (3H, t, J = 7.2Hz), 2.67 (3H, s), 4.39 (2H, q, J = 7.2Hz), 7.19 (1H, d, J = 3.6Hz), 7.56 (2H, d, J = 5.7Hz), 8.77 (2H, d, J = 5.7Hz).
(41 ) 62→63 (41) 62 → 63
化合物 62(910mg, 3.50mmol)を(38)と同様にして化合物 63を得た。収量 426mg(53%) 'H-NMR (DMSO): 2.57(3H, s), 7·25(1Η, d, J = 3.6Hz), 7.58(2H, d, J = 4.5Hz), 8.7 5(2H, br s). Compound 62 (910 mg, 3.50 mmol) was obtained in the same manner as (38) to give compound 63. Yield 426mg (53%) 'H-NMR (DMSO): 2.57 (3H, s), 7 · 25 (1Η, d, J = 3.6Hz), 7.58 (2H, d, J = 4.5Hz), 8.7 5 ( 2H, br s).
(42) 19 + 63→60 (42) 19 + 63 → 60
化合物 19(940mg, l. lOmmol)と化合物 63(230mg, l.OOmmol)から(27)と同様にして 化合物 60を粉末として得た。収量 424mg(60%, 2st印 s)。 Compound 60 was obtained as a powder from Compound 19 (940 mg, l.lOmmol) and Compound 63 (230 mg, l.OOmmol) in the same manner as in (27). Yield 424 mg (60%, 2st mark s).
'H-NMR (D O): 1.29(6H, d, J = 2.1Hz), 2.57(3H, s), 3.66, 3.66(2H, ABq, J = 18.3 'H-NMR (D 2 O): 1.29 (6H, d, J = 2.1Hz), 2.57 (3H, s), 3.66, 3.66 (2H, ABq, J = 18.3
Hz), 4.50(1H, m), 5.26(1H, d, J = 4.2Hz), 5.40(2H, d, J = 7.2Hz), 5.81(1H, d, J = 4. 2Hz), 6.12(1H, dt, J = 14.7, 7.2Hz), 6.95(1H, s), 6.98(1H, d, J = 14.7Hz), 7.26(1H, s), 8.68(2H, d, J = 3.9Hz), 9.01(2H, d, J = 3.9Hz). Hz), 4.50 (1H, m), 5.26 (1H, d, J = 4.2Hz), 5.40 (2H, d, J = 7.2Hz), 5.81 (1H, d, J = 4.2Hz), 6.12 (1H , dt, J = 14.7, 7.2Hz), 6.95 (1H, s), 6.98 (1H, d, J = 14.7Hz), 7.26 (1H, s), 8.68 (2H, d, J = 3.9Hz), 9.01 (2H, d, J = 3.9Hz).
IR (KBr) cm_1:3398, 1765, 1629, 1532, 1403, 1321. IR (KBr) cm _1 : 3398, 1765, 1629, 1532, 1403, 1321.
MS(ESI): 680+ (M-Na+2H)+ MS (ESI): 680 + (M-Na + 2H) +
元素分析 C H N O S Na-6.1H O - O. lNaHCO . Elemental analysis C H N O S Na-6.1H O-O.lNaHCO.
計算値: C,44.09; H,4.95; N,11.96; S,7.82; Na,3.08 (%) Calculated: C, 44.09; H, 4.95; N, 11.96; S, 7.82; Na, 3.08 (%)
実験値: C,44.00 H,4.60; N, 12.04; S,7.91; Na,3.09 (%) Experimental value: C, 44.00 H, 4.60; N, 12.04; S, 7.91; Na, 3.09 (%)
実施例 223 Example 223
[化 270] [Chemical 270]
(43) 65 + 66→67 (43) 65 + 66 → 67
化合物 65(5.00g, 15.0mmol)、化合物 66(1.35g, 15.0mmol)の THF(60ml)溶液に、ジィ ソプロピルェチルァミン (2.60ml, 15.0mmol)を加え、室温で 1.5時間攪拌した。溶媒を
減圧留去し、残渣に Et 0、精製水を加え懸濁させた後、沈殿をろ取し、カップリング 体を得た (3.06g)。このカップリング体(2.88g, 8.40mmol)を THF(30ml)に溶解させ、 Ts OH - H O(160mg, 0.84mmol)を加え、 60°Cで 2時間加熱攪拌した。減圧濃縮後、 Et 0 を加えろ取し、化合物 67を得た。収量 2.64g(96%) To a solution of compound 65 (5.00 g, 15.0 mmol) and compound 66 (1.35 g, 15.0 mmol) in THF (60 ml) was added dipropylethylamine (2.60 ml, 15.0 mmol) and stirred at room temperature for 1.5 hours. . Solvent After distilling off under reduced pressure, Et 0 and purified water were added to the residue and suspended, and then the precipitate was collected by filtration to obtain a coupled product (3.06 g). This coupled product (2.88 g, 8.40 mmol) was dissolved in THF (30 ml), Ts OH-HO (160 mg, 0.84 mmol) was added, and the mixture was stirred with heating at 60 ° C for 2 hr. After concentration under reduced pressure, Et 0 was added and collected by filtration to obtain Compound 67. Yield 2.64 g (96%)
'H-NMR (CDCl ): 2.97(3H, d, J = 3.0Hz), 6.98(1H, br s), 7.01(1H, s), 7.25-7.48(1 'H-NMR (CDCl): 2.97 (3H, d, J = 3.0Hz), 6.98 (1H, br s), 7.01 (1H, s), 7.25-7.48 (1
OH, m). OH, m).
(44) 67→68 (44) 67 → 68
化合物 67(2.74g, 8.45mmol)、イソニコチン酸クロライド塩酸塩 (1.50g, 8.45mmol)のジ クロロメタン (20ml)溶液に、 Et N(3.53ml, 25.4mmol)を加え、室温で 2時間攪拌した。さ らに 40度で 3時間攪拌した。精製水を加え、酢酸ェチルで抽出した。有機層を精製水 、飽和食塩水により洗浄し、無水硫酸マグネシウムで乾燥させた。溶媒を減圧留去し 、シリカゲルクロマトグラフィーに付し、酢酸ェチル—トルエン系で溶離し、化合物 68 を得た。収量 2.9 2g(80%) To a solution of compound 67 (2.74 g, 8.45 mmol) and isonicotinic acid chloride hydrochloride (1.50 g, 8.45 mmol) in dichloromethane (20 ml) was added Et N (3.53 ml, 25.4 mmol) and stirred at room temperature for 2 hours. did. Further, the mixture was stirred at 40 degrees for 3 hours. Purified water was added and extracted with ethyl acetate. The organic layer was washed with purified water and saturated brine, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was subjected to silica gel chromatography and eluted with ethyl acetate-toluene system to obtain Compound 68. Yield 2.9 2g (80%)
'H-NMR (CDCl ): 3.70(3H, s), 7.14(1H, s), 7.26-7.46(12H, m), 8.06(1H, s), 8.81(2 'H-NMR (CDCl): 3.70 (3H, s), 7.14 (1H, s), 7.26-7.46 (12H, m), 8.06 (1H, s), 8.81 (2
H, d, J = 6.0Hz). (H, d, J = 6.0Hz).
(45) 2 + 68→64 (45) 2 + 68 → 64
化合物 2(886mg, 1.20mmol)と化合物 68(429mg, l.OOmmol)から(27)と同様にして化 合物 64を粉末として得た。収量 334mg(46%, 2steps)0 Compound 64 was obtained as a powder from Compound 2 (886 mg, 1.20 mmol) and Compound 68 (429 mg, l.OOmmol) in the same manner as in (27). Yield 334 mg (46%, 2steps) 0
JH-NMR (D O): 1·30(3Η, t, J = 7.2Hz), 3.62(3H, s), 3.66(2H, m), 4.26(2H, q, J = 7 J H-NMR (DO): 1 · 30 (3Η, t, J = 7.2Hz), 3.62 (3H, s), 3.66 (2H, m), 4.26 (2H, q, J = 7
.2Hz), 5.27(1H, d, J = 4.8Hz), 5.42(2H, br s), 5.83(1H, d, J = 4.8Hz), 6.12(1H, m),.2Hz), 5.27 (1H, d, J = 4.8Hz), 5.42 (2H, br s), 5.83 (1H, d, J = 4.8Hz), 6.12 (1H, m),
6.99(1H, s), 7.01(1H, d, J = 14.7Hz), 7.89(1H, s), 8.30(2H, br s), 9.10(2H, br s).6.99 (1H, s), 7.01 (1H, d, J = 14.7Hz), 7.89 (1H, s), 8.30 (2H, br s), 9.10 (2H, br s).
IR (KBr) cm_1:3408, 1765, 1637, 1599, 1377, 1290. IR (KBr) cm _1 : 3408, 1765, 1637, 1599, 1377, 1290.
MS(FAB): 721+ (M+Na+H)+ MS (FAB): 721 + (M + Na + H) +
元素分析 C H N O S Na- 5.7H O. Elemental analysis C H N O S Na- 5.7H O.
計算値: C,40.84; H,4.46; N,13.61; S,11.68; Na,2.79 (%) Calculated values: C, 40.84; H, 4.46; N, 13.61; S, 11.68; Na, 2.79 (%)
実験値: C,40.84; H,4.32; N, 13.57; S,11.53; Na,2.72 (%) Experimental value: C, 40.84; H, 4.32; N, 13.57; S, 11.53; Na, 2.72 (%)
実施例 224 Example 224
[化 271]
[Chemical 271]
(50) 76→77 (50) 76 → 77
化合物 76(1.31g, 5.00mmol)とメチルカルバメート (1.13g, 15.0mmol)の THF溶液 (15ml) に、ピリジン (890 μ 1, l l.Ommol)をカ卩え、 4時間加熱還流した。溶媒留去後、精製水、 2 N-HC1、ァセトニトリルを加え、沈殿をろ取し、化合物 77を得た。収量 270mg(40%) 'H-NMR (DMSO): 3.80(3H, s), 8.72(2H, d, J = 6.6Hz), 9.01(2H, d, J = 6.6Hz), 9.2 7(1H, s), 11.44(1H, s). To a THF solution (15 ml) of compound 76 (1.31 g, 5.00 mmol) and methyl carbamate (1.13 g, 15.0 mmol) was added pyridine (890 μl, l l.O mmol) and heated to reflux for 4 hours. After the solvent was distilled off, purified water, 2 N-HC1, and acetonitrile were added, and the precipitate was collected by filtration to obtain Compound 77. Yield 270 mg (40%) 'H-NMR (DMSO): 3.80 (3H, s), 8.72 (2H, d, J = 6.6Hz), 9.01 (2H, d, J = 6.6Hz), 9.2 7 (1H, s), 11.44 (1H, s).
(51) (77→78)+2→75 (51) (77 → 78) + 2 → 75
化合物 77(300mg, l.OOmmol)のメタノール溶液に 1Mテトラメチルダァニジンを (メタノ ール溶液) pH力 を超えるまで加えた後、 1N-HC1で pHを 6.3とし、溶媒を減圧留去し、 化合物 78を得た。化合物 2(811mg, l.OOmmol)と化合物 78(全量, l.OOmmolとした)か ら(27)と同様にして化合物 75を粉末として得た。収量 260mg(37%, 3steps)0 1M tetramethyldanidine was added to a methanol solution of compound 77 (300 mg, l.OOmmol) until the pH force was exceeded (methanol solution), then the pH was adjusted to 6.3 with 1N-HC1, and the solvent was distilled off under reduced pressure. Compound 78 was obtained. Compound 75 was obtained as a powder from Compound 2 (811 mg, l.OOmmol) and Compound 78 (total amount, l.OOmmol) in the same manner as (27). Yield 260mg (37%, 3steps) 0
'H-NMR (DMSO) : 1.22(3H, t, J = 6.9Hz), 3.45, 3.52(2H, ABq, J = 17.2Hz), 3.80(3 H, s), 4.09(2H, q, J = 6.9Hz), 5.06(1H, d, J = 5.1Hz), 5.31(2H, d, J = 6.0Hz), 5.61( 1H, dd, J = 7.8, 5.1Hz), 5.94(1H, dt, J = 14.5, 6.0Hz), 6.72(1H, s), 7.22(3H, m), 8. 87(2H, d, J = 6.6Hz), 9.16(2H, d, J = 6.6Hz), 9.34(1H, s), 9.54(1H, d, J = 7.8Hz) IR (KBr) cm_1:3389, 1770, 1636, 1605, 1530, 1385, 1304, 1202. 'H-NMR (DMSO): 1.22 (3H, t, J = 6.9Hz), 3.45, 3.52 (2H, ABq, J = 17.2Hz), 3.80 (3 H, s), 4.09 (2H, q, J = 6.9Hz), 5.06 (1H, d, J = 5.1Hz), 5.31 (2H, d, J = 6.0Hz), 5.61 (1H, dd, J = 7.8, 5.1Hz), 5.94 (1H, dt, J = 14.5, 6.0Hz), 6.72 (1H, s), 7.22 (3H, m), 8. 87 (2H, d, J = 6.6Hz), 9.16 (2H, d, J = 6.6Hz), 9.34 (1H, s), 9.54 (1H, d, J = 7.8Hz) IR (KBr) cm _1 : 3389, 1770, 1636, 1605, 1530, 1385, 1304, 1202.
MS(ESI): 699+ (M+H)+ MS (ESI): 699+ (M + H) +
元素分析 C H N O S -4.1H O. Elemental analysis C H N O S -4.1H O.
計算値: C,43.53; H,4.46; N,14.50; S, 12.45 (%) Calculated value: C, 43.53; H, 4.46; N, 14.50; S, 12.45 (%)
実験値: C,43.50; H,4.41; N,14.54; S, 12.46 (%) Experimental value: C, 43.50; H, 4.41; N, 14.54; S, 12.46 (%)
実施例 225
[化 272] Example 225 [Chemical 272]
(52) 2 + 59→79 (52) 2 + 59 → 79
化合物 2(849mg, l.OOmmol)と化合物 59(202mg, l.OOmmolとした)力 (27)と同様にし て化合物 79を粉末として得た。収量 396mg(60%, 2steps)0 Compound 79 was obtained as a powder in the same manner as Compound 2 (849 mg, l.OOmmol) and Compound 59 (202 mg, l.OOmmol) force (27). Yield 396mg (60%, 2steps) 0
JH-NMR (D O) :1.28(3H, t, J = 6.9Hz), 2.50(3H, s), 3.65, 3.65(2H, ABq, J = 18.5H z), 4.22(2H, q, J = 6.9Hz), 5.11(2H, d, J = 5.4Hz), 5.24(1H, d, J = 4.5Hz), 5.78(1H, d, J = 4.5H), 6.07(1H, dt, J = 16.5, 5.4Hz), 6.90(1H, s), 6.93(1H, d, J = 16.5Hz), 7 .52(1H, s), 7.90(2H, d, J = 5.4Hz), 8.45(2H, d, J = 5.4Hz). J H-NMR (DO): 1.28 (3H, t, J = 6.9Hz), 2.50 (3H, s), 3.65, 3.65 (2H, ABq, J = 18.5H z), 4.22 (2H, q, J = 6.9Hz), 5.11 (2H, d, J = 5.4Hz), 5.24 (1H, d, J = 4.5Hz), 5.78 (1H, d, J = 4.5H), 6.07 (1H, dt, J = 16.5, 5.4Hz), 6.90 (1H, s), 6.93 (1H, d, J = 16.5Hz), 7.52 (1H, s), 7.90 (2H, d, J = 5.4Hz), 8.45 (2H, d, J = 5.4Hz).
IR (ATR) cm— 3309, 1758, 1632, 1561, 1531, 1397, 1332. IR (ATR) cm— 3309, 1758, 1632, 1561, 1531, 1397, 1332.
MS(ESI): 638+ (M-Na+2H)+ MS (ESI): 638 + (M-Na + 2H) +
元素分析 c H N O S Na- 5.0H O - 0.2NaHCO . Elemental analysis c H N O S Na- 5.0 H O-0.2 NaHCO.
計算値: C,44.19; H,4.76; N,12.79; S,8.37; Na,3.60 (%) Calculated value: C, 44.19; H, 4.76; N, 12.79; S, 8.37; Na, 3.60 (%)
実験値: C44.14; H,4.78; N,12.86; S,8.55; Na,3.65 (%) Experimental value: C44.14; H, 4.78; N, 12.86; S, 8.55; Na, 3.65 (%)
試験例 1 Test example 1
化合物 (I)の抗菌活性について調べた。 The antibacterial activity of compound (I) was investigated.
(試験方法) (Test method)
最小発育阻止濃度 (MIC: μ g/ml)の測定は日本化学療法学会標準法に準じ、接 種菌量は 1000 cfu/spot,試験培地は感受性ディスク培地を用いて、寒天平板希釈 法により実施した。対照として、 W097Z37996号記載の実施例 9記載の化合物(化 合物 A)を使用した。また体内動態 (ADME)として、サルに被験化合物を lmg/kg で静脈内投与して AUC等を調べた。
The minimum growth inhibitory concentration (MIC: μg / ml) was measured according to the standard method of the Japanese Society of Chemotherapy, the inoculum was 1000 cfu / spot, the test medium was a sensitive disk medium, and the agar plate dilution method was used. . As a control, the compound described in Example 9 described in W097Z37996 (Compound A) was used. As pharmacokinetics (ADME), AUC and the like were examined by intravenously administering the test compound to monkeys at lmg / kg.
Z90C/900Zdf/X3d 68S 0Ϊ/900Ζ OAV
Z90C / 900Zdf / X3d 68S 0Ϊ / 900Ζ OAV
本発明化合物は、グラム陽性菌およびグラム陰性菌に対して強い抗菌作用を示し 7こ。特 tこへニシリン [Ιϋ十生月—巾炎球菌、 penicillin— resistant Streptococcus pneumoniae: P RSP)や βーラクタマーゼ非産生アンピシリン耐性インフルエンザ菌(beta-lactamase- negative, ampiciliin-resistant Haemophilus influenzae: BLNAR)等 ίこメ寸しても ¾効て、、 ある。また体内動態も顕著に改善された。なお比較として、化合物(I)の R1に相当す る置換基が、 - COCH、 _ S〇 i _Pr等である化合物についても同様に調べたが、 The compound of the present invention exhibits strong antibacterial activity against gram-positive and gram-negative bacteria. Special t-Henicillin [Penicillin-resistant Streptococcus pneumoniae (PRSP), β-lactamase-negative, ampiciliin-resistant Haemophilus influenzae: BLNAR, etc. Even if this size is reduced, it is effective. The pharmacokinetics was also significantly improved. As a comparison, a compound in which the substituent corresponding to R 1 of the compound (I) is -COCH, _S0 i _Pr, etc. was examined in the same manner.
3 2 3 2
体内動態等は好ましくなかった。 Pharmacokinetics etc. were not preferable.
図面の簡単な説明 Brief Description of Drawings
[図 1]図 1は、化合物(G—1)のトリエチルァミン塩結晶の粉末 X線回折パターンを示 す。 [FIG. 1] FIG. 1 shows a powder X-ray diffraction pattern of a triethylamine salt crystal of compound (G-1).
[図 2]図 2は、化合物(G— 2)の塩酸塩結晶の粉末 X線回折パターンを示す。 FIG. 2 shows a powder X-ray diffraction pattern of hydrochloride crystals of compound (G-2).
[図 3]図 3は、化合物(G— 3)の塩酸塩結晶の粉末 X線回折パターンを示す。 FIG. 3 shows a powder X-ray diffraction pattern of hydrochloride crystals of compound (G-3).
[図 4]図 4は、化合物(G—4)の塩酸塩結晶の粉末 X線回折パターンを示す。
FIG. 4 shows a powder X-ray diffraction pattern of hydrochloride crystals of compound (G-4).
Claims
請求の範囲 The scope of the claims
[化 1] [Chemical 1]
(式中、 (Where
Acylは、 β—ラタタムの分野で使用可能なアシノレ基; Acyl is an acylol group that can be used in the field of β-latata;
Τは、 S SOまたは O ; Τ is S SO or O;
式: Formula:
[化 2] [Chemical 2]
\ノ で示される基は、 "一 Y1— Ar1— Y2— R1"以外の置換基で置換されていてもよい、力 チオン性 N原子を環内に有する複素環式基; The group represented by \ no is a heterocyclic group having a force thionic N atom in the ring, which may be substituted with a substituent other than “one Y 1 —Ar 1 —Y 2 —R 1 ”;
Y1および Y2はそれぞれ独立して、 1)単結合、 2)— NR2、 -CO - ,— NR2C〇—、 CONR2 NR2CONR3 NR2S〇 一、 SO NR2 NR2S〇 NR3— Y 1 and Y 2 are each independently 1) a single bond, 2) — NR 2 , —CO −, — NR 2 C〇—, CONR 2 NR 2 CONR 3 NR 2 S〇 1, SO NR 2 NR 2 S〇 NR 3 —
2 2 2 (R2および R3はそれぞれ独立して水素または低級アルキル)、 =N― — N = - O S SO—、および SO—からなる群から選択されるへテロ原子含有 2 2 2 (R 2 and R 3 are each independently hydrogen or lower alkyl), = N— — N = — OS SO—, and a heteroatom selected from the group consisting of SO—
2 2
基、または 3) 2)のへテロ原子含有基が介在していてもよい、低級アルキレンまたは 低級アルケニレン; A lower alkylene or a lower alkenylene, optionally intervened by a group, or 3) a heteroatom-containing group of 2);
Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; Ar 1 represents a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group;
R1は、 _CONHCN _C (〇H) =NCN、または _C〇OHもしくはその生物学的に 等価な酸性基; R 1 is _CONHCN _C (〇H) = NCN, or _C〇OH or a biologically equivalent acidic group thereof;
波線は、シス、トランスまたはその混合を意味する;
但し、 Wavy line means cis, trans or a mixture thereof; However,
1)カチオン性 N原子を環内に有する複素環式基がピリジニゥム基であり、かつ Ar1が 単結合である場合、 R1は、 CONHCNまたは一 C (OH) =NCNであるものとする;1) When the heterocyclic group having a cationic N atom in the ring is a pyridinium group and Ar 1 is a single bond, R 1 shall be CONHCN or one C (OH) = NCN;
2)カチオン性 N原子を環内に有する複素環式基が 2環性の複素環式基であり、 Ar1 が単結合であり、かつ R1は— CONHCNまたは _C (OH) =NCNのいずれでもな い場合、 "一 Y1— Ar1— Y2— R1"で示される基は、該 2環性の複素環式基において セフヱム 3位側鎖部分との結合手を有していない方の環上に存在するものとする) で示される化合物、その製薬上許容される塩またはそれらの溶媒和物。 2) A heterocyclic group having a cationic N atom in the ring is a bicyclic heterocyclic group, Ar 1 is a single bond, and R 1 is either CONHCN or _C (OH) = NCN Otherwise, the group represented by “one Y 1 — Ar 1 — Y 2 — R 1 ” does not have a bond with the side chain moiety of the caffeine 3-position in the bicyclic heterocyclic group. Or a pharmaceutically acceptable salt or solvate thereof.
[2] Tは、 Sである、請求項 1記載の化合物、その製薬上許容される塩またはそれらの溶 媒和物。 [2] The compound according to claim 1, wherein T is S, a pharmaceutically acceptable salt thereof, or a solvent thereof.
[3] Acylが式: [3] Acyl is the formula:
[化 3] [Chemical 3]
(式中、 (Where
Xは、 Nまたは CY (Yは水素またはハロゲン); X is N or CY (Y is hydrogen or halogen);
Rは、 =CHZ (Zは、水素、置換されていてもよい低級アルキル、置換されていてもよ ぃシクロアルキルまたは置換されていてもよい複素環式基)または = NOR° (R。は、 水素、置換されていてもよい低級アルキル、置換されていてもよい低級アルケニル、 置換されてレ、てもよレ、シクロアルキル、置換されてレ、てもよレ、ァリールまたは置換され ていてもよい複素環式基) R is = CHZ (Z is hydrogen, an optionally substituted lower alkyl, an optionally substituted cycloalkyl or an optionally substituted heterocyclic group) or = NOR ° (R. Hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, substituted les, may les, cycloalkyl, substituted les, may les, aryls or substituted Good heterocyclic group)
で示される基である、請求項 1記載の化合物、その製薬上許容される塩またはそれら の溶媒和物。 2. The compound according to claim 1, a pharmaceutically acceptable salt thereof, or a solvate thereof, which is a group represented by:
[4] Xが CH、及び/又は I^S = NOR° (R。は水素もしくは置換されていてもよい低級アル キル)である、請求項 3記載の化合物。 [4] The compound according to claim 3, wherein X is CH and / or I ^ S = NOR ° (R. is hydrogen or lower alkyl which may be substituted).
[5] 式: [5] Formula:
[化 4]
(Q) で示される基は、 "一 Y1— Ar1— Y2— R1"以外の置換基で置換されていてもよい、ピ リジニゥム基、またはカチオンを有する 2環性の複素環式基である、請求項 1記載の 化合物、その製薬上許容される塩またはそれらの溶媒和物。 [Chemical 4] A group represented by (Q) is "A Y 1 - Ar 1 - Y 2 - R 1" in a non-substituent may be substituted, Pi Rijiniumu group or bicyclic heterocyclic having cation, The compound according to claim 1, which is a group, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[6] Y1及び/又は Y2は、単結合である、請求項 1記載の化合物、その製薬上許容される 塩またはそれらの溶媒和物。 [6] The compound according to claim 1, wherein Y 1 and / or Y 2 is a single bond, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[7] Ar1は、単結合、置換されていてもよいァリール、または置換されていてもよいへテロ ァリールである、請求項 1記載の化合物、その製薬上許容される塩またはそれらの溶 媒和物。 [7] The compound according to claim 1, Ar 1 , a pharmaceutically acceptable salt thereof, or a solvent thereof, wherein Ar 1 is a single bond, an optionally substituted aryl, or an optionally substituted heteroaryl. Japanese products.
[8] R1は、 CONHCN、 -C (OH) =NCNまたは COOHである、請求項 1記載の 化合物、その製薬上許容される塩またはそれらの溶媒和物。 [8] The compound, pharmaceutically acceptable salt or solvate thereof according to claim 1, wherein R 1 is CONHCN, —C (OH) ═NCN or COOH.
[9] R1は、 CONHCNまたは— C (OH) =NCNである、請求項 1記載の化合物、その 製薬上許容される塩またはそれらの溶媒和物。 [9] The compound, pharmaceutically acceptable salt or solvate thereof according to claim 1, wherein R 1 is CONHCN or —C (OH) ═NCN.
[10] R1は、 COOHまたはその生物学的に等価な酸性基であり、該酸性基は、 -CON[10] R 1 is COOH or a biologically equivalent acidic group thereof, wherein the acidic group is -CON
HR4、 -SO H、 -SO NHR5、(R4および R5はそれぞれ独立してァミノ残基)、— P HR 4 , -SO H, -SO NHR 5 , (R 4 and R 5 are each independently an amino residue), —P
3 2 3 2
O H、一 OH、 -COCH = C (OH) CF、 -NHSO CF、 -CONHSO CF 一 N O H, One OH, -COCH = C (OH) CF, -NHSO CF, -CONHSO CF One N
3 2 3 2 3 2 3、3 2 3 2 3 2 3,
HSO Me、 -CONHSO Me、 _NHC〇Me、 _C〇NHCOMe、 -COCH COHSO Me, -CONHSO Me, _NHC〇Me, _C〇NHCOMe, -COCH CO
2 2 22 2 2
Me、または置換されていてもよく環構成原子として— NH_およびその他のヘテロ原 子を有する 5〜6員の複素環式基である、請求項 1記載の化合物、その製薬上許容 される塩またはそれらの溶媒和物。 The compound according to claim 1 or a pharmaceutically acceptable salt thereof, which is Me or a 5- to 6-membered heterocyclic group which may be substituted and has NH_ and other hetero atoms as a ring-constituting atom. Or a solvate thereof.
[11] 式: [11] Formula:
[化 5]
で示される基は、 "一 Y1— Ar1— Y2— R1"以外の置換基で置換されていてもよい、ピ
リジニゥム基; Y1及び Y2は、単結合; Ar1は、置換されていてもよいァリール、または 置換されていてもよいへテロアリール; R1は、 CONHCNまたは一 C (〇H) =NCN である、請求項 1記載の化合物、その製薬上許容される塩またはそれらの溶媒和物。 式: [Chemical 5] The group represented by can be substituted with a substituent other than “one Y 1 — Ar 1 — Y 2 — R 1 ”, A lysine group; Y 1 and Y 2 are a single bond; Ar 1 is an optionally substituted aryl, or an optionally substituted heteroaryl; R 1 is CONHCN or one C (〇H) = NCN The compound according to claim 1, a pharmaceutically acceptable salt thereof, or a solvate thereof. formula:
[化 6] [Chemical 6]
(式中、 (Where
Xは、 Nまたは CY (Yは水素またはハロゲン); X is N or CY (Y is hydrogen or halogen);
Rは、 =CHZ (Zは、水素、置換されていてもよい低級アルキル、置換されていてもよ ぃシクロアルキルまたは置換されていてもよい複素環式基)、または = NOR° (R°は、 水素、置換されていてもよい低級アルキル、置換されていてもよい低級アルケニル、 置換されてレ、てもよレ、シクロアルキル、置換されてレ、てもよレ、ァリールまたは置換され ていてもよい複素環式基) R is = CHZ (Z is hydrogen, an optionally substituted lower alkyl, an optionally substituted cycloalkyl or an optionally substituted heterocyclic group), or = NOR ° (R ° is Hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, substituted les, may les, cycloalkyl, substituted les, may les, aryls or substituted May be a heterocyclic group)
で示される基; A group represented by:
Y1および Y2はそれぞれ独立して、 1)単結合、 2)— NR2 -CO - ,— NR2C〇— CONR2 NR2CONR3 NR2S〇 一、 SO NR2 NR2S〇 NR3— Y 1 and Y 2 are each independently 1) single bond, 2) — NR 2 —CO −, — NR 2 C〇—CONR 2 NR 2 CONR 3 NR 2 S〇 1, SO NR 2 NR 2 S〇 NR 3 —
2 2 2 (R2および R3はそれぞれ独立して水素または低級アルキル)、 =N― — N = - O S SO—、および SO—からなる群から選択されるへテロ原子含有 2 2 2 (R 2 and R 3 are each independently hydrogen or lower alkyl), = N— — N = — OS SO—, and a heteroatom selected from the group consisting of SO—
2 2
基、または 3) 2)のへテロ原子含有基が介在していてもよい、低級アルキレンまたは 低級アルケニレン; A lower alkylene or a lower alkenylene, optionally intervened by a group, or 3) a heteroatom-containing group of 2);
Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; Ar 1 represents a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group;
R1は、 -CONHCN, _C (〇H) =NCN、または _C〇OHもしくはその生物学的に 等価な酸性基; R 1 is -CONHCN, _C (〇H) = NCN, or _C〇OH or a biologically equivalent acidic group thereof;
波線は、シス、トランスまたはその混合を意味する;
但し、 Ar1が単結合である場合、 R1は、 CONHCNまたは— C (〇H) =NCNであ るものとする。) Wavy line means cis, trans or a mixture thereof; However, when Ar 1 is a single bond, R 1 is CONHCN or —C (〇H) = NCN. )
で示される化合物、その製薬上許容される塩またはそれらの溶媒和物。 Or a pharmaceutically acceptable salt or solvate thereof.
[13] R1は、—CONHCNまたは _C (OH) =NCNである、請求項 12記載の化合物、そ の製薬上許容される塩またはそれらの溶媒和物。 [13] The compound according to claim 12, wherein R 1 is —CONHCN or —C (OH) ═NCN, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[14] Y1は単結合; Ar1は置換されてレ、てもよレ、ァリールまたは置換されてレ、てもよレ、へテ ロアリール; Y2は単結合; R1は、一CONHCNまたは一 C (〇H) =NCNである、請求 項 12記載の化合物、その製薬上許容される塩またはそれらの溶媒和物。 [14] Y 1 is a single bond; Ar 1 is substituted, may, Les, aryl, or substituted, may, heteroaryl; Y 2 is a single bond; R 1 is one CONHCN Or the compound according to claim 12, a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein C (OH) = NCN.
[15] Y1は単結合; Ar1は置換されていてもよいへテロアリール; Y2は単結合; R1は、 -CO NHCNまたは _C (〇H) =NCNである、請求項 12記載の化合物、その製薬上許容 される塩またはそれらの溶媒和物。 [15] The method according to claim 12, wherein Y 1 is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is —CO NHCN or _C (〇H) ═NCN Compound, its pharmaceutically acceptable salt or solvate thereof.
[16] は〇1^ ;1は=〇112 は、置換されていてもよい低級アルキル)または = N〇R° (R° は水素、置換されていてもよい低級アルキルまたは置換されていてもよいァリール); Y1は単結合; Ar1は置換されていてもよいへテロアリール; Y2は単結合; R1は、 -CO NHCNまたは— C (OH) =NCNである、請求項 12記載の化合物、その製薬上許容 される塩またはそれらの溶媒和物。 [16] is ○ 1 ^; 1 is = 〇112 is optionally substituted lower alkyl) or = N〇R ° (R ° is hydrogen, optionally substituted lower alkyl or optionally substituted) 13. Y 1 is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is —CO NHCN or —C (OH) ═NCN. Or a pharmaceutically acceptable salt or solvate thereof.
[17] Xは CH ; = NOR° (R。は水素、置換されていてもよい低級アルキルまたは置換さ れていてもよいァリール); Y1は単結合; Ar1は、置換されていてもよぐ〇、 Sおよび N 力 なる群から選択される同一又は異なる 1〜4個のへテロ原子を含有する 5または 6 員のへテロアリーノレ; Y2は単結合; R1は、 CONHCNまたは一 C (OH) =NCNで ある、請求項 12記載の化合物、その製薬上許容される塩またはそれらの溶媒和物。 [17] X is CH; = NOR ° (R. is hydrogen, optionally substituted lower alkyl or optionally substituted aryl); Y 1 is a single bond; Ar 1 is optionally substituted Yes, 5 and 6-membered heteroarynoles containing 1 to 4 heteroatoms identical or different selected from the group of S and N force; Y 2 is a single bond; R 1 is CONHCN or one C 13. The compound according to claim 12, a pharmaceutically acceptable salt thereof or a solvate thereof, wherein (OH) = NCN.
[18] Xは CH ;I^i = NOR° (R。は低級アルキルまたは置換されていてもよいァリール); Y1 は単結合; Ar1は〇、 Sおよび Nからなる群から選択される同一又は異なる 1〜4個の ヘテロ原子を含有する 5または 6員のへテロアリール; Y2は単結合; R1は— CONHC Nまたは— C (〇H) =NCNである、請求項 12記載の化合物、その製薬上許容される 塩またはそれらの溶媒和物。 [18] X is CH; I ^ i = NOR ° (R. is lower alkyl or optionally substituted aryl); Y 1 is a single bond; Ar 1 is selected from the group consisting of 〇, S and N The 5- or 6-membered heteroaryl containing 1 to 4 heteroatoms which are the same or different; Y 2 is a single bond; R 1 is —CONHC N or —C (〇H) ═NCN Compound, its pharmaceutically acceptable salt or solvate thereof.
[19] 式: [19] Formula:
(式中、 (Where
式: Formula:
[化 8]
で示される基は、カチオン性 N原子を有する 2環性の複素環式基; [Chemical 8] The group represented by is a bicyclic heterocyclic group having a cationic N atom;
Xは、 Nまたは CY (Yは水素またはハロゲン); X is N or CY (Y is hydrogen or halogen);
Rは、 =CHZ (Zは、水素、置換されていてもよい低級アルキル、置換されていてもよ ぃシクロアルキルまたは置換されていてもよい複素環式基)または = NOR° (R。は、 水素、置換されていてもよい低級アルキル、置換されていてもよい低級アルケニル、 置換されてレ、てもよレ、シクロアルキル、置換されてレ、てもよレ、ァリールまたは複素環 式基)で示される基; R is = CHZ (Z is hydrogen, an optionally substituted lower alkyl, an optionally substituted cycloalkyl or an optionally substituted heterocyclic group) or = NOR ° (R. Hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, substituted les, may les, cycloalkyl, substituted les, may les, aryls or heterocyclic groups) A group represented by:
Y1および Y2はそれぞれ独立して、 1)単結合、 2)— NR2、 -CO - ,— NR2C〇—、 CONR2 NR2CONR3 NR2S〇 一、 SO NR2 NR2S〇 NR3— Y 1 and Y 2 are each independently 1) a single bond, 2) — NR 2 , —CO −, — NR 2 C〇—, CONR 2 NR 2 CONR 3 NR 2 S〇 1, SO NR 2 NR 2 S〇 NR 3 —
2 2 2 2 2 2
、(R2および R3はそれぞれ独立して水素または低級アルキル)、 O—、— S―、— S O—、および SO—からなる群から選択されるへテロ原子含有基、または 3) 2)の , (R 2 and R 3 are each independently hydrogen or lower alkyl), a heteroatom-containing group selected from the group consisting of O—, —S—, —SO—, and SO—, or 3) 2) of
2 2
ヘテロ原子含有基が介在していてもよレ、、低級アルキレンまたは低級アルケニレン; Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; A hetero atom-containing group may be present, lower alkylene or lower alkenylene; Ar 1 is a single bond, an optionally substituted carbocyclic group or an optionally substituted heterocyclic group ;
R1は、 _CONHCN、 _C (〇H) =NCN、または _C〇OHもしくはその生物学的に 等価な酸性基; R 1 is _CONHCN, _C (〇H) = NCN, or _C〇OH or a biologically equivalent acidic group thereof;
波線は、シス、トランスまたはその混合を意味する; Wavy line means cis, trans or a mixture thereof;
但し、 Ar1が単結合であり、かつ R1は、 CONHCNまたは— C (OH) =NCNのい
ずれでもない場合、 "一 Y1— Ar1— Y2— R1"で示される基は、該 2環性の複素環式基 においてセフヱム 3位側鎖部分との結合手を有していない方の環上に存在するものと する) However, Ar 1 is a single bond, and R 1 is CONHCN or —C (OH) = NCN If not a shift, "A Y 1 - Ar 1 - Y 2 - R 1" groups represented by have no bond to Sefuwemu 3-position side chain moiety in said bicyclic heterocyclic group On the other ring)
で示される化合物、その製薬上許容される塩またはそれらの溶媒和物。 Or a pharmaceutically acceptable salt or solvate thereof.
[20] R1は、—CONHCNまたは _C (OH) =NCNである、請求項 19記載の化合物、そ の製薬上許容される塩またはそれらの溶媒和物。 [20] The compound according to claim 19, wherein R 1 is —CONHCN or —C (OH) ═NCN, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[21] Y1は単結合; Ar1は単結合; Y2は単結合; R1は、—CONHCNまたは _C (OH) =N[21] Y 1 is a single bond; Ar 1 is a single bond; Y 2 is a single bond; R 1 is —CONHCN or _C (OH) = N
CNである、請求項 19記載の化合物、その製薬上許容される塩またはそれらの溶媒 和物。 20. A compound according to claim 19, which is CN, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[22] Xは CH ;Rは、 =CHZ (Zは、置換されていてもよい低級アルキル)または = N〇R° ( R°は水素、置換されてレ、てもよレ、低級アルキルまたは置換されてレ、てもよレ、ァリール ); Y1は単結合; Ar1は単結合; Y2は単結合; R1は、—CONHCNまたは _C (OH) = NCNである、請求項 19記載の化合物、その製薬上許容される塩またはそれらの 溶媒和物。 [22] X is CH; R is = CHZ (Z is an optionally substituted lower alkyl) or = N ° R ° (R ° is hydrogen, substituted or less, lower alkyl or 21. Y 1 is a single bond; Ar 1 is a single bond; Y 2 is a single bond; R 1 is —CONHCN or —C (OH) = NCN Or a pharmaceutically acceptable salt or solvate thereof.
[23] 2環性の複素環式基が以下に示すいずれかである、請求項 19〜22のいずれかに記 載の化合物、その製薬上許容される塩またはそれらの溶媒和物。 [23] The compound according to any one of claims 19 to 22, the pharmaceutically acceptable salt or solvate thereof, wherein the bicyclic heterocyclic group is any of the following:
[化 9] [Chemical 9]
[24] 請求項 1〜23のいずれかに記載の化合物、その製薬上許容される塩またはそれら の溶媒和物を含有する医薬組成物。 [24] A pharmaceutical composition comprising the compound according to any one of claims 1 to 23, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[25] 請求項:!〜 23のいずれかに記載の化合物の 7位側鎖末端のァミノ及び/又はカル ボキシ部分が保護された化合物、その製薬上許容される塩またはそれらの溶媒和物 [25] Claim: A compound wherein the amino and / or carboxyl moiety at the 7-position side chain end of the compound according to any one of! To 23 is protected, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[26] 式: [26] Formula:
(式中、 (Where
Y1および Y2はそれぞれ独立して、 1)単結合、 2)— NR2、 -CO - ,— NR2C〇—、 一 CONR2—、一 NR2CONR3—、一 NR2S〇 一、一 SO NR2—、一 NR2S〇 NR3-Y 1 and Y 2 are each independently 1) a single bond, 2) — NR 2 , —CO −, — NR 2 C〇—, one CONR 2 —, one NR 2 CONR 3 —, one NR 2 S〇 One, one SO NR 2 —, one NR 2 S〇 NR 3-
2 2 22 2 2
、(R2および R3はそれぞれ独立して水素または低級アルキル)、 =N―、 _N =、 - 〇_、 _S―、 - SO- ,および一SO—からなる群から選択されるへテロ原子含有 , (R 2 and R 3 are each independently hydrogen or lower alkyl), = N-, _N =, -O_, _S-, -SO-, and a heteroatom selected from the group consisting of 1 SO- Contains
2 2
基、または 3) 2)のへテロ原子含有基が介在していてもよレ、、低級アルキレンまたは 低級アルケニレン; A group, or 3) a heteroatom-containing group of 2) may be interposed, lower alkylene or lower alkenylene;
Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; Ar 1 represents a single bond or an optionally substituted carbocyclic group or an optionally substituted heterocyclic group;
R1は、一CONHCNまたは一 C (OH) =NCN ; R 1 is one CONHCN or one C (OH) = NCN;
但し、 Y1および Y2が単結合でありかつ Ar1がピロリル、ピラゾリル、またはチェニルで ある場合を除く)で示される化合物、その製薬上許容される塩またはそれらの溶媒和 物。 Provided that Y 1 and Y 2 are a single bond and Ar 1 is pyrrolyl, pyrazolyl, or chenyl), a pharmaceutically acceptable salt thereof, or a solvate thereof.
[27] Y1および Y2が単結合; R1は、 CONHCNまたは一 C (〇H) =NCN ;Ar1が以下に 示すいずれかの複素環由来の基である、請求項 26記載の化合物、その製薬上許容 される塩またはそれらの溶媒和物。 [27] The compound according to claim 26, wherein Y 1 and Y 2 are a single bond; R 1 is CONHCN or one C (〇H) = NCN; Ar 1 is a group derived from any of the following heterocycles: , A pharmaceutically acceptable salt thereof, or a solvate thereof.
[28] 式: [28] Formula:
(式中、式: (Where formula:
[化 13] [Chemical 13]
で示される環は、 "一 Y1— Ar1— Y2— R1"以外の置換基で置換されていてもよい、 2 環性ピリジン環; The ring represented by is a bicyclic pyridine ring optionally substituted with a substituent other than “one Y 1 —Ar 1 —Y 2 —R 1 ”;
Y1および Y2はそれぞれ独立して、 1)単結合、 2)— NR2、 -CO - ,— NR2C〇—、 CONR2 NR2CONR3 NR2S〇 一、 SO NR2 NR2S〇 NR3— Y 1 and Y 2 are each independently 1) a single bond, 2) — NR 2 , —CO −, — NR 2 C〇—, CONR 2 NR 2 CONR 3 NR 2 S〇 1, SO NR 2 NR 2 S〇 NR 3 —
2 2 2 (R2および R3はそれぞれ独立して水素または低級アルキル)、 O— — S― — S 〇_、および— S〇—からなる群から選択されるへテロ原子含有基、または 3) 2)の 2 2 2 (R 2 and R 3 are each independently hydrogen or lower alkyl), a heteroatom-containing group selected from the group consisting of O——S——S 〇_, and —S〇—, or 3 2)
2 2
ヘテロ原子含有基が介在していてもよレ、、低級アルキレンまたは低級アルケニレン; Ar1は、単結合または、置換されていてもよい炭素環式基もしくは置換されていてもよ い複素環式基; A hetero atom-containing group may be present, lower alkylene or lower alkenylene; Ar 1 is a single bond, an optionally substituted carbocyclic group or an optionally substituted heterocyclic group ;
R1は、一CONHCNまたは _C (OH) =NCN) R 1 is one CONHCN or _C (OH) = NCN)
で示される化合物、その製薬上許容される塩またはそれらの溶媒和物。 Or a pharmaceutically acceptable salt or solvate thereof.
[29] Y1 Ar1および Y2は単結合; R1は、一CONHCNまたは一 C (〇H) =NCNである、 請求項 28記載の化合物、その製薬上許容される塩またはそれらの溶媒和物。 [29] Y 1 Ar 1 and Y 2 are a single bond; R 1 is one CONHCN or one C (〇H) ═NCN, The compound according to claim 28, a pharmaceutically acceptable salt thereof, or a solvent thereof Japanese products.
[30] Y1は単結合; Ar1は、置換されていてもよいァリールまたは置換されていてもよいへテ ロアリール; R1は、 COOHである、請求項 12記載の化合物、その製薬上許容され
る塩またはそれらの溶媒和物。 [30] Y 1 is a single bond; Ar 1 is an optionally substituted aryl or an optionally substituted heteroaryl; R 1 is COOH, The pharmaceutically acceptable compound thereof Is Salts or solvates thereof.
[31] Y1は単結合; Ar1は、置換されていてもよいへテロアリール; Y2は単結合; R1は、— C[31] Y 1 is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is — C
OOHの生物学的に等価な酸性基である、請求項 12記載の化合物、その製薬上許 容される塩またはそれらの溶媒和物。 13. The compound, its pharmaceutically acceptable salt or solvate thereof according to claim 12, which is a biologically equivalent acidic group of OOH.
[32] Y1は単結合; Ar1は、置換されていてもよいァリールまたは置換されていてもよいへテ ロアリール; R1は、 _CO〇Hの生物学的に等価な酸性基である、請求項 12記載の 化合物、その製薬上許容される塩またはそれらの溶媒和物。 [32] Y 1 is a single bond; Ar 1 is an optionally substituted aryl or an optionally substituted heteroaryl; R 1 is a biologically equivalent acidic group of _COOH. 13. The compound according to claim 12, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[33] Y1は単結合; Ar1は、置換されていてもよいへテロアリール; Y2は単結合; R1は、—C[33] Y 1 is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is —C
OOHの生物学的に等価な酸性基である、請求項 12記載の化合物、その製薬上許 容される塩またはそれらの溶媒和物。 13. The compound, its pharmaceutically acceptable salt or solvate thereof according to claim 12, which is a biologically equivalent acidic group of OOH.
[34] Y1は単結合; Ar1は、置換されていてもよいへテロアリール; Y2は単結合; R1は、置換 されていてもよぐ環構成原子として— NH_およびその他のヘテロ原子を有する 5[34] Y 1 is a single bond; Ar 1 is an optionally substituted heteroaryl; Y 2 is a single bond; R 1 is an optionally substituted ring atom — NH_ and other hetero Having an atom 5
〜6員の複素環式基である、請求項 12記載の化合物、その製薬上許容される塩また はそれらの溶媒和物。 13. The compound according to claim 12, which is a ˜6-membered heterocyclic group, a pharmaceutically acceptable salt thereof, or a solvate thereof.
[化 14]
で示される部分が以下のいずれかの構造である、請求項 12記載の化合物、その製 薬上許容される塩またはそれらの溶媒和物。 [Chemical 14] 13. The compound according to claim 12, a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein the moiety represented by is a structure of any of the following:
[化 15]
[Chemical 15]
[36] 以下のいずれかの化合物、その製薬上許容される塩またはそれらの溶媒和物。 [36] Any of the following compounds, pharmaceutically acceptable salts or solvates thereof:
[化 16]
[Chemical 16]
[化 19] [Chemical 19]
(式中、 BHはべンズヒドリル) で示される化合物の塩酸塩の結晶(Wherein BH is Benzhydryl) Hydrochloride crystals of the compound represented by
[40] 式: [40] Formula:
[化 20] [Chemical 20]
(式中、 BHはべンズヒドリル) で示される化合物の塩酸塩の結晶
(Wherein BH is Benzhydryl) Hydrochloride crystals of the compound represented by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006523884A JP3928086B2 (en) | 2005-03-29 | 2006-03-28 | 3-propenyl cephem derivative |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005093962 | 2005-03-29 | ||
JP2005-093962 | 2005-03-29 | ||
JP2005226577 | 2005-08-04 | ||
JP2005-226577 | 2005-08-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006104141A1 true WO2006104141A1 (en) | 2006-10-05 |
Family
ID=37053397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/306280 WO2006104141A1 (en) | 2005-03-29 | 2006-03-28 | 3-propenylcephem derivative |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP3928086B2 (en) |
TW (1) | TW200637559A (en) |
WO (1) | WO2006104141A1 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008011557A2 (en) * | 2006-07-20 | 2008-01-24 | Borchardt Allen J | Heteroaryl inhibitors of rho kinase |
WO2011031745A1 (en) | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Antibacterial fluoroquinolone analogs |
WO2012025460A1 (en) * | 2010-08-23 | 2012-03-01 | Bayer Cropscience Ag | Oxadiazolinone derivatives and use thereof in pest control |
WO2012052412A1 (en) | 2010-10-22 | 2012-04-26 | Bayer Cropscience Ag | Novel heterocyclic compounds as pesticides |
WO2012147773A1 (en) * | 2011-04-28 | 2012-11-01 | 塩野義製薬株式会社 | Novel cephem compound having catechol or pseudo-catechol structure |
WO2013002215A1 (en) * | 2011-06-27 | 2013-01-03 | 塩野義製薬株式会社 | Cephem compound having pyridinium group |
US8748442B2 (en) | 2010-06-30 | 2014-06-10 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
US8779144B2 (en) | 2006-03-16 | 2014-07-15 | Evotec (Us) Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
WO2014154723A1 (en) * | 2013-03-29 | 2014-10-02 | F. Hoffmann-La Roche Ag | Novel pyrrole derivatives for the treatment of cancer |
US8883773B2 (en) | 2010-04-05 | 2014-11-11 | Shionogi & Co., Ltd. | Cephem compound having pseudo-catechol group |
CN104478795A (en) * | 2014-11-24 | 2015-04-01 | 苏州乔纳森新材料科技有限公司 | Preparation method of 2-chloro nicotinaldehyde |
CN104513194A (en) * | 2014-11-29 | 2015-04-15 | 南京红太阳生物化学有限责任公司 | 2-chloro-3-aldehyde pyridine synthetic method |
US9061030B2 (en) | 2010-11-09 | 2015-06-23 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
US9139542B2 (en) | 2013-03-13 | 2015-09-22 | Theravance Biopharma Antibiotics Ip, Llc | Crystalline form of a substituted thiazolylacetic acid triethylamine salt |
US9139564B2 (en) | 2011-12-27 | 2015-09-22 | Ironwood Pharmaceuticals, Inc. | 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators |
US9145425B2 (en) | 2010-04-05 | 2015-09-29 | Shionogi & Co., Ltd. | Cephem compound having catechol group |
US9238657B2 (en) | 2008-10-31 | 2016-01-19 | Shionogi & Co., Ltd. | Cephalosporin having catechol group |
US9663529B2 (en) | 2013-07-02 | 2017-05-30 | Bristol-Myers Squibb Company | Tricyclic pyrido-carboxamide derivatives as rock inhibitors |
US9914740B2 (en) | 2013-07-02 | 2018-03-13 | Bristol-Myers Squibb Company | Tricyclic pyrido-carboxamide derivatives as rock inhibitors |
AU2016226036B2 (en) * | 2015-03-04 | 2020-06-04 | Dana-Farber Cancer Institute, Inc. | Salicylate inhibitors of MELK and methods of use |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107501171B (en) * | 2017-08-15 | 2020-09-18 | 南京红太阳生物化学有限责任公司 | Synthetic method of 2-chloro-3-pyridylaldehyde |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5857390A (en) * | 1981-09-08 | 1983-04-05 | イ−ライ・リリ−・アンド・カンパニ− | Thieno- and furo-pyridinium substituted cephalosporin derivative |
JPS5885886A (en) * | 1981-11-06 | 1983-05-23 | フア−ミタリア・カルロ・エルバ・ソシエタ・ペル・アツイオ−ニ | Ergoline derivative |
WO1986005184A1 (en) * | 1985-03-01 | 1986-09-12 | Takeda Chemical Industries, Ltd. | Antibacterial compound |
JPS62158291A (en) * | 1986-01-07 | 1987-07-14 | Sagami Chem Res Center | Cephalosporin derivative |
JPH04230289A (en) * | 1990-06-15 | 1992-08-19 | Roussel Uclaf | Novel cephalosporin having propenyl group substituted by quaternary ammonium at position-3, preparation thereof, use thereof as drug, composition containing same and novel intermediate |
JPH0741484A (en) * | 1993-07-29 | 1995-02-10 | Katayama Seiyakushiyo:Kk | Cephem compound and antimicrobial agent |
WO1997003875A1 (en) * | 1995-07-18 | 1997-02-06 | Rubio Ortega, Amadeo | Rear suspension for bicycle frame |
JPH09110877A (en) * | 1995-10-17 | 1997-04-28 | Katayama Seiyakushiyo:Kk | Cephem compound, its production and antibacterial agent containing the compound |
WO1997037996A1 (en) * | 1996-04-04 | 1997-10-16 | Shionogi & Co. Ltd. | Cephem compounds and drugs containing the compounds |
WO1999033839A1 (en) * | 1997-12-26 | 1999-07-08 | Cheil Jedang Corporation | Cephem derivatives and a method for producing the compounds and an antibacterial composition containing the compounds |
JP2002518505A (en) * | 1998-06-22 | 2002-06-25 | バジリア ファルマスーチカ アーゲー | Propenyl cephalosporin derivative |
-
2006
- 2006-03-28 JP JP2006523884A patent/JP3928086B2/en not_active Expired - Fee Related
- 2006-03-28 TW TW095110632A patent/TW200637559A/en unknown
- 2006-03-28 WO PCT/JP2006/306280 patent/WO2006104141A1/en active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5857390A (en) * | 1981-09-08 | 1983-04-05 | イ−ライ・リリ−・アンド・カンパニ− | Thieno- and furo-pyridinium substituted cephalosporin derivative |
JPS5885886A (en) * | 1981-11-06 | 1983-05-23 | フア−ミタリア・カルロ・エルバ・ソシエタ・ペル・アツイオ−ニ | Ergoline derivative |
WO1986005184A1 (en) * | 1985-03-01 | 1986-09-12 | Takeda Chemical Industries, Ltd. | Antibacterial compound |
JPS62158291A (en) * | 1986-01-07 | 1987-07-14 | Sagami Chem Res Center | Cephalosporin derivative |
JPH04230289A (en) * | 1990-06-15 | 1992-08-19 | Roussel Uclaf | Novel cephalosporin having propenyl group substituted by quaternary ammonium at position-3, preparation thereof, use thereof as drug, composition containing same and novel intermediate |
JPH0741484A (en) * | 1993-07-29 | 1995-02-10 | Katayama Seiyakushiyo:Kk | Cephem compound and antimicrobial agent |
WO1997003875A1 (en) * | 1995-07-18 | 1997-02-06 | Rubio Ortega, Amadeo | Rear suspension for bicycle frame |
JPH09110877A (en) * | 1995-10-17 | 1997-04-28 | Katayama Seiyakushiyo:Kk | Cephem compound, its production and antibacterial agent containing the compound |
WO1997037996A1 (en) * | 1996-04-04 | 1997-10-16 | Shionogi & Co. Ltd. | Cephem compounds and drugs containing the compounds |
WO1999033839A1 (en) * | 1997-12-26 | 1999-07-08 | Cheil Jedang Corporation | Cephem derivatives and a method for producing the compounds and an antibacterial composition containing the compounds |
JP2002518505A (en) * | 1998-06-22 | 2002-06-25 | バジリア ファルマスーチカ アーゲー | Propenyl cephalosporin derivative |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8779144B2 (en) | 2006-03-16 | 2014-07-15 | Evotec (Us) Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
WO2008011557A3 (en) * | 2006-07-20 | 2008-07-31 | Allen J Borchardt | Heteroaryl inhibitors of rho kinase |
WO2008011557A2 (en) * | 2006-07-20 | 2008-01-24 | Borchardt Allen J | Heteroaryl inhibitors of rho kinase |
US9238657B2 (en) | 2008-10-31 | 2016-01-19 | Shionogi & Co., Ltd. | Cephalosporin having catechol group |
WO2011031745A1 (en) | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Antibacterial fluoroquinolone analogs |
US8883773B2 (en) | 2010-04-05 | 2014-11-11 | Shionogi & Co., Ltd. | Cephem compound having pseudo-catechol group |
US9145425B2 (en) | 2010-04-05 | 2015-09-29 | Shionogi & Co., Ltd. | Cephem compound having catechol group |
US10189809B2 (en) | 2010-06-30 | 2019-01-29 | Ironwood Pharmaceuticals, Inc. | SGC stimulators |
US8748442B2 (en) | 2010-06-30 | 2014-06-10 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
WO2012025460A1 (en) * | 2010-08-23 | 2012-03-01 | Bayer Cropscience Ag | Oxadiazolinone derivatives and use thereof in pest control |
WO2012052412A1 (en) | 2010-10-22 | 2012-04-26 | Bayer Cropscience Ag | Novel heterocyclic compounds as pesticides |
US9173396B2 (en) | 2010-10-22 | 2015-11-03 | Bayer Intellectual Property Gmbh | Heterocyclic compounds as pesticides |
US9061030B2 (en) | 2010-11-09 | 2015-06-23 | Ironwood Pharmaceuticals, Inc. | sGC stimulators |
JP6006201B2 (en) * | 2011-04-28 | 2016-10-12 | 塩野義製薬株式会社 | Novel cephem compounds having catechol or pseudo-catechol structure |
US9334289B2 (en) | 2011-04-28 | 2016-05-10 | Shionogi & Co., Ltd. | Cephem compound having catechol or pseudo-catechol structure |
JPWO2012147773A1 (en) * | 2011-04-28 | 2014-07-28 | 塩野義製薬株式会社 | Novel cephem compounds having catechol or pseudo-catechol structure |
WO2012147773A1 (en) * | 2011-04-28 | 2012-11-01 | 塩野義製薬株式会社 | Novel cephem compound having catechol or pseudo-catechol structure |
US9242999B2 (en) | 2011-06-27 | 2016-01-26 | Shionogi & Co., Ltd. | Cephem compound having pyridinium group |
JPWO2013002215A1 (en) * | 2011-06-27 | 2015-02-23 | 塩野義製薬株式会社 | Cephem compound having pyridinium group |
WO2013002215A1 (en) * | 2011-06-27 | 2013-01-03 | 塩野義製薬株式会社 | Cephem compound having pyridinium group |
US9139564B2 (en) | 2011-12-27 | 2015-09-22 | Ironwood Pharmaceuticals, Inc. | 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators |
US9139542B2 (en) | 2013-03-13 | 2015-09-22 | Theravance Biopharma Antibiotics Ip, Llc | Crystalline form of a substituted thiazolylacetic acid triethylamine salt |
WO2014154723A1 (en) * | 2013-03-29 | 2014-10-02 | F. Hoffmann-La Roche Ag | Novel pyrrole derivatives for the treatment of cancer |
US9663529B2 (en) | 2013-07-02 | 2017-05-30 | Bristol-Myers Squibb Company | Tricyclic pyrido-carboxamide derivatives as rock inhibitors |
US9914740B2 (en) | 2013-07-02 | 2018-03-13 | Bristol-Myers Squibb Company | Tricyclic pyrido-carboxamide derivatives as rock inhibitors |
CN104478795A (en) * | 2014-11-24 | 2015-04-01 | 苏州乔纳森新材料科技有限公司 | Preparation method of 2-chloro nicotinaldehyde |
CN104513194A (en) * | 2014-11-29 | 2015-04-15 | 南京红太阳生物化学有限责任公司 | 2-chloro-3-aldehyde pyridine synthetic method |
AU2016226036B2 (en) * | 2015-03-04 | 2020-06-04 | Dana-Farber Cancer Institute, Inc. | Salicylate inhibitors of MELK and methods of use |
US10875844B2 (en) | 2015-03-04 | 2020-12-29 | Dana-Farber Cancer Institute, Inc. | Salicylate inhibitors of MELK and methods of use |
Also Published As
Publication number | Publication date |
---|---|
TW200637559A (en) | 2006-11-01 |
JP3928086B2 (en) | 2007-06-13 |
JPWO2006104141A1 (en) | 2008-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006104141A1 (en) | 3-propenylcephem derivative | |
KR930007418B1 (en) | Cephalosporin compound, preparation method thereof | |
CN106164072B (en) | For treating the monobactam organic compound of bacterium infection | |
CN114984003B (en) | Aromatic sulfonamide derivatives | |
TWI287449B (en) | Gyrase inhibitors and uses thereof | |
KR100189075B1 (en) | Cephalosporins and their homologues, and their preparation | |
JP2022105091A (en) | cGAS ANTAGONIST COMPOUNDS | |
KR20130018845A (en) | Cephem compound having catechol group | |
WO2018214980A1 (en) | Aromatic amide as kv2.1 inhibitor and preparation method, pharmaceutical composition, and use thereof | |
CN106817900A (en) | Novel naphthyridines and isoquinolin and its purposes as CDK8/19 inhibitor | |
CN104039787A (en) | Kinase inhibitors | |
CN102015699A (en) | Heterocyclic urea derivatives and methods of use thereof-211 | |
KR100203726B1 (en) | Thioalkylthio cephalosporins | |
WO1997037996A1 (en) | Cephem compounds and drugs containing the compounds | |
CN101247804B (en) | Chemical compounds | |
JPH06505979A (en) | benzofuran derivatives | |
CN109476658A (en) | Substituted 5,6,7,8-Tetrahydro[1,2,4]triazolo[4,3-A]pyridin-3(2H)-ones and 2,5,6,7-tetrahydro-3H -pyrrolo[2,1-c][1,2,4]triazol-3-one and uses thereof | |
CN102971291A (en) | Novel amide derivative and use thereof as medicine | |
WO2023284651A1 (en) | N-(2-aminophenyl)benzamide compound and application thereof | |
CN100516069C (en) | Process for preparing 6-alkylidene penem derivatives | |
US4477447A (en) | 7-Acylaminocephalosporanic acid derivatives | |
CN115867545A (en) | Antiviral toxin 1,3-dioxoindene compound | |
WO2018014823A1 (en) | Monocyclic β-lactam-iron carrier conjugate, and manufacturing method and application thereof | |
CN102056894A (en) | Homocysteine synthase inhibitor | |
JPH0741484A (en) | Cephem compound and antimicrobial agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2006523884 Country of ref document: JP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06730228 Country of ref document: EP Kind code of ref document: A1 |